Clustering O 0 6.798532292684456e-10
of O 0 6.525930403705749e-12
missense O 0 6.1164514590927865e-06
mutations O 0 5.3215768275549635e-05
in O 0 1.2224771195334938e-09
the O 0 1.87230725146037e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 0.030552096664905548
in O 0 2.053602565776913e-10
a O 0 1.7614232988849565e-11
sporadic B-Disease 0 2.3376869648927823e-05
T I-Disease 1 0.9997785687446594
- I-Disease 1 0.81439608335495
cell I-Disease 0 0.001094343839213252
leukaemia I-Disease 0 0.0066422829404473305
. O 0 2.1652171722230662e-10

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 0 0.0038933020550757647
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.280857256195922e-12
is O 0 2.915235666257378e-14
a O 0 1.4214451555909224e-13
recessive B-Disease 0 1.5380912543605518e-07
multi I-Disease 0 0.06438657641410828
- I-Disease 1 0.9999939203262329
system I-Disease 0 0.024302778765559196
disorder I-Disease 1 0.9990705847740173
caused O 0 1.6555518067562502e-09
by O 0 3.6197835093926267e-13
mutations O 0 6.079504455414053e-09
in O 0 1.7547416427884932e-13
the O 0 6.06026747475329e-15
ATM O 0 1.3555469247084062e-11
gene O 0 2.2618934503171317e-11
at O 0 7.656598445537899e-12
11q22 O 0 1.081764455790335e-09
- O 0 1.1609190408989889e-07
q23 O 0 1.7960016807094803e-09
( O 0 5.102619715646739e-13
ref O 0 1.2814219019219308e-08
. O 0 3.680468270103078e-14
3 O 0 7.928997492216358e-14
) O 0 2.7232649661246104e-14
. O 0 1.1767175775445615e-12

The O 0 2.0339170625494063e-10
risk O 0 6.785051596125413e-07
of O 0 5.8225559790292536e-12
cancer B-Disease 0 2.271546009069425e-06
, O 0 2.842811923364774e-12
especially O 0 4.844090129019207e-10
lymphoid B-Disease 0 1.4114223745309573e-07
neoplasias I-Disease 0 1.6350988516933285e-05
, O 0 5.616244773930246e-13
is O 0 1.3480536131815768e-12
substantially O 0 1.0830608632161898e-09
elevated O 0 7.648366562307274e-08
in O 0 1.5963012245379105e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.00022829760564491153
and O 0 7.2118973015733445e-09
has O 0 4.340930670476695e-10
long O 0 2.5018533252041397e-12
been O 0 3.817185716820104e-12
associated O 0 3.38024941370918e-10
with O 0 2.0659779442766535e-10
chromosomal O 1 1.0
instability O 1 0.9999998807907104
. O 0 3.710209028895406e-08

By O 0 9.736413064675986e-12
analysing O 0 1.8220877251451384e-08
tumour B-Disease 1 0.9999366998672485
DNA O 0 1.513770975236639e-08
from O 0 1.598638929567464e-11
patients O 0 5.601740859367821e-12
with O 0 3.9975444829365436e-13
sporadic B-Disease 0 7.7290584158618e-05
T I-Disease 1 0.999954104423523
- I-Disease 0 0.12185563892126083
cell I-Disease 0 6.881826266180724e-06
prolymphocytic I-Disease 0 0.006997540593147278
leukaemia I-Disease 0 0.0018700786167755723
( O 0 1.921614950495254e-11
T B-Disease 0 6.079750164644793e-05
- I-Disease 0 8.066920145211043e-07
PLL I-Disease 0 4.026777578047813e-09
) O 0 3.458674048117255e-14
, O 0 2.8311073057328085e-16
a O 0 8.691403377710481e-15
rare O 0 3.3610957766994076e-11
clonal B-Disease 0 6.258482621035455e-09
malignancy I-Disease 0 4.28424755227752e-06
with O 0 4.164046833580494e-14
similarities O 0 9.705375392243809e-12
to O 0 7.265493545335899e-13
a O 0 2.2469008598147155e-10
mature B-Disease 0 2.0475501514738426e-05
T I-Disease 0 0.004997933749109507
- I-Disease 0 0.0011416097404435277
cell I-Disease 0 6.303710620159109e-07
leukaemia I-Disease 0 3.984981231042184e-05
seen O 0 8.238828741014004e-06
in O 0 1.5774631378917547e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 2.8033448826181306e-11
we O 0 8.225258148197856e-12
demonstrate O 0 2.0398151212835253e-13
a O 0 5.187837938641464e-14
high O 0 2.5882616362660205e-12
frequency O 0 2.4641103393840957e-11
of O 0 3.35620915011426e-14
ATM O 0 1.0555999629957569e-08
mutations O 0 1.1904595709211208e-07
in O 0 1.1359130303034704e-09
T B-Disease 0 0.0002908693568315357
- I-Disease 0 2.3503749616793357e-05
PLL I-Disease 0 7.823127816664055e-07
. O 0 2.1486951107263508e-10

In O 0 1.3384823631390486e-11
marked O 0 4.0339051543547555e-12
contrast O 0 7.751656087851e-12
to O 0 2.021644536617708e-14
the O 0 1.997573384916046e-14
ATM O 0 6.956081932685265e-09
mutation O 0 3.722512742498907e-09
pattern O 0 6.337067759432102e-08
in O 0 1.957776607497408e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 2.604932112029723e-12
the O 0 3.9419723283924245e-15
most O 0 5.931565265340972e-16
frequent O 0 9.563467503808862e-14
nucleotide O 0 2.2670147009629105e-12
changes O 0 5.431068463880584e-13
in O 0 8.121798454044024e-14
this O 0 5.967592414148071e-13
leukaemia B-Disease 0 7.513463629038597e-08
were O 0 1.1003883568228012e-11
missense O 0 8.894115808288916e-07
mutations O 0 2.5494339297438273e-06
. O 0 1.6004793323975974e-10

These O 0 1.4367593486469543e-12
clustered O 0 5.6599641640175946e-11
in O 0 1.4268514755139128e-12
the O 0 1.8571771995701952e-13
region O 0 6.159862203647393e-11
corresponding O 0 4.5994742736699123e-11
to O 0 5.014529237809193e-14
the O 0 2.744078005594659e-15
kinase O 0 3.2125798549165197e-11
domain O 0 1.385754844207554e-10
, O 0 1.0385402526022838e-13
which O 0 3.2643687557752654e-13
is O 0 2.0621401992677174e-13
highly O 0 1.3340520094856645e-12
conserved O 0 1.603215281885395e-12
in O 0 1.6318505791437787e-13
ATM O 0 3.449845964453857e-10
- O 0 1.2917079628138595e-09
related O 0 6.024529486392538e-11
proteins O 0 1.25868781543359e-12
in O 0 3.5181373873177657e-13
mouse O 0 1.236644342483828e-09
, O 0 2.1843197552367383e-13
yeast O 0 1.6691595328133246e-10
and O 0 8.651952418392561e-12
Drosophila O 0 6.372888328165516e-11
. O 0 2.7786231648896376e-11

The O 0 3.692059245136159e-12
resulting O 0 1.4916080523508235e-11
amino O 0 2.2582378675362058e-11
- O 0 6.050350775943514e-10
acid O 0 2.601873360860707e-12
substitutions O 0 2.224727780469893e-12
are O 0 5.477335165288144e-15
predicted O 0 1.933097101445777e-13
to O 0 1.3712718027053539e-15
interfere O 0 8.159894634984788e-12
with O 0 1.903395925031623e-13
ATP O 0 9.736714906560806e-11
binding O 0 4.0130489209477815e-11
or O 0 3.1948330699721472e-12
substrate O 0 4.321057733847056e-09
recognition O 0 6.269773589195893e-09
. O 0 7.877579699666626e-10

Two O 0 9.944385592763894e-12
of O 0 6.913318658860468e-13
seventeen O 0 1.3284368050037187e-10
mutated O 0 1.6363770782845677e-08
T B-Disease 0 4.465153779165121e-06
- I-Disease 0 7.88796157280558e-08
PLL I-Disease 0 3.401446946327269e-08
samples O 0 1.5188728497150805e-08
had O 0 4.271949807788111e-11
a O 0 9.224119948761378e-13
previously O 0 2.1248313331057034e-08
reported O 0 2.4226983441621996e-05
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
allele O 0 3.2945595194178168e-06
. O 0 1.7948535713241398e-10

In O 0 1.036139785082213e-10
contrast O 0 9.46805522872296e-10
, O 0 3.8033898946965294e-13
no O 0 7.731961598755888e-11
mutations O 0 8.183973498887553e-09
were O 0 6.593848383973366e-11
detected O 0 8.798364433459938e-06
in O 0 9.095363351363517e-13
the O 0 9.013048045804304e-15
p53 O 0 5.158631226180599e-14
gene O 0 1.3858671155109192e-12
, O 0 7.898438766940909e-16
suggesting O 0 8.554188607456936e-12
that O 0 2.486775705062144e-13
this O 0 3.115258268363008e-12
tumour B-Disease 1 0.9999998807907104
suppressor O 0 6.855774472569465e-07
is O 0 3.512135582361964e-10
not O 0 9.623256184976281e-12
frequently O 0 1.2449838382444511e-10
altered O 0 4.054290680954864e-09
in O 0 7.552054467896419e-12
this O 0 3.9500788057145186e-11
leukaemia B-Disease 0 1.5691020962549374e-06
. O 0 2.696207493380065e-11

Occasional O 0 2.073441862648906e-07
missense O 0 1.4804768397880252e-05
mutations O 0 1.4088565194469993e-06
in O 0 7.557544867697885e-12
ATM O 0 3.243119772733394e-09
were O 0 1.2418059636143397e-10
also O 0 3.4806686612792737e-12
found O 0 7.867636403480205e-11
in O 0 4.9474643132318974e-11
tumour B-Disease 1 0.9999996423721313
DNA O 0 1.5427561450565008e-08
from O 0 3.944257247201488e-12
patients O 0 4.644696953437499e-12
with O 0 2.8962617894257026e-12
B B-Disease 0 0.07945700734853745
- I-Disease 0 0.3644181787967682
cell I-Disease 0 0.45704251527786255
non I-Disease 1 0.9989560842514038
- I-Disease 1 0.9999958276748657
Hodgkins I-Disease 1 0.998883068561554
lymphomas I-Disease 0 0.009523137472569942
( O 0 3.460183875536593e-11
B B-Disease 0 4.309990799811203e-06
- I-Disease 0 4.765684380458879e-08
NHL I-Disease 0 8.759393210766575e-10
) O 0 3.589823039252659e-15
and O 0 4.640901988335784e-14
a O 0 5.482444359605765e-12
B B-Disease 0 1.4777904198126635e-06
- I-Disease 0 7.041839467092359e-07
NHL I-Disease 0 1.3241327145863124e-08
cell O 0 6.427531840103029e-10
line O 0 9.412453039203683e-10
. O 0 5.129457188862707e-12

The O 0 6.297938516183765e-13
evidence O 0 8.191937796511728e-13
of O 0 1.5608884923985831e-15
a O 0 5.669882694857992e-15
significant O 0 3.156875802434733e-13
proportion O 0 3.851050145442514e-09
of O 0 6.657203542766166e-13
loss O 0 9.527987288038275e-09
- O 0 2.6099405303625645e-08
of O 0 1.7431214457963584e-11
- O 0 1.5560966858174652e-05
function O 0 1.2688569084318146e-09
mutations O 0 3.764109024473328e-09
and O 0 5.02695927690356e-14
a O 0 2.620867153131038e-14
complete O 0 5.959471197775068e-13
absence O 0 7.251628464377546e-11
of O 0 1.5514299507623022e-14
the O 0 5.078385086586257e-13
normal O 0 7.83032059331612e-13
copy O 0 1.6323339164722728e-12
of O 0 1.1136715075116656e-15
ATM O 0 2.8269003457537245e-11
in O 0 3.7016188183212895e-13
the O 0 3.170634056953031e-13
majority O 0 1.7166937316126507e-10
of O 0 2.5670743308836563e-10
mutated O 0 0.3665490448474884
tumours B-Disease 1 0.9999998807907104
establishes O 0 3.758405586751223e-09
somatic O 0 5.03118990913265e-10
inactivation O 0 1.1003858269020839e-08
of O 0 3.645533666742995e-15
this O 0 7.769550527917551e-16
gene O 0 9.116030413175435e-13
in O 0 3.151057092662911e-14
the O 0 1.4314623027504234e-14
pathogenesis O 0 1.2926976329652451e-11
of O 0 6.342126666501399e-14
sporadic B-Disease 0 4.1290577428299e-06
T I-Disease 1 0.9857237935066223
- I-Disease 0 0.00012575412984006107
PLL I-Disease 0 4.321340156820952e-07
and O 0 1.055471508804029e-11
suggests O 0 4.682501348468593e-12
that O 0 3.3315633289095333e-15
ATM O 0 8.561240258386782e-12
acts O 0 6.162646781771031e-11
as O 0 5.648688439739702e-13
a O 0 1.3182446800819037e-10
tumour B-Disease 1 0.9999996423721313
suppressor O 0 1.9472701751510613e-05
. O 0 6.693016141312569e-10

As O 0 6.154984074496772e-12
constitutional O 0 1.3341773866248907e-11
DNA O 0 3.1490146601420577e-10
was O 0 1.8951827607249783e-10
not O 0 3.247357962502147e-14
available O 0 1.461988523136521e-14
, O 0 6.708536941154317e-16
a O 0 8.83130916486119e-14
putative O 0 1.947371863764147e-08
hereditary O 0 0.0004396750300657004
predisposition O 0 0.00011686406651278958
to O 0 4.174061096762216e-09
T B-Disease 0 0.1999163031578064
- I-Disease 0 4.643547072191723e-06
PLL I-Disease 0 3.173134999201466e-08
will O 0 4.6078839528729265e-12
require O 0 7.768758509760221e-14
further O 0 7.444822448137486e-15
investigation O 0 8.36970163314854e-12
. O 0 1.3190129327309008e-12
. O 0 4.366319372034466e-12

Myotonic B-Disease 1 0.9999958276748657
dystrophy I-Disease 1 0.9999972581863403
protein O 0 1.0546765594199314e-07
kinase O 0 1.2015495087780437e-07
is O 0 3.867474483026934e-12
involved O 0 1.2620629367965375e-12
in O 0 9.652635000979501e-15
the O 0 4.544420700478783e-16
modulation O 0 3.980903876942693e-13
of O 0 2.0705171941798025e-15
the O 0 8.719003438076994e-14
Ca2 O 0 2.76957834444147e-09
+ O 0 5.488563381561562e-09
homeostasis O 0 2.2840038127469597e-06
in O 0 1.4396794867366225e-10
skeletal O 0 6.590140401385725e-05
muscle O 0 3.2253790323011344e-06
cells O 0 1.4295103767381079e-08
. O 0 1.1115457859700584e-10

Myotonic B-Disease 1 0.9999847412109375
dystrophy I-Disease 1 0.9999974966049194
( O 0 2.8486778091973974e-07
DM B-Disease 1 1.0
) O 0 8.263376094497232e-12
, O 0 5.67260887039873e-15
the O 0 9.206112265471977e-15
most O 0 9.974584092714567e-13
prevalent O 0 1.1608105410232383e-07
muscular B-Disease 0 6.095011849538423e-05
disorder I-Disease 0 0.17752060294151306
in O 0 8.837561793484383e-10
adults O 0 5.376046274818691e-08
, O 0 7.432287749652156e-13
is O 0 1.3339661840416905e-11
caused O 0 2.24057564168767e-10
by O 0 2.7677242008666836e-13
( O 0 1.804716586676497e-13
CTG O 0 1.24556809311116e-10
) O 0 1.1996275216144374e-14
n O 0 5.579630646401768e-10
- O 0 4.4459969927856946e-08
repeat O 0 2.5335426201422706e-08
expansion O 0 2.6070907585551417e-11
in O 0 2.763154966336015e-14
a O 0 5.615722031782012e-16
gene O 0 1.5229293249662684e-14
encoding O 0 1.426645904005746e-14
a O 0 2.5947390666202635e-14
protein O 0 1.0995780024350421e-12
kinase O 0 9.590580773988222e-09
( O 0 1.4488499289200263e-10
DM B-Disease 1 1.0
protein O 0 1.361056378712533e-09
kinase O 0 2.273874599723058e-08
; O 0 1.7494615782084888e-13
DMPK O 0 9.358303021400616e-10
) O 0 1.401425646232015e-15
and O 0 5.786474344827823e-16
involves O 0 2.6060923574320813e-14
changes O 0 1.8163137010043795e-12
in O 0 2.0118519209518654e-13
cytoarchitecture O 0 3.6128311453609285e-09
and O 0 5.76949208894173e-12
ion O 0 4.7363604949168803e-07
homeostasis O 0 8.89067814568989e-05
. O 0 1.6328657315156647e-09

To O 0 1.154072388868943e-12
obtain O 0 4.2604578719129815e-12
clues O 0 1.7500116633595297e-10
to O 0 6.148668813682479e-13
the O 0 7.747098860859392e-13
normal O 0 1.6684901724128842e-11
biological O 0 8.132610904154625e-12
role O 0 2.0690191910015948e-13
of O 0 6.74567255962784e-15
DMPK O 0 1.4685858751306569e-08
in O 0 1.2357513016342248e-12
cellular O 0 8.154157904449733e-11
ion O 0 7.612273833501604e-08
homeostasis O 0 5.396924734668573e-06
, O 0 7.15570831755219e-12
we O 0 2.2591006842986872e-10
have O 0 3.4911852055119486e-13
compared O 0 2.9795198426552094e-12
the O 0 2.0029222285713674e-14
resting O 0 2.174989632841573e-10
[ O 0 2.0932404030601925e-13
Ca2 O 0 7.706027114161296e-13
+ O 0 1.7519234760815516e-12
] O 0 1.907570108816703e-11
i O 0 1.317611159068477e-10
, O 0 1.3150054984405617e-17
the O 0 2.372924751424745e-17
amplitude O 0 6.160336455361681e-13
and O 0 3.733113536179278e-13
shape O 0 1.8507028132219716e-09
of O 0 3.028835320571799e-13
depolarization O 0 7.859709327817654e-09
- O 0 4.465980964596383e-05
induced O 0 9.177039714813873e-07
Ca2 O 0 2.0233856812268414e-09
+ O 0 1.0817721718403561e-10
transients O 0 3.4627554157395934e-09
, O 0 1.3438523297631955e-14
and O 0 8.820021730861021e-16
the O 0 3.46719569719849e-17
content O 0 7.115615469890577e-15
of O 0 3.26581493747776e-16
ATP O 0 4.3250091008584235e-12
- O 0 1.955651890428456e-10
driven O 0 2.614064298356311e-09
ion O 0 5.555837390147644e-08
pumps O 0 2.0962103164379187e-08
in O 0 2.1876658470865173e-11
cultured O 0 1.5647632523041466e-08
skeletal O 0 3.6206594700161077e-07
muscle O 0 2.0278365653325636e-09
cells O 0 1.1526693662056164e-11
of O 0 2.0704985171033155e-14
wild O 0 5.550006565435694e-10
- O 0 1.0467749689269112e-06
type O 0 1.9260048702562926e-06
and O 0 2.686300661081109e-11
DMPK O 0 4.482029680730193e-08
[ O 0 4.445040169276382e-11
- O 0 2.3889572986490748e-08
/ O 0 1.0667547201137495e-07
- O 0 5.235148705651227e-07
] O 0 1.4674371717759982e-09
knockout O 0 1.0059534361062106e-07
mice O 0 2.0921046939292864e-07
. O 0 1.0117806592546685e-10

In O 0 4.1619593882380457e-10
vitro O 0 2.0753725493705133e-07
- O 0 3.2756797736510634e-05
differentiated O 0 9.352296359566026e-08
DMPK O 0 2.479863042026409e-06
[ O 0 3.4036453655517107e-09
- O 0 1.7993616552303138e-07
/ O 0 3.568792408259469e-07
- O 0 3.445311946848051e-08
] O 0 1.6166656555127723e-11
myotubes O 0 1.1122138626751266e-10
exhibit O 0 1.9415313107229437e-11
a O 0 3.6143761594775725e-12
higher O 0 4.011528054181923e-10
resting O 0 2.334095416944848e-10
[ O 0 1.6259390752185188e-12
Ca2 O 0 8.10810880241819e-12
+ O 0 9.726687337507922e-12
] O 0 1.1599303462173083e-10
i O 0 8.656620309466234e-09
than O 0 1.792011499043497e-13
do O 0 1.98723893243824e-12
wild O 0 4.851843319469973e-12
- O 0 1.8757855269058155e-09
type O 0 5.953938675418158e-09
myotubes O 0 1.2074387711891177e-07
because O 0 6.153955123266996e-11
of O 0 5.416969456477935e-16
an O 0 1.1656938359123014e-15
altered O 0 2.13390936865121e-11
open O 0 9.963831842929594e-11
probability O 0 1.1492228176035457e-11
of O 0 6.255236129418251e-13
voltage O 0 6.873142410768196e-07
- O 0 1.62782034749398e-05
dependent O 0 1.3755523298186745e-07
l O 0 5.858046279172413e-07
- O 0 3.489416755542152e-08
type O 0 2.4184641844726684e-08
Ca2 O 0 2.2670430810389774e-10
+ O 0 6.324066270657625e-11
and O 0 2.7993148164068282e-12
Na O 0 1.2073064770135034e-09
+ O 0 6.109512201701861e-11
channels O 0 5.482460041505988e-10
. O 0 3.215744892592909e-10

The O 0 1.8943360768908235e-11
mutant O 0 2.8309485311517335e-10
myotubes O 0 3.4575153851079676e-09
exhibit O 0 1.1232763330593087e-10
smaller O 0 1.8969176923677722e-11
and O 0 1.2346344649763474e-12
slower O 0 4.6577762480293217e-11
Ca2 O 0 3.583982555177556e-10
+ O 0 1.2771164681346647e-10
responses O 0 9.809451168019123e-11
upon O 0 8.872475237148292e-13
triggering O 0 1.3249289686212418e-11
by O 0 1.9101595847594022e-14
acetylcholine O 0 2.899818996038306e-10
or O 0 1.3033304213649899e-08
high O 0 8.45241299174404e-09
external O 0 2.1041405489086173e-05
K O 0 5.939462425885722e-06
+ O 0 5.451771811770811e-10
. O 0 3.049591135173557e-11

In O 0 2.0402490460980083e-11
addition O 0 3.1692211788919566e-12
, O 0 7.980035631859755e-14
we O 0 4.109966761454281e-13
observed O 0 1.415096203194119e-13
that O 0 6.741887804661271e-16
these O 0 1.001332174695288e-15
Ca2 O 0 1.4083956223487348e-11
+ O 0 4.777645293274624e-11
transients O 0 1.872855115436778e-08
partially O 0 5.998404883911235e-09
result O 0 2.106322928574489e-11
from O 0 2.3475105204591147e-15
an O 0 9.263242308423674e-17
influx O 0 7.098176755572505e-13
of O 0 3.8848441065615635e-14
extracellular O 0 1.2893774589683993e-12
Ca2 O 0 8.616676816508573e-12
+ O 0 2.4307604540307892e-12
through O 0 3.7564969310090873e-14
the O 0 4.867301223523968e-13
l O 0 7.557483527875775e-09
- O 0 1.2705158036752096e-09
type O 0 3.890229915981536e-09
Ca2 O 0 4.075096649014398e-10
+ O 0 2.687429445646927e-10
channel O 0 9.602295847344067e-09
. O 0 2.4230570883077007e-09

Neither O 0 1.4361540401353068e-08
the O 0 1.725074076641686e-13
content O 0 3.917349084003874e-12
nor O 0 3.738042930745422e-10
the O 0 2.0432057602900663e-14
activity O 0 1.6445286105115642e-11
of O 0 5.956079034109222e-15
Na O 0 6.617765224703476e-10
+ O 0 4.029478140044063e-11
/ O 0 1.0355002411088776e-09
K O 0 1.944290506372681e-09
+ O 0 2.4941076981477295e-11
ATPase O 0 1.0030288821738509e-09
and O 0 4.307243364060076e-12
sarcoplasmic O 0 3.303757267758556e-08
reticulum O 0 1.27409105488141e-08
Ca2 O 0 1.404695648687948e-08
+ O 0 1.8479031638207744e-08
- O 0 1.2485352272051387e-06
ATPase O 0 1.810254985912252e-07
are O 0 2.2925840045817658e-11
affected O 0 1.154517627333096e-11
by O 0 1.656710792857785e-13
DMPK O 0 4.353536041890038e-06
absence O 0 2.3351387490322395e-09
. O 0 7.0724628410678836e-12

In O 0 1.8677484558971003e-10
conclusion O 0 3.467127279721538e-11
, O 0 7.577715988331055e-14
our O 0 7.9916582791488e-14
data O 0 5.945889397160342e-14
suggest O 0 1.1616583346293896e-12
that O 0 5.8178178461289025e-15
DMPK O 0 1.202737243133356e-09
is O 0 2.5396795533564817e-14
involved O 0 2.4461492944063967e-13
in O 0 9.379203448243393e-15
modulating O 0 4.235842145788871e-12
the O 0 5.076733897499538e-15
initial O 0 2.9196317672536276e-14
events O 0 3.5356124224086155e-14
of O 0 2.1961744895533306e-14
excitation O 0 2.8986531219743483e-07
- O 0 0.02004389278590679
contraction O 0 1.04894559171953e-06
coupling O 0 1.1946353239977725e-08
in O 0 5.409370867903718e-12
skeletal O 0 6.220806625378827e-08
muscle O 0 9.65992175139263e-09
. O 0 7.448185297687093e-12
. O 0 1.8226899156648102e-11

Constitutional O 0 1.1452101489339839e-06
RB1 O 0 0.001262173056602478
- O 0 2.080631020362489e-05
gene O 0 1.0021576457575065e-07
mutations O 0 6.870193374197697e-06
in O 0 4.056320210277242e-11
patients O 0 1.2942221946921073e-11
with O 0 6.693516184028137e-13
isolated O 0 1.1361285601196869e-07
unilateral B-Disease 0 0.0002042876585619524
retinoblastoma I-Disease 0 0.001272766967304051
. O 0 7.014946401540101e-09

In O 0 9.826772728871447e-11
most O 0 1.6009692486648741e-12
patients O 0 4.728506648732367e-12
with O 0 6.14408480689721e-13
isolated O 0 4.790299357182448e-08
unilateral B-Disease 0 4.6856352128088474e-05
retinoblastoma I-Disease 0 3.267602005507797e-05
, O 0 2.0079504465392306e-12
tumor B-Disease 0 5.589195772870426e-10
development O 0 6.012238504358308e-14
is O 0 2.4376061539817077e-14
initiated O 0 1.0584682273457463e-13
by O 0 2.3862618542795254e-15
somatic O 0 6.224746846444917e-12
inactivation O 0 4.470859682470518e-09
of O 0 6.257174682902655e-15
both O 0 5.009662864120627e-14
alleles O 0 3.2023125470792557e-12
of O 0 9.674943138304748e-14
the O 0 5.1309247649233836e-12
RB1 O 0 2.602653026428925e-08
gene O 0 2.8437923127455633e-09
. O 0 1.0608244144227896e-10

However O 0 2.712084445910534e-10
, O 0 2.2434318129333636e-14
some O 0 7.480374009120525e-16
of O 0 1.2273031373198455e-14
these O 0 1.0496535064741241e-11
patients O 0 3.220788913349537e-11
can O 0 9.261574146490759e-11
transmit O 0 1.975984105229145e-07
retinoblastoma B-Disease 0 5.528069024762772e-08
predisposition O 0 2.446693088131724e-06
to O 0 1.491847756440734e-10
their O 0 4.6556822286270005e-10
offspring O 0 5.953825876758856e-09
. O 0 2.3026811360460364e-11

To O 0 1.4520521287100796e-12
determine O 0 3.140615545405012e-11
the O 0 5.3904865055139084e-14
frequency O 0 9.653395860453884e-10
and O 0 4.383088672826191e-13
nature O 0 2.2601684412926204e-11
of O 0 7.208124342631544e-14
constitutional O 0 3.6037053341431147e-09
RB1 O 0 2.231588723589084e-06
- O 0 1.0773708147837624e-08
gene O 0 9.002298351212801e-10
mutations O 0 2.943044563608055e-08
in O 0 1.7458558470434538e-12
patients O 0 1.2358926815975169e-12
with O 0 2.6393380617986337e-14
isolated O 0 7.69346752971245e-10
unilateral B-Disease 0 1.3598585724139411e-07
retinoblastoma I-Disease 0 2.723927927661407e-08
, O 0 1.047694171544579e-13
we O 0 4.824909731731414e-14
analyzed O 0 4.867298648543808e-14
DNA O 0 5.89031102539439e-13
from O 0 2.0779322476550087e-14
peripheral O 0 1.6410357794871544e-10
blood O 0 2.430144263598777e-08
and O 0 2.4792314867738696e-09
from O 0 4.3291148443813654e-10
tumor B-Disease 0 2.2532118236995302e-05
tissue O 0 0.00025968928821384907
. O 0 3.770252110513184e-09

The O 0 4.827802654178148e-13
analysis O 0 2.050126214625525e-11
of O 0 2.4110175661506972e-11
tumors B-Disease 1 1.0
from O 0 1.8920250782761272e-11
54 O 0 3.1447982239141137e-12
( O 0 3.709568256412589e-14
71 O 0 1.848272836862952e-12
% O 0 7.240657184069688e-14
) O 0 6.792125117004687e-15
of O 0 1.235013203900251e-13
76 O 0 1.1067197505654214e-11
informative O 0 5.1715303150956515e-09
patients O 0 3.571802853485906e-09
showed O 0 3.3362346130161313e-06
loss O 0 1.83835489053763e-08
of O 0 5.888187615439577e-13
constitutional O 0 3.052577540074708e-06
heterozygosity O 1 0.9929934144020081
( O 0 3.2300587093914146e-08
LOH O 1 0.999996542930603
) O 0 4.566327524435643e-11
at O 0 3.4961998574001285e-11
intragenic O 0 2.555381861668593e-08
loci O 0 2.0232158171040737e-09
. O 0 5.493165644576692e-11

Three O 0 4.2020307372547805e-11
of O 0 6.163569004138947e-13
13 O 0 1.0332381651656508e-11
uninformative O 0 9.571224836690817e-06
patients O 0 2.083319827761443e-08
had O 0 1.776373909079254e-10
constitutional O 0 3.8167963234414515e-10
deletions O 0 1.4774071814827039e-06
. O 0 1.0383462978325042e-09

For O 0 7.171735427746739e-12
39 O 0 5.774779612832681e-11
randomly O 0 7.827405945626253e-10
selected O 0 4.341608018876286e-06
tumors B-Disease 1 1.0
, O 0 1.183610674748703e-11
SSCP O 0 6.50258079986088e-05
, O 0 9.935910601222009e-12
hetero O 0 9.76154069576296e-07
- O 0 5.857694329591823e-10
duplex O 0 2.1792044557766843e-10
analysis O 0 3.399831631500927e-12
, O 0 7.589681228683528e-17
sequencing O 0 2.1622072401706596e-15
, O 0 1.988790373231024e-15
and O 0 5.839277087034411e-14
Southern O 0 1.77026606264577e-13
blot O 0 5.983079032212402e-10
analysis O 0 7.999031992333983e-12
were O 0 4.588762095997234e-13
used O 0 7.882708700189534e-13
to O 0 1.1152546984874445e-12
identify O 0 1.1274872235844668e-07
mutations O 0 2.3321836124523543e-06
. O 0 2.8824542752659e-10

Mutations O 0 1.600024370418396e-05
were O 0 2.1494248048092857e-10
detected O 0 6.732751245408508e-08
in O 0 2.0280539400618913e-12
21 O 0 1.073021012321096e-12
( O 0 1.4772560590767194e-15
91 O 0 3.509597330093005e-14
% O 0 1.8336709849630338e-14
) O 0 1.1315318663605509e-13
of O 0 3.4361866130261376e-10
23 O 0 0.004543541930615902
tumors B-Disease 1 1.0
with O 0 0.00016125601541716605
LOH O 1 0.9999998807907104
. O 0 7.567742272840405e-07

In O 0 7.113676314673967e-11
6 O 0 5.854371241259537e-12
( O 0 1.323613409224796e-14
38 O 0 3.117004267541579e-13
% O 0 5.016480462906488e-14
) O 0 1.0162913398207088e-13
of O 0 4.3116701875511865e-10
16 O 0 0.03718740493059158
tumors B-Disease 1 1.0
without O 0 0.2893058657646179
LOH O 1 0.9999998807907104
, O 0 2.9203712365033496e-11
one O 0 1.567705600752367e-12
mutation O 0 5.398790858812674e-10
was O 0 2.3212017377649552e-11
detected O 0 5.5324889558505674e-08
, O 0 2.0791296134292474e-14
and O 0 1.5962309599104607e-12
in O 0 8.422704265813319e-13
9 O 0 8.751664215371491e-13
( O 0 7.264456840535931e-16
56 O 0 1.0775936214310264e-14
% O 0 2.4299130619415653e-15
) O 0 1.3801677662338922e-14
of O 0 1.0296557009792373e-11
the O 0 0.03795942664146423
tumors B-Disease 1 1.0
without O 1 0.9434236288070679
LOH O 1 0.9999997615814209
, O 0 3.470448234343948e-11
both O 0 6.5352849000499535e-12
mutations O 0 1.0094006741567796e-09
were O 0 5.782293480832701e-12
found O 0 3.0206000894983376e-11
. O 0 3.959779726336876e-11

Thus O 0 3.4020536388013056e-10
, O 0 1.0434638687774247e-14
a O 0 1.1495981135079252e-14
total O 0 4.5402145042693076e-14
of O 0 2.0631149309020998e-14
45 O 0 9.524807158267645e-13
mutations O 0 3.4727694053771074e-09
were O 0 7.149958403118717e-10
identified O 0 0.000351886497810483
in O 0 1.073872795132047e-06
tumors B-Disease 1 1.0
of O 0 1.7350354486467268e-10
36 O 0 2.094870277247196e-09
patients O 0 1.2871034793526803e-10
. O 0 1.067380073216384e-10

Thirty O 0 5.68313085480554e-09
- O 0 3.4598262033114224e-08
nine O 0 2.2449709192323697e-12
of O 0 2.877766486209226e-15
the O 0 3.472005330267501e-14
mutations O 0 1.275923394716827e-10
- O 0 1.4588688590499999e-10
including O 0 1.5321720129614358e-13
34 O 0 2.636315644954923e-13
small O 0 7.874293665027787e-13
mutations O 0 6.391692863871867e-08
, O 0 1.1168590873097614e-13
2 O 0 4.299269206159244e-14
large O 0 2.0359874810388368e-12
structural O 0 3.351889972691424e-05
alterations O 0 8.762590368860401e-07
, O 0 1.2855620214191621e-11
and O 0 4.179833215656181e-11
hypermethylation O 0 0.00010792064131237566
in O 0 1.4118236322246958e-06
3 O 0 0.0006892922101542354
tumors O 1 1.0
- O 1 0.9228290915489197
were O 0 1.1808500630650087e-06
not O 0 5.11514208767494e-09
detected O 0 1.6575596362145006e-07
in O 0 1.0152005646725526e-13
the O 0 5.710519947535464e-14
corresponding O 0 2.901953156941861e-11
peripheral O 0 2.452268110797462e-10
blood O 0 1.1161713775464932e-09
DNA O 0 1.4663745773191295e-08
. O 0 2.0940421618931282e-10

In O 0 2.642678020858824e-10
6 O 0 2.530834222747025e-11
( O 0 4.338935081452805e-14
17 O 0 5.257249171587708e-13
% O 0 5.031503185149106e-15
) O 0 4.565932690361082e-16
of O 0 4.32681751281268e-15
the O 0 3.289690785404642e-12
36 O 0 4.682003396094814e-11
patients O 0 1.097719246230533e-12
, O 0 1.2277566811114528e-15
a O 0 3.4785298556536115e-13
mutation O 0 1.1254885023959105e-08
was O 0 1.2832744589186262e-10
detected O 0 1.4384376356701978e-08
in O 0 3.0810233921443886e-14
constitutional O 0 5.425436033594522e-13
DNA O 0 4.143075466034318e-11
, O 0 1.2993079682099232e-14
and O 0 2.1714092112920524e-13
1 O 0 9.644970369246386e-13
of O 0 1.296676931409821e-13
these O 0 1.920480025008331e-10
mutations O 0 3.6799723268643447e-09
is O 0 1.742408436500656e-13
known O 0 1.0470235789483695e-12
to O 0 5.043502074308925e-12
be O 0 1.4123595626358565e-09
associated O 0 2.1004046502071105e-08
with O 0 6.198959678904714e-10
reduced O 0 2.0676850454037776e-06
expressivity O 0 0.0004008963005617261
. O 0 2.3690540640330937e-09

The O 0 1.0329539957762424e-12
presence O 0 6.960106102571473e-12
of O 0 2.900735266881684e-15
a O 0 2.2249132332514965e-13
constitutional O 0 7.591923201211159e-10
mutation O 0 6.119503836998774e-08
was O 0 2.46346304466627e-10
not O 0 3.945030337560579e-13
associated O 0 1.2845883211320963e-12
with O 0 4.061010950667755e-15
an O 0 4.763549817999365e-15
early O 0 1.944791216956787e-09
age O 0 1.3435847101561649e-08
at O 0 2.9387416979054226e-12
treatment O 0 2.963950959666839e-11
. O 0 1.251358652115675e-11

In O 0 1.3970637979809908e-09
1 O 0 6.784476869192702e-10
patient O 0 1.2907285018570747e-08
, O 0 6.548917224485917e-14
somatic O 0 1.2075961064450524e-10
mosaicism O 0 3.8333180896188424e-07
was O 0 5.12210052150408e-10
demonstrated O 0 7.682970470761219e-13
by O 0 3.159087727332534e-16
molecular O 0 1.1208177804920491e-13
analysis O 0 1.3879289597229939e-14
of O 0 1.0888400749184158e-16
DNA O 0 8.442797676255775e-12
and O 0 2.8976747759069943e-13
RNA O 0 3.56650104414713e-12
from O 0 3.821707490400672e-13
peripheral O 0 4.920066132285683e-09
blood O 0 2.324599677194783e-07
. O 0 7.273712743227634e-10

In O 0 3.476830490178884e-10
2 O 0 1.892044160234363e-10
patients O 0 8.253802502578012e-11
without O 0 8.316634186877891e-11
a O 0 1.1104502734005095e-10
detectable O 0 0.09211904555559158
mutation O 0 2.537373802624643e-06
in O 0 9.157266958603749e-12
peripheral O 0 1.2469481447396902e-08
blood O 0 8.540869345097235e-08
, O 0 1.6354213989988597e-13
mosaicism O 0 3.940345383313115e-09
was O 0 3.373839055353933e-11
suggested O 0 9.52577877688654e-11
because O 0 7.60564094343108e-12
1 O 0 2.7414219643819536e-14
of O 0 1.16345036327238e-15
the O 0 2.2782949138377973e-11
patients O 0 4.361365046889887e-09
showed O 0 0.00019552939920686185
multifocal O 1 0.9999959468841553
tumors B-Disease 1 1.0
and O 0 8.742359369762198e-08
the O 0 3.769324262437035e-13
other O 0 1.0163184448750209e-13
later O 0 1.9391988015371453e-12
developed O 0 4.406864630157603e-12
bilateral B-Disease 0 8.185175204289408e-09
retinoblastoma I-Disease 0 5.7914331108577244e-08
. O 0 6.510073036203323e-10

In O 0 6.012487729911697e-11
conclusion O 0 6.804894755324531e-12
, O 0 3.276081188556719e-14
our O 0 9.296502369998683e-13
results O 0 4.269662355334096e-14
emphasize O 0 2.337433361015301e-13
that O 0 9.130707698441504e-15
the O 0 3.441963062155817e-15
manifestation O 0 5.601516212677682e-12
and O 0 1.0332530051828867e-13
transmissibility O 0 6.352221526562118e-11
of O 0 1.5963565147571993e-15
retinoblastoma B-Disease 0 5.188160231289762e-12
depend O 0 4.387423584162331e-12
on O 0 2.0683730336118478e-12
the O 0 1.4829932461625332e-14
nature O 0 2.464157176917947e-11
of O 0 2.598982532279418e-15
the O 0 1.4064016471597787e-14
first O 0 3.6835885361928555e-13
mutation O 0 7.555267175773928e-12
, O 0 3.1957041675489495e-16
its O 0 3.635837839414453e-16
time O 0 3.358644200431027e-13
in O 0 1.513795260476257e-14
development O 0 2.6845944815990152e-15
, O 0 5.284105350679283e-15
and O 0 4.856080815240915e-13
the O 0 1.002376621376394e-13
number O 0 6.115224993052948e-11
and O 0 1.0043851167429452e-11
types O 0 7.298676329980935e-09
of O 0 9.360020354273746e-13
cells O 0 1.9316470298291755e-11
that O 0 1.6064751525574072e-12
are O 0 1.941345304998232e-12
affected O 0 8.499575175624496e-12
. O 0 1.2905929580239728e-12
. O 0 2.5624355068365468e-11

Hereditary B-Disease 1 0.9998401403427124
deficiency I-Disease 1 0.9999804496765137
of I-Disease 0 4.485991092484376e-11
the I-Disease 0 4.223836991973373e-12
fifth I-Disease 0 8.141756019375279e-11
component I-Disease 0 1.257234334001156e-11
of I-Disease 0 3.8274759202967454e-14
complement I-Disease 0 4.4584565206395865e-11
in O 0 2.367588243512575e-11
man O 0 3.3918638564500725e-06
. O 0 1.4777247481223554e-10

I O 0 0.0006383606814779341
. O 0 1.6746004583012564e-09

Clinical O 0 8.508626336833913e-08
, O 0 2.4311639940793883e-12
immunochemical O 0 2.698537855394534e-07
, O 0 2.3677091103707637e-12
and O 0 4.3275504707507295e-12
family O 0 2.6155691501550393e-10
studies O 0 1.0044378662144027e-09
. O 0 5.018153254043867e-11

The O 0 9.298633911469789e-12
first O 0 3.735715296132591e-12
recognized O 0 1.0215946838476597e-10
human O 0 7.612901281595086e-11
kindred O 0 2.7855318762703973e-07
with O 0 2.8841479204899656e-10
hereditary B-Disease 1 0.9999353885650635
deficiency I-Disease 1 0.9998639822006226
of I-Disease 0 1.5625441478900326e-12
the I-Disease 0 2.785530920507151e-12
fifth I-Disease 0 3.864098971351204e-11
component I-Disease 0 1.5080511492349125e-11
of I-Disease 0 1.3790712820836715e-13
complement I-Disease 0 9.804330680651674e-10
( O 0 7.063160820108827e-12
C5 O 0 4.421655930286761e-09
) O 0 2.4568430514841644e-13
is O 0 1.9632479236059153e-12
described O 0 1.7242453020926973e-09
. O 0 1.0119156901300386e-10

The O 0 8.082862504310562e-12
proband O 0 3.862319797320879e-09
, O 0 1.489064439515273e-14
a O 0 7.342683319006005e-14
20 O 0 2.517985277748769e-13
- O 0 1.9566490649935986e-09
year O 0 1.783486275330759e-10
- O 0 5.568265351030277e-07
old O 0 6.85773073882956e-08
black O 0 4.538704345691258e-08
female O 0 1.6544468053325545e-06
with O 0 3.531186898442229e-09
systemic B-Disease 1 0.9999998807907104
lupus I-Disease 0 0.14907777309417725
erythematosus I-Disease 1 0.9999973773956299
since O 0 0.0011599306017160416
age O 0 4.907659558739397e-07
11 O 0 5.676989694308743e-12
, O 0 2.9190523967177057e-14
lacked O 0 3.061910902601994e-08
serum O 0 6.20985289856435e-08
hemolytic O 0 2.3320639641610796e-08
complement O 0 6.636137386134555e-12
activity O 0 2.29540408902551e-09
, O 0 1.1894885372358034e-14
even O 0 5.1753610078031365e-12
during O 0 1.1889331186232255e-10
remission O 0 3.5757634631039537e-09
. O 0 2.8612529012761456e-12

C5 O 0 9.94983347482048e-05
was O 0 1.9906572390482324e-08
undetectable O 0 1.6000132063709316e-06
in O 0 4.060273818551341e-12
her O 0 2.263827146575803e-11
serum O 0 1.3782607000134561e-10
by O 0 1.9043899351358848e-14
both O 0 1.6180439149984793e-12
immunodiffusion O 0 1.5391549368359847e-06
and O 0 6.535724739187287e-11
hemolytic O 0 3.536796810976739e-08
assays O 0 6.046087008826362e-08
. O 0 1.493051932088818e-10

Other O 0 1.8642763114501415e-12
complement O 0 7.321782936886567e-12
components O 0 9.54897272364974e-11
were O 0 7.210799232021392e-12
normal O 0 6.15859585550993e-10
during O 0 1.6351026088656795e-10
remission O 0 1.2711872665605028e-09
of O 0 8.847895255814555e-15
lupus O 0 3.4646630009405044e-10
, O 0 2.332663413557451e-13
but O 0 9.157044567054129e-11
C1 O 0 3.774909984599617e-08
, O 0 3.432077340628412e-15
C4 O 0 4.097041456097017e-11
, O 0 6.475759598695285e-13
C2 O 0 3.224418732017398e-09
, O 0 3.57625204677834e-14
and O 0 4.526913913172059e-11
C3 O 0 7.148134955059504e-06
levels O 0 1.7668032796791522e-06
fell O 0 1.7650252459588955e-07
during O 0 1.8009412849906425e-09
exacerbations O 0 0.0001222941791638732
. O 0 8.003969154124491e-10

A O 0 4.189814717392437e-09
younger O 0 7.998433027012197e-09
half O 0 6.855419010243224e-11
- O 0 5.5696627754286965e-08
sister O 0 2.902129203619097e-08
, O 0 1.6644081946015632e-12
who O 0 1.5774871187090866e-08
had O 0 8.846238586102118e-08
no O 0 2.215067297584028e-06
underlying O 0 0.02994002029299736
disease O 0 1.7488277080701664e-05
, O 0 1.704566663599666e-13
was O 0 1.1254965848195297e-09
also O 0 1.476647623621652e-11
found O 0 1.0427133982637837e-11
to O 0 5.756963655789704e-11
lack O 0 3.6662223124039883e-07
immunochemically O 0 0.43560561537742615
detectable O 1 0.860668420791626
C5 O 0 5.795101287731086e-07
. O 0 1.1221500118008265e-10

By O 0 5.0775286752902105e-11
hemolytic O 0 5.372303917283716e-07
assay O 0 9.864472794163248e-09
, O 0 9.527828179201059e-12
she O 0 2.8820199005075153e-10
exhibited O 0 3.5615693727564235e-10
1 O 0 4.360874183463592e-13
- O 0 7.923824096867094e-11
2 O 0 1.6947826876698852e-13
% O 0 6.519749390837331e-15
of O 0 1.4204898167758675e-15
the O 0 1.6832440389441539e-12
normal O 0 1.5784132889606894e-09
serum O 0 2.1741063116476056e-10
C5 O 0 1.278081390720942e-10
level O 0 4.813466292219459e-10
and O 0 1.2064851071316718e-12
normal O 0 1.5355204954770052e-11
concentrations O 0 2.9490540565113577e-10
of O 0 7.795888805654187e-15
other O 0 5.807765428517478e-14
complement O 0 1.3373283600306984e-12
components O 0 3.214162824782818e-10
. O 0 3.466360185000461e-11

C5 O 0 0.00013835311983712018
levels O 0 2.555529135861434e-06
of O 0 6.399188226839311e-14
other O 0 1.476535636379256e-14
family O 0 7.973406548726636e-13
members O 0 8.33763464627886e-14
were O 0 5.9131428052638935e-12
either O 0 1.2196142706866198e-10
normal O 0 2.4584687063899935e-10
or O 0 1.516861289352356e-11
approximately O 0 3.2079840086435274e-13
half O 0 6.445037836755318e-10
- O 0 0.03867275267839432
normal O 0 4.959924737590882e-08
, O 0 3.874772207192352e-14
consistent O 0 2.6896432997469688e-11
with O 0 2.4223668454144767e-14
autosomal O 0 8.641735660397387e-10
codominant O 0 2.916286934162571e-10
inheritance O 0 4.5506795554040025e-10
of O 0 4.906727354612138e-14
the O 0 3.2357604551509767e-13
gene O 0 1.2001351024082396e-07
determining O 0 0.004003288224339485
C5 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 1.2129128812432555e-09

Normal O 0 2.1802185074193403e-05
hemolytic O 0 0.003465695306658745
titers O 0 0.0006842355360276997
were O 0 1.1557078904989027e-10
restored O 0 1.185441855788838e-09
to O 0 6.262330064232824e-12
both O 0 1.1684270440071032e-08
homozygous O 1 0.9999856948852539
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 1.396784732321521e-08
C5D B-Disease 1 1.0
) O 0 4.679552643820084e-13
sera O 0 1.0088760556137277e-11
by O 0 4.1995041197965036e-16
addition O 0 7.733409453179046e-14
of O 0 4.8576343414288153e-14
highly O 0 1.3847276658651708e-09
purified O 0 6.247745654164305e-10
human O 0 9.348097851358261e-10
C5 O 0 3.9654842964864656e-08
. O 0 1.6011655543102243e-11

In O 0 1.078554051625602e-10
specific O 0 2.750887295732696e-10
C5 O 0 7.839410898213828e-08
titrations O 0 1.0624008837112342e-06
, O 0 2.2468728266833438e-12
however O 0 4.6551625401680674e-12
, O 0 5.996513507099122e-14
it O 0 3.065280776599899e-13
was O 0 2.6068270805867932e-11
noted O 0 1.213811863520764e-11
that O 0 5.043862666398967e-14
when O 0 8.42400083608634e-14
limited O 0 2.3115300431674098e-15
amounts O 0 9.166995504697462e-13
of O 0 1.9995376882020466e-13
C5 O 0 4.357446903302531e-10
were O 0 1.1522731553637033e-12
assayed O 0 5.514604883849472e-10
in O 0 1.9225039041195074e-13
the O 0 2.7769433074645994e-15
presence O 0 3.455123557052908e-12
of O 0 2.6743950614195947e-14
low O 0 1.7356213688479727e-10
dilutions O 0 1.4654197300068006e-10
of O 0 4.5432402414821715e-13
either O 0 4.086379590262368e-07
C5D B-Disease 1 1.0
serum O 0 2.254192423833956e-07
, O 0 3.032520252705534e-15
curving O 0 1.6490940015455313e-13
rather O 0 6.849399519781585e-13
than O 0 4.288906435675945e-15
linear O 0 1.1453003530368516e-13
dose O 0 1.4010457682900324e-08
- O 0 1.304829453374623e-07
response O 0 1.480689876265373e-10
plots O 0 2.2989148362739797e-08
were O 0 2.20226947789115e-10
consistently O 0 3.030203588050284e-10
obtained O 0 3.725559628593028e-13
, O 0 1.089155859389064e-16
suggesting O 0 5.464034376323999e-14
some O 0 3.2256253417129116e-16
inhibitory O 0 2.1522379364813382e-11
effect O 0 3.9246672578485686e-10
. O 0 4.002331799313197e-11

Further O 0 2.1954405307611502e-11
studies O 0 1.9267457421201506e-11
suggested O 0 2.7381026265760333e-11
that O 0 4.220452925942503e-13
low O 0 3.139718762756871e-10
dilutions O 0 8.017927655146195e-08
of O 0 8.658097849778557e-11
C5D B-Disease 1 1.0
serum O 0 2.8631811233026383e-07
contain O 0 1.9386588688552475e-12
a O 0 3.073598640141936e-14
factor O 0 1.1415344581058862e-12
( O 0 4.297373377016699e-15
or O 0 1.3111618995392815e-12
factors O 0 8.040654080054832e-12
) O 0 8.692393982742295e-16
interfering O 0 2.7204746701897653e-12
at O 0 4.750380861243131e-13
some O 0 3.662202004595539e-16
step O 0 7.283479375175261e-12
in O 0 4.399891095994285e-13
the O 0 1.3567327870975948e-13
hemolytic O 0 2.931400122641037e-10
assay O 0 9.231152647837249e-11
of O 0 4.709099321424659e-13
C5 O 0 6.279060826841487e-09
, O 0 4.17072382489711e-14
rather O 0 4.050241912689767e-12
than O 0 4.024957179615124e-13
a O 0 1.1706710904488271e-12
true O 0 1.2598568854826908e-09
C5 O 0 2.1559204421706113e-10
inhibitor O 0 2.64737233870993e-12
or O 0 5.646903517703139e-12
inactivator O 0 1.4098361589276465e-07
. O 0 1.0227586833000402e-10

Of O 0 4.481578302906186e-11
clinical O 0 1.1468465288544394e-08
interest O 0 5.153921733835887e-07
are O 0 6.883441299593285e-12
( O 0 1.7952641394422715e-14
a O 0 1.6526458478625938e-13
) O 0 6.594237044702401e-15
the O 0 1.1121393519650247e-14
documentation O 0 1.5657147800496318e-09
of O 0 6.400210916801541e-11
membranous O 1 0.9998111128807068
glomerulonephritis B-Disease 1 1.0
, O 0 9.310548421126441e-07
vasculitis B-Disease 1 1.0
, O 0 1.142122063590989e-09
and O 0 1.7968852716876427e-06
arthritis B-Disease 1 1.0
in O 0 1.9390740749192226e-11
an O 0 3.0808426014321266e-13
individual O 0 4.2853891102367925e-08
lacking O 0 4.894581593362091e-07
C5 O 0 1.3562085676710467e-08
( O 0 3.027229617154348e-13
and O 0 6.418089258837523e-13
its O 0 5.3815052457675816e-15
biologic O 0 3.334191917784418e-13
functions O 0 3.106977498087797e-14
) O 0 1.2004790438363121e-14
, O 0 9.745203843653134e-15
and O 0 1.9721127942490257e-12
( O 0 1.9594983730227e-13
b O 0 1.0700019759113388e-09
) O 0 8.004448646058929e-16
a O 0 1.7650897765424632e-14
remarkable O 0 4.505662856701953e-11
propensity O 0 1.8381048505489161e-07
to O 0 6.543854169649421e-07
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 8.201857942813362e-11
the O 0 1.909336268734671e-14
proband O 0 4.238771833531274e-10
, O 0 1.1490407446528082e-15
even O 0 8.26295751114349e-14
during O 0 5.185882105684936e-13
periods O 0 1.7286381215342317e-09
of O 0 3.9182586754164805e-13
low O 0 6.616546670557e-07
- O 0 1.4577861406905868e-07
dose O 0 1.256106774150112e-09
or O 0 1.5389001921731205e-12
alternate O 0 7.831425937430969e-13
- O 0 7.204074226052626e-09
day O 0 3.1914835357804705e-12
corticosteroid O 0 5.392775648260795e-08
therapy O 0 1.945177130480147e-09
. O 0 4.466488810750402e-12

Other O 0 1.5720504325383855e-12
observations O 0 4.771770825695576e-11
indicate O 0 1.3747766813843043e-10
that O 0 8.661024371650616e-14
the O 0 5.200670623317638e-13
C5D B-Disease 1 1.0
state O 0 7.085212277990749e-11
is O 0 3.2865658979031043e-13
compatible O 0 4.747029050226892e-13
with O 0 1.364364892765535e-13
normal O 0 1.5233812475368147e-12
coagulation O 0 4.787474128069291e-13
function O 0 7.328325446476214e-11
and O 0 8.532967084654008e-13
the O 0 2.3555593239854566e-13
capacity O 0 2.8275407189248813e-12
to O 0 1.2343232447427355e-13
mount O 0 7.362324083715066e-08
a O 0 2.639728613473835e-08
neutrophilic O 1 0.9703159928321838
leukocytosis O 1 0.8268740177154541
during O 0 3.2016891964303795e-06
pyogenic B-Disease 1 0.9961896538734436
infection I-Disease 1 0.998314380645752
. O 0 2.8254933115423597e-11
. O 0 2.431753930165481e-11

Susceptibility O 0 0.006946912966668606
to O 0 4.7589446694473736e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.07604002952575684
twins O 0 0.0007930112769827247
: O 0 6.742820006771372e-14
the O 0 8.5640970785952385e-16
role O 0 1.5248231280060032e-12
of O 0 1.9075453022709965e-14
genes O 0 1.537905436679865e-12
, O 0 2.885142025597443e-15
HLA O 0 6.8948995818329806e-12
, O 0 3.841811105896077e-14
and O 0 1.3631898344509952e-12
the O 0 3.5440962230931516e-12
environment O 0 2.9244623078739096e-07
. O 0 5.616904164007508e-11

OBJECTIVE O 0 4.1908032599735634e-10
To O 0 5.100262185785305e-14
determine O 0 2.8279616062082402e-12
the O 0 5.416848119008241e-15
relative O 0 6.658721490859776e-11
effects O 0 1.6596547747216306e-10
of O 0 3.009035840726435e-15
genetic O 0 6.024001436566451e-11
and O 0 8.239696631159171e-14
environmental O 0 1.135943878023682e-12
factors O 0 1.1856345983121686e-12
in O 0 2.0044366557184223e-13
susceptibility O 0 1.2315310868871165e-06
to O 0 7.07713127212628e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 1.553348010929767e-05
AS B-Disease 1 0.9999998807907104
) O 0 4.9833772525209596e-11
. O 0 2.261444850826244e-11

METHODS O 0 1.8067956261802465e-05
Twins O 0 0.0027308615390211344
with O 0 2.1676457503949642e-11
AS B-Disease 1 0.9999996423721313
were O 0 8.175337490312629e-11
identified O 0 6.458056311942073e-10
from O 0 6.021099959764575e-13
the O 0 1.6749716847883067e-12
Royal O 0 1.548169052512094e-06
National O 0 1.0025897978493958e-07
Hospital O 0 2.846570978931595e-09
for O 0 2.6554208831797155e-10
Rheumatic B-Disease 0 0.1372499316930771
Diseases I-Disease 0 9.486570888839196e-07
database O 0 2.048385017161536e-09
. O 0 3.212667076812892e-10

Clinical O 0 3.0013890750524297e-07
and O 0 2.1362958277371114e-11
radiographic O 0 8.490600521326996e-06
examinations O 0 7.710353202128317e-06
were O 0 1.563962154227383e-10
performed O 0 4.966288144614417e-11
to O 0 2.8306999146489147e-14
establish O 0 7.405211860378458e-11
diagnoses O 0 2.640948196130921e-06
, O 0 4.123472125815847e-13
and O 0 2.793750342178214e-09
disease O 0 7.320222721318714e-06
severity O 0 1.096764208341483e-05
was O 0 6.42770073278065e-11
assessed O 0 4.446675232888664e-12
using O 0 4.7871791573157393e-14
a O 0 3.092446546233696e-13
combination O 0 8.96156673174664e-12
of O 0 1.448557663792996e-13
validated O 0 2.4689855715465114e-10
scoring O 0 5.41876023218979e-11
systems O 0 4.499754041598081e-11
. O 0 4.822292305056708e-12

HLA O 0 3.0319756660901476e-06
typing O 0 3.5717501845056177e-08
for O 0 4.325223339207707e-12
HLA O 0 5.060394414613256e-08
- O 0 2.870485715789073e-08
B27 O 0 8.813725305145681e-10
, O 0 5.3994288017446615e-14
HLA O 0 6.238763672339331e-11
- O 0 2.621331277041783e-11
B60 O 0 8.27460495955723e-12
, O 0 6.791010845162574e-15
and O 0 1.238520733453513e-13
HLA O 0 1.7122341322561851e-09
- O 0 3.2414646966572036e-07
DR1 O 0 0.017521711066365242
was O 0 3.182138164081749e-10
performed O 0 1.7666770824043e-13
by O 0 1.9968703793335604e-16
polymerase O 0 5.4511262718342016e-14
chain O 0 2.049734297224215e-12
reaction O 0 7.963709986597012e-13
with O 0 3.645853421680584e-15
sequence O 0 8.732288980448089e-13
- O 0 8.820813870991095e-12
specific O 0 1.5780126229152092e-13
primers O 0 8.092122111280631e-11
, O 0 1.6703313537001774e-14
and O 0 2.8454401514036234e-14
zygosity O 0 8.796997574833654e-10
was O 0 1.0763668602253862e-11
assessed O 0 1.8325268386076843e-11
using O 0 3.362915198049099e-12
microsatellite O 0 4.826010524539015e-08
markers O 0 1.4074544196773786e-07
. O 0 6.710322852931938e-10

Genetic O 0 7.34159826265568e-08
and O 0 1.0426631346510673e-12
environmental O 0 2.8950578913333747e-12
variance O 0 2.691633157678175e-12
components O 0 3.2819416628804277e-10
were O 0 7.606337434906685e-12
assessed O 0 1.656562553797869e-09
with O 0 1.6939885908937025e-12
the O 0 7.460181561044776e-13
program O 0 3.8173329081070406e-11
Mx O 0 1.6344726960770828e-10
, O 0 7.944542869521635e-18
using O 0 1.1770474390675184e-16
data O 0 5.632794849042694e-14
from O 0 2.1985034489934536e-15
this O 0 2.1554554134931535e-14
and O 0 1.606530446868204e-12
previous O 0 1.1215764428307295e-10
studies O 0 3.8092452803173416e-11
of O 0 1.3156662174648726e-12
twins O 0 1.4759622217752622e-06
with O 0 4.825521926488108e-12
AS B-Disease 1 0.9999997615814209
. O 0 7.836488680190712e-10

RESULTS O 0 6.435437853724579e-07
Six O 0 7.367216559028833e-11
of O 0 3.739679572956067e-12
8 O 0 4.686957932875657e-09
monozygotic O 0 0.24827192723751068
( O 0 5.798269087087249e-10
MZ O 1 0.9990429282188416
) O 0 4.39411307340265e-09
twin O 1 0.9809494614601135
pairs O 0 0.0031974182929843664
were O 0 2.714012126148191e-08
disease O 0 8.087673819545671e-08
concordant O 0 4.88641460627548e-10
, O 0 9.632483070724784e-14
compared O 0 3.645622866088605e-12
with O 0 4.4528911672314306e-14
4 O 0 1.63747910630202e-12
of O 0 5.333890338958536e-13
15 O 0 3.164269887778737e-11
B27 O 0 5.34439301702605e-08
- O 0 0.03020591102540493
positive O 0 4.61930625306195e-07
dizygotic O 0 3.321153053548187e-05
( O 0 5.010766974955505e-12
DZ O 0 4.652341431210516e-06
) O 0 3.587569477603303e-12
twin O 0 5.693657811889352e-08
pairs O 0 1.1564928875662517e-10
( O 0 9.793726973069544e-15
27 O 0 2.1834700117840528e-13
% O 0 1.5570705972679528e-15
) O 0 2.9901556880903733e-15
and O 0 3.195150090687382e-12
4 O 0 8.120721976812018e-12
of O 0 6.057911117185455e-11
32 O 0 5.204801922786828e-08
DZ O 1 0.9996604919433594
twin O 0 0.19212761521339417
pairs O 0 5.130974614075967e-07
overall O 0 3.4489000544368764e-09
( O 0 2.2633757118962344e-13
12 O 0 1.57563076626753e-13
. O 0 1.9516335789338196e-15
5 O 0 1.1233239138137494e-13
% O 0 9.826608114455598e-14
) O 0 6.548357776164915e-13
. O 0 6.797271079328482e-11

Nonsignificant O 0 2.7102466901851585e-06
increases O 0 2.0727174643297985e-08
in O 0 5.404178284886506e-14
similarity O 0 7.83653632437098e-13
with O 0 4.109978772381473e-15
regard O 0 3.2153123479677914e-12
to O 0 8.88270793725221e-12
age O 0 7.351547282041793e-08
at O 0 1.4196049891168627e-10
disease O 0 1.03713693189178e-09
onset O 0 3.1183871457285406e-11
and O 0 6.745447841786933e-13
all O 0 1.7544263093628894e-14
of O 0 3.561669358151821e-15
the O 0 1.2891960936289859e-11
disease O 0 1.8692171011025493e-07
severity O 0 3.6438088102386246e-08
scores O 0 3.4982277491435454e-11
assessed O 0 1.0219493307150884e-10
were O 0 1.5959875565227377e-12
noted O 0 2.392922526794905e-10
in O 0 2.1003394579111045e-09
disease O 0 0.00034116616006940603
- O 0 0.11892729252576828
concordant O 1 0.6348863244056702
MZ O 1 0.9999841451644897
twins O 0 0.0032972500193864107
compared O 0 5.888006193721651e-10
with O 0 1.823941692125075e-11
concordant O 0 0.00033945965697057545
DZ O 1 0.9998818635940552
twins O 0 0.0031600298825651407
. O 0 8.003461782202237e-11

HLA O 0 1.542764402984176e-05
- O 0 3.8143409142321616e-07
B27 O 0 2.928975728622163e-09
and O 0 4.551436809906162e-13
B60 O 0 2.640167771905677e-11
were O 0 9.786337457637698e-14
associated O 0 1.3714622970270596e-12
with O 0 5.6581316373741433e-14
the O 0 4.480157564379361e-12
disease O 0 4.83806283924082e-09
in O 0 5.289348908139261e-15
probands O 0 6.649088918342372e-11
, O 0 3.4232122938024486e-15
and O 0 3.2732456610624905e-14
the O 0 7.123104189821206e-13
rate O 0 4.018526851723436e-06
of O 0 4.382217109804784e-14
disease O 0 2.4014265576077776e-10
concordance O 0 7.245454778682936e-13
was O 0 2.069375486940528e-12
significantly O 0 3.8443387362363524e-11
increased O 0 9.89529222450436e-11
among O 0 1.9624177283183997e-11
DZ O 1 0.9556058049201965
twin O 0 0.00019986553525086492
pairs O 0 1.0726204635602699e-07
in O 0 3.4017578250805647e-12
which O 0 1.8962802248584376e-12
the O 0 3.8232893413703284e-13
co O 0 0.0001560003584017977
- O 0 0.09727054089307785
twin O 0 0.0034565343521535397
was O 0 2.6868759994691516e-10
positive O 0 9.007712110931099e-13
for O 0 3.72562656113652e-15
both O 0 3.110008724074159e-13
B27 O 0 8.082871039150064e-10
and O 0 3.131776227238703e-10
DR1 O 0 0.0006263413233682513
. O 0 7.321567241369564e-10

Additive O 0 1.2198800858342906e-09
genetic O 0 1.1841544633739431e-08
effects O 0 1.0225728175328186e-07
were O 0 6.734228626126271e-12
estimated O 0 3.081424275897665e-13
to O 0 8.36766060900631e-15
contribute O 0 9.280327157787371e-13
97 O 0 2.761117614928643e-13
% O 0 3.459815170903796e-14
of O 0 5.3515554313020904e-15
the O 0 1.37623853285751e-13
population O 0 7.02405933980868e-14
variance O 0 2.694889884163887e-12
. O 0 2.5969859943075768e-11

CONCLUSION O 0 7.125248724371147e-10
Susceptibility O 0 1.9028277620236622e-07
to O 0 4.641900752666572e-11
AS B-Disease 1 0.9999959468841553
is O 0 2.2040156158475988e-12
largely O 0 3.1893883150821423e-13
genetically O 0 3.1325135627785494e-12
determined O 0 1.9180868005008733e-09
, O 0 3.153442464497321e-15
and O 0 1.3693541201127701e-14
the O 0 4.085842145032988e-15
environmental O 0 1.1729230087187403e-10
trigger O 0 3.7173172873217197e-10
for O 0 4.767572512991147e-13
the O 0 5.956230508807892e-10
disease O 0 1.1559425274754176e-06
is O 0 1.5585593579614532e-11
probably O 0 6.011929287730311e-10
ubiquitous O 0 6.640550331837858e-10
. O 0 3.069385023923843e-11

HLA O 0 2.7688620320986956e-06
- O 0 7.026626036577e-08
B27 O 0 2.9316571392712376e-10
accounts O 0 5.821178608589328e-12
for O 0 1.3162162493206005e-15
a O 0 2.7446972713823965e-14
minority O 0 2.5064447045641813e-11
of O 0 7.725519002462194e-15
the O 0 5.651110411867763e-14
overall O 0 5.519429097794459e-12
genetic O 0 4.4262839921094255e-11
susceptibility O 0 4.774992490297336e-08
to O 0 6.613399272659137e-10
AS B-Disease 1 0.9999998807907104
. O 0 7.186891526345107e-09

Cell O 0 5.758536758548871e-07
cycle O 0 1.8208618257631315e-07
- O 0 2.603723487482057e-06
dependent O 0 1.3160346146179336e-09
colocalization O 0 5.345800246914223e-08
of O 0 6.470277872511199e-13
BARD1 O 0 5.298375072015915e-07
and O 0 2.650479445295839e-12
BRCA1 O 0 2.842954344162152e-11
proteins O 0 4.91023183484679e-13
in O 0 5.3153838210258375e-14
discrete O 0 2.5143800930216287e-10
nuclear O 0 8.16112969914684e-06
domains O 0 4.102763639934892e-08
. O 0 1.877302202579756e-10

Germ O 0 0.0008242044132202864
- O 0 0.0020474400371313095
line O 0 2.6948287157324557e-08
mutations O 0 1.0395213578817675e-09
of O 0 6.476370292509597e-15
the O 0 7.041440371183044e-15
BRCA1 O 0 1.1244568644264152e-11
gene O 0 9.890606562923399e-12
predispose O 0 6.469198093883577e-11
women O 0 1.737437992956059e-12
to O 0 2.5313034139476734e-14
early O 0 5.399741098699451e-09
- O 1 0.9970167875289917
onset O 1 0.9479706883430481
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 8.17942380493264e-11
compromising O 0 2.529820676500094e-06
the O 0 2.0777115108689542e-13
genes O 0 9.86825812038239e-12
presumptive O 0 5.846248640750673e-08
function O 0 2.5600527253644145e-10
as O 0 2.0176009029714698e-13
a O 0 5.78900295755691e-12
tumor B-Disease 0 1.7855924738796602e-07
suppressor O 0 5.2563977988029364e-06
. O 0 4.063270608867242e-09

Although O 0 3.815731758338714e-11
the O 0 5.423239575518338e-14
biochemical O 0 9.414351243020036e-11
properties O 0 2.2233979934949133e-10
of O 0 3.55664906163608e-13
BRCA1 O 0 2.1683602469124708e-08
polypeptides O 0 1.2054427456220651e-09
are O 0 8.070815717131641e-12
not O 0 3.2001270123399594e-12
understood O 0 7.765481313537492e-11
, O 0 1.918037075872162e-15
their O 0 2.3394035257692965e-14
expression O 0 1.9768738729331048e-11
pattern O 0 1.339643396214285e-09
and O 0 4.238410024424294e-13
subcellular O 0 4.7365427552348294e-11
localization O 0 6.616761825950501e-12
suggest O 0 4.961104769184155e-13
a O 0 1.4911449218403192e-14
role O 0 3.417634578117834e-11
in O 0 2.259366652102024e-11
cell O 0 1.7188119372235633e-08
- O 0 2.8622657737287227e-06
cycle O 0 1.1241583663945676e-08
regulation O 0 4.657869645541268e-09
. O 0 3.0769584796752625e-11

When O 0 2.296727963368994e-08
resting O 0 1.4784711765969405e-07
cells O 0 3.6489516963555957e-10
are O 0 2.2257252464685795e-12
induced O 0 1.0342216860692588e-08
to O 0 2.0838470109630497e-13
proliferate O 0 1.0300078845393301e-10
, O 0 2.8849220087893935e-15
the O 0 9.245353607852374e-15
steady O 0 1.0274301409651798e-09
- O 0 1.7835211085781566e-09
state O 0 1.7463828994035424e-11
levels O 0 9.617334012501644e-11
of O 0 1.940208639722576e-16
BRCA1 O 0 5.933724106683969e-13
increase O 0 1.9942244199305098e-13
in O 0 3.2167936256334226e-14
late O 0 9.663956917690952e-13
G1 O 0 3.837333228950968e-12
and O 0 4.766915418711985e-14
reach O 0 5.3905481695124685e-14
a O 0 4.840450414621278e-14
maximum O 0 1.2004625592199059e-11
during O 0 9.530595063145242e-11
S O 0 8.030964636418503e-06
phase O 0 9.910823273173719e-10
. O 0 2.0455961924348287e-10

Moreover O 0 4.738146763827444e-09
, O 0 3.034108608888225e-13
in O 0 3.170718624722485e-13
S O 0 4.902186674371478e-07
phase O 0 1.3807506249463586e-09
cells O 0 2.3094910706067395e-10
, O 0 3.917569055072144e-14
BRCA1 O 0 4.279616244717843e-11
polypeptides O 0 1.4498526511308452e-11
are O 0 5.948679862501777e-14
hyperphosphorylated O 0 1.1598755289554674e-09
and O 0 5.316237901287213e-13
accumulate O 0 1.0176352122082122e-10
into O 0 2.1635543020776665e-13
discrete O 0 4.98741159482563e-10
subnuclear O 0 4.307738890929613e-06
foci O 0 5.560867748499732e-07
termed O 0 7.926360012788791e-08
" O 0 7.228546650139833e-09
BRCA1 O 0 5.296071208249487e-07
nuclear O 0 4.139545580983395e-06
dots O 0 2.309113824594533e-06
. O 0 9.458127614436762e-10

" O 0 3.2224758417243038e-09
BRCA1 O 0 2.596717507685753e-08
associates O 0 1.120647397101493e-08
in O 0 7.62969062928498e-11
vivo O 0 1.6439059891126817e-06
with O 0 7.47097869679969e-12
a O 0 2.738500815002709e-10
structurally O 0 7.802788104527281e-08
related O 0 4.1045364329583833e-10
protein O 0 1.192657916870843e-10
termed O 0 3.870595932653487e-08
BARD1 O 0 0.008073695935308933
. O 0 4.690676180807429e-10

Here O 0 9.438057446686798e-09
we O 0 1.6962486103222485e-12
show O 0 1.6121015113113035e-12
that O 0 4.947001060748649e-15
the O 0 1.7477522191341175e-15
steady O 0 1.7761468684707182e-10
- O 0 4.672569442476515e-09
state O 0 3.3903661128542595e-11
levels O 0 6.607498992394767e-10
of O 0 2.9467733604495274e-16
BARD1 O 0 4.739237891016046e-10
, O 0 4.49217888466569e-16
unlike O 0 1.7807507042295195e-13
those O 0 1.1128211796062465e-13
of O 0 2.4653368268286874e-15
BRCA1 O 0 5.138429612361328e-11
, O 0 7.095740011189844e-13
remain O 0 1.4655120172957226e-10
relatively O 0 1.1586029878551951e-11
constant O 0 9.058058481059561e-08
during O 0 2.9568507642352415e-09
cell O 0 1.5057231905757362e-07
cycle O 0 5.086907339801883e-09
progression O 0 6.000862584620847e-10
. O 0 8.474710516681583e-12

However O 0 8.616718449871996e-10
, O 0 2.0975047057298496e-13
immunostaining O 0 8.862751421645498e-09
revealed O 0 1.0762863489333085e-08
that O 0 8.334983094340775e-13
BARD1 O 0 1.4570372286470956e-06
resides O 0 3.2201841193568725e-09
within O 0 4.562249016071274e-13
BRCA1 O 0 3.646210555707796e-10
nuclear O 0 5.333471442270366e-10
dots O 0 1.2115088099395876e-10
during O 0 9.502528972027413e-12
S O 0 2.2109670538839055e-08
phase O 0 1.5171506412281488e-11
of O 0 2.7466871211820863e-14
the O 0 1.6006265052530971e-13
cell O 0 2.018512301749098e-10
cycle O 0 6.855353784640528e-11
, O 0 5.773358357276945e-15
but O 0 1.6265398858524016e-13
not O 0 4.921029675333116e-14
during O 0 9.658681460970181e-14
the O 0 4.0710334680161414e-14
G1 O 0 3.8188330969690654e-11
phase O 0 3.248725594096058e-11
. O 0 1.966719495594127e-11

Nevertheless O 0 4.4962305878470943e-07
, O 0 6.123252078993335e-12
BARD1 O 0 5.024654470275891e-08
polypeptides O 0 1.8164922344077183e-10
are O 0 6.334052070821813e-14
found O 0 5.481006544894723e-14
exclusively O 0 2.001793912922989e-12
in O 0 1.900817394109855e-12
the O 0 1.4483973373967396e-13
nuclear O 0 1.3929016273728223e-10
fractions O 0 3.099347764112109e-14
of O 0 7.165376749717635e-16
both O 0 1.6046729171674025e-14
G1 O 0 7.055086376217545e-11
- O 0 1.0553623752684871e-08
and O 0 4.697818523080599e-11
S O 0 2.5037115847226232e-06
- O 0 8.851634980544532e-09
phase O 0 1.5068730985223766e-10
cells O 0 2.3173764296391397e-10
. O 0 5.599625797769736e-12

Therefore O 0 7.347503716559345e-10
, O 0 2.2818096899273298e-14
progression O 0 4.756103497149944e-12
to O 0 6.036160747667843e-14
S O 0 2.1730818389187334e-06
phase O 0 2.7885649345193997e-09
is O 0 1.9915419140204005e-12
accompanied O 0 1.0955173400384322e-11
by O 0 1.6905784904581653e-14
the O 0 2.653338330570621e-15
aggregation O 0 6.586547849013816e-14
of O 0 1.3498025668110675e-13
nuclear O 0 7.958715464440047e-09
BARD1 O 0 1.5088180704836418e-09
polypeptides O 0 1.500190423275871e-11
into O 0 2.4739418413161074e-12
BRCA1 O 0 2.3020257700068214e-08
nuclear O 0 2.6319571588828694e-07
dots O 0 2.250607309406405e-07
. O 0 2.392265274764327e-10

This O 0 1.1399532359734899e-11
cell O 0 7.041551786102218e-10
cycle O 0 1.097270829752972e-09
- O 0 5.949354999756906e-07
dependent O 0 1.1124350329794197e-09
colocalization O 0 1.467169852276129e-07
of O 0 8.689124723557096e-13
BARD1 O 0 4.188461389276199e-06
and O 0 2.4609727450330965e-11
BRCA1 O 0 2.630227147193409e-10
indicates O 0 2.6489546667285424e-11
a O 0 6.8805032641717796e-15
role O 0 3.901821899431057e-13
for O 0 2.5819722472260678e-14
BARD1 O 0 1.4982089169279789e-07
in O 0 3.772298445836597e-11
BRCA1 O 0 3.6043022078047215e-07
- O 0 2.9468212233041413e-05
mediated O 0 2.430552967780386e-07
tumor B-Disease 0 2.7205535388930002e-06
suppression O 0 5.03375815696927e-07
. O 0 1.506944985463221e-10

Ethnic O 0 1.184859854674869e-07
differences O 0 3.1128357136367413e-07
in O 0 4.6326664726592526e-11
the O 0 1.0612185609437663e-11
HFE O 0 4.743023055198137e-06
codon O 0 4.516232721130109e-09
282 O 0 1.4200274289777326e-10
( O 0 2.243058863649061e-11
Cys O 0 0.00012247354607097805
/ O 0 4.3275363168504555e-06
Tyr O 0 1.5622969584683233e-08
) O 0 1.0090064634510343e-12
polymorphism O 0 6.431447374666277e-09
. O 0 5.811641445863103e-11

Recent O 0 4.504006334560273e-10
studies O 0 2.2757683237895066e-10
have O 0 1.6001816842067806e-12
shown O 0 3.6263744784825747e-10
that O 0 2.453636760435529e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 5.277378932078136e-06
HH B-Disease 1 0.999996542930603
) O 0 3.4248222747362833e-13
is O 0 7.213519603692375e-13
likely O 0 1.8124075157333053e-11
to O 0 1.6082831409951898e-13
be O 0 5.58167401187859e-10
caused O 0 4.6885717530642523e-11
by O 0 1.1311370134818588e-13
homozygosity O 0 2.9722265537657222e-08
for O 0 1.6149782249355593e-13
a O 0 4.7716869518155125e-12
Cys282Tyr O 0 2.2498456075936701e-07
mutation O 0 1.0365836189407673e-08
in O 0 9.110954178603858e-13
the O 0 1.0392357005332975e-13
HFE O 0 2.7715967299002386e-09
gene O 0 1.399345778141381e-10
located O 0 4.689307275818067e-10
4 O 0 6.502082205983584e-10
. O 0 1.6558288074008942e-10

5 O 0 2.710555113694113e-09
Mb O 0 1.4315654084384732e-07
telomeric O 0 1.2936663551954553e-05
to O 0 1.1382164100126602e-09
HLA O 0 2.2725669623469003e-05
- O 0 4.575582715915516e-05
A O 0 3.904301326684845e-09
. O 0 1.7129618556932513e-10

Population O 0 2.1330558153120904e-10
studies O 0 2.606255489201459e-11
of O 0 1.519221692349547e-14
this O 0 6.519152656125991e-15
polymorphism O 0 1.1180543990629843e-10
are O 0 7.778480584522216e-15
facilitated O 0 2.2588893171878073e-14
by O 0 1.5030465817821893e-14
the O 0 7.66928787322577e-15
fact O 0 1.3446587593390902e-12
that O 0 1.6041894307611097e-14
the O 0 1.0504770474708061e-14
Cys282Tyr O 0 5.453189011461745e-09
mutation O 0 2.4065069381684623e-10
creates O 0 2.514838164102695e-12
a O 0 2.1011446434734266e-13
Rsal O 0 7.381383837490318e-10
restriction O 0 2.3073326235745206e-11
site O 0 2.782156449665507e-10
. O 0 5.412005218974336e-11

We O 0 1.3723756353556382e-08
have O 0 1.7531035217260849e-12
studied O 0 6.599053335026861e-12
the O 0 3.197446647729141e-13
codon O 0 2.66490250006024e-11
282 O 0 1.8879650447167773e-12
( O 0 3.202469756394266e-13
Cys O 0 1.6662273765177815e-06
/ O 0 1.7588408951496604e-08
Tyr O 0 1.2481080058357463e-10
) O 0 3.357641567531362e-15
polymorphism O 0 7.137677254798191e-11
in O 0 1.8141834334708257e-13
different O 0 6.780867371509319e-14
ethnic O 0 5.994450161944664e-12
groups O 0 8.178566157646117e-11
. O 0 4.5839547435644334e-11

In O 0 4.032576356172157e-11
agreement O 0 2.436423241977681e-12
with O 0 2.6986525603696528e-14
previous O 0 1.590051180999641e-11
observations O 0 1.2743334165676856e-09
the O 0 5.003410880055625e-13
Tyr O 0 3.2383956627413113e-10
allele O 0 3.5697084177499505e-11
appeared O 0 5.857356960570215e-11
to O 0 1.1904901706365906e-13
be O 0 1.9661746189503226e-12
rare O 0 1.3421151343062654e-11
or O 0 1.1775681540981964e-09
absent O 0 3.57778446868906e-08
in O 0 2.1390428490974944e-12
Asiatic O 0 1.2458858597574896e-11
( O 0 1.516494585072567e-14
Indian O 0 1.710520288779327e-13
, O 0 2.0591286244457316e-14
Chinese O 0 3.6180233071655965e-13
) O 0 1.0349353481414053e-13
populations O 0 1.9701811362904387e-11
. O 0 1.2070980499878647e-11

The O 0 9.548026258521247e-11
highest O 0 1.793899584434655e-09
allele O 0 5.472062733491434e-11
frequency O 0 3.516076596543627e-10
( O 0 3.895959550521792e-14
7 O 0 2.053384046997453e-13
. O 0 1.854230507471969e-15
5 O 0 1.530202796884341e-14
% O 0 3.576373003083208e-15
) O 0 7.140495368650277e-15
was O 0 1.0597409616508457e-09
found O 0 2.848220548301583e-10
in O 0 8.096109338495694e-10
Swedes O 0 2.2879476091475226e-06
. O 0 1.523828063731969e-09

Saamis O 0 3.115645483831031e-07
( O 0 4.308993700047337e-12
2 O 0 2.620900024785655e-12
% O 0 3.26907310900168e-13
) O 0 3.8304263054586216e-14
and O 0 4.2870381181635275e-13
Mordvinians O 0 9.409329981835413e-10
( O 0 9.649983787854595e-15
1 O 0 1.5964243409204507e-14
. O 0 1.1206520119091067e-15
8 O 0 7.109131432679345e-15
% O 0 1.5449231124829217e-16
) O 0 5.325546014107226e-16
had O 0 3.3243463537502294e-11
significantly O 0 1.0042980891356024e-09
lower O 0 2.264916587613186e-10
frequencies O 0 1.135194049872723e-09
of O 0 4.85701648171577e-13
the O 0 6.751475246924432e-12
Tyr O 0 3.549337490582616e-09
allele O 0 1.2938680127305702e-09
. O 0 3.842579379687017e-11

Comparisons O 0 1.0052889631850803e-09
with O 0 7.920401530817078e-13
allele O 0 9.044200804941838e-11
frequencies O 0 4.090747879326173e-11
based O 0 4.985320966807705e-13
on O 0 7.037932736597696e-12
prevalence O 0 1.9509483806245953e-08
estimates O 0 1.3080850638780284e-11
of O 0 4.054405736923089e-13
HH B-Disease 1 0.9999995231628418
showed O 0 1.7871336694952333e-06
some O 0 1.466968907459787e-14
disagreements O 0 8.528973360899528e-11
with O 0 5.056054011608798e-15
the O 0 4.660732088422191e-16
RFLP O 0 3.320439355327526e-13
data O 0 6.245412715634446e-13
, O 0 6.62332701484731e-16
particularly O 0 5.956016387552443e-13
in O 0 6.320879149951386e-12
Finns O 0 1.0118727544750072e-07
. O 0 2.210138461133937e-10

The O 0 4.719915014383957e-10
newly O 0 5.2126378768946324e-09
described O 0 7.178859728895759e-10
HFE O 0 5.7784685481010456e-08
marker O 0 3.3884603456435514e-10
provides O 0 2.4675129561141373e-13
a O 0 9.57996635036866e-15
new O 0 2.2688455118564238e-15
approach O 0 5.681057092311349e-14
to O 0 7.897926841403413e-16
the O 0 7.992640477378612e-16
screening O 0 2.4849087631312328e-12
of O 0 4.967760686321043e-13
HH B-Disease 1 0.9999909400939941
as O 0 1.8586391106745204e-11
well O 0 4.4075789025488366e-12
as O 0 7.739267533042257e-14
studies O 0 5.567223995716665e-14
of O 0 2.801573913840011e-16
the O 0 1.496039247616144e-14
relationship O 0 1.7107480709821488e-10
between O 0 1.0596802298493135e-13
the O 0 4.599548281310206e-13
HFE O 0 4.135992242026987e-07
Tyr O 0 7.870371576679247e-10
allele O 0 4.826852251227365e-10
and O 0 3.5663377632999538e-12
different O 0 1.4285704563743451e-11
disorders O 0 3.746541210603027e-07
including O 0 3.9938391482863267e-10
cancer B-Disease 0 0.00023911555763334036

Autosomal B-Disease 1 0.9998027682304382
dominant I-Disease 1 0.9985284805297852
neurohypophyseal I-Disease 1 0.9999388456344604
diabetes I-Disease 1 0.9999595880508423
insipidus I-Disease 1 0.9994900226593018
associated O 0 5.2877549023833126e-05
with O 0 1.4188571324791344e-11
a O 0 1.9689113187060236e-11
missense O 0 5.335400032890902e-07
mutation O 0 4.8616697334580294e-09
encoding O 0 4.942908582439287e-11
Gly23 O 0 2.2825688574812375e-06
- O 0 2.1754252884420566e-05
- O 0 1.3310678923517116e-06
> O 0 6.855029877073093e-10
Val O 0 1.9900200243228028e-07
in O 0 2.024530022792792e-11
neurophysin O 0 9.68004428614222e-07
II O 0 6.762714292563032e-06
. O 0 1.8355958419924434e-10

Autosomal B-Disease 1 0.999722421169281
dominant I-Disease 1 0.994511604309082
neurohypophyseal I-Disease 1 0.9996775388717651
diabetes I-Disease 1 0.999848484992981
insipidus I-Disease 1 0.985564649105072
( O 0 3.587381502967446e-10
ADNDI B-Disease 0 1.4236405831979937e-06
) O 0 1.6103714499046684e-12
is O 0 4.6269706815982303e-11
an O 0 3.063207998366124e-08
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.006095871329307556
by O 0 1.0722278100117055e-11
progressive O 0 6.641036520704802e-07
degeneration O 0 1.408468222052761e-07
of O 0 7.870010117769569e-14
the O 0 2.341730596325947e-13
magnocellular O 0 1.8245698285568324e-09
neurons O 0 5.2492791363656366e-11
of O 0 1.4242996227418515e-14
the O 0 5.972486231704127e-14
hypothalamus O 0 1.0162211350195349e-10
leading O 0 8.9799435248894e-12
to O 0 8.044684167950178e-13
decreased O 0 1.772895963370047e-08
ability O 0 2.8902425591725844e-11
to O 0 2.79252451241066e-13
produce O 0 7.160336559786096e-12
the O 0 1.1729490642653495e-11
hormone O 0 4.846337997577166e-09
arginine O 0 6.972625948842293e-11
vasopressin O 0 1.1774237140826926e-10
( O 0 9.747403079997385e-14
AVP O 0 9.937408534943515e-12
) O 0 2.8798944023793183e-13
. O 0 5.427529519569374e-12

Affected O 0 1.6520519352525298e-07
individuals O 0 6.011226238999967e-11
are O 0 6.199209982155063e-13
not O 0 7.102388338911525e-13
symptomatic O 0 7.277955321738361e-11
at O 0 1.1798680921160098e-09
birth O 0 1.2495794976530306e-07
, O 0 3.1602978155416406e-13
but O 0 2.680568093882396e-11
usually O 0 4.943846665383944e-09
develop O 0 2.5087970811910054e-08
diabetes B-Disease 0 1.7662758864389616e-06
insipidus I-Disease 0 1.1867491593875457e-05
at O 0 9.453429328232232e-08
1 O 0 3.608177578939831e-08
- O 0 0.03304480016231537
6 O 0 3.818567684277241e-09
yr O 0 2.836698058672482e-07
of O 0 7.67758339542679e-12
age O 0 2.4704387868723643e-08
. O 0 2.647318128601306e-11

The O 0 2.0437536212003504e-12
genetic O 0 8.906225062998985e-11
locus O 0 8.489862146632277e-10
of O 0 5.738356838314029e-12
the O 0 4.364791861277695e-10
disease O 0 2.149067995560472e-06
is O 0 1.3788114530330353e-12
the O 0 9.432742537366853e-14
AVP O 0 3.405611070927961e-10
- O 0 1.5121239016480104e-07
neurophysin O 0 2.2372176999851945e-07
II O 0 1.6973596927982726e-07
( O 0 2.8607809345179355e-14
NPII O 0 3.4571442930619867e-10
) O 0 4.3116732519300424e-16
gene O 0 9.663477700330714e-13
, O 0 1.24991129371501e-14
and O 0 1.0963320095508378e-12
mutations O 0 3.8439887384278393e-10
that O 0 3.7320317734616804e-13
cause O 0 1.0668305128191946e-10
ADNDI B-Disease 0 5.205918932915665e-05
have O 0 1.666396021171579e-09
been O 0 1.9158154229703683e-10
found O 0 1.8454066399997693e-11
in O 0 3.7960045805481013e-13
both O 0 7.369579664399939e-14
the O 0 1.0727498635221527e-14
signal O 0 2.400700731958194e-12
peptide O 0 2.0928411456101748e-13
of O 0 9.551421445925308e-17
the O 0 1.9675258228484416e-15
prepro O 0 8.215424784907555e-09
- O 0 7.182780148440315e-09
AVP O 0 1.029634641436239e-10
- O 0 8.455799616058357e-09
NPII O 0 1.0280829521036594e-09
precursor O 0 1.1174520510304209e-12
and O 0 4.874929127908489e-13
within O 0 2.1680901973915312e-13
NPII O 0 5.6066475906391133e-08
itself O 0 3.824666694463019e-10
. O 0 2.9019642591721073e-11

An O 0 4.180175997015034e-11
affected O 0 1.2350586331422164e-08
girl O 0 0.0005566388135775924
who O 0 5.460284446812125e-10
presented O 0 1.5953613430319535e-11
at O 0 1.4704720730993048e-12
9 O 0 2.3490982921890724e-13
months O 0 2.671775561208234e-13
of O 0 6.466425024566e-14
age O 0 4.2266020727765863e-07
and O 0 7.408860192015254e-10
her O 0 6.8939240982501815e-09
similarly O 0 4.4595687143100804e-08
affected O 0 5.174559003506829e-09
younger O 0 4.3360839363515424e-09
brother O 0 5.144271852941529e-08
and O 0 3.344649279757306e-10
father O 0 1.4776276202610461e-08
were O 0 1.84669626812628e-10
all O 0 4.4079194775562686e-14
found O 0 7.141537253056718e-13
to O 0 5.252781716535981e-12
have O 0 2.9481975888367984e-11
a O 0 2.048318247871786e-13
novel O 0 3.546464510950642e-11
missense O 0 5.5426600198416054e-08
mutation O 0 2.152765743446139e-09
( O 0 4.786594704582134e-14
G1758 O 0 1.1131264660013684e-10
- O 0 2.7885778308700537e-07
- O 0 2.907647633776378e-08
> O 0 8.28452237366939e-12
T O 0 1.2778613237007796e-11
) O 0 7.942906706270005e-18
encoding O 0 9.490047026754038e-16
the O 0 4.942226547783213e-16
amino O 0 3.580277401453577e-15
acid O 0 1.857253144544246e-15
substitution O 0 1.9854259160128826e-14
Gly23 O 0 1.4367333711629016e-10
- O 0 4.9597353779518016e-08
- O 0 9.512120868748752e-08
> O 0 2.0617817175772046e-10
Val O 0 1.1383704645595571e-07
within O 0 1.1095864504984121e-10
NPII O 0 2.7207895527681103e-06
. O 0 1.2136135152385208e-10

The O 0 9.75634642519374e-11
mutation O 0 3.1515114073954464e-08
was O 0 2.6636828159842807e-11
confirmed O 0 3.3694381919996408e-12
by O 0 2.9645104950628285e-15
restriction O 0 6.933972710246317e-13
endonuclease O 0 1.3485544902991364e-09
analysis O 0 3.789890068439661e-10
. O 0 1.9357371608408336e-11

A O 0 4.668202491231455e-10
T1 O 0 9.214839735705027e-08
- O 0 5.5883133676104535e-09
weighted O 0 4.966979605391941e-11
magnetic O 0 4.496753247540397e-10
resonance O 0 2.3771109525227985e-09
imaging O 0 5.26821395396837e-07
of O 0 1.3277579036241605e-10
the O 0 2.7438471050800217e-08
fathers O 0 0.0004899571067653596
pituitary O 0 1.2790187611244619e-06
gland O 0 4.701067979340223e-09
demonstrates O 0 4.2057992505339925e-11
an O 0 4.375911118919065e-14
attenuated O 0 1.8254361293656984e-06
posterior O 0 1.7679309166851453e-05
pituitary O 0 0.2143854796886444
bright O 0 0.0002542218426242471
spot O 0 4.941463339491747e-05
. O 0 1.0897975855073128e-09

This O 0 8.663582351520205e-11
mutation O 0 2.8403462692949688e-08
may O 0 6.067658875341664e-11
be O 0 1.90558060934984e-15
valuable O 0 1.3562535697373562e-14
for O 0 1.8456701807487803e-15
developing O 0 3.2659584672106723e-12
models O 0 1.9809069939924484e-09
of O 0 9.663966155093462e-11
dominantly B-Disease 1 0.9973881840705872
inherited I-Disease 1 0.9999761581420898
neurodegeneration I-Disease 1 1.0
, O 0 8.756339295139248e-13
as O 0 4.076050020646255e-15
the O 0 1.6606003639164121e-15
early O 0 2.171041775175797e-12
age O 0 6.095336041456179e-11
of O 0 1.3023472918312611e-14
onset O 0 6.804914409741514e-10
of O 0 1.568723276279549e-11
symptoms O 0 2.1646707182298996e-07
suggests O 0 6.13907449181772e-12
that O 0 2.9000951217317966e-14
this O 0 1.9278307249182003e-14
mutation O 0 1.61930510667041e-10
may O 0 3.2359365187417666e-11
be O 0 2.4097279618766343e-13
particularly O 0 8.207921104938509e-13
deleterious O 0 7.732879336863618e-10
to O 0 6.7544377209405315e-12
the O 0 1.1412194106386053e-11
magnocellular O 0 4.260239094833196e-08
neuron O 0 4.573636580573748e-09
. O 0 8.215283379790772e-13
. O 0 3.840869896437615e-12

Frequent O 0 1.8035999005405756e-07
inactivation O 0 8.220426366278843e-07
of O 0 1.703105885486611e-11
PTEN O 0 8.241500836447813e-06
/ O 0 6.018707426846959e-05
MMAC1 O 0 0.0003458511200733483
in O 0 4.646210527425865e-09
primary O 1 0.9906005859375
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.839603762884508e-07

Sporadic B-Disease 1 0.9843168258666992
prostate I-Disease 1 0.9999943971633911
carcinoma I-Disease 1 1.0
is O 0 5.811311893921811e-07
the O 0 1.2647836337281726e-12
most O 0 1.815419152896916e-13
common O 0 5.035411670961665e-11
male B-Disease 0 6.442327844524698e-07
cancer I-Disease 0 1.9734335054977237e-08
in O 0 2.580678726271657e-13
the O 0 2.932937638415456e-14
Western O 0 1.5062458225134634e-11
world O 0 2.4058197656273705e-09
, O 0 9.510382593751719e-15
yet O 0 3.368215808260272e-13
many O 0 2.5192195836886284e-17
of O 0 3.309115526439196e-17
the O 0 8.657905580456958e-17
major O 0 8.720657354609803e-16
genetic O 0 2.186921027299074e-13
events O 0 3.999260232874502e-13
involved O 0 3.486344546388409e-11
in O 0 4.180564314865132e-12
the O 0 3.8311571254855126e-14
progression O 0 4.9721333821028946e-12
of O 0 3.0711707896052213e-15
this O 0 1.1010853687154487e-11
often O 0 2.8104275884288654e-07
fatal O 0 0.003465814283117652
cancer B-Disease 0 5.946061355643906e-05
remain O 0 1.2399485171954439e-07
to O 0 4.685252619901492e-12
be O 0 9.167901438011938e-10
elucidated O 0 1.4190194974617043e-07
. O 0 5.444889331074343e-11

Numerous O 0 6.419714759786643e-10
cytogenetic O 0 0.0002598980790935457
and O 0 2.605302362734818e-10
allelotype O 0 5.839823643327691e-06
studies O 0 3.594842645782137e-09
have O 0 2.3838193571878996e-11
reported O 0 2.939434251558737e-10
frequent O 0 8.221726410795327e-09
loss O 0 1.552411532657061e-08
of O 0 1.3580300349969737e-13
heterozygosity O 0 1.4722236301167868e-05
on O 0 2.661750597710011e-09
chromosomal O 0 0.06293264776468277
arm O 0 2.423541809548624e-05
10q O 0 3.6799957570110564e-07
in O 0 1.7332569823835797e-09
sporadic B-Disease 1 0.5004011392593384
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.553706224261987e-07

Deletion O 0 4.558111470487347e-07
mapping O 0 3.941347870295431e-07
studies O 0 2.5947867854370088e-08
have O 0 4.925826413426648e-11
unambiguously O 0 1.9782197213658037e-08
identified O 0 1.5567012123796076e-09
a O 0 9.864438259288288e-12
region O 0 2.006720789538008e-09
of O 0 6.391457458773675e-13
chromosome O 0 6.732890689420401e-09
10q23 O 0 2.094102252714336e-10
to O 0 5.185703754427562e-13
be O 0 3.473731285258408e-12
the O 0 1.1962687818686899e-14
minimal O 0 3.726320585428766e-09
area O 0 1.2305451102534448e-10
of O 0 1.8658648237579456e-10
loss O 0 1.0047125442724791e-06
. O 0 1.6509975331313598e-10

A O 0 3.401690040760741e-10
new O 0 3.589008604198973e-11
tumor B-Disease 0 1.445856145920743e-08
suppressor O 0 2.0177136406118734e-08
gene O 0 2.3434971296865115e-08
, O 0 4.971789581593999e-13
PTEN O 0 9.034885550818217e-08
/ O 0 8.06392790764221e-07
MMAC1 O 0 3.451186421443708e-05
, O 0 1.3998062691616964e-12
was O 0 2.2870811147712722e-11
isolated O 0 2.731521120402647e-10
recently O 0 5.668637470535032e-08
at O 0 7.824625669616836e-11
this O 0 4.562597044968641e-13
region O 0 1.0652887426354507e-11
of O 0 3.244188026400342e-14
chromosome O 0 5.745097730880389e-10
10q23 O 0 3.491402306154967e-11
and O 0 3.2982462789578337e-13
found O 0 1.3840752816855068e-13
to O 0 1.1175943119079781e-13
be O 0 5.267871642372635e-12
inactivated O 0 1.594990944875363e-10
by O 0 9.749145934989656e-15
mutation O 0 7.369300170090298e-10
in O 0 7.068030188905894e-11
three O 0 4.888437956651615e-07
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.0008287524105980992
lines O 0 2.5903418645611964e-06
. O 0 3.8667258284164063e-10

We O 0 3.225736833201154e-08
screened O 0 2.6181530756730353e-06
80 O 0 6.223820747663922e-08
prostate B-Disease 1 0.9970226883888245
tumors I-Disease 1 1.0
by O 0 7.113356128088388e-13
microsatellite O 0 6.347664083250493e-08
analysis O 0 2.0090644703429916e-09
and O 0 3.6997145798356446e-12
found O 0 1.732520594002751e-12
chromosome O 0 5.654884893679935e-10
10q23 O 0 3.4620933897500095e-10
to O 0 1.3393449760715215e-12
be O 0 2.339776159279716e-12
deleted O 0 1.8011232505443786e-09
in O 0 3.1862193439202713e-10
23 O 0 2.592551694158285e-11
cases O 0 1.2277030086993435e-11
. O 0 3.710104445886486e-11

We O 0 1.7170612709449529e-09
then O 0 3.744623426442384e-13
proceeded O 0 3.276737130871073e-14
with O 0 6.107932083338098e-17
sequence O 0 4.8982157746350636e-15
analysis O 0 6.0784193908129495e-15
of O 0 6.684830077147445e-16
the O 0 2.4285984668074266e-14
entire O 0 8.8970532330368e-12
PTEN O 0 1.0738339994986745e-08
/ O 0 6.814850905811909e-10
MMAC1 O 0 3.959496730487899e-09
coding O 0 2.355645012386276e-09
region O 0 8.497577752564212e-09
and O 0 1.1968372126691662e-10
tested O 0 3.796265968247781e-09
for O 0 1.6008325544878462e-15
homozygous O 0 1.2428170471923128e-11
deletion O 0 2.578182112245031e-11
with O 0 2.870236193901546e-14
new O 0 3.038636169397889e-14
intragenic O 0 1.580035963177906e-10
markers O 0 1.463384302624604e-09
in O 0 1.065908646069591e-11
these O 0 1.0049594620017976e-12
23 O 0 3.4245609820127143e-13
cases O 0 5.307400366091376e-14
with O 0 7.115700173185302e-14
10q23 O 0 1.227634616185469e-08
loss O 0 3.3669074639419705e-08
of O 0 1.1035095580369525e-11
heterozygosity O 0 7.070369611028582e-05
. O 0 3.580219898324799e-09

The O 0 3.824558942114309e-13
identification O 0 3.2136077653122097e-12
of O 0 1.5009981173025495e-14
the O 0 4.0676958193907806e-14
second O 0 1.433020911136007e-12
mutational O 0 7.895244458211437e-09
event O 0 2.7797180113253717e-09
in O 0 5.0586084800186004e-12
10 O 0 1.9819385119624472e-13
( O 0 1.0539450544667494e-14
43 O 0 6.439673447267147e-12
% O 0 6.274109703996444e-11
) O 0 1.0133734207329326e-07
tumors B-Disease 1 1.0
establishes O 0 2.9383185392362066e-05
PTEN O 0 3.963759809266776e-05
/ O 0 5.387421424529748e-06
MMAC1 O 0 7.743402079540829e-07
as O 0 9.245287369875899e-14
a O 0 2.1749395429722547e-14
main O 0 3.969515417322905e-13
inactivation O 0 1.9517316929285045e-10
target O 0 6.162760839839576e-12
of O 0 5.881346164205922e-15
10q O 0 9.84237047418901e-09
loss O 0 2.0355825824935891e-07
in O 0 7.252143885416729e-10
sporadic B-Disease 1 0.9861682057380676
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.1087692420328494e-09
. O 0 5.901967803367825e-11

Risk O 0 1.835366902014357e-06
reversals O 0 5.237912326094829e-09
in O 0 2.326199996516287e-12
predictive O 0 6.053097467706436e-10
testing O 0 8.937030004929625e-10
for O 0 8.600753442777886e-11
Huntington B-Disease 1 0.9999988079071045
disease I-Disease 1 1.0
. O 0 1.5746673298622227e-08

The O 0 9.9450450045252e-13
first O 0 6.44413924891056e-14
predictive O 0 2.5573671652567853e-11
testing O 0 2.2796610432695985e-10
for O 0 6.291486082110609e-11
Huntington B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
( O 0 3.500363540687168e-11
HD B-Disease 0 9.847216233538347e-07
) O 0 6.363905171065387e-13
was O 0 1.6219774004802567e-12
based O 0 1.136200593381204e-14
on O 0 1.1570052641657336e-13
analysis O 0 5.719351858432531e-13
of O 0 6.9881891038550605e-15
linked O 0 2.0859340643664126e-10
polymorphic O 0 8.223094080661575e-12
DNA O 0 5.348032780516654e-12
markers O 0 6.89778009016484e-12
to O 0 2.2857692301425647e-14
estimate O 0 6.422717717911863e-13
the O 0 2.533862215778034e-15
likelihood O 0 6.791438939002248e-11
of O 0 9.173829637566452e-14
inheriting O 0 2.0899972863475114e-09
the O 0 7.081327169609908e-13
mutation O 0 1.9116577765210252e-10
for O 0 4.754332778161841e-13
HD B-Disease 0 1.7756802606072597e-07
. O 0 4.95496532693096e-10

Limits O 0 7.547699132359753e-10
to O 0 5.172029932153446e-14
accuracy O 0 3.8589395351049105e-13
included O 0 4.705357489852692e-16
recombination O 0 8.465480920427648e-13
between O 0 5.910543051084599e-14
the O 0 1.1205194512528614e-15
DNA O 0 6.239614402415994e-13
markers O 0 2.284670022612012e-11
and O 0 5.209715037840512e-13
the O 0 6.758503668822732e-14
mutation O 0 2.6331701263870855e-09
, O 0 2.7880153833379287e-14
pedigree O 0 2.6319446622125042e-09
structure O 0 8.694840958334282e-10
, O 0 9.669919555301172e-15
and O 0 8.436314323447165e-15
whether O 0 1.0700773898702706e-13
DNA O 0 8.965019698825571e-12
samples O 0 8.018451180813457e-11
were O 0 3.463283533653577e-13
available O 0 1.6230007789108658e-13
from O 0 2.2296627163933408e-13
family O 0 6.451749551272812e-11
members O 0 1.0871495544073628e-11
. O 0 4.6758635158239414e-11

With O 0 9.421455586175465e-13
direct O 0 1.041659900696823e-11
tests O 0 1.0249990856081581e-09
for O 0 1.4872763529636193e-14
the O 0 6.922550911409725e-14
HD B-Disease 0 1.27064296862045e-07
mutation O 0 6.330151403055595e-10
, O 0 1.1395601801598987e-14
we O 0 9.487849145662502e-14
have O 0 6.305765892592201e-16
assessed O 0 6.930267042746033e-14
the O 0 2.8965321305787306e-16
accuracy O 0 8.758498266925319e-12
of O 0 4.683494616571993e-15
results O 0 2.0919086775317286e-12
obtained O 0 1.327378555378636e-13
by O 0 7.918984609867747e-16
linkage O 0 1.3365326640563113e-12
approaches O 0 3.475372929977877e-13
when O 0 4.036856366220788e-14
requested O 0 3.296779285655825e-14
to O 0 5.871657327016777e-13
do O 0 1.7271517549488635e-09
so O 0 3.923409177836873e-14
by O 0 3.1260149023905164e-15
the O 0 1.786472852245355e-13
test O 0 7.1412008251225956e-12
individuals O 0 5.042364637809771e-13
. O 0 3.887872229019207e-12

For O 0 5.579497367597108e-12
six O 0 3.199307138657126e-13
such O 0 3.3829709866761704e-14
individuals O 0 1.2878051056097739e-11
, O 0 2.828714909877683e-13
there O 0 6.352472801257614e-12
was O 0 4.6656337647499324e-12
significant O 0 6.40414912940479e-13
disparity O 0 2.2994463971803825e-11
between O 0 3.820636027603713e-13
the O 0 5.501131234569856e-12
tests O 0 7.164278059690332e-10
. O 0 2.1685131988691264e-12

Three O 0 1.2957981042338584e-11
went O 0 2.248824737538513e-11
from O 0 2.3406574733444117e-14
a O 0 2.561828353619955e-12
decreased O 0 6.722986256590957e-08
risk O 0 2.102591878383464e-09
to O 0 3.987741330180837e-14
an O 0 2.9799317039554823e-14
increased O 0 7.028314286117165e-08
risk O 0 0.0003878050483763218
, O 0 3.471994013907326e-13
while O 0 1.92692199002531e-11
in O 0 8.632261843267292e-14
another O 0 2.124550264447772e-13
three O 0 1.4700479061043742e-13
the O 0 3.1408417533462796e-12
risk O 0 1.3845879038854036e-06
was O 0 7.075091179586934e-09
decreased O 0 2.139700541192724e-07
. O 0 3.7174572448117615e-11

Knowledge O 0 1.3284773281441176e-10
of O 0 1.4656606820134116e-13
the O 0 1.815740313909197e-14
potential O 0 2.2343552789211296e-12
reasons O 0 2.473036098821213e-12
for O 0 5.338727434953279e-16
these O 0 8.266479876478823e-16
changes O 0 1.5815259800551484e-13
in O 0 2.6532385500894345e-14
results O 0 5.835252853830797e-12
and O 0 3.507885713675829e-13
impact O 0 9.319341826019567e-11
of O 0 3.34288837117256e-14
these O 0 1.3693085294114171e-12
risk O 0 1.1367925351057906e-10
reversals O 0 3.4245889544287644e-12
on O 0 3.238145212039467e-12
both O 0 3.834860380635963e-12
patients O 0 1.929521429785974e-12
and O 0 2.8384705610257077e-13
the O 0 8.91462400317948e-14
counseling O 0 2.7309987604695607e-11
team O 0 2.763468707339678e-12
can O 0 1.3372918224174857e-13
assist O 0 8.230868514969708e-14
in O 0 1.7213140635075064e-13
the O 0 4.155364915277727e-15
development O 0 1.790742211701707e-15
of O 0 1.7862655631661293e-16
strategies O 0 7.229548177559858e-14
for O 0 1.5416094931234832e-15
the O 0 3.27581860834307e-14
prevention O 0 4.286071497716648e-10
and O 0 1.1876580448266782e-12
, O 0 3.0348116885860936e-15
where O 0 1.3250135038646305e-13
necessary O 0 1.1704907876275428e-11
, O 0 5.757039420515144e-15
management O 0 8.344809354155283e-14
of O 0 3.5116961612692706e-16
a O 0 2.3392184456821896e-12
risk O 0 2.1431583174802427e-09
reversal O 0 7.598594496671662e-12
in O 0 5.185256182218233e-14
any O 0 8.992412120923526e-14
predictive O 0 1.486824725838165e-11
testing O 0 7.474285079744902e-12
program O 0 1.667560187157413e-12
. O 0 1.6832809628043906e-14
. O 0 4.972377761272573e-13

A O 0 1.6173173911226968e-10
novel O 0 2.5490594010579848e-11
common O 0 2.0372897813203394e-11
missense O 0 4.842146239525391e-08
mutation O 0 4.54943194228008e-09
G301C O 0 3.600913733858846e-10
in O 0 2.693213761815333e-13
the O 0 4.0134409874268903e-14
N O 0 6.81225813536912e-08
- O 0 9.403055969414709e-07
acetylgalactosamine O 0 0.00019334918761160225
- O 0 0.0031937307212501764
6 O 0 4.983334633834602e-09
- O 0 2.1074598066661565e-07
sulfate O 0 6.388231099663244e-08
sulfatase O 0 7.190209316831897e-09
gene O 0 5.240918254934002e-10
in O 0 1.1131428244437469e-11
mucopolysaccharidosis B-Disease 0 2.0632438690881827e-07
IVA I-Disease 0 9.155516636383254e-06
. O 0 3.533639159059021e-09

Mucopolysaccharidosis B-Disease 0 0.00012791315384674817
IVA I-Disease 0 0.05406932532787323
( O 0 2.109027036567568e-06
MPS B-Disease 1 0.9999997615814209
IVA I-Disease 1 1.0
) O 0 7.795492029671891e-10
is O 0 1.9600312692324984e-11
an O 0 7.718843793302899e-12
autosomal B-Disease 1 0.9999979734420776
recessive I-Disease 1 0.9999958276748657
lysosomal I-Disease 1 0.9999954700469971
storage I-Disease 1 0.9999862909317017
disorder I-Disease 1 0.9999995231628418
caused O 0 1.349468220723793e-06
by O 0 2.5562247631116808e-12
a O 0 3.764584732834919e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.8831046444400812e-10
N O 0 1.0450623904034728e-06
- O 0 1.7797958207665943e-05
acetylgalactosamine O 0 0.436664879322052
- O 1 0.9921737909317017
6 O 0 1.0038687605629093e-06
- O 0 0.00030096565023995936
sulfate O 0 2.757035144895781e-05
sulfatase O 0 2.0070955031314952e-07
( O 0 1.002468832771164e-12
GALNS O 0 3.8185095085907506e-09
) O 0 4.04367105121331e-13
. O 0 2.0964219943353513e-12

In O 0 1.2002319971227138e-10
previous O 0 2.2929338983068703e-11
studies O 0 1.0806538823515677e-11
, O 0 7.6162885134963e-14
we O 0 3.46478679080775e-11
have O 0 1.4194782773247622e-13
found O 0 2.2353347200586987e-13
two O 0 1.166499639530848e-14
common O 0 1.7677084297208767e-13
mutations O 0 5.239676054147324e-11
in O 0 1.3400188619318298e-13
Caucasians O 0 2.6939816696880392e-11
and O 0 1.3149818040014694e-11
Japanese O 0 1.1252356557633902e-07
, O 0 5.174904016587434e-13
respectively O 0 1.705310614941169e-10
. O 0 3.662630615464124e-11

To O 0 3.472684813321525e-12
characterize O 0 6.399543117652229e-10
the O 0 4.557621641199106e-13
mutational O 0 2.2305064462102564e-08
spectrum O 0 6.673346875096797e-10
in O 0 6.764281111149364e-14
various O 0 5.3133940559294424e-15
ethnic O 0 1.3913442880458815e-12
groups O 0 1.1894677083568173e-11
, O 0 2.3137279242589452e-14
mutations O 0 5.271972528669844e-12
in O 0 6.390524773854794e-15
the O 0 1.5118727074442265e-15
GALNS O 0 1.2768533452778286e-10
gene O 0 1.4055403542434508e-11
in O 0 6.593542985905421e-12
Colombian O 0 2.3196169252059917e-07
MPS B-Disease 1 0.9999994039535522
IVA I-Disease 1 1.0
patients O 0 1.2723039617412724e-05
were O 0 1.9398260775460585e-10
investigated O 0 5.853099338537504e-08
, O 0 1.0930408596461494e-13
and O 0 1.3755896378572774e-14
genetic O 0 2.071236411549382e-11
backgrounds O 0 1.3900783857323518e-09
were O 0 2.2784926072619283e-13
extensively O 0 1.4251162099368497e-12
analyzed O 0 6.5912292984693366e-12
to O 0 1.223236701546667e-14
identify O 0 3.641710197288539e-12
racial O 0 4.6430519151652305e-11
origin O 0 1.6165956073788124e-10
, O 0 6.686054039756228e-16
based O 0 1.198739555800007e-15
on O 0 9.625027147909873e-14
mitochondrial O 0 1.3857778639880802e-11
DNA O 0 5.5025612538672775e-11
( O 0 5.715968741078561e-14
mtDNA O 0 9.029803814397663e-12
) O 0 3.9050230063453206e-13
lineages O 0 5.565470306834186e-11
. O 0 1.1850744344177322e-11

Three O 0 3.993061992169089e-10
novel O 0 1.2662652038031297e-09
missense O 0 2.0068013327545486e-05
mutations O 0 0.00014587549958378077
never O 0 2.7204239927414164e-07
identified O 0 1.7139266672572262e-09
previously O 0 1.506298280551377e-10
in O 0 3.9299574879081423e-13
other O 0 1.401496513243547e-13
populations O 0 1.2003784077840862e-10
and O 0 1.114992126405312e-10
found O 0 1.2777157110122062e-10
in O 0 2.050572038558851e-11
16 O 0 3.9263159238613066e-13
out O 0 3.344325142339011e-13
of O 0 1.0719035929045509e-13
19 O 0 4.1588171795226003e-10
Colombian O 0 3.010533760061662e-07
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 0.9999996423721313
unrelated O 0 3.406771611480508e-07
alleles O 0 5.777823219865752e-10
account O 0 1.1750726780501708e-10
for O 0 2.2867647987874495e-13
84 O 0 8.522431892143967e-12
. O 0 1.0227054446365624e-11

2 O 0 5.515653905829865e-11
% O 0 3.096591559559325e-12
of O 0 4.047040751565395e-14
the O 0 3.1620824123175517e-13
alleles O 0 3.8538242042029935e-11
in O 0 1.4998664202986456e-12
this O 0 1.1862040483982123e-13
study O 0 1.6110656645557109e-12
. O 0 4.121768031051243e-12

The O 0 7.91078747647278e-12
G301C O 0 1.7407842944905383e-09
and O 0 1.1663184524071668e-12
S162F O 0 8.764067249700247e-11
mutations O 0 1.2310122365910559e-10
account O 0 1.1159319128484224e-11
for O 0 5.021499167000287e-13
68 O 0 9.940882145231811e-11
. O 0 4.0082218794035285e-11

4 O 0 1.5198921010650679e-09
% O 0 3.8326536389021726e-11
and O 0 2.1655217549709782e-11
10 O 0 3.923669722460943e-11
. O 0 4.219909491287588e-11

5 O 0 1.7839114907491904e-10
% O 0 3.0237804447830197e-12
of O 0 1.2109803719691226e-13
mutations O 0 2.771027318715369e-08
, O 0 9.337730241809616e-13
respectively O 0 4.76637063151486e-10
, O 0 1.9178406489316936e-14
whereas O 0 1.5173301851079124e-11
the O 0 3.645134324589683e-13
remaining O 0 2.4523041583512928e-11
F69V O 0 3.210470822523348e-06
is O 0 3.567508267965369e-12
limited O 0 1.4999828636119705e-13
to O 0 1.6728094332906646e-13
a O 0 6.199780706178659e-12
single O 0 2.2212034433977124e-09
allele O 0 1.914198355379426e-09
. O 0 4.539355349941765e-11

The O 0 8.600294781890838e-11
skewed O 0 1.9703232823076178e-08
prevalence O 0 2.577282032234507e-07
of O 0 4.639565709158196e-14
G301C O 0 1.4598292019663006e-10
in O 0 1.301196021590012e-13
only O 0 1.3814293371055327e-14
Colombian O 0 1.0187688366525283e-11
patients O 0 1.556787061459189e-13
and O 0 1.3486996452104476e-15
haplotype O 0 2.597247287031146e-12
analysis O 0 1.729547257636136e-14
by O 0 1.2302039710543073e-15
restriction O 0 1.050035384163317e-12
fragment O 0 1.2319840460295328e-11
length O 0 7.684719180445221e-12
polymorphisms O 0 3.067550435886801e-09
in O 0 1.827994786790521e-12
the O 0 1.3185646693426867e-13
GALNS O 0 1.5281337084616098e-08
gene O 0 9.88129786327896e-11
suggest O 0 1.5679466058848845e-10
that O 0 4.3615207067715725e-14
G301C O 0 1.12820352018983e-11
originated O 0 1.4376427132090086e-11
from O 0 2.592765141039982e-14
a O 0 2.6841468500973797e-13
common O 0 2.6963915041727793e-12
ancestor O 0 1.963272322491605e-10
. O 0 8.849836835578273e-11

Investigation O 0 1.2052236986193066e-10
of O 0 6.358915537142337e-14
the O 0 8.328332022232345e-15
genetic O 0 3.204929724387462e-11
background O 0 9.01850860657305e-09
by O 0 1.0443205409596187e-13
means O 0 9.285483840160147e-12
of O 0 2.150116268365078e-15
mtDNA O 0 2.1776235328840876e-12
lineages O 0 7.437307063609677e-13
indicate O 0 2.2621609446771274e-11
that O 0 2.5605860205606124e-13
all O 0 1.3357809866901271e-12
our O 0 1.5189727253783758e-10
patients O 0 4.967692381584177e-14
are O 0 1.4748693531654172e-14
probably O 0 4.378679276800801e-12
of O 0 9.874117176027555e-15
native O 0 1.759886125718424e-10
American O 0 1.925002152347588e-06
descent O 0 0.0006380315753631294

Low O 0 8.418924721809162e-07
frequency O 0 4.681313825471989e-08
of O 0 1.511338905586801e-12
BRCA1 O 0 8.465611323060784e-09
germline O 0 2.7390887780143203e-08
mutations O 0 8.41760154912663e-08
in O 0 2.360509183951809e-11
45 O 0 3.479503907222181e-10
German O 1 0.9997591376304626
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 9.376958769280463e-05
. O 0 8.937882656212537e-10

In O 0 5.5023693934508344e-12
this O 0 3.68154739007788e-15
study O 0 5.910452926779011e-14
we O 0 5.107449836325162e-13
investigated O 0 6.614661041126624e-10
45 O 0 9.405808770734936e-11
German O 1 0.9997369647026062
breast B-Disease 1 0.9999997615814209
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.8476061791616871e-09
for O 0 5.910700938025967e-14
germline O 0 3.7144840536740276e-09
mutations O 0 3.509166290882604e-08
in O 0 7.96644434447602e-13
the O 0 1.2480537165803635e-13
BRCA1 O 0 2.0231272213067086e-09
gene O 0 3.839068796196443e-08
. O 0 3.511331780892135e-10

We O 0 4.909566975186408e-09
identified O 0 6.062595425682105e-10
four O 0 2.7067370155127446e-13
germline O 0 4.070965786695524e-09
mutations O 0 4.779849405167624e-07
in O 0 1.1609634260889568e-11
three O 0 9.300673946277538e-12
breast B-Disease 0 0.0011901978868991137
cancer I-Disease 0 0.0001037014153553173
families O 0 2.90835466820738e-10
and O 0 1.0132154143471794e-10
in O 0 2.501714169156344e-09
one O 0 0.4378141760826111
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 3.7422273635456804e-07
. O 0 4.7538585752366497e-14
among O 0 1.0981636047968603e-15
these O 0 7.061776361697199e-15
were O 0 2.8407725932884376e-13
one O 0 5.009636911031123e-13
frameshift O 0 1.5295661626169021e-07
mutation O 0 2.1728812527044283e-08
, O 0 4.664578930903794e-14
one O 0 3.7253056542341234e-12
nonsense O 0 2.2913015982339857e-06
mutation O 0 8.453658750795512e-08
, O 0 1.0995102940093704e-13
one O 0 2.164118697071081e-14
novel O 0 2.8559842208189523e-13
splice O 0 5.870980090971756e-11
site O 0 7.018529091240566e-10
mutation O 0 3.9290111999434885e-06
, O 0 8.397952472316561e-13
and O 0 1.690960631066385e-12
one O 0 1.9706396237051393e-11
missense O 0 2.237430635432247e-05
mutation O 0 3.200347418896854e-05
. O 0 2.0807922052057393e-10

The O 0 5.0625881958810126e-11
missense O 0 8.978039431895013e-07
mutation O 0 1.2181587862869492e-06
was O 0 5.433936633991721e-10
also O 0 1.662821573142348e-12
found O 0 1.9807839396479565e-11
in O 0 1.960457490790546e-11
2 O 0 3.3506386554194023e-10
. O 0 4.221626659361988e-10

8 O 0 7.025333093046982e-10
% O 0 1.2416246416430132e-12
of O 0 1.5984382464558425e-14
the O 0 7.054631808193698e-14
general O 0 7.085276376023186e-12
population O 0 9.89994544675632e-13
, O 0 1.943010232959355e-14
suggesting O 0 7.536165469446132e-09
that O 0 8.679125126920262e-12
it O 0 1.0468817653042084e-12
is O 0 6.218279363645607e-12
not O 0 2.0500030561976246e-09
disease O 0 1.893045897816137e-08
associated O 0 2.2720223480376944e-09
. O 0 1.81094347850852e-10

The O 0 1.936154361836806e-11
average O 0 1.5950503140516048e-08
age O 0 4.2024497770576374e-10
of O 0 8.59697295990669e-13
disease O 0 2.4882868387976487e-07
onset O 0 4.710252454742658e-08
in O 0 3.7096447441653524e-11
those O 0 1.2264789878146942e-11
families O 0 3.219712257224172e-12
harbouring O 0 2.0506305986600637e-07
causative O 0 3.7957326526338875e-07
mutations O 0 5.011962755929744e-08
was O 0 2.915140004389194e-11
between O 0 1.5570135241879668e-12
32 O 0 3.804525444683904e-11
. O 0 2.130119344800896e-11

3 O 0 6.227380833223606e-09
and O 0 1.0461124327898474e-10
37 O 0 2.2755426709597515e-10
. O 0 4.718148788329657e-11

4 O 0 2.0492056940213388e-09
years O 0 3.7330888380537885e-11
, O 0 1.1377011969505597e-14
whereas O 0 2.3192797508897467e-12
the O 0 3.642060408142779e-14
family O 0 5.815208557746754e-12
harbouring O 0 1.9390073191516422e-07
the O 0 2.0156391746656288e-13
missense O 0 2.2840056512762885e-09
mutation O 0 6.298621069156241e-10
had O 0 5.366678781058842e-13
an O 0 9.722586158137313e-16
average O 0 1.3447787328146887e-09
age O 0 9.049170440755816e-11
of O 0 1.502989898337359e-13
onset O 0 1.4164520667492297e-09
of O 0 1.5299513392297293e-11
51 O 0 1.9706114517958895e-09
. O 0 6.550678888217476e-10

2 O 0 1.6820214554513768e-08
years O 0 9.317195903690845e-10
. O 0 9.63183630076081e-11

These O 0 5.0477556162720205e-12
findings O 0 9.060910008407141e-12
show O 0 7.028335136105568e-10
that O 0 1.781492162990228e-12
BRCA1 O 0 3.016743799211241e-10
is O 0 2.9311733162201703e-12
implicated O 0 7.889854991560696e-09
in O 0 2.695556993760617e-13
a O 0 1.4368511263608552e-14
small O 0 1.5146912858091804e-13
fraction O 0 4.167632905449636e-09
of O 0 3.069803642574698e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 8.750012270297702e-09
suggesting O 0 1.5286159837923918e-10
the O 0 8.276076865650333e-15
involvement O 0 3.672527126158398e-12
of O 0 8.410126605816904e-15
another O 0 6.610413171709295e-13
susceptibility O 0 9.9755787630329e-08
gene O 0 5.5082399086359146e-08
( O 0 6.468115487656689e-10
s O 0 0.00031870490056462586
) O 0 4.684509224972544e-09

Paternal O 0 0.0032214983366429806
transmission O 0 0.00047027223627083004
of O 0 5.090539900720614e-08
congenital B-Disease 1 0.999995231628418
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 6.435992872866336e-06

We O 0 9.045710847033206e-09
report O 0 5.616697211496824e-12
a O 0 2.411225482246062e-14
rare O 0 2.8343766136224025e-12
case O 0 5.351056056590586e-11
of O 0 3.404277901242203e-11
paternally O 1 0.9883715510368347
transmitted O 1 0.9999644756317139
congenital B-Disease 1 0.9999984502792358
myotonic I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 0 3.8669917557854205e-05
DM B-Disease 1 1.0
) O 0 1.7131160934269474e-09
. O 0 3.407833459867504e-10

The O 0 2.178496966154242e-11
proband O 0 4.1257642635628144e-08
is O 0 3.1177727500414365e-12
a O 0 9.786267933173387e-13
23 O 0 1.0070879893908646e-11
year O 0 5.844129867538239e-12
old O 0 3.4349461657257052e-06
, O 0 6.710610733762223e-08
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 1 0.9999164342880249
who O 0 5.0044021918438375e-05
suffers O 1 0.540432870388031
severe O 0 0.04365905374288559
muscular B-Disease 0 0.09257915616035461
weakness I-Disease 1 0.7985315918922424
. O 0 1.2288130513127271e-08

He O 0 1.0672361883123926e-09
presented O 0 3.974567064357615e-10
with O 0 3.750564303572901e-09
respiratory O 1 0.9957261085510254
and O 0 1.8813437918652198e-08
feeding O 0 1.3644068985740887e-06
difficulties O 0 2.742400101851672e-05
at O 0 7.01992552976094e-09
birth O 0 3.1990836646400567e-08
. O 0 3.236535345285674e-11

His O 0 7.488394793142561e-09
two O 0 1.053027331998635e-09
sibs O 1 0.5716192722320557
suffer O 0 7.239614933496341e-05
from O 0 7.147122338402312e-10
childhood O 0 0.09227465093135834
onset O 1 0.9355880618095398
DM B-Disease 1 1.0
. O 0 9.738548811810688e-08

Their O 0 8.462277406584562e-11
late O 0 2.4923207941895953e-10
father O 0 1.8733186113450984e-09
had O 0 2.885190567361584e-12
the O 0 6.976229845672777e-15
adult O 0 1.2666117286952439e-11
type O 0 1.0503400815764508e-08
of O 0 2.2890798631602927e-11
DM B-Disease 1 1.0
, O 0 3.64838454586236e-12
with O 0 1.3823769602974711e-12
onset O 0 7.677269375783169e-10
around O 0 7.602167784170888e-10
30 O 0 1.5382172965927587e-11
years O 0 9.416107650539463e-12
. O 0 1.1771312223574082e-11

Only O 0 1.5961435298472715e-11
six O 0 5.3905586727210145e-14
other O 0 1.0800087241218852e-15
cases O 0 5.406271133892582e-14
of O 0 5.035115526559261e-14
paternal O 0 0.002923809690400958
transmission O 0 0.0002945858577731997
of O 0 4.356543126249335e-09
congenital B-Disease 1 0.9999994039535522
DM I-Disease 1 1.0
have O 0 0.0009457613923586905
been O 0 1.609788213841057e-08
reported O 0 7.135561475024588e-09
recently O 0 1.899475687849872e-09
. O 0 3.339216750330998e-11

We O 0 3.080111513065198e-11
review O 0 1.0410271413354225e-13
the O 0 6.808389843657864e-15
sex O 0 4.651836554847577e-11
related O 0 1.9205890350315613e-11
effects O 0 8.414451357907637e-09
on O 0 5.429794835976054e-09
transmission O 0 3.953864961658837e-06
of O 0 7.621390185619248e-10
congenital B-Disease 1 0.9999864101409912
DM I-Disease 1 1.0
. O 0 1.6602395191966934e-07

Decreased O 0 9.76347678260936e-07
fertility O 0 3.153609995365514e-08
of O 0 8.097363383106904e-13
males O 0 1.8141939062132906e-09
with O 0 1.467641980168466e-12
adult O 0 8.31859736649676e-08
onset O 0 1.5871009964030236e-05
DM B-Disease 1 1.0
and O 0 4.230890748857519e-09
contraction O 0 8.059317102571129e-10
of O 0 1.5315743761600063e-15
the O 0 1.806909656620892e-14
repeat O 0 2.882366012535442e-10
upon O 0 1.1092001882956337e-12
male O 0 2.747195804175817e-10
transmission O 0 5.060934310519016e-12
contribute O 0 6.494755904959404e-14
to O 0 7.26086264680667e-14
the O 0 9.731246841324093e-13
almost O 0 2.1525951160450418e-11
absent O 0 1.1809194733203299e-09
occurrence O 0 1.0499694447219099e-08
of O 0 1.14660136853878e-12
paternal O 0 3.790129085246008e-06
transmission O 0 1.1204539305254002e-06
of O 0 7.592256268118547e-10
congenital B-Disease 1 0.9999775886535645
DM I-Disease 1 1.0
. O 0 3.569128921299125e-07

Also O 0 1.723701875677719e-10
the O 0 1.3766829473280118e-12
fathers O 0 5.4386412040585697e-11
of O 0 2.4243590669064188e-14
the O 0 5.515114406828836e-12
reported O 0 2.754660499704187e-06
congenitally O 0 0.02183542400598526
affected O 0 3.257703085068897e-08
children O 0 1.8781545763069118e-10
showed O 0 2.8544123509277597e-08
, O 0 9.266750507132965e-15
on O 0 6.614932126364215e-12
average O 0 1.6610546271778048e-10
, O 0 9.879198314919897e-16
shorter O 0 6.887105035574548e-12
CTG O 0 3.350996702344844e-10
repeat O 0 3.6068958930712824e-09
lengths O 0 6.353103287892736e-08
and O 0 1.6071748099033556e-11
hence O 0 2.0930600308499692e-10
less O 0 4.178838663992934e-10
severe O 0 3.3655644529062556e-06
clinical O 0 9.075487810150662e-07
symptoms O 0 6.484363257186487e-05
than O 0 1.86201713769929e-11
the O 0 1.5958756885425807e-11
mothers O 0 1.030743934649081e-08
of O 0 1.1442698188719042e-13
children O 0 9.953745466750874e-11
with O 0 8.902854453651798e-09
congenital B-Disease 1 0.9999806880950928
DM I-Disease 1 1.0
. O 0 5.098021915728168e-07

We O 0 3.7929562268779193e-10
conclude O 0 3.20436732703655e-11
that O 0 7.34507872818084e-14
paternal O 0 3.2623788115415664e-08
transmission O 0 5.565701499676834e-08
of O 0 1.8284455546857536e-11
congenital B-Disease 1 0.999997615814209
DM I-Disease 1 1.0
is O 0 1.7159350607087731e-09
rare O 0 1.1317343590055984e-10
and O 0 5.815760199812114e-13
preferentially O 0 7.345790642432348e-11
occurs O 0 3.2058448777572135e-12
with O 0 3.010298766850791e-15
onset O 0 4.194965555481822e-12
of O 0 1.1152292197363911e-12
DM B-Disease 1 1.0
past O 0 4.1263197658736317e-07
30 O 0 1.651280154280066e-11
years O 0 1.7211310501807908e-12
in O 0 3.068842041923335e-14
the O 0 4.9033402392626574e-14
father O 0 9.285316404650246e-10
. O 0 2.5943296447748787e-13
. O 0 1.2820304713667685e-12

The O 0 1.1080467099411351e-10
RB1 O 0 4.229497108099167e-07
gene O 0 5.400492941731727e-09
mutation O 0 1.874295634252121e-07
in O 0 2.3485083235769144e-12
a O 0 3.0123722960517796e-11
child O 0 0.0001358514855382964
with O 0 2.911522187787341e-07
ectopic B-Disease 1 0.9999798536300659
intracranial I-Disease 1 0.9999948740005493
retinoblastoma I-Disease 1 0.9997110962867737
. O 0 6.604646841879003e-06

The O 0 1.3396478371063836e-10
RB1 O 0 2.450823899380339e-07
gene O 0 3.038006068933896e-09
mutation O 0 3.9250082295438915e-08
was O 0 4.58421495208583e-12
investigated O 0 1.6322554419190283e-09
in O 0 2.99782963210371e-12
a O 0 1.5187552604434273e-10
child O 0 0.01960349828004837
with O 0 4.8118188544776785e-08
ectopic B-Disease 1 0.9997677206993103
intracranial I-Disease 1 0.9982568621635437
retinoblastoma I-Disease 0 4.540046560919109e-08
using O 0 2.6709619758980008e-12
DNA O 0 6.07906114336032e-10
obtained O 0 3.3799060772388145e-11
from O 0 2.0950607785077957e-14
both O 0 3.496868118961667e-14
the O 0 3.0069561207310413e-13
pineal B-Disease 0 3.830803052551346e-08
and I-Disease 0 2.8886582015275053e-09
retinal I-Disease 0 7.722347618255299e-06
tumours I-Disease 1 1.0
of O 0 4.77878431270895e-11
the O 0 9.592016070314457e-11
patient O 0 3.13935082374428e-08
. O 0 2.8829365977811605e-11

A O 0 8.125475403630844e-09
nonsense O 0 1.2538964710984146e-06
mutation O 0 5.460060847894965e-08
in O 0 3.826019796121516e-12
exon O 0 3.229565948004165e-08
17 O 0 5.884323583948969e-10
( O 0 4.702383366592469e-14
codon O 0 1.5772492903756707e-12
556 O 0 1.3424516760816158e-13
) O 0 2.1196908448997036e-15
of O 0 4.027225771017096e-15
the O 0 4.702340947182471e-13
RB1 O 0 1.7428639642602661e-09
gene O 0 1.2985443449686773e-11
was O 0 1.238437043887819e-11
found O 0 1.4967448938238426e-13
to O 0 2.900858806637041e-14
be O 0 1.1403837943402273e-11
present O 0 7.594595091697798e-12
homozygously O 0 6.783099706808571e-06
in O 0 1.7820845493732307e-11
both O 0 1.592764115043721e-12
the O 0 3.8447747047719305e-13
retinal B-Disease 0 3.2674216665640188e-09
and I-Disease 0 8.092527759018253e-10
the I-Disease 0 2.5036125950173016e-10
pineal I-Disease 0 0.0005661940085701644
tumours I-Disease 1 0.9999998807907104
. O 0 8.418673758114892e-09

The O 0 1.3107075320928363e-11
same O 0 6.277577849905791e-12
mutation O 0 1.043593406135912e-10
was O 0 3.754163592408627e-13
present O 0 2.6234931246741158e-14
heterozygously O 0 2.652358332966287e-10
in O 0 6.751335821913182e-15
the O 0 1.716282509923897e-16
DNA O 0 3.3104161772934404e-13
from O 0 3.4460751953565e-15
the O 0 4.387885623694399e-15
constitutional O 0 5.12106936717549e-12
cells O 0 1.6036770435906567e-12
of O 0 5.403495491627724e-15
the O 0 2.0255680813208166e-12
patient O 0 1.4839364181895576e-09
, O 0 8.817638391905684e-15
proving O 0 2.7209534972372218e-11
it O 0 5.047377988655344e-13
to O 0 1.4929100707397613e-13
be O 0 5.409786507648562e-11
of O 0 1.366667196078808e-13
germline O 0 1.4148002769331924e-08
origin O 0 9.247924737110225e-08
. O 0 2.867046322574396e-10

The O 0 5.9304124111481116e-12
initial O 0 2.578939319042295e-11
mutation O 0 1.1310400394037856e-09
was O 0 3.963994063549414e-12
shown O 0 7.161155782947626e-12
to O 0 3.9192902937836005e-13
have O 0 8.844133064789261e-11
occurred O 0 3.6966238958768827e-09
in O 0 5.506618923865891e-13
the O 0 3.8003150973353605e-13
paternally O 0 8.170201404311683e-09
derived O 0 2.0132179257004168e-10
RB1 O 0 7.329482087925498e-08
allele O 0 8.94890650471325e-09
. O 0 5.4158878770582675e-11

The O 0 1.823607931328297e-11
mutation O 0 2.5043065399188436e-09
is O 0 3.6285969888527614e-13
in O 0 1.0607494395386326e-14
an O 0 8.179745820262351e-16
area O 0 9.343280316098657e-11
of O 0 1.0101771849568841e-12
the O 0 1.1483977831183712e-13
gene O 0 2.310832731763912e-12
that O 0 8.169549131764185e-16
encodes O 0 9.136660645994808e-16
the O 0 7.155815865325502e-16
protein O 0 2.835122761557507e-12
- O 0 9.141087389252789e-07
binding O 0 4.610486570300054e-08
region O 0 2.0282688029116258e-10
known O 0 5.076615343380109e-12
as O 0 1.7292785042463676e-12
the O 0 5.277181144326681e-13
pocket O 0 0.00042666253284551203
region O 0 1.6777505152276717e-05
and O 0 7.876653285165958e-07
has O 0 4.4617124217438686e-08
been O 0 3.7735956026629935e-10
detected O 0 1.93770958389905e-07
in O 0 6.14477341080201e-14
other O 0 3.76511693120341e-15
cases O 0 7.001347337174182e-14
of O 0 3.867925131659927e-15
retinoblastoma B-Disease 0 8.807872486915613e-11
. O 0 5.541369880318614e-12
. O 0 3.921148475360958e-11

Low O 0 0.00310620479285717
levels O 0 8.326001079694834e-07
of O 0 8.24221130257298e-14
beta O 0 2.3680024954786383e-12
hexosaminidase O 0 5.4780415759125844e-09
A O 0 1.1108246267266253e-11
in O 0 1.2920215028064397e-12
healthy O 0 8.298491060987345e-11
individuals O 0 1.5988202244337363e-13
with O 0 2.8671569242064154e-13
apparent O 0 5.613106168311788e-06
deficiency O 0 0.0691644549369812
of O 0 6.58332895440766e-15
this O 0 8.834763026406914e-14
enzyme O 0 1.5462213107109157e-11
. O 0 1.2666545329970136e-12

Appreciable O 0 3.588659410524997e-06
beta O 0 1.1616695161364987e-08
hexosaminidase O 0 1.4696024663862772e-06
A O 0 1.3577160229427676e-10
( O 0 1.367848705396274e-13
hex O 0 5.326776780084641e-12
A O 0 8.887702314559764e-13
) O 0 5.098723719843207e-15
activity O 0 5.595133731328694e-11
has O 0 5.033563084573534e-13
been O 0 1.502623871683928e-12
detected O 0 2.249706199108914e-07
in O 0 1.2608190316440449e-12
cultured O 0 1.8205176033347925e-08
skin O 0 2.446658299959381e-06
fibroblasts O 0 2.247120489684562e-09
and O 0 2.261586296015139e-08
melanoma B-Disease 0 0.0017493589548394084
tissue O 0 4.113977922770573e-07
from O 0 8.636161924480135e-11
healthy O 0 2.200708726363132e-09
individuals O 0 2.5748587290097547e-12
previously O 0 4.42108016862619e-10
reported O 0 4.118568153188562e-09
as O 0 3.343818277823374e-11
having O 0 4.446679668035358e-05
deficiency B-Disease 0 0.00789530761539936
of I-Disease 0 1.988715622573429e-14
hex I-Disease 0 8.414439284232245e-12
A I-Disease 0 1.465013006740623e-12
activity O 0 2.2174000482988454e-11
indistinguishable O 0 6.589642026488818e-13
from O 0 3.58167077065181e-15
that O 0 1.4592888597270322e-14
of O 0 2.1113727357181117e-13
patients O 0 1.226046902891298e-10
with O 0 3.80360143026337e-05
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.920494794845581
( O 0 1.7300043776008467e-12
TSD B-Disease 0 7.2499211078991266e-09
) O 0 4.6610710083272444e-12
. O 0 1.342051036273828e-11

Identification O 0 5.11348385856536e-09
and O 0 1.0169652446545552e-11
quantitation O 0 2.3089125988917658e-07
of O 0 1.0043712823232243e-12
hex O 0 2.86480533739919e-10
A O 0 1.5916349835332078e-11
, O 0 1.4156624277786994e-14
amounting O 0 3.790269313685979e-12
to O 0 5.956948259319694e-13
3 O 0 8.866428424791906e-11
. O 0 2.8334065649282536e-10

5 O 0 2.2002595301273686e-09
% O 0 4.990142188354696e-10
- O 0 2.5064900910365395e-05
6 O 0 3.0821889485110887e-09
. O 0 1.451942871488754e-10

9 O 0 1.3681201727067105e-09
% O 0 3.1072234629031525e-12
of O 0 1.0712843101761543e-13
total O 0 2.777307897550152e-12
beta O 0 1.0737750098799292e-11
hexosaminidase O 0 3.3867036108858883e-07
activity O 0 8.330172107662293e-08
, O 0 1.0191248852578407e-14
has O 0 2.1299780176924597e-14
been O 0 3.2549337404790945e-15
obtained O 0 3.026293205290499e-14
by O 0 5.1608133524593154e-15
cellulose O 0 2.5030350014887404e-10
acetate O 0 5.222653906566954e-11
gel O 0 3.6597136432447996e-10
electrophoresis O 0 2.6756081725198833e-11
, O 0 6.47200256711708e-14
DEAE O 0 1.4014627680580816e-08
- O 0 1.2395584558788642e-09
cellulose O 0 9.768156283840312e-10
ion O 0 1.2748013489272125e-07
- O 0 2.0097877495572902e-06
exchange O 0 3.300543616191476e-09
chromatography O 0 3.9390360417890236e-10
, O 0 2.8972589166112103e-14
radial O 0 1.6031387372120176e-12
immunodiffusion O 0 6.162676591259242e-09
, O 0 4.4268958616054677e-13
and O 0 7.745094496303118e-12
radioimmunoassay O 0 5.449754212349944e-07
. O 0 2.9076890895041174e-10

Previous O 0 2.5599269370957245e-09
family O 0 1.6705355154744694e-10
studies O 0 9.784817053826167e-12
suggested O 0 3.480736532335271e-11
that O 0 1.5796930007572901e-13
these O 0 1.396159832981348e-14
individuals O 0 1.561537140912228e-12
may O 0 4.92702212362417e-10
be O 0 1.2181065617983267e-12
compound O 0 1.7070663459184399e-12
heterozygotes O 0 3.944582507853234e-11
for O 0 8.225780049242373e-15
the O 0 4.559714896780996e-14
common O 0 2.9285133346101944e-12
mutant O 0 3.151933575251675e-11
TSD B-Disease 0 6.34877261873612e-10
gene O 0 5.49652212633589e-10
and O 0 1.724824926982449e-12
a O 0 3.198282296553584e-13
rare O 0 2.4827795375159667e-10
( O 0 9.643683421267646e-13
allelic O 0 9.210706863882479e-09
) O 0 2.7620830969632415e-12
mutant O 0 3.1192096128229707e-10
gene O 0 2.288319400634009e-08
. O 0 1.3098934437127951e-10

Thus O 0 3.602370346467154e-10
, O 0 5.0054510774937e-14
the O 0 1.2599402485137957e-14
postulated O 0 1.0874062539301121e-08
rate O 0 6.187648438071847e-08
mutant O 0 4.376107982928534e-12
gene O 0 1.269359183736496e-11
appears O 0 3.3854076226386143e-12
to O 0 3.275596844529567e-16
code O 0 6.025617686221721e-16
for O 0 6.632374517864068e-17
the O 0 1.148313926856593e-14
expression O 0 1.727902126935632e-10
of O 0 4.984950169664715e-13
low O 0 1.3964436718083562e-08
amounts O 0 6.312207700975847e-11
of O 0 9.683570134991215e-13
hex O 0 2.280556854472593e-10
A O 0 2.43238151842462e-10
. O 0 6.859028622852037e-11

Heterozygotes O 0 1.8089502873408492e-07
for O 0 8.091805220669657e-13
the O 0 3.477030404049064e-13
rare O 0 1.1056991433555652e-10
mutant O 0 5.388652724036547e-08
may O 0 2.464925330514234e-07
be O 0 6.445129586279963e-12
indistinguishable O 0 5.954887277725973e-11
from O 0 3.786024499550372e-14
heterozygotes O 0 1.441619601472155e-10
for O 0 1.1078501465267183e-14
the O 0 1.9566526133704687e-13
common O 0 1.627708384743798e-11
TSD B-Disease 0 1.2388263748164263e-08
mutant O 0 3.0801849959516403e-09
. O 0 9.53797874014839e-11

However O 0 2.5115605775671845e-11
, O 0 2.268395525603195e-15
direct O 0 2.2019963164063988e-14
visualization O 0 1.9793640684828695e-11
and O 0 4.001848765561311e-12
quantitation O 0 2.9469090350175975e-06
of O 0 7.891735225376562e-13
hex O 0 2.1049694973185318e-11
A O 0 1.3820651708577186e-13
by O 0 2.0525713188845624e-15
the O 0 8.962368794020658e-16
methods O 0 3.5149467971645754e-12
described O 0 2.819379452123627e-10
may O 0 9.939062073360816e-11
prevent O 0 4.823810188098188e-12
false O 0 1.0712502884757669e-08
- O 0 1.0346344225808934e-07
positive O 0 1.1788095673204158e-11
prenatal O 0 1.639989299917488e-08
diagnosis O 0 1.519567360830365e-09
of O 0 5.237707003411061e-15
TSD B-Disease 0 6.360922810699776e-08
in O 0 3.566940354193804e-10
fetuses O 0 3.9868101708862014e-08
having O 0 6.064095753322007e-11
the O 0 7.731624585352592e-14
incomplete O 0 2.7034359993682866e-12
hex B-Disease 0 1.2471459628904391e-11
A I-Disease 0 2.0242725551344876e-10
deficiency I-Disease 0 6.360663246596232e-05
of O 0 2.7042378956238476e-14
the O 0 4.504732524501787e-12
type O 0 0.039126940071582794
described O 0 2.345286702620797e-06
in O 0 1.209302324944872e-09
the O 0 2.5687283897180002e-11
four O 0 2.839530832687842e-10
healthy O 0 1.1309587044650016e-08
individuals O 0 8.96992147225717e-10

The O 0 3.0189256650103857e-10
tumor B-Disease 0 1.767128878782387e-07
suppressor O 0 5.398054980787492e-08
gene O 0 3.388618807775856e-08
Smad4 O 0 6.354920287776622e-07
/ O 0 3.849943936984346e-07
Dpc4 O 0 2.0102307374259e-08
is O 0 2.986738460719618e-13
required O 0 2.176450141530388e-14
for O 0 1.9362012474397771e-16
gastrulation O 0 6.383204381732455e-11
and O 0 1.4708656168038736e-11
later O 0 1.4493108102531238e-11
for O 0 1.8314767291725126e-13
anterior O 0 2.1975868347290373e-10
development O 0 3.596974877239506e-13
of O 0 3.9716334740294915e-14
the O 0 3.525782096835961e-13
mouse O 0 1.9680610474637206e-09
embryo O 0 1.6349350762112635e-09
. O 0 1.4300324813198984e-10

Mutations O 0 1.026933887260384e-06
in O 0 1.871702272338016e-11
the O 0 6.0318395243841305e-12
SMAD4 O 0 0.00043942779302597046
/ O 0 0.0026211044751107693
DPC4 O 0 0.00025563276722095907
tumor B-Disease 0 2.40238733795195e-07
suppressor O 0 1.5827101407239752e-08
gene O 0 9.049628602042503e-09
, O 0 1.7032406843427161e-13
a O 0 5.5616410321547224e-14
key O 0 1.2719427074092682e-11
signal O 0 1.725708603794729e-10
transducer O 0 3.484435140421738e-08
in O 0 3.965705541730813e-11
most O 0 1.9310787777865324e-12
TGFbeta O 0 1.735083969833795e-06
- O 0 2.0835372538385855e-07
related O 0 3.4793976033675733e-10
pathways O 0 2.4061639182851313e-13
, O 0 1.8974493048144357e-15
are O 0 4.541612786258635e-16
involved O 0 4.929221161559423e-14
in O 0 1.1122269690530887e-13
50 O 0 3.280516049780635e-13
% O 0 7.565761710702501e-13
of O 0 3.8894043541404244e-10
pancreatic B-Disease 0 0.11248350143432617
cancers I-Disease 1 0.9998581409454346
. O 0 1.8801959100755994e-08

Homozygous O 0 1.7738466340233572e-05
Smad4 O 0 0.00011769565753638744
mutant O 0 2.9920325687271543e-05
mice O 0 0.00383208435960114
die O 0 0.0006676166085526347
before O 0 1.120721154768134e-10
day O 0 2.707348754904526e-11
7 O 0 1.04520636937111e-11
. O 0 4.6415445272007805e-12

5 O 0 7.300928195341783e-10
of O 0 5.8579456389817874e-12
embryogenesis O 0 5.1039176440781375e-08
. O 0 4.482147097917277e-09

Mutant O 0 1.4906206047271553e-08
embryos O 0 1.8917816202446147e-09
have O 0 7.700039911240353e-11
reduced O 0 2.9061919537554104e-10
size O 0 1.653010173185976e-07
, O 0 2.8766966239657243e-11
fail O 0 2.1126112415004172e-07
to O 0 1.1037426398199934e-12
gastrulate O 0 1.6309437341988087e-05
or O 0 3.6423337679281076e-09
express O 0 3.834962729321045e-12
a O 0 4.529022827343826e-14
mesodermal O 0 1.40318381913751e-10
marker O 0 2.8162205900628123e-09
, O 0 4.86850848264303e-13
and O 0 2.945812864474373e-12
show O 0 1.175347051685094e-06
abnormal O 0 1.5462005364952347e-07
visceral O 0 9.489627750269847e-09
endoderm O 0 4.6247367890828173e-07
development O 0 4.4834681106609153e-11
. O 0 4.8743110242499554e-11

Growth B-Disease 1 0.999997615814209
retardation I-Disease 1 0.9999979734420776
of O 0 1.5154617144519378e-11
the O 0 1.0307226426531368e-11
Smad4 O 0 2.8057247618562542e-05
- O 0 2.5778186682146043e-05
deficient O 0 6.056634749285195e-09
embryos O 0 8.292237556328796e-12
results O 0 2.777966225109285e-11
from O 0 9.752647908006784e-14
reduced O 0 2.0463911815093994e-11
cell O 0 2.741223636970602e-10
proliferation O 0 9.708607251468493e-10
rather O 0 6.127735580237215e-13
than O 0 4.887700284111375e-14
increased O 0 3.5899633417900423e-13
apoptosis O 0 1.4649411891887176e-11
. O 0 9.16163412495452e-12

Aggregation O 0 1.816333750070953e-09
of O 0 1.1970374344527634e-11
mutant O 0 6.6572174439727405e-09
Smad4 O 0 8.936115705182601e-07
ES O 0 1.585021180972035e-08
cells O 0 8.508918396266107e-12
with O 0 5.246688093750798e-14
wild O 0 3.2224021229154687e-09
- O 0 2.3571401470690034e-05
type O 0 4.048546543344855e-06
tetraploid O 0 2.602266420126398e-07
morulae O 0 5.725008804802201e-07
rescues O 0 3.9491204972819105e-08
the O 0 3.73830306987788e-12
gastrulation B-Disease 0 5.0732865020108875e-08
defect I-Disease 0 3.033812390640378e-06
. O 0 2.017477018778635e-10

These O 0 4.5660922959323e-11
results O 0 1.1679825162591584e-10
indicate O 0 2.7579796779697574e-10
that O 0 1.7797929471354001e-13
Smad4 O 0 4.3984065278834805e-09
is O 0 1.1004465567954202e-12
initially O 0 1.210043350241552e-12
required O 0 1.6070712062542583e-14
for O 0 4.176066982843773e-17
the O 0 2.1731129217154567e-16
differentiation O 0 4.554262799809404e-15
of O 0 7.655137552567176e-16
the O 0 1.3962342871774117e-14
visceral O 0 2.584031877361781e-10
endoderm O 0 5.352684517845319e-09
and O 0 4.508056254681758e-13
that O 0 8.223144929743464e-15
the O 0 6.885071736372796e-15
gastrulation B-Disease 0 8.812291868443012e-11
defect I-Disease 0 6.69575195288985e-09
in O 0 1.418731126502648e-13
the O 0 1.632529154178483e-13
epiblast O 0 4.88358464778571e-09
is O 0 6.046355777167278e-11
secondary O 0 1.9133294948403545e-09
and O 0 3.266274806179581e-09
non O 0 2.4727405616431497e-06
- O 0 0.00013951549772173166
cell O 0 2.3492462730700936e-07
autonomous O 0 3.297317263672994e-08
. O 0 9.670645395587485e-10

Rescued O 0 3.815021045738831e-06
embryos O 0 6.386915885059352e-08
show O 0 0.00016153378237504512
severe O 0 0.4012106657028198
anterior O 0 0.19896183907985687
truncations O 0 0.03723108395934105
, O 0 1.3640606422171686e-09
indicating O 0 2.1426078689046335e-08
a O 0 7.14372137833319e-12
second O 0 1.0674238186056395e-12
important O 0 1.869744085307521e-14
role O 0 3.2395600958745607e-12
for O 0 1.7972727256107546e-13
Smad4 O 0 3.5672371723194374e-07
in O 0 3.3728804471611085e-11
anterior O 0 4.314751222977975e-08
patterning O 0 5.372713758333703e-07
during O 0 7.259381984425772e-10
embryogenesis O 0 2.7086029419365332e-08
. O 0 2.8371271998395287e-10

Prevalence O 0 9.06222194316797e-05
of O 0 3.158636329922415e-12
p16 O 0 2.774516394410398e-09
and O 0 6.002847958291868e-12
CDK4 O 0 7.382347888551521e-08
germline O 0 2.521827191515058e-08
mutations O 0 9.581022197835409e-08
in O 0 1.1364103234823286e-11
48 O 0 4.0957071067992956e-10
melanoma B-Disease 1 0.9952805638313293
- O 1 0.9999866485595703
prone O 1 0.9999922513961792
families O 0 5.062595960225735e-07
in O 0 1.368410451618729e-08
France O 0 0.0002916655212175101
. O 0 8.32720947752108e-10

The O 0 2.099846962977381e-09
French O 0 7.582084435853176e-06
Familial B-Disease 0 0.0024716730695217848
Melanoma I-Disease 1 0.9532592296600342
Study O 0 7.148939218382111e-09
Group O 0 2.484907835054173e-09
. O 0 5.019455337484935e-11

Germline O 0 5.145575869391905e-06
mutations O 0 4.87883880850859e-06
in O 0 2.8586779211164925e-12
the O 0 3.979018923703191e-14
p16 O 0 1.2411736916018157e-10
and O 0 5.873530828370832e-12
CDK4 O 0 6.293655019362632e-07
genes O 0 1.1993674942090138e-09
have O 0 1.1040337914713927e-11
been O 0 7.848268042398576e-12
reported O 0 9.141565282533293e-11
in O 0 7.0786331643805066e-15
a O 0 1.734251170405418e-14
subset O 0 9.46243083888021e-12
of O 0 5.306153780249012e-11
melanoma B-Disease 0 0.4608290195465088
pedigrees O 0 2.424829472147394e-05
, O 0 1.6108144332283025e-11
but O 0 1.4967879158334085e-09
their O 0 3.518706714888964e-10
prevalence O 0 1.4003890669300745e-07
is O 0 1.931284993039739e-12
not O 0 1.152018259432952e-12
well O 0 6.145268755669564e-13
known O 0 1.0996497983029041e-11
. O 0 4.124326227761266e-11

We O 0 4.085881979976058e-11
searched O 0 7.5237168925546e-12
for O 0 2.2742004541489655e-15
such O 0 4.020796282727668e-14
germline O 0 4.178513979269383e-09
mutations O 0 4.196710889914357e-08
in O 0 1.0006774055215661e-11
48 O 0 1.0430739605382655e-10
French O 0 8.57858030940406e-05
melanoma B-Disease 1 0.9999845027923584
- O 1 0.9999959468841553
prone O 1 0.9999725818634033
families O 0 2.3645388425030944e-10
selected O 0 2.322848077079831e-12
according O 0 2.460252325215545e-13
to O 0 9.1654301200483e-15
two O 0 2.8219116513596198e-15
major O 0 2.384003367980614e-13
criteria O 0 4.572081602205458e-10
families O 0 1.5558838194055548e-14
with O 0 3.3209824050906694e-14
at O 0 1.1313895376119376e-09
least O 0 3.348675503556109e-11
three O 0 2.5487079894498388e-12
affected O 0 6.046214310467812e-12
members O 0 1.20267463793889e-14
( O 0 1.8847824776596633e-14
n O 0 3.4193792242120935e-09
= O 0 6.81650558220781e-09
20 O 0 1.047680280204244e-13
) O 0 1.3157444519689798e-15
or O 0 2.1725796509053374e-11
families O 0 6.449676404930715e-13
with O 0 6.457086384678568e-13
two O 0 1.0308524867053137e-11
affected O 0 1.0479371710669927e-11
members O 0 6.0742473300312485e-15
, O 0 5.384831967667923e-15
one O 0 8.721360391956024e-15
of O 0 3.726735327264476e-15
them O 0 3.6013480067022263e-13
affected O 0 5.110139199814012e-13
before O 0 3.1681555707867293e-13
the O 0 1.5645115953623334e-13
age O 0 1.1954226497579157e-10
of O 0 8.863502684900663e-15
50 O 0 2.1488968373825634e-13
( O 0 3.0134369392170735e-14
n O 0 1.3725097858241497e-07
= O 0 2.081963202726911e-06
28 O 0 9.810273426946736e-11
) O 0 3.409061973143855e-14
, O 0 4.360871879533976e-14
and O 0 1.672631542819214e-12
one O 0 1.4544268567284746e-13
additional O 0 9.128035783831367e-13
minor O 0 1.4040787421620848e-09
criterion O 0 6.548359188229824e-09
. O 0 3.3327665627247427e-10

Sixteen O 0 3.6123486424344264e-09
different O 0 1.8651521299650753e-11
p16 O 0 1.5287510146677619e-09
germline O 0 1.8186122829888518e-08
mutations O 0 1.3969396661650535e-07
were O 0 7.969624959969224e-12
found O 0 6.632265049655306e-12
in O 0 2.8396688212667387e-12
21 O 0 6.742672826326457e-12
families O 0 1.1401869845408669e-13
, O 0 1.5608863959920387e-14
while O 0 2.4757558850230232e-11
one O 0 1.303859906327809e-12
germline O 0 3.91109900022002e-09
mutation O 0 5.190126994847333e-09
, O 0 5.5896288642044885e-15
Arg24His O 0 2.321406400440651e-10
, O 0 6.319438380789424e-14
was O 0 2.5580565443661385e-10
detected O 0 7.969721991685219e-06
in O 0 4.0245601989896684e-12
the O 0 6.758687034515154e-13
CDK4 O 0 2.9602503559544857e-07
gene O 0 2.6171373956884736e-09
. O 0 9.46765305043229e-11

The O 0 2.409728883448481e-12
frequency O 0 3.187824171302367e-10
of O 0 3.5851032022639687e-14
p16 O 0 4.2164421260038054e-11
gene O 0 3.809522974851376e-10
mutation O 0 7.370863919220483e-09
in O 0 1.9768266342444496e-13
our O 0 3.651192778566896e-14
sample O 0 9.337903985207757e-14
( O 0 1.3280534288793609e-15
44 O 0 6.476419843937011e-15
% O 0 9.469439562180288e-15
) O 0 3.950507879401906e-15
is O 0 3.0406550216056927e-13
among O 0 4.835061591010846e-14
the O 0 2.8108177677760304e-12
highest O 0 4.096588963875547e-05
rates O 0 4.529749639914371e-05
yet O 0 2.6723850563015183e-11
reported O 0 1.0463852874453838e-11
and O 0 5.88633213894664e-14
the O 0 1.5112221437890878e-14
CDK4 O 0 3.2510612868463795e-08
mutation O 0 1.4230587541685935e-10
is O 0 5.0317362039128954e-14
the O 0 6.638684251576623e-15
second O 0 4.741801135771384e-12
mutation O 0 2.441786328688522e-09
detected O 0 2.2027765567145252e-07
in O 0 7.859254832218512e-14
this O 0 1.3914038276858099e-14
gene O 0 2.1174444142513238e-11
worldwide O 0 2.0389575444701435e-11
. O 0 1.918037430270747e-11

In O 0 4.7856257151535075e-11
summary O 0 1.7474366398317898e-10
, O 0 1.780261593524457e-13
our O 0 2.6878061408497356e-12
results O 0 5.377714332871486e-13
show O 0 3.5026994325837446e-12
frequent O 0 3.1460639215302733e-12
involvement O 0 6.012464831561815e-11
of O 0 1.4571250293599763e-14
the O 0 1.036544880147778e-14
p16 O 0 6.188144614782676e-12
gene O 0 6.919051442899615e-11
in O 0 1.0970347893990429e-12
familial B-Disease 0 1.6173951280507026e-06
melanoma I-Disease 0 0.26115119457244873
and O 0 6.531013924115925e-11
confirm O 0 1.6217548193253606e-08
the O 0 3.658938386649768e-14
role O 0 7.738878114726955e-12
of O 0 1.520656735568785e-14
the O 0 4.3520474902894804e-14
CDK4 O 0 4.629067351658023e-09
gene O 0 1.256922604192523e-11
as O 0 4.679847004709914e-13
a O 0 4.8313356787454964e-11
melanoma B-Disease 0 0.12243171781301498
- O 0 3.273604079367942e-06
predisposing O 0 4.724817870283005e-09
gene O 0 1.8148282876495614e-08
. O 0 1.5279420090275053e-11
. O 0 1.4270345322087152e-11

Progression O 0 1.1431703228481638e-07
of O 0 5.58364899455599e-12
somatic O 0 9.371828646465019e-09
CTG O 0 2.941695811387035e-07
repeat O 0 5.5700450474205354e-08
length O 0 4.012574300604754e-11
heterogeneity O 0 2.346282057530402e-09
in O 0 4.072499629192983e-11
the O 0 2.937284963866471e-12
blood O 0 8.940751250463563e-09
cells O 0 1.648204350779281e-09
of O 0 1.8823145819801823e-10
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
patients O 0 2.3797198082320392e-05
. O 0 6.788774542521026e-10

The O 0 8.709101690686227e-13
genetic O 0 1.1716573544706677e-10
basis O 0 7.127012174867886e-11
of O 0 2.33502606139524e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.3034969015279785e-05
DM B-Disease 1 1.0
) O 0 2.6527972527001786e-11
is O 0 1.9311586834866445e-13
the O 0 3.738525602373782e-15
expansion O 0 7.233331772091289e-13
of O 0 8.876630848550157e-15
an O 0 4.90306254798123e-13
unstable O 0 7.01262763413979e-07
CTG O 0 1.6049380491267584e-08
repeat O 0 9.245543708402693e-08
in O 0 7.402860334286554e-13
the O 0 1.8095447761198e-14
34 O 0 1.716134558679e-13
UTR O 0 8.316566185717633e-12
of O 0 1.6300610356954556e-14
the O 0 6.491979176459495e-11
DM B-Disease 1 1.0
protein O 0 3.8445754912963537e-10
kinase O 0 6.968697618958686e-09
gene O 0 3.6990712715123664e-09
on O 0 5.058131691271228e-10
chromosome O 0 8.095558996501495e-07
19 O 0 3.8501229981946494e-10
. O 0 7.248900698447747e-12

One O 0 1.0063992000874933e-10
of O 0 7.218663465374461e-14
the O 0 5.77574012922133e-14
principal O 0 1.122785284884964e-11
features O 0 4.641367151725362e-12
of O 0 2.726592823049101e-13
the O 0 1.0097168434697323e-08
DM B-Disease 1 1.0
mutation O 0 6.553230377903674e-06
is O 0 5.976557139811267e-13
an O 0 2.255710783701588e-15
extraordinarily O 0 1.0122815474744584e-08
high O 0 8.928502381877479e-08
level O 0 1.131666920173302e-07
of O 0 3.420407471252558e-14
somatic O 0 5.620933579697507e-11
mosaicism O 0 1.0098863079122111e-08
, O 0 3.055456820715008e-13
due O 0 2.6974407950353108e-12
to O 0 1.1003851773999304e-13
an O 0 7.068490622463494e-14
extremely O 0 2.2147789024984377e-07
high O 0 1.8469481943839128e-08
degree O 0 4.997758296099164e-08
of O 0 3.7283603938551013e-13
somatic O 0 2.4075825777458704e-09
instability O 0 1.6462719258925063e-06
both O 0 2.121636720475717e-11
within O 0 2.489277881045915e-12
and O 0 3.32135968034164e-12
between O 0 4.3082928175529334e-13
different O 0 5.415121476226581e-12
tissues O 0 5.381008527649556e-09
. O 0 1.284174936527771e-11

This O 0 5.51605358611873e-11
instability O 0 1.6780481004730063e-08
appears O 0 1.0209129375216008e-10
to O 0 4.63999939002719e-14
be O 0 1.901486306192697e-14
biased O 0 2.713870523706613e-13
towards O 0 1.4470932793524648e-14
further O 0 4.163520572010365e-15
expansion O 0 8.421109404417593e-14
and O 0 6.824589772290576e-15
continuous O 0 9.909914821257595e-14
throughout O 0 6.380446843610998e-13
the O 0 1.3942818254120137e-13
life O 0 9.676909447364768e-12
of O 0 2.2225771312060457e-16
an O 0 1.1017639183391647e-15
individual O 0 7.925981919398861e-12
, O 0 5.86250857497546e-15
features O 0 5.565833904874751e-10
that O 0 1.7950812392086846e-08
could O 0 2.367253841839556e-07
be O 0 1.536048510608623e-10
associated O 0 6.565414323311813e-10
with O 0 4.7373446311616e-12
the O 0 1.749462553990444e-12
progressive O 0 1.0558235175039954e-08
nature O 0 9.891679155771271e-07
of O 0 9.958868799064824e-12
the O 0 1.5438681444379654e-09
disease O 0 1.0765490969788516e-06
. O 0 5.051842277836727e-11

Although O 0 2.1450713427739743e-10
increasing O 0 8.449439065083553e-11
measured O 0 9.962663582996356e-09
allele O 0 1.7409635955090152e-09
size O 0 2.4054999769873575e-08
between O 0 3.2143221417868517e-10
patients O 0 8.215071678474573e-11
clearly O 0 1.2040328803419875e-11
correlates O 0 5.106514711951393e-13
with O 0 3.7160439185855547e-16
an O 0 1.1309158277683423e-15
increased O 0 7.2540706774759656e-09
severity O 0 6.672854942735285e-05
of O 0 4.7713069606381e-11
symptoms O 0 6.756472998858953e-07
and O 0 3.142995710697302e-14
an O 0 3.84921549734406e-16
earlier O 0 2.588601333286533e-09
age O 0 1.3995012926315553e-09
of O 0 1.488621441283859e-14
onset O 0 1.964462620351881e-11
, O 0 4.817936532993143e-15
this O 0 1.1119946999134573e-15
correlation O 0 6.055678094391004e-12
is O 0 9.348297960384833e-13
not O 0 5.14423898444194e-13
precise O 0 1.5258088126302027e-09
and O 0 1.4631428013611725e-11
measured O 0 3.5094338102226175e-08
allele O 0 7.874031288102046e-11
length O 0 6.970851007537249e-09
cannot O 0 7.130828976187331e-07
be O 0 1.7099274470314119e-12
used O 0 2.3749310352517983e-13
as O 0 4.217151394802013e-14
an O 0 4.014433879447662e-15
accurate O 0 3.725298824974743e-08
predictor O 0 1.3027417367084126e-07
of O 0 8.249360396173078e-12
age O 0 1.0460958321800717e-07
of O 0 7.397302388689742e-12
onset O 0 2.5724192553866487e-08
. O 0 8.423954311886916e-10

In O 0 1.4623281752168538e-11
order O 0 9.595441303501817e-14
to O 0 1.1527197263800889e-15
further O 0 2.7593934200722007e-15
characterize O 0 2.1639775041326637e-11
the O 0 1.9676555035926663e-13
dynamics O 0 4.331138503399501e-10
of O 0 1.49084286582557e-11
DM B-Disease 1 1.0
CTG O 0 3.7854010770388413e-07
repeat O 0 9.816048418542778e-09
somatic O 0 1.5245629758631196e-10
instability O 0 2.0443188475383067e-08
, O 0 6.434461389268412e-14
we O 0 1.2072218225078757e-12
have O 0 1.2533920062051621e-14
studied O 0 5.549479062047502e-13
repeat O 0 1.7449711814387925e-11
length O 0 4.685015125415609e-14
changes O 0 4.293377244978143e-14
over O 0 3.2666469355902006e-14
time O 0 2.1887582891955137e-12
in O 0 6.610845117854813e-12
111 O 0 3.139952464703555e-10
myotonic B-Disease 1 0.9999986886978149
dystrophy I-Disease 1 1.0
patients O 0 7.375561494882277e-09
with O 0 1.4189368538648772e-13
varying O 0 1.265861304666771e-10
clinical O 0 3.3656539777382477e-09
severity O 0 7.199666924861958e-07
and O 0 3.4635822855622056e-12
CTG O 0 5.257057011931465e-10
repeat O 0 1.4168410888970584e-09
size O 0 6.987033729366487e-10
over O 0 2.6688751902925745e-11
time O 0 3.999142336730266e-11
intervals O 0 1.6825324120062213e-11
of O 0 1.9843354457965874e-14
1 O 0 6.974085371702632e-12
- O 0 4.6370718109756126e-07
7 O 0 4.3560235279960224e-11
years O 0 2.2806426885901843e-11
. O 0 3.2435727281149296e-12

We O 0 9.132428857583363e-08
have O 0 1.0463747923683542e-12
found O 0 3.222332543482108e-14
a O 0 2.706042414614678e-15
direct O 0 2.2415851455830776e-13
progression O 0 3.66265837103974e-11
of O 0 2.338902548132643e-15
the O 0 2.866809479761781e-15
size O 0 1.660482623795645e-12
heterogeneity O 0 1.6523126183248804e-12
over O 0 2.4452597065238724e-12
time O 0 1.1610580118864844e-12
related O 0 1.3097123212346684e-12
to O 0 3.0030498588881887e-15
initial O 0 1.2892472462874838e-12
CTG O 0 9.824823593573839e-11
repeat O 0 7.911882260458469e-10
size O 0 1.4960886973724996e-09
and O 0 6.259356748195e-12
the O 0 6.407371242736146e-14
time O 0 9.950399879055105e-12
interval O 0 6.618213355819025e-12
and O 0 7.140553475110459e-14
always O 0 7.776827142327858e-13
biased O 0 4.8563932687544983e-14
towards O 0 1.3215448700643062e-14
further O 0 5.2919348997272284e-14
expansion O 0 2.6626671353890963e-11
. O 0 2.3672180535228016e-11

Attempts O 0 3.344930166182536e-10
to O 0 2.3141449694008553e-12
mathematically O 0 3.052595398678193e-10
model O 0 1.6505305802660963e-11
the O 0 3.8544081121250073e-13
dynamics O 0 2.249432554890518e-06
have O 0 4.042476575705223e-09
proved O 0 7.51594075865114e-09
only O 0 2.495034127220075e-12
partially O 0 2.422396283563444e-09
successful O 0 1.2932007027732784e-11
suggesting O 0 2.026443457481264e-10
that O 0 3.93313989233493e-15
individual O 0 9.233188520663908e-16
specific O 0 1.5614841683187397e-15
genetic O 0 8.277710656680315e-13
and O 0 1.448005127260843e-13
/ O 0 1.754132117337548e-10
or O 0 1.7700585788760215e-11
environmental O 0 1.078962430511865e-08
factors O 0 1.174742081389013e-08
also O 0 1.0361635160993643e-10
play O 0 2.520141872963677e-10
a O 0 1.0208178838908358e-13
role O 0 3.2593448773265976e-11
in O 0 6.111394485093513e-13
somatic O 0 6.475185665433258e-11
mosaicism O 0 1.3160201817186135e-08
. O 0 7.529545563433881e-12
. O 0 1.364886849375413e-11

Aspartylglucosaminuria B-Disease 1 0.9999924898147583
among O 0 4.263342123778102e-09
Palestinian O 0 4.523528218669526e-08
Arabs O 0 1.5901020944397715e-08
. O 0 3.44478306990581e-10

Aspartylglucosaminuria B-Disease 1 0.9999985694885254
( O 0 2.1565886854091332e-08
AGU B-Disease 1 0.9999802112579346
) O 0 4.812286420047274e-12
is O 0 1.869481267924647e-13
a O 0 1.1017858988441459e-13
rare O 0 1.1586887893599851e-08
disorder B-Disease 0 0.008056899532675743
of I-Disease 0 6.7709735387944114e-12
glycoprotein I-Disease 1 0.9959155917167664
metabolism I-Disease 0 0.02276935987174511
caused O 0 1.2326434317699864e-09
by O 0 1.2678872708671296e-12
the O 0 1.7073750191443082e-09
deficiency B-Disease 0 0.051856812089681625
of I-Disease 0 2.768071145561879e-14
the I-Disease 0 4.4249795342655995e-13
lysosomal I-Disease 0 4.633926131702992e-09
enzyme I-Disease 0 1.7038931376944788e-10
aspartylglucosaminidase I-Disease 0 2.3124722137168874e-09
( O 0 1.7067300535095892e-13
AGA O 0 3.933426154234532e-11
) O 0 1.4749889677700967e-12
. O 0 3.725350236627456e-11

AGU B-Disease 1 0.9999924898147583
is O 0 5.383965273608737e-09
inherited O 0 1.2274424534552963e-06
as O 0 1.8540908825609437e-13
an O 0 1.4746618639746578e-13
autosomal O 1 0.8103848695755005
recessive O 1 0.6277261972427368
trait O 0 0.4263487756252289
and O 0 4.052139179755443e-10
occurs O 0 5.598197252987269e-11
with O 0 7.289996472082424e-16
a O 0 1.6195096479154625e-13
high O 0 2.269716775638031e-10
frequency O 0 4.953385996486759e-06
in O 0 2.9100888809807657e-08
Finland O 0 0.07038848847150803
because O 0 2.1937612615374746e-08
of O 0 1.0454823991127085e-13
a O 0 1.260768507822807e-12
founder O 0 2.2927109863402073e-11
effect O 0 3.3800191534538726e-09
. O 0 7.245697097868486e-11

While O 0 1.0269677330754234e-09
very O 0 1.1819412636115967e-11
few O 0 8.933407832922846e-12
patients O 0 5.43443892317419e-12
with O 0 6.202986475162264e-12
AGU B-Disease 1 1.0
have O 0 1.1642980801696012e-08
been O 0 1.3461477592346949e-11
reported O 0 8.796338657468539e-11
from O 0 5.233598385397109e-13
non O 0 2.486448602567748e-09
- O 0 6.065330637738953e-08
Finnish O 0 6.743096747641175e-08
origin O 0 2.489415784623361e-08
, O 0 1.0814662533553676e-11
we O 0 6.417860021201705e-08
diagnosed O 0 3.6232225397725415e-07
the O 0 2.600295629859306e-12
disorder O 0 1.303648218708986e-06
in O 0 1.2466133160471404e-11
8 O 0 2.10349654361508e-11
patients O 0 1.7149237759028768e-13
originating O 0 2.3685988066735053e-12
from O 0 8.521358098312337e-12
3 O 0 6.328805101513124e-12
unrelated O 0 6.094722504457195e-10
families O 0 4.13065588678041e-11
, O 0 6.044029344934657e-14
all O 0 1.178630896223401e-13
Palestinian O 0 5.764940955166331e-11
Arabs O 0 1.7026578064127662e-11
from O 0 3.628695868090892e-12
the O 0 4.609325508081463e-12
region O 0 1.3200569526361505e-09
of O 0 4.8855454404250764e-11
Jerusalem O 0 7.902891070443729e-07
. O 0 6.409171859900198e-09

The O 0 4.6953101129343366e-11
clinical O 0 1.79886860962597e-08
diagnosis O 0 4.199415707262233e-05
of O 0 2.61715121796513e-10
AGU B-Disease 1 1.0
is O 0 4.725072244582407e-08
often O 0 2.2036729385721543e-10
difficult O 0 6.426903453871091e-11
, O 0 3.7784983577041336e-15
in O 0 5.46047878612131e-15
particular O 0 2.0570178861038096e-13
early O 0 4.205813648738843e-12
in O 0 2.480754588297246e-13
the O 0 8.777704854200791e-14
course O 0 2.7167182392595635e-10
of O 0 3.2151740986382724e-14
the O 0 6.592339174549267e-11
disease O 0 1.9077228330388607e-07
, O 0 5.0661129513739165e-15
and O 0 2.549124648344725e-13
most O 0 2.6349218014182392e-14
of O 0 2.1077262927614998e-14
the O 0 6.157242077309277e-11
patients O 0 2.2030594015731708e-10
are O 0 1.1902762109272658e-10
diagnosed O 0 3.211323189589166e-07
after O 0 7.572233638730719e-12
the O 0 7.732366179638572e-13
age O 0 1.1101457531026426e-09
of O 0 1.9966516436628438e-14
5 O 0 6.1787445819472264e-12
years O 0 2.4430790723783957e-11
. O 0 3.059518610681877e-11

However O 0 1.4693689320832704e-10
, O 0 1.4493480471767378e-13
since O 0 3.0576446322788664e-12
these O 0 8.305651359816896e-14
patients O 0 6.557416014265488e-14
excrete O 0 4.374252696170977e-13
early O 0 2.846183846331313e-14
large O 0 4.805420520054629e-14
amounts O 0 7.453415488967163e-12
of O 0 2.6502354455969213e-13
aspartylglucosamine O 0 1.6593056670899387e-06
in O 0 4.76874130461713e-11
urine O 0 1.8773800222748882e-11
, O 0 3.4097737455173447e-16
biochemical O 0 5.753573615804863e-14
screening O 0 3.198221581231925e-13
is O 0 1.5601460553148205e-13
easy O 0 7.034578215076026e-12
by O 0 7.599575808057979e-13
urine O 0 6.61250082467646e-11
chromatography O 0 9.13340861274925e-11
. O 0 1.5903112160486899e-12
. O 0 1.848464263598526e-11

Detection O 0 3.177301621803963e-08
of O 0 1.8162305426977499e-12
heterozygous O 0 3.388042069119024e-09
carriers O 0 2.5320823215935206e-09
of O 0 1.7919074210559494e-11
the O 0 1.1503635732879047e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.5636472939248875e-11
ATM O 0 1.3068289506090736e-10
) O 0 1.1550659017648649e-15
gene O 0 1.5397714570389298e-13
by O 0 6.674437088763753e-15
G2 O 0 2.344034168155762e-11
phase O 0 3.4822110472898515e-11
chromosomal O 0 7.734324185548758e-07
radiosensitivity O 0 3.2052025744633283e-06
of O 0 1.796952343868785e-11
peripheral O 0 5.458849500428187e-06
blood O 0 0.0006367146270349622
lymphocytes O 0 0.00013060617493465543
. O 0 7.947454916390484e-10

In O 0 2.275071165058762e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.007615352049469948
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 9.731595529416381e-10
patients O 0 7.121658124331631e-11
, O 0 1.3068013298811031e-14
mutations O 0 1.7214939196374957e-10
in O 0 1.0735813957664722e-13
a O 0 4.724264938125479e-14
single O 0 1.837060370360813e-13
gene O 0 6.1661439842986e-13
, O 0 1.885830580346728e-16
ATM O 0 1.5500738713425388e-12
, O 0 6.691390453203048e-15
result O 0 4.1937942008019036e-10
in O 0 2.394119569260056e-09
an O 0 0.12575913965702057
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 2.1828926222156042e-08
embraces O 0 1.5814589915397192e-10
a O 0 8.39301569324942e-14
variety O 0 6.185297499877729e-13
of O 0 1.841992575450039e-14
clinical O 0 4.743375397325833e-12
features O 0 2.505338603242535e-09
and O 0 7.375744015547525e-09
manifests O 0 6.0407834290288065e-09
extreme O 0 6.423980902781068e-09
radiosensitivity O 0 3.4079198485414963e-06
and O 0 9.472453203762665e-12
a O 0 4.970604548619473e-13
strong O 0 2.603270654599754e-10
pre O 0 1.07468868009164e-05
- O 0 0.00010143213148694485
disposition O 0 8.691333874821794e-08
to O 0 2.0907168357675587e-11
malignancy B-Disease 0 5.1746692406595685e-06
. O 0 1.3728343982444269e-11

Heterozygotes O 0 7.770381671434734e-08
for O 0 4.0966308036821664e-13
the O 0 3.0595256959430744e-14
ATM O 0 9.144913298841928e-11
gene O 0 5.787176293736707e-10
have O 0 1.1875497980817773e-11
no O 0 1.3887724520725286e-12
clinical O 0 1.9261421884547714e-12
expression O 0 1.9001666906603987e-10
of O 0 1.1394619622850932e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 0.002835041144862771
may O 0 2.1449911855597747e-06
be O 0 6.001279473366594e-08
cancer B-Disease 0 6.588765586457157e-07
prone O 0 7.830346476112027e-06
with O 0 3.122453128847312e-14
a O 0 6.429066805833938e-13
moderate O 0 1.2405991789421478e-09
increase O 0 3.8976177840766013e-10
in O 0 2.3315047809058242e-11
in O 0 3.106359613980203e-11
vitro O 0 8.3320434995926e-09
radiosensitivity O 0 6.188611223478802e-07
. O 0 1.192967252761079e-10

We O 0 3.310708862613865e-08
performed O 0 2.5679151513524623e-11
a O 0 3.5477599590744147e-13
blind O 0 5.5820119360117104e-11
chromosomal O 0 8.101117998648988e-09
analysis O 0 1.8441539961777664e-11
on O 0 8.738436948867168e-13
G2 O 0 1.6944751157765836e-10
- O 0 8.2178388538523e-09
phase O 0 1.1987241754773947e-10
lymphocytes O 0 1.8455633687963768e-09
from O 0 2.965463432539478e-13
7 O 0 1.0711096939952647e-11
unrelated O 0 7.806688273603868e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.0051753633888438e-06
, O 0 6.076084188740005e-13
13 O 0 2.148422498932101e-12
obligate O 0 2.3553406336418448e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 2.840654633473605e-05
( O 0 2.1262052448539626e-12
parents O 0 8.283985476753575e-12
of O 0 2.257828366069724e-15
the O 0 1.574777499157784e-13
patients O 0 1.1664378230663575e-13
) O 0 7.816729204288431e-16
, O 0 5.59720345633531e-15
and O 0 1.3105999792373257e-11
14 O 0 7.323850727269932e-12
normal O 0 4.241632739487855e-11
controls O 0 2.652921438084377e-09
following O 0 8.474774701450194e-12
X O 0 8.069907408980725e-08
- O 0 9.075590945428758e-09
irradiation O 0 1.7424775511365453e-10
with O 0 2.1774903928573064e-12
1 O 0 5.740688740346611e-12
Gy O 0 9.973562242748812e-08
in O 0 8.696399178033387e-14
order O 0 1.1764111955631443e-14
to O 0 1.099329333890519e-14
evaluate O 0 1.205804813636524e-11
this O 0 9.335619367942423e-15
cytogenetic O 0 1.1043417569300829e-10
method O 0 6.768062266225908e-14
as O 0 5.179351939059397e-15
a O 0 1.2931733532652577e-15
tool O 0 3.2593914546519276e-13
for O 0 3.92221782599656e-15
detection O 0 1.9826863761895908e-10
of O 0 1.6025939256203436e-13
ATM O 0 6.742203026988136e-07
carriers O 0 8.104455773150221e-09
. O 0 1.357265549950526e-10

Both O 0 6.616698300376811e-08
A B-Disease 1 0.999998927116394
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
homozygotes O 0 0.011160530149936676
and O 0 6.456054874731665e-12
heterozygotes O 0 1.0199072697503198e-09
showed O 0 4.063878400462073e-11
significantly O 0 8.14961466366615e-12
increased O 0 3.3347213879153514e-12
levels O 0 1.65163369092447e-10
of O 0 2.523905563711626e-12
radiation O 1 0.9999997615814209
- O 1 0.9989340901374817
induced O 0 0.022416818886995316
chromatid O 0 0.00011947764869546518
damage O 0 5.617540409730282e-06
relative O 0 1.2753359257544616e-08
to O 0 4.68587571089002e-13
that O 0 2.9666799073770067e-13
of O 0 2.565083020121539e-13
normal O 0 2.283565780913932e-09
controls O 0 6.544515258610772e-07
. O 0 1.4196436248781197e-09

These O 0 2.354446715716052e-12
results O 0 6.736399632556456e-12
show O 0 9.482974301644465e-12
that O 0 1.7409259594363714e-14
the O 0 5.196014771197783e-15
G2 O 0 2.373213847661759e-10
- O 0 8.001607376684206e-09
phase O 0 4.252665927739763e-11
chromosomal O 0 3.404250747962578e-08
radiosensitivity O 0 4.005505260806785e-09
assay O 0 8.848621141366309e-11
can O 0 3.031709215270406e-12
be O 0 1.5591033704622447e-15
used O 0 1.2331357638429912e-15
for O 0 3.6362957666015623e-16
the O 0 8.033819513504972e-15
detection O 0 3.60246978914347e-08
of O 0 5.910239520012794e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 0.0010131169110536575
. O 0 6.529522478260219e-10

In O 0 1.8839660734237818e-11
combination O 0 5.208607503637275e-11
with O 0 1.0435798275879038e-13
molecular O 0 7.702492810235384e-11
genetic O 0 4.992160573813464e-10
analyses O 0 2.1473196554211427e-09
, O 0 1.7512700951948304e-14
this O 0 5.6519296621343473e-14
test O 0 3.1423995350277067e-12
may O 0 1.4951906900095846e-12
be O 0 3.003154636863764e-14
of O 0 1.6763713762404583e-16
value O 0 1.019780301869666e-10
in O 0 9.457135053368704e-14
studies O 0 3.7405264974831043e-13
of O 0 7.935923680626056e-15
familial B-Disease 0 1.7120397615144611e-06
and I-Disease 0 2.3859017872496224e-08
sporadic I-Disease 0 8.236502617364749e-05
cancers I-Disease 1 0.7100908160209656
aimed O 0 1.6042425166062912e-09
at O 0 3.861505559754619e-11
determination O 0 6.261974966337291e-11
of O 0 1.1619822434165514e-15
the O 0 3.4285032321679134e-16
potential O 0 9.064426862099087e-14
involvement O 0 3.6906653948232115e-12
of O 0 1.0144418942023559e-13
ATM O 0 1.057758481692872e-06
mutations O 0 1.2075810218448169e-06
in O 0 5.1361460223775524e-11
tumor B-Disease 0 5.021980541641824e-06
risk O 0 6.575322004209738e-06
or O 0 5.2202141914703404e-11
development O 0 1.1183028244751703e-12
. O 0 1.7064087773008274e-12
. O 0 2.7863718277121308e-11

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
: O 0 8.965816422623618e-10
identification O 0 1.8713890159727242e-10
and O 0 1.1537942639066462e-13
detection O 0 4.694253666337467e-11
of O 0 8.274719071835884e-15
founder O 0 8.192668765616418e-10
- O 0 0.00010002241469919682
effect O 0 2.0354635310582125e-08
mutations O 0 5.465476071719877e-09
in O 0 2.5556176641051975e-14
the O 0 6.961126930585878e-16
ATM O 0 3.555226642595888e-12
gene O 0 1.1890389714497296e-11
in O 0 2.5037821208689914e-12
ethnic O 0 1.194315063512974e-10
populations O 0 2.5583371865423032e-08
. O 0 4.3698647478329633e-10

To O 0 5.984233833293551e-13
facilitate O 0 2.654930854155413e-13
the O 0 1.5786230965009543e-14
evaluation O 0 4.846208612359348e-13
of O 0 1.0610402683010724e-15
ATM O 0 2.3933226928063434e-11
heterozygotes O 0 1.3873521775842335e-10
for O 0 9.2953217754768e-15
susceptibility O 0 3.42007879794437e-08
to O 0 3.4969052393335476e-12
other O 0 1.96420130160746e-10
diseases O 0 3.5315433706273325e-06
, O 0 2.2156281258463306e-15
such O 0 4.369616376630886e-13
as O 0 1.3937110132644648e-08
breast B-Disease 1 0.9169394969940186
cancer I-Disease 0 0.0041052596643567085
, O 0 6.729850184072905e-12
we O 0 2.969626974880235e-11
have O 0 8.504329375045791e-15
attempted O 0 3.942788478518422e-13
to O 0 8.55054213739527e-14
define O 0 2.434772106152394e-10
the O 0 5.061095856642717e-13
most O 0 1.7466876469501846e-13
common O 0 3.4811582327702595e-13
mutations O 0 1.9485738023128363e-10
and O 0 1.3796112689756779e-12
their O 0 2.116845761179764e-12
frequencies O 0 3.350009336600124e-08
in O 0 8.513300144841196e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.031835004687309265
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.4155322747289034e-11
homozygotes O 0 1.8815699220908755e-08
from O 0 1.3107118472174828e-12
10 O 0 1.8615819064211891e-13
ethnic O 0 2.111974007137918e-12
populations O 0 3.968387840558307e-09
. O 0 2.8368565829772763e-10

Both O 0 1.685255927863505e-11
genomic O 0 4.196580860593713e-09
mutations O 0 1.4963488865760155e-05
and O 0 3.320911601267795e-11
their O 0 1.101215039295278e-12
effects O 0 3.036880746876136e-10
on O 0 1.3760948760696556e-12
cDNA O 0 8.00486239793674e-12
were O 0 4.690888302794072e-11
characterized O 0 9.141221113395659e-10
. O 0 9.033890302490022e-11

Protein O 0 3.6200462627533625e-09
- O 0 2.4721202862565406e-09
truncation O 0 2.2749002681621278e-10
testing O 0 2.385764030776727e-09
of O 0 7.99447788242362e-14
the O 0 4.6903710841476876e-14
entire O 0 4.4548137964964263e-13
ATM O 0 9.801964795386198e-12
cDNA O 0 4.645991057150578e-12
detected O 0 5.527307056496511e-09
92 O 0 7.402153434470093e-13
( O 0 5.433590995760143e-15
66 O 0 1.8424855825066588e-13
% O 0 3.281365657708049e-14
) O 0 2.439322581546024e-14
truncating O 0 1.4031096284838895e-09
mutations O 0 4.4404885102267144e-08
in O 0 3.5002951058460408e-12
140 O 0 1.8690827965212042e-12
mutant O 0 4.339208714565501e-10
alleles O 0 5.907931921456111e-09
screened O 0 4.496141627896577e-06
. O 0 1.6542766045901658e-09

The O 0 3.9333115757489434e-12
haplotyping O 0 2.9046875127392013e-08
of O 0 5.124763460817583e-12
patients O 0 1.3002353360658248e-10
with O 0 5.425958640725703e-11
identical O 0 0.0005497131496667862
mutations O 0 4.596604412654415e-07
indicates O 0 7.186562456240608e-09
that O 0 3.8993813603407923e-13
almost O 0 4.1820374745669964e-13
all O 0 1.4655006605490163e-14
of O 0 7.789968786506708e-16
these O 0 2.2293639509321853e-14
represent O 0 9.385668511916606e-14
common O 0 1.4345003050003635e-12
ancestry O 0 8.352780866971443e-08
and O 0 8.723657907161453e-11
that O 0 8.211590261930635e-12
very O 0 8.824318359357264e-11
few O 0 4.787670260242294e-11
spontaneously O 0 2.990950265235881e-10
recurring O 0 1.0085965840289646e-08
ATM O 0 2.8522200068437087e-07
mutations O 0 2.7518403840076644e-06
exist O 0 3.624220923370558e-08
. O 0 1.325371895566363e-10

Assays O 0 1.9364048142733736e-08
requiring O 0 1.1176323061468096e-10
minimal O 0 9.607291628910275e-10
amounts O 0 2.0387474694572028e-11
of O 0 1.2679923978202792e-14
genomic O 0 8.511190016657899e-12
DNA O 0 3.953187999172769e-09
were O 0 2.000614517799759e-12
designed O 0 3.743839873532329e-12
to O 0 1.1732784442077242e-14
allow O 0 1.1660864060372006e-13
rapid O 0 7.914285004261001e-13
screening O 0 2.8966481990799764e-12
for O 0 3.853435786064195e-14
common O 0 2.0745998235288665e-12
ethnic O 0 9.334000933280961e-11
mutations O 0 1.761866883498442e-07
. O 0 3.6139303355442465e-11

These O 0 1.1901938636038611e-11
rapid O 0 8.890984476428443e-11
assays O 0 5.276366454864956e-09
detected O 0 4.527360886186216e-08
mutations O 0 2.5195949771017467e-09
in O 0 4.639559678283611e-13
76 O 0 3.0097408940110704e-12
% O 0 3.725623596521205e-13
of O 0 1.5153509957260836e-12
Costa O 0 1.0645270776876714e-05
Rican O 0 2.732670736804721e-06
patients O 0 1.1583892872701895e-10
( O 0 1.726916712115143e-14
3 O 0 3.1410780281047185e-14
) O 0 1.0780247612011788e-15
, O 0 3.6911787370233126e-16
50 O 0 1.799920110146739e-14
% O 0 2.943035626399443e-14
of O 0 1.6976378636179845e-11
Norwegian O 1 0.9999192953109741
patients O 0 3.8704776272879826e-08
( O 0 4.6787287856942666e-14
1 O 0 1.396837018882019e-13
) O 0 1.9319745795027578e-15
, O 0 6.150371875066887e-16
25 O 0 3.932151913105253e-14
% O 0 8.361152007839608e-15
of O 0 2.095766268861432e-12
Polish O 1 0.9589408040046692
patients O 0 2.9745915952616997e-08
( O 0 2.186929429865911e-13
4 O 0 6.849007580696231e-13
) O 0 9.46344511001257e-15
, O 0 1.6034980824695608e-14
and O 0 4.134673506350772e-12
14 O 0 1.7414723092398776e-12
% O 0 4.484153798061871e-14
of O 0 9.43616712545392e-13
Italian O 0 0.0008782771183177829
patients O 0 8.816520846721687e-09
( O 0 1.1815710085696929e-12
1 O 0 3.5144387400265487e-11
) O 0 6.026891225668907e-13
, O 0 4.427619769843509e-14
as O 0 3.9346450360008833e-13
well O 0 6.197865571461181e-12
as O 0 5.719398479125948e-12
in O 0 6.814315084424649e-11
patients O 0 2.156711875062056e-12
of O 0 9.861400162170658e-14
Amish O 0 5.174825457032739e-09
/ O 0 4.3887135348086304e-07
Mennonite O 0 3.975069606809711e-09
and O 0 2.419451661239691e-08
Irish O 0 7.575266067760822e-07
English O 0 2.384623343232306e-08
backgrounds O 0 2.1021399732035206e-08
. O 0 2.7365467530904297e-11

Additional O 0 5.3133643318492574e-11
mutations O 0 9.706744918958066e-08
were O 0 5.448816398079259e-11
observed O 0 6.483336534301998e-09
in O 0 2.1541631325949773e-12
Japanese O 0 5.7607039138929395e-09
, O 0 6.3920091990948575e-16
Utah O 0 9.153026169568708e-15
Mormon O 0 5.8532348347524465e-15
, O 0 7.251365205182287e-15
and O 0 7.971076056156878e-14
African O 0 1.266755390904109e-13
American O 0 1.9445788035366007e-10
patients O 0 5.1615101082092e-12
. O 0 2.4567834745747863e-12

These O 0 6.404344285795838e-13
assays O 0 2.7925222897962065e-11
should O 0 3.7237391176201534e-14
facilitate O 0 6.066095908463347e-15
screening O 0 4.830881354667138e-12
for O 0 2.383123733074033e-11
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
heterozygotes O 0 1.2471215313780704e-06
in O 0 4.189161170731204e-12
the O 0 3.04260299409647e-14
populations O 0 1.155964646920582e-12
studied O 0 2.4062580053496596e-11
. O 0 1.6439498688129023e-13
. O 0 1.799819082833054e-12

The O 0 8.241057258828732e-08
von B-Disease 1 0.999708354473114
Hippel I-Disease 1 0.9999805688858032
- I-Disease 1 0.9999970197677612
Lindau I-Disease 1 0.9998643398284912
tumor I-Disease 0 0.26952651143074036
suppressor O 0 8.543091212231957e-07
gene O 0 3.6788090795880635e-08
is O 0 3.775895828644904e-12
required O 0 3.2206751371735565e-13
for O 0 1.1228221314957959e-14
cell O 0 8.969647247170087e-10
cycle O 0 7.288847303499324e-11
exit O 0 5.894228161107407e-11
upon O 0 2.8987721945039624e-11
serum O 0 1.7168853005955498e-08
withdrawal O 0 4.3231374036167836e-08
. O 0 1.3417829347606158e-10

The O 0 4.763865951024071e-12
inactivation O 0 2.939161358739284e-09
of O 0 2.6432285180066906e-13
the O 0 1.074492508856828e-10
von B-Disease 1 0.9999805688858032
Hippel I-Disease 1 0.9999966621398926
- I-Disease 1 0.9999994039535522
Lindau I-Disease 1 0.9999253749847412
( I-Disease 0 2.3765734624703327e-07
VHL I-Disease 0 0.0007812094409018755
) I-Disease 0 6.762649468194937e-12
tumor I-Disease 0 4.787501950431761e-09
suppressor O 0 2.617781325042756e-09
gene O 0 4.534375985798533e-09
predisposes O 0 5.0593328637660306e-08
affected O 0 1.8415398372884084e-10
individuals O 0 3.4050102147575867e-12
to O 0 1.5142356769512477e-12
the O 0 7.314731043095435e-09
human O 0 0.3921518921852112
VHL B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9999977350234985
syndrome I-Disease 1 0.9999991655349731
and O 0 3.1514225257156525e-11
is O 0 2.0293279209826487e-11
associated O 0 3.051352948091335e-08
with O 0 2.322656511566379e-09
sporadic B-Disease 1 0.9824119210243225
renal I-Disease 1 0.9999066591262817
cell I-Disease 1 0.9999808073043823
carcinomas I-Disease 1 1.0
( O 0 1.7297644205882534e-07
RCC B-Disease 0 0.009958979673683643
) O 0 3.23115811884378e-10
and O 0 5.89315485299835e-09
brain B-Disease 0 1.9257078747614287e-05
hemangioblastomas I-Disease 0 0.0001589835883351043
. O 0 7.25230986375891e-10

VHL O 0 0.05841593071818352
- O 0 0.000276745151495561
negative O 0 3.6468654798227362e-06
786 O 0 1.2264695214980748e-07
- O 0 3.040818774024956e-05
0 O 0 1.5676175635359613e-10
RCC B-Disease 0 8.888280333962939e-09
cells O 0 1.568107102500882e-11
are O 0 8.889173034806741e-14
tumorigenic O 0 6.427991365853813e-07
in O 0 6.893551840470025e-10
nude O 1 0.9999303817749023
mice O 0 0.0041954731568694115
which O 0 1.2686741414358327e-11
is O 0 4.908627418919419e-14
suppressed O 0 2.0754775122925478e-13
by O 0 5.461704972191579e-16
the O 0 3.850215790315208e-15
reintroduction O 0 7.416812823624053e-12
of O 0 1.5260596605837229e-12
VHL B-Disease 0 2.085542973873089e-07
. O 0 7.124140687098102e-12

Remarkably O 0 1.931893045536981e-08
, O 0 7.483292821129292e-14
this O 0 1.2995285355893883e-14
occurs O 0 2.9964789330372277e-13
without O 0 7.808630722279733e-14
affecting O 0 2.034596720702081e-13
the O 0 3.050168353568167e-14
growth O 0 5.73529090885927e-09
rate O 0 6.762210347233122e-08
and O 0 3.8074015782599974e-14
cell O 0 2.620900024785655e-12
cycle O 0 1.5521270249965746e-12
profile O 0 2.166481161136602e-10
of O 0 2.2210367700277282e-14
these O 0 2.819611948437495e-13
cells O 0 1.014486888592514e-12
in O 0 5.957220936166074e-13
culture O 0 2.548220745524077e-09
. O 0 2.1340894329480165e-10

The O 0 6.871101604355445e-11
786 O 0 1.1028062907314506e-08
- O 0 3.618771870605997e-06
0 O 0 1.4153710148345766e-10
cell O 0 9.152525959343905e-10
line O 0 4.295731326209307e-09
, O 0 3.595743376037493e-15
like O 0 4.037274800496732e-13
many O 0 5.861113596414627e-14
cancer B-Disease 0 2.5775540035688493e-10
cells O 0 7.628038825591155e-13
, O 0 3.774291568571595e-15
fails O 0 1.940180308079853e-11
to O 0 5.13924196439159e-15
exit O 0 5.114880741174943e-12
the O 0 1.6769623341870987e-13
cell O 0 5.00693153604459e-10
cycle O 0 9.93996725207058e-12
upon O 0 8.495000492977911e-13
serum O 0 2.740131177514371e-10
withdrawal O 0 3.5518568086700952e-09
. O 0 9.557536706505942e-11

Here O 0 2.447504812153056e-07
, O 0 1.8643178906034563e-13
it O 0 1.474756867190022e-14
is O 0 3.731372832650693e-15
shown O 0 4.899302263796507e-14
that O 0 1.082214556735213e-16
reintroduction O 0 1.0527758101863596e-14
of O 0 4.270423541492146e-16
the O 0 9.497295087683693e-15
wild O 0 2.374274332694881e-09
- O 0 6.496259447885677e-05
type O 0 4.141211775277043e-06
VHL B-Disease 0 3.254088909443453e-08
gene O 0 1.5339228498501e-10
restores O 0 9.231244657570414e-10
the O 0 1.3311435829478635e-13
ability O 0 6.663015972296904e-11
of O 0 6.802143483891632e-12
VHL O 0 0.004382602870464325
- O 0 0.0004898590268567204
negative O 0 0.00017538166139274836
RCC B-Disease 0 0.0001943891547853127
cancer I-Disease 0 2.470401128107369e-08
cells O 0 6.155641968375036e-12
to O 0 2.6699455973476678e-14
exit O 0 1.0114616609546712e-11
the O 0 4.4892564600614027e-13
cell O 0 5.173105832589897e-10
cycle O 0 3.5683265370289874e-11
and O 0 4.5062768078661664e-13
enter O 0 8.080769386964448e-11
G0 O 0 2.1174921371880373e-08
/ O 0 2.547988842138693e-08
quiescence O 0 1.0712935960555114e-07
in O 0 4.191562652522407e-10
low O 0 1.737037678140041e-06
serum O 0 2.3370965607227845e-07
. O 0 5.198702232589447e-11

Both O 0 2.212434235815408e-09
VHL O 0 5.686304939445108e-05
- O 0 7.305075541808037e-06
positive O 0 3.960705541317111e-09
and O 0 3.2948307970848134e-10
VHL O 0 5.1638518925756216e-05
- O 0 1.0892371165027726e-06
negative O 0 9.111671062100868e-08
RCC B-Disease 0 2.658474329564342e-08
cells O 0 4.910224570692234e-12
exit O 0 4.365786811927341e-12
the O 0 8.98103070861786e-14
cell O 0 9.211330309621957e-11
cycle O 0 4.791769845496896e-12
by O 0 3.720835149863787e-14
contact O 0 5.389184210002895e-09
inhibition O 0 7.624592512911477e-09
. O 0 1.1032049579418057e-10

The O 0 4.526821140160564e-10
cyclin O 0 0.0001607464801054448
- O 0 1.640382379264338e-06
dependent O 0 6.652111639304792e-10
kinase O 0 3.081895183498773e-09
inhibitor O 0 1.3776063623183177e-10
, O 0 2.2810904319001688e-15
p27 O 0 1.1934445619254941e-11
, O 0 1.5637254174971746e-15
accumulates O 0 4.4243315608372136e-12
upon O 0 1.4057560725286994e-13
serum O 0 3.812501703226445e-11
withdrawal O 0 9.171429588006319e-11
, O 0 2.486739867098146e-15
only O 0 4.9896822039278456e-15
in O 0 1.518659601285749e-14
the O 0 2.2005267142429126e-14
presence O 0 2.5204158204950033e-10
of O 0 6.45406905003254e-13
VHL B-Disease 0 5.042031148150272e-08
, O 0 3.3764196526972793e-15
as O 0 1.457107580481263e-15
a O 0 2.603200925763334e-14
result O 0 2.9586756655763935e-11
of O 0 3.2188293846188536e-15
the O 0 2.034401699836305e-14
stabilization O 0 4.0504832127252755e-11
of O 0 1.0178622132433687e-14
the O 0 4.3660173675193203e-13
protein O 0 3.2445209713349854e-11
. O 0 3.2329014465481976e-11

We O 0 3.493813571786575e-11
propose O 0 2.4633101548127145e-12
that O 0 2.4387828521520334e-14
the O 0 6.530352972787534e-15
loss O 0 7.394311725417158e-12
of O 0 7.952378142659419e-15
wild O 0 2.2506561947466253e-08
- O 0 0.02479180507361889
type O 0 5.385390613810159e-05
VHL B-Disease 0 5.1358700403625335e-08
gene O 0 5.678400805120276e-11
results O 0 2.1075446943186193e-11
in O 0 2.456034499243704e-15
a O 0 2.7942215090391662e-15
specific O 0 4.140655700257678e-12
cellular O 0 1.831747020730745e-08
defect O 0 1.676677698014828e-06
in O 0 4.5227106781897675e-11
serum O 0 4.649032689485466e-06
- O 0 0.03024284541606903
dependent O 0 1.0149814443138894e-05
growth O 0 1.264700017600262e-06
control O 0 6.596273038894651e-08
, O 0 4.137069647362074e-13
which O 0 9.441387558914438e-13
may O 0 2.9060132772373848e-11
initiate O 0 5.852119483451546e-11
tumor B-Disease 0 2.281912969692712e-07
formation O 0 1.7329073287442043e-08
. O 0 3.4121458436509045e-10

This O 0 2.3694494283299505e-11
is O 0 3.3165530326402515e-13
corrected O 0 1.074455108218686e-11
by O 0 7.906664780347729e-17
the O 0 1.1911310823512953e-16
reintroduction O 0 7.344462088195239e-14
of O 0 1.5732966145154403e-14
wild O 0 9.330912043026274e-09
- O 0 0.2001069039106369
type O 0 0.026078978553414345
VHL B-Disease 0 0.00010491208377061412
, O 0 2.8685682843844484e-13
implicating O 0 2.7367073940354203e-08
VHL B-Disease 0 7.063390228267963e-08
as O 0 1.2608784730281514e-13
the O 0 6.800317196154057e-15
first O 0 3.820831116232125e-14
tumor B-Disease 0 3.91003375510568e-12
suppressor O 0 1.1209535036305063e-11
involved O 0 7.452534249441367e-12
in O 0 2.0822419851719565e-13
the O 0 3.970225027644797e-14
regulation O 0 8.542942048217483e-11
of O 0 6.026359560028574e-14
cell O 0 1.0152738372237735e-10
cycle O 0 4.632224812062269e-11
exit O 0 9.885784552077226e-11
, O 0 7.997074682151994e-13
which O 0 1.3160908994558351e-11
is O 0 3.026782643966719e-11
consistent O 0 9.708000625607838e-09
with O 0 5.0518925387389377e-14
its O 0 5.371847376102988e-14
gatekeeper O 0 4.636704215021936e-12
function O 0 5.044293802103361e-11
in O 0 2.4011860208505986e-12
the O 0 1.967093805552156e-12
kidney O 0 1.5672954045697907e-09
. O 0 1.6111188771983365e-11
. O 0 1.3508451301991187e-10

Piebaldism B-Disease 1 0.9999995231628418
with O 0 4.3478292354848236e-05
deafness B-Disease 1 1.0
: O 0 1.2429433871030682e-10
molecular O 0 7.09427239176108e-11
evidence O 0 1.749616944379806e-11
for O 0 1.1745509079230665e-13
an O 0 2.2895064750311223e-12
expanded O 0 0.006420197896659374
syndrome O 1 0.9999938011169434
. O 0 5.290071047880929e-09

In O 0 3.7538239877621393e-11
a O 0 5.484808354022652e-12
South O 0 7.059878376347584e-11
African O 0 3.152162211805809e-11
girl O 0 1.1080609851887857e-07
of O 0 7.500926691838411e-14
Xhosa O 0 9.474373369178224e-11
stock O 0 3.367808115717352e-11
with O 0 2.3627768578476926e-13
severe O 0 2.5196635888846686e-08
piebaldism B-Disease 0 0.00014158959675114602
and O 0 8.345423196942647e-08
profound O 0 0.00045010895701125264
congenital O 1 0.9999983310699463
sensorineural B-Disease 1 0.9999984502792358
deafness I-Disease 1 1.0
we O 0 1.8858776456909254e-05
identified O 0 8.322636468882649e-10
a O 0 8.095999863349732e-14
novel O 0 1.437153212191164e-13
missense O 0 5.690761403776001e-11
substitution O 0 5.761296929980564e-13
at O 0 3.2176542788704687e-13
a O 0 3.0720394218926306e-14
highly O 0 1.538886379437443e-11
conserved O 0 3.661415268196855e-11
residue O 0 8.210662372221122e-09
in O 0 1.4067244005940005e-13
the O 0 1.1898153225468541e-14
intracellular O 0 1.7026871232395102e-11
kinase O 0 4.9605035357114247e-11
domain O 0 4.71226703491201e-11
of O 0 1.2621537658335374e-13
the O 0 1.0681473934515129e-11
KIT O 0 8.821563824312761e-05
proto O 0 4.307463677832857e-05
- O 0 7.207954331533983e-05
oncogene O 0 9.209969675794127e-09
, O 0 3.189704631065965e-13
R796G O 0 7.226226839129879e-10
. O 0 1.4305527248903438e-11

Though O 0 6.605734848008638e-10
auditory B-Disease 0 2.705194068752803e-09
anomalies I-Disease 0 5.9780708397738636e-05
have O 0 5.668534530656189e-10
been O 0 4.4073456689774915e-11
observed O 0 5.0092459069617234e-09
in O 0 2.454362017442757e-12
mice O 0 1.2728425424768375e-08
with O 0 3.2272194899068962e-12
dominant O 0 3.354273658828788e-08
white O 0 8.726544820092386e-09
spotting O 0 5.374907345867541e-07
( O 0 1.3339807774029322e-12
W O 0 2.4637796741444618e-05
) O 0 2.6170423250357344e-13
due O 0 1.7698432996926527e-10
to O 0 1.1004707561879101e-10
KIT O 1 0.9484977722167969
mutations O 1 0.5292434096336365
, O 0 9.07205954803203e-09
deafness B-Disease 1 1.0
is O 0 2.340328819627757e-09
not O 0 1.9461437669732184e-11
typical O 0 4.553857291256236e-10
in O 0 1.5035132860941047e-11
human O 0 5.1587963068033815e-11
piebaldism B-Disease 0 8.53170035952644e-07
. O 0 1.8167138626790091e-10

Thus O 0 1.1753868989217153e-09
, O 0 1.1727511323167406e-13
the O 0 5.911693660640149e-14
occurrence O 0 1.157098594717354e-08
of O 0 2.3086883099709965e-11
sensorineural B-Disease 1 0.9999934434890747
deafness I-Disease 1 1.0
in O 0 6.541994679309937e-08
this O 0 1.3098478031381422e-11
patient O 0 3.727839981149117e-10
extends O 0 2.4922518476050426e-12
considerably O 0 4.413408440789857e-12
the O 0 5.804738386873875e-15
phenotypic O 0 1.0321553334247113e-10
range O 0 9.812724938162987e-11
of O 0 5.605945937493806e-14
piebaldism B-Disease 0 3.928430913902048e-08
due O 0 8.310403060152183e-11
to O 0 1.966387393626673e-13
KIT O 0 6.555457066070858e-09
gene O 0 2.0179541371234677e-10
mutation O 0 2.346089766902537e-09
in O 0 1.7056528986512248e-13
humans O 0 4.223482674703405e-12
and O 0 3.7088394692647714e-14
tightens O 0 1.4644733203894589e-09
the O 0 1.3971320573982066e-14
clinical O 0 8.819895904116706e-14
similarity O 0 3.22492873334676e-13
between O 0 1.600986866950177e-13
piebaldism B-Disease 0 3.371386370076834e-08
and O 0 8.773893070412875e-13
the O 0 3.069671753046818e-15
various O 0 4.52869451737347e-14
forms O 0 4.937024122853018e-09
of O 0 2.1267960903514904e-07
Waardenburg B-Disease 1 0.9999723434448242
syndrome I-Disease 1 0.9998200535774231
. O 0 1.2936002963259696e-11
. O 0 5.944038317107214e-11

Cycloheximide O 0 1.9042358800902548e-08
facilitates O 0 2.4014529947935515e-11
the O 0 5.257707653581398e-14
identification O 0 4.689669225871329e-12
of O 0 1.3916294772629585e-14
aberrant O 0 1.3636272666595062e-11
transcripts O 0 1.1161496032974227e-10
resulting O 0 1.5521225971149022e-10
from O 0 2.2097738135856693e-12
a O 0 1.907569154718791e-12
novel O 0 2.1390030371937208e-11
splice O 0 8.736900092287669e-10
- O 0 1.3264335052554088e-07
site O 0 2.336331683672199e-10
mutation O 0 6.319083212247278e-08
in O 0 6.161124128239992e-13
COL17A1 O 0 3.590424313415497e-08
in O 0 9.4896638290487e-13
a O 0 6.968793164058296e-12
patient O 0 2.3833217621671565e-09
with O 0 2.728229100967816e-11
generalized O 0 4.24220797867747e-06
atrophic B-Disease 1 0.9995899796485901
benign I-Disease 1 0.9998428821563721
epidermolysis I-Disease 1 0.9970213770866394
bullosa I-Disease 1 0.9785659909248352
. O 0 1.3084618899483758e-07

Patients O 0 3.779009318805038e-07
with O 0 1.6415052650486928e-10
generalized O 0 5.586543011304457e-06
atrophic B-Disease 1 0.9997194409370422
benign I-Disease 1 0.9997424483299255
epidermolysis I-Disease 1 0.9981032609939575
bullosa I-Disease 1 0.9276592135429382
often O 0 2.345343830256752e-08
show O 0 1.0639542580292982e-08
decreased O 0 2.31016308305243e-08
expression O 0 9.374858528365948e-11
of O 0 4.1973886931272186e-13
type O 0 3.0381870601559058e-06
XVII O 0 1.2860741804843201e-08
collagen O 0 3.610048038282798e-09
, O 0 2.9328270497938624e-13
a O 0 1.831966869869639e-12
transmembrane O 0 2.991887626535572e-09
hemidesmosomal O 0 1.0406402406459847e-09
protein O 0 5.114341567434566e-13
encoded O 0 3.680519430893092e-13
by O 0 1.8782734699171466e-13
COL17A1 O 0 1.7447196114517283e-06
. O 0 5.359247420844149e-11

This O 0 6.870315427676132e-11
report O 0 1.0882241288645567e-11
documents O 0 2.164133455773154e-12
a O 0 4.3541087619072827e-13
novel O 0 2.8649008079056903e-12
splice O 0 3.062779807549987e-09
- O 0 3.9100720528040256e-07
site O 0 5.009988535142895e-10
mutation O 0 1.4314835539153137e-07
in O 0 8.786956080288066e-13
COL17A1 O 0 3.3115867381638964e-08
in O 0 2.531333703845867e-13
a O 0 2.043024603659571e-12
patient O 0 1.059688448101781e-09
with O 0 2.551149612742276e-12
generalized O 0 5.826055939905928e-07
atrophic B-Disease 1 0.999782145023346
benign I-Disease 1 0.9995991587638855
epidermolysis I-Disease 1 0.790601372718811
bullosa I-Disease 0 0.4727148413658142
, O 0 8.156102876410998e-11
and O 0 6.437594598021623e-13
applies O 0 1.3079247971128916e-12
a O 0 1.9283079856323307e-15
new O 0 1.5563995354154906e-15
methodology O 0 6.462796589529847e-15
to O 0 1.4835809599729856e-15
define O 0 1.527793343225614e-11
and O 0 4.588746049805081e-12
characterize O 0 5.311525885787205e-09
the O 0 9.276172711902841e-12
resulting O 0 9.244666837604498e-11
mRNA O 0 5.575688782205601e-12
splice O 0 2.1881926826061715e-10
variants O 0 5.779057787869135e-10
. O 0 3.543011717344058e-10

Mutational O 0 2.1724581529269926e-06
analysis O 0 5.398996805183742e-10
of O 0 1.673563306166248e-12
COL17A1 O 0 3.0536346002918435e-06
identified O 0 2.4003620424650762e-08
a O 0 2.2006391500739575e-11
maternally O 0 1.4610593098041136e-05
inherited O 0 4.389013338368386e-05
G O 0 4.266929863661062e-06
- O 0 3.3685395806060114e-07
to O 0 3.2816660500145645e-10
- O 0 8.857802640704904e-06
T O 0 3.8025724791168614e-08
transversion O 0 4.973428335830476e-10
at O 0 1.2778266942833905e-12
the O 0 1.4483358766860868e-14
- O 0 2.5299968786640648e-09
1 O 0 8.855873391382107e-13
position O 0 7.781790489769236e-11
of O 0 3.766857160393544e-14
exon O 0 2.6460370006198275e-10
32 O 0 7.10419778560123e-11
. O 0 2.3858890557670875e-11

This O 0 3.957512702962296e-12
acceptor O 0 3.096847431272032e-11
splice O 0 1.39075728711191e-09
- O 0 5.996771079708196e-08
site O 0 1.5166363998009302e-10
mutation O 0 1.1123167276139156e-08
led O 0 1.9068416550610534e-12
to O 0 3.796039139492349e-14
the O 0 5.74456050761972e-14
formation O 0 9.718639087941128e-12
of O 0 3.228127265280864e-14
aberrant O 0 2.6692812456902137e-12
transcripts O 0 4.4176871362433534e-12
present O 0 9.740982326311709e-12
at O 0 4.552641319488515e-10
extremely O 0 7.469282081729034e-07
low O 0 0.07832535356283188
levels O 0 1.964995863090735e-05
. O 0 2.656494746400284e-10

Based O 0 7.384478445393583e-11
on O 0 1.619987130552225e-11
our O 0 6.558620833929663e-13
recent O 0 1.0512793570784454e-13
finding O 0 4.1721582243713085e-13
that O 0 2.1478191404231128e-13
cycloheximide O 0 5.149602699816569e-08
stabilized O 0 2.2552590905888792e-07
mutant O 0 1.6959550083739394e-11
COL17A1 O 0 2.0085548779746887e-09
transcripts O 0 3.798000455801365e-11
in O 0 6.573445265759328e-14
keratinocytes O 0 2.4373728729765176e-11
homozygous O 0 1.0072148844131323e-11
for O 0 6.8572619506485424e-15
a O 0 9.349777896350275e-13
frameshift O 0 5.340847337720334e-07
mutation O 0 7.611428820553101e-09
, O 0 9.348340955777235e-15
the O 0 1.2962509415999877e-14
effects O 0 6.46994777753207e-08
of O 0 1.7159193987578703e-12
the O 0 9.430193171483525e-13
splice O 0 3.8743759311898884e-09
- O 0 9.269239598097556e-08
site O 0 1.0869012634362463e-10
mutation O 0 2.496298168175315e-10
on O 0 1.6267499839046386e-14
splicing O 0 1.4716889816177026e-13
of O 0 2.0267783186077217e-15
COL17A1 O 0 5.991047241638014e-11
transcripts O 0 2.6575766327169292e-12
were O 0 3.258067643799323e-13
determined O 0 1.4127320190418513e-12
using O 0 2.8171551463146427e-13
reverse O 0 1.113209247005642e-10
transcriptase O 0 1.9249310478919313e-11
polymerase O 0 9.546559506454222e-13
chain O 0 5.32697974273133e-12
reaction O 0 5.1411028212378085e-12
of O 0 5.443777837500297e-15
total O 0 1.257074227833466e-14
RNA O 0 4.2981072802435183e-13
from O 0 2.798543325245942e-14
keratinocytes O 0 1.6124999946409702e-10
incubated O 0 6.544827613891302e-12
for O 0 2.551779588414599e-14
2 O 0 5.678798577213318e-12
. O 0 1.1489159450206454e-11

5 O 0 8.397548767469232e-10
h O 0 1.0023428558270098e-06
in O 0 9.264621405116746e-13
the O 0 1.0954431128471984e-13
presence O 0 1.3167199552910347e-09
or O 0 8.177368782114058e-10
absence O 0 1.3701773049490384e-10
of O 0 4.941948678624866e-14
10 O 0 1.2820739478738852e-13
microg O 0 9.633379510765039e-11
cycloheximide O 0 2.800429665938964e-09
per O 0 5.6765814271386716e-11
ml O 0 4.808121545352151e-08
. O 0 7.534835949618568e-11

Using O 0 3.647744432899724e-12
this O 0 7.483725011220299e-13
approach O 0 1.5426789845562894e-09
, O 0 2.3965831489475287e-12
an O 0 4.196339998575882e-13
abnormally O 0 6.781636585628803e-08
spliced O 0 6.321204892856258e-08
transcript O 0 3.290924723842181e-05
was O 0 1.8825661527444026e-06
identified O 0 8.10096434378238e-09
that O 0 2.8643625286321056e-14
contains O 0 2.7306703210725706e-15
an O 0 1.7327284486882272e-16
extra O 0 3.164725155112985e-13
264 O 0 4.3302624805124576e-14
bases O 0 4.554756311697661e-12
upstream O 0 8.403107582596187e-14
from O 0 1.4152602565353431e-14
exon O 0 9.6143620842426e-11
32 O 0 6.0786605783624825e-12
, O 0 2.7655896778396027e-15
resulting O 0 2.1559264790083077e-12
in O 0 2.6001815717907606e-12
a O 0 2.717117364436916e-10
premature O 0 5.084465470872601e-08
termination O 0 3.5524377883788816e-10
codon O 0 5.6279814142357054e-11
27 O 0 3.842782862750749e-12
bp O 0 6.692437576338861e-11
downstream O 0 8.018278749299945e-12
from O 0 7.702739487913668e-12
the O 0 5.732931056962043e-12
cryptic O 0 1.0911953562953158e-09
splice O 0 7.356281694903544e-10
site O 0 4.50488490955081e-09
. O 0 3.0025423813917484e-10

Three O 0 4.130623967868452e-11
other O 0 2.925953343545576e-14
splice O 0 3.350247163025344e-11
variants O 0 7.738629875797542e-11
, O 0 6.04334968569778e-14
including O 0 1.0717231748867857e-14
one O 0 9.523167031431218e-14
derived O 0 3.6140643429327657e-13
from O 0 7.796175272196948e-14
the O 0 1.83775351436221e-14
skipping O 0 5.132902349685997e-12
of O 0 1.3707339367838474e-14
exon O 0 7.301802218417919e-11
32 O 0 6.21015183721596e-11
, O 0 9.25612559689315e-13
were O 0 9.074196949399038e-11
also O 0 1.0798528737865354e-10
identified O 0 1.8925265976577066e-07
. O 0 1.6137645386660182e-10

These O 0 1.689652584513368e-11
results O 0 1.260798063174029e-11
indicate O 0 3.912092438190795e-12
the O 0 1.6360780189395713e-15
usefulness O 0 2.0915322425374416e-13
of O 0 1.0616597670228705e-15
cycloheximide O 0 1.3383458785654057e-09
treatment O 0 1.0159396761355577e-11
in O 0 2.5780208385271265e-14
evaluating O 0 3.5986168472196267e-12
the O 0 5.5804919198024563e-14
abnormal O 0 4.1439269550525015e-12
processing O 0 1.338246191379816e-13
of O 0 1.8525628690054148e-14
mRNA O 0 1.635699822116754e-12
due O 0 1.5292014182710645e-11
to O 0 2.3389940700425937e-13
splice O 0 2.1560038199197606e-09
- O 0 3.9403519735969894e-07
site O 0 6.087043646907375e-10
mutations O 0 1.656981254427592e-07
, O 0 1.8000790474089617e-13
because O 0 3.5456800689948054e-11
( O 0 6.741717644212497e-13
i O 0 2.183288501100833e-07
) O 0 1.0812871933008235e-14
aberrant O 0 1.0553260739246118e-12
splicing O 0 2.3104890396752342e-12
often O 0 4.950775032985799e-12
generates O 0 1.0560710292373265e-12
a O 0 1.0349971747702913e-12
premature O 0 7.530586709769693e-10
termination O 0 7.893082021315223e-11
codon O 0 2.3233011001155823e-11
, O 0 2.495255385778425e-14
( O 0 1.2102267836966094e-14
ii O 0 9.120431521125738e-09
) O 0 1.3478523581533092e-13
transcripts O 0 4.795978544858137e-11
with O 0 2.2231201254885313e-12
premature O 0 1.8595548711974885e-10
termination O 0 1.0315973335978113e-12
codons O 0 2.615784650515651e-13
can O 0 1.3366525768165882e-12
occur O 0 6.338675244410563e-12
at O 0 3.5120717098435783e-12
low O 0 3.060941253352212e-06
or O 0 2.641046648932388e-06
undetectable O 0 0.0007100813672877848
levels O 0 6.277338826521373e-08
due O 0 3.059180339604062e-11
to O 0 2.0896286437310785e-11
nonsense O 0 6.305385340965586e-06
- O 0 9.155149527373396e-09
mediated O 0 1.270357707916503e-10
mRNA O 0 1.7165053016118814e-12
decay O 0 2.5550025636866813e-11
, O 0 2.6597517464098754e-16
and O 0 1.4496341029085198e-15
( O 0 2.911531495887828e-16
iii O 0 4.284105622337497e-12
) O 0 2.999847007086054e-13
the O 0 1.684317615935349e-11
levels O 0 2.8833898113589385e-07
of O 0 3.2240644717493588e-15
these O 0 1.8955621577596005e-14
transcripts O 0 3.861781500049538e-13
can O 0 1.469390754904598e-11
be O 0 4.524629911191458e-13
increased O 0 2.723069165988523e-13
by O 0 2.017673951092841e-13
cycloheximide O 0 1.970755192814977e-06
. O 0 9.283132595960808e-11

A O 0 1.270265559405459e-10
deletion O 0 6.323204182479003e-09
mutation O 0 2.8179091060565042e-08
in O 0 1.3189627341703147e-12
COL17A1 O 0 1.0627540092400523e-07
in O 0 8.87116075043437e-12
five O 0 2.4832410433495156e-12
Austrian O 0 6.708513410558226e-06
families O 0 4.3722220288699987e-11
with O 0 7.861751180615606e-12
generalized O 0 1.0334546232115827e-06
atrophic B-Disease 1 0.9998642206192017
benign I-Disease 1 0.9999549388885498
epidermolysis I-Disease 1 0.9991987347602844
bullosa I-Disease 1 0.7830114960670471
represents O 0 6.222655279941591e-09
propagation O 0 7.222782372195979e-10
of O 0 9.359193650117226e-14
an O 0 5.729394552105721e-14
ancestral O 0 1.8860222894545586e-07
allele O 0 3.742962633168645e-07
. O 0 1.4367387835001466e-10

Patients O 0 2.934447138613905e-07
with O 0 9.091347813461326e-11
generalized O 0 1.0797552931762766e-05
atrophic B-Disease 1 0.999876856803894
benign I-Disease 1 0.9999328851699829
epidermolysis I-Disease 1 0.998965859413147
bullosa I-Disease 1 0.96478271484375
, O 0 1.9538053466772176e-11
a O 0 9.652461122056089e-13
usually O 0 2.612226407405771e-12
nonlethal O 0 8.219993435920614e-11
form O 0 7.39521846537805e-11
of O 0 8.274798901641844e-11
junctional B-Disease 0 0.07000771909952164
epidermolysis I-Disease 1 0.5596686601638794
bullosa I-Disease 0 0.045679353177547455
, O 0 1.0735496693003999e-11
have O 0 3.575462950884678e-13
generalized O 0 4.2941209615898757e-11
blistering B-Disease 0 2.1490089707754123e-08
, O 0 8.335830289918356e-12
nail B-Disease 1 0.9994538426399231
dystrophy I-Disease 0 0.3135789632797241
, O 0 1.315148129288346e-10
patchy B-Disease 0 8.982319559436291e-05
alopecia I-Disease 1 0.9795190691947937
, O 0 2.399326515245548e-09
and O 0 1.426954440830741e-06
dental B-Disease 1 0.999721109867096
abnormalities I-Disease 1 0.9996984004974365
. O 0 1.264947790957649e-08

Skin B-Disease 1 0.9878451228141785
fragility I-Disease 0 0.0005130416830070317
in O 0 1.4018296072559888e-11
most O 0 4.264274548163201e-14
cases O 0 4.1568360082192e-13
is O 0 5.873348140304768e-13
due O 0 1.8931873430050317e-11
to O 0 1.3252720318726596e-12
mutations O 0 9.357592922754066e-09
in O 0 1.4419472831473518e-13
the O 0 5.8337077607029195e-15
gene O 0 6.1587657716744015e-12
encoding O 0 3.7811732911396945e-11
type O 0 2.182099024139461e-06
XVII O 0 4.6530768571528824e-08
collagen O 0 1.4108201717988322e-08
( O 0 3.83399909043014e-11
COL17A1 O 0 5.650271759805037e-06
) O 0 2.772175544674127e-11
. O 0 6.062916141358343e-11

Recently O 0 1.335255461754059e-07
, O 0 5.9779854677532995e-12
we O 0 6.375733274666118e-11
reported O 0 6.397709445549182e-11
five O 0 3.501054426837541e-13
Austrian O 0 6.447564260270156e-07
families O 0 1.2664329654410444e-11
with O 0 3.2650368953640596e-12
generalized O 0 2.924211344179639e-07
atrophic B-Disease 1 0.999427080154419
benign I-Disease 1 0.9995087385177612
epidermolysis I-Disease 1 0.7663061618804932
bullosa I-Disease 0 0.009360810741782188
who O 0 1.3219018768495516e-08
share O 0 1.1575036068522948e-10
the O 0 4.2081382866168693e-13
same O 0 2.5253757418575162e-11
COL17A1 O 0 8.430984053120483e-07
mutation O 0 2.735361093186839e-08
. O 0 3.127160336235946e-11

Affected O 0 1.3174974355933955e-07
individuals O 0 4.1599276801029816e-10
in O 0 2.2191347717748222e-11
three O 0 2.7746817430479576e-12
families O 0 9.589500417697683e-13
are O 0 3.4224158710737928e-15
homozygous O 0 4.408493156030785e-13
for O 0 3.280362516588616e-15
4003delTC O 0 1.0740212885718137e-10
, O 0 1.3035750660883062e-14
whereas O 0 8.979480353721314e-12
those O 0 7.512246033569703e-12
in O 0 1.0184710063157465e-12
two O 0 3.1681677680611697e-13
others O 0 9.481852802917246e-12
are O 0 1.0173547117589554e-12
compound O 0 2.8936364415699245e-10
heterozygotes O 0 1.3661552600297e-07
. O 0 5.576045181143741e-10

To O 0 1.945808531661486e-12
determine O 0 4.956581811654814e-10
if O 0 4.52346146651017e-11
the O 0 1.3648534105475344e-14
occurrence O 0 1.7133505725297482e-10
of O 0 7.311640069708903e-15
4003delTC O 0 3.6018516169633585e-08
in O 0 7.120129681160992e-13
these O 0 2.0869644987847602e-14
unrelated O 0 1.272573626337481e-11
families O 0 1.167446131086769e-13
signifies O 0 1.8996058252871567e-13
propagation O 0 1.2811743311212653e-13
of O 0 7.555453950773962e-16
an O 0 3.5335745458408164e-15
ancestral O 0 2.2850176861766158e-08
allele O 0 1.3261849396428715e-08
or O 0 2.220147676812445e-10
a O 0 1.1690984985657238e-11
mutational O 0 6.437613592424896e-06
hot O 0 4.091447863174835e-06
spot O 0 2.6416839773446554e-06
, O 0 1.093140945059197e-13
haplotypes O 0 1.8730747508577394e-10
were O 0 1.109772690410793e-10
determined O 0 1.3463263837110162e-09
for O 0 7.176733979232658e-15
polymorphisms O 0 1.1227869300967086e-08
both O 0 2.5175653228792783e-11
within O 0 7.424951278811598e-12
and O 0 3.987716754028092e-11
flanking O 0 1.2239356692589354e-06
COL17A1 O 0 0.001982963178306818
. O 0 1.0761257440705663e-09

Five O 0 4.162149791486769e-10
intragenic O 0 1.3431953327369683e-08
polymorphisms O 0 3.3904420604358165e-08
were O 0 1.974288788009204e-11
chosen O 0 2.2943676038916783e-12
based O 0 3.0632291950390134e-13
on O 0 2.3390947165302656e-11
their O 0 3.8387682789464694e-12
informativeness O 0 4.235349493342255e-08
. O 0 8.849461094473376e-12

One O 0 2.1215691703435624e-10
of O 0 1.1007693237821692e-13
these O 0 1.956428590096579e-13
, O 0 5.5424530253939813e-14
not O 0 1.5143232154346542e-11
previously O 0 6.815530806392189e-09
reported O 0 7.609109076156528e-08
, O 0 2.8162081973609303e-14
was O 0 2.4206003954724276e-12
2988 O 0 1.5356266258592655e-10
A O 0 3.175867208105032e-11
or O 0 1.2743315735974647e-08
C O 0 4.317056223612781e-08
that O 0 8.275511894674514e-14
introduces O 0 4.952803033149433e-13
a O 0 6.772129379625444e-14
new O 0 1.466585709754449e-14
restriction O 0 1.9500755041789927e-14
site O 0 1.3226046776879108e-13
for O 0 4.2940653745444923e-14
Eco0109 O 0 6.7360375055613986e-09
I O 0 3.524196654325351e-05
. O 0 3.465731868157462e-11

All O 0 7.657650555326079e-12
the O 0 1.7499355100831365e-13
4003delTC O 0 5.362195132363468e-10
alleles O 0 2.8073593449917666e-10
showed O 0 1.156067908070213e-09
the O 0 1.577939879725699e-14
same O 0 3.821661886146792e-14
haplotype O 0 3.760271174296781e-12
for O 0 9.454965463177607e-15
these O 0 5.05711771558396e-14
five O 0 6.332481332924425e-14
polymorphic O 0 4.660459865246658e-11
markers O 0 1.0961628049699357e-08
. O 0 5.742096242933314e-10

Fourteen O 0 3.053522990015267e-09
microsatellite O 0 2.1173548248043517e-08
polymorphisms O 0 9.397339795214066e-08
were O 0 1.0545619932855743e-11
selected O 0 3.834653406441235e-13
based O 0 5.179910862219972e-13
on O 0 1.584493508621776e-10
their O 0 3.7478572328941695e-11
high O 0 3.6395123026444764e-10
heterozygosity O 0 8.929371375643314e-08
and O 0 1.2815574990110434e-10
their O 0 4.0600704222237827e-13
location O 0 1.0626505751731852e-11
within O 0 2.971579796465229e-12
10q23 O 0 9.903136977129634e-09
- O 0 4.773335149366176e-07
q25 O 0 6.912857841712139e-09
near O 0 8.233182136052619e-09
COL17A1 O 0 4.442159024620196e-06
. O 0 1.819279865644674e-10

Three O 0 1.0250361670571806e-09
families O 0 1.5760780180951173e-10
shared O 0 4.014779134142721e-11
microsatellite O 0 2.3855514896808927e-08
polymorphisms O 0 2.2588717456528684e-06
covering O 0 8.958932085079141e-07
at O 0 2.6525519558617816e-09
most O 0 1.8964320131625856e-12
19 O 0 1.4444482068776132e-11
cM O 0 1.0083801849081198e-10
, O 0 1.5213710553938636e-13
whereas O 0 5.630604316131382e-10
the O 0 2.5511008236445143e-12
others O 0 8.192567284293073e-12
shared O 0 1.6429226685696352e-12
smaller O 0 1.2149845018960548e-10
regions O 0 2.794140741002593e-08
consistent O 0 2.8245233352208743e-07
with O 0 1.6761150301893013e-13
cross O 0 4.1628167579688125e-10
- O 0 1.91424902595827e-07
over O 0 7.005736702564436e-12
events O 0 1.4991142008313751e-12
during O 0 2.4338861546839563e-13
passage O 0 2.2197577502773742e-14
of O 0 2.719329185183546e-15
this O 0 9.514954877600998e-15
mutation O 0 6.911314511144628e-13
through O 0 1.3282002832165911e-15
several O 0 5.257507414992667e-14
generations O 0 2.893342510024155e-11
. O 0 3.910525982891988e-12

These O 0 5.2118073745610616e-11
results O 0 2.3804298809881885e-11
indicate O 0 3.8407034497200954e-11
that O 0 5.836849151794402e-14
4003delTC O 0 1.0968742714112523e-07
occurs O 0 3.0979002696440716e-10
on O 0 1.299386162903482e-12
a O 0 3.1072337086136825e-13
single O 0 2.4507694051240092e-12
ancestral O 0 1.923680381654691e-10
allele O 0 1.2358797318867687e-10
. O 0 5.445153876404429e-13
. O 0 2.5981291770782455e-12

The O 0 3.138389825796395e-10
haptoglobin O 0 1.473392785555916e-06
- O 0 1.5712233292219935e-08
gene O 0 4.1787270865789594e-10
deletion O 0 2.4789950092696245e-09
responsible O 0 5.483945519912936e-10
for O 0 1.3326761569287804e-12
anhaptoglobinemia B-Disease 0 1.3427966223389376e-06
. O 0 4.512459017558257e-10

We O 0 1.131621516492487e-07
have O 0 1.8182235231312127e-12
found O 0 5.0666275238893735e-14
an O 0 3.040431752191126e-15
allelic O 0 1.7516020855978809e-09
deletion O 0 4.647610740704522e-09
of O 0 1.3900126709376348e-12
the O 0 1.8687475612094717e-12
haptoglobin O 0 9.800259270775769e-09
( O 0 6.730661441736599e-15
Hp O 0 1.0934989520046835e-14
) O 0 5.621123455007535e-16
gene O 0 3.4983512397709915e-13
from O 0 3.182922404375982e-13
an O 0 7.198475620922781e-15
individual O 0 2.8800675386242425e-11
with O 0 8.311808706584767e-12
anhaptoglobinemia B-Disease 0 7.460265806003008e-06
. O 0 3.348102350919646e-10

The O 0 5.231664927662916e-12
Hp O 0 1.2731563199530616e-11
gene O 0 5.797569369025979e-11
cluster O 0 1.235787860931481e-10
consists O 0 1.3761525556252319e-12
of O 0 6.508446667892465e-14
coding O 0 1.6585994799811488e-08
regions O 0 2.2120385523294317e-08
of O 0 6.280667826097375e-12
the O 0 2.823909509008793e-11
alpha O 0 2.0364312666720785e-11
chain O 0 2.224048056831407e-09
and O 0 1.9409972761008643e-12
beta O 0 5.367238839243567e-14
chain O 0 5.606112362527282e-12
of O 0 9.069438417234812e-15
the O 0 7.600006507370999e-14
haptoglobin O 0 9.620525903697441e-11
gene O 0 8.463349921057628e-13
( O 0 5.141298878024879e-16
Hp O 0 2.8650929674941704e-15
) O 0 2.5016112245530896e-15
and O 0 3.503205212897209e-13
of O 0 5.5781297143191536e-14
the O 0 3.952043987204279e-12
alpha O 0 5.602328496945308e-12
chain O 0 8.747271795783718e-10
and O 0 2.324017931223943e-12
beta O 0 7.656138364346005e-14
chain O 0 1.440365448440728e-11
of O 0 1.3144314196106288e-13
the O 0 4.366402638761313e-12
haptoglobin O 0 3.55101917648426e-07
- O 0 1.0604556877069626e-07
related O 0 7.433206272722259e-10
gene O 0 1.061770338317558e-09
( O 0 2.518532799845874e-13
Hpr O 0 1.9791536465252335e-10
) O 0 9.834708459936781e-14
, O 0 2.737247277798116e-14
in O 0 3.3534915296062895e-13
tandem O 0 2.2054159387607797e-08
from O 0 9.79635816911184e-12
the O 0 1.1212727274445555e-10
5 O 0 1.7724927081630426e-09
side O 0 9.204509296978358e-07
. O 0 1.989426179349607e-09

Southern O 0 6.2781384535526286e-09
blot O 0 5.045995266073078e-08
and O 0 4.169167181627964e-13
PCR O 0 5.118679785587332e-11
analyses O 0 6.337412261636644e-10
have O 0 2.5126024850129214e-13
indicated O 0 6.822660925803747e-12
that O 0 2.4837724989256772e-15
the O 0 1.0907862654636305e-15
individual O 0 3.174548026795704e-14
with O 0 6.8938762203430305e-15
anhaptoglobinemia B-Disease 0 8.557624053828761e-10
was O 0 1.7120683126412017e-12
homozygous O 0 2.7711064779639694e-12
for O 0 2.2322646999633523e-15
the O 0 1.2937456299002463e-15
gene O 0 8.494124999723629e-13
deletion O 0 2.347479328979052e-11
and O 0 3.4342828060529573e-12
that O 0 1.1774527919783829e-14
the O 0 6.215373712834774e-16
gene O 0 3.2371555522964224e-13
deletion O 0 1.0153584570349317e-11
was O 0 5.70645353886734e-12
included O 0 1.418203662145734e-13
at O 0 1.8280096186762407e-11
least O 0 1.086066525883729e-13
from O 0 2.808817360557686e-13
the O 0 6.845507233982362e-13
promoter O 0 3.652970917755738e-06
region O 0 1.6844639016966312e-09
of O 0 1.0682339073638664e-13
Hp O 0 1.6969313324302626e-12
to O 0 1.0900434201099873e-12
Hpr O 0 2.2966915036448654e-09
alpha O 0 3.3142783222722683e-12
but O 0 3.266223402853541e-10
not O 0 3.4045101807156364e-12
to O 0 5.657292668180547e-13
Hpr O 0 3.882246524256061e-09
beta O 0 9.644754613014062e-12
( O 0 4.867245387112085e-13
Hpdel O 0 5.394099833466726e-09
) O 0 2.370402051726783e-12
. O 0 1.3068282567196832e-11

In O 0 9.498433289900632e-12
addition O 0 6.316090771056604e-13
, O 0 1.5758592618753814e-13
we O 0 5.93130579373824e-12
found O 0 4.3258812872960795e-13
seven O 0 5.400530283389271e-14
individuals O 0 4.535313402229905e-15
with O 0 4.75539797291499e-15
hypohaptoglobinemia B-Disease 0 3.6344317777547985e-07
in O 0 1.0270848060933702e-10
three O 0 6.768671994422659e-13
families O 0 1.0978904282010413e-13
, O 0 4.859578366746059e-15
and O 0 3.5190231804926864e-13
the O 0 1.5726043514283083e-13
genotypes O 0 4.56699206230482e-10
of O 0 4.787072431164385e-13
six O 0 7.82283092470859e-12
of O 0 9.328931534604082e-14
the O 0 6.138407056960338e-12
seven O 0 1.3716741501315632e-12
individuals O 0 3.1277714793165323e-13
were O 0 8.4722541482396e-12
found O 0 5.5780497408564056e-12
to O 0 1.1702407272384807e-11
be O 0 1.4801712078238438e-09
Hp2 O 0 6.483696779469028e-07
/ O 0 6.093380306992913e-07
Hpdel O 0 4.7253246293621487e-07
. O 0 2.972331270001405e-10

The O 0 9.698847974748404e-11
phenotypes O 0 1.249603229780405e-07
and O 0 2.648383595760251e-11
genotypes O 0 7.258807244170384e-08
in O 0 3.0284687951853684e-11
one O 0 6.573890737326948e-12
of O 0 3.0168186335556915e-14
these O 0 1.899059902388256e-12
three O 0 8.46097768670423e-13
families O 0 9.12239684833227e-13
showed O 0 2.5358149358112314e-08
the O 0 4.36316212109808e-13
father O 0 1.1530096877265805e-08
to O 0 2.293868870892335e-12
be O 0 3.5193757630391787e-11
hypohaptoglobinemic B-Disease 0 1.2618633249417144e-08
( O 0 4.3217718222491805e-14
Hp2 O 0 2.116569419730041e-10
) O 0 3.128265468931371e-14
and O 0 1.9638686564547175e-13
Hp2 O 0 1.2310292785144838e-09
/ O 0 1.5215453341710372e-09
Hpdel O 0 5.846825246180742e-09
, O 0 4.366131954136425e-14
the O 0 3.6075333123336203e-14
mother O 0 2.149401323592315e-09
to O 0 1.7214846898244013e-13
be O 0 9.765911170023234e-12
Hp2 O 0 1.0084312052072164e-08
- O 0 1.4293772210294264e-07
1 O 0 3.1483030158568903e-12
and O 0 5.793572544453285e-13
Hp1 O 0 4.967626310303785e-10
/ O 0 1.6927564905344639e-10
Hp2 O 0 5.478519859991593e-10
, O 0 1.8816718338641666e-14
one O 0 2.4981315708541216e-14
of O 0 4.1555550741743854e-15
the O 0 2.2651550231865547e-13
two O 0 1.5650467033445636e-12
children O 0 7.552511675952556e-13
to O 0 6.886720469063967e-13
be O 0 4.641000084237845e-10
hypohaptoglobinemic B-Disease 0 1.1481755279874051e-07
( O 0 7.481694300551234e-14
Hp2 O 0 4.999106684167032e-10
) O 0 2.9168538379998124e-14
and O 0 4.3746533088737105e-13
Hp2 O 0 3.1040470194199088e-09
/ O 0 1.1252475617951063e-09
Hpdel O 0 6.342361302813515e-09
, O 0 4.233560117056223e-14
and O 0 4.6315819154105556e-14
the O 0 5.0018409383692074e-15
other O 0 5.971142498636603e-14
child O 0 5.698714833357599e-10
to O 0 5.705468243038039e-14
be O 0 7.28392433174685e-12
Hp1 O 0 1.9931560846231378e-09
and O 0 2.9318106102571573e-12
Hp1 O 0 7.734771934053697e-09
/ O 0 1.956970940852898e-08
Hpdel O 0 9.936096390106286e-09
, O 0 3.0296430511903005e-14
showing O 0 1.1071932953798935e-10
an O 0 3.327828760645089e-15
anomalous O 0 6.399710622551069e-11
inheritance O 0 3.106386703422004e-09
of O 0 1.613091929995869e-12
Hp O 0 1.803899564445377e-11
phenotypes O 0 3.173134999201466e-08
in O 0 2.9003485377265825e-11
the O 0 2.8192274903471315e-11
child O 0 1.2542228660095134e-06
with O 0 1.486410820816797e-11
Hp1 O 0 3.865845314976468e-07
. O 0 3.01179386985595e-10

The O 0 1.6791790180548105e-11
Hp2 O 0 1.59319260006896e-08
/ O 0 1.680065686571197e-08
Hpdel O 0 4.405881526281519e-08
individuals O 0 1.6534050517602594e-10
had O 0 3.123656888703863e-10
an O 0 4.458825886635709e-13
extremely O 0 1.3771973499387968e-06
low O 0 0.0005179316503927112
level O 0 5.169244943203921e-08
of O 0 4.932682138181904e-14
Hp O 0 3.0954915280351214e-13
( O 0 2.084164038454548e-14
mean O 0 3.7976091021851843e-11
+ O 0 2.1214412605080613e-12
/ O 0 1.0233932590253403e-09
- O 0 4.2943875122603e-09
SD O 0 3.8154104231580277e-07
= O 0 6.418178344347325e-08
0 O 0 1.536882058249256e-12
. O 0 1.858585527370277e-15
049 O 0 1.3835857806676621e-11
+ O 0 2.0487648036415784e-12
/ O 0 2.1487331913760954e-09
- O 0 7.182342276479403e-09
0 O 0 1.700605693592816e-12
. O 0 8.971916972918582e-15
043 O 0 7.657230405300197e-11
mg O 0 3.046126545447336e-11
/ O 0 6.92293167237068e-11
ml O 0 2.260945597409858e-10
; O 0 9.939420028129073e-15
n O 0 1.8468476747912632e-10
= O 0 9.303114389958012e-10
6 O 0 2.35876476770841e-13
) O 0 3.847483050269129e-16
, O 0 6.327404408020996e-16
compared O 0 2.243382779890113e-12
with O 0 1.4941749280992372e-13
the O 0 3.0879174217623984e-11
level O 0 9.993117799922402e-08
( O 0 3.3935678347144426e-15
1 O 0 1.445096314476018e-14
. O 0 5.89441492966999e-16
64 O 0 8.096825529890891e-16
+ O 0 7.288307869550426e-14
/ O 0 8.514864507924713e-11
- O 0 2.2080581807415456e-09
1 O 0 4.628563699850263e-13
. O 0 9.991349077026392e-15
07 O 0 4.842835659400746e-13
mg O 0 1.8689687384526588e-12
/ O 0 3.5266583490317638e-12
ml O 0 4.447421163983334e-12
) O 0 4.369026382184223e-16
obtained O 0 1.5479074456665326e-13
from O 0 1.7371123799386073e-13
52 O 0 2.5354130687299525e-12
healthy O 0 1.434269092381868e-10
volunteers O 0 2.9593456591509026e-12
having O 0 1.1236984953644225e-10
phenotype O 0 5.71183822462018e-10
Hp2 O 0 1.313491121424093e-10
, O 0 1.723664613817455e-15
whereas O 0 1.2724315958528853e-13
the O 0 5.388468703626959e-15
serum O 0 5.3342191774774506e-12
Hp O 0 4.362652342789104e-14
level O 0 1.3584387781317986e-10
of O 0 4.398091523675866e-15
an O 0 5.2181426599118546e-15
individual O 0 5.970191355175736e-12
with O 0 1.007944595843302e-12
Hp1 O 0 8.115303273825702e-08
/ O 0 5.80480374878789e-08
Hpdel O 0 4.725793445459203e-08
was O 0 1.0320403198704753e-08
0 O 0 8.972893955627725e-11
. O 0 6.98404225077387e-12

50 O 0 1.8675070379003955e-09
mg O 0 2.121816944367083e-09
/ O 0 1.1928593224297401e-08
ml O 0 4.854194912695675e-07
, O 0 6.525753245070764e-13
which O 0 2.7782284936148094e-13
was O 0 5.146685595064371e-12
approximately O 0 8.919399236122921e-15
half O 0 2.61376993182863e-13
the O 0 1.4214940802139558e-13
level O 0 5.1297532194238826e-11
of O 0 1.1971310402331711e-15
Hp O 0 1.0005738642140938e-12
in O 0 6.219750409153235e-12
control O 0 1.1825613910332322e-07
sera O 0 1.1014572010026313e-07
from O 0 7.868798928417631e-13
the O 0 5.72605385416175e-13
Hp1 O 0 9.086814856118508e-09
phenotype O 0 1.0961365148887126e-10
( O 0 6.742276381025824e-15
1 O 0 1.617345715904453e-13
. O 0 1.206161872582736e-14
26 O 0 6.456848808877522e-14
+ O 0 5.1687065136815993e-14
/ O 0 9.985329924022679e-11
- O 0 3.5187219804555525e-09
0 O 0 1.4000759102419935e-12
. O 0 5.223380711657675e-15
33 O 0 1.273315220623461e-13
mg O 0 2.3398832784543577e-12
/ O 0 1.7810615829394472e-11
ml O 0 1.8294127324125498e-10
; O 0 2.9789484681103096e-14
n O 0 1.0175308373661096e-09
= O 0 8.841781529156378e-09
9 O 0 3.348379733203455e-12
) O 0 2.4411455658551046e-15
, O 0 9.647476570330722e-16
showing O 0 6.769818594598576e-10
a O 0 1.2225195899009944e-12
gene O 0 2.7669502244975774e-08
- O 0 0.00012557581067085266
dosage O 0 3.9599979118065676e-07
effect O 0 6.297939503241423e-09
. O 0 7.042099542386993e-11

The O 0 1.2204000830740025e-11
other O 0 3.1452040949973836e-13
allele O 0 1.9855965482928895e-10
( O 0 4.212135265688373e-14
Hp2 O 0 1.0318699367184436e-10
) O 0 1.0490954520305396e-14
of O 0 1.4867082056142485e-15
individuals O 0 1.293431236681214e-13
with O 0 8.324557135199612e-14
Hp2 O 0 1.9599816880599974e-08
/ O 0 2.9989033478727833e-09
Hpdel O 0 3.520997715611429e-09
was O 0 1.1494645513199231e-10
found O 0 4.0725728995757993e-13
to O 0 3.514234259496818e-13
have O 0 1.6950374437385562e-10
, O 0 9.550415064904852e-14
in O 0 4.8316736896147905e-12
all O 0 5.524998319093866e-13
exons O 0 1.904987669346103e-12
, O 0 1.5521262118449453e-13
no O 0 3.700168296760786e-11
mutation O 0 1.0052207330413232e-11
, O 0 2.5175192312214644e-17
by O 0 9.211583886553003e-17
DNA O 0 4.038599424500966e-13
sequencing O 0 2.3639319668422587e-12
. O 0 9.05341253354397e-12

On O 0 1.576757613364066e-10
the O 0 1.1761560692394313e-13
basis O 0 5.65837144934217e-13
of O 0 4.921515109915188e-15
the O 0 4.8641777556496495e-15
present O 0 1.9929012867042628e-13
study O 0 2.3432260160536657e-14
, O 0 1.241058512984914e-16
the O 0 9.181833177769675e-17
mechanism O 0 2.9659442762029753e-13
of O 0 1.4925271102036487e-15
anhaptoglobinemia B-Disease 0 6.561661436421673e-09
and O 0 7.946928163270195e-13
the O 0 4.642883198399412e-15
mechanism O 0 4.93475540378624e-13
of O 0 5.411475389023807e-16
anomalous O 0 6.0663253934056804e-12
inheritance O 0 2.3484669764428645e-09
of O 0 2.258857380657564e-12
Hp O 0 1.111746632254107e-11
phenotypes O 0 9.535750855604874e-09
were O 0 8.063961165483136e-10
well O 0 6.594933488202059e-10
explained O 0 3.2887382417357003e-07
. O 0 1.0345659051669287e-10

However O 0 2.85423518153749e-10
, O 0 1.594087377018976e-14
the O 0 7.11192494733939e-15
mechanism O 0 1.0202855921237486e-11
of O 0 1.1865847930961348e-12
hypohaptoglobinemia B-Disease 0 0.0002189749211538583
remains O 0 2.6734960556495935e-07
unknown O 0 1.8218673858427792e-06

ATM O 0 1.068287360794784e-06
mutations O 0 9.126804070547223e-05
and O 0 2.4500066420074518e-09
phenotypes O 0 0.011167884804308414
in O 0 4.178231847618008e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 2.6851352231460623e-05
in O 0 2.0576242099057396e-11
the O 0 3.045617685999702e-13
British O 0 1.0688868457009448e-08
Isles O 0 3.9966735476681947e-10
: O 0 1.230324978181152e-13
expression O 0 2.054641450466993e-13
of O 0 5.609595468944302e-17
mutant O 0 1.1983195333372873e-14
ATM O 0 2.557844127476505e-12
and O 0 1.7189419646793797e-13
the O 0 3.9181093265672207e-13
risk O 0 2.232354972875328e-06
of O 0 5.215051723794772e-10
leukemia B-Disease 1 0.9993100166320801
, O 0 2.644703272380866e-06
lymphoma B-Disease 1 1.0
, O 0 1.6676955649774783e-10
and O 0 5.4780858960157275e-08
breast B-Disease 1 0.9989697933197021
cancer I-Disease 1 0.9223638772964478
. O 0 7.572334936867264e-08

We O 0 6.974278932148081e-10
report O 0 4.859425578943033e-13
the O 0 1.049058881383042e-15
spectrum O 0 9.83077551655609e-13
of O 0 2.950201525133214e-14
59 O 0 9.189421142433152e-13
ATM O 0 3.1830138524924223e-09
mutations O 0 8.668940267853031e-07
observed O 0 5.29700810147915e-06
in O 0 1.0665222589523182e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.26433801651000977
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.7024646409579134e-10
patients O 0 6.505945955581627e-12
in O 0 8.681400596229766e-14
the O 0 3.4016848582743564e-13
British O 0 9.827964504438569e-07
Isles O 0 3.8816413194808774e-08
. O 0 1.6927759194373948e-10

Of O 0 1.5051236645913235e-10
51 O 0 2.585086866790931e-10
ATM O 0 4.626421912234946e-08
mutations O 0 2.9452510261762654e-06
identified O 0 3.9577551547154144e-07
in O 0 1.1234149895067436e-11
families O 0 9.551513226180308e-13
native O 0 4.221582285135472e-12
to O 0 1.71500324792212e-12
the O 0 5.443599130489085e-12
British O 0 7.993340886969236e-07
Isles O 0 1.4178475282733416e-08
, O 0 2.2860331249513477e-12
11 O 0 6.278317167367209e-13
were O 0 4.276981397624731e-14
founder O 0 3.626604225259733e-13
mutations O 0 2.541996335647667e-10
, O 0 1.3017612297350559e-14
and O 0 3.5091905509904153e-13
2 O 0 2.3497615528680904e-13
of O 0 3.4589312073200415e-14
these O 0 1.9622420008302832e-11
11 O 0 1.3328211147592417e-12
conferred O 0 4.109546036801248e-12
a O 0 2.0343251280578734e-13
milder O 0 1.6973353833549254e-09
clinical O 0 7.221538644852643e-11
phenotype O 0 1.6603513008917048e-10
with O 0 1.4711052742730907e-13
respect O 0 1.772038904501727e-10
to O 0 6.006398069885455e-12
both O 0 1.008065408925063e-09
cerebellar B-Disease 0 0.0001859688200056553
degeneration I-Disease 0 7.722915142949205e-06
and O 0 1.975789254426985e-10
cellular O 0 4.0114361832266354e-10
features O 0 4.00673583200728e-09
. O 0 1.1785388220886261e-09

We O 0 7.237486165934115e-09
report O 0 1.0790267117311014e-11
, O 0 6.778510332926995e-15
in O 0 2.1993362263762056e-13
two O 0 3.32344152198516e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 7.799031420674396e-10
, O 0 5.859713366249521e-15
an O 0 2.964474760860366e-16
ATM O 0 6.124321050293702e-10
mutation O 0 1.8040208216163478e-10
( O 0 4.908896436583467e-15
7271T O 0 2.9982200749900656e-11
- O 0 2.7410433034447124e-08
- O 0 1.9206870760513084e-08
> O 0 3.776027407420557e-11
G O 0 4.6440992718110863e-10
) O 0 2.0410703055267435e-15
that O 0 1.8604176088132113e-13
may O 0 7.483689362652868e-11
be O 0 2.9956831286426233e-14
associated O 0 1.8935394430815572e-13
with O 0 2.482351601156658e-15
an O 0 2.7466766179735404e-14
increased O 0 3.9810964835851337e-07
risk O 0 0.0026681211311370134
of O 0 2.484680239334125e-09
breast B-Disease 1 0.9999639987945557
cancer I-Disease 0 0.23111188411712646
in O 0 6.293961463121889e-10
both O 0 1.019473047647601e-10
homozygotes O 0 1.1865598708027392e-06
and O 0 1.7903905788485552e-11
heterozygotes O 0 4.351709659289327e-09
( O 0 1.0921682395276244e-12
relative O 0 3.4479424471101083e-07
risk O 0 1.1372064363968093e-05
12 O 0 2.682316174729138e-12
. O 0 2.3012594298687725e-14
7 O 0 1.0228903227910147e-12
; O 0 1.6455435104811844e-13
P O 0 0.00018590268155094236
= O 0 5.05165758113435e-08
. O 0 3.965094379676688e-14
0025 O 0 2.585282855849247e-11
) O 0 7.286052051405298e-15
, O 0 1.3144801494160844e-15
although O 0 2.5964779913796587e-13
there O 0 1.7712792495759577e-13
is O 0 3.98045379751584e-14
a O 0 2.678439609861416e-13
less O 0 4.8903633143027037e-08
severe O 1 0.9833553433418274
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 2.1857375031686388e-05
in O 0 1.8644220282221236e-12
terms O 0 3.816792368271926e-12
of O 0 5.687773301253423e-16
the O 0 2.7587736037130474e-14
degree O 0 6.146004816187656e-10
of O 0 5.362312156809157e-12
cerebellar B-Disease 0 3.0533719836967066e-05
degeneration I-Disease 0 1.2758123375533614e-06
. O 0 7.690195147347367e-10

This O 0 1.2059244228201926e-11
mutation O 0 4.301017042518396e-10
( O 0 8.971403670952546e-15
7271T O 0 1.8881892577260473e-11
- O 0 1.3409316990120601e-09
- O 0 1.5053887025828772e-09
> O 0 1.5888566504140833e-11
G O 0 4.716421350692279e-11
) O 0 8.761567193077614e-17
also O 0 1.8610252204863859e-16
allows O 0 3.402044728692327e-15
expression O 0 2.4984105496256293e-12
of O 0 5.581915358670317e-15
full O 0 2.164554343056513e-12
- O 0 1.2443428232256082e-10
length O 0 2.5515668137382486e-13
ATM O 0 3.621953865301508e-12
protein O 0 5.677720798938704e-14
at O 0 3.727421745824272e-13
a O 0 4.5170247750525583e-13
level O 0 4.445417811638208e-09
comparable O 0 3.8904079957546855e-09
with O 0 2.866386056461778e-13
that O 0 2.3132062237918305e-11
in O 0 2.059422424260937e-11
unaffected O 0 1.5191684354931567e-08
individuals O 0 6.448698519623264e-11
. O 0 1.101997798569343e-10

In O 0 5.390810627753373e-12
addition O 0 5.89631316862127e-13
, O 0 4.757287364607135e-14
we O 0 1.03564535419709e-11
have O 0 3.7873336736736485e-13
studied O 0 2.636583751325361e-08
18 O 0 9.307115078627248e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.344914307172985e-08
, O 0 2.0457209399236433e-14
in O 0 1.319626374320093e-13
15 O 0 7.64067493086093e-14
families O 0 2.002418243967751e-14
, O 0 4.5479021752985876e-14
who O 0 1.315864572859482e-08
developed O 0 3.274516075180145e-06
leukemia B-Disease 1 0.9997504353523254
, O 0 1.7453336340622627e-06
lymphoma B-Disease 1 1.0
, O 0 2.2516231934499586e-11
preleukemic O 0 0.0002396521158516407
T O 0 0.03563327342271805
- O 0 3.618424671003595e-05
cell O 0 9.045920990047307e-08
proliferation O 0 5.873648660781328e-06
, O 0 3.9663688999880264e-12
or O 0 0.00027207989478483796
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 5.295133775895522e-11
mostly O 0 1.8695579806493612e-11
in O 0 6.046774192469684e-10
childhood O 0 3.394790837774053e-05
. O 0 4.918205842585621e-10

A O 0 1.2924565584437886e-10
wide O 0 2.7128695123668223e-11
variety O 0 2.144468977394176e-11
of O 0 4.168499313089713e-13
ATM O 0 5.2902759506423536e-08
mutation O 0 2.0463280847593524e-08
types O 0 4.3356869205979365e-09
, O 0 7.403784548875962e-15
including O 0 3.3907098184954645e-14
missense O 0 6.057261430214567e-07
mutations O 0 2.345560642424971e-05
and O 0 1.5179162371481425e-09
in O 0 1.1403279015498313e-10
- O 0 9.843582802204764e-07
frame O 0 9.006596997096494e-07
deletions O 0 4.5300816964299884e-07
, O 0 2.5244318788142373e-11
were O 0 4.869088812697875e-11
seen O 0 2.4953109800662787e-07
in O 0 3.704982935032186e-12
these O 0 4.4975546724390636e-12
patients O 0 2.391022059164416e-12
. O 0 5.997102987820302e-12

We O 0 1.4931694769515502e-09
also O 0 2.7367827649298418e-14
show O 0 7.985658575376808e-13
that O 0 4.644601404732917e-15
25 O 0 4.124632442368973e-15
% O 0 3.270864577332376e-16
of O 0 1.0911905331135313e-14
all O 0 1.3863377112954822e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.726960404852434e-08
carried O 0 1.2111720515406432e-09
in O 0 6.809984867683916e-12
- O 0 6.4956644507674355e-09
frame O 0 9.120674882012736e-09
deletions O 0 1.818889749927166e-08
or O 0 9.412991497370626e-10
missense O 0 7.174485716632262e-08
mutations O 0 3.9363811765724677e-08
, O 0 1.3667551689207098e-14
many O 0 1.3168692058438151e-15
of O 0 2.341751670505675e-14
which O 0 1.3956354127930837e-10
were O 0 2.443168722887634e-10
also O 0 3.764335024247778e-11
associated O 0 4.458758251502104e-09
with O 0 1.2268182129904215e-11
expression O 0 2.8607334279229235e-09
of O 0 1.0074020339711359e-13
mutant O 0 1.4507821159692735e-11
ATM O 0 3.422737926417341e-10
protein O 0 9.657737803925315e-11
. O 0 2.627478096206559e-11

The O 0 1.2224922463222043e-11
DMPK O 0 2.476307514598375e-08
gene O 0 3.4056388820147276e-09
of O 0 6.411721154009342e-11
severely O 0 0.04995310306549072
affected O 0 0.004966188687831163
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.0021333089098334312
is O 0 1.9140794851879583e-11
hypermethylated O 0 3.290235417452436e-09
proximal O 0 4.034261119612026e-11
to O 0 8.426384047986735e-13
the O 0 1.9231456162803473e-13
largely O 0 2.016679531702259e-11
expanded O 0 1.7303822263947666e-10
CTG O 0 5.163726868318008e-08
repeat O 0 1.5155512755882228e-07
. O 0 3.277354776454189e-11

Using O 0 1.2174428999645048e-11
methylation O 0 1.1023924884057124e-07
- O 0 9.90272269518755e-07
sensitive O 0 3.224356248665572e-07
restriction O 0 6.211904601816087e-11
enzymes O 0 1.9054092071507656e-12
, O 0 1.7232439560800248e-15
we O 0 3.516015806954119e-14
characterized O 0 6.43014287649013e-14
the O 0 6.801092231300794e-16
methylation O 0 1.1292714159616413e-11
pattern O 0 1.0914758680202752e-10
on O 0 8.458524679288981e-13
the O 0 5.0046491066992396e-14
5 O 0 2.742401303875569e-13
side O 0 5.997629476395261e-12
of O 0 2.5919726993661784e-15
the O 0 5.721477165741146e-14
CTG O 0 8.924526673226296e-10
repeat O 0 1.853847186872315e-09
in O 0 1.5186545868507012e-13
the O 0 2.0962106680853408e-15
DMPK O 0 6.059724944051936e-11
gene O 0 6.442176436402547e-13
of O 0 1.3088741889096239e-14
normal O 0 6.065064249438645e-12
individuals O 0 1.647330411186712e-13
and O 0 1.1948652787682756e-12
of O 0 3.2201854030522448e-12
patients O 0 2.6996631596887255e-09
affected O 0 4.209656179199328e-09
with O 0 9.410486256911099e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 7.029802955027531e-12
showing O 0 6.729673762695398e-11
expansions O 0 1.6509335565295657e-11
of O 0 5.305154034715258e-14
the O 0 1.0663290996720809e-12
repetitive O 0 9.801907907558416e-08
sequence O 0 7.938759094550107e-10
. O 0 9.625518437861302e-11

The O 0 4.094024164819077e-12
gene O 0 8.467444106985411e-11
segment O 0 2.5167779318935324e-11
analyzed O 0 4.423903951500385e-11
corresponds O 0 1.3074265628465476e-11
to O 0 1.9625721200630143e-14
the O 0 4.968753544460497e-14
genomic O 0 5.119521473417876e-10
SacI O 0 5.773636644335056e-07
- O 0 1.020045715449669e-06
HindIII O 0 3.3785834574473483e-08
fragment O 0 9.214058960260729e-10
carrying O 0 2.327767839593875e-11
exons O 0 1.783010128431073e-10
11 O 0 9.509241311045358e-11
- O 0 3.137219550808368e-08
15 O 0 2.4201907838916625e-11
. O 0 7.290373166268793e-12

There O 0 1.2594575382607331e-10
is O 0 1.190871674276034e-13
constitutive O 0 5.7466483828483295e-12
methylation O 0 7.483304254041201e-11
in O 0 1.9367729533863176e-13
intron O 0 3.5528868735923425e-09
12 O 0 4.451622230561281e-12
at O 0 3.837505129205415e-14
restriction O 0 3.438579038476594e-14
sites O 0 2.849900762429136e-13
of O 0 1.1359622383098466e-14
SacII O 0 5.156659810268138e-08
and O 0 2.003414274753812e-11
HhaI O 0 1.631583934624814e-08
, O 0 1.5390719094684514e-14
localized O 0 2.6952513138001066e-11
1 O 0 3.0473699952349165e-11
, O 0 6.788035980748522e-14
159 O 0 3.016399792703933e-13
- O 0 3.7611807002235764e-09
1 O 0 1.1783122220998532e-12
, O 0 4.262288001792005e-15
232 O 0 1.430954591201839e-14
bp O 0 2.4612529896106405e-12
upstream O 0 2.634470874958439e-13
of O 0 1.741556998982076e-14
the O 0 5.178389726571975e-13
CTG O 0 7.857880568451492e-09
repeat O 0 1.0172791498064271e-08
, O 0 1.969321447993326e-14
whereas O 0 1.3519360056359758e-13
most O 0 7.249843934009018e-15
, O 0 1.2569542879681348e-14
if O 0 4.4572681656696034e-10
not O 0 1.9903202350124438e-11
all O 0 4.87928924694514e-14
, O 0 9.040348764727257e-16
of O 0 4.1640113217241803e-16
the O 0 5.956669839589932e-15
other O 0 4.041816337050025e-15
sites O 0 6.150521715195256e-13
of O 0 1.4095846614502888e-13
SacII O 0 1.1204165595302129e-08
, O 0 8.442161222475472e-14
HhaI O 0 5.220923693372015e-10
, O 0 5.74656560401246e-14
and O 0 9.058382299462209e-13
HpaII O 0 5.2165267661052894e-09
in O 0 1.6850857514905115e-11
this O 0 3.804872215906752e-12
region O 0 1.6001831804057787e-10
are O 0 1.0934813167787216e-12
unmethylated O 0 1.4103701539980307e-09
, O 0 4.829773733727727e-13
in O 0 8.642348989229554e-13
normal O 0 2.2158020210327756e-11
individuals O 0 8.730323321909372e-13
and O 0 1.3204729193763698e-12
most O 0 4.0679750014501956e-14
of O 0 7.722041932213715e-15
the O 0 6.136791162042465e-12
patients O 0 5.982950940230936e-11
. O 0 3.9687097358465095e-11

In O 0 8.275015221659299e-12
a O 0 1.4841598815814455e-13
number O 0 6.833675335674028e-13
of O 0 9.851999451708851e-14
young O 0 4.184090869330248e-07
and O 0 6.20011178398272e-07
severely O 0 0.2520448863506317
affected O 0 2.922951125583495e-07
patients O 0 7.454271921947253e-11
, O 0 1.361769532993171e-14
however O 0 2.9850869497603794e-13
, O 0 4.723791573762906e-16
complete O 0 2.0115122437993575e-15
methylation O 0 5.496013366634855e-12
of O 0 2.8520730123036877e-15
these O 0 3.53840369243135e-15
restriction O 0 3.476180186257928e-14
sites O 0 2.4547926625456684e-12
was O 0 3.635656664613407e-09
found O 0 1.9960616493008843e-10
in O 0 2.85093498288147e-12
the O 0 2.6858688884079385e-12
mutated O 0 6.280353570531361e-09
allele O 0 1.1861452930972405e-09
. O 0 4.801378739038853e-11

In O 0 1.5837986477862387e-10
most O 0 8.55581135995355e-14
of O 0 5.2423440852808045e-15
these O 0 6.785683126508957e-13
patients O 0 8.687103228606496e-13
, O 0 9.364004289037862e-16
the O 0 1.4754826050192293e-14
onset O 0 1.427144236121336e-10
of O 0 1.024731731760764e-12
the O 0 4.144757070889682e-08
disease O 0 0.010480008088052273
was O 0 8.486565548082581e-07
congenital O 1 0.9994196891784668
. O 0 4.313835955116474e-09

Preliminary O 0 9.252490826838766e-07
in O 0 2.4168292367399147e-10
vivo O 0 7.763952680761577e-08
footprinting O 0 1.5194413549579622e-07
data O 0 2.2532975919170584e-12
gave O 0 6.589111309525386e-14
evidence O 0 3.488960219366101e-14
for O 0 5.093977264844149e-16
protein O 0 1.413307811710604e-13
- O 0 3.762649913863214e-10
DNA O 0 4.703577527465086e-10
contact O 0 1.2802934179489966e-05
in O 0 2.5157809169229495e-10
normal O 0 2.8536800700251774e-10
genes O 0 2.0016946000039892e-12
at O 0 8.36466516169164e-14
an O 0 3.215477357609213e-16
Sp1 O 0 1.72972487028078e-11
consensus O 0 2.2407303876953444e-13
binding O 0 1.884173372879161e-12
site O 0 8.935993221423355e-13
upstream O 0 2.1257621314260677e-13
of O 0 1.0053706795570307e-14
the O 0 1.4100823102474597e-13
CTG O 0 2.0240340514732225e-09
repeat O 0 1.2774149737992957e-08
and O 0 4.160744421525739e-14
for O 0 5.378031550416002e-17
a O 0 3.745689542343863e-16
significant O 0 6.587800864852689e-15
reduction O 0 2.825546220608377e-12
of O 0 4.299798114707333e-16
this O 0 7.57008506850924e-15
interaction O 0 2.2942101777362334e-12
in O 0 4.957984977432828e-12
cells O 0 2.6726743648092244e-12
with O 0 1.710304024327234e-14
a O 0 1.6777981998519764e-12
hypermethylated O 0 5.039156647512755e-08
DMPK O 0 1.3884230654070961e-08
gene O 0 1.4842639617373976e-10
. O 0 1.6147943442471058e-12
. O 0 4.342681596269937e-12

The O 0 1.3565053524899895e-09
hemochromatosis B-Disease 1 0.9999772310256958
gene O 0 1.9969281339626832e-08
product O 0 2.3793494952073502e-11
complexes O 0 6.169844496417554e-11
with O 0 1.0561223526576666e-14
the O 0 6.075316031500799e-14
transferrin O 0 1.0997390775813187e-09
receptor O 0 3.9383132172110535e-11
and O 0 2.299784147841155e-11
lowers O 0 1.9800685535642515e-09
its O 0 6.681363065415215e-16
affinity O 0 9.144196698126529e-15
for O 0 7.593594256202047e-16
ligand O 0 7.575989315056209e-12
binding O 0 3.369917400686262e-10
. O 0 3.769809811537961e-11

We O 0 3.1998219185425114e-08
recently O 0 9.45221234616156e-10
reported O 0 4.4862051573613115e-11
the O 0 2.5841141394397898e-15
positional O 0 4.607277667018073e-12
cloning O 0 5.020685473269837e-13
of O 0 9.749624508604855e-16
a O 0 4.018695641018477e-14
candidate O 0 1.928792014993519e-09
gene O 0 5.61014559252726e-08
for O 0 9.512973520031665e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 0.023966282606124878
HFE O 1 0.5134958624839783
. O 0 9.206773121661627e-09

The O 0 1.707320266067236e-12
gene O 0 6.900283816557717e-11
product O 0 3.5826886596312946e-11
, O 0 9.40693784803534e-15
a O 0 4.9708009925006e-14
member O 0 1.0755331087547448e-12
of O 0 4.6900580207703824e-14
the O 0 4.0237903070269865e-13
major O 0 2.8125567846926103e-11
histocompatibility O 0 3.031390249930155e-09
complex O 0 6.7440466544610445e-09
class O 0 1.0158989027786447e-07
I O 0 0.004129493143409491
- O 0 2.5304808914938803e-08
like O 0 9.679387846794896e-11
family O 0 4.748274343158165e-11
, O 0 1.41652477508164e-13
was O 0 2.902634035906182e-11
found O 0 5.593583755902909e-12
to O 0 6.771128796545511e-12
have O 0 2.975530377646862e-10
a O 0 6.204513031821124e-12
mutation O 0 1.3739078319474629e-08
, O 0 2.0197571100420003e-13
Cys O 0 6.966135401853535e-08
- O 0 4.356977356678726e-08
282 O 0 1.8287218961354768e-10
- O 0 0.00017810259305406362
- O 0 2.519219742680434e-05
> O 0 4.2723430349056457e-10
Tyr O 0 1.514433717320074e-10
( O 0 1.016019493066617e-14
C282Y O 0 6.073279899820871e-13
) O 0 8.676326297128473e-16
, O 0 1.6654081229250275e-16
in O 0 2.2534057952938724e-15
85 O 0 3.643547459184979e-14
% O 0 5.780434724628192e-14
of O 0 5.326796729404615e-12
patient O 0 3.902631306118565e-06
chromosomes O 0 6.3288297269537e-08
. O 0 3.822858141155905e-10

This O 0 1.1567129198919446e-11
mutation O 0 1.3736818349485702e-09
eliminates O 0 3.0511576598613033e-10
the O 0 2.5539135693405934e-13
ability O 0 1.463974774740251e-11
of O 0 2.4080265776174614e-14
HFE O 0 1.8587694938787536e-08
to O 0 6.798145488380591e-13
associate O 0 6.014067282372748e-12
with O 0 1.1412640038739597e-13
beta2 O 0 3.272886260674568e-06
- O 0 9.590055014996324e-06
microglobulin O 0 1.0672655292864874e-07
( O 0 5.258530291979771e-14
beta2m O 0 4.547729137716061e-10
) O 0 3.472668048845433e-14
and O 0 1.2844627163104139e-13
prevents O 0 7.883043176559745e-12
cell O 0 6.272635033610641e-08
- O 0 0.003019137540832162
surface O 0 0.023996811360120773
expression O 0 7.4266472438466735e-06
. O 0 1.0466677524689771e-09

A O 0 5.740563024936307e-10
second O 0 2.1784470061181338e-11
mutation O 0 2.169153523468026e-09
that O 0 1.2093605197133206e-12
has O 0 5.029822478658241e-12
no O 0 1.5510507808680352e-11
effect O 0 1.8731174944441875e-10
on O 0 7.108467287020304e-11
beta2m O 0 8.479737516609021e-07
association O 0 6.011965556461385e-13
, O 0 1.1351516277793242e-15
H63D O 0 2.3205563859374223e-10
, O 0 9.75085694154311e-15
was O 0 1.0759317048414374e-11
found O 0 1.0027791097488858e-11
in O 0 6.795905851952888e-12
eight O 0 3.441141252155666e-12
out O 0 2.2255182072217217e-11
of O 0 3.4752005418324516e-13
nine O 0 6.076820296962993e-11
patients O 0 2.656875912852852e-13
heterozygous O 0 3.0879450472337533e-12
for O 0 6.508347056817868e-14
the O 0 6.413316600874241e-13
C282Y O 0 3.601396514341104e-09
mutant O 0 4.454465685199693e-09
. O 0 1.0278058959478642e-10

In O 0 3.6623929583479153e-11
this O 0 1.0693101813079656e-13
report O 0 1.349401601742628e-12
, O 0 1.3957064797721539e-15
we O 0 9.9398435446027e-14
demonstrate O 0 2.416290908677232e-13
in O 0 4.846972907128315e-14
cultured O 0 1.0073652328967952e-10
293 O 0 2.675275365821017e-12
cells O 0 1.7633316681808786e-12
overexpressing O 0 2.8201230239943698e-09
wild O 0 4.2459435967145964e-09
- O 0 1.1259542588959448e-05
type O 0 5.972258350084303e-06
or O 0 2.1650271853079772e-10
mutant O 0 4.800529418425015e-10
HFE O 0 2.7532820467968122e-09
proteins O 0 4.399471780804076e-13
that O 0 2.2668556197050866e-15
both O 0 8.521113862291227e-16
the O 0 8.466748217242012e-15
wild O 0 7.766700060862775e-10
- O 0 2.3023742414807202e-06
type O 0 6.600138476642314e-06
and O 0 7.387609413100904e-10
H63D O 0 3.5199800549889915e-06
HFE O 0 3.1303224545808916e-07
proteins O 0 5.038066075435665e-10
form O 0 9.009666901427238e-10
stable O 0 3.5292131883579714e-07
complexes O 0 3.736296549927687e-10
with O 0 3.400555932762256e-13
the O 0 2.7641489357826954e-12
transferrin O 0 4.136241571472965e-09
receptor O 0 9.424340474684101e-11
( O 0 9.842957178485268e-12
TfR O 0 6.327948653961357e-08
) O 0 3.26675454265582e-13
. O 0 3.934969971391977e-12

The O 0 4.510294915327506e-12
C282Y O 0 3.5133702613876494e-09
mutation O 0 4.249445595405632e-08
nearly O 0 5.7475474032897544e-12
completely O 0 1.8787414332588348e-11
prevents O 0 7.648498154266825e-12
the O 0 7.872036898205759e-14
association O 0 1.0645604271155781e-13
of O 0 2.345818783905211e-15
the O 0 1.5409753619075213e-14
mutant O 0 1.9922646865566662e-11
HFE O 0 5.878815212412292e-10
protein O 0 1.5832684555766585e-12
with O 0 2.5434133423506144e-13
the O 0 3.5353886485012254e-11
TfR O 0 3.98090605813195e-06
. O 0 1.028943076575306e-11

Studies O 0 8.928192407609004e-09
on O 0 6.061482565877796e-11
cell O 0 1.2814170169406225e-08
- O 0 1.2774057722708676e-07
associated O 0 1.4226951561280288e-10
transferrin O 0 4.908646822343599e-10
at O 0 2.9877902235631026e-11
37 O 0 3.0546075651533e-12
degrees O 0 3.2152788764783224e-10
C O 0 2.4404733789396005e-09
suggest O 0 2.602570936538484e-10
that O 0 6.418921384004905e-13
the O 0 2.3281206064547366e-13
overexpressed O 0 1.2644996161270683e-07
wild O 0 1.123378101652861e-08
- O 0 1.4520117019856116e-06
type O 0 7.216619479777364e-08
HFE O 0 1.6012625891903554e-08
protein O 0 1.1990850153076327e-11
decreases O 0 3.034957007930217e-11
the O 0 8.834635696179118e-16
affinity O 0 4.636516322785444e-13
of O 0 7.641126230015227e-14
the O 0 2.7921161476623935e-12
TfR O 0 8.464077438929962e-09
for O 0 7.022291412641171e-14
transferrin O 0 1.0946537010170232e-09
. O 0 5.04633383691111e-11

The O 0 1.596330012620939e-10
overexpressed O 0 6.939836794117582e-07
H63D O 0 7.877196850358814e-08
protein O 0 6.062476909374226e-11
does O 0 1.6414020143074026e-10
not O 0 1.343617925253504e-12
have O 0 4.67198708106048e-14
this O 0 1.7525057680341087e-15
effect O 0 1.738774922654951e-11
, O 0 2.789214909046183e-16
providing O 0 1.3659935168945387e-15
the O 0 7.077414495727644e-16
first O 0 1.475397562911325e-15
direct O 0 6.340720930622136e-15
evidence O 0 1.6811241634884233e-11
for O 0 4.810895741025681e-14
a O 0 3.891794926689368e-13
functional O 0 1.2486557621205208e-10
consequence O 0 2.967231668704606e-11
of O 0 1.4260340074046494e-14
the O 0 1.1750713249658595e-12
H63D O 0 1.729622636048589e-05
mutation O 0 4.473523418369041e-08
. O 0 3.8379206063199334e-11

Addition O 0 7.652587591389093e-11
of O 0 2.0466792323425853e-12
soluble O 0 1.6315091500018752e-08
wild O 0 2.2104609698203603e-08
- O 0 7.703318988205865e-05
type O 0 9.709328878670931e-06
HFE O 0 1.375649208057439e-05
/ O 0 8.899087333702482e-07
beta2m O 0 6.777447225658761e-08
heterodimers O 0 6.014249098740265e-09
to O 0 1.5968857096024247e-12
cultured O 0 1.2336077714891758e-09
cells O 0 8.893798891795868e-11
also O 0 1.2291832048733076e-12
decreased O 0 2.92120667932938e-11
the O 0 4.154522964528156e-16
apparent O 0 3.915950137940716e-13
affinity O 0 6.140277630968527e-13
of O 0 1.4981924053680644e-14
the O 0 2.8614532076275123e-13
TfR O 0 5.111335799057315e-10
for O 0 6.937398361359733e-17
its O 0 2.5780463527476846e-17
ligand O 0 2.5581828186826625e-14
under O 0 7.50989168855215e-13
steady O 0 2.4065129888839465e-09
- O 0 4.578863013193768e-07
state O 0 4.5764089739996905e-10
conditions O 0 2.6218509674436064e-07
, O 0 1.5123226936974554e-15
both O 0 1.05131493246223e-14
in O 0 3.295781074268145e-13
293 O 0 8.894192890865349e-14
cells O 0 4.2933470906052207e-13
and O 0 2.7446738458392073e-12
in O 0 8.989505320688984e-12
HeLa O 0 1.45345913082906e-09
cells O 0 7.360997922312151e-10
. O 0 3.1338123068769264e-11

Furthermore O 0 3.854357277788267e-09
, O 0 1.5585845331358983e-13
at O 0 1.3720326957900042e-12
4 O 0 4.224320546142302e-12
degrees O 0 3.5664793340828282e-09
C O 0 2.7185825501874206e-07
, O 0 4.1299898071757435e-13
the O 0 7.293822663900773e-12
added O 0 2.5346446719254345e-08
soluble O 0 6.68594735131478e-10
complex O 0 6.8718711276893885e-12
of O 0 7.955723753394484e-13
HFE O 0 8.945801255322294e-07
/ O 0 1.522722037350377e-08
beta2m O 0 5.1248489896238425e-09
inhibited O 0 6.001316804615797e-11
binding O 0 6.3572727811156415e-12
of O 0 1.5534347083418637e-14
transferrin O 0 5.139566203182788e-11
to O 0 3.60430478865692e-12
HeLa O 0 1.0096840696860454e-08
cell O 0 9.644074339121289e-08
TfR O 0 2.089736653942964e-06
in O 0 1.7245575898317683e-13
a O 0 2.0452118731223434e-12
concentration O 0 5.081452036392875e-05
- O 0 8.645742491353303e-05
dependent O 0 4.5092114930866956e-08
manner O 0 4.121912752452772e-06
. O 0 1.4249709745506323e-10

Scatchard O 0 2.140557739949145e-07
plots O 0 7.0093824078298894e-09
of O 0 1.1224120591291076e-12
these O 0 6.752846843987789e-14
data O 0 2.251991345139648e-12
indicate O 0 5.970334227001217e-10
that O 0 1.4394769284973435e-13
the O 0 9.884543135168719e-14
added O 0 3.32807670311297e-11
heterodimer O 0 9.370461351299042e-11
substantially O 0 9.57385282163159e-10
reduced O 0 1.6559092421916666e-12
the O 0 1.216938905704713e-15
affinity O 0 9.787761963767072e-13
of O 0 2.44232178968698e-13
TfR O 0 1.385245473883856e-09
for O 0 1.608392916465154e-14
transferrin O 0 4.537920594849254e-10
. O 0 3.893469921467663e-11

These O 0 7.13081954595296e-11
results O 0 5.209462028421541e-11
establish O 0 9.843557392807956e-12
a O 0 1.2599753055134166e-12
molecular O 0 1.4040626439282278e-09
link O 0 1.3793193254230118e-08
between O 0 1.4999107511570742e-10
HFE O 0 4.926298970531207e-06
and O 0 7.94632588896338e-12
a O 0 4.663511330577075e-14
key O 0 1.1352225583183273e-12
protein O 0 7.529624168091387e-14
involved O 0 8.676956722575291e-12
in O 0 1.0954922732842043e-11
iron O 0 9.460118235438131e-07
transport O 0 8.074138690972177e-09
, O 0 4.3654012696348055e-13
the O 0 9.510356911712758e-13
TfR O 0 5.64566526861654e-08
, O 0 1.2268437913525495e-15
and O 0 1.7237708317490406e-14
raise O 0 1.5602778400888861e-12
the O 0 4.78084411319993e-15
possibility O 0 3.7714026780016896e-13
that O 0 2.2354688138445785e-15
alterations O 0 1.7266936036368363e-13
in O 0 8.370374502569312e-15
this O 0 7.66349353259184e-16
regulatory O 0 4.530331838836776e-12
mechanism O 0 9.431394554226813e-10
may O 0 8.757526259728365e-09
play O 0 2.4183346297723674e-12
a O 0 7.41446817543968e-15
role O 0 3.3757809915491155e-12
in O 0 1.3511883127127755e-13
the O 0 4.4962124979121623e-14
pathogenesis O 0 4.728565872191837e-10
of O 0 1.6910171873885105e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.5382847777800635e-06
. O 0 2.582519198490729e-10

Genomic O 0 1.182881259609303e-08
organization O 0 9.701160014197185e-11
of O 0 6.13924709680358e-13
the O 0 1.5028990421953048e-12
UBE3A O 0 1.2936437769894837e-06
/ O 0 4.370369310890965e-08
E6 O 0 1.932165716311829e-08
- O 0 2.6634172172634862e-05
AP O 0 1.5569179367957986e-06
gene O 0 4.915655105186545e-10
and O 0 2.690360304327677e-12
related O 0 1.441850527861277e-10
pseudogenes O 0 2.7977620220553945e-08
. O 0 1.4770146217202296e-10

The O 0 4.9295297011031636e-11
UBE3A O 0 9.664643130236072e-08
gene O 0 6.949549963275459e-11
encodes O 0 9.900289789366301e-12
the O 0 1.4470609226938796e-13
E6 O 0 3.0837767894809076e-09
- O 0 8.301593879878055e-06
AP O 0 1.6645407185933436e-06
ubiquitin O 0 1.152300616036328e-10
- O 0 1.089396003961518e-10
protein O 0 3.986828567476876e-14
ligase O 0 2.740284995444986e-12
and O 0 1.879155061808649e-13
has O 0 7.329935811963006e-14
recently O 0 1.1141044684026546e-12
been O 0 6.626062952442766e-14
shown O 0 4.196075995346882e-13
to O 0 3.707962281944595e-14
be O 0 2.8330485526972815e-11
mutated O 0 2.7816722081297485e-07
in O 0 1.4200759324012324e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 4.469006307772361e-05
who O 0 4.5793341341138216e-10
lack O 0 4.595422653519421e-11
15q11 O 0 1.244182090687218e-09
- O 0 2.0557992641556666e-08
q13 O 0 2.0176078863176627e-10
deletions O 0 5.827564653060335e-09
or O 0 4.148741350462615e-09
chromosome O 0 1.3567005225922912e-05
15 O 0 6.202708902058873e-10
paternal O 0 1.6295769000862492e-06
uniparental B-Disease 0 0.00046929216478019953
disomy I-Disease 0 0.0002888657618314028
. O 0 1.7204412339211217e-09

Previous O 0 6.476633673813126e-10
UBE3A O 0 4.0257045696989735e-08
cDNA O 0 1.9847172516573863e-11
analysis O 0 9.163771130804577e-11
has O 0 2.0358271546425805e-13
shown O 0 3.0655496587386755e-13
a O 0 7.063693027850246e-14
coding O 0 2.4253074548674647e-10
region O 0 2.2501774055161405e-10
of O 0 9.333384759502295e-13
approximately O 0 1.7057001644449343e-11
2 O 0 2.0338628003990777e-10
. O 0 2.7505620003864806e-10

6 O 0 3.0430631348110637e-09
kb O 0 9.666925038231966e-09
and O 0 1.2574820351662908e-10
a O 0 2.968853829443674e-09
3 O 0 5.884054417037987e-07
- O 1 0.9997883439064026
untranslated O 1 0.9930289387702942
region O 0 2.112838046741672e-06
( O 0 4.0356979910671775e-12
UTR O 0 1.1430410784551981e-10
) O 0 2.701875224272424e-15
of O 0 3.6061419760144604e-15
< O 0 2.8513824981701852e-11
50 O 0 8.909507924178064e-14
bp O 0 3.015925356675275e-11
, O 0 4.965415980538431e-15
whereas O 0 1.6500890280893299e-12
Northern O 0 1.572065502948583e-12
analysis O 0 1.1927533960509606e-10
has O 0 1.4404039593018947e-11
indicated O 0 9.857234820054295e-12
mRNA O 0 5.209129026566284e-13
sizes O 0 3.6346408521792384e-11
of O 0 3.0203376149944006e-13
5 O 0 1.4221417099502531e-10
- O 0 3.3048904697352555e-06
8 O 0 8.223945135998889e-11
kb O 0 1.5283406540334e-08
. O 0 1.0199324718129787e-09

We O 0 7.1205517038208654e-09
have O 0 1.905306424784814e-13
analyzed O 0 2.70235223087667e-13
additional O 0 4.615089082784683e-15
cDNA O 0 3.0097506518306227e-13
clones O 0 3.331212259163885e-12
and O 0 3.938321701093053e-14
provide O 0 2.5492777919015885e-15
evidence O 0 2.9046028277891767e-13
for O 0 5.173664959851531e-15
an O 0 1.9984336315772774e-15
additional O 0 6.9024651445925844e-12
0 O 0 2.7386470868862034e-10
. O 0 8.739662465950815e-11

5 O 0 4.520763763338209e-10
kb O 0 6.490660897640055e-09
of O 0 1.893815833320378e-11
5 O 0 5.402478464588967e-10
- O 0 3.433141955611063e-06
UTR O 0 9.6584145126144e-08
and O 0 8.210618816784088e-12
> O 0 6.693238411431546e-12
2 O 0 9.401703862047667e-14
kb O 0 5.5573656787544223e-11
of O 0 1.506636655712601e-11
3 O 0 1.3588417502319317e-08
- O 0 0.001269846921786666
UTR O 0 1.0961272209897288e-06
. O 0 2.873545013049039e-10

We O 0 1.9692748765010037e-08
have O 0 2.1437060839565175e-13
established O 0 1.600546342054969e-14
the O 0 2.4304122819848533e-16
genomic O 0 3.533510832022524e-13
organization O 0 2.3819113660074852e-14
of O 0 3.554595997767537e-16
UBE3A O 0 7.79234010650498e-10
and O 0 1.4705105893814824e-13
the O 0 4.501615890489287e-15
sequence O 0 5.911086507423557e-13
of O 0 3.6347464480498276e-14
intron O 0 2.04587937702172e-08
- O 0 2.598724904601113e-06
exon O 0 3.467529197109798e-08
borders O 0 1.8346950980685506e-07
. O 0 2.2064404470167887e-10

We O 0 3.931384284783235e-08
have O 0 1.3714754158733466e-12
also O 0 3.134578574893847e-14
mapped O 0 1.07000608373653e-09
two O 0 1.1341182984056508e-13
highly O 0 1.953368456569793e-12
homologous O 0 3.882655481846076e-12
processed O 0 3.355465558185777e-11
pseudogenes O 0 3.034495155151973e-10
, O 0 7.342553384151896e-15
UBE3AP1 O 0 3.5708203061091126e-10
and O 0 3.028327100803446e-13
UBE3AP2 O 0 8.863292322303096e-09
, O 0 2.365102166575813e-14
to O 0 7.480695479299831e-14
chromosomes O 0 2.157943441993826e-11
2 O 0 8.231878178242835e-13
and O 0 6.17905449029621e-11
21 O 0 1.629093734911713e-11
, O 0 2.398794087898979e-14
respectively O 0 4.735659642207679e-10
, O 0 5.727135345828804e-13
and O 0 2.33766894730536e-10
determined O 0 2.690843814434629e-07
their O 0 3.8401816448985215e-12
genomic O 0 5.65846397515557e-11
organization O 0 2.20542941548052e-11
. O 0 3.867311852701061e-12

These O 0 5.2266004024748014e-11
results O 0 5.756450871530205e-10
will O 0 2.9416354335037864e-12
form O 0 1.575594716545295e-13
the O 0 3.28038750406056e-15
basis O 0 2.7678390585343313e-14
for O 0 4.936423313303337e-16
studies O 0 3.548680446718855e-13
of O 0 8.979587703288917e-15
mutation O 0 5.377230327674454e-10
and O 0 9.180171813699678e-13
imprinting O 0 1.5203154291043575e-09
of O 0 4.139708107558926e-12
UBE3A O 0 5.658786903950386e-06
. O 0 5.582866391407038e-10

Mutation O 0 2.4521565933355305e-07
spectrum O 0 3.810428239603425e-08
and O 0 1.2368442381394118e-10
genotype O 0 4.4236538087716326e-05
- O 0 1.076029093383113e-05
phenotype O 0 4.501409023305314e-08
analyses O 0 6.608762870286e-09
in O 0 7.436318921749674e-12
Cowden B-Disease 0 0.00016628310550004244
disease I-Disease 0 0.0004135754134040326
and O 0 8.625783642912666e-09
Bannayan B-Disease 1 0.999957799911499
- I-Disease 1 0.9999998807907104
Zonana I-Disease 1 0.9999957084655762
syndrome I-Disease 1 0.9999986886978149
, O 0 2.33224182154268e-12
two O 0 4.115475755323006e-12
hamartoma B-Disease 0 0.00034773824154399335
syndromes I-Disease 0 0.0001766517962096259
with O 0 7.072763208437749e-11
germline O 0 5.267673259368166e-05
PTEN O 0 0.0006384415901266038
mutation O 0 0.00023267306096386164
. O 0 2.222593442624543e-09

The O 0 1.3150948063866963e-07
tumour B-Disease 1 0.9999961853027344
suppressor O 0 2.696940464375075e-05
gene O 0 5.775746103608981e-07
PTEN O 0 4.140260443818988e-06
, O 0 1.0706496453294356e-12
which O 0 1.3268843116539131e-14
maps O 0 9.81524844040349e-12
to O 0 6.366980293687208e-12
10q23 O 0 2.1897652402458334e-07
. O 0 4.671747433349083e-10

3 O 0 3.8006106595211975e-10
and O 0 1.6160004581776237e-14
encodes O 0 1.4399465235633013e-13
a O 0 1.1081761186861397e-13
403 O 0 3.041745728991213e-13
amino O 0 2.5453155750622403e-13
acid O 0 2.795553285389607e-12
dual O 0 2.5998381225633693e-09
specificity O 0 6.103825000991492e-08
phosphatase O 0 0.0767984613776207
( O 0 1.2250037789707235e-11
protein O 0 1.262820958913835e-09
tyrosine O 0 7.912100841167558e-08
phosphatase O 0 0.0004378247249405831
; O 0 2.1095302154411355e-12
PTPase O 0 3.5009746213177095e-09
) O 0 5.375763040011555e-14
, O 0 8.890389204712409e-15
was O 0 1.5654953028354512e-11
shown O 0 1.422836959363849e-09
recently O 0 1.2327215692664595e-08
to O 0 2.3331362883349804e-12
play O 0 5.1713078264015166e-11
a O 0 4.265763293271295e-14
broad O 0 1.248582942765808e-12
role O 0 7.596804851850436e-10
in O 0 6.825358334072718e-11
human O 0 2.304084922855054e-09
malignancy B-Disease 0 3.906265646946849e-06
. O 0 3.832281020299533e-11

Somatic O 0 5.573003818426514e-07
PTEN O 0 1.437655328118126e-06
deletions O 0 1.145651040701523e-07
and O 0 3.195933517829985e-10
mutations O 0 2.9749035235226984e-08
were O 0 2.8786506164890646e-11
observed O 0 1.3117348984792443e-08
in O 0 1.484266182183447e-11
sporadic B-Disease 0 6.839873094577342e-05
breast I-Disease 1 0.9999969005584717
, I-Disease 0 1.5276986005119397e-06
brain I-Disease 1 0.9734756350517273
, I-Disease 0 1.2843869301448763e-09
prostate I-Disease 1 0.8981961607933044
and I-Disease 0 1.1770759556384291e-05
kidney I-Disease 0 0.014343823306262493
cancer I-Disease 0 0.3115571439266205
cell O 0 0.00031665508868172765
lines O 0 6.135476724011824e-05
and O 0 9.370054732116273e-10
in O 0 7.292538426427464e-13
several O 0 5.633603392812825e-13
primary O 0 0.004265548195689917
tumours B-Disease 1 1.0
such O 0 3.72481401278435e-09
as O 0 3.4929239518532995e-06
endometrial B-Disease 1 0.9999994039535522
carcinomas I-Disease 1 1.0
, O 1 0.9999654293060303
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999780654907227
thyroid B-Disease 1 0.9999995231628418
tumours I-Disease 1 1.0
. O 0 1.0523476845492041e-07

In O 0 9.429411418349076e-11
addition O 0 1.1891273556108306e-11
, O 0 3.6383944495470624e-14
PTEN O 0 1.5634565642130838e-08
was O 0 1.4408635395923852e-10
identified O 0 2.515080366194411e-10
as O 0 4.2397336319889914e-14
the O 0 1.0913737463400224e-14
susceptibility O 0 1.0801850525155032e-09
gene O 0 3.3946106342552795e-11
for O 0 2.8588908584231687e-12
two O 0 5.521287871346203e-10
hamartoma B-Disease 1 0.998525083065033
syndromes I-Disease 1 0.999774158000946
Cowden B-Disease 1 0.9991835951805115
disease I-Disease 1 0.9999485015869141
( O 0 1.7572431010304257e-10
CD B-Disease 0 2.2192664346221136e-06
; O 0 1.3202015869406836e-11
MIM O 0 2.0183449578325963e-08
158350 O 0 1.7378384287169979e-09
) O 0 4.0335492107815285e-13
and O 0 2.938350951442459e-11
Bannayan B-Disease 0 0.0008473485358990729
- I-Disease 0 0.3067989945411682
Zonana I-Disease 0 3.485994238872081e-05
( I-Disease 0 2.2510123105778934e-12
BZS I-Disease 0 2.8158353870821884e-08
) I-Disease 0 1.2997671786519477e-13
or I-Disease 0 6.326644503423795e-12
Ruvalcaba I-Disease 0 5.638687980535906e-06
- I-Disease 0 0.14110764861106873
Riley I-Disease 0 0.01113893836736679
- I-Disease 1 0.9999960660934448
Smith I-Disease 0 0.021702751517295837
syndrome I-Disease 1 0.9947798252105713
( O 0 5.2360169151832725e-12
MIM O 0 3.47322171023734e-08
153480 O 0 9.069430539909717e-09
) O 0 5.308226514594283e-12
. O 0 6.760366572100551e-12

Constitutive O 0 4.068450909500143e-09
DNA O 0 2.1885069312332917e-09
from O 0 1.0751685132481814e-11
37 O 0 6.272108700466905e-12
CD B-Disease 0 3.943052107047151e-09
families O 0 1.9956647445695808e-11
and O 0 5.779360497115693e-12
seven O 0 7.701843503238326e-12
BZS B-Disease 0 4.4729091541739763e-07
families O 0 2.7319677770032413e-11
was O 0 1.1741578195834101e-11
screened O 0 3.941247328498321e-09
for O 0 7.93066914223095e-12
germline O 0 5.30038619217521e-07
PTEN O 0 5.904464615014149e-06
mutations O 0 2.4068069706117967e-06
. O 0 2.064670101553645e-10

PTEN O 0 1.9407998479437083e-05
mutations O 0 1.2322570910328068e-05
were O 0 5.577265732581438e-11
identified O 0 7.093897136378757e-10
in O 0 1.6352755738066604e-12
30 O 0 1.2480663204306186e-12
of O 0 4.733645319796552e-14
37 O 0 3.780147635884523e-12
( O 0 6.298632541099428e-14
81 O 0 1.2696538698869775e-12
% O 0 6.692976522396782e-14
) O 0 6.878483090592578e-15
CD B-Disease 0 1.8308832228086658e-09
families O 0 4.530804984664849e-13
, O 0 4.932018741977615e-16
including O 0 2.151003408322385e-14
missense O 0 1.7459582522860728e-05
and O 0 2.4416812038907665e-07
nonsense O 0 0.00016741885337978601
point O 0 5.639535505252979e-10
mutations O 0 8.887377500599314e-10
, O 0 1.6750162558737495e-16
deletions O 0 5.312327834572361e-12
, O 0 3.4756213986226244e-15
insertions O 0 3.9925440731281014e-10
, O 0 1.6706117216057186e-14
a O 0 1.6120670065771642e-13
deletion O 0 1.0444028752942813e-08
/ O 0 4.100933779227489e-07
insertion O 0 4.76594319565038e-10
and O 0 4.6372836126629124e-10
splice O 0 1.0952765805427589e-08
site O 0 6.750895664708878e-08
mutations O 0 1.6845033314893954e-05
. O 0 6.401447705250973e-10

These O 0 2.1663644836356077e-11
mutations O 0 1.1850349590503129e-09
were O 0 5.203954671698097e-13
scattered O 0 2.236879735259545e-12
over O 0 7.752309905129096e-11
the O 0 8.041988082407858e-12
entire O 0 8.623322889089735e-11
length O 0 4.599239322722326e-10
of O 0 6.94846605383756e-14
PTEN O 0 3.3247431474592304e-09
, O 0 1.6304279703682062e-14
with O 0 6.625528559356343e-15
the O 0 4.457905263465997e-14
exception O 0 2.930224465846898e-11
of O 0 2.1010672585433654e-14
the O 0 1.944768673357855e-13
first O 0 5.1374886983479584e-11
, O 0 6.373100289690237e-13
fourth O 0 1.6198672958545046e-10
and O 0 8.261961254030226e-11
last O 0 1.464696003372623e-10
exons O 0 5.986457995987848e-10
. O 0 3.706640550049656e-10

A O 0 1.8997075024174137e-09
hot O 0 7.187318828982825e-08
spot O 0 6.108169259277929e-08
for O 0 2.200596259036014e-12
PTEN O 0 3.3725812045304338e-06
mutation O 0 8.067927410593256e-06
in O 0 1.3766836629014456e-11
CD B-Disease 0 1.917948821983373e-08
was O 0 8.623064484680754e-10
identified O 0 1.4042608187381234e-09
in O 0 1.64016966241326e-13
exon O 0 3.7441294509221734e-10
5 O 0 1.3042037935728779e-11
that O 0 7.980858270258129e-14
contains O 0 5.133193132708658e-13
the O 0 1.619340620796772e-12
PTPase O 0 9.657563850851147e-07
core O 0 4.360026117922189e-09
motif O 0 1.8746266761127117e-09
, O 0 6.0075350151055e-15
with O 0 1.7078461041208914e-14
13 O 0 1.1708133919839658e-13
of O 0 7.907216039977714e-15
30 O 0 6.673883993189855e-13
( O 0 1.7857631402795095e-14
43 O 0 3.8111692621245474e-12
% O 0 1.5336932028195416e-12
) O 0 3.4828983772570987e-13
CD B-Disease 0 1.1691564338889293e-07
mutations O 0 1.6795152646409406e-07
identified O 0 3.978118279235332e-09
in O 0 4.217934053245276e-13
this O 0 1.4612365950485845e-13
exon O 0 1.663449045175014e-09
. O 0 2.0548250601049034e-10

Seven O 0 8.517316713030354e-11
of O 0 1.5704940874248369e-13
30 O 0 1.0811769231636181e-12
( O 0 2.000562733593496e-14
23 O 0 5.650908343687866e-13
% O 0 4.54814510434786e-14
) O 0 6.839892015405788e-14
were O 0 2.2721945158732382e-10
within O 0 8.07219688227917e-13
the O 0 1.2757347261915797e-12
core O 0 5.974959416121806e-10
motif O 0 4.636963382709247e-11
, O 0 3.8204718048558996e-15
the O 0 2.5618145147956626e-15
majority O 0 6.11918610400608e-13
( O 0 7.506537438081023e-14
five O 0 2.2429024512226475e-13
of O 0 1.9591834800542288e-14
seven O 0 3.634041039011354e-13
) O 0 6.408736829253709e-15
of O 0 1.1397760719174949e-13
which O 0 1.785870007431356e-09
were O 0 5.2341078138340436e-09
missense O 0 1.0486571227374952e-05
mutations O 0 2.0014256278955145e-06
, O 0 2.118585526195843e-13
possibly O 0 2.135187859853005e-11
pointing O 0 3.787918867459439e-09
to O 0 8.591169767778462e-13
the O 0 7.707129205669627e-13
functional O 0 1.0779658415893678e-10
significance O 0 4.819915577769507e-10
of O 0 4.579214069565241e-13
this O 0 7.780006673618889e-12
region O 0 6.820823461595182e-09
. O 0 2.6563544697211228e-09

Germline O 0 2.0802461222046986e-05
PTEN O 0 9.284522093366832e-06
mutations O 0 4.924546828988241e-06
were O 0 4.970296396678009e-11
identified O 0 7.668316648334894e-09
in O 0 9.372743900448732e-12
four O 0 9.106472086822803e-13
of O 0 9.717627500209144e-14
seven O 0 3.883425699069409e-12
( O 0 9.919067520472447e-14
57 O 0 2.1207050872329436e-12
% O 0 3.1631560435188555e-13
) O 0 6.315549212071447e-13
BZS B-Disease 0 6.411852382370853e-07
families O 0 3.79591462429385e-11
studied O 0 1.009131622708992e-08
. O 0 2.721100011982003e-10

Interestingly O 0 9.692514346681946e-09
, O 0 1.6057981767209073e-12
none O 0 2.4106083448827142e-11
of O 0 9.046390650740022e-15
these O 0 5.488499195058227e-13
mutations O 0 1.8989323447016204e-09
was O 0 1.7112833372578962e-10
observed O 0 1.4745242804536929e-09
in O 0 1.472195195612036e-12
the O 0 7.734814850245131e-13
PTPase O 0 6.96774336006456e-08
core O 0 1.2896604673073853e-08
motif O 0 2.7155865112149513e-08
. O 0 6.639267607910782e-11

It O 0 2.6700630595399844e-10
is O 0 1.6603876476853352e-12
also O 0 3.5106080098056686e-14
worthy O 0 6.96434576674676e-11
of O 0 1.0397453433170015e-13
note O 0 4.7383029055936277e-08
that O 0 1.1859643041928214e-13
a O 0 4.472044479522652e-13
single O 0 4.887719673440927e-10
nonsense O 0 1.1341168004719293e-08
point O 0 1.932272484378439e-12
mutation O 0 3.993408034808077e-12
, O 0 1.6357216033572344e-16
R233X O 0 6.366830890627839e-13
, O 0 1.2679682573812825e-14
was O 0 5.549464013321348e-11
observed O 0 1.6598139529477862e-09
in O 0 2.689107075036501e-13
the O 0 3.2813135228301456e-15
germline O 0 6.986787450674603e-12
DNA O 0 1.5602287517513247e-10
from O 0 1.1137497174518174e-12
two O 0 3.773386429164159e-14
unrelated O 0 1.4796558076013433e-11
CD B-Disease 0 1.3466177506415988e-07
families O 0 2.2770002897076758e-11
and O 0 8.738457873969097e-12
one O 0 5.814767764511508e-11
BZS B-Disease 0 7.147958058340009e-06
family O 0 3.4496634437886087e-09
. O 0 1.9280994856263334e-10

Genotype O 0 0.005102838389575481
- O 0 0.0007577098440378904
phenotype O 0 1.1803771258200868e-06
studies O 0 3.7029328492366176e-09
were O 0 5.111664910795177e-11
not O 0 7.696846090164688e-13
performed O 0 3.668110086507692e-12
on O 0 6.660632874237737e-13
this O 0 5.918075630381237e-15
small O 0 7.342991638998805e-14
group O 0 1.6315037862368875e-11
of O 0 4.348531354881474e-13
BZS B-Disease 0 1.3267640497360844e-06
families O 0 1.3058124026521511e-10
. O 0 4.724668573041768e-11

However O 0 6.100804861297604e-10
, O 0 8.090971469199015e-13
genotype O 0 2.685403188706914e-08
- O 0 3.435036433074856e-08
phenotype O 0 2.5740869435963987e-09
analysis O 0 8.214926135174938e-12
inthe O 0 1.1609688765901183e-09
group O 0 2.480000059479348e-11
of O 0 2.192541565242557e-14
CD B-Disease 0 1.0997668553613948e-08
families O 0 1.9721201668237986e-12
revealed O 0 1.1828078794184904e-10
two O 0 5.0833420250375426e-15
possible O 0 6.807435474695533e-13
associations O 0 9.438070035791904e-14
worthy O 0 2.0240550555050696e-11
of O 0 2.5602622845681718e-14
follow O 0 2.673501524330657e-11
- O 0 6.232801865735382e-07
up O 0 8.75912564701764e-10
in O 0 3.9831823278081713e-13
independent O 0 6.329058804821486e-12
analyses O 0 1.0450246001880714e-08
. O 0 1.2968414536684847e-11

The O 0 6.818266784502924e-11
first O 0 1.4447677429418881e-11
was O 0 5.805946348691471e-11
an O 0 8.252054164233254e-15
association O 0 5.490174829515804e-13
noted O 0 7.781023048103464e-10
in O 0 2.6193808407015684e-12
the O 0 6.699081935880591e-14
group O 0 3.131283210153213e-12
of O 0 7.350877176924564e-15
CD B-Disease 0 1.689487483247376e-08
families O 0 1.2834696846986127e-11
with O 0 7.29683480304999e-10
breast B-Disease 1 0.9981411695480347
disease I-Disease 1 0.9659874439239502
. O 0 1.673470251262188e-09

A O 0 6.968903232262846e-11
correlation O 0 4.975933554085543e-10
was O 0 3.8737957286372193e-11
observed O 0 9.066273426450167e-11
between O 0 1.207474468719119e-13
the O 0 3.199013048817839e-14
presence O 0 4.796438246579271e-10
/ O 0 4.977343337486673e-08
absence O 0 3.493427075396127e-11
of O 0 4.824242269768977e-16
a O 0 1.9440630949127922e-14
PTEN O 0 5.905866906630308e-10
mutation O 0 3.531777648113632e-10
and O 0 3.4299393024146e-14
the O 0 5.869691414368177e-15
type O 0 4.62766642783663e-08
of O 0 1.6624798759856674e-11
breast O 0 0.09324594587087631
involvement O 0 0.0038812842685729265
( O 0 6.471697844290247e-09
unaffected O 0 2.1139116142876446e-05
versus O 0 1.9042750864173286e-05
benign O 0 0.0010927477851510048
versus O 0 7.27661654309486e-06
malignant O 0 4.041806732857367e-06
) O 0 5.783376902379622e-11
. O 0 3.7500738625517727e-11

Specifically O 0 1.057265719417444e-09
and O 0 3.340151506076028e-12
more O 0 1.513131356052199e-14
directly O 0 3.525434501619462e-12
, O 0 2.461782405531465e-13
an O 0 2.855249131746007e-13
association O 0 1.1470728533691243e-10
was O 0 2.6979400047366653e-08
also O 0 2.1371392502911313e-11
observed O 0 1.676191130339788e-10
between O 0 5.273596636419173e-14
the O 0 4.307318814366886e-15
presence O 0 4.5661512765304835e-12
of O 0 3.621236526651006e-15
a O 0 1.8528616141377796e-12
PTEN O 0 1.8113505575456657e-05
mutation O 0 4.207954407320358e-05
and O 0 9.7546852373398e-08
malignant B-Disease 1 0.999725878238678
breast I-Disease 1 0.9999809265136719
disease I-Disease 1 0.9999188184738159
. O 0 2.4412102561655047e-08

Secondly O 0 6.1048081079206895e-06
, O 0 2.7561414522175864e-12
there O 0 2.239979469270681e-12
appeared O 0 2.8811514285465023e-10
to O 0 2.004028670440916e-12
be O 0 3.9086359149287375e-10
an O 0 2.069042907924118e-13
interdependent O 0 5.702923772332724e-06
association O 0 3.80329058177753e-12
between O 0 6.091098762525671e-13
mutations O 0 3.99184157950927e-11
upstream O 0 1.841143611267665e-13
and O 0 3.0636265551352293e-13
within O 0 3.3292972193140966e-14
the O 0 2.8185150068894826e-13
PTPase O 0 7.651372158079539e-08
core O 0 2.2034891689060032e-09
motif O 0 6.299849975022198e-09
, O 0 6.125839175112266e-14
the O 0 3.438631554519324e-14
core O 0 1.2806093685480135e-10
motif O 0 3.452898730826881e-11
containing O 0 7.666282973023408e-13
the O 0 2.7075322778062627e-13
majority O 0 7.669036412860653e-12
of O 0 1.0965850623378959e-12
missense O 0 1.0479126331119915e-06
mutations O 0 1.457446927588535e-07
, O 0 6.074597747561528e-14
and O 0 9.728384141012916e-14
the O 0 8.869488666738909e-15
involvement O 0 1.3960940181689807e-09
of O 0 5.0201613699396574e-12
all O 0 5.8803790829731195e-12
major O 0 2.571434211395829e-11
organ O 0 1.3516246788469743e-08
systems O 0 1.3381985297655774e-08
( O 0 2.5486106280947496e-12
central O 0 4.0152908553636735e-08
nervous O 0 0.01250359695404768
system O 0 9.312865927313396e-07
, O 0 1.332532695297317e-10
thyroid O 0 0.000638068129774183
, O 0 2.8944740701475347e-11
breast O 1 0.7312294840812683
, O 0 1.1236801356062642e-06
skin O 1 0.9999977350234985
and O 1 0.6396568417549133
gastrointestinal O 1 0.9997256398200989
tract O 0 0.00954979658126831
) O 0 1.614273270611477e-09
. O 0 4.006855680582788e-10

However O 0 6.01901972707708e-10
, O 0 6.665103039794895e-14
these O 0 3.2775605315990986e-15
observations O 0 3.08579793661945e-11
would O 0 7.438815188831605e-12
need O 0 2.060242601520379e-12
to O 0 2.859778115271022e-13
be O 0 1.4155870919907443e-10
confirmed O 0 1.2019386874673188e-10
by O 0 2.503874962456274e-14
studying O 0 2.758904216193514e-11
a O 0 7.092177729426871e-14
larger O 0 1.5294048579667097e-12
number O 0 1.3110949825811957e-11
of O 0 2.1041926068308264e-13
CD B-Disease 0 9.508780181022303e-07
families O 0 1.1972527136361322e-10
. O 0 4.001003695019989e-11

Molecular O 0 0.0020882864482700825
defects O 1 0.9959533214569092
leading O 0 1.1908445340935714e-09
to O 0 5.251379192605654e-12
human O 0 8.957884989335696e-10
complement B-Disease 0 7.59681934141554e-05
component I-Disease 1 0.9987851977348328
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 9.491442354292445e-12
an O 0 5.136314618525879e-14
African O 0 2.0332758046692767e-11
- O 0 6.822126579208998e-07
American O 0 3.003579052140992e-10
family O 0 9.3331099793037e-11
. O 0 3.3581590199588396e-12

Complement B-Disease 0 1.018427519738907e-05
component I-Disease 0 0.47369179129600525
C6 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
( O 0 7.040151794868166e-11
C6D B-Disease 0 1.1830142057078774e-06
) O 0 8.248258846765832e-12
was O 0 3.503214998090698e-07
diagnosed O 0 0.003522924380376935
in O 0 4.30702175313602e-12
a O 0 2.0901856634392146e-12
16 O 0 1.7664959122212776e-12
- O 0 2.115715602712953e-08
year O 0 1.4124908187529428e-10
- O 0 1.3433079537605863e-08
old O 0 1.8156004699676487e-08
African O 0 6.245666310522591e-12
- O 0 1.0927935001348033e-08
American O 0 1.089786663688308e-10
male O 0 8.698428644038358e-09
with O 0 1.5007529663435548e-09
meningococcal B-Disease 1 0.9999997615814209
meningitis I-Disease 1 0.9999984502792358
. O 0 7.835557896962442e-11

The O 0 1.2155136897007424e-09
patients O 0 4.110453311056972e-09
father O 0 3.6206424169904494e-07
and O 0 1.1948624312196898e-09
two O 0 5.248755857029108e-12
brothers O 0 1.7134176744093566e-08
also O 0 1.2293385927286682e-11
had O 0 1.1510742879694558e-11
C6D B-Disease 0 2.8596110368539485e-08
, O 0 2.5482581336396838e-14
but O 0 1.4540662239808516e-13
gave O 0 7.759432744773587e-13
no O 0 4.070901671315852e-10
history O 0 7.745397101466267e-10
of O 0 7.357540271479834e-11
meningitis B-Disease 1 0.9999998807907104
or O 0 4.7750307180516316e-11
other O 0 1.4821359417549473e-11
neisserial B-Disease 0 0.04344860464334488
infection I-Disease 1 0.7061846256256104
. O 0 6.887085901574608e-10

By O 0 4.814855111834326e-13
using O 0 7.84778437980943e-13
exon O 0 2.016150801864569e-09
- O 0 2.0936199440768632e-09
specific O 0 8.530754228019966e-13
polymerase O 0 4.45558086953346e-12
chain O 0 1.7673562266451448e-11
reaction O 0 4.0550653113147206e-12
( O 0 7.33706185779661e-16
PCR O 0 4.3618724626139083e-13
) O 0 1.2347314680365e-15
/ O 0 6.4008061004261485e-12
single O 0 3.997355398077662e-12
- O 0 1.2673180560529573e-10
strand O 0 3.972168514249086e-12
conformation O 0 2.3021189121674723e-11
polymorphism O 0 3.619571222607254e-12
as O 0 1.7958923573094704e-16
a O 0 1.4675551230807139e-16
screening O 0 2.5794374164281146e-14
step O 0 2.9141584436363777e-13
and O 0 9.995460998468838e-16
nucleotide O 0 1.005527888872041e-14
sequencing O 0 1.3393427898794846e-15
of O 0 6.131397278257207e-16
target O 0 1.1403680734087263e-12
exons O 0 1.1657067455414505e-12
, O 0 8.219636180462758e-14
we O 0 1.3738978704713745e-11
determined O 0 7.503485333071325e-11
that O 0 8.689882445350391e-14
the O 0 2.2173120273454722e-14
proband O 0 3.064014606479759e-07
was O 0 2.194160825252922e-10
a O 0 2.8502921594134034e-13
compound O 0 1.105074538820805e-11
heterozygote O 0 4.4057260617513805e-10
for O 0 1.1373161527133968e-12
two O 0 6.918361283164698e-12
C6 O 0 4.076111181916531e-08
gene O 0 1.0446857601209558e-08
mutations O 0 7.173636618063028e-07
. O 0 8.063833628613182e-11

The O 0 3.002518025874146e-11
first O 0 1.2008238370678215e-12
, O 0 5.317043920899161e-15
1195delC O 0 6.061852408922874e-11
located O 0 9.138596997193549e-12
in O 0 4.5889563850265436e-12
exon O 0 1.38193687604371e-08
7 O 0 1.2105630275982548e-08
, O 0 1.491506842078022e-13
is O 0 2.9422512061276496e-13
a O 0 1.3631995109553846e-13
novel O 0 9.726130491272134e-12
mutation O 0 4.931055563872633e-10
, O 0 4.283624761733341e-15
while O 0 2.362119018179537e-13
the O 0 2.592201525316879e-14
second O 0 2.94043123183485e-11
, O 0 2.3995994468252284e-14
1936delG O 0 5.544029124671113e-10
in O 0 2.736388806517942e-12
exon O 0 1.0252533266807973e-09
12 O 0 2.841112622942177e-10
, O 0 6.002178463450358e-14
has O 0 9.994871250085247e-12
been O 0 3.557668699569194e-12
described O 0 3.792259908874662e-11
before O 0 1.3526439517075328e-11
to O 0 2.374740757770527e-13
cause O 0 9.210276291637953e-11
C6D B-Disease 0 1.0650697959135869e-06
in O 0 1.4287005823190868e-12
an O 0 1.2503165989802712e-14
unrelated O 0 6.069375002581978e-10
African O 0 9.768449243940935e-11
- O 0 4.477270749703166e-07
American O 0 3.041164542416652e-10
individual O 0 4.6345757093169127e-11
. O 0 5.012698155865136e-12

Both O 0 1.7762079307370726e-10
mutations O 0 2.1811138140037656e-07
result O 0 2.4194501957452985e-09
in O 0 4.625435451321991e-11
premature O 0 2.195418957740003e-08
termination O 0 1.3215231131624705e-09
codons O 0 8.387384120567276e-10
and O 0 1.6267339905673417e-11
C6 O 0 2.2457747661519534e-07
null O 0 1.8696429293640904e-08
alleles O 0 1.1679101241668377e-08
. O 0 2.4364352202432826e-10

Allele O 0 2.5856425622805546e-07
- O 0 1.0358360835738267e-09
specific O 0 1.1180618063322267e-12
PCR O 0 2.1978301123493083e-10
indicated O 0 4.300040878923994e-10
that O 0 3.223980191971107e-14
the O 0 7.764340216500753e-15
probands O 0 1.0491710611404415e-07
two O 0 1.007756161505724e-12
brothers O 0 3.3177477432033697e-10
also O 0 3.540013876653092e-13
inherited O 0 7.302794480246177e-10
the O 0 1.7163431998345677e-14
1195delC O 0 3.7424585652701126e-10
mutation O 0 2.2668741883613563e-10
from O 0 4.868340973407381e-13
their O 0 1.1066939465537162e-12
heterozygous O 0 1.6749543418903556e-10
mother O 0 3.691445149556216e-09
and O 0 1.9728415136342076e-13
the O 0 2.662261822669945e-14
1936delG O 0 2.1102497527181185e-09
mutation O 0 2.0458508220855265e-09
from O 0 1.722595915736036e-12
their O 0 1.3324144305243424e-12
homozygous O 0 3.122566927249437e-10
father O 0 8.716792843088683e-10
. O 0 2.7118839942760764e-13
. O 0 1.1035995251332253e-12

PAX6 O 0 0.0003137127496302128
mutations O 0 1.562823490530718e-05
reviewed O 0 1.8442521820816182e-07
. O 0 2.2856441184160303e-09

Mutations O 0 1.934428837557789e-05
in O 0 3.3344053212980285e-11
PAX6 O 0 1.032469967299221e-07
are O 0 2.0138034035471764e-12
responsible O 0 1.136379965821499e-11
for O 0 2.4155306119037767e-13
human O 0 6.579102818093929e-10
aniridia B-Disease 1 1.0
and O 0 1.2782907106156927e-06
have O 0 1.6742100761302225e-10
also O 0 1.8339236379505408e-13
been O 0 3.1755728688992457e-13
found O 0 3.065953252997383e-13
in O 0 2.2175891765258138e-12
patients O 0 7.132253771954811e-13
with O 0 6.853218947194817e-12
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 6.864322887878416e-09
with O 0 3.3960325254156487e-06
congenital B-Disease 1 0.9999995231628418
cataracts I-Disease 1 0.9999504089355469
, O 0 9.164072833911519e-10
with O 0 2.4861925851382694e-09
autosomal B-Disease 1 0.9941051006317139
dominant I-Disease 0 0.0007866364321671426
keratitis I-Disease 0 0.011703098192811012
, O 0 1.849703168410599e-10
and O 0 2.2921862324887243e-11
with O 0 2.1724648469056973e-10
isolated B-Disease 0 0.03408695012331009
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 7.391822691715788e-07

No O 0 2.431644052780513e-10
locus O 0 5.860633645049518e-10
other O 0 1.0169841314563999e-12
than O 0 9.005976303252949e-13
chromosome O 0 2.7940594282682696e-09
11p13 O 0 4.158612565419162e-09
has O 0 3.2803943589287954e-11
been O 0 2.659878827609985e-12
implicated O 0 1.0907448455554913e-07
in O 0 7.188998840668148e-10
aniridia B-Disease 1 1.0
, O 0 9.08791097931072e-12
and O 0 9.84002376108739e-13
PAX6 O 0 1.1022553536577107e-08
is O 0 3.8177482009071895e-11
clearly O 0 3.1270590283849486e-11
the O 0 9.883457831853402e-16
major O 0 1.4766883733603048e-13
, O 0 6.459546439407937e-14
if O 0 1.3018588429503097e-09
not O 0 4.3438853208899175e-11
only O 0 4.3647746685417446e-14
, O 0 9.874903857877318e-16
gene O 0 4.7439361466894425e-12
responsible O 0 7.682018576815608e-09
. O 0 5.1588355115539386e-11

Twenty O 0 4.45844383634153e-09
- O 0 2.917982442340872e-07
eight O 0 9.977524362270174e-11
percent O 0 2.399229148686288e-10
of O 0 4.4924404907914495e-14
identified O 0 7.567768633975902e-09
PAX6 O 0 1.164251330010302e-06
mutations O 0 6.589249323951663e-07
are O 0 1.6230178659371042e-11
C O 0 8.574319849685708e-07
- O 0 3.7970778066664934e-05
T O 0 2.511311322450638e-06
changes O 0 9.215964796860376e-12
at O 0 1.1792671873733784e-13
CpG O 0 6.7198837640225495e-12
dinucleotides O 0 1.9349372104571216e-10
, O 0 6.339052275716045e-15
20 O 0 8.378489078204009e-15
% O 0 1.630862413566853e-15
are O 0 1.4931990190890582e-15
splicing O 0 8.724198121735915e-13
errors O 0 3.9950959207502024e-10
, O 0 8.94259586865819e-16
and O 0 3.7130417691226894e-15
more O 0 1.1720879817520057e-15
than O 0 3.117420059074727e-13
30 O 0 3.1405883752985697e-13
% O 0 2.4722223576569176e-14
are O 0 4.398261269078496e-14
deletion O 0 9.174328831351719e-12
or O 0 3.0051763161287326e-11
insertion O 0 1.0923541585161622e-11
events O 0 1.3050319047636094e-08
. O 0 8.659687966705576e-10

There O 0 4.6191520053362467e-10
is O 0 1.4036481395598988e-12
a O 0 3.2601577687474403e-12
noticeably O 0 8.784849825360652e-08
elevated O 0 1.6824698434447782e-07
level O 0 2.4160113909488246e-08
of O 0 1.627637674433361e-14
mutation O 0 3.4626151945715833e-10
in O 0 1.3967937524390732e-14
the O 0 2.330867381836752e-16
paired O 0 9.151011112068508e-13
domain O 0 6.872601446272775e-13
compared O 0 1.3357356887233607e-11
with O 0 2.0229869144325167e-14
the O 0 8.3561543101629e-13
rest O 0 1.1752019496436006e-11
of O 0 1.2211480877053274e-14
the O 0 1.0521058579470582e-13
gene O 0 1.3852288760496378e-10
. O 0 2.6604791286688467e-11

Increased O 0 1.2700875906546116e-08
mutation O 0 1.4393245351129735e-07
in O 0 2.273900468960366e-12
the O 0 3.9353933387878057e-14
homeodomain O 0 5.808430403320131e-10
is O 0 8.922062307709089e-13
accounted O 0 2.625552986829094e-12
for O 0 1.5928762946049478e-16
by O 0 4.241171046900482e-15
the O 0 1.1605438290061831e-13
hypermutable O 0 4.157821464900735e-08
CpG O 0 1.228617874104998e-09
dinucleotide O 0 3.8249456935091075e-09
in O 0 6.882771696331558e-12
codon O 0 1.331747490063151e-10
240 O 0 3.643704261924174e-12
. O 0 6.2298183105269356e-12

Very O 0 7.404127866372789e-10
nearly O 0 3.6980778682360604e-12
all O 0 1.1591213557558822e-13
mutations O 0 6.248957601373561e-11
appear O 0 4.8765984306253785e-11
to O 0 1.482901475224896e-12
cause O 0 2.7347778086550534e-07
loss O 0 1.6586223239301034e-07
of O 0 1.3180415417944624e-13
function O 0 1.9570072229413427e-09
of O 0 1.4894117569049653e-13
the O 0 5.059725425096695e-13
mutant O 0 3.270460985360657e-11
allele O 0 7.120378071878708e-12
, O 0 3.873713754821463e-15
and O 0 2.3427332546366005e-15
more O 0 1.191549172520104e-16
than O 0 2.2356660454663467e-14
80 O 0 4.02877795889294e-15
% O 0 8.800902714933834e-15
of O 0 2.5759169780927363e-14
exonic O 0 3.414434956994228e-07
substitutions O 0 9.34004695807289e-09
result O 0 3.37997576593807e-08
in O 0 9.659396199568349e-11
nonsense O 0 8.21029075837032e-08
codons O 0 2.712922664294126e-10
. O 0 4.028107708498041e-12

In O 0 1.5585950932650583e-11
a O 0 8.21769207044222e-14
gene O 0 8.208411381160907e-12
with O 0 4.733175724730594e-14
such O 0 3.2373902820667655e-13
extraordinarily O 0 1.9171044129961956e-07
high O 0 1.2581179154036448e-10
sequence O 0 1.0041490208778647e-12
conservation O 0 7.367696540751603e-14
throughout O 0 6.895217497015008e-15
evolution O 0 7.195075291859324e-14
, O 0 3.693898824514742e-15
there O 0 1.855014080710815e-13
are O 0 5.280103611282616e-12
presumed O 0 1.1941144748561783e-06
undiscovered O 0 5.2911518650944345e-06
missense O 0 1.1107829323009355e-06
mutations O 0 2.037341346294852e-06
, O 0 7.822151400996985e-14
these O 0 3.5308544689372987e-14
are O 0 1.007955146485693e-14
hypothesized O 0 2.9142044680185997e-12
to O 0 5.0143451890694024e-11
exist O 0 1.1024219048749728e-07
in O 0 1.1023824908473756e-10
as O 0 6.771888383383384e-09
- O 1 0.5043082237243652
yet O 0 1.2234875157446368e-06
unidentified O 0 1.1330534732678643e-07
phenotypes O 0 2.552331235250449e-09
. O 0 4.035488577417562e-13
. O 0 4.423032252953707e-12

Genetic O 0 2.3443759289420996e-07
heterogeneity O 0 1.98215573732341e-07
and O 0 1.5077635320825955e-11
penetrance O 0 1.6931521074070588e-08
analysis O 0 2.6390702123624266e-11
of O 0 1.1936710842853915e-13
the O 0 1.942612086816564e-12
BRCA1 O 0 7.864856854666868e-08
and O 0 1.0975722553041578e-09
BRCA2 O 0 1.9370629900095082e-07
genes O 0 3.5250515395546245e-08
in O 0 8.531971240621772e-10
breast B-Disease 1 0.7574312090873718
cancer I-Disease 0 0.4196217954158783
families O 0 1.702388345847794e-07
. O 0 2.107201080292498e-09

The O 0 3.7158613395149587e-06
Breast B-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.9999994039535522
Linkage O 0 0.0005897759692743421
Consortium O 0 1.0306612239219248e-06
. O 0 6.421049802973755e-10

The O 0 1.9743019339605455e-13
contribution O 0 9.183607867224719e-12
of O 0 4.97831586880864e-14
BRCA1 O 0 6.8988170731643095e-09
and O 0 3.419083904887543e-10
BRCA2 O 0 7.541234663221985e-05
to O 0 0.0035862475633621216
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 5.432546095107682e-05
assessed O 0 1.6341065389724463e-08
by O 0 4.6418757374119476e-14
linkage O 0 4.158985600355436e-09
and O 0 7.192746290067553e-13
mutation O 0 2.6513240387882053e-12
analysis O 0 1.1277311956449029e-13
in O 0 2.520212279833031e-15
237 O 0 2.5237717240356302e-15
families O 0 6.734153758578129e-15
, O 0 3.562958330539305e-16
each O 0 1.715884955010103e-14
with O 0 1.8893844822009953e-12
at O 0 6.742525426872703e-10
least O 0 3.240542599883267e-12
four O 0 7.31733955112307e-13
cases O 0 1.3727453201939355e-11
of O 0 3.9399435103337765e-11
breast B-Disease 1 0.9964432120323181
cancer I-Disease 0 0.008685620501637459
, O 0 3.864085700716613e-14
collected O 0 3.088261525847902e-13
by O 0 1.4575296265056936e-12
the O 0 6.719383236486465e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999998807907104
Linkage O 0 1.4162133084028028e-05
Consortium O 0 7.024157699930811e-09
. O 0 3.7157842774915295e-11

Families O 0 4.55890925010749e-09
were O 0 7.17679496560486e-13
included O 0 2.8211380985205398e-14
without O 0 5.026942404007251e-13
regard O 0 6.047848853663051e-13
to O 0 2.5532253042489725e-14
the O 0 9.203308417009975e-14
occurrence O 0 5.685927728649176e-09
of O 0 7.662398493479827e-12
ovarian B-Disease 0 1.1344855010975152e-05
or I-Disease 0 9.68933875356015e-08
other I-Disease 0 6.036060540282051e-09
cancers I-Disease 0 0.3145400881767273
. O 0 5.890724574797446e-10

Overall O 0 5.6902817959780805e-06
, O 0 1.2012654204696105e-09
disease O 0 1.841459743445739e-05
was O 0 6.435689203776462e-10
linked O 0 8.774299686820086e-08
to O 0 2.604197022956778e-12
BRCA1 O 0 3.195591846694157e-10
in O 0 1.1026332028419433e-13
an O 0 8.034551138213163e-16
estimated O 0 1.8802055181885158e-13
52 O 0 7.186064216553253e-14
% O 0 1.276352341959136e-13
of O 0 2.6449835702734015e-13
families O 0 1.7429354834397337e-11
, O 0 3.1683778999947246e-14
to O 0 1.7840552169259838e-13
BRCA2 O 0 3.554375960224121e-10
in O 0 8.849950286493602e-12
32 O 0 5.708355879999183e-13
% O 0 9.028864353215205e-14
of O 0 3.511420212758132e-13
families O 0 1.7437809529674553e-10
, O 0 2.7076366322653644e-12
and O 0 1.7742948776877654e-10
to O 0 2.7434647435764514e-12
neither O 0 2.496299389420642e-09
gene O 0 7.166241905443016e-11
in O 0 1.852564759582953e-12
16 O 0 1.1058660904323878e-13
% O 0 3.3963395382760955e-15
( O 0 1.9104864124221002e-15
95 O 0 1.2017586361809385e-12
% O 0 3.2160621388221955e-11
confidence O 0 0.03268275037407875
interval O 0 2.7317009099192546e-08
[ O 0 5.368475455846955e-11
CI O 0 6.11467143585287e-09
] O 0 1.7060865524151647e-12
6 O 0 7.650911832248267e-14
% O 0 3.004987954974801e-14
- O 0 1.555942041875369e-08
28 O 0 1.2241232333343177e-11
% O 0 4.7358218556578166e-14
) O 0 3.554299324477761e-15
, O 0 2.362945790098693e-15
suggesting O 0 1.0585889803627069e-10
other O 0 4.256800532724536e-13
predisposition O 0 6.96972124458739e-09
genes O 0 2.549838395982107e-10
. O 0 1.0694051547077699e-11

The O 0 1.2559568836334467e-11
majority O 0 4.64205800534967e-12
( O 0 3.528485148377239e-14
81 O 0 1.727794068841909e-13
% O 0 6.021645736973809e-15
) O 0 1.7016478981777107e-15
of O 0 1.35164720128228e-13
the O 0 3.6253364669391885e-05
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.677796022813709e-07
were O 0 3.601344916726035e-11
due O 0 2.3756489830883964e-11
to O 0 7.573442198892388e-13
BRCA1 O 0 2.449687397376721e-10
, O 0 4.3034864137970336e-14
with O 0 4.950732410287893e-14
most O 0 1.905691723131861e-13
others O 0 7.725717851916891e-13
( O 0 5.808729013198274e-14
14 O 0 9.433143285594858e-13
% O 0 3.5260629729612705e-14
) O 0 2.9205729902646166e-14
due O 0 1.7720186429315277e-10
to O 0 1.2338242649789777e-09
BRCA2 O 0 4.3754757825809065e-06
. O 0 2.2337112159931394e-09

Conversely O 0 3.103326662312611e-08
, O 0 2.74945078640107e-13
the O 0 2.978840725519419e-14
majority O 0 6.16806139584064e-13
of O 0 6.55619086581058e-14
families O 0 9.366506702190858e-12
with O 0 4.0814673862854534e-10
male B-Disease 1 0.6306831240653992
and I-Disease 0 0.0005504376604221761
female I-Disease 1 0.9983137845993042
breast I-Disease 1 0.9882745742797852
cancer I-Disease 0 0.072651706635952
were O 0 1.556214268561007e-09
due O 0 1.985297343187753e-10
to O 0 2.9920430282687205e-12
BRCA2 O 0 1.9235235626524627e-09
( O 0 1.4726614025462048e-12
76 O 0 1.681797756614145e-11
% O 0 2.6737806847060286e-12
) O 0 5.962407650939028e-12
. O 0 1.0861178623144951e-10

The O 0 1.5894325786081076e-11
largest O 0 2.1042992001674143e-11
proportion O 0 2.46312942264737e-10
( O 0 1.9154725819803958e-13
67 O 0 2.1137915636598725e-12
% O 0 6.524679207293646e-14
) O 0 4.962518280825874e-15
of O 0 2.002884112088741e-14
families O 0 4.192438063377324e-12
due O 0 1.308934349797397e-10
to O 0 1.9418934776166408e-12
other O 0 1.4981765827926097e-12
genes O 0 2.373891708207232e-11
was O 0 1.4672096870782525e-10
found O 0 2.4891271335758525e-11
in O 0 3.0900839612796327e-12
families O 0 2.289121312209347e-13
with O 0 2.773659123558869e-13
four O 0 2.4076248807125555e-12
or O 0 2.104340313113795e-10
five O 0 5.482358273953269e-13
cases O 0 4.316816869243123e-12
of O 0 1.3359217378161592e-11
female O 1 0.7471509575843811
breast B-Disease 1 0.9985411167144775
cancer I-Disease 0 0.015384413301944733
only O 0 1.4952956650660099e-09
. O 0 1.3473866466995332e-10

These O 0 2.4378459320684165e-12
estimates O 0 5.845883499500104e-11
were O 0 5.045192779176699e-13
not O 0 1.1026778448663954e-12
substantially O 0 4.2562389723777017e-10
affected O 0 1.69137024264715e-12
either O 0 7.863292265583577e-13
by O 0 2.845175538310901e-13
changing O 0 2.0808328393684405e-09
the O 0 3.6293860169837877e-13
assumed O 0 9.409903967139144e-10
penetrance O 0 4.0349688867902245e-11
model O 0 1.1694548324517329e-12
for O 0 3.132198031147236e-15
BRCA1 O 0 1.7148397502345092e-12
or O 0 2.568134290295565e-12
by O 0 4.856800861008717e-14
including O 0 9.751685136477617e-13
or O 0 2.5858573060588697e-09
excluding O 0 6.502732929902777e-08
BRCA1 O 0 1.873508814753677e-08
mutation O 0 3.292961636702785e-08
data O 0 1.6515431244812362e-09
. O 0 7.425493553370188e-11

Among O 0 3.023055417106235e-11
those O 0 2.53194318809713e-12
families O 0 1.210343457402896e-12
with O 0 5.384737360863978e-12
disease O 0 2.321392685189494e-06
due O 0 7.043822192187577e-10
to O 0 1.611521333044763e-11
BRCA1 O 0 6.340788782921436e-09
that O 0 2.0906740227921716e-10
were O 0 1.224724072157457e-10
tested O 0 1.753499845325024e-10
by O 0 3.5221758117113785e-15
one O 0 5.856588407597216e-14
of O 0 2.54944185159556e-16
the O 0 4.907957712319672e-16
standard O 0 4.267770846059582e-15
screening O 0 1.837254696659572e-15
methods O 0 6.488357485838481e-13
, O 0 4.639395116722619e-15
mutations O 0 7.306716863497709e-12
were O 0 2.4645602399175903e-12
detected O 0 3.167753277466545e-07
in O 0 1.4511468198960542e-12
the O 0 1.5545647180561367e-13
coding O 0 7.205441104884969e-11
sequence O 0 1.074705168607748e-11
or O 0 1.5581892059187558e-13
splice O 0 4.2353390217707287e-13
sites O 0 9.673883222260926e-12
in O 0 1.5582188859532276e-13
an O 0 8.84104530037011e-15
estimated O 0 2.2722280654252636e-11
63 O 0 7.1569091798784346e-12
% O 0 3.249515457062757e-13
( O 0 1.0715806361824218e-13
95 O 0 6.952870896213825e-13
% O 0 1.5624667358549171e-12
CI O 0 3.1008360679152247e-07
51 O 0 6.155598253343442e-11
% O 0 1.3404291565599635e-11
- O 0 2.0751028841914376e-06
77 O 0 7.340888313889238e-11
% O 0 2.780000188384868e-12
) O 0 2.1550630203981402e-12
. O 0 3.0987913623992114e-11

The O 0 7.902191921649315e-12
estimated O 0 3.605929443928346e-11
sensitivity O 0 4.547066012605683e-08
was O 0 2.9874400730989237e-09
identical O 0 7.456604084188356e-11
for O 0 1.5973364524678337e-16
direct O 0 2.8707600414277753e-15
sequencing O 0 2.2468619575565646e-14
and O 0 5.945436065126972e-14
other O 0 3.147373473430244e-15
techniques O 0 5.215625847876382e-11
. O 0 1.4487110296113048e-11

The O 0 4.100326744804761e-10
penetrance O 0 9.36780793381331e-07
of O 0 1.6626757479501486e-12
BRCA2 O 0 1.4515094903799763e-08
was O 0 1.3586849700875092e-10
estimated O 0 1.2082209419148754e-13
by O 0 8.415160099105963e-16
maximizing O 0 2.0432128211567147e-11
the O 0 5.325229189903635e-13
LOD O 0 3.3287702535744756e-05
score O 0 8.21695655961463e-10
in O 0 6.002341093776231e-13
BRCA2 O 0 3.2761893198340886e-09
- O 0 1.558452424887946e-07
mutation O 0 1.8443994775907413e-08
families O 0 2.8401237524983136e-12
, O 0 3.3451766306795677e-15
over O 0 1.7474739645757797e-13
all O 0 2.5966070114381845e-13
possible O 0 6.893863951917822e-11
penetrance O 0 2.424403611200887e-08
functions O 0 3.8525599377337016e-11
. O 0 6.017386589007856e-11

The O 0 1.7470358493199e-11
estimated O 0 5.299195110497479e-11
cumulative O 0 1.500991331226942e-08
risk O 0 1.9947219698224217e-06
of O 0 5.5450199987205906e-11
breast B-Disease 1 0.9982503056526184
cancer I-Disease 1 0.6035902500152588
reached O 0 4.816888008463138e-07
28 O 0 4.789093167173464e-12
% O 0 8.95140607010082e-15
( O 0 1.3834300077511237e-15
95 O 0 4.750033713260028e-14
% O 0 1.341737457900491e-13
CI O 0 2.297770684833722e-08
9 O 0 8.878304341708443e-12
% O 0 4.3375367994634775e-14
- O 0 1.5245425755150421e-10
44 O 0 9.334021863803901e-14
% O 0 2.5024891742029187e-15
) O 0 1.1144145142250852e-16
by O 0 5.792155627739118e-14
age O 0 4.321412117036516e-09
50 O 0 1.7517988470418244e-13
years O 0 1.4880487792488795e-13
and O 0 2.1289949512538764e-14
84 O 0 8.454064745889826e-15
% O 0 1.72615838469329e-15
( O 0 6.561237911626794e-16
95 O 0 4.189660093465927e-14
% O 0 9.928474329571474e-14
CI O 0 2.0323833282986925e-08
43 O 0 1.2666037923353413e-12
% O 0 6.763713260261525e-14
- O 0 2.2426406565134727e-10
95 O 0 2.286729833267387e-13
% O 0 3.6428247706743813e-14
) O 0 3.2905643931635834e-15
by O 0 1.0668396504751043e-12
age O 0 7.168166149540411e-08
70 O 0 4.009634638202364e-12
years O 0 1.2635858505360975e-11
. O 0 8.648850732817515e-12

The O 0 2.4373578710878974e-08
corresponding O 1 0.9753090739250183
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9999794960021973
were O 0 2.151806199890416e-08
0 O 0 2.142377830693931e-09
. O 0 1.098025576712347e-11

4 O 0 6.193818791189187e-10
% O 0 3.2771905848771876e-12
( O 0 3.6427624290494634e-14
95 O 0 2.935642180734721e-13
% O 0 1.1847501332849092e-13
CI O 0 5.422573678970366e-08
0 O 0 1.5565384267959836e-12
% O 0 3.9967266556853107e-14
- O 0 1.321502213214032e-10
1 O 0 2.3980451413670167e-13
% O 0 3.2239662159274773e-15
) O 0 6.784246201817784e-17
by O 0 2.2544042777320958e-14
age O 0 6.411944308837292e-10
50 O 0 5.316123789008559e-14
years O 0 9.632777160564071e-14
and O 0 1.1847253321602136e-13
27 O 0 1.5957917767154411e-13
% O 0 1.106692167784527e-15
( O 0 5.539551535208985e-16
95 O 0 3.14079071452901e-14
% O 0 6.563122305824551e-14
CI O 0 2.5186160712564742e-08
0 O 0 2.2140347281235373e-12
% O 0 1.0823400552542606e-13
- O 0 6.217716896905756e-10
47 O 0 7.909395794564178e-13
% O 0 2.056193147063727e-14
) O 0 1.2650012491978164e-15
by O 0 1.173684847227685e-12
age O 0 1.1993719795100333e-07
70 O 0 3.900105065290926e-12
years O 0 9.889323734912914e-12
. O 0 8.184226733820577e-12

The O 0 6.388198303675097e-11
lifetime O 0 1.6295071247895976e-07
risk O 0 4.916995749226771e-06
of O 0 6.00166027986404e-11
breast B-Disease 1 0.9985502362251282
cancer I-Disease 0 0.009050559252500534
appears O 0 1.8658370404267544e-09
similar O 0 3.2790536778903867e-12
to O 0 1.4491794537389163e-13
the O 0 1.8797509122175926e-12
risk O 0 1.8816149349731859e-06
in O 0 4.868306278937862e-12
BRCA1 O 0 4.775078665808508e-10
carriers O 0 7.409506341815586e-11
, O 0 2.294646677530876e-13
but O 0 5.352033052852256e-12
there O 0 4.374661440390004e-13
was O 0 1.202567993102699e-12
some O 0 8.138440126240597e-17
suggestion O 0 2.473894570101387e-12
of O 0 3.0392446778671964e-14
a O 0 7.54593887375421e-11
lower O 0 6.946842177057988e-07
risk O 0 1.2259881259524263e-05
in O 0 1.451978034333612e-11
BRCA2 O 0 4.856106627926238e-10
carriers O 0 3.9226746850751226e-11
< O 0 8.266548556790099e-11
50 O 0 9.837752357536034e-13
years O 0 5.82724135871765e-13
of O 0 2.073633555447693e-13
age O 0 2.798400844383764e-09
. O 0 2.6558857543768077e-11

Eye B-Disease 1 0.9910106658935547
movement I-Disease 0 3.6766809898836073e-06
abnormalities I-Disease 0 0.027908438816666603
correlate O 0 8.313489985312117e-08
with O 0 3.717230342981104e-11
genotype O 0 0.001942817005328834
in O 0 2.544553900918345e-09
autosomal O 1 0.999751627445221
dominant O 1 0.9963257908821106
cerebellar B-Disease 1 0.9920074939727783
ataxia I-Disease 1 0.9997021555900574
type I-Disease 1 0.9999904632568359
I I-Disease 1 0.9995627999305725
. O 0 1.83434367695412e-09

We O 0 1.0958199680999314e-08
compared O 0 1.4493787281466552e-09
horizontal O 0 5.33640559297055e-05
eye O 1 0.9999279975891113
movements O 0 0.2520986497402191
( O 0 1.3660073072685464e-10
visually O 0 1.1952134837400763e-09
guided O 0 1.6362640131717399e-09
saccades O 0 3.846207903279719e-07
, O 0 6.552915219996958e-14
antisaccades O 0 3.9935649231992443e-10
, O 0 7.542038960592704e-15
and O 0 2.5612587341273217e-14
smooth O 0 2.7298321589319663e-11
pursuit O 0 4.2657880006125026e-10
) O 0 1.9134788697104665e-13
in O 0 9.906537395965032e-13
control O 0 2.164953993855079e-09
subjects O 0 1.1058271809361031e-07
( O 0 1.9680309085948894e-13
n O 0 2.161011103396504e-08
= O 0 4.373738349272571e-08
14 O 0 4.564120349020984e-13
) O 0 4.305347345182151e-15
and O 0 5.716562639923595e-12
patients O 0 7.770881377613947e-13
with O 0 6.330331902117473e-14
three O 0 7.339396018019029e-13
forms O 0 1.9775235615693276e-10
of O 0 2.1020857277065375e-10
autosomal O 1 0.9985039234161377
dominant O 0 0.2629756033420563
cerebellar B-Disease 0 0.025053568184375763
ataxias I-Disease 0 0.02304954081773758
type I-Disease 1 0.9935190081596375
I I-Disease 0 0.0005935689550824463
spinocerebellar B-Disease 0 2.0765515728271566e-05
ataxias I-Disease 0 4.022062057629228e-06
1 I-Disease 0 8.02079569428571e-10
and I-Disease 0 3.1478825622544004e-12
2 I-Disease 0 6.908941734690144e-13
( O 0 1.0797332266557907e-14
SCA1 B-Disease 0 1.2686814443441108e-07
, O 0 1.0047731147534017e-13
n O 0 8.860622457973477e-09
= O 0 3.549515525946845e-08
11 O 0 2.4112450317664846e-13
; O 0 5.198133200598866e-16
SCA2 B-Disease 0 3.18798210052762e-10
, O 0 9.066359452471542e-15
n O 0 8.643944449104879e-10
= O 0 6.97531987725597e-09
10 O 0 2.040021255221569e-13
) O 0 1.5182482820865623e-14
and O 0 3.36556255087217e-10
SCA3 B-Disease 1 1.0
/ O 0 0.0027213471475988626
Machado B-Disease 0 2.1352741441660328e-06
- I-Disease 0 0.006090269889682531
Joseph I-Disease 0 1.4473936971626244e-05
disease I-Disease 0 0.004343017004430294
( O 0 5.344137892632217e-12
MJD B-Disease 1 0.9999998807907104
) O 0 8.148646687966554e-13
( O 0 4.251094376690745e-14
n O 0 5.3732780003201697e-08
= O 0 1.3808467258513701e-07
16 O 0 5.517987108905054e-12
) O 0 2.311779240260492e-13
. O 0 3.483870093454189e-12

In O 0 8.44357431195597e-11
SCA1 B-Disease 0 1.7438024357829818e-08
, O 0 5.32268829434978e-14
saccade O 0 1.6491467913493096e-10
amplitude O 0 2.676860400008252e-10
was O 0 2.186873078457996e-11
significantly O 0 5.814124529046616e-11
increased O 0 1.7450643360894524e-11
, O 0 1.9442113256785618e-14
resulting O 0 3.343127857879935e-12
in O 0 8.626839693992583e-12
hypermetria B-Disease 0 1.067975745172589e-06
. O 0 1.765416562937716e-10

The O 0 5.956769799642103e-12
smooth O 0 1.2359412104867573e-10
pursuit O 0 8.137305274047435e-10
gain O 0 2.536790777440956e-09
was O 0 2.529110432192283e-08
decreased O 0 1.2366737678348727e-07
. O 0 5.7142110487795605e-11

In O 0 6.055866225151973e-11
SCA2 B-Disease 0 2.272968302463596e-08
, O 0 7.177913726721594e-14
saccade O 0 1.5833705457879432e-09
velocity O 0 1.743422517463955e-09
was O 0 1.4794429015196897e-09
markedly O 0 3.9115525396482553e-07
decreased O 0 6.180194134230987e-08
. O 0 3.5330696701585396e-11

The O 0 1.0435729537461302e-11
percentage O 0 2.0601120809260465e-09
of O 0 2.3829974316524546e-14
errors O 0 1.6782632575318424e-11
in O 0 3.253768646660146e-14
antisaccades O 0 8.263246087381049e-09
was O 0 1.4091137978677892e-10
greatly O 0 3.8101896637776633e-11
increased O 0 5.667040101076104e-11
and O 0 2.5896641601963477e-12
was O 0 8.577458188163689e-11
significantly O 0 2.6417645848653137e-11
correlated O 0 3.320518859872834e-11
with O 0 1.151723790122905e-12
age O 0 2.1586957998920298e-08
at O 0 1.0581408665943925e-10
disease O 0 4.661575569997467e-09
onset O 0 7.615810204697482e-10
. O 0 3.955891864082517e-11

In O 0 1.3681031134360477e-11
addition O 0 9.224226200574281e-13
, O 0 3.592137980297505e-15
a O 0 4.76762192889329e-15
correlation O 0 7.824084262419984e-12
between O 0 8.100031740178662e-14
smooth O 0 1.1362418644855765e-10
pursuit O 0 9.583956961378703e-10
gain O 0 9.907081821580732e-10
and O 0 1.3578804964123337e-12
the O 0 2.3324039843063658e-14
number O 0 2.4719598113245866e-13
of O 0 7.988655716757373e-14
trinucleotide O 0 2.5420133553666346e-08
repeats O 0 1.2683801786650406e-09
was O 0 1.2082872202778816e-10
found O 0 1.4371109337274479e-11
. O 0 1.925559017790235e-11

In O 0 5.769193123228433e-09
SCA3 B-Disease 1 0.9999991655349731
, O 0 1.716182890243445e-10
gaze B-Disease 0 0.24969786405563354
- I-Disease 0 0.016152342781424522
evoked I-Disease 0 1.9395190520299366e-06
nystagmus I-Disease 0 8.977937113741064e-07
was O 0 1.0264782357438662e-09
often O 0 2.5231451043078446e-12
present O 0 8.659570863113128e-14
as O 0 1.4845755037080043e-14
was O 0 6.007437928189086e-13
saccade O 0 7.187624107007906e-11
hypometria O 0 1.1352025985900127e-09
and O 0 2.2093089890092704e-13
smooth O 0 2.932673895394977e-11
pursuit O 0 1.4572676398927342e-09
gain O 0 3.1864519911550815e-09
was O 0 1.5538008213411558e-08
markedly O 0 5.481487619363179e-07
decreased O 0 2.1704789077148234e-08
. O 0 1.749176324616908e-11

Three O 0 2.780733629470511e-11
major O 0 4.249939376116396e-12
criteria O 0 3.4185994313151724e-11
, O 0 1.9257571459116744e-15
saccade O 0 6.648353395588558e-11
amplitude O 0 2.100289386852694e-11
, O 0 1.5644950528088735e-15
saccade O 0 9.974936848733407e-11
velocity O 0 8.925032934925525e-11
, O 0 8.374111611932598e-15
and O 0 6.937964200544322e-14
presence O 0 2.498679874118892e-10
of O 0 3.507300699867599e-11
gaze B-Disease 1 0.9988358616828918
- I-Disease 0 0.0009773048805072904
evoked I-Disease 0 1.012224046803567e-07
nystagmus I-Disease 0 2.7518749501354023e-09
, O 0 6.0878405147687855e-15
permitted O 0 3.385178354536715e-14
the O 0 2.9898363566692584e-15
correct O 0 3.162313510010617e-12
assignment O 0 2.0504993915922837e-13
of O 0 1.3375296099767684e-16
90 O 0 1.6850725221911281e-15
% O 0 2.5720570489520984e-15
of O 0 1.966925488247075e-15
the O 0 2.2349254337385854e-13
SCA1 B-Disease 0 6.108518846303923e-08
, O 0 1.2719116192672249e-14
90 O 0 4.55450632178174e-15
% O 0 7.510887629891532e-15
of O 0 1.11074022294275e-14
the O 0 4.605623066082642e-13
SCA2 B-Disease 0 1.7626248904889508e-07
, O 0 3.2660238581542003e-14
and O 0 1.044527759099835e-13
93 O 0 9.42378194522444e-15
% O 0 6.701301585718871e-15
of O 0 1.0880482102858073e-14
the O 0 2.566167243978068e-11
patients O 0 1.5787609067285935e-11
with O 0 1.0705643836705914e-11
SCA3 B-Disease 1 1.0
to O 0 4.562318522971509e-09
their O 0 3.080289356915955e-10
genetically O 0 1.5451281920597637e-10
confirmed O 0 6.088579418417339e-09
patient O 0 1.4496883693482232e-09
group O 0 3.8478872865788105e-12
and O 0 5.069020290321413e-12
, O 0 5.497810662128712e-14
therefore O 0 1.503484663156751e-11
, O 0 1.8229034004935835e-13
may O 0 1.2946406169334068e-09
help O 0 6.446460726339254e-11
orient O 0 1.0125098270918897e-07
diagnoses O 0 1.0782958952404442e-06
of O 0 1.537737493763347e-13
SCA1 B-Disease 0 1.459277285675853e-07
, O 0 4.351549434916495e-14
SCA2 B-Disease 0 7.5393424836534e-09
, O 0 8.746135597443444e-14
and O 0 7.914108604567538e-12
SCA3 B-Disease 1 1.0
at O 0 9.093394093273588e-11
early O 0 3.1526534854942057e-12
clinical O 0 4.558615204069971e-12
stages O 0 3.469230458463812e-11
of O 0 3.2541550292093657e-13
the O 0 4.918336848902527e-10
diseases O 0 1.308503442487563e-06
. O 0 4.1709013630028546e-13
. O 0 1.141201889931498e-11

Genetic O 0 1.4678634308040728e-08
basis O 0 8.631040326889661e-11
and O 0 9.241942064072695e-13
molecular O 0 8.699987397164932e-09
mechanism O 0 5.456510052681551e-07
for O 0 7.074836503306869e-06
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999995231628418
fibrillation I-Disease 1 1.0
. O 0 0.0009603514918126166

Ventricular B-Disease 0 0.03431554138660431
fibrillation I-Disease 0 0.003370850346982479
causes O 0 2.477014220403362e-07
more O 0 6.335649236147156e-13
than O 0 7.721210823485869e-13
300 O 0 2.715734809342202e-13
, O 0 6.866659357681855e-15
000 O 0 1.1582202211202208e-12
sudden O 0 1.2602721644050519e-10
deaths O 0 2.120035952346555e-10
each O 0 7.149469818251708e-13
year O 0 3.80005662353744e-12
in O 0 4.7938490335555986e-14
the O 0 2.5946958340586357e-13
USA O 0 1.4065561160236939e-08
alone O 0 2.412464450429752e-09
. O 0 6.066822825362417e-12

In O 0 7.778081650977597e-11
approximately O 0 2.2703726919315326e-12
5 O 0 1.1720339325796414e-12
- O 0 1.4453515717605114e-08
12 O 0 4.352732584089747e-12
% O 0 1.9710048412726992e-14
of O 0 1.3179345615332242e-15
these O 0 1.4203881939980206e-13
cases O 0 1.4138021265860945e-12
, O 0 4.819113061756879e-15
there O 0 3.24425165551534e-13
are O 0 3.9289754717904135e-13
no O 0 1.1108718112051719e-10
demonstrable O 0 7.431876383634517e-06
cardiac O 0 1.0014771305577597e-06
or O 0 2.7231751573708607e-06
non O 1 0.7331169247627258
- O 1 0.9998162388801575
cardiac O 0 2.1804056814289652e-05
causes O 0 1.299292620160486e-07
to O 0 3.095959469692766e-12
account O 0 2.2406299038379984e-11
for O 0 2.5157181771247837e-14
the O 0 3.0343966000902917e-14
episode O 0 5.707961880929702e-10
, O 0 5.398484393889791e-13
which O 0 4.5335192848036665e-13
is O 0 1.2571713418549346e-12
therefore O 0 4.1228551822536375e-11
classified O 0 2.8217815639663968e-08
as O 0 1.1573069969017524e-06
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999986886978149
fibrillation I-Disease 1 1.0
( O 0 9.020582183438819e-06
IVF B-Disease 1 0.9999995231628418
) O 0 2.3924671133102038e-09
. O 0 1.0996105415106427e-10

A O 0 1.628615992066429e-10
distinct O 0 3.8621904285829345e-11
group O 0 3.10710068784914e-11
of O 0 1.8344878567611023e-12
IVF B-Disease 1 0.9999998807907104
patients O 0 3.0140012086121715e-07
has O 0 1.1342497774347038e-10
been O 0 5.82566633822168e-12
found O 0 6.195711261744452e-13
to O 0 4.341435183899921e-14
present O 0 1.5650526664565123e-12
with O 0 1.9490837980043474e-13
a O 0 1.0483770102043266e-11
characteristic O 0 5.032500283164154e-08
electrocardiographic O 0 8.493508175888564e-06
pattern O 0 2.8304818897595396e-06
. O 0 2.750399075157617e-10

Because O 0 2.8830713372229866e-09
of O 0 6.782535687602231e-14
the O 0 2.56260737998594e-14
small O 0 1.649449484332835e-13
size O 0 1.0542115624900816e-08
of O 0 1.2384405024927492e-13
most O 0 5.492580741899185e-14
pedigrees O 0 8.206051810288884e-11
and O 0 5.733416942165642e-14
the O 0 2.6795316386183342e-14
high O 0 1.257168480428561e-09
incidence O 0 2.5922670374711743e-06
of O 0 1.210375766627636e-12
sudden B-Disease 0 4.918032914247306e-07
death I-Disease 0 3.178293850325531e-09
, O 0 4.04999613422166e-15
however O 0 2.8296202864543443e-14
, O 0 5.063692660606256e-17
molecular O 0 3.006094857630273e-14
genetic O 0 1.0183428536189587e-12
studies O 0 4.2234564370108307e-13
of O 0 2.29826466018046e-13
IVF B-Disease 1 0.9999998807907104
have O 0 1.2710987107311666e-07
not O 0 4.0297317566162505e-11
yet O 0 1.9942644757797723e-11
been O 0 1.802969774346297e-12
done O 0 1.2142757632727097e-10
. O 0 5.456499401618187e-12

Because O 0 1.6189986240533472e-07
IVF B-Disease 1 0.9999954700469971
causes O 0 0.03419017046689987
cardiac O 0 0.4475077688694
rhythm O 0 0.00019754390814341605
disturbance O 0 2.2512192288104416e-07
, O 0 6.239375877938047e-13
we O 0 1.943976013149551e-12
investigated O 0 3.321494121411028e-11
whether O 0 2.0453222449035025e-11
malfunction O 0 3.6974769912490046e-09
of O 0 1.2256843726543478e-14
ion O 0 3.51453799396495e-08
channels O 0 5.4538118092750665e-06
could O 0 0.0004962127422913909
cause O 0 9.294981140328673e-08
the O 0 4.030267439225632e-12
disorder O 0 1.1664474719452755e-08
by O 0 4.865625334956507e-15
studying O 0 1.1133614863378938e-11
mutations O 0 2.302128904174694e-10
in O 0 2.554946542960429e-13
the O 0 2.2714456997165872e-13
cardiac O 0 6.365626914472955e-10
sodium O 0 7.472183427559287e-10
channel O 0 6.294024856856595e-09
gene O 0 2.0825399360546726e-07
SCN5A O 0 1.0059137821372133e-05
. O 0 1.0100626585130001e-10

We O 0 9.311927584576551e-08
have O 0 4.491828350244864e-12
now O 0 1.9111017022371835e-12
identified O 0 2.0503373304725514e-11
a O 0 7.883430778836409e-13
missense O 0 1.6855242392921355e-06
mutation O 0 5.4740961985544345e-08
, O 0 3.753214424228593e-15
a O 0 1.8978086585423083e-14
splice O 0 3.223028954835172e-09
- O 0 2.587134986242745e-06
donor O 0 2.109703345354319e-08
mutation O 0 5.0050704885507e-05
, O 0 3.701209260950633e-13
and O 0 9.681588619995726e-14
a O 0 1.0758204223304535e-12
frameshift O 0 5.733685384257114e-07
mutation O 0 7.713130578679284e-09
in O 0 6.756247850677605e-14
the O 0 9.384679516247392e-15
coding O 0 7.476683855367483e-11
region O 0 4.4018264727663237e-11
of O 0 1.8136575954171702e-13
SCN5A O 0 7.684009688091464e-06
in O 0 2.5317610855002393e-11
three O 0 6.084089395480552e-12
IVF B-Disease 1 0.9999219179153442
families O 0 2.395502685104134e-10
. O 0 2.9219088953924555e-11

We O 0 2.593724957034027e-10
show O 0 6.3571274980245285e-12
that O 0 2.9517363911852864e-15
sodium O 0 3.5546808281172043e-14
channels O 0 2.0081409679659906e-13
with O 0 1.9308261722328704e-14
the O 0 7.946499225785705e-14
missense O 0 2.1246853165735047e-08
mutation O 0 1.5085100946166108e-09
recover O 0 1.3466518178351095e-10
from O 0 6.241869644578717e-15
inactivation O 0 9.278301044135517e-11
more O 0 7.968594588434602e-15
rapidly O 0 4.269552593416659e-12
than O 0 5.156577747265911e-13
normal O 0 2.6076526354890106e-11
and O 0 1.4738360271798756e-12
that O 0 4.5418624915714856e-13
the O 0 7.214482375221543e-13
frameshift O 0 1.115923851102707e-06
mutation O 0 1.2816949723770676e-09
causes O 0 1.9374472512434515e-11
the O 0 2.2761272423457322e-15
sodium O 0 1.846549036723863e-13
channel O 0 2.242340167712964e-11
to O 0 1.5345345827366685e-10
be O 0 3.0092991210040054e-08
non O 0 1.3270332033243903e-07
- O 0 2.0707675503217615e-06
functional O 0 2.9848199467608083e-09
. O 0 5.21634228867196e-11

Our O 0 3.888323441003649e-09
results O 0 1.2713121354257506e-11
indicate O 0 1.4109499159309369e-11
that O 0 6.910388195913511e-14
mutations O 0 7.290143488880574e-10
in O 0 1.044105990902211e-12
cardiac O 0 5.197021923919465e-09
ion O 0 3.1285399018088356e-06
- O 0 0.001275185844860971
channel O 0 1.1168108215997563e-08
genes O 0 8.900859216343093e-11
contribute O 0 5.680756429496392e-13
to O 0 2.5403576879340535e-14
the O 0 8.975756065048718e-14
risk O 0 2.1975953001796e-10
of O 0 5.66069789309444e-15
developing O 0 2.099920758114049e-11
IVF B-Disease 1 0.9988709092140198
. O 0 5.453409425426603e-12
. O 0 5.813855907116361e-12

Molecular O 0 4.764800554113435e-09
heterogeneity O 0 1.3541690435658893e-08
in O 0 8.145251140234677e-11
mucopolysaccharidosis B-Disease 0 5.293975391396089e-07
IVA I-Disease 0 5.6329110520891845e-05
in O 0 5.273931513727348e-09
Australia O 0 8.380688143461157e-09
and O 0 3.5753094929091844e-11
Northern O 0 7.138661328731644e-10
Ireland O 0 3.5787513752438826e-06
: O 0 5.043155563294599e-12
nine O 0 1.9144198216709124e-14
novel O 0 6.38173392711501e-14
mutations O 0 4.557676284988599e-12
including O 0 2.6599864804153833e-15
T312S O 0 3.696902159400217e-11
, O 0 8.74234563322425e-15
a O 0 1.1474321655585012e-13
common O 0 3.717186281004814e-12
allele O 0 4.286649854523539e-11
that O 0 2.1056780993324031e-13
confers O 0 7.563724646608705e-10
a O 0 4.077116075307252e-11
mild O 0 7.69441214742983e-07
phenotype O 0 2.243060635009897e-07
. O 0 2.3697263595856555e-10

Mucopolysaccharidosis B-Disease 0 0.0002824102120939642
IVA I-Disease 0 0.07193964719772339
( O 0 1.5212087873806013e-06
MPS B-Disease 1 0.9999997615814209
IVA I-Disease 1 0.9999998807907104
) O 0 8.444899779469495e-10
is O 0 1.9566247927427227e-11
an O 0 3.6272287257110847e-12
autosomal B-Disease 1 0.999992847442627
recessive I-Disease 1 0.999981164932251
lysosomal I-Disease 1 0.9999423027038574
storage I-Disease 1 0.9999438524246216
disorder I-Disease 1 0.9999986886978149
caused O 0 1.4306158391264034e-06
by O 0 3.3389220208124293e-12
a O 0 9.613074070102812e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 4.8240571537405685e-09
N O 0 8.160055585904047e-06
- O 0 5.6509892601752654e-05
acetylgalactosamine O 0 0.031444039195775986
- O 1 0.5053374767303467
6 O 0 2.703852430840925e-07
- O 0 6.077500802348368e-05
sulfate O 0 1.7008391296258196e-05
sulfatase O 0 6.532811198667332e-07
( O 0 2.813435248660845e-12
GALNS O 0 1.4480833421259831e-08
) O 0 2.0430128942761083e-12
. O 0 4.56496689407726e-12

Previous O 0 8.995655331744956e-10
studies O 0 4.725110233638752e-11
of O 0 2.479127200836345e-13
patients O 0 8.373006281370277e-12
from O 0 1.2427328588936193e-13
a O 0 9.460644073699953e-12
British O 0 3.928981641365681e-06
- O 0 0.0010062246583402157
Irish O 0 3.5087316518911393e-07
population O 0 3.549196526952958e-12
showed O 0 1.1339599398363376e-10
that O 0 2.7685981271100132e-15
the O 0 1.1669929726951527e-15
I113F O 0 6.889732707959784e-12
mutation O 0 1.894140920499776e-11
is O 0 7.419759590261178e-15
the O 0 3.763779783817051e-16
most O 0 6.215207482618875e-16
common O 0 1.4087910424006884e-14
single O 0 1.226897750061795e-11
mutation O 0 1.2104059976536519e-08
among O 0 7.015223402184745e-10
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 1.0
patients O 0 0.012107541784644127
and O 0 8.051312394563581e-10
produces O 0 5.907602185217797e-10
a O 0 3.6405123360339076e-10
severe O 0 1.2552421139844228e-05
clinical O 0 7.719800976246916e-08
phenotype O 0 2.4191067495848984e-06
. O 0 6.793774431912425e-10

We O 0 5.10957409716184e-09
studied O 0 7.750998176625501e-10
mutations O 0 2.1523141047197214e-09
in O 0 5.86989563401176e-14
the O 0 4.6407050531755475e-15
GALNS O 0 1.4560555539055997e-10
gene O 0 4.194773868537727e-12
from O 0 2.713301317566058e-13
23 O 0 1.1654333097535496e-12
additional O 0 4.251263230337088e-11
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 5.939712082181359e-06
( O 0 2.3182449883363265e-12
15 O 0 1.967041113326573e-12
from O 0 3.3661604319917826e-13
Australia O 0 5.855368273577355e-11
, O 0 1.242893371637124e-14
8 O 0 2.1573072646850766e-13
from O 0 2.1354624882632955e-13
Northern O 0 1.2414579086961197e-10
Ireland O 0 5.3333646832243176e-08
) O 0 2.6022576698732716e-14
, O 0 6.049820990945023e-17
with O 0 1.4635409810041165e-16
various O 0 5.011356997777772e-13
clinical O 0 5.105835754193322e-08
phenotypes O 0 5.352493417376536e-07
( O 0 2.6831975877272818e-11
severe O 0 0.0008077452657744288
, O 0 4.693689534263079e-11
16 O 0 1.1443385301845854e-11
cases O 0 1.0877800396547066e-11
; O 0 4.966830102043872e-14
intermediate O 0 1.4230525612057843e-11
, O 0 2.6136287483769817e-14
4 O 0 1.4910383041091824e-12
cases O 0 2.601756865505678e-10
; O 0 6.83758050179506e-11
mild O 0 3.4219167446281062e-06
, O 0 1.4857986369021248e-11
3 O 0 7.246512417902196e-11
cases O 0 1.2650526459712097e-10
) O 0 4.957436804814419e-12
. O 0 6.265547108919023e-11

We O 0 3.364769796121436e-08
found O 0 7.92962570606015e-12
two O 0 1.0242148756444813e-14
common O 0 1.8332206683669555e-13
mutations O 0 2.8370606211525207e-11
that O 0 6.741401819507784e-15
together O 0 3.49404140061009e-14
accounted O 0 3.0433255741868503e-12
for O 0 5.814863712846235e-16
32 O 0 1.5408377698755693e-13
% O 0 2.5452950429835988e-14
of O 0 3.102340839734527e-14
the O 0 3.444820470543952e-11
44 O 0 4.7944946623967866e-12
unrelated O 0 4.182193480417595e-11
alleles O 0 8.73519589994487e-11
in O 0 2.9660208317183745e-11
these O 0 3.9320532940756436e-11
patients O 0 1.0451928905697017e-10
. O 0 2.3483616093389337e-11

One O 0 8.084809210995303e-11
is O 0 2.649962768750541e-13
the O 0 2.31331304752138e-14
T312S O 0 3.3646141428533838e-09
mutation O 0 1.6574482231135335e-08
, O 0 1.0718785207293122e-14
a O 0 1.082256961322135e-14
novel O 0 3.668614023677463e-12
mutation O 0 6.821769815701373e-10
found O 0 2.0895068173539671e-13
exclusively O 0 2.0722429848463175e-12
in O 0 4.700244967542622e-12
milder O 0 1.2594539633425939e-08
patients O 0 2.489266015537339e-10
. O 0 4.9482758168739593e-11

The O 0 1.1134188189487748e-11
other O 0 1.9005952952948213e-13
is O 0 2.3450515075802703e-13
the O 0 9.865081875579194e-15
previously O 0 9.980697691924778e-12
described O 0 9.52279574639725e-12
I113F O 0 1.2124334869412223e-10
that O 0 2.17014638681165e-13
produces O 0 7.855571661913308e-13
a O 0 3.309060707737399e-12
severe O 0 6.546338227053639e-07
phenotype O 0 1.9922626393054088e-07
. O 0 2.2859657222706886e-10

The O 0 1.9193695244279496e-11
I113F O 0 2.6210238424084764e-09
and O 0 2.0848023828123896e-12
T312S O 0 3.8494912812936377e-10
mutations O 0 3.2349384282426286e-10
accounted O 0 4.6371843864800866e-11
for O 0 7.122432391050079e-15
8 O 0 2.9376419916418706e-13
( O 0 8.374654560051788e-15
18 O 0 5.500876989160408e-13
% O 0 3.0620461271809243e-15
) O 0 3.387876620341841e-15
and O 0 5.481691489617191e-12
6 O 0 1.0687805892042879e-12
( O 0 3.5405907315011606e-15
14 O 0 5.624474613808404e-14
% O 0 2.559558019024177e-15
) O 0 1.5942143684335931e-15
of O 0 4.3712981774883183e-14
44 O 0 3.9003113347542417e-13
unrelated O 0 2.898523608629855e-11
alleles O 0 2.1652130088867239e-10
, O 0 8.521358098312337e-12
respectively O 0 1.2242347580126989e-08
. O 0 1.9142191998167135e-10

The O 0 6.307201982913568e-11
relatively O 0 1.263200932744013e-10
high O 0 2.067866433641541e-10
residual O 0 8.390134098590352e-07
GALNS O 0 1.1290821930742823e-05
activity O 0 1.0514284554119513e-08
seen O 0 9.130800004975015e-10
when O 0 3.686146982269378e-13
the O 0 3.4720037209049013e-15
T312S O 0 1.17634959932722e-12
mutant O 0 3.3634651053909836e-13
cDNA O 0 1.2646653472711544e-12
is O 0 5.881902495445679e-13
overexpressed O 0 2.7501554811237838e-08
in O 0 1.410927689786401e-12
mutant O 0 6.112286371484643e-11
cells O 0 1.0424365363970178e-12
provides O 0 6.410643923934452e-15
an O 0 5.453270575444845e-17
explanation O 0 5.29647181148063e-13
for O 0 1.3502394664052612e-14
the O 0 6.857874077642601e-12
mild O 0 1.0863914212677628e-06
phenotype O 0 6.07970491728338e-07
in O 0 5.351300999545394e-11
patients O 0 2.302117697861039e-12
with O 0 1.7873103306609642e-14
this O 0 2.1196538448065017e-12
mutation O 0 6.309891276146118e-09
. O 0 5.404297235417355e-12

The O 0 5.155387835381608e-13
distribution O 0 3.294247741345707e-13
and O 0 1.225628756471031e-13
relative O 0 1.8150644182091114e-11
frequencies O 0 5.792739204979469e-11
of O 0 1.1231218964558292e-14
the O 0 1.8756948305751614e-14
I113F O 0 1.3818318884972758e-11
and O 0 2.692729428376093e-14
T312S O 0 1.6170874318419126e-12
mutations O 0 9.997006694684174e-12
in O 0 1.7218189290253878e-14
Australia O 0 2.478662687968071e-14
corresponded O 0 3.697157529669419e-14
to O 0 1.485847238975012e-14
those O 0 2.274385107331467e-13
observed O 0 5.55058603246561e-11
in O 0 3.6368371422040857e-12
Northern O 0 3.627073363876576e-10
Ireland O 0 2.6768664156406885e-06
and O 0 1.3309932322957962e-10
are O 0 1.4912701133099233e-14
unique O 0 2.2877143566026395e-14
to O 0 2.899311379086361e-13
these O 0 1.0029585668924756e-12
two O 0 9.005095931088891e-14
populations O 0 3.710498922004923e-12
, O 0 3.0887493490628845e-14
suggesting O 0 2.3924295877719715e-10
that O 0 1.3996060170204383e-12
both O 0 4.146549640107744e-13
mutations O 0 3.245641255755771e-11
were O 0 3.628889506598898e-12
probably O 0 1.5131270802298813e-12
introduced O 0 2.0122702874651732e-13
to O 0 2.0284204275012457e-13
Australia O 0 6.46671561785328e-12
by O 0 7.57517217898386e-14
Irish O 0 2.7147355474710366e-09
migrants O 0 1.7341305258086748e-12
during O 0 8.184752788714666e-13
the O 0 4.1286330636821494e-14
19th O 0 2.3039814847636286e-11
century O 0 4.428809055601057e-11
. O 0 4.8463514451535517e-11

Haplotype O 0 1.3379071788222063e-06
analysis O 0 4.923424445912872e-10
using O 0 3.564857437021729e-11
6 O 0 4.23158071083396e-11
RFLPs O 0 2.5783997159578576e-10
provides O 0 2.859711640125322e-14
additional O 0 3.5042309952073225e-15
data O 0 1.225264898221945e-12
that O 0 7.610276612449868e-14
the O 0 3.712647390582448e-14
I113F O 0 7.230225307353066e-10
mutation O 0 7.481163605271846e-11
originated O 0 3.0175521369829594e-12
from O 0 1.2897796098829649e-14
a O 0 5.5985625206991796e-14
common O 0 6.136531170361503e-13
ancestor O 0 6.62397497963596e-11
. O 0 5.417830420406666e-11

The O 0 1.1942051514335361e-11
other O 0 4.1829148651750803e-13
9 O 0 1.8498882980999554e-12
novel O 0 1.2945672095074356e-12
mutations O 0 4.097496508759235e-10
identified O 0 3.5070499837530633e-09
in O 0 3.328887729706076e-12
these O 0 2.640841321663312e-12
23 O 0 4.54004819849807e-11
patients O 0 2.186675970503038e-12
were O 0 6.050875078766893e-12
each O 0 1.0573429068058693e-12
limited O 0 6.6185290754916526e-12
to O 0 1.884921038697307e-12
a O 0 4.8701570554143814e-11
single O 0 1.743742750193178e-08
family O 0 2.3040189756073914e-09
. O 0 1.1926896970049228e-10

These O 0 1.006561370711645e-12
data O 0 8.858728095702262e-13
provide O 0 7.010965396290255e-15
further O 0 2.1881954815418424e-15
evidence O 0 3.7177796648538153e-13
for O 0 1.3620753542387771e-15
extensive O 0 5.9133678856349015e-12
allelic O 0 2.3457150888361866e-08
heterogeneity O 0 4.061614333750185e-08
in O 0 3.5494476691155796e-08
MPS B-Disease 1 0.9999992847442627
IVA I-Disease 1 0.9999998807907104
in O 0 7.82539643751079e-07
British O 0 0.012111715972423553
- O 1 0.9600880742073059
Irish O 0 4.019226980744861e-05
patients O 0 1.3954251643077953e-10
and O 0 6.163833346181126e-15
provide O 0 8.517279450018125e-16
evidence O 0 1.4525860169648658e-13
for O 0 2.047278294700465e-14
their O 0 1.77236751750659e-13
transmission O 0 2.8730871848292594e-12
to O 0 2.852808999231557e-14
Australia O 0 5.477163319243805e-13
by O 0 1.1247345963654246e-13
British O 0 5.045940724812681e-06
- O 0 1.7616361219552346e-05
Irish O 0 2.6227942040435437e-09
migrants O 0 3.169759160009944e-12
. O 0 7.584135820444884e-14
. O 0 6.403159252821311e-13

Identification O 0 7.83562159600848e-10
of O 0 2.2070654765588005e-12
constitutional O 0 7.34425242843173e-10
WT1 O 0 5.330304020390031e-07
mutations O 0 3.940280350889225e-07
, O 0 3.5592687651353483e-13
in O 0 1.2121871431972076e-12
patients O 0 2.7603778637863563e-11
with O 0 3.442272161757742e-11
isolated O 0 0.01989913173019886
diffuse B-Disease 1 0.9999843835830688
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 7.770544624419173e-12
and O 0 1.2202493857482906e-14
analysis O 0 1.6400350858186002e-13
of O 0 7.50029785457837e-14
genotype O 0 3.270335469096608e-07
/ O 0 1.8664616163732717e-07
phenotype O 0 1.2578713626254512e-09
correlations O 0 1.839215064969313e-11
by O 0 4.430303763143474e-15
use O 0 9.461433372881523e-13
of O 0 6.870867671473699e-14
a O 0 1.7004759145927695e-12
computerized O 0 7.9182910894815e-08
mutation O 0 3.988664509790851e-09
database O 0 2.2256127496511624e-10
. O 0 1.7385658884760957e-11

Constitutional O 0 1.4689445215765318e-08
mutations O 0 1.810807646052126e-07
of O 0 6.063603937532525e-13
the O 0 1.214162640870639e-13
WT1 O 0 6.99515501079162e-10
gene O 0 2.065511997551006e-11
, O 0 8.172915558333929e-16
encoding O 0 7.682527167597944e-14
a O 0 1.132839568679378e-11
zinc O 0 0.003457424696534872
- O 0 7.972298590175342e-07
finger O 0 1.083801706158738e-07
transcription O 0 1.1481016137793176e-10
factor O 0 4.770497191719514e-11
involved O 0 6.703335109214947e-11
in O 0 6.354051312884579e-11
renal O 0 9.401871920999838e-07
and O 0 4.727936264714572e-09
gonadal O 0 0.0001447194954380393
development O 0 1.0135098316155222e-09
, O 0 1.1406617837772526e-12
are O 0 6.776638983036626e-14
found O 0 8.391963881616837e-13
in O 0 9.074914756289354e-13
most O 0 3.2403448414070057e-12
patients O 0 1.4024606996565492e-11
with O 0 2.608265825543299e-10
Denys B-Disease 1 0.9999986886978149
- I-Disease 1 1.0
Drash I-Disease 1 0.9999984502792358
syndrome I-Disease 1 0.9999996423721313
( O 0 4.912796280898135e-10
DDS B-Disease 1 0.999998927116394
) O 0 1.3414266225586502e-11
, O 0 6.387777134499173e-13
or O 0 2.0932457545086436e-08
diffuse B-Disease 1 0.9985841512680054
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 2.6522853247001876e-08
DMS B-Disease 0 0.004705912433564663
) O 0 9.432891750690842e-13
associated O 0 2.5148499949168013e-10
with O 0 4.881735640727136e-11
pseudohermaphroditism B-Disease 1 1.0
and O 0 4.6435818035206466e-07
/ O 0 2.2540973077411763e-05
or O 0 1.888133311922502e-07
Wilms B-Disease 0 0.0026780422776937485
tumor I-Disease 0 0.0013404065975919366
( O 0 3.4684685346064725e-08
WT B-Disease 1 0.9999994039535522
) O 0 8.541329449274215e-11
. O 0 3.54013901526784e-11

Most O 0 7.238873389603384e-11
mutations O 0 4.842399903282057e-07
in O 0 2.1341639566685444e-09
DDS B-Disease 1 1.0
patients O 0 0.00014822548837400973
lie O 0 7.84613803261891e-05
in O 0 6.807906668959696e-12
exon O 0 1.1378261888239649e-08
8 O 0 1.27893001744539e-10
or O 0 4.853527735965146e-12
exon O 0 1.3174057400533457e-09
9 O 0 4.2435426700349055e-11
, O 0 1.4780620109260318e-15
encoding O 0 1.393219740963847e-11
zinc O 0 0.00017549173207953572
finger O 0 0.0002600976440589875
2 O 0 2.551874977996249e-08
or O 0 1.4412682958209189e-07
zinc O 0 0.04553703963756561
finger O 0 0.0027128984220325947
3 O 0 4.463327929471461e-09
, O 0 8.299068897377193e-13
respectively O 0 2.529871201417677e-09
, O 0 5.533052314932174e-14
with O 0 8.114090996325096e-13
a O 0 1.2723079256815595e-09
hot O 0 0.000569268420804292
spot O 0 1.4995259334682487e-05
( O 0 5.371563653946976e-13
R394W O 0 3.2305037117597024e-11
) O 0 9.037048724364755e-14
in O 0 5.189345047423854e-13
exon O 0 1.1483146655777432e-09
9 O 0 2.082810368619903e-09
. O 0 5.139037112522615e-11

We O 0 4.5286863148419343e-10
analyzed O 0 2.486175848526173e-11
a O 0 1.2235290634387413e-13
series O 0 1.947791537434962e-12
of O 0 1.947145136099726e-12
24 O 0 1.5283865284487774e-09
patients O 0 1.7692146359049588e-11
, O 0 4.976305283642402e-13
10 O 0 1.5115175821048266e-12
with O 0 7.858243569747181e-12
isolated B-Disease 0 9.525630957796238e-06
DMS I-Disease 1 0.9989332556724548
( O 0 1.4339948499475508e-11
IDMS B-Disease 0 1.083959432435222e-06
) O 0 5.90029934632863e-12
, O 0 2.1413032208917465e-13
10 O 0 3.4898538052441364e-13
with O 0 2.8370483046158412e-12
DDS B-Disease 1 1.0
, O 0 9.301583808740688e-11
and O 0 2.0568639846896275e-10
4 O 0 2.851045441398803e-11
with O 0 7.991030059883997e-11
urogenital B-Disease 0 0.0007405376527458429
abnormalities I-Disease 1 0.9996604919433594
and O 0 3.9850768018823146e-08
/ O 0 0.0029071674216538668
or O 0 0.0010119447251781821
WT B-Disease 1 0.9999998807907104
. O 0 3.2639457803185223e-09

We O 0 1.069312993706717e-08
report O 0 1.0281235585107851e-10
WT1 O 0 1.2511964087025262e-07
heterozygous O 0 2.508854457516918e-08
mutations O 0 1.7701125898383907e-07
in O 0 1.2528113269016927e-10
16 O 0 1.9291515607200438e-10
patients O 0 6.7407218695692e-11
, O 0 3.598828049802827e-13
4 O 0 2.043980609767182e-11
of O 0 5.4785763599352055e-12
whom O 0 1.3597799579656566e-06
presented O 0 1.8132008960947132e-07
with O 0 3.442669704867285e-09
IDMS B-Disease 0 0.0016629882156848907
. O 0 1.0241587578008193e-09

One O 0 1.4394743175216718e-09
male O 0 1.6542037428735057e-06
and O 0 4.074644094353985e-11
two O 0 3.5729440239773425e-11
female O 0 0.00018251394794788212
IDMS B-Disease 1 0.9679930210113525
patients O 0 1.2703346818909722e-08
with O 0 2.698795527333875e-11
WT1 O 0 0.0001250399072887376
mutations O 0 0.0003505962959025055
underwent O 0 1.1964352779614273e-06
normal O 0 1.7853382132670959e-06
puberty O 0 1.22511282825144e-05
. O 0 1.5544572573578108e-10

Two O 0 8.504318915747433e-10
mutations O 0 1.0795820344355889e-06
associated O 0 1.0108922587903635e-08
with O 0 8.842289747623688e-12
IDMS B-Disease 0 0.0001087485215975903
are O 0 6.89492560268512e-12
different O 0 2.351824247501244e-13
from O 0 8.778713975372832e-13
those O 0 1.473375761673612e-11
described O 0 2.2824988565872673e-09
in O 0 5.60292434670373e-09
DDS B-Disease 1 0.9999998807907104
patients O 0 6.002412789030132e-08
. O 0 3.0151908747555467e-10

No O 0 3.4628744316478333e-09
WT1 O 0 3.08069246557352e-07
mutations O 0 2.4045144186857215e-07
were O 0 1.621072026614101e-11
detected O 0 2.7180328743270366e-07
in O 0 1.4148298418253935e-12
the O 0 7.451406570761765e-13
six O 0 3.1273794318109616e-12
other O 0 9.409997737616638e-13
IDMS B-Disease 0 0.00016746581241022795
patients O 0 1.7016067721531414e-10
, O 0 6.435734310381545e-15
suggesting O 0 1.3147311364591907e-11
genetic O 0 1.6733289753823044e-10
heterogeneity O 0 5.20561038719336e-10
of O 0 3.0327793228146493e-12
this O 0 5.181342022098079e-10
disease O 0 5.009118467569351e-06
. O 0 7.880852220809587e-11

We O 0 3.634270218100255e-09
analyzed O 0 8.8009626253438e-09
genotype O 0 6.983389084780356e-07
/ O 0 2.930900677711179e-07
phenotype O 0 2.7666215984822884e-09
correlations O 0 6.101107952183327e-10
, O 0 4.408600153232682e-14
on O 0 9.18279883556361e-13
the O 0 1.8178194409815274e-14
basis O 0 6.950245500653152e-13
of O 0 1.045694784153903e-15
the O 0 3.1769660686908896e-13
constitution O 0 1.110225730793779e-10
of O 0 2.1013667693935145e-15
a O 0 1.672206481357491e-13
WT1 O 0 4.0913114562890485e-10
mutation O 0 1.520702661017559e-11
database O 0 6.576357839370439e-13
of O 0 6.653290657125666e-14
84 O 0 5.987434072846076e-12
germ O 0 1.1213849575142376e-05
- O 0 0.0021701985970139503
line O 0 1.2492292000843008e-07
mutations O 0 1.4700312078730349e-09
, O 0 4.719001073050591e-16
to O 0 4.709307839760449e-16
compare O 0 1.335620416348382e-12
the O 0 1.1266055947371204e-15
distribution O 0 1.4600636238232267e-13
and O 0 3.182743651963804e-11
type O 0 8.608707844359742e-07
of O 0 1.1094800425603957e-11
mutations O 0 2.296500234422183e-08
, O 0 1.5097584708562324e-14
according O 0 4.064918906576502e-14
to O 0 1.4680724897461056e-13
the O 0 7.868893037166202e-12
different O 0 4.3030623508855115e-09
symptoms O 0 3.551310783223016e-07
. O 0 3.101795209570213e-11

This O 0 1.183448131159004e-11
demonstrated O 0 1.1658785915857894e-11
( O 0 1.402715359773328e-14
1 O 0 1.6157485505791103e-13
) O 0 1.0729052940679738e-14
the O 0 8.557754114721372e-14
association O 0 1.7790880530929587e-12
between O 0 5.20874142428962e-13
mutations O 0 3.946925564157766e-10
in O 0 7.772700939909921e-14
exons O 0 7.134679132214661e-12
8 O 0 1.1942347284688015e-11
and O 0 3.653168479528235e-12
9 O 0 3.440014245681411e-11
and O 0 2.686386486525083e-12
DMS B-Disease 0 1.3718852642341517e-05
; O 0 4.726502934697396e-13
( O 0 3.473529311946201e-14
2 O 0 8.694347325421958e-13
) O 0 5.50565012146214e-14
among O 0 3.1567691169409606e-12
patients O 0 2.2832530137406604e-12
with O 0 1.7268154408559694e-13
DMS B-Disease 0 1.4443010059039807e-06
, O 0 5.1249508245055156e-15
a O 0 4.96725632902293e-14
higher O 0 5.020680746148365e-11
frequency O 0 1.4689821581370666e-10
of O 0 4.205263795607067e-14
exon O 0 5.770697808493708e-10
8 O 0 1.1402729455101124e-11
mutations O 0 3.552342864310276e-10
among O 0 3.6791227074443877e-13
46 O 0 6.734973689859203e-12
, O 0 3.2029462632490735e-13
XY O 0 4.7508004286100913e-07
patients O 0 5.328771104928798e-11
with O 0 7.505857914369418e-12
female O 0 3.3601445466047153e-06
phenotype O 0 2.6349798787350664e-08
than O 0 3.324319335432091e-12
among O 0 6.540219754658239e-13
46 O 0 1.0504506119113355e-11
, O 0 4.1218368778891956e-13
XY O 0 2.8299592713665334e-07
patients O 0 6.069751472270735e-12
with O 0 3.384044075776388e-13
sexual O 0 5.2475048306632743e-08
ambiguity O 0 2.4410413690389987e-09
or O 0 1.011497996472599e-08
male O 0 1.8788735189900763e-07
phenotype O 0 1.1286910295282837e-09
; O 0 4.545485353130846e-13
and O 0 6.4790495017674754e-12
( O 0 1.8317561822824707e-13
3 O 0 1.9940999806261628e-12
) O 0 5.354986338254944e-15
statistically O 0 1.0492121223486944e-13
significant O 0 5.783269235682884e-14
evidence O 0 1.4205862042260264e-09
that O 0 3.2841753622170344e-11
mutations O 0 7.77870823309712e-10
in O 0 7.618816737437265e-14
exons O 0 1.2240461248758105e-11
8 O 0 2.1408236294817584e-11
and O 0 9.268814882279486e-12
9 O 0 4.078266890861215e-11
preferentially O 0 2.3545410954284307e-08
affect O 0 3.312452179216052e-08
amino O 0 8.777144809568593e-12
acids O 0 1.1096990161626671e-13
with O 0 1.992229168178199e-16
different O 0 1.6138735796228918e-16
functions O 0 2.0909889217237548e-14
. O 0 7.652371439422975e-14
. O 0 5.658828440557873e-12

The O 0 4.207829570890276e-11
185delAG O 0 3.470440290698207e-08
BRCA1 O 0 4.264513187024477e-09
mutation O 0 8.000016760156825e-10
originated O 0 1.3237771122331932e-11
before O 0 6.861020405242099e-14
the O 0 2.5121864308995595e-16
dispersion O 0 2.378068878969297e-12
of O 0 3.813919581492414e-15
Jews O 0 5.991409625372146e-12
in O 0 5.79152882335815e-13
the O 0 4.768970320642024e-14
diaspora O 0 1.3848583738096387e-11
and O 0 1.9548201946051336e-10
is O 0 2.2626085033339294e-12
not O 0 1.7496217690794735e-13
limited O 0 7.841645356058274e-14
to O 0 1.137641630205577e-12
Ashkenazim O 0 1.456151554890539e-08
. O 0 4.338362655231798e-11

The O 0 1.4010009298515147e-11
185delAG O 0 3.483916799496001e-08
mutation O 0 3.3298405810455733e-08
in O 0 8.380510911967787e-13
BRCA1 O 0 8.464412504238794e-10
is O 0 1.110864872311268e-11
detected O 0 8.666024342574019e-08
in O 0 3.3572927424230237e-13
Ashkenazi O 0 2.1621910858971027e-11
Jews O 0 4.582204407577173e-12
both O 0 1.0527286507799882e-12
in O 0 6.670098501304622e-11
familial B-Disease 1 0.9998637437820435
breast I-Disease 1 0.9999998807907104
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.5343699689983623e-06
in O 0 1.3762418938842447e-12
the O 0 3.057962411935622e-14
general O 0 8.369089926282824e-13
population O 0 2.063109015223996e-12
. O 0 1.5179437568013654e-11

All O 0 9.818104107495174e-10
tested O 0 8.859439404318437e-09
Ashkenazi O 0 1.2367292745452119e-09
mutation O 0 4.380939222503599e-10
carriers O 0 1.1239036611099262e-11
share O 0 3.0195041345743023e-12
the O 0 4.801645802428485e-14
same O 0 1.7294434113968027e-12
allelic O 0 9.147796409259001e-10
pattern O 0 1.1176504166598988e-08
at O 0 3.677793486422942e-11
the O 0 1.244460372425149e-12
BRCA1 O 0 5.318378626384401e-09
locus O 0 1.0613967305062033e-07
. O 0 1.2963975448698761e-09

Our O 0 3.129281722635824e-09
previous O 0 1.586893984273363e-11
study O 0 1.3367519981558051e-12
showed O 0 2.096575968391079e-10
that O 0 1.6141952615604353e-14
this O 0 9.787153997398851e-15
Ashkenazi O 0 2.946820218396873e-11
mutation O 0 3.9208348373565016e-11
also O 0 1.493696252840085e-13
occurs O 0 2.2455017446160186e-12
in O 0 3.059123185886539e-14
Iraqi O 0 2.725961123495324e-11
Jews O 0 1.836458936310681e-12
with O 0 2.2805305007703863e-14
a O 0 2.9579051881445384e-13
similar O 0 2.2791117951226347e-11
allelic O 0 3.384956315244381e-08
pattern O 0 6.113315862421587e-07
. O 0 2.4796606434840385e-10

We O 0 2.0752521923128597e-09
extended O 0 6.440075794693356e-13
our O 0 2.6193980591873202e-14
analysis O 0 3.9571138893575424e-15
to O 0 1.6359843159197813e-15
other O 0 5.172069573295378e-14
non O 0 4.680701937154197e-10
- O 0 3.1663258681646766e-09
Ashkenazi O 0 1.9084508279254564e-11
subsets O 0 4.319040351058456e-12
354 O 0 2.1340293085165413e-13
of O 0 2.667059586689783e-14
Moroccan O 0 1.612224020952624e-09
origin O 0 1.2897576062709248e-10
, O 0 4.173906974712892e-14
200 O 0 5.062174841092247e-14
Yemenites O 0 1.7149975883867796e-11
and O 0 1.1428307302233098e-12
150 O 0 8.973415001507778e-13
Iranian O 0 1.8905037257876955e-10
Jews O 0 2.48698339699871e-10
. O 0 8.729200001722504e-11

Heteroduplex O 0 3.7436763022924424e-08
analysis O 0 5.709578209528443e-12
complemented O 0 6.29750646161803e-13
by O 0 4.432887901846869e-16
direct O 0 6.9195120960081555e-15
DNA O 0 2.8970725016001786e-13
sequencing O 0 4.592392750259709e-14
of O 0 1.665937285583001e-14
abnormally O 0 9.157563596318141e-12
migrating O 0 4.4325903624659047e-13
bands O 0 2.1609429523561374e-10
were O 0 5.331292005084087e-11
employed O 0 3.3825520162622524e-10
. O 0 1.0225376968764355e-11

Four O 0 2.0235428610515527e-10
of O 0 2.545053740237585e-13
Moroccan O 0 6.33269081617982e-09
origin O 0 7.260652495899578e-11
( O 0 5.838293597079354e-15
1 O 0 3.556265711464812e-15
. O 0 1.973433110031932e-16
1 O 0 2.660554627764754e-15
% O 0 5.187278473379802e-16
) O 0 7.890127256145977e-16
and O 0 4.817732150719234e-12
none O 0 3.328256281687203e-10
of O 0 2.4735229767474266e-15
the O 0 3.263053821827948e-14
Yemenites O 0 5.858161178373678e-11
or O 0 3.095670204553147e-12
Iranians O 0 9.986138435266745e-13
was O 0 2.2779460609467783e-12
a O 0 6.546768471305323e-14
carrier O 0 9.550060395269178e-12
of O 0 4.761660511010514e-15
the O 0 2.465649754680721e-13
185delAG O 0 1.2919304737124548e-08
mutation O 0 6.707076227741027e-09
. O 0 1.4223253651246548e-11

BRCA1 O 0 1.0946126167254988e-05
allelic O 0 4.274248567526229e-06
patterns O 0 1.341075221716892e-05
were O 0 1.420761702730644e-10
determined O 0 3.3200220350693144e-09
for O 0 1.4016302766865774e-13
four O 0 1.229487432002907e-13
of O 0 2.083153443445179e-15
these O 0 4.969777099073959e-14
individuals O 0 7.396476687420231e-14
and O 0 4.147884089694166e-14
for O 0 9.413326170523532e-15
12 O 0 4.1469113570575394e-14
additional O 0 2.8375232393774985e-13
non O 0 5.431227378949188e-08
- O 0 2.4315365863003535e-06
Ashkenazi O 0 5.06247432863205e-10
185delAG O 0 4.460312952314638e-10
mutation O 0 5.205868514046585e-10
carriers O 0 6.909581934388953e-11
who O 0 7.228763698741147e-10
had O 0 5.716503324038058e-07
breast B-Disease 1 0.9999886751174927
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.5652150270616403e-07

Six O 0 9.816198520695707e-09
non O 0 2.737689008824873e-08
- O 0 5.761991701547231e-07
Ashkenazi O 0 3.09973424705845e-09
individuals O 0 7.0706014827781605e-12
shared O 0 3.0853958710858054e-12
the O 0 2.7228704181777794e-14
common O 0 2.5510753991035695e-13
Ashkenazi O 0 3.755569206315146e-12
haplotype O 0 1.517214964774638e-10
, O 0 5.072180197553122e-13
four O 0 5.590871190487567e-13
had O 0 9.030992099978707e-12
a O 0 1.5405469326428e-13
closely O 0 1.9663452810458892e-10
related O 0 2.358278017311477e-10
pattern O 0 1.9268956208406962e-08
, O 0 6.938017055400231e-14
and O 0 2.1383236977964848e-13
the O 0 3.508019612644131e-13
rest O 0 1.398145210718127e-10
( O 0 2.987638890623867e-13
n O 0 3.7333441582632076e-07
= O 0 3.579218855520594e-06
6 O 0 9.254687988180521e-11
) O 0 4.896798095591244e-14
displayed O 0 1.9409716500717877e-08
a O 0 9.86054380508472e-12
distinct O 0 7.147353819902946e-10
BRCA1 O 0 2.5727040053880046e-08
allelic O 0 2.3397504378408485e-07
pattern O 0 1.1872245522681624e-05
. O 0 1.945102967582102e-09

We O 0 2.531120035786927e-10
conclude O 0 8.470024161211231e-12
that O 0 2.9105669900587015e-15
the O 0 3.660178866401022e-15
185delAG O 0 3.824697891730011e-09
BRCA1 O 0 3.221056532609623e-09
mutation O 0 5.504813049839186e-09
occurs O 0 3.7854233636558376e-11
in O 0 7.095990140019168e-15
some O 0 2.6231864987472098e-15
non O 0 4.2702574809538874e-10
- O 0 1.6922618328862882e-07
Ashkenazi O 0 1.7809174135408057e-09
populations O 0 8.245262250738961e-10
at O 0 1.9873773460243882e-10
rates O 0 3.5335197878794133e-08
comparable O 0 8.870043588515841e-12
with O 0 2.2841120101812617e-15
that O 0 1.1541245389934396e-13
of O 0 6.762619435794759e-13
Ashkenazim O 0 6.021333120997951e-08
. O 0 1.408793914858819e-10

The O 0 1.426721588093649e-11
majority O 0 1.924824709342854e-11
of O 0 3.5414794469397493e-13
Jewish O 0 8.435112053284399e-10
185delAG O 0 1.6797747548480402e-07
mutation O 0 3.9626115722057875e-08
carriers O 0 7.453319211814247e-11
have O 0 5.667161347405053e-14
a O 0 1.0489994831976157e-14
common O 0 1.7095091347282126e-13
allelic O 0 1.2561450768444615e-09
pattern O 0 8.482214752802975e-08
, O 0 2.429589834168893e-14
supporting O 0 2.255645540141793e-12
the O 0 4.3329147100769e-14
founder O 0 1.3149888079475036e-12
effect O 0 1.5533954331181654e-11
notion O 0 4.405385344713464e-12
, O 0 1.577250733719813e-14
but O 0 1.767236666250574e-13
dating O 0 2.538270427177025e-10
the O 0 6.926087189261217e-15
mutations O 0 3.112389686255046e-12
origin O 0 9.261494566051298e-13
to O 0 1.482597512369576e-14
an O 0 5.380088583163299e-15
earlier O 0 3.5999525582752767e-10
date O 0 9.575212800427835e-08
than O 0 1.9571174542099e-11
currently O 0 6.342463360065054e-11
estimated O 0 2.5301198636196176e-11
. O 0 1.036489713501787e-10

However O 0 6.410925956767954e-11
, O 0 7.213346978377725e-15
the O 0 7.238123115601387e-16
different O 0 6.77181580802837e-15
allelic O 0 1.629498619371006e-10
pattern O 0 3.95348198622969e-09
at O 0 4.297961726101862e-12
the O 0 3.433846834806874e-14
BRCA1 O 0 1.8093956888343143e-11
locus O 0 2.2519419662359041e-10
even O 0 3.361302625126683e-10
in O 0 1.0965447300170794e-13
some O 0 7.620963796551965e-15
Jewish O 0 3.008984381103197e-11
mutation O 0 2.281863364927972e-09
carriers O 0 1.559511027260374e-11
, O 0 6.927091346820187e-15
might O 0 5.316139455729951e-12
suggest O 0 1.472487930198607e-11
that O 0 8.027604324551199e-14
the O 0 5.857280941734891e-14
mutation O 0 7.358677556190685e-11
arose O 0 6.416570833694957e-13
independently O 0 5.289437724625978e-12
. O 0 1.1102600230242926e-13
. O 0 3.3544716483702164e-12

Crystal O 0 4.921128947898978e-06
structure O 0 3.986734142813475e-08
of O 0 4.41173399895467e-12
the O 0 3.3069819105335796e-10
hemochromatosis B-Disease 1 0.9999998807907104
protein O 0 1.6917744005695567e-07
HFE O 0 1.2440045793482568e-06
and O 0 1.5388708102942461e-12
characterization O 0 9.424646479905263e-11
of O 0 2.4232957017444358e-14
its O 0 4.5276147197723104e-14
interaction O 0 1.2926574958008197e-12
with O 0 6.034931668980059e-13
transferrin O 0 2.354252570668791e-09
receptor O 0 2.544450761199357e-10
. O 0 3.7958566845297526e-11

HFE O 0 2.848078656825237e-05
is O 0 5.832632155033934e-10
an O 0 4.429522612418857e-13
MHC O 0 1.6840202761159162e-06
- O 0 8.597715606128986e-08
related O 0 1.9845590448763772e-10
protein O 0 5.48618919390953e-12
that O 0 2.215650487516138e-14
is O 0 2.0576670690952443e-15
mutated O 0 1.0720390504134758e-12
in O 0 5.235142695866543e-14
the O 0 3.5865707105620093e-12
iron B-Disease 1 0.9999481439590454
- I-Disease 1 1.0
overload I-Disease 1 0.9999849796295166
disease I-Disease 1 0.9999914169311523
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.0509758794796653e-05

HFE O 0 6.518542704725405e-06
binds O 0 2.5191626562559577e-09
to O 0 1.9268182969295333e-12
transferrin O 0 2.662857712110167e-09
receptor O 0 2.429483558774592e-10
( O 0 1.8856834496649988e-12
TfR O 0 9.231411013388424e-08
) O 0 4.833915809543095e-15
and O 0 9.354976611886025e-15
reduces O 0 1.7929014392917275e-12
its O 0 5.529712718131035e-16
affinity O 0 5.197504617448709e-14
for O 0 3.2183829982556506e-14
iron O 0 5.201279122957203e-07
- O 0 4.506332516029943e-06
loaded O 0 2.1679281980713228e-10
transferrin O 0 9.14768746862471e-11
, O 0 1.7131576783265337e-14
implicating O 0 4.664324038117229e-09
HFE O 0 3.406225914659444e-07
in O 0 6.370044769443695e-11
iron O 0 2.922944531746907e-06
metabolism O 0 1.0762334312630628e-07
. O 0 3.09672912313097e-11

The O 0 2.9532307155299975e-10
2 O 0 2.1654980586482964e-10
. O 0 6.405706520773435e-11

6 O 0 3.813030957644514e-08
A O 0 1.4168781425905053e-10
crystal O 0 3.74685951101128e-05
structure O 0 1.5795924355188617e-06
of O 0 4.3411580753771606e-12
HFE O 0 6.672425115539227e-06
reveals O 0 1.936669713487049e-09
the O 0 3.121464810804456e-14
locations O 0 1.4887998819879122e-11
of O 0 2.4379493215875847e-11
hemochromatosis B-Disease 1 1.0
mutations O 1 0.9204843044281006
and O 0 5.3290757223711793e-11
a O 0 7.795465661875056e-13
patch O 0 6.753651859980891e-08
of O 0 3.353049988271545e-13
histidines O 0 1.9485837299271225e-07
that O 0 2.408194303693545e-12
could O 0 2.3375114344137415e-11
be O 0 7.247224196628432e-13
involved O 0 9.835806648317291e-12
in O 0 3.6287961524550383e-10
pH O 0 0.005595844238996506
- O 0 8.930969670473132e-06
dependent O 0 3.489875766149453e-08
interactions O 0 8.928005001962447e-09
. O 0 6.242643901810396e-11

We O 0 2.4268080878186993e-09
also O 0 2.8179449875972984e-13
demonstrate O 0 7.901830231804574e-12
that O 0 4.404561784743244e-12
soluble O 0 4.335838070801401e-07
TfR O 0 9.716670774650993e-07
and O 0 1.281438198824994e-13
HFE O 0 4.394834274279447e-09
bind O 0 1.5333904979097923e-10
tightly O 0 4.6560108546422896e-10
at O 0 3.2631315184661336e-12
the O 0 2.1262598818671923e-14
basic O 0 2.152829130241951e-11
pH O 0 1.731214199773845e-10
of O 0 1.450491512009378e-15
the O 0 8.700214892054178e-14
cell O 0 1.3464676040797485e-09
surface O 0 1.4192012713465374e-05
, O 0 4.973155134230245e-13
but O 0 2.6500412975138943e-11
not O 0 1.8783104412112284e-12
at O 0 6.439080497099015e-13
the O 0 1.1325839354911493e-12
acidic O 0 8.093136472098195e-08
pH O 0 1.7431449350624462e-07
of O 0 5.14330982318012e-12
intracellular O 0 1.2411541661094816e-07
vesicles O 0 5.058271668190173e-08
. O 0 1.432088558850353e-09

TfR O 0 0.04359010234475136
HFE O 0 9.997643246606458e-06
stoichiometry O 0 6.37545042536658e-07
( O 0 1.7784782327390225e-11
2 O 0 7.614408235878667e-12
1 O 0 1.551706679814302e-12
) O 0 2.0428782973526578e-14
differs O 0 1.1811660156901826e-11
from O 0 7.379968164356043e-12
TfR O 0 1.0309547349152126e-07
transferrin O 0 8.241815563359012e-11
stoichiometry O 0 1.9249687954747685e-10
( O 0 5.853505885295568e-14
2 O 0 1.0213340318875747e-13
2 O 0 1.6212373240773181e-13
) O 0 6.994109864156368e-15
, O 0 1.2616566337264644e-15
implying O 0 9.950438042971577e-12
a O 0 1.459266667463814e-14
different O 0 1.2307304020310258e-14
mode O 0 4.80553574364051e-12
of O 0 3.036964105184185e-16
binding O 0 8.099649423387589e-13
for O 0 1.3294632728684183e-14
HFE O 0 1.4943839943271087e-08
and O 0 6.4948246433771395e-12
transferrin O 0 4.621707738738934e-10
to O 0 2.5755242383240784e-10
TfR O 0 2.942799801530782e-05
, O 0 2.5495317323791754e-14
consistent O 0 1.626790507858189e-10
with O 0 1.5270314038858673e-13
our O 0 3.0481823662387164e-12
demonstration O 0 7.689684934815422e-13
that O 0 3.0613529154168914e-14
HFE O 0 2.5248664270449694e-10
, O 0 2.2479797022337614e-15
transferrin O 0 1.5704599079513493e-11
, O 0 1.1959369041955603e-12
and O 0 1.8130352774647918e-09
TfR O 0 3.244648723921273e-06
form O 0 1.1175976810662291e-11
a O 0 5.1827695780881644e-12
ternary O 0 3.895479050441963e-09
complex O 0 2.477175353732264e-09
. O 0 3.1681124390559035e-10

Identification O 0 1.3415559774188068e-09
of O 0 5.587534558301743e-13
three O 0 1.0270263643436667e-13
novel O 0 4.177320381965055e-12
mutations O 0 4.517852758567642e-09
and O 0 6.938682484483594e-13
a O 0 5.147930150738167e-13
high O 0 5.782781545282667e-11
frequency O 0 5.402220892847254e-10
of O 0 3.647886639567173e-14
the O 0 5.719646761423447e-13
Arg778Leu O 0 2.931163294306316e-07
mutation O 0 1.1714126557649251e-08
in O 0 4.9855258810183045e-11
Korean O 0 1.7650100403443503e-07
patients O 0 1.9752756721946874e-11
with O 0 5.567909414777583e-12
Wilson B-Disease 0 1.1951458873227239e-05
disease I-Disease 0 1.5040411653899355e-06
. O 0 2.9700967379975296e-11

Four O 0 5.023432780859594e-10
mutations O 0 3.3437794400015264e-07
- O 0 3.764667417271994e-05
- O 0 9.767798019311158e-07
R778L O 0 2.1971435781864557e-09
, O 0 4.9912055926834824e-15
A874V O 0 1.1942044575441457e-12
, O 0 2.5137584711101043e-16
L1083F O 0 2.4114751536775947e-13
, O 0 3.584908395274012e-16
and O 0 3.1274821752133976e-15
2304delC O 0 6.63830518332631e-11
- O 0 1.1260253174327772e-08
- O 0 1.704850660644297e-08
in O 0 1.0777057414881885e-12
the O 0 1.4280596019947134e-13
copper O 0 2.911975105490683e-09
- O 0 2.0746564188822703e-11
transporting O 0 2.5754170931285847e-13
enzyme O 0 3.038614282066532e-13
, O 0 3.681266598655865e-15
P O 0 3.341591892080942e-08
- O 0 2.0369395059560702e-08
type O 0 3.814562887782813e-07
ATPase O 0 2.247953290179794e-08
( O 0 4.3480337060843033e-13
ATP7B O 0 2.525678155507194e-08
) O 0 1.9173724091184514e-14
, O 0 7.664082855764892e-15
were O 0 1.961069761441392e-12
identified O 0 4.556155630552894e-08
in O 0 1.9344732482551308e-09
Korean O 0 2.676973963389173e-05
Patients O 0 1.4419927925335418e-11
with O 0 6.295971990283311e-12
Wilson B-Disease 0 4.086767876287922e-05
disease I-Disease 0 3.7240740766719682e-06
. O 0 2.564356713086191e-11

Arg778Leu O 0 5.124568360770354e-07
, O 0 2.1423828423100533e-12
the O 0 5.810867601983502e-14
most O 0 1.279050108014823e-13
frequently O 0 6.167965027614741e-10
reported O 0 7.689257008891559e-10
mutation O 0 2.1834649366336834e-10
of O 0 3.1224040009363713e-15
this O 0 1.0097555997183767e-15
enzyme O 0 5.667071816022528e-15
, O 0 1.531544491778836e-16
was O 0 3.220443226328862e-12
found O 0 3.663077480231536e-11
in O 0 1.0699259533897276e-10
six O 0 3.208695678949547e-12
of O 0 1.1810702155862218e-13
eight O 0 8.238762103096597e-12
unrelated O 0 1.4069479803424656e-08
patients O 0 1.8752337183070011e-10
studied O 0 1.2363519097391418e-09
, O 0 1.0307328788768978e-14
an O 0 4.743835549668495e-16
allele O 0 2.4713482128790876e-12
frequency O 0 1.2921885783612197e-09
of O 0 4.460452840415741e-12
37 O 0 1.0550494505823238e-10
. O 0 3.285259217444825e-11

5 O 0 8.200704004757142e-10
% O 0 1.2527079200352897e-11
, O 0 8.902492458495725e-14
which O 0 1.0280906443012328e-13
is O 0 4.335386352216988e-14
considerably O 0 1.0816105823485689e-11
higher O 0 4.4127711901209565e-11
than O 0 4.539645569179296e-13
those O 0 1.6885779341620222e-13
in O 0 1.8316924854048372e-14
other O 0 3.626657961029907e-14
Asian O 0 2.6696784973662124e-12
populations O 0 3.831528497255654e-11
. O 0 2.384010176770257e-11

The O 0 5.805943399661562e-12
novel O 0 4.150539720942925e-12
single O 0 1.0528250363531222e-12
nucleotide O 0 5.544555092829029e-11
deletion O 0 8.354680836042405e-11
, O 0 6.679352844473144e-15
2304delC O 0 1.1608421862652207e-10
, O 0 9.312148762600364e-14
was O 0 5.421510809733299e-11
found O 0 1.0679217926634621e-10
in O 0 3.7449272849432447e-11
one O 0 2.620322847590728e-10
patient O 0 1.2683107009081596e-08
. O 0 4.777581108506013e-11

Since O 0 2.598802062436789e-09
a O 0 1.02703273403143e-12
mutation O 0 1.8752908947927693e-10
at O 0 2.6642848083985315e-13
cDNA O 0 2.0967271321947756e-11
nucleotide O 0 1.9507464532608765e-09
2302 O 0 9.959665447922816e-08
( O 0 2.913918021804629e-14
2302insC O 0 1.261623860937533e-10
) O 0 3.640465207933874e-13
had O 0 4.797627850550157e-10
been O 0 1.239673780295547e-10
previously O 0 3.239130630383613e-10
described O 0 9.386709187708675e-10
, O 0 3.768129065067141e-14
this O 0 2.048493109353417e-14
region O 0 4.904215488571451e-12
of O 0 3.118019419588204e-14
the O 0 3.289149551680137e-13
ATP7B O 0 6.13354984579928e-08
gene O 0 1.3379368446475581e-10
may O 0 6.504413674335296e-10
be O 0 8.396943622195063e-13
susceptible O 0 1.5484221904671358e-08
to O 0 8.766302787843738e-12
gene O 0 1.0721480066422373e-05
rearrangements O 0 0.20695973932743073
causing O 0 0.0013921101344749331
Wilson B-Disease 0 0.1893172413110733
disease I-Disease 0 0.0018335275817662477
. O 0 4.055664970525896e-10

Disruption O 0 4.116756002758848e-08
of O 0 1.297310241003824e-13
splicing O 0 3.9136617557833375e-11
regulated O 0 9.331400929735167e-11
by O 0 2.830710926077229e-14
a O 0 5.029186702504296e-13
CUG O 0 2.4222508727689274e-06
- O 0 1.9150828478586845e-08
binding O 0 9.851976873198609e-11
protein O 0 4.054116070628666e-11
in O 0 4.9221259013076946e-11
myotonic B-Disease 1 0.9999990463256836
dystrophy I-Disease 1 0.9999994039535522
. O 0 2.285209532715271e-08

Myotonic B-Disease 1 0.9999854564666748
dystrophy I-Disease 1 0.9999991655349731
( O 0 1.915531356644351e-05
DM B-Disease 1 1.0
) O 0 2.011531030632341e-08
is O 0 5.223035337564852e-10
caused O 0 8.76057490439841e-11
by O 0 1.760701807062507e-14
a O 0 2.3125555290159916e-13
CTG O 0 1.8091689257815347e-10
expansion O 0 5.4534510587900265e-12
in O 0 1.00730079659328e-12
the O 0 2.6121203182231933e-13
3 O 0 4.337102725571196e-12
untranslated O 0 7.733207851856605e-09
region O 0 4.4361916917701194e-10
of O 0 2.8385314931878014e-12
the O 0 5.729976937374204e-09
DM B-Disease 1 1.0
gene O 0 3.6564873084898863e-07
. O 0 5.291965754494754e-10

One O 0 2.9336581774952464e-11
model O 0 2.0870244421544726e-10
of O 0 1.7699572710250244e-11
DM B-Disease 1 1.0
pathogenesis O 0 1.349966396446689e-06
suggests O 0 4.3672651606208035e-10
that O 0 9.559888281386944e-15
RNAs O 0 4.0405660588216374e-12
from O 0 2.329882875442158e-14
the O 0 2.4364938726670208e-15
expanded O 0 7.720691084069434e-14
allele O 0 1.3803475235659585e-13
create O 0 9.350195957931722e-15
a O 0 3.732656002862489e-14
gain O 0 6.107729599857947e-11
- O 0 1.9897157699233503e-08
of O 0 3.938656692459297e-12
- O 0 1.924719526869012e-06
function O 0 1.4441652040897424e-10
mutation O 0 1.784145400862691e-11
by O 0 9.175079942899894e-16
the O 0 6.43806396862385e-16
inappropriate O 0 6.4198060929776535e-12
binding O 0 1.6165262487974341e-12
of O 0 1.0891604916004943e-15
proteins O 0 2.7476499435332303e-15
to O 0 1.1139694513508623e-14
the O 0 6.609076892531707e-13
CUG O 0 1.4226417306417716e-06
repeats O 0 8.570369303129155e-09
. O 0 3.399081016652872e-11

Data O 0 2.9266791767845746e-10
presented O 0 4.787389928928576e-10
here O 0 1.667899290902497e-10
indicate O 0 1.6949275316591184e-10
that O 0 4.150012852897206e-14
the O 0 1.52484768518521e-14
conserved O 0 3.6337741843306404e-11
heterogeneous O 0 1.562465296034432e-10
nuclear O 0 9.9614663184866e-09
ribonucleoprotein O 0 1.6145010883761302e-09
, O 0 4.787142565492418e-14
CUG O 0 6.977931121809888e-08
- O 0 1.1816725375979331e-08
binding O 0 2.662220097149337e-11
protein O 0 3.475518755170076e-13
( O 0 2.8967434123595114e-15
CUG O 0 1.808929006585913e-08
- O 0 1.0063061495202419e-08
BP O 0 6.678911312896219e-10
) O 0 3.368379192445468e-15
, O 0 2.443465589097634e-15
may O 0 1.016043694491986e-12
mediate O 0 1.3147136157520833e-11
the O 0 9.441674872490147e-13
trans O 0 3.172998530587279e-10
- O 0 3.895436293532839e-06
dominant O 0 2.0247957976948783e-08
effect O 0 4.171034628797088e-10
of O 0 1.3155167059852868e-14
the O 0 2.979005388724365e-14
RNA O 0 1.9057809150235805e-11
. O 0 2.034589944438503e-12

CUG O 0 3.089799065492116e-05
- O 0 9.278468496631831e-06
BP O 0 2.124856024465771e-07
was O 0 1.3709765094016557e-11
found O 0 7.647571134304296e-14
to O 0 2.0638929730158002e-15
bind O 0 1.942063697357721e-12
to O 0 9.379816530690616e-14
the O 0 1.986931886382992e-12
human O 0 1.4176223528394871e-09
cardiac O 0 5.712606139240961e-07
troponin O 0 0.00017402136290911585
T O 0 1.8564458059699973e-07
( O 0 2.8664174305621445e-14
cTNT O 0 1.1571277790112244e-11
) O 0 1.2281649933436768e-14
pre O 0 1.4534876413563325e-08
- O 0 1.1367496943748279e-09
messenger O 0 2.072954655152337e-12
RNA O 0 5.732788809637013e-12
and O 0 1.6242016005795293e-14
regulate O 0 2.5609619676639217e-13
its O 0 5.878520038777408e-15
alternative O 0 2.548609381262251e-13
splicing O 0 3.844295021204758e-11
. O 0 1.3271394400105052e-11

Splicing O 0 1.1883374284593629e-09
of O 0 4.3224690320087245e-12
cTNT O 0 3.3839862023654632e-09
was O 0 2.0801492472966032e-10
disrupted O 0 7.771107846110681e-08
in O 0 4.830315036841171e-10
DM B-Disease 1 1.0
striated O 1 0.9980134963989258
muscle O 0 0.03538065403699875
and O 0 7.797453349667194e-07
in O 0 8.470597556708981e-10
normal O 0 5.763957311444301e-09
cells O 0 3.278655472116476e-11
expressing O 0 7.499789851650451e-12
transcripts O 0 9.279003780615636e-12
that O 0 1.7996190746372848e-13
contain O 0 2.2288402026782173e-11
CUG O 0 2.4932086262197117e-07
repeats O 0 3.389142477772111e-08
. O 0 3.1393339317009605e-11

Altered O 0 1.8222932851585938e-07
expression O 0 5.911302114469663e-09
of O 0 2.680248601186208e-13
genes O 0 2.7060170076920187e-11
regulated O 0 1.1482111095251213e-10
posttranscriptionally O 0 5.022225413320314e-10
by O 0 8.526292600554916e-14
CUG O 0 2.207626948802499e-06
- O 0 5.263026991997322e-07
BP O 0 1.6113947509666104e-08
therefore O 0 5.169885353151216e-12
may O 0 1.2835401144717373e-12
contribute O 0 2.828272826441852e-13
to O 0 6.90183327156646e-12
DM B-Disease 1 0.9999994039535522
pathogenesis O 0 7.430884796377768e-09
. O 0 1.39244334378813e-12
. O 0 3.737775280260314e-12

Identification O 0 8.996616229772769e-10
of O 0 3.884979360782581e-13
a O 0 7.693528973617969e-13
novel O 0 6.683495423764896e-11
nonsense O 0 6.371490599121898e-06
mutation O 0 7.645956756618943e-09
and O 0 2.3055518540322784e-14
a O 0 1.930088872403933e-15
missense O 0 1.2376955363380127e-11
substitution O 0 2.2637123566707912e-13
in O 0 6.505365077327059e-15
the O 0 4.466754978995615e-15
vasopressin O 0 1.2005044180973812e-10
- O 0 1.9966615028010892e-08
neurophysin O 0 1.3066009607598517e-08
II O 0 6.368981786408767e-09
gene O 0 4.133130296346543e-11
in O 0 5.098748029688793e-13
two O 0 4.4403222147337135e-14
Spanish O 0 5.5188215108969985e-11
kindreds O 0 6.355863391149796e-09
with O 0 4.025220261272278e-12
familial B-Disease 0 0.002572764875367284
neurohypophyseal I-Disease 1 0.9987509250640869
diabetes I-Disease 1 0.9922820925712585
insipidus I-Disease 1 0.8211523294448853
. O 0 6.785543860132748e-08

Familial B-Disease 1 0.9991939663887024
neurohypophyseal I-Disease 1 0.9998935461044312
diabetes I-Disease 1 0.9999183416366577
insipidus I-Disease 1 0.999419093132019
( O 0 1.559552629259997e-07
FNDI B-Disease 1 1.0
) O 0 5.603835104284194e-12
is O 0 1.781961080429828e-12
an O 0 1.9805337925227207e-12
autosomal B-Disease 1 0.9999992847442627
dominant I-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999978542327881
caused O 0 1.6082036609077477e-06
by O 0 3.262929648695234e-10
deficiency O 0 0.37509286403656006
in O 0 7.521073065556994e-13
the O 0 2.7169694445661197e-12
antidiuretic O 0 9.95424034044845e-06
hormone O 0 2.501686680034254e-08
arginine O 0 3.950246518780176e-10
vasopressin O 0 3.289869765499276e-10
( O 0 3.7969657935366455e-14
AVP O 0 5.584189252498539e-13
) O 0 3.004858909505287e-16
encoded O 0 6.317374161496966e-15
by O 0 1.3790198248321258e-15
the O 0 3.365144670081435e-14
AVP O 0 1.7971897581237073e-10
- O 0 7.992885997509802e-08
neurophysin O 0 2.3401297255531972e-07
II O 0 2.988980725149304e-07
( O 0 1.6455937903569334e-13
AVP O 0 1.3915472940606577e-10
- O 0 2.1044873221853777e-07
NPII O 0 4.655882079873663e-08
) O 0 1.1472980802429509e-14
gene O 0 3.4548204141254812e-12
on O 0 2.9673431680560247e-12
chromosome O 0 4.836623546111696e-09
20p13 O 0 9.287516533618145e-09
. O 0 5.41661125674775e-11

In O 0 5.5820972844067285e-11
this O 0 4.4326135372873415e-14
study O 0 2.504975122729486e-13
, O 0 1.7525065938912322e-14
we O 0 7.780595286978331e-13
analyzed O 0 1.3572072068632202e-12
two O 0 3.5024399440403533e-15
families O 0 2.1233743794290758e-14
with O 0 5.3003191706523303e-14
FNDI B-Disease 1 0.999998927116394
using O 0 4.1067228285542046e-13
direct O 0 1.6010914382497132e-12
automated O 0 7.625344800032963e-10
fluorescent O 0 1.4531764680469905e-09
, O 0 5.1847913305367796e-14
solid O 0 1.1269996741392063e-10
phase O 0 3.532665479588637e-11
, O 0 6.220028561220586e-14
single O 0 3.173251245103259e-11
- O 0 1.7107650851500011e-09
stranded O 0 3.6168778475703656e-13
DNA O 0 1.578343067408592e-14
sequencing O 0 4.3870322380000406e-15
of O 0 8.835781837635871e-16
PCR O 0 7.331205087446335e-11
- O 0 2.118929254280033e-09
amplified O 0 8.062945866527116e-10
AVP O 0 7.685634906273719e-10
- O 0 1.7454730993904377e-08
NPII O 0 9.971256709206955e-09
DNA O 0 1.1380622000345397e-09
. O 0 2.9030271242458383e-11

In O 0 3.060137560018106e-11
one O 0 2.437393548711947e-13
of O 0 7.68378399508508e-15
the O 0 1.0530253291519617e-13
families O 0 1.2059927709251461e-12
, O 0 7.083512243563281e-14
affected O 0 3.734084222384304e-12
individuals O 0 1.1372532689873927e-12
presented O 0 4.849227269732026e-11
a O 0 3.0259614258731915e-12
novel O 0 6.251389683686881e-11
nonsense O 0 9.769651754254483e-09
mutation O 0 2.4718773902754343e-11
in O 0 3.879185164144252e-15
exon O 0 4.330853384248989e-12
3 O 0 9.725680547370552e-13
of O 0 8.29295230305848e-15
the O 0 9.266790487088075e-14
gene O 0 8.730998563022396e-11
, O 0 1.3304880133280066e-14
consisting O 0 4.3258047155176477e-14
in O 0 3.5870340985705296e-13
a O 0 5.329601777265269e-12
G O 0 7.557069636732194e-08
to O 0 5.8432716130985e-12
T O 0 7.244847438414581e-06
transition O 0 6.479302649964325e-10
at O 0 6.268655733387973e-11
nucleotide O 0 9.084591967578604e-10
2101 O 0 8.746504076562189e-10
, O 0 7.587575451837095e-15
which O 0 4.069447398822408e-15
produces O 0 8.750724483138489e-14
a O 0 5.651034856528868e-14
stop O 0 7.845787214355582e-11
signal O 0 1.8867737594518985e-08
in O 0 9.035407838586806e-11
codon O 0 2.6318833223903937e-10
82 O 0 1.1428923779588374e-11
( O 0 1.4469504695975577e-13
Glu O 0 1.1492634621745879e-09
) O 0 2.2941652917662925e-13
of O 0 4.42630470037092e-13
NPII O 0 2.261189183627721e-05
. O 0 3.2029634500219117e-10

The O 0 2.070514593111028e-10
premature O 0 5.994733598413404e-09
termination O 0 4.6119129348820564e-11
eliminates O 0 2.1208276454465214e-11
part O 0 1.2371190226748152e-12
of O 0 1.0675576362587785e-13
the O 0 2.966064243173361e-12
C O 0 1.6865060459281267e-08
- O 0 5.019620830104543e-10
terminal O 0 2.9923494780127735e-13
domain O 0 2.3172623216972943e-13
of O 0 1.5131421980739239e-15
NPII O 0 4.677777276640427e-09
, O 0 4.770403267454718e-16
including O 0 7.587191745911988e-17
a O 0 2.6849631526893077e-15
cysteine O 0 2.0544926437188193e-13
residue O 0 2.3020980954857606e-10
in O 0 1.0353623340619844e-12
position O 0 3.4141718341373917e-09
85 O 0 7.112325051822355e-13
, O 0 1.1946452738186876e-14
which O 0 5.314679685924917e-12
could O 0 1.974083785327707e-09
be O 0 2.8792548206757473e-11
involved O 0 3.776128368326859e-11
in O 0 3.903969855723055e-11
the O 0 2.379794104834243e-11
correct O 0 1.893672987307582e-07
folding O 0 1.2411742744689036e-09
of O 0 5.064552835269687e-13
the O 0 1.43528097393264e-11
prohormone O 0 1.9682410368204728e-07
. O 0 2.6072063952220503e-10

In O 0 2.305934609925231e-10
the O 0 7.723993970462639e-13
second O 0 4.332836173182031e-12
family O 0 4.273813941635396e-12
, O 0 6.351175858290096e-16
a O 0 3.9487130165866743e-16
G279A O 0 4.0622216148592655e-14
substitution O 0 2.0799863025521004e-14
at O 0 1.5258143869472524e-13
position O 0 5.069641581534334e-11
- O 0 4.711990797545695e-10
1 O 0 8.010657566968893e-14
of O 0 1.0746292178738731e-15
the O 0 1.58973633817552e-14
signal O 0 3.171573463925381e-12
peptide O 0 1.1532184712378934e-12
was O 0 2.486927493366292e-13
observed O 0 2.8547223179103964e-12
in O 0 1.4120307570766877e-13
all O 0 1.0952697082622365e-13
affected O 0 3.343497787661187e-12
individuals O 0 1.0638633203552406e-11
. O 0 1.0071116163246074e-10

This O 0 1.169987023930119e-10
missense O 0 1.5071818779688329e-05
mutation O 0 3.006281804118771e-05
, O 0 4.562268531710378e-12
which O 0 5.748423872325992e-12
replaces O 0 3.6737535680231304e-08
Ala O 0 3.183059024691737e-11
with O 0 3.929844730882204e-13
Thr O 0 1.346240310340363e-07
, O 0 1.4003048395307138e-13
is O 0 3.869491803799169e-14
frequent O 0 3.616793808891572e-10
among O 0 1.761982892922731e-09
FNDI B-Disease 1 1.0
patients O 0 8.325041989110105e-08
and O 0 4.168247344504827e-12
is O 0 5.649593748553727e-13
thought O 0 3.6986000200023295e-12
to O 0 7.762800310602645e-15
reduce O 0 7.116399917267424e-12
the O 0 4.687410873403623e-14
efficiency O 0 3.566720876979623e-11
of O 0 2.744465311409791e-15
cleavage O 0 2.9806312973335025e-10
by O 0 2.8724226231076344e-13
signal O 0 3.0306890330678016e-10
peptidases O 0 1.8178413219160916e-09
. O 0 1.3724880607024481e-12
. O 0 4.4525394655992034e-12

Genetic O 0 1.1090924623147203e-08
heterogeneity O 0 1.5621987259351044e-08
of O 0 9.33346594456097e-11
Saethre B-Disease 1 0.9996696710586548
- I-Disease 1 0.9999996423721313
Chotzen I-Disease 1 0.9999969005584717
syndrome I-Disease 1 0.999998927116394
, O 0 7.337548537517113e-13
due O 0 4.419946179889944e-12
to O 0 1.2563173700137764e-13
TWIST O 0 1.682631101118659e-08
and O 0 2.1127213867266903e-10
FGFR O 0 1.1536320698724012e-06
mutations O 0 1.2192596265947486e-08
. O 0 1.817947008209142e-11

Thirty O 0 1.888009109052291e-07
- O 0 1.4676677892566659e-05
two O 0 9.930487421955236e-13
unrelated O 0 1.1765779461825332e-09
patients O 0 9.630839528651514e-12
with O 0 2.526044948707824e-15
features O 0 2.410448507461638e-10
of O 0 6.79310108164799e-10
Saethre B-Disease 1 0.9999680519104004
- I-Disease 1 0.9999998807907104
Chotzen I-Disease 1 0.9999915361404419
syndrome I-Disease 1 0.9999967813491821
, O 0 2.6080366368592088e-14
a O 0 2.595566990504228e-13
common O 0 3.3547503663911016e-10
autosomal B-Disease 1 0.6837266087532043
dominant I-Disease 1 0.9902819395065308
condition I-Disease 0 0.007080144714564085
of O 0 1.920127425114604e-11
craniosynostosis B-Disease 1 0.9487299919128418
and O 0 1.196060708252844e-07
limb B-Disease 0 0.0011997580295428634
anomalies I-Disease 0 0.0031162570230662823
, O 0 6.8144929803171106e-12
were O 0 4.16699140470822e-12
screened O 0 1.3479921179282428e-08
for O 0 2.1289647562233727e-12
mutations O 0 6.4123510945535145e-09
in O 0 3.323265057239566e-13
TWIST O 0 1.8507866073047552e-10
, O 0 3.1278297551833034e-14
FGFR2 O 0 4.042491674738358e-09
, O 0 6.709311383377992e-14
and O 0 2.7079931179396777e-12
FGFR3 O 0 2.211871333201998e-06
. O 0 1.7151488562738848e-10

Nine O 0 1.4233003664543276e-10
novel O 0 3.112041180308722e-11
and O 0 7.794358214407993e-11
three O 0 2.8526703568787504e-12
recurrent O 0 1.0553623042142135e-06
TWIST O 0 3.896455211815919e-07
mutations O 0 7.238894340844126e-06
were O 0 1.5363063599060922e-10
found O 0 3.2045505138356134e-11
in O 0 1.5487271187719642e-11
12 O 0 8.811212176551564e-12
families O 0 9.873116213476862e-12
. O 0 2.7241056632654193e-11

Seven O 0 2.0954977753007142e-09
families O 0 5.232205987915073e-11
were O 0 1.1102331077053607e-12
found O 0 2.3503007266084674e-12
to O 0 6.108923588342419e-13
have O 0 8.282531778480706e-12
the O 0 7.569539748697798e-14
FGFR3 O 0 1.1189392523647257e-07
P250R O 0 1.2197375054423532e-10
mutation O 0 6.473435121279181e-10
, O 0 7.894316575223978e-15
and O 0 3.3074922195595186e-14
one O 0 7.110666764599538e-14
individual O 0 3.080644463485105e-12
was O 0 2.6447757872638533e-10
found O 0 9.66916043759758e-12
to O 0 9.265615184828047e-12
have O 0 1.5267679481789642e-11
an O 0 2.315895820384148e-14
FGFR2 O 0 8.44602595861943e-07
VV269 O 0 5.093042876325171e-09
- O 0 1.7223027271029423e-07
270 O 0 2.3222290410074287e-11
deletion O 0 5.033284899980117e-09
. O 0 2.3088833622786353e-10

To O 0 5.081430502068551e-12
date O 0 2.634856777206096e-10
, O 0 1.4138195381953583e-14
our O 0 1.3110211972023472e-13
detection O 0 2.9201984580451423e-11
rate O 0 4.540657017049199e-10
for O 0 1.9639554730966464e-16
TWIST O 0 3.708802709390113e-11
or O 0 7.36854761235195e-12
FGFR O 0 5.387242207888221e-09
mutations O 0 2.19835712134131e-11
is O 0 2.7660657103559597e-14
68 O 0 1.7050934503302223e-13
% O 0 3.088843539126619e-14
in O 0 5.1356345391606606e-12
our O 0 4.846072556574654e-07
Saethre B-Disease 1 0.9862455129623413
- I-Disease 1 0.9999996423721313
Chotzen I-Disease 1 0.9999951124191284
syndrome I-Disease 1 0.9999988079071045
patients O 0 3.461183784025934e-09
, O 0 7.291641621824229e-15
including O 0 8.22672482979174e-14
our O 0 5.290411442260279e-10
five O 0 1.05598656988809e-12
patients O 0 7.227566527039098e-13
elsewhere O 0 9.260585354109452e-11
reported O 0 2.5409152559774384e-10
with O 0 5.843134678364115e-13
TWIST O 0 7.930215417673026e-08
mutations O 0 3.76803313884011e-07
. O 0 1.0874030842433768e-10

More O 0 2.817135196994669e-12
than O 0 7.496025284867147e-13
35 O 0 2.4503381094997945e-13
different O 0 1.5006347401681774e-14
TWIST O 0 1.361869172988861e-09
mutations O 0 7.067713525543695e-09
are O 0 4.699166945322519e-13
now O 0 9.36805754497838e-13
known O 0 8.334855700585508e-13
in O 0 9.93708045536612e-13
the O 0 4.276828999456861e-13
literature O 0 2.953208233513749e-10
. O 0 2.5466052877565204e-11

The O 0 1.253006639417853e-11
most O 0 3.787345870948089e-14
common O 0 3.5565524321174574e-14
phenotypic O 0 6.864329243905232e-11
features O 0 6.5878453803236425e-09
, O 0 3.010761128255379e-13
present O 0 1.1083485691731898e-11
in O 0 6.424531046045345e-13
more O 0 1.288574620812201e-14
than O 0 5.2097716874040245e-14
a O 0 3.1921757988676025e-13
third O 0 1.2388564618603937e-09
of O 0 1.292041820755152e-11
our O 0 2.0240995013409702e-07
patients O 0 1.1530645145294005e-12
with O 0 2.401879998332416e-14
TWIST O 0 1.835446994391532e-08
mutations O 0 1.4569383210982778e-07
, O 0 7.247966739591313e-14
are O 0 1.9401809735089363e-14
coronal B-Disease 0 9.183963312064947e-11
synostosis I-Disease 0 1.4630592204412096e-07
, O 0 5.365317565231287e-13
brachycephaly B-Disease 0 5.1235010687378235e-06
, O 0 1.2420908745980341e-09
low B-Disease 1 0.999850869178772
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 4.404417268233374e-06
facial B-Disease 1 0.9999675750732422
asymmetry I-Disease 0 0.048449136316776276
, O 0 1.7608003943792028e-09
ptosis B-Disease 1 0.9986024498939514
, O 0 2.2228711926697287e-11
hypertelorism B-Disease 0 3.4518416214268655e-05
, O 0 5.811106370406938e-12
broad B-Disease 0 5.991498852608856e-09
great I-Disease 0 5.422188223747071e-06
toes I-Disease 0 0.004837839398533106
, O 0 2.725137010581996e-13
and O 0 1.639848196469118e-12
clinodactyly B-Disease 0 4.5016321337243426e-08
. O 0 6.247837663897471e-11

Significant O 0 1.237663166397951e-10
intra O 0 3.983463781054297e-09
- O 0 1.3208229574956931e-05
and O 0 1.933666941844603e-11
interfamilial O 0 2.9749658736477613e-08
phenotypic O 0 8.500933290633839e-09
variability O 0 1.0486375003893045e-06
is O 0 1.0778702149577546e-12
present O 0 8.462006187990104e-14
for O 0 3.3809824074259014e-15
either O 0 1.247926414982281e-11
TWIST O 0 9.2618837044256e-09
mutations O 0 1.9150389718447514e-08
or O 0 7.791355755015772e-11
FGFR O 0 1.8422745142743224e-06
mutations O 0 1.4894075661686657e-07
. O 0 8.802431006316169e-11

The O 0 5.296625985029557e-12
overlap O 0 5.815566431199848e-11
in O 0 9.52934996537036e-13
clinical O 0 3.4361567410878813e-12
features O 0 1.574843810914217e-09
and O 0 2.0636228836856674e-10
the O 0 2.3741612517093336e-13
presence O 0 5.089554333537194e-10
, O 0 4.339539185350787e-14
in O 0 2.7244650424042803e-14
the O 0 8.7847015157517e-15
same O 0 5.853598313530772e-13
genes O 0 1.2024504113770929e-13
, O 0 7.466458448937219e-17
of O 0 3.474279010219904e-17
mutations O 0 6.030041375081063e-13
for O 0 1.8016090091402693e-15
more O 0 2.1048577309823284e-14
than O 0 3.640529717963137e-12
one O 0 7.653605180180101e-12
craniosynostotic B-Disease 0 9.041548037203029e-05
condition I-Disease 0 3.967500742874108e-05
- O 0 7.448793137854182e-09
such O 0 4.2437832761810235e-12
as O 0 7.267049809134285e-12
Saethre B-Disease 0 8.652943250808676e-08
- I-Disease 0 8.666503248377921e-08
Chotzen I-Disease 0 2.555770262091528e-09
, I-Disease 0 1.1238334041315228e-14
Crouzon I-Disease 0 2.1439708342008146e-10
, I-Disease 0 4.247261044384651e-14
and I-Disease 0 4.7796844607206346e-12
Pfeiffer I-Disease 0 1.857594725152012e-06
syndromes I-Disease 0 3.5459567016005167e-07
- O 0 6.08434191917695e-09
support O 0 6.821164293124848e-12
the O 0 4.641781208535034e-13
hypothesis O 0 2.4533417831984483e-12
that O 0 1.7201045343401451e-15
TWIST O 0 1.7337700285863233e-12
and O 0 9.843040553632332e-14
FGFRs O 0 5.908951106192717e-11
are O 0 2.5436739913291435e-14
components O 0 3.550578017361139e-12
of O 0 2.499541287788237e-15
the O 0 1.0305997591789073e-13
same O 0 1.266301842030304e-12
molecular O 0 4.380681744003273e-13
pathway O 0 1.4794779323764858e-15
involved O 0 1.5744111743487554e-13
in O 0 2.3394836550861067e-14
the O 0 6.9415607871416585e-15
modulation O 0 3.276468818480538e-10
of O 0 2.2536124008598613e-11
craniofacial O 1 0.9624771475791931
and O 0 1.2478716371333576e-07
limb O 0 4.2660144572437275e-06
development O 0 2.2722582496137456e-11
in O 0 2.5224005176238684e-11
humans O 0 2.4634193990236142e-11
. O 0 1.0652896208392104e-13
. O 0 2.1813980743273786e-12

Mutation O 0 1.4644858481460687e-07
analysis O 0 7.952762337559705e-10
of O 0 1.1326218435359081e-10
UBE3A O 1 0.98846834897995
in O 0 0.0025807407218962908
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0015293959295377135
. O 0 1.1367285779328995e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.739824983815197e-05
AS B-Disease 1 0.9999998807907104
) O 0 5.724902496506701e-11
is O 0 8.971953041614356e-11
caused O 0 4.006351361773852e-10
by O 0 6.452112065111204e-13
chromosome O 0 3.691658889692917e-07
15q11 O 0 1.2201786248056123e-08
- O 0 2.783341779277748e-09
q13 O 0 1.3964549135103699e-11
deletions O 0 1.7074164304631267e-10
of O 0 7.187589824535212e-13
maternal O 0 1.1388726406380556e-08
origin O 0 5.882704740001188e-11
, O 0 5.9807590330933705e-15
by O 0 7.819570322200112e-14
paternal O 0 2.508530087652616e-06
uniparental B-Disease 0 0.00012561341281980276
disomy I-Disease 0 6.357473466778174e-05
( O 0 1.3196432835371752e-10
UPD B-Disease 1 0.9999963045120239
) O 0 2.276543103335582e-12
15 O 0 4.613597373061273e-13
, O 0 3.4239154899673473e-16
by O 0 1.2536986151914092e-13
imprinting O 0 0.006433616392314434
defects O 1 0.99964439868927
, O 0 2.9508668186913056e-13
and O 0 1.3100413494889634e-13
by O 0 5.321371598573932e-13
mutations O 0 2.2974901980887807e-08
in O 0 4.266621778103996e-12
the O 0 1.0675011222205377e-12
UBE3A O 0 9.956797697441289e-08
gene O 0 5.455852214453216e-09
. O 0 1.3075519833538607e-10

UBE3A O 0 1.9523557057254948e-05
encodes O 0 6.170141619854519e-10
a O 0 4.8904656366199895e-12
ubiquitin O 0 2.776802121573496e-10
- O 0 1.998851528739465e-09
protein O 0 2.5186638798885275e-12
ligase O 0 1.590082232549861e-10
and O 0 2.3185687744731176e-11
shows O 0 1.1647532573988428e-06
brain O 0 7.266429747687653e-05
- O 0 2.0198321237785422e-07
specific O 0 5.659913648869974e-10
imprinting O 0 1.0204154250459396e-06
. O 0 9.707268322500795e-11

Here O 0 6.746387892775374e-09
we O 0 1.1610054063970754e-11
describe O 0 3.0234360154368645e-11
UBE3A O 0 1.5803971109562553e-07
coding O 0 6.888096208967909e-07
- O 0 0.03657202795147896
region O 0 1.8952937352878507e-07
mutations O 0 1.5106493265193421e-06
detected O 0 4.187507585129424e-08
by O 0 1.0405066226486757e-14
SSCP O 0 3.099584755528184e-10
analysis O 0 1.3881633472920263e-12
in O 0 1.0642442873146085e-12
13 O 0 4.067327637885532e-12
AS B-Disease 1 0.9999966621398926
individuals O 0 8.441771587319735e-11
or O 0 3.83071396825585e-09
families O 0 3.398266112952797e-10
. O 0 2.3983964814178194e-10

Two O 0 1.9428374464780518e-09
identical O 0 1.3220865469065757e-07
de O 0 2.699088668123295e-07
novo O 0 6.301534938302211e-08
5 O 0 1.5707841971579484e-10
- O 0 1.1760783458214519e-08
bp O 0 2.59318722051205e-09
duplications O 0 1.1258062926344792e-08
in O 0 3.8135614457979194e-12
exon O 0 1.4520681324015072e-09
16 O 0 8.467670314926679e-11
were O 0 4.754308058352308e-12
found O 0 7.071818824977427e-11
. O 0 1.2166566365490183e-10

Among O 0 3.7030205290999874e-11
the O 0 2.085111461746711e-13
other O 0 8.252546459782198e-14
11 O 0 1.3716393472418265e-13
unique O 0 4.168642156725938e-13
mutations O 0 1.1768922503208046e-09
, O 0 1.145418395548381e-13
8 O 0 1.127731805508625e-12
were O 0 5.2744314720919866e-14
small O 0 4.1734773596020444e-14
deletions O 0 4.519835172800413e-09
or O 0 1.1849852210588097e-09
insertions O 0 9.682177051217877e-07
predicted O 0 2.1654523152392358e-06
to O 0 2.8166045884514546e-11
cause O 0 1.660561999017318e-08
frameshifts O 0 9.031112131197006e-05
, O 0 6.14766354142815e-12
1 O 0 1.8049286024113265e-11
was O 0 4.765961514330286e-10
a O 0 3.3646733402920015e-12
mutation O 0 5.69588987087144e-10
to O 0 2.4623962672489993e-14
a O 0 3.380599023373315e-13
stop O 0 2.9783564503560456e-11
codon O 0 1.1464548928252771e-12
, O 0 4.322957160155568e-15
1 O 0 3.0386476890459715e-14
was O 0 3.2671610642603932e-12
a O 0 7.017527834871085e-13
missense O 0 1.1997987314771308e-07
mutation O 0 2.0466481842618123e-08
, O 0 4.577255255052738e-14
and O 0 4.0386764028552125e-13
1 O 0 2.8105068185929616e-12
was O 0 4.488340810127056e-09
predicted O 0 2.335353599391965e-08
to O 0 1.0927286636305822e-12
cause O 0 1.8636132914640058e-10
insertion O 0 8.875290259668933e-12
of O 0 1.96683121178598e-12
an O 0 1.4487959443254539e-12
isoleucine O 0 1.9130113741994137e-06
in O 0 2.2521760931898394e-12
the O 0 6.107871912235108e-14
hect O 0 6.998638335531382e-10
domain O 0 6.924235924216093e-12
of O 0 3.776900599455728e-14
the O 0 2.2117965553687668e-13
UBE3A O 0 3.4210556609792775e-09
protein O 0 1.0532874919477742e-11
, O 0 1.5394154660318578e-14
which O 0 6.850568696299339e-15
functions O 0 3.136408504873095e-14
in O 0 1.7290393766809624e-14
E2 O 0 4.98857639225081e-12
binding O 0 1.161317743358925e-11
and O 0 4.808106969750141e-14
ubiquitin O 0 1.2212307987785609e-12
transfer O 0 7.722558703626703e-11
. O 0 3.3512123631673774e-11

Eight O 0 7.411089103515067e-11
of O 0 4.6938527283740816e-14
the O 0 2.139213014628466e-13
cases O 0 7.509208532763267e-12
were O 0 1.0761553974336646e-11
familial O 0 3.3053086667678144e-07
, O 0 5.603068703452507e-11
and O 0 1.0673292111240684e-10
five O 0 3.786916526887785e-12
were O 0 8.029087811278757e-11
sporadic O 0 1.1636036845175113e-07
. O 0 1.216483136445845e-09

In O 0 9.83125386655459e-11
two O 0 2.020843751669374e-13
familial O 0 1.8782877475587156e-07
cases O 0 5.151832738192752e-08
and O 0 7.24039231347895e-11
one O 0 4.329911863082403e-12
sporadic O 0 5.74722669455241e-09
case O 0 2.32105334951882e-09
, O 0 2.3796772319058072e-14
mosaicism O 0 1.4657084435043544e-09
for O 0 9.267449004382589e-13
UBE3A O 0 6.638731520069996e-07
mutations O 0 8.050767519307556e-08
was O 0 6.90296916849853e-11
detected O 0 1.9464960132609122e-07
in O 0 5.83861474792724e-12
the O 0 3.712381964338096e-12
mother O 0 3.904604454874061e-06
of O 0 5.625456697688769e-12
three O 0 4.213871473979225e-10
AS B-Disease 1 1.0
sons O 0 1.3501360740519885e-07
, O 0 1.117191463038264e-13
in O 0 4.1352709559579204e-13
the O 0 2.683436806094619e-12
maternal O 0 1.2415897288065025e-07
grandfather O 0 2.386566144707558e-08
of O 0 6.456175112752593e-13
two O 0 1.9602632017612365e-11
AS B-Disease 1 1.0
first O 0 4.129649400219648e-10
cousins O 0 2.5034296413650736e-07
, O 0 5.358179178127642e-13
and O 0 8.95214111173992e-11
in O 0 5.633738267563082e-11
the O 0 1.0162386210321728e-10
mother O 0 5.221321771387011e-05
of O 0 1.6128673917259473e-12
an O 0 3.744041882081106e-11
AS B-Disease 1 1.0
daughter O 1 0.9844471216201782
. O 0 1.2419019590481639e-08

The O 0 4.638747719276637e-12
frequencies O 0 4.736472880573217e-10
with O 0 5.25532417063046e-13
which O 0 1.144598305025113e-11
we O 0 8.498833581338516e-11
detected O 0 3.7271999375754206e-10
mutations O 0 2.6766136182465594e-11
were O 0 1.2812232557442987e-13
5 O 0 5.136185022484949e-15
( O 0 2.65149555745431e-16
14 O 0 9.419037713686868e-15
% O 0 5.247303463186978e-16
) O 0 7.785126934421965e-16
of O 0 5.864658937518655e-14
35 O 0 4.253815615723466e-12
in O 0 4.108242608949486e-13
sporadic O 0 3.991268826553096e-08
cases O 0 8.203652868132849e-08
and O 0 3.1512785436671464e-11
8 O 0 2.9061320949534675e-13
( O 0 1.1283302596968485e-15
80 O 0 7.721570981895041e-15
% O 0 6.898822045722048e-15
) O 0 1.0832400277607183e-14
of O 0 4.617400754282353e-13
10 O 0 1.0749963419431907e-11
in O 0 6.397544169770009e-13
familial O 0 5.412571368879071e-08
cases O 0 6.416560172084473e-09
. O 0 6.217200365643549e-12
. O 0 4.888239119038573e-11

The O 0 2.149721289868012e-09
hemochromatosis B-Disease 1 0.9999004602432251
845 O 0 1.133887934656741e-07
G O 0 1.961644557013642e-06
- O 0 1.1065825589184897e-07
- O 0 9.441298409740284e-09
> O 0 5.319648801321852e-12
A O 0 1.6486160039127368e-13
and O 0 2.1672374723828713e-14
187 O 0 5.868653544897906e-14
C O 0 1.098840549801361e-11
- O 0 2.2687223211192986e-09
- O 0 7.2532269079772504e-09
> O 0 1.8548824975983536e-10
G O 0 3.384439750675483e-08
mutations O 0 2.3430175577487944e-09
: O 0 5.325818453784381e-13
prevalence O 0 1.0310349018993747e-08
in O 0 8.965293785134776e-12
non O 0 2.7428069415691425e-07
- O 0 3.760093022719957e-05
Caucasian O 0 9.979401056625647e-07
populations O 0 1.9466018841285404e-07
. O 0 6.312331768398849e-10

Hemochromatosis B-Disease 0 0.0006470925291068852
, O 0 1.9854526356333224e-10
the O 0 1.8637360099660327e-08
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 0 2.856540559648124e-09
iron I-Disease 0 0.059001341462135315
metabolism I-Disease 0 1.0474050213815644e-06
, O 0 1.1628120815949765e-14
leads O 0 1.0731643438482985e-12
, O 0 5.659880591003634e-14
if O 0 1.9007442286778087e-09
untreated O 0 1.3054942682444448e-09
, O 0 8.285959516683304e-16
to O 0 1.25488053108469e-13
progressive O 0 7.925942554720677e-06
iron B-Disease 1 0.9999644756317139
overload I-Disease 1 0.9413484334945679
and O 0 1.282573293792666e-06
premature B-Disease 0 3.9975245158530015e-07
death I-Disease 0 8.88800855136651e-09
. O 0 2.7151680209724915e-11

The O 0 5.912587752732179e-09
hemochromatosis B-Disease 1 0.9999970197677612
gene O 0 5.04719719174318e-06
, O 0 8.493643288698394e-12
HFE O 0 2.5571085870979005e-07
, O 0 9.488270629257056e-13
recently O 0 3.787666180699034e-09
has O 0 1.0984219783738425e-10
been O 0 1.876283633669984e-12
identified O 0 5.543923098372261e-10
, O 0 2.42640253389167e-15
and O 0 3.984166004110477e-15
characterization O 0 3.851081346178953e-12
of O 0 1.7315465730290114e-15
this O 0 2.7640919118306203e-15
gene O 0 1.4968864689435257e-11
has O 0 1.8956735486908016e-11
shown O 0 7.681806579729056e-11
that O 0 3.9805092273519083e-13
it O 0 3.213026785413688e-15
contains O 0 3.983966263153602e-16
two O 0 3.8090631180893314e-15
mutations O 0 7.0971106595763e-12
that O 0 1.5553209490714454e-13
result O 0 1.0587626608771217e-10
in O 0 8.633633087964943e-13
amino O 0 3.9290356450109865e-13
acid O 0 3.1110883183874116e-13
substitutions O 0 1.1960988840001296e-12
- O 0 2.499135013517284e-12
cDNA O 0 5.323523197785229e-13
nucleotides O 0 2.2543035146926904e-12
845 O 0 8.56810108973427e-12
G O 0 2.536287624366196e-09
- O 0 2.5556060379017254e-08
- O 0 9.529296463028913e-09
> O 0 8.678760834990307e-12
A O 0 8.615653221237529e-13
( O 0 1.480381187135614e-15
C282Y O 0 2.9473960164866364e-13
) O 0 7.463556699348383e-16
and O 0 1.524071464192346e-14
187 O 0 1.0957126048496968e-13
C O 0 7.134302176803331e-11
- O 0 1.3674111620787244e-08
- O 0 7.623781783649974e-08
> O 0 1.7872661683959734e-10
G O 0 9.954249868826537e-09
( O 0 6.224467013864199e-14
H63D O 0 3.294895467575998e-09
) O 0 3.2674213269918984e-13
. O 0 2.771170012211277e-12

Although O 0 1.0903246305815628e-07
hemochromatosis B-Disease 1 0.9999997615814209
is O 0 3.2199673483113145e-10
common O 0 1.4304709326784515e-11
in O 0 8.407135664717513e-13
Caucasians O 0 2.8403215890371314e-10
, O 0 2.3668079215249938e-14
affecting O 0 2.233405300977598e-12
> O 0 1.3968085585749912e-12
= O 0 2.4428740280635353e-11
1 O 0 4.7080015667250175e-14
/ O 0 6.1514400344353515e-12
300 O 0 2.5926762025805204e-14
individuals O 0 1.2231581307704797e-13
of O 0 3.783461377851981e-14
northern O 0 5.259463975448853e-10
European O 0 5.312177009386687e-08
origin O 0 1.3583079550016919e-08
, O 0 7.161397668452307e-13
it O 0 2.087882601184421e-12
has O 0 1.275197742539591e-11
not O 0 7.896854285933952e-13
been O 0 3.165763549743683e-13
recognized O 0 1.3531052363638385e-12
in O 0 2.836760232098612e-13
other O 0 1.4780409155704805e-13
populations O 0 5.564451330264397e-11
. O 0 5.0530371553669795e-11

The O 0 9.574587216815145e-13
present O 0 1.4956177301402723e-13
study O 0 1.0936408300233486e-14
used O 0 2.2060812174978274e-15
PCR O 0 1.2167603730128818e-11
and O 0 4.892233265631901e-14
restriction O 0 1.2163049430483075e-12
- O 0 3.5229874573161624e-12
enzyme O 0 6.296518346863081e-14
digestion O 0 2.8105147807026658e-14
to O 0 2.1693855797008438e-16
analyze O 0 3.477746790634534e-13
the O 0 7.40988742126093e-15
frequency O 0 2.0313029036600483e-11
of O 0 3.0386807233309145e-15
the O 0 1.887671368229569e-14
845 O 0 2.8401237524983136e-12
G O 0 9.002950607239768e-10
- O 0 1.9927834937760736e-09
- O 0 4.6391945840440485e-10
> O 0 6.414343882432672e-13
A O 0 1.6487196807454807e-13
and O 0 4.715208461853436e-14
187 O 0 7.651291303008637e-14
C O 0 8.170984722166708e-12
- O 0 1.829779106010676e-10
- O 0 1.2647444203039981e-09
> O 0 3.895371178397333e-11
G O 0 9.870075867723926e-10
mutations O 0 8.027954689904249e-11
in O 0 1.5349478415735418e-13
HLA O 0 7.414482916523468e-11
- O 0 8.391924655182237e-11
typed O 0 4.573021128440047e-11
samples O 0 2.6053657495306304e-11
from O 0 1.0769967816876003e-12
non O 0 1.9386618976824366e-09
- O 0 7.035336011540494e-07
Caucasian O 0 1.1936467814166463e-08
populations O 0 6.138659025545223e-10
, O 0 2.6037272720367578e-14
comprising O 0 3.467610923337146e-14
Australian O 0 1.9520322858124217e-11
Aboriginal O 0 2.9078095833967588e-11
, O 0 3.834812580872683e-14
Chinese O 0 1.7110978974867186e-13
, O 0 6.456734798242821e-15
and O 0 2.8111275243367095e-13
Pacific O 0 2.5950142642366947e-12
Islanders O 0 3.9913716776140973e-10
. O 0 1.611733489725875e-11

Results O 0 2.9894135167296554e-08
showed O 0 6.489568327161521e-10
that O 0 4.8193911426734626e-14
the O 0 1.2007676279614417e-14
845 O 0 1.1062639519721085e-11
G O 0 1.6642463407379182e-08
- O 0 2.163898926710317e-07
- O 0 3.061934350512274e-08
> O 0 3.3933398625729527e-12
A O 0 3.65054747498636e-13
mutation O 0 4.015835927684286e-11
was O 0 8.200817412304384e-13
present O 0 2.0365381202171878e-13
in O 0 4.3334934029864644e-14
these O 0 4.91637641513408e-14
populations O 0 5.887255743672326e-13
( O 0 1.8144792512573248e-15
allele O 0 4.4035348284454656e-13
frequency O 0 3.2278613809610945e-11
0 O 0 1.6603233544965068e-13
. O 0 4.957445082867413e-16
32 O 0 7.873834471526422e-15
% O 0 1.65963156998299e-15
) O 0 3.2443225352323662e-15
, O 0 6.565977145669977e-14
and O 0 5.443601819310473e-11
, O 0 1.0914054761942266e-13
furthermore O 0 5.143393488893366e-10
, O 0 2.1786276938311894e-13
it O 0 7.465369988857162e-11
was O 0 1.0578497011692889e-07
always O 0 1.5618418274243595e-06
seen O 0 6.01389587018275e-08
in O 0 6.630842251144353e-14
conjunction O 0 6.341135299139933e-14
with O 0 9.37375828000131e-13
HLA O 0 1.7663706053383521e-09
haplotypes O 0 1.3230666562336069e-09
common O 0 9.918501575612026e-10
in O 0 5.29835376961163e-12
Caucasians O 0 2.1516673859300894e-11
, O 0 1.257553182613491e-15
suggesting O 0 9.53831414893247e-13
that O 0 6.879060343546132e-15
845 O 0 5.063026820711913e-13
G O 0 1.3595202741356616e-09
- O 0 1.7599138857349317e-07
- O 0 3.361149651937012e-07
> O 0 1.5316542478771566e-10
A O 0 7.980721639100352e-10
may O 0 4.2575422298796184e-08
have O 0 3.9761233585136613e-13
been O 0 5.460450071704398e-14
introduced O 0 6.253873287287437e-14
into O 0 1.1056674273249387e-14
these O 0 1.6291877447268364e-14
populations O 0 4.298719651183065e-14
by O 0 1.150322513025076e-13
Caucasian O 0 8.718621935521753e-10
admixture O 0 7.002754376372877e-09
. O 0 1.4002596859796768e-09

187 O 0 7.95222021565678e-09
C O 0 3.217696757928934e-07
- O 0 1.644820457613605e-07
- O 0 2.332763244794478e-07
> O 0 4.987620871865772e-10
G O 0 7.233400989292704e-09
was O 0 5.438721521755507e-12
present O 0 6.59982729274769e-14
at O 0 4.846750984496134e-14
an O 0 1.2260198400531079e-16
allele O 0 5.495192517170067e-13
frequency O 0 3.077957888564242e-10
of O 0 7.545528329759577e-13
2 O 0 2.820733403796627e-11
. O 0 5.6984514329450064e-11

68 O 0 3.35994543299023e-09
% O 0 3.4459182035595504e-11
in O 0 2.839018950484551e-12
the O 0 5.154630520164127e-13
two O 0 4.694123778917203e-13
populations O 0 3.3793950710708787e-12
analyzed O 0 5.964810589897951e-11
( O 0 7.767039371690473e-14
Australian O 0 1.873518673534136e-09
Aboriginal O 0 2.094938222896303e-09
and O 0 7.23902535137988e-11
Chinese O 0 2.101646764604559e-12
) O 0 4.38071535427062e-13
. O 0 2.712159490048105e-12

In O 0 3.566516526554153e-11
the O 0 1.9745129468083655e-13
Australian O 0 4.941786563295025e-11
Aboriginal O 0 6.298350729849744e-12
samples O 0 3.751953608910341e-12
, O 0 2.410699813598996e-15
187 O 0 2.0208503585263625e-14
C O 0 1.1130260775538137e-11
- O 0 2.589716219247862e-10
- O 0 1.729241638770418e-09
> O 0 3.1401242717166156e-11
G O 0 2.995999226484969e-09
was O 0 1.0333722592903438e-11
found O 0 5.313845609193624e-13
to O 0 2.201888302764965e-13
be O 0 1.7213289821293998e-11
associated O 0 2.5034027628656474e-10
with O 0 4.196998651395667e-12
HLA O 0 3.4459675113396315e-09
haplotypes O 0 1.8004501223245484e-09
common O 0 2.1556008089618217e-09
in O 0 3.757625720995916e-12
Caucasians O 0 7.15127748684985e-11
, O 0 1.0610205747850487e-14
suggesting O 0 4.99454887170625e-11
that O 0 8.015643812760154e-13
it O 0 1.0217237348059474e-13
was O 0 1.977822338414606e-13
introduced O 0 1.0826910657076028e-13
by O 0 4.512757338360996e-15
recent O 0 1.003106278596455e-11
admixture O 0 1.6537277103267911e-09
. O 0 4.3947315231385176e-10

In O 0 7.768651694162187e-11
the O 0 1.8572480792872215e-13
Chinese O 0 5.922688554871325e-13
samples O 0 7.089963924115927e-13
analyzed O 0 2.278124303783935e-12
, O 0 1.6158393313352322e-15
187 O 0 1.8446436191683555e-14
C O 0 2.511195244803144e-12
- O 0 4.427474359358641e-11
- O 0 3.6030708971956926e-10
> O 0 1.4246223124791957e-11
G O 0 6.479504044420992e-09
was O 0 1.06884695538767e-10
present O 0 7.852554023690672e-11
in O 0 2.1584373177674365e-11
association O 0 9.399122105624436e-14
with O 0 7.478381046474754e-15
a O 0 8.540322854293236e-14
wide O 0 8.567856493724157e-12
variety O 0 1.0274590206416079e-10
of O 0 9.983511413402812e-13
HLA O 0 8.464267065022568e-10
haplotypes O 0 1.2774865887354991e-10
, O 0 2.3438741656649047e-14
showing O 0 8.0239433153384e-11
this O 0 6.509560007998336e-15
mutation O 0 6.319356930101216e-13
to O 0 6.69879690929384e-15
be O 0 3.1759723973998066e-13
widespread O 0 8.31212616098087e-12
and O 0 3.1255953381048585e-09
likely O 0 4.4170933577447613e-10
to O 0 5.692381245189782e-14
predate O 0 1.2684643613258828e-10
the O 0 1.3119617425869784e-13
more O 0 2.2743100602123402e-14
genetically O 0 4.3211804577267254e-13
restricted O 0 5.755903566273535e-13
845 O 0 1.239937926639234e-11
G O 0 2.979895263877097e-08
- O 0 7.113576430128887e-07
- O 0 4.443631596018349e-08
> O 0 2.0773808021012918e-11
A O 0 9.081429185042733e-12
mutation O 0 4.034065526070663e-09
. O 0 7.2465922151820905e-12

Genotype O 0 0.15103526413440704
- O 0 0.002645648317411542
phenotype O 0 1.0342400855734013e-05
correlations O 0 9.680210268925293e-07
in O 0 2.68137512193789e-08
attenuated B-Disease 1 0.9950201511383057
adenomatous I-Disease 1 0.9999977350234985
polyposis I-Disease 1 0.999947190284729
coli I-Disease 1 0.9999970197677612
. O 0 3.565781128145318e-07

Germ O 0 0.0022481048945337534
- O 0 0.0019351319642737508
line O 0 3.2671614746959676e-08
mutations O 0 8.622081715259355e-09
of O 0 2.584776095688069e-14
the O 0 2.6812251962930744e-13
tumor B-Disease 0 2.6213937687202815e-09
suppressor O 0 4.755031479675154e-09
APC O 0 6.101479876896576e-10
are O 0 7.958824571607792e-12
implicated O 0 4.545688625512412e-06
in O 0 5.642694134166959e-08
attenuated B-Disease 1 0.9998183846473694
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999966621398926
coli I-Disease 1 0.9999998807907104
( O 0 3.358580897838692e-06
AAPC B-Disease 1 0.999998927116394
) O 0 6.787023720811192e-11
, O 0 4.62025268033444e-14
a O 0 6.745010366210336e-13
variant O 0 3.133138079647324e-06
of O 0 6.337786544463597e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999992847442627
polyposis I-Disease 1 1.0
( O 0 3.6087769217374444e-07
FAP B-Disease 0 1.8038630287264823e-06
) O 0 1.37258107657523e-10
. O 0 1.11478791475772e-10

AAPC B-Disease 1 0.9999946355819702
is O 0 8.698158859843375e-10
recognized O 0 6.714695206105903e-12
by O 0 1.651542299457593e-14
the O 0 1.1857335046553535e-13
occurrence O 0 4.112343354734094e-09
of O 0 1.3089180347231055e-12
< O 0 5.783738998843546e-08
100 O 0 4.9918029779161266e-12
colonic B-Disease 0 3.042751473003591e-08
adenomas I-Disease 0 9.723792970817158e-08
and O 0 3.885552036370088e-12
a O 0 6.752321683560492e-13
later O 0 3.938457615593194e-10
onset O 0 2.580400746410305e-07
of O 0 1.5423554941662587e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 8.283966401734233e-09
age O 0 1.1805935784536814e-08
> O 0 5.834988048292189e-11
40 O 0 3.394556987931785e-12
years O 0 3.2577399979027977e-12
) O 0 3.2583411337973323e-13
. O 0 9.597776566561134e-12

The O 0 6.888760395451499e-12
aim O 0 2.1382158196803225e-11
of O 0 5.231576602455308e-15
this O 0 3.956057215755843e-15
study O 0 1.946771736871522e-14
was O 0 3.215801377357691e-13
to O 0 1.4958431086668778e-13
assess O 0 1.3698163456865586e-06
genotype O 0 0.00048088954645209014
- O 0 7.874792572692968e-06
phenotype O 0 9.177038684526906e-09
correlations O 0 2.284428202159461e-09
in O 0 2.758168970995456e-10
AAPC B-Disease 1 0.9999822378158569
families O 0 3.458926922661476e-09
. O 0 1.05889998158748e-10

By O 0 3.842152290767231e-12
protein O 0 8.091349812389126e-11
- O 0 9.832763048223114e-09
truncation O 0 8.261697437283999e-10
test O 0 1.7944540298131528e-09
( O 0 4.745956096651946e-15
PTT O 0 2.3394060126580296e-12
) O 0 1.9836439598621845e-17
assay O 0 1.5358638568840205e-14
, O 0 6.641691880283866e-17
the O 0 2.67158797305657e-16
entire O 0 3.794895306200377e-14
coding O 0 1.859571871487553e-11
region O 0 3.0950051549405444e-11
of O 0 1.4706584135714372e-14
the O 0 2.3813889160856187e-14
APC B-Disease 0 3.3580804153013344e-13
gene O 0 7.13875952709081e-13
was O 0 3.6747415006754824e-12
screened O 0 1.3779248853040826e-09
in O 0 2.7609030513187083e-12
affected O 0 8.192129266615389e-12
individuals O 0 3.4419947361058467e-12
from O 0 9.087602892421387e-11
11 O 0 8.917673710584495e-09
AAPC B-Disease 1 0.999998927116394
kindreds O 0 4.7018693294376135e-06
, O 0 1.373205585700199e-12
and O 0 1.7071770429602506e-12
their O 0 1.6285274994851107e-12
phenotypic O 0 8.631921843971213e-09
differences O 0 2.8836486308136955e-05
were O 0 5.758619892048955e-08
examined O 0 4.0958451563710696e-07
. O 0 4.034955980447563e-10

Five O 0 4.487020754950777e-10
novel O 0 9.345905160884627e-10
germ O 0 2.9100225219735876e-05
- O 0 6.580726039828733e-05
line O 0 2.646837415909431e-08
APC B-Disease 0 2.588511072154631e-10
mutations O 0 2.499072060402341e-09
were O 0 2.524016369173654e-12
identified O 0 6.489221382466326e-10
in O 0 8.307434601340091e-12
seven O 0 2.4164777817636818e-11
kindreds O 0 2.492203066140064e-07
. O 0 2.288007144857218e-10

Mutations O 0 5.019414402340772e-06
were O 0 6.48619907783754e-11
located O 0 1.727512403959519e-11
in O 0 1.3827996039883494e-11
three O 0 1.314506636136345e-13
different O 0 3.1026261204311623e-13
regions O 0 1.0476694164984757e-11
of O 0 3.634330385466136e-14
the O 0 6.861621459821471e-14
APC B-Disease 0 7.595141421172513e-13
gene O 0 9.818200939759603e-13
( O 0 3.478446677018191e-15
1 O 0 8.821439028740014e-15
) O 0 1.5336205960023359e-15
at O 0 2.3697556503915473e-12
the O 0 9.018799704448022e-13
5 O 0 2.407121030278958e-11
end O 0 4.3601632720990935e-11
spanning O 0 2.7493842705977878e-12
exons O 0 2.8624059719706274e-11
4 O 0 2.834048273836487e-11
and O 0 1.459452524110727e-11
5 O 0 2.3890798193926255e-12
, O 0 5.203396239816631e-14
( O 0 3.0794136907314265e-14
2 O 0 3.762593806400788e-13
) O 0 1.2986860766200491e-14
within O 0 3.4006970145699505e-14
exon O 0 7.691335762727292e-11
9 O 0 4.746421033985371e-10
, O 0 2.4336574557881976e-14
and O 0 2.2480003969427287e-12
( O 0 2.105146908030521e-14
3 O 0 2.1742357263557222e-13
) O 0 1.4400171661111023e-14
at O 0 1.1667417032512617e-11
the O 0 2.37064057620473e-13
3 O 0 2.886432954631035e-13
distal O 0 1.1016331076529884e-12
end O 0 7.499869059124364e-10
of O 0 4.096269290020278e-14
the O 0 5.027958843543956e-13
gene O 0 9.975893444647e-10
. O 0 1.297797286303748e-10

Variability O 0 5.190266620047623e-06
in O 0 2.6056887550418573e-11
the O 0 6.761910367573953e-13
number O 0 4.136145037580974e-10
of O 0 1.5048588863919576e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 5.332080036168918e-06
most O 0 1.185539025890664e-13
apparent O 0 7.485587844024977e-11
in O 0 8.706810229394679e-13
individuals O 0 8.420471893540171e-13
with O 0 4.166241733116055e-13
mutations O 0 2.0779543419280344e-08
in O 0 1.3108424935792673e-11
region O 0 6.852532985490711e-10
1 O 0 2.5978194595488446e-10
, O 0 4.8819286287138386e-12
and O 0 1.5963506427851826e-07
upper O 1 0.9940628409385681
- O 1 0.9999996423721313
gastrointestinal O 1 0.9994254112243652
manifestations O 0 0.0001382096525048837
were O 0 2.980563018617488e-10
more O 0 2.151752517484673e-12
severe O 0 3.838344042605968e-08
in O 0 1.2021994511002276e-11
them O 0 3.9662502449022696e-11
. O 0 1.252799392004178e-10

In O 0 3.186327243720477e-11
individuals O 0 4.2688361526210805e-12
with O 0 4.80159369296157e-13
mutations O 0 2.7787017131686298e-08
in O 0 3.434127288093336e-11
either O 0 4.489976390686934e-09
region O 0 3.5713416224325556e-08
2 O 0 2.458187264853251e-10
or O 0 3.220585043095525e-08
region O 0 5.120051937979042e-09
3 O 0 6.81528661630737e-12
, O 0 1.6009068392773204e-14
the O 0 1.9828611680112324e-13
average O 0 6.938203345185912e-10
number O 0 8.261472323573774e-15
of O 0 2.471655269098731e-15
adenomas B-Disease 0 1.4419852811808909e-10
tended O 0 1.3751734195821541e-09
to O 0 1.4962924996253513e-11
be O 0 1.2016138084547379e-09
lower O 0 7.927028478071918e-11
than O 0 7.000473551538322e-12
those O 0 1.156597604148879e-12
in O 0 1.6861158465535792e-13
individuals O 0 3.297692522698237e-13
with O 0 6.845037232340589e-13
mutations O 0 1.5740067027536497e-08
in O 0 1.9060726608177703e-10
region O 0 1.3030271972525043e-08
1 O 0 6.017114584366823e-10
, O 0 7.354670800326091e-13
although O 0 6.235177707480943e-09
age O 0 9.67124478279402e-08
at O 0 5.632384836307125e-11
diagnosis O 0 7.019550718467826e-09
was O 0 4.494032923574309e-11
similar O 0 8.431729620062001e-11
. O 0 8.593849937232889e-11

In O 0 1.1181812809013536e-08
all O 0 1.1702195878982025e-09
AAPC B-Disease 1 0.9999862909317017
kindreds O 0 1.14915947051486e-05
, O 0 1.534178058031077e-13
a O 0 1.6498679863714144e-13
predominance O 0 2.514103369932741e-09
of O 0 3.485030042327253e-10
right O 1 0.999984622001648
- O 1 0.9999995231628418
sided O 1 0.9999995231628418
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 8.327187970280647e-05
rectal B-Disease 1 0.9944536089897156
polyp I-Disease 0 0.0008157612173818052
sparing O 0 5.91169690977722e-09
was O 0 4.2408099254487297e-10
observed O 0 7.751249642140579e-10
. O 0 2.045134894768097e-11

No O 0 2.5085564629989676e-06
desmoid B-Disease 1 0.9992061257362366
tumors I-Disease 1 1.0
were O 0 3.1735588379433466e-08
found O 0 7.980204830282389e-10
in O 0 2.4902288564554453e-11
these O 0 1.7269128835262215e-11
kindreds O 0 5.399433575803414e-07
. O 0 8.148747648872856e-11

Our O 0 5.070591724276596e-10
data O 0 2.8647260345154857e-12
suggest O 0 1.0517337868665155e-11
that O 0 1.350132164271503e-13
, O 0 6.19778818653112e-14
in O 0 1.7389773648845974e-11
AAPC B-Disease 1 1.0
families O 0 1.663635340598546e-10
, O 0 1.7901274775402373e-15
the O 0 2.4658529345913613e-16
location O 0 7.934145419656591e-13
of O 0 3.328985850002686e-14
the O 0 5.727487494694428e-12
APC B-Disease 0 1.520136372334946e-08
mutation O 0 2.896478576985828e-07
may O 0 4.181240242928652e-09
partially O 0 9.659401056794081e-10
predict O 0 1.4355062971649346e-10
specific O 0 1.6437226579846254e-11
phenotypic O 0 3.005656878940499e-07
expression O 0 3.791115523199551e-05
. O 0 2.0703101455410433e-09

This O 0 8.108958816921419e-12
should O 0 8.293739826858992e-12
help O 0 6.015578660201193e-13
in O 0 5.803524165143986e-14
the O 0 1.3914702350688746e-14
design O 0 1.6120817181164426e-10
of O 0 2.1152422532717124e-13
tailored O 0 9.628906560976702e-09
clinical O 0 4.003191111934257e-09
- O 0 8.322835043372834e-08
management O 0 2.170164005096953e-12
protocols O 0 1.6857871638887266e-14
in O 0 1.2025684623589517e-15
this O 0 2.149016422552848e-16
subset O 0 1.140091303699145e-13
of O 0 1.4844911053451398e-13
FAP B-Disease 0 2.3360128054150664e-08
patients O 0 1.0325767324514956e-10
. O 0 9.847383325434222e-13
. O 0 1.0504386423193512e-11

Wilms B-Disease 0 0.015401693992316723
' I-Disease 0 1.3778870879832539e-06
tumor I-Disease 0 9.985191695704998e-08
1 O 0 6.08890993181177e-11
and O 0 2.5755953359657413e-12
Dax O 0 0.0036536026746034622
- O 0 1.3996481129652238e-07
1 O 0 7.685461967353591e-13
modulate O 0 7.651857619750402e-11
the O 0 1.0288640599209753e-12
orphan O 0 4.2254530430163584e-10
nuclear O 0 3.2183711251576597e-10
receptor O 0 2.3826409595306686e-12
SF O 0 1.0105204637511633e-06
- O 0 1.2755791090057755e-08
1 O 0 1.519544906569692e-12
in O 0 1.4831523867126634e-13
sex O 0 3.1795049926230945e-10
- O 0 1.4937091494249266e-11
specific O 0 4.739918310278646e-13
gene O 0 3.916125757008615e-11
expression O 0 5.819142390173226e-10
. O 0 1.0097749893189789e-11

Products O 0 5.37065947270321e-10
of O 0 8.374950039025109e-13
steroidogenic O 0 6.004485442190344e-08
factor O 0 6.452319234462323e-10
1 O 0 1.8645083740831403e-11
( O 0 4.598030940369813e-13
SF O 0 0.31612440943717957
- O 0 0.00018405867740511894
1 O 0 3.697727193885392e-11
) O 0 1.3707397304892066e-13
and O 0 1.6879388511914506e-11
Wilms B-Disease 0 1.0332948932045838e-06
tumor I-Disease 0 2.1200114588282304e-06
1 O 0 1.813321437449389e-10
( O 0 2.0556412203952962e-13
WT1 O 0 1.6766267263434997e-09
) O 0 8.18256392005369e-14
genes O 0 2.3664674820428333e-12
are O 0 2.7624579852753668e-15
essential O 0 6.551462304382532e-15
for O 0 3.8409137803675796e-16
mammalian O 0 1.7948071414503053e-12
gonadogenesis O 0 1.5556496368862582e-10
prior O 0 1.7092231493001653e-12
to O 0 1.3344330523391845e-13
sexual O 0 1.0467476885267502e-09
differentiation O 0 7.303236487787856e-11
. O 0 1.9943177317904848e-11

In O 0 3.1234484443309896e-10
males O 0 4.124046881770482e-09
, O 0 1.359614135686138e-12
SF O 0 0.012967394664883614
- O 0 1.0522850288907648e-06
1 O 0 2.7256374240947068e-12
participates O 0 5.74278038317777e-12
in O 0 1.0451175650816671e-13
sexual O 0 2.6269906389098097e-12
development O 0 1.1757824218305737e-15
by O 0 1.1433391541266027e-15
regulating O 0 7.67986889360639e-12
expression O 0 1.3543530012760652e-11
of O 0 9.184329966200385e-15
the O 0 5.454381588857089e-14
polypeptide O 0 2.488835360026087e-09
hormone O 0 2.603225968123013e-10
Mullerian O 0 1.0212133361164888e-09
inhibiting O 0 2.1107438019640767e-10
substance O 0 5.850197126733292e-08
( O 0 9.511191747385572e-13
MIS O 0 3.098955403402215e-08
) O 0 5.312366215329267e-13
. O 0 2.1708390293695423e-12

Here O 0 1.3703928658514997e-08
, O 0 1.681953052312321e-13
we O 0 1.1734766804105679e-12
show O 0 3.8145819836188366e-11
that O 0 1.1100340481864923e-12
WT1 O 0 1.9153246455516637e-07
- O 0 2.2708846358909796e-07
KTS O 0 1.5464094005324114e-08
isoforms O 0 1.8314603306146537e-12
associate O 0 3.6108689822900164e-12
and O 0 3.600549695090098e-14
synergize O 0 7.090272258203356e-10
with O 0 3.632511392376303e-12
SF O 0 0.1446649581193924
- O 0 6.534152817039285e-06
1 O 0 1.8409418087173002e-11
to O 0 1.005256641817276e-12
promote O 0 1.4396006609018741e-09
MIS O 0 4.655960583477281e-05
expression O 0 2.5029850192481717e-08
. O 0 2.7892965714926277e-11

In O 0 3.3626620932203366e-10
contrast O 0 4.6458912272839825e-09
, O 0 2.406963734227774e-12
WT1 O 0 4.1444576481808326e-07
missense O 0 5.502587100636447e-06
mutations O 0 1.3665465985468472e-06
, O 0 6.573194544006941e-14
associated O 0 9.865817190979342e-11
with O 0 1.0912384884598225e-10
male B-Disease 0 0.4718727171421051
pseudohermaphroditism I-Disease 1 1.0
in O 0 1.6075565554274363e-06
Denys B-Disease 1 0.9999958276748657
- I-Disease 1 0.9999996423721313
Drash I-Disease 1 0.9999828338623047
syndrome I-Disease 1 0.9999977350234985
, O 0 1.1094420521162718e-11
fail O 0 8.49761061516574e-09
to O 0 4.1803946372251377e-13
synergize O 0 1.5284680898730585e-07
with O 0 1.855131159800294e-09
SF O 1 0.9997753500938416
- O 0 0.032813213765621185
1 O 0 2.703533175107964e-09
. O 0 1.2918847935861066e-10

Additionally O 0 3.218876054589259e-09
, O 0 4.797199963657572e-13
the O 0 9.518954228364754e-14
X O 0 9.988074452849105e-06
- O 0 1.2337245607341174e-05
linked O 0 3.8089858662715415e-06
, O 0 1.388046172142235e-13
candidate O 0 3.4531655312974863e-09
dosage O 0 1.1756586673072889e-06
- O 0 1.1380692832574368e-08
sensitive O 0 4.6594809646194335e-06
sex O 0 6.452694378822343e-08
- O 0 1.4349751942255295e-10
reversal O 0 1.5317110644078036e-12
gene O 0 1.638210183826927e-12
, O 0 4.548169244786857e-15
Dax O 0 5.429817520052893e-07
- O 0 1.114427661264017e-08
1 O 0 2.1739703678740063e-13
, O 0 1.2863884075995139e-15
antagonizes O 0 1.0755829386865923e-11
synergy O 0 1.397586690474184e-12
between O 0 4.9813412943133795e-12
SF O 0 0.025102553889155388
- O 0 7.943285709188785e-06
1 O 0 1.741124432130814e-11
and O 0 1.5602829358390968e-13
WT1 O 0 6.892417886428248e-11
, O 0 5.548076392427508e-15
most O 0 2.691998608349202e-15
likely O 0 1.8781803640555844e-13
through O 0 3.1159295457853554e-16
a O 0 5.234211298437742e-15
direct O 0 4.313505932648787e-13
interaction O 0 1.1410654365828776e-10
with O 0 4.52896248281931e-10
SF O 1 0.9999065399169922
- O 0 0.060933668166399
1 O 0 8.368192250252093e-10
. O 0 2.5713264850679707e-11

We O 0 2.8436661358988147e-10
propose O 0 9.616453466865238e-11
that O 0 1.0168187364149872e-13
WT1 O 0 1.5648281559421662e-09
and O 0 3.1468139725931987e-12
Dax O 0 0.0003618873015511781
- O 0 3.7398908716568258e-06
1 O 0 2.283313945902754e-12
functionally O 0 1.1950157660298166e-12
oppose O 0 3.23447887397299e-12
each O 0 1.4948476755472645e-13
other O 0 2.6866809355063394e-14
in O 0 4.5693873354122824e-14
testis O 0 5.086155455136243e-11
development O 0 1.130920698207789e-14
by O 0 1.3283739884982493e-13
modulating O 0 5.265652447405955e-08
SF O 1 0.8410731554031372
- O 0 0.00012203579535707831
1 O 0 6.745818348363741e-10
- O 0 4.154634680730851e-08
mediated O 0 1.5011365483985628e-09
transactivation O 0 3.97302493126972e-08
. O 0 1.6837707443595473e-12
. O 0 2.025900280866466e-12

A O 0 5.171525013780709e-11
mouse O 0 1.7803331031629455e-09
model O 0 1.2894145307029703e-08
for O 0 7.150701009095428e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9456627368927002
- O 0 0.2679176926612854
centre O 0 2.181897684749856e-08
mutations O 0 3.3238731589335657e-07
. O 0 1.6278520198476087e-10

Imprinting O 0 3.768134035908588e-07
in O 0 1.771483827683884e-11
the O 0 3.668625733060926e-13
15q11 O 0 4.8586663581318135e-09
- O 0 1.1902983487743768e-07
q13 O 0 4.336050629660804e-09
region O 0 1.0340431289002083e-10
involves O 0 7.906202602325774e-12
an O 0 2.2471233519240873e-14
imprinting O 0 1.0269423089681595e-09
centre O 0 4.802881009569049e-11
( O 0 1.1151216702690123e-14
IC O 0 9.031366149728215e-13
) O 0 1.565719015417656e-15
, O 0 1.1335888255218604e-16
mapping O 0 1.3796848863031896e-12
in O 0 8.313734764639133e-14
part O 0 1.8646024936737338e-13
to O 0 6.655629281211717e-13
the O 0 1.5320959832840902e-13
promoter O 0 5.070597808298771e-07
and O 0 4.502174674736459e-11
first O 0 3.1348309907121286e-13
exon O 0 1.98275718760188e-11
of O 0 1.4098785073440867e-12
SNRPN O 0 7.479000487364829e-06
. O 0 1.7236262417341663e-10

Deletion O 0 5.542850090023421e-08
of O 0 1.6759783665054595e-12
this O 0 3.2489329694455893e-13
IC O 0 4.77832218237495e-10
abolishes O 0 4.338317705077088e-09
local O 0 2.486952484226368e-12
paternally O 0 4.568185274500536e-10
derived O 0 3.3055014888455636e-13
gene O 0 1.7102675178848337e-11
expression O 0 4.4879596566849145e-11
and O 0 1.0226346679187426e-12
results O 0 6.434965338364407e-10
in O 0 5.994793355057482e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.6970745946309762e-06
PWS B-Disease 1 0.9999914169311523
) O 0 3.969006789894536e-10
. O 0 1.0294991248382956e-10

We O 0 1.3120400765842533e-08
have O 0 5.091400933666945e-13
created O 0 8.397147181152947e-14
two O 0 8.944169020599479e-15
deletion O 0 9.735303535540751e-11
mutations O 0 7.204129293114647e-09
in O 0 1.319392945592357e-12
mice O 0 1.558257745060132e-09
to O 0 3.240037405038976e-11
understand O 0 1.1056886251026299e-05
PWS B-Disease 1 0.9999998807907104
and O 0 1.503835389549124e-10
the O 0 9.326867484718213e-14
mechanism O 0 6.88789303371351e-12
of O 0 1.1717041487719574e-14
this O 0 2.7541377923927246e-13
IC O 0 3.868687870056675e-10
. O 0 9.78354810360349e-12

Mice O 0 4.473114586289739e-06
harbouring O 0 8.245095841630246e-07
an O 0 3.283733690778029e-13
intragenic O 0 1.6678571057582303e-07
deletion O 0 1.262501712062658e-07
in O 0 1.6251933132593877e-10
Snrpn O 0 3.2864649256225675e-05
are O 0 5.507730382880993e-10
phenotypically O 0 3.65649111699895e-06
normal O 0 2.7891926546175227e-09
, O 0 1.2466589413074377e-14
suggesting O 0 5.578031439523734e-11
that O 0 1.466085689265026e-13
mutations O 0 9.969472296311732e-12
of O 0 3.969193426218336e-15
SNRPN O 0 3.20845110479695e-08
are O 0 3.328009796996906e-13
not O 0 1.581031312813952e-13
sufficient O 0 1.8079803062662214e-12
to O 0 3.438280909984215e-12
induce O 0 5.031176328884612e-07
PWS B-Disease 1 0.9999995231628418
. O 0 8.298293607822416e-09

Mice O 0 3.471391892162501e-06
with O 0 5.223425858513764e-13
a O 0 1.4106174995448528e-13
larger O 0 9.92249793614619e-13
deletion O 0 7.005850344299347e-10
involving O 0 7.249198463732398e-10
both O 0 2.869253662787785e-12
Snrpn O 0 1.3687477462553943e-07
and O 0 3.312420433429497e-12
the O 0 8.587156593437006e-13
putative O 0 6.931279017408087e-08
PWS O 1 0.9999970197677612
- O 0 2.178680460929172e-06
IC O 0 4.364294703407268e-09
lack O 0 4.3182871167779524e-10
expression O 0 8.980912125089446e-10
of O 0 8.692601759924257e-14
the O 0 4.782016254332999e-13
imprinted O 0 1.684532158208185e-08
genes O 0 2.3434887710949148e-11
Zfp127 O 0 3.533475734229796e-10
( O 0 1.8988333990018966e-14
mouse O 0 6.33316801779138e-11
homologue O 0 2.2530548260402128e-10
of O 0 8.746591233406431e-13
ZNF127 O 0 2.0366730950627243e-06
) O 0 4.673781435655944e-13
, O 0 1.2544394471477368e-14
Ndn O 0 8.832316128470907e-11
and O 0 3.5197905787903716e-12
Ipw O 0 4.155161770214022e-10
, O 0 2.28121579785856e-12
and O 0 3.013700053400292e-11
manifest O 0 5.373515868378753e-11
several O 0 4.281193184251658e-14
phenotypes O 0 2.677974952902673e-09
common O 0 5.553352777631915e-10
to O 0 2.010313835398847e-07
PWS B-Disease 1 1.0
infants O 1 0.7133804559707642
. O 0 1.223043888387565e-09

These O 0 3.6367173920741347e-13
data O 0 3.8082896753645346e-13
demonstrate O 0 1.8193823184131652e-12
that O 0 1.666401290231507e-14
both O 0 3.2639377854117024e-14
the O 0 1.309696573198113e-13
position O 0 6.0458775763549966e-09
of O 0 2.7360610505071338e-15
the O 0 4.079270439911716e-15
IC O 0 1.7860545941522643e-12
and O 0 5.813628251765193e-14
its O 0 3.8603619215343344e-16
role O 0 7.074753109737042e-13
in O 0 5.481748884569697e-14
the O 0 6.733101320141165e-15
coordinate O 0 5.0226156567134694e-11
expression O 0 7.006437652279374e-10
of O 0 1.4512401154929966e-13
genes O 0 1.0810578994491227e-11
is O 0 3.09147781159258e-14
conserved O 0 2.93141921327289e-12
between O 0 8.257695064848788e-14
mouse O 0 1.1281013900799053e-09
and O 0 3.9410352759006173e-10
human O 0 6.889158687961583e-11
, O 0 2.072660890573702e-13
and O 0 6.834447938142141e-12
indicate O 0 2.409769495059777e-09
that O 0 8.097795979773725e-13
the O 0 1.0176912819946128e-14
mouse O 0 3.27783633569112e-11
is O 0 1.7022014765603888e-13
a O 0 4.515667743567762e-15
suitable O 0 2.7714460934524787e-11
model O 0 3.9846419497280294e-09
system O 0 6.666295987445281e-11
in O 0 2.161879616296991e-13
which O 0 2.4976170830419593e-14
to O 0 1.6007959203128775e-15
investigate O 0 3.963580505472741e-11
the O 0 6.265803847993467e-13
molecular O 0 7.37594776922812e-11
mechanisms O 0 3.0361132444950423e-12
of O 0 2.566431267874672e-15
imprinting O 0 1.0236724801160335e-09
in O 0 2.7536193811239507e-12
this O 0 4.278762674031489e-13
region O 0 1.118920581189009e-10
of O 0 1.679427132300973e-13
the O 0 2.0378823953857983e-13
genome O 0 5.109564030561509e-13
. O 0 1.629104566091416e-13
. O 0 1.6499097010500008e-12

Mutations O 0 3.219461746084562e-07
of O 0 1.2181785528225797e-12
the O 0 9.234185139629647e-14
ATM O 0 8.785326910398794e-10
gene O 0 8.373977067321903e-09
detected O 0 0.00020309789397288114
in O 0 5.0878972146506385e-09
Japanese O 1 0.9997846484184265
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.0003327441227156669
: O 0 9.44697228430491e-13
possible O 0 6.914755768840097e-13
preponderance O 0 3.080976584968198e-10
of O 0 1.0163902055063123e-13
the O 0 3.1280460535167143e-13
two O 0 9.649014443349757e-14
founder O 0 3.605762173217175e-12
mutations O 0 1.0078110568301213e-10
4612del165 O 0 6.919182587994399e-11
and O 0 2.6719759217697092e-12
7883del5 O 0 1.5360082095128291e-09
. O 0 2.851056196684354e-11

The O 0 9.299096215276137e-12
ATM O 0 2.4992782954313952e-08
( O 0 1.2062154608472042e-09
A O 1 0.9999998807907104
- O 1 1.0
T O 1 1.0
, O 0 1.3241407102737579e-11
mutated O 0 3.181620591985457e-11
) O 0 3.976331372864848e-15
gene O 0 6.942339498411387e-12
on O 0 1.4561938460611046e-11
human O 0 3.520893299135963e-11
chromosome O 0 1.9515288940397113e-08
11q22 O 0 2.76822760270079e-08
. O 0 1.2848959396460913e-10

3 O 0 1.6291894056053025e-08
has O 0 1.1782728959186528e-10
recently O 0 9.549524504492979e-10
been O 0 9.868182659911184e-12
identified O 0 2.5659665364718975e-11
as O 0 6.793912780039867e-15
the O 0 1.4079892516007293e-16
gene O 0 4.55591612341915e-14
responsible O 0 2.537777659458035e-13
for O 0 1.6114935229202257e-15
the O 0 8.642118054166814e-13
human O 0 3.236087309232971e-07
recessive B-Disease 1 0.9999828338623047
disease I-Disease 1 0.9999977350234985
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.5131886601448059
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.873379560483727e-10
. O 0 3.943672471917736e-11

In O 0 1.4828201166938726e-11
order O 0 1.678933820312492e-13
to O 0 5.463770779670814e-15
define O 0 3.961137407665349e-12
the O 0 7.708447731036641e-14
types O 0 3.572881368540948e-08
of O 0 1.9578501320172137e-10
disease O 0 0.050859320908784866
- O 0 8.859915396897122e-06
causing O 0 8.175361720930141e-09
ATM O 0 1.2589303821641806e-08
mutations O 0 5.5603326387654306e-08
in O 0 5.732777967615288e-12
Japanese O 0 1.1030588211724535e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.2422458439687034e-07
as O 0 3.6807652737357033e-13
well O 0 2.4544355805601603e-13
as O 0 6.587071993001577e-15
to O 0 2.6462224067807377e-15
look O 0 6.711224891792211e-12
for O 0 4.869392302231184e-16
possible O 0 8.829865007567439e-13
mutational O 0 4.336976999752551e-09
hotspots O 0 1.9920605442980133e-10
, O 0 2.862931381764425e-14
reverse O 0 9.357213892613458e-10
- O 0 4.4160319845332197e-10
transcribed O 0 3.4016932066310845e-12
RNA O 0 8.154243881682011e-13
derived O 0 2.271739145810834e-14
from O 0 4.732938894318542e-15
ten O 0 1.1299079347940749e-13
patients O 0 2.0051927850897773e-14
belonging O 0 7.595924215141048e-13
to O 0 1.1264011641823335e-12
eight O 0 1.1930913071736549e-12
unrelated O 0 2.1036752340108933e-09
Japanese O 0 0.03342065587639809
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
families O 0 4.464032199447132e-10
was O 0 1.0657683936765583e-11
analyzed O 0 4.122373883225228e-12
for O 0 2.5542032884898723e-15
mutations O 0 1.2985537124754476e-12
by O 0 5.156972693318228e-16
the O 0 1.0334331352094498e-15
restriction O 0 4.171344530640858e-14
endonuclease O 0 5.929733700588136e-12
fingerprinting O 0 2.4721650074277512e-11
method O 0 1.7552122949515692e-11
. O 0 1.3766495755851427e-11

As O 0 2.197687448690644e-10
has O 0 4.758655622327801e-11
been O 0 6.708729492072019e-12
reported O 0 4.958186292092215e-11
by O 0 7.512882731295495e-14
others O 0 1.8619638816885775e-11
, O 0 1.5529605392979907e-14
mutations O 0 5.170437862578314e-12
that O 0 3.014711596747749e-15
lead O 0 2.5263366160328815e-13
to O 0 4.614419926756352e-15
exon O 0 1.0133004851864413e-10
skipping O 0 1.3842259560803427e-09
or O 0 2.2429198498485903e-09
premature O 0 1.0756162627245658e-10
protein O 0 3.0360653227590184e-13
truncation O 0 6.860546852838212e-11
were O 0 1.3727572412136624e-09
also O 0 3.2099461977352917e-11
predominant O 0 2.987208347349224e-07
in O 0 9.701937170314423e-11
our O 0 6.052127687894426e-10
mutants O 0 1.9273568852007372e-10
. O 0 8.051810954090577e-12

Six O 0 2.3705221119385556e-10
different O 0 3.8914165401311707e-13
mutations O 0 1.09553879856783e-10
were O 0 9.722305426007605e-13
identified O 0 5.596555996412178e-10
on O 0 5.706459194065872e-10
12 O 0 2.64328055971097e-12
of O 0 1.5858872510566072e-14
the O 0 2.3217673443542974e-12
16 O 0 1.2287290976353837e-11
alleles O 0 4.24926066555642e-11
examined O 0 8.50260732931929e-08
. O 0 1.2941295812751719e-09

Four O 0 2.0705808595478103e-11
were O 0 3.7321576086763245e-14
deletions O 0 3.199798759290218e-11
involving O 0 6.124192264422845e-10
a O 0 1.8912873489540516e-09
loss O 0 1.3589813079306623e-06
of O 0 1.2458893779935393e-13
a O 0 8.347269923880685e-12
single O 0 3.8378128452976057e-10
exon O 0 1.054490605945091e-09
exon O 0 6.4645919728434365e-09
7 O 0 6.735944579894237e-10
, O 0 1.4610657654437822e-14
exon O 0 2.9219604513741615e-10
16 O 0 2.5528884561865084e-11
, O 0 6.1210471709164695e-15
exon O 0 2.267527277055592e-10
33 O 0 4.699673636365809e-11
or O 0 4.0680740026610707e-11
exon O 0 5.628548649383447e-08
35 O 0 2.948082666875962e-09
. O 0 3.52900347833085e-10

The O 0 3.1940672329255904e-11
others O 0 9.3834766345946e-12
were O 0 2.2964318502891913e-14
minute O 0 1.4626529696616652e-13
deletions O 0 4.1736270689485266e-11
, O 0 1.1187604391071221e-14
4649delA O 0 1.8012074470830086e-11
in O 0 4.90909599754584e-14
exon O 0 1.1098213320570594e-10
33 O 0 7.947235751426529e-12
and O 0 1.6470067768382252e-13
7883del5 O 0 9.132066630668234e-11
in O 0 3.4724727433765867e-12
exon O 0 1.0186382404242522e-08
55 O 0 5.395311419853499e-10
. O 0 1.1415814127335722e-10

The O 0 2.8213145361610792e-11
mutations O 0 1.283845585398069e-09
4612del165 O 0 1.7771702165436665e-10
and O 0 5.384159914786912e-13
7883del5 O 0 1.0874217498679783e-10
were O 0 1.2143861437274861e-11
found O 0 8.84369053683054e-12
in O 0 9.075018839697913e-13
more O 0 6.401239401824382e-14
than O 0 1.6781846366113046e-13
two O 0 2.451279679794292e-15
unrelated O 0 1.1031659526844484e-12
families O 0 6.013679815621356e-15
; O 0 2.924800796402159e-16
44 O 0 2.864426564322918e-15
% O 0 3.6699095808990796e-15
( O 0 1.327109537714588e-14
7 O 0 1.1600846151760269e-11
of O 0 5.324630168203337e-13
16 O 0 2.9259786867713578e-12
) O 0 3.67641098228573e-15
of O 0 9.746394771976974e-15
the O 0 1.663499524760803e-13
mutant O 0 1.1006114075673423e-10
alleles O 0 2.3704167101401552e-11
had O 0 8.229095738165881e-10
one O 0 1.098336577395019e-13
of O 0 2.5836213780227246e-15
the O 0 6.138237026954638e-14
two O 0 9.570369670364176e-13
mutations O 0 2.3523671899283727e-09
. O 0 3.348311558570849e-11

The O 0 3.4877927369142414e-12
4612del165 O 0 6.15771489353989e-10
mutations O 0 4.891452576316624e-09
in O 0 1.2840689882914758e-12
three O 0 1.9467790213548684e-14
different O 0 4.177873799411473e-14
families O 0 7.966413986815191e-13
were O 0 1.2485352378702186e-12
all O 0 4.928391323380998e-15
ascribed O 0 8.668813280057752e-13
to O 0 7.594761001735242e-14
the O 0 1.6966973887064946e-13
same O 0 1.0604097461230921e-10
T O 0 2.800372556066577e-08
- O 0 8.480912083719261e-10
- O 0 6.171445993130575e-11
> O 0 1.6370216136428126e-14
A O 0 1.6885085113416652e-15
substitution O 0 1.8009573866939466e-14
at O 0 1.6821254404577463e-14
the O 0 3.1647567600298296e-16
splice O 0 1.3762629274063909e-12
donor O 0 3.767752169286931e-12
site O 0 5.6627182110080554e-11
in O 0 5.416154070375656e-12
intron O 0 9.553649249482987e-08
33 O 0 4.986082213775944e-09
. O 0 6.290489656946008e-11

Microsatellite O 0 1.9731228348973673e-06
genotyping O 0 4.428401894074341e-07
around O 0 2.425747103185216e-10
the O 0 2.2502556458817158e-13
ATM O 0 1.0632822400324926e-09
locus O 0 1.8059298056982698e-08
also O 0 6.801229579522783e-10
indicated O 0 3.8377882560780563e-07
that O 0 5.432042077431476e-13
a O 0 8.960908593922887e-14
common O 0 2.0312465359891008e-13
haplotype O 0 1.1713334469032333e-10
was O 0 7.748019240083615e-12
shared O 0 9.357908192916473e-14
by O 0 3.717804211868627e-15
the O 0 2.413816217218534e-14
mutant O 0 1.0549562959316638e-11
alleles O 0 3.150086962111498e-12
in O 0 1.494021811647428e-12
both O 0 3.42888976760658e-12
mutations O 0 1.4318434438109762e-08
. O 0 4.191704622291681e-11

This O 0 1.0514910123160526e-11
suggests O 0 1.8694698566967816e-10
that O 0 1.4769926275949585e-13
these O 0 1.1573511754807333e-14
two O 0 1.2265168366349093e-14
founder O 0 6.090802862068756e-11
mutations O 0 5.335878228152069e-08
may O 0 1.1711038805373164e-09
be O 0 1.065912115516543e-12
predominant O 0 5.21169052358772e-10
among O 0 4.632573621585201e-13
Japanese O 0 9.188278471405908e-10
ATM O 0 1.1402240263080898e-09
mutant O 0 7.202092255909065e-10
alleles O 0 3.933407377587628e-09
. O 0 2.1347572320973285e-10

W474C O 0 2.44506885849205e-08
amino O 0 1.3225663619831352e-10
acid O 0 5.359858390452388e-12
substitution O 0 3.2646614903618365e-13
affects O 0 2.6295813942110724e-13
early O 0 2.0048016252747353e-15
processing O 0 1.655017167420409e-14
of O 0 1.226689313718794e-15
the O 0 9.283415033337246e-15
alpha O 0 1.0276475444258651e-13
- O 0 4.690921696220984e-12
subunit O 0 1.4183253638395954e-13
of O 0 2.4748551054635734e-14
beta O 0 5.25961652703133e-13
- O 0 2.4174067192461735e-09
hexosaminidase O 0 1.8734507278850288e-09
A O 0 5.973290004984699e-12
and O 0 1.31909847628231e-12
is O 0 2.859527122468092e-13
associated O 0 1.3870822546113715e-10
with O 0 3.290960212676275e-11
subacute O 0 3.7461348256329075e-05
G B-Disease 0 1.0706551620387472e-05
( I-Disease 0 1.033564943700438e-12
M2 I-Disease 0 3.4256584058312e-07
) I-Disease 0 1.404332483634363e-10
gangliosidosis I-Disease 0 1.5493429600610398e-05
. O 0 1.2790575265597681e-09

Mutations O 0 1.7150125131593086e-05
in O 0 7.214256275700492e-11
the O 0 6.993770254766496e-13
HEXA O 0 4.59721789525247e-08
gene O 0 3.306009285775069e-11
, O 0 6.491529217650133e-16
encoding O 0 8.874632697827584e-15
the O 0 7.960117482698481e-15
alpha O 0 2.765782394775762e-13
- O 0 3.2066356514537375e-11
subunit O 0 1.147811446583491e-12
of O 0 1.0389086780530216e-13
beta O 0 1.2759957153385404e-11
- O 0 1.0340505696149194e-07
hexosaminidase O 0 3.534868042720518e-08
A O 0 6.077826176370538e-12
( O 0 5.4864106998015e-15
Hex O 0 1.1810611353930273e-13
A O 0 3.206308103135408e-13
) O 0 4.868669994885413e-15
, O 0 8.741641007691252e-16
that O 0 6.465213174528363e-15
abolish O 0 2.302997376135707e-11
Hex O 0 1.8090980102858367e-12
A O 0 2.8200529476711533e-13
enzyme O 0 2.350355673974569e-11
activity O 0 4.516562412959502e-08
cause O 0 0.09613680839538574
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.978412926197052
( O 0 7.237526550296636e-13
TSD B-Disease 0 5.29262245141382e-10
) O 0 1.3982658618200833e-13
, O 0 1.268355266734883e-14
the O 0 7.613213445084588e-13
fatal O 0 3.357654713909142e-05
infantile B-Disease 0 0.00012859261187259108
form I-Disease 0 1.1171133351695062e-08
of I-Disease 0 2.3705207935487138e-11
G I-Disease 0 5.550223818318045e-07
( I-Disease 0 5.224080784388581e-14
M2 I-Disease 0 7.781012278940125e-09
) I-Disease 0 1.4478015140928502e-12
gangliosidosis I-Disease 0 1.829748441650736e-07
, I-Disease 0 1.502457663490886e-12
Type I-Disease 0 3.4578803820295434e-07
1 I-Disease 0 7.737188112422189e-10
. O 0 4.708621270665958e-10

Less O 0 7.919771150000088e-08
severe O 0 4.390679168864153e-05
, O 0 1.5806109893157227e-11
subacute O 0 5.0431888666935265e-05
( O 0 2.4341870186184167e-10
juvenile O 0 0.26279741525650024
- O 0 0.48323389887809753
onset O 0 4.754925157612888e-06
) O 0 4.83912188098401e-10
and O 0 4.7933792046706e-08
chronic O 0 0.0020429068244993687
( O 0 2.2617210188036196e-11
adult O 0 0.00021108724467922002
- O 1 0.5798907279968262
onset O 0 3.317618677556311e-07
) O 0 1.6184998491170638e-13
variants O 0 6.524934672430538e-12
are O 0 1.2726548059751458e-13
characterized O 0 4.332503323115078e-13
by O 0 2.3679627662452803e-15
a O 0 3.5253568862964393e-14
broad O 0 7.670393183459301e-13
spectrum O 0 9.51565996137882e-12
of O 0 1.0943446127585632e-13
clinical O 0 2.5602955519565818e-11
manifestations O 0 4.310395651518917e-10
and O 0 1.0699840536157468e-12
are O 0 7.179967612212096e-14
associated O 0 9.198092287832083e-11
with O 0 9.054418326215341e-11
residual O 1 0.9980618357658386
levels O 0 0.00790876243263483
of O 0 1.801363555932814e-13
Hex O 0 1.2748377874183259e-11
A O 0 2.1708802290520968e-12
enzyme O 0 1.9737617790172024e-11
activity O 0 4.4756012784752386e-10
. O 0 1.0233727927577707e-11

We O 0 1.1799176080629081e-09
identified O 0 2.948523716850282e-11
a O 0 6.219510041531595e-13
1422 O 0 4.563780908739545e-09
G O 0 1.437862096054232e-07
- O 0 5.178195578992018e-07
- O 0 8.872546004567994e-07
> O 0 7.020751757735866e-10
C O 0 8.184796729260313e-10
( O 0 1.3126061948994026e-15
amino O 0 7.061776361697199e-15
acid O 0 3.3683408642046046e-15
W474C O 0 2.5356026567264047e-15
) O 0 1.799030978338517e-18
substitution O 0 3.7593887120789253e-16
in O 0 6.579358593346524e-16
the O 0 1.342150809978751e-15
first O 0 3.1341254461483836e-13
position O 0 3.549038007921723e-10
of O 0 2.6966854534045967e-15
exon O 0 1.1803535926446784e-10
13 O 0 2.15066939951436e-12
of O 0 2.9800001442176205e-14
HEXA O 0 7.052054797895835e-07
of O 0 1.305459971893963e-12
a O 0 3.701172701653377e-10
non O 0 6.294087597780162e-07
- O 0 1.1098404684162233e-05
Jewish O 0 2.4584512203773556e-09
proband O 0 9.368432074552402e-05
who O 0 2.832446277523104e-09
manifested O 0 3.306370177647011e-10
a O 0 1.391455744029213e-12
subacute O 0 1.382893977108779e-08
variant O 0 4.703985467813254e-08
of O 0 2.81412376040846e-11
G B-Disease 0 4.930458544549765e-06
( I-Disease 0 3.773561324527108e-13
M2 I-Disease 0 2.4241637675004313e-07
) I-Disease 0 5.768306665654421e-11
gangliosidosis I-Disease 0 1.7959078832063824e-05
. O 0 9.264901068561926e-10

On O 0 2.1548267337134774e-10
the O 0 4.9473107902042734e-12
second O 0 9.46115408240189e-11
maternally O 0 2.0322825093899155e-06
inherited O 0 2.9989911354277865e-07
allele O 0 1.041237762677838e-09
, O 0 7.222023136856451e-14
we O 0 3.468664429035623e-13
identified O 0 1.9499699164399198e-12
the O 0 1.967948373704509e-13
common O 0 2.1200380118102657e-08
infantile O 1 0.9876075387001038
disease O 1 0.9987406134605408
- O 0 0.05554373562335968
causing O 0 1.5872614312684163e-05
4 O 0 1.6561266802384011e-09
- O 0 9.007404173644318e-07
bp O 0 7.03600733231724e-10
insertion O 0 9.07107809006158e-12
, O 0 8.60904500899623e-14
+ O 0 2.9799630645033215e-12
TATC O 0 2.551931999050794e-09
1278 O 0 8.807810036870478e-10
, O 0 1.157201640284225e-13
in O 0 5.327362899779087e-13
exon O 0 7.528278445079195e-09
11 O 0 7.706494331571889e-10
. O 0 1.53124457558107e-11

Pulse O 0 1.4693511730001774e-05
- O 0 1.4300202799688577e-08
chase O 0 1.1490677853664977e-10
analysis O 0 3.2051707750564706e-13
using O 0 8.020901244619807e-14
proband O 0 9.594766092746454e-10
fibroblasts O 0 1.918092247532588e-11
revealed O 0 4.365690864371885e-10
that O 0 1.649470795681788e-14
the O 0 2.6567616142269494e-15
W474C O 0 1.7850032216215617e-11
- O 0 7.977046106999452e-12
containing O 0 1.6939554414122787e-13
alpha O 0 2.4987272044226308e-14
- O 0 7.529598689340333e-13
subunit O 0 2.7419972691597287e-14
precursor O 0 1.1568750243797638e-13
was O 0 1.2739044194520766e-11
normally O 0 1.351858485180643e-13
synthesized O 0 1.625932055009452e-13
, O 0 2.5929602868431177e-16
but O 0 1.756592680828787e-14
not O 0 1.5100687390248117e-15
phosphorylated O 0 3.630886688315779e-14
or O 0 2.5640546204796187e-14
secreted O 0 2.9819004795754445e-13
, O 0 1.3059242272642213e-14
and O 0 1.2686517418189491e-12
the O 0 1.6663489164903122e-12
mature O 0 1.4633675382569322e-09
lysosomal O 0 2.3427215722904293e-10
alpha O 0 6.650401258335992e-13
- O 0 4.5801118453425715e-10
subunit O 0 3.7544663558652935e-12
was O 0 5.966739990981296e-09
not O 0 3.3493480211532756e-10
detected O 0 1.3661527020758513e-07
. O 0 2.1414850795431484e-11

When O 0 2.3209416333269672e-10
the O 0 1.2009422861551655e-13
W474C O 0 5.166282956992063e-10
- O 0 2.633590567846511e-10
containing O 0 9.80360432591143e-13
alpha O 0 9.73982613311497e-13
- O 0 1.2061643350769202e-10
subunit O 0 1.2817957415964254e-12
was O 0 3.162773515308359e-11
transiently O 0 4.177531376381438e-10
co O 0 3.2489646528688354e-09
- O 0 1.6383564505062509e-09
expressed O 0 2.236683494666325e-12
with O 0 9.357117911176684e-15
the O 0 7.708857017356754e-15
beta O 0 3.510668318551513e-14
- O 0 4.595797267054058e-12
subunit O 0 6.409278083307005e-14
to O 0 1.7297395341151628e-13
produce O 0 3.464452845696603e-13
Hex O 0 2.1785954117115036e-12
A O 0 1.282194294315031e-12
( O 0 6.059018948189037e-15
alphabeta O 0 1.4887892307857697e-10
) O 0 3.378805278641574e-14
in O 0 3.895932242179573e-13
COS O 0 2.763657107607287e-07
- O 0 7.321447128560976e-07
7 O 0 1.1048341928832084e-11
cells O 0 3.8065995668079555e-12
, O 0 2.365317482351005e-15
the O 0 8.62386520566116e-15
mature O 0 2.696077736064062e-12
alpha O 0 2.0390778722765646e-15
- O 0 3.380600487046248e-12
subunit O 0 6.778242246999189e-14
was O 0 6.975525712604735e-11
present O 0 7.662365208473132e-13
, O 0 7.428821995763852e-15
but O 0 1.525619501606748e-13
its O 0 6.834176914704074e-15
level O 0 8.556277214522012e-12
was O 0 1.4460738379309945e-12
much O 0 5.375696415788056e-12
lower O 0 4.873381559411527e-11
than O 0 2.867010665333347e-12
that O 0 3.4696106664816595e-13
from O 0 4.313160343206307e-13
normal O 0 1.480951212357029e-12
alpha O 0 6.499138961648266e-15
- O 0 1.5167245714584054e-12
subunit O 0 3.4440120348552252e-15
transfections O 0 1.3420741080960585e-11
, O 0 2.0635615184356278e-16
although O 0 1.3364752657156736e-14
higher O 0 4.375297867065253e-12
than O 0 1.397561943559597e-13
in O 0 6.162076057747434e-13
those O 0 1.666454647886173e-11
cells O 0 7.460920986926411e-13
transfected O 0 9.085744309689225e-12
with O 0 1.3056203965460412e-14
an O 0 9.114977449578045e-15
alpha O 0 6.933509755918665e-13
- O 0 5.314325690619626e-08
subunit O 0 3.6724519258957145e-11
associated O 0 1.1088728513186652e-07
with O 0 7.25219939656796e-10
infantile O 0 0.009471137076616287
TSD B-Disease 0 1.1071774679294322e-05
. O 0 6.490223913857562e-10

Furthermore O 0 2.8397273421632008e-09
, O 0 5.588842648222847e-14
the O 0 1.0621296585503598e-15
precursor O 0 3.4869129068512694e-13
level O 0 1.4181625318521185e-10
of O 0 2.2793595200724546e-15
the O 0 8.765855032675293e-15
W474C O 0 6.70054506671236e-12
alpha O 0 2.9558959582310154e-14
- O 0 1.3247943323954625e-12
subunit O 0 6.606502589998411e-14
was O 0 8.093414827214929e-12
found O 0 3.633096766681755e-14
to O 0 1.5649555422706483e-14
accumulate O 0 1.4351961459546647e-11
in O 0 5.749884533209687e-15
comparison O 0 3.728317567869288e-13
to O 0 1.2040661436646394e-13
the O 0 1.3052781511896372e-12
normal O 0 1.5874762615553095e-10
alpha O 0 2.156501024844562e-13
- O 0 3.2752425771498395e-11
subunit O 0 9.049885949137526e-13
precursor O 0 1.9135793644098342e-11
levels O 0 2.06575823114008e-09
. O 0 2.049272860779605e-12

We O 0 4.4802644927344204e-10
conclude O 0 7.878864227706117e-12
that O 0 6.163597871021789e-15
the O 0 1.0143156015899202e-14
1422 O 0 2.2811497135677428e-09
G O 0 9.9500958583576e-08
- O 0 5.104565161673236e-07
- O 0 9.640806410970981e-07
> O 0 7.309999272564482e-10
C O 0 2.572933199829208e-09
mutation O 0 5.37758948482292e-10
is O 0 1.5436057380219248e-13
the O 0 8.156599480308325e-15
cause O 0 5.060528818906507e-12
of O 0 9.311717792236801e-15
Hex B-Disease 0 2.4827842559638214e-10
A I-Disease 0 5.783495993227916e-08
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 7.940446911103294e-12
the O 0 2.8072013030094878e-12
proband O 0 2.1804637526656734e-06
. O 0 9.651918847497498e-11

The O 0 2.512153245842752e-12
resulting O 0 3.5902390001923967e-12
W474C O 0 3.540078299946181e-11
substitution O 0 4.56407004204018e-12
clearly O 0 2.777055148339702e-11
interferes O 0 1.5006168183062663e-11
with O 0 9.522394156218496e-16
alpha O 0 2.2962128075690313e-14
- O 0 2.6510645892083295e-13
subunit O 0 3.617094959055406e-15
processing O 0 1.4313810553501227e-13
, O 0 2.2231804833622868e-15
but O 0 1.1567729907909375e-14
because O 0 6.3788340251167905e-15
the O 0 1.2828153843999788e-16
base O 0 2.050295087245406e-14
substitution O 0 9.557736817700918e-15
falls O 0 1.0957848343984278e-11
at O 0 1.6321338269613406e-13
the O 0 1.0327795645873484e-14
first O 0 1.3045420646506933e-11
position O 0 8.321498157215501e-09
of O 0 2.268457062546813e-14
exon O 0 1.043617747775727e-09
13 O 0 1.2124560036519405e-11
, O 0 2.61059831860159e-15
aberrant O 0 8.037046505746104e-13
splicing O 0 1.2305679045199192e-11
may O 0 3.4953500094303536e-09
also O 0 9.660763129141353e-14
contribute O 0 2.2208697554593204e-12
to O 0 2.448232372040393e-12
Hex B-Disease 0 2.0154202751143657e-09
A I-Disease 0 7.304305427169311e-08
deficiency I-Disease 0 0.020998207852244377
in O 0 2.6345462270094266e-13
this O 0 1.05655813416837e-13
proband O 0 1.6461788376886943e-08
. O 0 1.1962061115949885e-12
. O 0 1.006488902638436e-11

Two O 0 8.997504130636713e-11
frequent O 0 9.019475299965052e-08
missense O 0 0.007869078777730465
mutations O 1 0.8608450889587402
in O 0 1.4983537766966037e-05
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.1963826668525144e-07

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 4.504390290094307e-06
an O 0 2.0831444999203086e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.8302913904190063
by O 0 6.051988910016348e-10
early O 0 6.6463990151532926e-06
childhood O 1 0.9999774694442749
deafness B-Disease 1 1.0
and O 0 0.003480437910184264
goiter B-Disease 1 1.0
. O 0 1.0857093002414331e-07

A O 0 1.6090957732917133e-10
century O 0 7.722436405621647e-12
after O 0 1.4757656902064653e-12
its O 0 7.382998360350342e-15
recognition O 0 2.375203766308287e-12
as O 0 4.925335313210599e-12
a O 0 1.6602571539792166e-09
syndrome O 0 0.0515301488339901
by O 0 9.014496641550698e-14
Vaughan O 0 3.2626353008158304e-11
Pendred O 0 1.0806348704761604e-08
, O 0 2.9890751874518673e-13
the O 0 2.3790396735945407e-12
disease O 0 5.32107780060187e-09
gene O 0 3.405154977431657e-11
( O 0 1.4232302944679198e-13
PDS O 0 8.65618687839742e-10
) O 0 8.379995780410585e-14
was O 0 1.3299471766925475e-11
mapped O 0 1.3926002573327878e-08
to O 0 3.3322244269440304e-11
chromosome O 0 1.485807104018022e-07
7q22 O 0 1.8291534331638104e-07
- O 0 5.963971034361748e-06
q31 O 0 7.941098800756663e-08
. O 0 9.319981592037507e-11

1 O 0 8.236292536878409e-09
and O 0 3.929661457346967e-11
, O 0 2.3725314247935447e-13
recently O 0 2.5202584463812627e-09
, O 0 5.388635907930747e-14
found O 0 8.680374669924051e-14
to O 0 9.476196344000536e-15
encode O 0 4.0047102461450435e-13
a O 0 4.979403174509844e-12
putative O 0 2.6959751764366047e-08
sulfate O 0 4.921410891256528e-06
transporter O 0 4.5559819028540005e-08
. O 0 5.068813146991147e-10

We O 0 2.4154938049747443e-09
performed O 0 8.482116918562266e-12
mutation O 0 8.900991055327268e-12
analysis O 0 1.397700450387132e-13
of O 0 8.175596947007581e-16
the O 0 8.118417776144943e-15
PDS B-Disease 0 4.717466972614659e-10
gene O 0 7.297569493136535e-11
in O 0 6.301017867194059e-12
patients O 0 2.72272764230419e-12
from O 0 4.260975795290778e-13
14 O 0 5.893344623073005e-13
Pendred B-Disease 0 9.449215715440218e-11
families O 0 7.408478127843288e-14
originating O 0 6.449823856426173e-13
from O 0 2.392180637605934e-12
seven O 0 1.2015020055267112e-12
countries O 0 2.0060468314698349e-13
and O 0 7.174550125006729e-13
identified O 0 2.1451980469766596e-10
all O 0 4.323375858705791e-12
mutations O 0 8.358095882066152e-10
. O 0 4.5703336948310636e-12

The O 0 4.5498611822569757e-11
mutations O 0 1.6691984461303377e-09
include O 0 2.4848755865447547e-12
three O 0 6.710030751519436e-13
single O 0 1.8294536024976438e-11
base O 0 2.7178205866396077e-11
deletions O 0 1.1439359459686216e-09
, O 0 2.8213548034297653e-13
one O 0 8.671698003225557e-15
splice O 0 1.1668173371948143e-11
site O 0 3.149976113281383e-10
mutation O 0 1.8372460317550576e-06
and O 0 4.700991679262856e-11
10 O 0 7.989440706235307e-12
missense O 0 1.360797114102752e-06
mutations O 0 1.1680208444886375e-05
. O 0 7.214300823399356e-10

One O 0 7.132564538991915e-10
missense O 0 2.08563574233267e-06
mutation O 0 6.102952454511978e-08
( O 0 2.3884954886317644e-13
L236P O 0 6.479744518728126e-11
) O 0 2.2223684752274014e-13
was O 0 6.18638959504203e-11
found O 0 3.058573533332165e-11
in O 0 3.5769090055322306e-13
a O 0 9.723857596942789e-14
homozygous O 0 6.054921564135896e-10
state O 0 1.5266893652055025e-11
in O 0 6.8946103166933614e-12
two O 0 9.4955252970437e-14
consanguineous O 0 1.5976658218619377e-08
families O 0 2.6547713680158402e-11
and O 0 1.0463034952334915e-11
in O 0 4.0155942807040823e-13
a O 0 4.342414557274854e-13
heterozygous O 0 5.5192211911858635e-11
state O 0 2.056549028295329e-11
in O 0 1.0746232029235081e-11
five O 0 1.2582934639984028e-13
additional O 0 2.202729318390162e-12
non O 0 1.7753953898136388e-06
- O 0 0.005489995237439871
consanguineous O 0 0.00022160436492413282
families O 0 2.0139227174809093e-08
. O 0 1.8813599289568828e-10

Another O 0 2.5095123201701597e-10
missense O 0 1.6579942894168198e-06
mutation O 0 1.3123447217822104e-07
( O 0 2.9433516713327224e-13
T416P O 0 8.40873135010689e-11
) O 0 2.783973138825724e-13
was O 0 3.3442920654991326e-10
found O 0 1.7272168417736822e-10
in O 0 9.916538076804038e-13
a O 0 4.258138302680112e-14
homozygous O 0 1.6528438340213114e-10
state O 0 3.6512334822269565e-11
in O 0 4.086129438279906e-12
one O 0 4.023199687893525e-13
family O 0 4.6800213010511627e-11
and O 0 3.755594446541721e-10
in O 0 1.737464555909285e-12
a O 0 1.7738563439298471e-12
heterozygous O 0 3.6630096178491556e-10
state O 0 5.685339421468427e-10
in O 0 5.377865930356052e-10
four O 0 9.692979925646217e-12
families O 0 1.6021675305899485e-11
. O 0 3.180358754129031e-11

Pendred B-Disease 0 8.12467624200508e-05
patients O 0 1.602503942876865e-07
in O 0 1.4390261204866306e-10
three O 0 1.8231140555546865e-11
non O 0 4.0891472963267006e-07
- O 0 3.0148201403790154e-05
consanguineous O 0 0.0001817751326598227
families O 0 4.546898857427095e-09
were O 0 1.199780379212978e-11
shown O 0 5.576861542011535e-11
to O 0 1.593316136579842e-13
be O 0 1.3438614370614443e-12
compound O 0 2.2700044968737565e-12
heterozygotes O 0 5.6467230197254636e-11
for O 0 1.689888497419332e-14
L236P O 0 1.1162900465100378e-10
and O 0 6.965444714068791e-12
T416P O 0 2.5380393342544494e-09
. O 0 4.640324929860995e-11

In O 0 1.8829322823155081e-10
total O 0 2.3593555494721974e-12
, O 0 3.290064008449993e-14
one O 0 1.1540937747567953e-13
or O 0 1.2100348500965197e-11
both O 0 8.949024789435545e-13
of O 0 2.2110331415140655e-13
these O 0 2.770186857681267e-12
mutations O 0 1.0323818189217349e-10
were O 0 2.4998310713120198e-12
found O 0 2.2792162254758885e-11
in O 0 1.0944793682465814e-11
nine O 0 8.16009315240257e-13
of O 0 1.9955171277332914e-14
the O 0 8.790011253589913e-12
14 O 0 2.6624485602311232e-11
families O 0 2.534702265785671e-12
analyzed O 0 9.121313704341105e-10
. O 0 2.0320169158427603e-10

The O 0 5.854491154019814e-13
identification O 0 1.5900876101926364e-11
of O 0 3.173391657416112e-14
two O 0 1.0212853105524486e-13
frequent O 0 3.0279403429034346e-09
PDS B-Disease 0 2.2622155029239366e-06
mutations O 0 1.2919994851756655e-08
will O 0 8.526243811457154e-14
facilitate O 0 2.8059938270499907e-14
the O 0 1.4131407090507697e-13
molecular O 0 6.803908547681203e-08
diagnosis O 0 1.894009801617358e-05
of O 0 6.759179314030916e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.8937671459061676e-07

Insertional O 0 2.49672552854463e-06
mutation O 0 2.6079302273274152e-08
by O 0 1.6454996002931987e-13
transposable O 0 1.5715677648131532e-08
element O 0 2.195585269149092e-09
, O 0 7.539194285142645e-14
L1 O 0 2.3705221119385556e-10
, O 0 6.94423969824394e-14
in O 0 1.1655749336623306e-13
the O 0 1.2410943583604506e-12
DMD B-Disease 1 0.9999959468841553
gene O 0 2.9381408417350485e-09
results O 0 1.0811846973268757e-09
in O 0 4.880339188328975e-11
X B-Disease 1 0.9999923706054688
- I-Disease 1 0.9999997615814209
linked I-Disease 1 0.9999996423721313
dilated I-Disease 1 0.9999936819076538
cardiomyopathy I-Disease 1 1.0
. O 0 1.994321365828e-07

X B-Disease 1 0.9999946355819702
- I-Disease 1 0.9999997615814209
linked I-Disease 1 0.9999988079071045
dilated I-Disease 1 0.9999988079071045
cardiomyopathy I-Disease 1 1.0
( O 0 3.6989584728530644e-09
XLDCM B-Disease 0 9.19869762583403e-06
) O 0 2.1277254860351674e-13
is O 0 3.4029484281437525e-14
a O 0 8.823059063954933e-14
clinical O 0 3.49469342353359e-11
phenotype O 0 7.056758510870509e-10
of O 0 2.999594049166686e-14
dystrophinopathy B-Disease 0 2.1782482235721545e-06
which O 0 7.671699213396277e-12
is O 0 1.3949892673295605e-13
characterized O 0 8.816099434684477e-13
by O 0 1.4313264386656838e-13
preferential O 0 5.15819458257738e-08
myocardial B-Disease 0 9.821941603149753e-06
involvement I-Disease 0 6.8691425880729184e-09
without O 0 3.012200211482963e-11
any O 0 9.340758418477368e-13
overt O 0 5.656462853664834e-09
clinical O 0 1.1675442834757632e-09
signs O 0 5.023197857667583e-08
of O 0 1.1839280666947616e-09
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 2.63417350652162e-05

To O 0 1.7632315746363147e-11
date O 0 3.31011218435151e-10
, O 0 3.818111971064849e-15
several O 0 3.854154070003467e-15
mutations O 0 1.159291662666817e-09
in O 0 3.1905461345821395e-12
the O 0 1.789124959294952e-10
Duchenne B-Disease 0 0.05736207589507103
muscular I-Disease 0 5.899836833123118e-05
dystrophy I-Disease 0 6.546914846694563e-06
gene O 0 8.648683547107794e-07
, O 0 7.897495157838108e-11
DMD O 1 0.9999998807907104
, O 0 2.485910262362001e-11
have O 0 3.190426048349515e-11
been O 0 2.5963420649532942e-11
identified O 0 4.976403289447262e-08
in O 0 2.2183993531044166e-10
patients O 0 7.383431539775831e-12
with O 0 8.082761754823684e-14
XLDCM B-Disease 0 1.3000653780181892e-05
, O 0 6.049267532205749e-13
but O 0 3.688355231044188e-13
a O 0 1.1554190933280462e-14
pathogenic O 0 3.4760128803101864e-11
correlation O 0 4.221652324595815e-13
of O 0 2.8454657317986305e-15
these O 0 9.87623204789026e-14
cardiospecific O 0 1.949162964365314e-08
mutations O 0 2.3513457847457175e-08
in O 0 1.8656574549136273e-11
DMD O 1 0.9999996423721313
with O 0 3.225736301334936e-12
the O 0 7.112247422946805e-12
XLDCM B-Disease 0 0.001065578660927713
phenotype O 0 1.450998297514161e-06
has O 0 6.939804841898933e-10
remained O 0 2.0227364228020406e-10
to O 0 7.654634033831681e-14
be O 0 2.4374379251068667e-11
elucidated O 0 2.7074356978573633e-08
. O 0 3.0349799062801e-11

We O 0 9.087300689714084e-09
report O 0 3.7556714682640546e-11
here O 0 3.190167314343073e-13
the O 0 3.973888159268052e-16
identification O 0 1.2903984521542289e-12
of O 0 1.2407285248305314e-14
a O 0 1.5329385981074917e-12
unique O 0 9.016538904393911e-11
de O 0 2.395774423291641e-08
novo O 0 8.712172094860193e-10
L1 O 0 6.543982022932937e-11
insertion O 0 1.696284172153506e-12
in O 0 6.395530806335703e-13
the O 0 6.776859211602912e-14
muscle O 0 1.0066392164276294e-10
exon O 0 2.7786301037835415e-10
1 O 0 2.801785470296636e-10
in O 0 1.7164186738582998e-10
DMD O 1 1.0
in O 0 3.540466586571256e-09
three O 0 8.60191431972801e-12
XLDCM B-Disease 0 2.1710169676225632e-05
patients O 0 8.798335671134083e-11
from O 0 2.2208854221807128e-13
two O 0 3.4720338583371646e-13
unrelated O 0 1.7949161046360018e-09
Japanese O 0 5.092714218335459e-06
families O 0 6.277365433016158e-11
. O 0 3.5957237187744795e-11

The O 0 2.221022194284772e-12
insertion O 0 1.3586271864485244e-11
was O 0 4.391720667684673e-11
a O 0 2.0795164635406538e-12
5 O 0 6.5136689444966756e-12
- O 0 8.373433502129046e-09
truncated O 0 1.073721667133043e-11
form O 0 4.674062178966487e-11
of O 0 5.253487396624998e-14
human O 0 7.364300684022107e-13
L1 O 0 8.696921655060308e-12
inversely O 0 1.488941782368247e-11
integrated O 0 1.9251440719347812e-11
in O 0 1.2285369770104193e-11
the O 0 1.9152544133982374e-12
5 O 0 1.0492276492080066e-10
- O 0 1.5397891957036336e-06
untranslated O 0 4.211476152704563e-06
region O 0 7.841789084750417e-08
in O 0 1.2931660950399326e-11
the O 0 1.3174735553813516e-13
muscle O 0 2.0019399332715793e-11
exon O 0 9.342580528648448e-12
1 O 0 7.308862716437492e-12
, O 0 1.0405582069551635e-14
which O 0 4.564129022638364e-13
affected O 0 6.503784056449691e-13
the O 0 1.1863656749900426e-15
transcription O 0 5.152514970675065e-14
or O 0 7.589146867360841e-13
the O 0 3.743100935541671e-14
stability O 0 2.0438812864398415e-09
of O 0 1.3480033841278046e-14
the O 0 1.4603205797381058e-12
muscle O 0 1.0122660931699556e-08
form O 0 1.5588627610974015e-11
of O 0 3.041065459890614e-14
dystrophin O 0 3.7391300992950516e-12
transcripts O 0 1.2767309778838332e-11
but O 0 7.846142138778767e-12
not O 0 4.134574830400549e-14
that O 0 2.8382458347144717e-15
of O 0 2.1604922102107064e-15
the O 0 2.16589350621188e-11
brain O 0 9.94731453829445e-06
or O 0 3.6613281295672095e-09
Purkinje O 0 1.0049983956150754e-07
cell O 0 2.6358804916526424e-07
form O 0 7.268948820637888e-08
, O 0 2.2944225686050146e-10
probably O 0 9.16470753509202e-07
due O 0 8.336717094437063e-09
to O 0 1.9776130386062185e-11
its O 0 1.0728490578565397e-12
unique O 0 2.462826166962917e-12
site O 0 2.4217653923908067e-11
of O 0 3.976881757933315e-13
integration O 0 1.4571781281613738e-10
. O 0 1.9652730831598575e-10

We O 0 2.3478030630741387e-10
speculate O 0 1.654192754996231e-11
that O 0 1.1175270956084488e-15
this O 0 2.4925117415066388e-17
insertion O 0 4.563305723554291e-15
of O 0 1.3929512933529725e-15
an O 0 3.8814645298053136e-15
L1 O 0 1.1801566834890309e-08
sequence O 0 7.86416354259245e-09
in O 0 1.0190166488399655e-09
DMD O 1 1.0
is O 0 1.0843212439048955e-10
responsible O 0 2.4736886150567017e-11
for O 0 3.056339666215272e-15
some O 0 1.0806185878439083e-15
of O 0 1.3846125716246091e-15
the O 0 3.404579949125436e-13
population O 0 2.465165658410706e-13
of O 0 1.2037309896680698e-13
Japanese O 0 1.2200073797430377e-05
patients O 0 3.72233466923097e-13
with O 0 5.956673143018426e-14
XLDCM B-Disease 0 9.40580378028244e-08
. O 0 1.7896044889054163e-12
. O 0 2.931039308831651e-12

Severe O 0 0.0009708215366117656
early O 0 5.396775122790132e-06
- O 1 0.9999898672103882
onset O 1 0.9999408721923828
obesity B-Disease 1 1.0
, O 0 5.299693839333486e-07
adrenal B-Disease 1 0.9999998807907104
insufficiency I-Disease 1 1.0
and O 0 1.00165699734589e-07
red O 0 0.00030037909164093435
hair O 1 0.9997803568840027
pigmentation O 1 0.6862843036651611
caused O 0 7.108596822291702e-09
by O 0 1.8776011561499883e-12
POMC O 0 2.84805594219506e-07
mutations O 0 2.2145545841567582e-08
in O 0 4.237668375928205e-12
humans O 0 1.184901066153543e-10
. O 0 1.1806435169792184e-11

Sequential O 0 2.9834865133970823e-10
cleavage O 0 1.9120971472830206e-08
of O 0 2.452657217946741e-13
the O 0 1.7531818485567834e-14
precursor O 0 1.9866694281420877e-13
protein O 0 7.599648449603535e-13
pre O 0 2.0989584754715906e-06
- O 0 0.005290663335472345
pro O 0 4.937775156577118e-05
- O 0 0.0001198380850837566
opiomelanocortin O 0 2.962580083476496e-07
( O 0 7.390807665310847e-14
POMC O 0 1.2778474112185023e-10
) O 0 2.2454942958082804e-15
generates O 0 1.524133195953542e-13
the O 0 2.5714304139777197e-14
melanocortin O 0 5.900600452690696e-09
peptides O 0 2.581396485457077e-10
adrenocorticotrophin O 0 1.8751210362211168e-08
( O 0 6.739891847754031e-13
ACTH O 0 7.0121100037567885e-09
) O 0 3.0626319351672454e-14
, O 0 3.7892679581119984e-14
melanocyte O 0 3.691669462568825e-06
- O 0 8.658448496134952e-05
stimulating O 0 2.255507934023626e-05
hormones O 0 1.132588295149617e-06
( O 0 7.292562685451073e-14
MSH O 0 2.638799734278052e-10
) O 0 2.0557606096892117e-15
alpha O 0 1.6742834400254765e-14
, O 0 4.3378055418418176e-16
beta O 0 3.839026061565505e-15
and O 0 2.8035102840969937e-15
gamma O 0 4.2760378029214896e-13
as O 0 2.031253278371361e-14
well O 0 5.306469646288933e-14
as O 0 3.3669407187427933e-15
the O 0 5.895632645410787e-15
opioid O 0 1.8361508060532605e-12
- O 0 6.590553797147791e-11
receptor O 0 1.843171882481842e-12
ligand O 0 1.6659471024915717e-10
beta O 0 6.215973291645582e-10
- O 0 1.4533121429849416e-05
endorphin O 0 5.051087555330014e-06
. O 0 7.64794685914616e-11

While O 0 3.483227248302079e-11
a O 0 1.8607512720317937e-13
few O 0 2.774447338538266e-13
cases O 0 3.4226430283695874e-12
of O 0 8.188754362092876e-12
isolated O 0 0.2833808660507202
ACTH B-Disease 1 0.9999977350234985
deficiency I-Disease 1 0.9999781847000122
have O 0 1.6073911091041282e-09
been O 0 9.848219462149643e-11
reported O 0 2.9133417900339964e-09
( O 0 3.210457073798967e-13
OMIM O 0 4.7661480095939623e-08
201400 O 0 4.637036032928421e-10
) O 0 7.223373646187553e-14
, O 0 6.89729611586757e-15
an O 0 2.6904411858097443e-13
inherited O 1 0.9726924896240234
POMC O 1 0.6959930658340454
defect O 1 0.9991294741630554
has O 0 5.787915711152891e-07
not O 0 4.074783566121454e-11
been O 0 1.596203638015714e-12
described O 0 4.9164589066563735e-11
so O 0 4.795527690226731e-12
far O 0 1.511881592142217e-11
. O 0 5.153424128406803e-12

Recent O 0 2.939099630339115e-09
studies O 0 1.7852979095067667e-09
in O 0 1.0194019023010426e-12
animal O 0 1.6852238354791993e-11
models O 0 4.144877496781163e-11
elucidated O 0 2.220948286391078e-10
a O 0 1.8874707569463411e-13
central O 0 5.203716689321236e-13
role O 0 5.039742494855615e-12
of O 0 2.1939218901334025e-14
alpha O 0 2.2990713065967894e-13
- O 0 8.929499362153592e-10
MSH O 0 6.9659300550029e-10
in O 0 4.589651751642394e-14
the O 0 1.3320210370834184e-15
regulation O 0 5.00793633992358e-13
of O 0 2.4790097385423847e-16
food O 0 1.1747026454052376e-14
intake O 0 1.5029605232347483e-14
by O 0 1.5132914611610979e-16
activation O 0 4.335741767241656e-14
of O 0 1.373172714045582e-14
the O 0 6.853297443432105e-12
brain O 0 4.5375011836767953e-07
melanocortin O 0 1.7013302056057e-07
- O 0 1.528162283648271e-05
4 O 0 2.463829418264396e-10
- O 0 3.18847037661385e-09
receptor O 0 1.3272508959938367e-11
( O 0 3.8153421394460096e-13
MC4 O 0 1.1404861055552828e-07
- O 0 1.063076311424993e-07
R O 0 6.85817482803941e-08
; O 0 8.350716900742614e-14
refs O 0 3.686122587720497e-11
3 O 0 8.678353988125082e-14
- O 0 1.1641896648095784e-11
5 O 0 1.065226178071461e-14
) O 0 5.729735181111503e-17
and O 0 1.3550892382480605e-15
the O 0 8.315565965167802e-16
linkage O 0 3.7273403113990966e-11
of O 0 5.150552293692323e-13
human O 0 4.5682600102736615e-07
obesity B-Disease 1 1.0
to O 0 5.405854149737044e-12
chromosome O 0 1.659827475464226e-08
2 O 0 8.522463984528272e-12
in O 0 1.5351938199414245e-13
close O 0 6.272216253322416e-12
proximity O 0 1.5902088673636072e-11
to O 0 2.559143348623838e-11
the O 0 2.998441555809861e-12
POMC O 0 6.1717457811028e-09
locus O 0 1.0263719735226218e-10
, O 0 3.2141806983977325e-14
led O 0 6.967962041777923e-14
to O 0 2.34701919899806e-14
the O 0 8.036153258681247e-14
proposal O 0 7.31215712979072e-11
of O 0 3.801328352028184e-14
an O 0 6.919858024263814e-14
association O 0 4.512606922250223e-13
of O 0 6.918010814812442e-14
POMC O 0 2.757441563971952e-07
with O 0 1.4840120798886858e-10
human O 0 6.70567351335194e-06
obesity B-Disease 1 0.9999997615814209
. O 0 9.597272976336058e-10

The O 0 1.7895849732663116e-11
dual O 0 1.7864525414523769e-09
role O 0 4.5260243469735784e-11
of O 0 2.146250706455341e-13
alpha O 0 1.4748377866191653e-11
- O 0 7.146351066467105e-08
MSH O 0 2.9480954566452056e-08
in O 0 6.707954775409669e-14
regulating O 0 1.0282642792791563e-11
food O 0 1.9656383725558113e-12
intake O 0 1.2011633875042005e-11
and O 0 2.6176562545159043e-13
influencing O 0 4.284324894854308e-09
hair O 0 0.0001608909369679168
pigmentation O 0 5.118095486977836e-06
predicts O 0 5.295742178113017e-10
that O 0 8.970958978655238e-15
the O 0 5.781865532682694e-15
phenotype O 0 1.4509571322207648e-10
associated O 0 1.3252170194544277e-11
with O 0 3.9102106426901206e-13
a O 0 3.945547777384206e-10
defect O 0 6.180588388815522e-05
in O 0 1.0070688206964551e-11
POMC O 0 1.517014069918332e-08
function O 0 2.884180949624948e-10
would O 0 1.0871495544073628e-11
include O 0 3.771149503783988e-10
obesity B-Disease 1 1.0
, O 0 5.389255664997594e-13
alteration O 0 3.0159068131752065e-08
in O 0 3.875839205136344e-09
pigmentation O 1 0.9998549222946167
and O 0 0.0006169456755742431
ACTH B-Disease 1 0.999931812286377
deficiency I-Disease 1 0.9064720869064331
. O 0 8.086783326310965e-11

The O 0 7.37135873174477e-12
observation O 0 6.057971346784541e-10
of O 0 4.0992415625135115e-13
these O 0 2.3060402198904484e-10
symptoms O 0 3.001045456585416e-07
in O 0 6.50387946624087e-14
two O 0 2.8987333045108485e-15
probands O 0 1.4282687532674032e-10
prompted O 0 1.553572374912715e-12
us O 0 1.6859624590512268e-12
to O 0 1.908403346646565e-15
search O 0 1.9241436243801202e-13
for O 0 1.5189268571212666e-13
mutations O 0 4.427960220709792e-09
within O 0 2.725138474254929e-12
their O 0 2.4910554521917483e-11
POMC O 0 4.947386855747027e-08
genes O 0 1.6871488650593847e-09
. O 0 4.280611975993054e-11

Patient O 0 1.7686455976217985e-05
1 O 0 4.556446608905418e-10
was O 0 1.3672012133536526e-10
found O 0 1.162024469703038e-11
to O 0 4.0600877694585424e-12
be O 0 1.1311231465360727e-11
a O 0 7.186407095490302e-14
compound O 0 1.4236817020424342e-12
heterozygote O 0 7.243831923187116e-11
for O 0 1.2246521613641648e-13
two O 0 1.2044130883598347e-13
mutations O 0 3.5872721459995205e-10
in O 0 2.6351997298688923e-13
exon O 0 1.0168087205553178e-10
3 O 0 7.978734860303316e-12
( O 0 1.429767898042736e-14
G7013T O 0 4.924558330565709e-11
, O 0 3.498382613871358e-14
C7133delta O 0 1.3749582583599818e-09
) O 0 1.5076923880912897e-14
which O 0 8.018113828596983e-15
interfere O 0 5.145308549885097e-13
with O 0 1.7060416698333556e-15
appropriate O 0 5.1781793913505125e-14
synthesis O 0 9.623851466179084e-14
of O 0 1.337700160060698e-13
ACTH O 0 2.093296274097156e-07
and O 0 3.309433239603865e-12
alpha O 0 6.829916493478194e-11
- O 0 1.8101676687365398e-05
MSH O 0 9.921637911247672e-07
. O 0 7.635733018096502e-11

Patient O 0 2.823245813488029e-05
2 O 0 7.378803817958968e-11
was O 0 4.330589272599772e-12
homozygous O 0 4.727823688099875e-11
for O 0 2.3298564480142038e-14
a O 0 1.7409709741553203e-12
mutation O 0 8.857309552467996e-09
in O 0 2.5059498204825503e-13
exon O 0 3.2868591182122486e-10
2 O 0 2.9321257227765685e-11
( O 0 8.48152589285299e-14
C3804A O 0 9.109091259063007e-10
) O 0 6.886155599732102e-13
which O 0 5.5808170584814576e-12
abolishes O 0 7.68307728549189e-08
POMC O 0 1.4014818816576735e-07
translation O 0 5.45404943430583e-10
. O 0 5.286495546874548e-11

These O 0 2.1021077673682997e-12
findings O 0 2.8635895737982864e-12
represent O 0 2.0534974816497492e-13
the O 0 2.0754278676915093e-15
first O 0 4.103085618256718e-15
examples O 0 2.1879556272221684e-13
of O 0 1.2222852294370163e-14
a O 0 9.365105357872494e-10
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 1.6516840672942124e-10
the O 0 1.5750478720745476e-13
POMC O 0 6.825661147402684e-10
gene O 0 3.025628358965804e-11
and O 0 1.8579282806251846e-13
define O 0 2.3750600444683023e-11
a O 0 3.0609122007863032e-12
new O 0 1.0331914490624428e-10
monogenic B-Disease 0 0.00048878975212574
endocrine I-Disease 0 0.00018452169024385512
disorder I-Disease 0 0.00456594442948699
resulting O 0 7.144763669586496e-10
in O 0 5.527881277722635e-11
early O 0 5.4800684665679e-06
- O 1 0.9999992847442627
onset O 1 0.9999949932098389
obesity B-Disease 1 1.0
, O 0 2.0999614207539707e-06
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 3.4640585511169775e-08
red O 0 1.7121425344157615e-06
hair O 0 0.0007910251733846962
pigmentation O 0 1.5399596122733783e-06
. O 0 5.859119179413286e-12
. O 0 2.8243770169855686e-12

A O 0 1.1255244514174478e-09
European O 0 7.793232170705267e-10
multicenter O 0 7.07476260686235e-07
study O 0 1.0100212222141636e-08
of O 0 3.771721992507082e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 5.632706800984266e-11
classification O 0 9.426803782019988e-11
of O 0 3.983696917264287e-14
105 O 0 3.0914160120687484e-12
mutations O 0 4.298591704809951e-09
and O 0 8.852697763218897e-13
a O 0 8.76462192211068e-14
general O 0 8.53984987109549e-14
system O 0 5.34205600762061e-13
for O 0 3.4732622001062844e-15
genotype O 0 3.0338412337904686e-10
- O 0 4.683702869989759e-10
based O 0 9.447368018097868e-13
prediction O 0 1.154355222521275e-10
of O 0 1.1973918628534544e-14
metabolic O 0 1.8607275720228245e-08
phenotype O 0 8.033567588938695e-09
. O 0 4.3412762967820484e-11

Phenylketonuria B-Disease 0 0.0023262458853423595
( O 0 2.876182347844036e-10
PKU B-Disease 0 4.78303661566315e-07
) O 0 5.781025397971762e-12
and O 0 5.795413454690035e-11
mild B-Disease 0 0.00020183651940897107
hyperphenylalaninemia I-Disease 1 1.0
( O 0 2.0467425088099844e-07
MHP B-Disease 1 1.0
) O 0 1.515299864751629e-11
are O 0 5.545993525535309e-11
allelic B-Disease 0 0.00015357877418864518
disorders I-Disease 1 0.8687157034873962
caused O 0 3.4709086715878357e-09
by O 0 5.667336717106453e-13
mutations O 0 4.963312605354986e-08
in O 0 5.947819819128453e-13
the O 0 7.790748840323658e-14
gene O 0 3.0461411171245345e-09
encoding O 0 1.660663251357164e-08
phenylalanine O 0 0.0009797977982088923
hydroxylase O 0 0.0096510648727417
( O 0 2.203269511280581e-10
PAH O 0 4.0936268419500266e-07
) O 0 4.9219547708367895e-12
. O 0 1.4371327912432452e-11

Previous O 0 2.6171174116740303e-09
studies O 0 7.501797100184504e-11
have O 0 1.5623586408983203e-13
suggested O 0 1.0534397789849215e-12
that O 0 2.0365524858959733e-14
the O 0 3.9618736215980485e-14
highly O 0 7.323005535297966e-10
variable O 0 7.686792287131539e-07
metabolic O 0 3.0767325370106846e-05
phenotypes O 0 1.609610421837715e-06
of O 0 2.881486715899939e-10
PAH B-Disease 1 0.9994807839393616
deficiency I-Disease 0 0.2851961553096771
correlate O 0 1.2251790337813873e-07
with O 0 5.381252110581158e-10
PAH O 0 0.000371053465642035
genotypes O 0 1.8040194618151872e-06
. O 0 1.571257568500073e-10

We O 0 4.858407010033261e-09
identified O 0 6.417251452450756e-11
both O 0 1.7501291756961967e-13
causative O 0 3.615686949842711e-08
mutations O 0 4.268258635420352e-08
in O 0 4.794531091589782e-12
686 O 0 4.3795522763900863e-10
patients O 0 1.1729817117611674e-09
from O 0 9.317280974530107e-11
seven O 0 5.8011203479813034e-11
European O 0 5.727657237386552e-10
centers O 0 1.35694969150002e-10
. O 0 5.1018463759211485e-11

On O 0 4.6306437850862636e-11
the O 0 5.0075517192028907e-14
basis O 0 1.4636492159329079e-13
of O 0 3.3884306328289045e-16
the O 0 8.491265585900288e-15
phenotypic O 0 3.437892637236928e-09
characteristics O 0 3.361178357863537e-07
of O 0 1.2739475273304546e-12
297 O 0 3.5749209148505656e-11
functionally O 0 1.7176172983912608e-10
hemizygous O 0 4.792063350578246e-07
patients O 0 1.4968527806136223e-10
, O 0 5.446498930843351e-15
105 O 0 9.975506172780948e-15
of O 0 3.1938046432251725e-15
the O 0 8.110037706503259e-13
mutations O 0 1.1881198247465363e-09
were O 0 5.730361497813252e-12
assigned O 0 1.9563027413294076e-12
to O 0 1.5317044507745514e-13
one O 0 2.269674384417289e-13
of O 0 3.626005745660521e-15
four O 0 2.036164205992952e-14
arbitrary O 0 1.7420181616656372e-11
phenotype O 0 3.1814312961842006e-08
categories O 0 2.1492711610449078e-08
. O 0 8.918090571574666e-11

We O 0 3.275869020491484e-10
proposed O 0 1.7963997260214692e-12
and O 0 1.922645029295289e-11
tested O 0 7.565600368408809e-10
a O 0 1.7576953483195226e-14
simple O 0 1.6626336538008019e-13
model O 0 8.105955143222765e-13
for O 0 1.9748263468812673e-16
correlation O 0 2.804937488873338e-12
between O 0 7.849281120908547e-13
genotype O 0 9.453258176250756e-10
and O 0 9.590209350393217e-14
phenotypic O 0 2.956781486318505e-10
outcome O 0 6.14505824003686e-09
. O 0 9.533031308794904e-11

The O 0 5.434158765332819e-12
observed O 0 2.7246940814684706e-10
phenotype O 0 1.2191171405717682e-09
matched O 0 1.8490152464689658e-10
the O 0 1.4197212402553526e-14
predicted O 0 1.249941816716671e-11
phenotype O 0 1.2463374950144601e-11
in O 0 7.63338807582229e-15
79 O 0 5.5157928327857417e-14
% O 0 1.1338754879409909e-14
of O 0 5.454940461195688e-15
the O 0 8.206386958864442e-13
cases O 0 2.2645708919188934e-10
, O 0 1.2644525454897498e-13
and O 0 1.3931559898761048e-11
in O 0 4.954355068559346e-12
only O 0 9.070519400682098e-13
5 O 0 9.238870925893858e-14
of O 0 1.0349289106910062e-14
184 O 0 6.87594512577272e-13
patients O 0 6.082441408178374e-12
was O 0 9.080157736818251e-10
the O 0 2.6019973935892393e-12
observed O 0 3.530405523477498e-09
phenotype O 0 2.9074935167794358e-11
more O 0 4.4196358066892795e-15
than O 0 4.866760274402533e-14
one O 0 6.866269976636002e-14
category O 0 1.813452860099929e-10
away O 0 5.8205825576029824e-11
from O 0 2.0224141372010562e-12
that O 0 1.9650397628523386e-11
expected O 0 2.711148527900775e-10
. O 0 2.493960073179924e-11

Among O 0 4.154202815076502e-10
the O 0 1.0732174697547503e-12
seven O 0 8.719136930469482e-14
contributing O 0 3.313638155099524e-13
centers O 0 6.12890136862318e-14
, O 0 1.5563877828333474e-15
the O 0 3.7965602341615e-14
proportion O 0 2.5889270727219582e-09
of O 0 7.241241569040657e-13
patients O 0 2.949731821647039e-12
for O 0 3.0743077761253776e-14
whom O 0 5.41822586797025e-10
the O 0 6.451915282416898e-13
observed O 0 3.2466024313393405e-10
phenotype O 0 2.1203190592178345e-10
did O 0 2.195955917105863e-11
not O 0 5.319625490975144e-13
match O 0 1.956803989677791e-11
the O 0 3.4160001894214045e-14
predicted O 0 2.242340167712964e-11
phenotype O 0 8.370994869499881e-12
was O 0 2.572806551137674e-12
4 O 0 1.287764518501447e-13
% O 0 2.6196593180295713e-13
- O 0 8.619239224572084e-07
23 O 0 4.733102104692577e-11
% O 0 1.444110673057275e-13
( O 0 8.332054393222349e-14
P O 0 4.066345809405902e-06
< O 0 6.299366028805764e-10
. O 0 2.6975614125269998e-14
0001 O 0 1.0620467179311976e-11
) O 0 1.0295927937057172e-15
, O 0 9.36253574566556e-17
suggesting O 0 4.016814658669432e-12
that O 0 2.3130396252860064e-14
differences O 0 5.731257916169463e-12
in O 0 6.756205414326947e-15
methods O 0 1.0588291311439124e-14
used O 0 6.003456974980944e-15
for O 0 1.8348815644512496e-14
mutation O 0 5.720307214018838e-11
detection O 0 2.655684283592308e-10
or O 0 1.3844576873811576e-10
phenotype O 0 1.2992974518510891e-07
classification O 0 5.920024470640328e-09
may O 0 2.1533189120681584e-10
account O 0 6.208534662939524e-13
for O 0 1.5472594146399062e-15
a O 0 4.7081628417981747e-14
considerable O 0 4.600599345927492e-10
proportion O 0 7.988182346707617e-07
of O 0 4.781823270683105e-10
genotype O 0 0.10529086738824844
- O 0 0.02033334970474243
phenotype O 0 2.497363311704248e-07
inconsistencies O 0 6.378439998400154e-09
. O 0 6.020302312226278e-11

Our O 0 4.598108283015989e-10
data O 0 6.7909436754498564e-12
indicate O 0 5.0237081855586396e-11
that O 0 7.991551214184267e-14
the O 0 1.1272177852586496e-12
PAH O 0 2.934597068815492e-05
- O 0 1.0526488125606193e-07
mutation O 0 4.663594399545445e-09
genotype O 0 1.173418029409845e-09
is O 0 7.974402693353925e-15
the O 0 1.5382778743139156e-16
main O 0 1.2162897608297609e-14
determinant O 0 6.126593156408067e-12
of O 0 8.745285176364401e-14
metabolic O 0 1.468163475237816e-07
phenotype O 0 2.5273262593827894e-08
in O 0 5.712966124477026e-12
most O 0 3.2022898222017204e-11
patients O 0 7.687306347037293e-10
with O 0 1.335279762315622e-07
PAH B-Disease 1 0.9995414018630981
deficiency I-Disease 1 0.5072779059410095
. O 0 3.249285007722591e-10

In O 0 1.2465520282667342e-10
the O 0 1.0719771831270083e-13
present O 0 6.299704681522744e-13
study O 0 1.9994651821817616e-13
, O 0 1.7800086101941006e-15
the O 0 3.646743653308148e-15
classification O 0 1.662004388280902e-11
of O 0 6.721107503014634e-14
105 O 0 4.087448435274865e-11
PAH O 0 4.965812649970758e-08
mutations O 0 1.09056075281444e-09
may O 0 5.118022759070806e-12
allow O 0 3.3731003423352265e-14
the O 0 3.1881703494666264e-14
prediction O 0 1.4380705827543583e-11
of O 0 1.032609064796e-16
the O 0 6.7401935270085256e-15
biochemical O 0 1.3151003896982871e-10
phenotype O 0 1.6980621769802084e-11
in O 0 3.744107549496188e-14
> O 0 1.5347679724331265e-11
10 O 0 3.5691074661697852e-12
, O 0 8.46252253927475e-14
000 O 0 1.4766616748818073e-11
genotypes O 0 3.921715574506379e-08
, O 0 2.7142461889173575e-11
which O 0 3.2784084336157093e-09
may O 0 1.4404996306893736e-08
be O 0 2.21939071396067e-13
useful O 0 4.0145739786971377e-14
for O 0 1.6072451232941533e-15
the O 0 1.1182574370617246e-13
management O 0 1.3073592555756797e-11
of O 0 8.307969113011127e-13
hyperphenylalaninemia B-Disease 1 1.0
in O 0 2.168014816561481e-06
newborns O 0 2.531012796680443e-06
. O 0 1.1850609035746196e-11

Somatic O 0 1.827298348189288e-07
instability O 0 4.316728791309288e-06
of O 0 1.7629011314981846e-12
the O 0 1.1323615656255726e-12
CTG O 0 9.068880046925187e-08
repeat O 0 2.1237094927073485e-07
in O 0 4.672150253487439e-13
mice O 0 8.781029722793043e-12
transgenic O 0 3.064785187786856e-12
for O 0 2.8202449869809548e-14
the O 0 3.226414968526825e-11
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 1.9407758372835815e-05
is O 0 7.632479537278414e-09
age O 0 3.8128109558499546e-09
dependent O 0 2.021975295529721e-11
but O 0 9.477617258710214e-13
not O 0 2.1496335866400852e-14
correlated O 0 1.656199049432372e-13
to O 0 6.039378795241052e-16
the O 0 8.565603738450167e-15
relative O 0 8.857605621193088e-11
intertissue O 0 7.97970578503282e-09
transcription O 0 3.9927267048156523e-10
levels O 0 1.5584910784127715e-07
and O 0 8.119409311557746e-11
proliferative O 0 4.170720058027655e-05
capacities O 0 1.005397152198384e-07
. O 0 1.24517382515954e-10

A O 0 1.7135769470044693e-09
( O 0 1.1128663095216762e-12
CTG O 0 6.844552147278193e-10
) O 0 1.9851682485903278e-14
nexpansion O 0 2.0414190338158278e-09
in O 0 2.0371449752781823e-12
the O 0 6.800583316965425e-13
3 O 0 1.9379964300014763e-09
- O 0 0.011010699905455112
untranslated O 0 0.0001339661394013092
region O 0 4.813342968645884e-08
( O 0 6.402902839007518e-13
UTR O 0 9.173389131644782e-11
) O 0 2.9424503689845375e-15
of O 0 3.743148708199896e-15
the O 0 1.4939912154621204e-11
DM O 1 0.9999998807907104
protein O 0 4.534805864153668e-10
kinase O 0 9.294038427754003e-09
gene O 0 2.065750459578908e-09
( O 0 2.906503705248087e-13
DMPK O 0 2.2784721664947938e-08
) O 0 1.0451928324293602e-14
is O 0 5.792133943695668e-14
responsible O 0 3.756982572267198e-11
for O 0 1.466982264830552e-11
causing O 0 0.0016980617074295878
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.8159107387182303e-05
DM B-Disease 1 1.0
) O 0 1.1918034337199401e-09
. O 0 1.7447955580340846e-10

Major O 0 2.8510605432074954e-08
instability O 0 0.0010609253076836467
, O 0 1.0532910264468565e-12
with O 0 6.47286654072328e-14
very O 0 1.8242251784671148e-13
large O 0 1.1440777795621027e-13
expansions O 0 6.376174033206894e-10
between O 0 1.8547993002604457e-12
generations O 0 7.551381742132435e-11
and O 0 1.0431118468989808e-10
high O 0 3.2633669100334828e-09
levels O 0 1.6295553795231399e-09
of O 0 1.0801617406238067e-14
somatic O 0 1.541836103235994e-11
mosaicism O 0 7.464808327029004e-09
, O 0 1.6361827799744877e-13
is O 0 3.390860454834804e-13
observed O 0 1.679311134594741e-10
in O 0 2.2682876410495822e-11
patients O 0 2.8457102993484362e-11
. O 0 4.398469088950918e-11

There O 0 1.901744983712206e-09
is O 0 8.179541028871529e-13
a O 0 1.55764249697328e-13
good O 0 8.734025655487976e-12
correlation O 0 1.5007542084055636e-11
between O 0 2.7426067059771464e-12
repeat O 0 1.0173470066376922e-08
size O 0 1.3401033616133873e-09
( O 0 8.216031208239244e-14
at O 0 1.0345634071651233e-11
least O 0 2.547914407669688e-13
in O 0 1.529544177945874e-13
leucocytes O 0 5.458659635415586e-10
) O 0 9.676045297575715e-15
, O 0 2.3756987181525538e-15
clinical O 0 9.277800749885046e-12
severity O 0 1.8127165049008909e-06
and O 0 1.426559759210022e-09
age O 0 9.520684685071501e-09
of O 0 1.1796839546884819e-12
onset O 0 8.618826541351154e-09
. O 0 2.0735420325213028e-10

The O 0 3.0229990732877354e-10
trinucleotide O 0 3.0268561204138678e-06
repeat O 0 1.126047308730449e-07
instability O 0 2.041415037012939e-09
mechanisms O 0 9.774632492298707e-12
involved O 0 2.2779255912097618e-11
in O 0 1.961538396988427e-11
DM B-Disease 1 1.0
and O 0 2.744932892095875e-10
other O 0 2.5199000872055954e-11
human O 0 1.8672092494398385e-07
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 6.2055346972123e-11
unknown O 0 4.192172387007531e-09
. O 0 5.690269436198214e-12

We O 0 1.6298102867295938e-09
studied O 0 1.683486683390356e-10
somatic O 0 4.1201450584615884e-10
instability O 0 5.8003653435889646e-08
by O 0 7.075994521224538e-13
measuring O 0 3.497956981846073e-07
the O 0 1.5288507222363523e-12
CTG O 0 1.404218785694411e-08
repeat O 0 5.192424268329887e-09
length O 0 1.1715494893649314e-11
at O 0 4.0698938360075876e-13
several O 0 1.5090847408499863e-14
ages O 0 1.2658299408663254e-10
in O 0 6.920993726039493e-14
various O 0 8.998490429353023e-13
tissues O 0 1.3729044567867277e-08
of O 0 1.7532829842906855e-13
transgenic O 0 1.1966147184239162e-08
mice O 0 2.332469648536062e-07
carrying O 0 1.615479833239064e-10
a O 0 7.960585315935909e-12
( O 0 7.585485516624357e-13
CTG O 0 4.695939748167177e-10
) O 0 1.5206828241835606e-14
55expansion O 0 4.69486505227934e-10
surrounded O 0 1.54069257352063e-11
by O 0 1.9274677882409608e-13
45 O 0 1.515881333218755e-14
kb O 0 6.798301071392343e-13
of O 0 7.325379452333136e-14
the O 0 8.238357218637304e-11
human O 0 1.8258609770782641e-06
DM B-Disease 1 1.0
region O 0 4.98928159231582e-07
, O 0 6.682542431739324e-14
using O 0 7.870734771396604e-13
small O 0 1.781147451751508e-10
- O 0 0.056233927607536316
pool O 0 1.1334857674683008e-07
PCR O 0 1.272124183770984e-08
. O 0 2.4474353099712687e-11

These O 0 5.996099450289449e-11
mice O 0 6.8441505796101865e-09
have O 0 1.046893799948323e-12
been O 0 1.398425781640525e-13
shown O 0 3.854513062895304e-12
to O 0 7.835022236037104e-14
reproduce O 0 7.550031710934491e-10
the O 0 2.411361981605512e-15
intergenerational O 0 4.838673732521226e-12
and O 0 7.427436758081912e-14
somatic O 0 7.999291333493641e-12
instability O 0 1.7363076532106447e-09
of O 0 4.8097488584150985e-14
the O 0 3.4493537041414835e-13
55 O 0 7.931542792341539e-13
CTG O 0 2.494941475639223e-10
repeat O 0 5.989267415351662e-10
suggesting O 0 3.8531425272658737e-10
that O 0 2.8034583186256797e-14
surrounding O 0 9.638460819402783e-13
sequences O 0 4.827239163951447e-10
and O 0 1.0754797660078586e-12
the O 0 3.8926894104223276e-15
chromatin O 0 6.2454516384924386e-12
environment O 0 7.107874289147276e-10
are O 0 2.5227092482582418e-14
involved O 0 3.0005466427479588e-12
in O 0 1.2329830732793479e-11
instability O 0 8.219155134270295e-09
mechanisms O 0 2.6576265632627383e-09
. O 0 1.1918778464181656e-10

As O 0 5.153031213539494e-12
observed O 0 7.30560542616665e-11
in O 0 1.108268580802662e-14
some O 0 3.04876909749095e-16
of O 0 2.2555557766722406e-15
the O 0 5.403524416108807e-12
tissues O 0 1.840288490484454e-07
of O 0 1.0352632084931201e-09
DM B-Disease 1 1.0
patients O 0 7.716502068433329e-07
, O 0 1.1209572766540665e-12
there O 0 1.3853543963035508e-12
is O 0 9.227688058111028e-14
a O 0 1.7441799212065436e-14
tendency O 0 2.377996454264175e-12
for O 0 5.4408741238538144e-14
repeat O 0 2.3727453779542884e-08
length O 0 4.706823472644395e-11
and O 0 8.471631192776344e-14
somatic O 0 1.7661852611938061e-13
mosaicism O 0 2.7359935497739407e-11
to O 0 5.3558465849161754e-14
increase O 0 1.4212507039312872e-12
with O 0 5.18782065916934e-13
the O 0 4.55954787814683e-11
age O 0 1.1951553346989385e-07
of O 0 1.6068352228751533e-14
the O 0 2.4312135963287795e-13
mouse O 0 5.646136447268191e-09
. O 0 1.2343484567800544e-10

Furthermore O 0 1.1475160377472093e-08
, O 0 1.3796507339347563e-12
we O 0 1.1684023974029012e-12
observed O 0 5.896020976135785e-13
no O 0 2.0915632100619932e-14
correlation O 0 4.2619513061954717e-13
between O 0 7.21962349251688e-15
the O 0 3.4531945072781723e-15
somatic O 0 8.13092440599128e-11
mutation O 0 6.060935930918276e-08
rate O 0 1.6680398857715772e-06
and O 0 5.0009328275701925e-12
tissue O 0 7.774325183618203e-08
proliferation O 0 5.0244816520716995e-06
capacity O 0 2.433017398661974e-10
. O 0 5.9766401896976795e-12

The O 0 4.980999120107743e-12
somatic O 0 2.4864674763591665e-09
mutation O 0 9.801980240808916e-07
rates O 0 9.650644642533734e-06
in O 0 3.5906206393571116e-13
different O 0 1.8672398154583048e-13
tissues O 0 5.17914822140142e-10
were O 0 1.472176200389974e-11
also O 0 8.788481552744754e-13
not O 0 1.315821095745212e-13
correlated O 0 8.613910908346345e-13
to O 0 4.859151885657116e-15
the O 0 8.538758892659426e-14
relative O 0 7.452050709844116e-08
inter O 0 1.4651501345497309e-08
- O 0 7.275797543115914e-05
tissue O 0 1.7213436649399227e-06
difference O 0 1.8925693012761258e-08
in O 0 3.873383411972034e-14
transcriptional O 0 3.5179114395850197e-12
levels O 0 6.229587401485048e-10
of O 0 1.136286651928645e-15
the O 0 9.7565916934092e-14
three O 0 1.0004512816059671e-13
genes O 0 3.579276903076939e-13
( O 0 1.7898543094147477e-15
DMAHP O 0 1.1452458981153768e-09
, O 0 1.537789670992898e-14
DMPK O 0 1.3117048780486584e-08
and O 0 6.2007981214973196e-12
59 O 0 1.3946993787736922e-13
) O 0 9.884702970285866e-16
surrounding O 0 2.9278320219650045e-12
the O 0 6.253322165639119e-11
repeat O 0 3.954113708459772e-06
. O 0 6.892755897297542e-12
. O 0 1.0308957680560393e-11

A O 0 2.8867017110023596e-10
novel O 0 2.1366554359136813e-10
missense O 0 7.060075859044446e-06
mutation O 0 2.496361412340775e-05
in O 0 1.332390309194409e-10
patients O 0 6.876371694275463e-11
from O 0 1.4745042480838327e-13
a O 0 7.162535321791896e-12
retinoblastoma B-Disease 0 4.510260964707413e-07
pedigree O 0 0.00021758547518402338
showing O 0 1.6098053947644075e-06
only O 0 1.4476585728784297e-11
mild O 0 7.109325350640461e-10
expression O 0 1.2150030981317173e-10
of O 0 8.013759740434917e-14
the O 0 2.5468030462327818e-12
tumor B-Disease 0 4.1293542807352424e-08
phenotype O 0 1.7400349605622978e-08
. O 0 2.2330358048772148e-11

We O 0 2.027512557845057e-08
have O 0 1.2739177659808198e-13
used O 0 2.4347020168187516e-14
single O 0 1.1785235331032706e-12
strand O 0 1.2378513145061554e-11
conformation O 0 2.09175801679784e-11
polymorphism O 0 3.853101865347597e-12
analysis O 0 2.458530612165638e-13
to O 0 6.445562433668537e-15
study O 0 2.670288035827584e-13
the O 0 4.313505932648787e-13
27 O 0 8.737686680963808e-13
exons O 0 4.1326452893467036e-13
of O 0 1.0350868823356691e-14
the O 0 5.417181934692754e-14
RB1 O 0 2.2173461677876816e-10
gene O 0 3.7128776615713566e-12
in O 0 1.1207429027795118e-13
individuals O 0 1.2022968612444146e-13
from O 0 5.732345614893955e-14
a O 0 1.4843643892162306e-12
family O 0 3.0618860780151635e-09
showing O 0 0.0020145501475781202
mild O 0 1.6634204484944348e-06
expression O 0 4.338995829300529e-09
of O 0 1.5678841417451211e-13
the O 0 1.3687079898280774e-12
retinoblastoma B-Disease 0 5.897248023245538e-09
phenotype O 0 1.2895227996523317e-08
. O 0 3.557290573219518e-11

In O 0 6.407658691837126e-12
this O 0 2.436462828909504e-14
family O 0 3.0554465207943693e-12
affected O 0 8.992935736362728e-12
individuals O 0 3.378106171528228e-12
developed O 0 6.071080527192407e-09
unilateral B-Disease 1 0.9999829530715942
tumors I-Disease 1 1.0
and O 0 1.503714202044648e-07
, O 0 1.975423473345346e-14
as O 0 1.8938924864139728e-14
a O 0 5.764756483587694e-14
result O 0 1.861828746729799e-11
of O 0 2.1381911032589216e-15
linkage O 0 7.984402722316375e-11
analysis O 0 6.861802792634819e-11
, O 0 1.3826793713884317e-13
unaffected O 0 2.157418688142343e-09
mutation O 0 2.988807867865262e-09
carriers O 0 5.516287981954804e-10
were O 0 5.454348431244149e-11
also O 0 7.06890275481431e-12
identified O 0 6.478449998681413e-10
within O 0 5.740160408627959e-13
the O 0 3.5817577202779116e-12
pedigree O 0 7.643844810445444e-07
. O 0 3.723503103070236e-11

A O 0 1.196321930407862e-09
single O 0 3.3753579792294985e-11
band O 0 2.125241302386449e-11
shift O 0 6.201531475846789e-12
using O 0 9.72345468031044e-13
SSCP O 0 8.974238880909979e-07
was O 0 3.245358148884492e-10
identified O 0 2.979539948100296e-10
in O 0 2.546753227142956e-13
exon O 0 4.598423863910739e-10
21 O 0 3.9263575030146214e-11
which O 0 6.168670581936306e-14
resulted O 0 1.6929614177554897e-12
in O 0 3.0509958708763163e-13
a O 0 1.756698410869395e-12
missense O 0 2.540402306294709e-07
mutation O 0 3.885187283003688e-09
converting O 0 1.3806806392624438e-11
a O 0 4.1065371589321664e-12
cys O 0 1.365349362458801e-06
- O 0 2.924060709119658e-07
- O 0 1.0821838536401174e-08
> O 0 7.490897659112594e-12
arg O 0 1.5206735176631625e-11
at O 0 8.545894975833454e-14
nucleotide O 0 2.063401359497785e-11
position O 0 2.924977204887824e-10
28 O 0 3.8425165826971863e-13
in O 0 6.0844511124303474e-15
the O 0 1.7229136682877372e-13
exon O 0 8.112591487474674e-09
. O 0 4.151652355233182e-10

The O 0 4.9520713918393966e-11
mutation O 0 1.851289788135091e-08
destroyed O 0 1.5501877559387367e-10
an O 0 1.7072892646613665e-14
NdeI O 0 1.0129807215264464e-08
restriction O 0 4.283274429583983e-11
enzyme O 0 3.999368978352402e-12
site O 0 2.302435152257143e-11
. O 0 7.186880431053755e-12

Analysis O 0 1.0675619277478177e-09
of O 0 1.0086831543631991e-12
all O 0 1.29451462570207e-13
family O 0 8.471554078896826e-13
members O 0 9.59437607486735e-15
demonstrated O 0 9.351971237345214e-13
that O 0 7.30807151990212e-15
the O 0 4.364649985291909e-14
missense O 0 5.704092842506725e-08
mutation O 0 1.7774025806716054e-08
co O 0 6.890705606110714e-08
- O 0 2.273931585250466e-07
segregated O 0 7.448430761058944e-11
with O 0 1.563668985959943e-11
patients O 0 7.316289796222009e-10
with O 0 3.4591462139133e-08
tumors B-Disease 1 1.0
or O 0 8.88850845512934e-05
who O 0 2.2603016702760215e-07
, O 0 2.355077362238469e-14
as O 0 1.6049209284143585e-14
a O 0 5.96486130887558e-13
result O 0 7.92062040955166e-11
of O 0 1.89829633776169e-15
linkage O 0 5.1869356032518965e-11
analysis O 0 1.5703167932645812e-10
had O 0 1.5131439434767913e-09
been O 0 2.3992462530597614e-11
predicted O 0 3.407909718311508e-11
to O 0 6.365201199237322e-14
carry O 0 4.5961501965452456e-11
the O 0 1.1410795268743112e-12
predisposing O 0 1.266043714309717e-08
mutation O 0 4.204298420518171e-07
. O 0 1.612764505276587e-10

These O 0 1.0883772182113116e-12
observations O 0 1.6301753349989845e-11
point O 0 1.6739656535924574e-12
to O 0 1.4833157963088477e-14
another O 0 2.7987955377763163e-13
region O 0 4.574905732024348e-11
of O 0 1.4693330102968916e-13
the O 0 4.375314780619144e-12
RB1 O 0 8.631049652763068e-09
gene O 0 5.2472064887565395e-11
where O 0 3.2542685993869336e-12
mutations O 0 8.607219798006938e-11
only O 0 1.6714053914772958e-14
modify O 0 1.4269549084011679e-12
the O 0 1.781864247623298e-14
function O 0 2.3342443429552606e-12
of O 0 1.5367829935109098e-15
the O 0 2.1235403978867376e-14
gene O 0 1.3955929467623918e-10
and O 0 4.506004076809678e-12
raise O 0 7.000416414083832e-13
important O 0 9.007926037572257e-15
questions O 0 7.017875863768452e-13
for O 0 1.0742556234045748e-16
genetic O 0 5.010557073414912e-12
counseling O 0 5.288993635416128e-12
in O 0 7.739566908367135e-13
families O 0 3.652197901743426e-13
with O 0 3.157393780022638e-13
these O 0 2.030713965039954e-11
distinctive O 0 3.3732906246086714e-08
phenotypes O 0 5.924850654537295e-08
. O 0 1.2042826588384847e-12
. O 0 9.785116293625773e-12

Maternal B-Disease 0 0.00025127182016149163
disomy I-Disease 0 0.0020932883489876986
and O 0 0.0001407991658197716
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 1.0111786650668364e-05
with O 0 1.248420312439935e-13
gamete O 0 4.968156996909556e-10
complementation O 0 9.939901124411676e-10
in O 0 7.061725878533542e-14
a O 0 3.046040592609607e-14
case O 0 4.873471851768452e-12
of O 0 2.7874997096796403e-14
familial O 0 6.700059174136186e-08
translocation O 0 3.2065125310509757e-07
( O 0 5.2091737173798336e-11
3 O 0 1.93410329418775e-10
; O 0 1.6114384132626114e-11
15 O 0 1.391429853281334e-11
) O 0 1.3696153450737034e-14
( O 0 1.5964295713489e-15
p25 O 0 4.729532737668407e-13
; O 0 4.994329026676483e-15
q11 O 0 6.290450799140146e-12
. O 0 7.473820959899916e-14
2 O 0 2.872104951871096e-13
) O 0 1.6354588039738105e-13
. O 0 8.83143645019624e-12

Maternal B-Disease 0 0.010799655690789223
uniparental I-Disease 0 0.030397338792681694
disomy I-Disease 0 0.0052735391072928905
( I-Disease 0 4.7012833626070005e-09
UPD I-Disease 1 0.9999946355819702
) I-Disease 0 1.0325369032004872e-11
for I-Disease 0 1.2084796054481761e-12
chromosome I-Disease 0 3.5978566756966757e-06
15 I-Disease 0 5.005277095571081e-11
is O 0 6.57648035421593e-14
responsible O 0 4.716182414217507e-13
for O 0 1.2097277965873818e-15
an O 0 1.7192713715574021e-15
estimated O 0 5.713867421743013e-13
30 O 0 9.548521099234791e-14
% O 0 9.467778530570722e-15
of O 0 5.42223634969561e-14
cases O 0 4.253500307527247e-08
of O 0 0.0014939685352146626
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.0959014389300137e-06
PWS B-Disease 1 0.9999958276748657
) O 0 2.631551920817543e-10
. O 0 2.3526701420362173e-11

We O 0 1.0741986855578034e-08
report O 0 2.5413052738565423e-12
on O 0 4.802742455985295e-15
an O 0 8.366466193289008e-18
unusual O 0 1.3344941742366584e-13
case O 0 1.5311365023085166e-11
of O 0 2.2166535100509588e-13
maternal B-Disease 0 1.0135261163668474e-07
disomy I-Disease 0 8.119364792946726e-06
15 I-Disease 0 3.25980686888272e-10
in O 0 4.8667864877005584e-11
PWS B-Disease 1 0.9999997615814209
that O 0 8.78609338061942e-11
is O 0 4.294929863146724e-12
most O 0 8.85255817218919e-14
consistent O 0 1.2639143898152128e-10
with O 0 2.923576907908759e-14
adjacent O 0 1.234207180900171e-10
- O 0 0.0038173615466803312
1 O 0 4.0658268418702903e-10
segregation O 0 2.320742487071925e-10
of O 0 3.7146304641185596e-14
a O 0 3.4990534775181104e-12
paternal O 0 3.467832954129335e-08
t O 0 1.8139388657800737e-08
( O 0 5.981697884412107e-14
3 O 0 4.946893047107215e-13
; O 0 1.7239130316402257e-13
15 O 0 3.76362732212171e-13
) O 0 1.4303971376434274e-15
( O 0 4.084983147745354e-16
p25 O 0 1.5153096876233119e-13
; O 0 1.8532121621111326e-15
q11 O 0 1.1237059460017518e-12
. O 0 1.3032742846887362e-14
2 O 0 5.489760715107891e-15
) O 0 2.541595679526025e-16
with O 0 2.0247472183035006e-14
simultaneous O 0 7.072254448736714e-10
maternal O 0 9.819684976264398e-08
meiotic O 0 5.989110540838283e-09
nondisjunction O 0 4.1732270972261176e-08
for O 0 1.0322133772722175e-12
chromosome O 0 1.1376096153981052e-07
15 O 0 2.6845706213585174e-10
. O 0 2.9048496247296995e-11

The O 0 1.5918788509594606e-10
patient O 0 2.7807589120243392e-08
( O 0 1.2168363105330426e-12
J O 0 7.811416253389325e-06
. O 0 2.3145600019924828e-12
B O 0 1.7540401131554972e-08
. O 0 1.4771714616611123e-15
) O 0 2.5848917686249284e-16
, O 0 2.278845265194353e-16
a O 0 1.0821893511522851e-13
17 O 0 7.096055080341168e-12
- O 0 3.300507600556557e-08
year O 0 1.1406591227114404e-09
- O 0 8.594511200499255e-06
old O 0 8.397137776228192e-07
white O 0 8.570864338253159e-06
male O 0 1.8349730908084894e-06
with O 0 2.6826449048278356e-11
PWS B-Disease 1 0.9999973773956299
, O 0 1.7820892873367244e-13
was O 0 7.133074079318513e-12
found O 0 1.3655475404952822e-12
to O 0 3.010729859864725e-11
have O 0 8.56720276942724e-08
47 O 0 6.394585555513643e-11
chromosomes O 0 2.8134380936073455e-10
with O 0 9.082084043154914e-13
a O 0 2.2267156868371885e-11
supernumerary O 0 2.71820859154559e-08
, O 0 4.514193706339764e-12
paternal O 0 2.5919186441569764e-07
der O 0 0.21586544811725616
( O 0 6.182162854556639e-12
15 O 0 7.434527711340511e-13
) O 0 5.270855743680976e-16
consisting O 0 7.527656341148325e-14
of O 0 1.7967047120925894e-12
the O 0 4.793292429638996e-10
short O 0 1.7138989960585604e-07
arm O 0 3.194648172666348e-07
and O 0 2.48228104737791e-11
the O 0 1.3153242600996706e-13
proximal O 0 2.2125931642413832e-10
long O 0 3.372480534835631e-07
arm O 0 1.459338454878889e-05
of O 0 8.332921158649143e-12
chromosome O 0 2.83953386315261e-06
15 O 0 7.923778300167328e-11
, O 0 2.515439842098316e-14
and O 0 5.389361266289194e-12
distal O 0 2.8885668257316865e-07
chromosome O 1 0.974319338798523
arm O 0 0.025833768770098686
3p O 0 3.844092498184182e-05
. O 0 2.7448612271996353e-09

The O 0 3.7357406057481057e-10
t O 0 4.007242182524351e-08
( O 0 1.2002004208186423e-13
3 O 0 8.110590514085955e-14
; O 0 4.313337406973601e-15
15 O 0 1.003945038403507e-14
) O 0 2.7787540521475923e-16
was O 0 1.6519218718619166e-12
present O 0 3.698042740085672e-12
in O 0 8.09091021177627e-13
the O 0 2.7807822301881453e-14
balanced O 0 1.7242223204760876e-09
state O 0 5.932255988522206e-12
in O 0 1.1181561752893199e-11
the O 0 2.7815928380081623e-11
patients O 0 1.5205089964887009e-10
father O 0 1.1667345312105226e-08
and O 0 6.857119039249682e-11
a O 0 3.777561943807406e-11
sister O 0 3.1149850201472873e-06
. O 0 7.148989733529731e-10

Fluorescent O 0 1.4687259408674436e-08
in O 0 1.722819261383568e-12
situ O 0 3.589432917561197e-11
hybridization O 0 1.9300624466700445e-12
analysis O 0 8.780359252169578e-12
demonstrated O 0 9.699305594801366e-12
that O 0 2.6693904519540373e-14
the O 0 6.596784750401152e-13
PWS B-Disease 1 0.9999982118606567
critical O 0 1.1625311824303708e-09
region O 0 1.0652166926305995e-09
resided O 0 3.5956175814533253e-09
on O 0 1.7453871681283317e-11
the O 0 6.458930477048694e-14
derivative O 0 8.256951372631605e-11
chromosome O 0 1.4942513892890474e-10
3 O 0 1.6063281347428182e-12
and O 0 1.3078056866622223e-11
that O 0 5.961816543914589e-12
there O 0 3.326858233343444e-11
was O 0 2.9226795983383624e-10
no O 0 1.0922187633488623e-11
deletion O 0 8.81765147009439e-12
of O 0 1.5905287883196534e-13
the O 0 1.9430031195089015e-10
PWS B-Disease 1 1.0
region O 0 1.302581949857995e-06
on O 0 4.681081477997395e-08
the O 0 1.9212896551490388e-10
normal O 0 4.548078358368457e-09
pair O 0 2.73719519272575e-10
of O 0 2.2797346286131462e-14
15s O 0 1.3975466834140193e-12
present O 0 1.3316978813085467e-12
in O 0 7.057401191223889e-11
J O 0 5.533668809221126e-05
. O 0 1.5849076218099611e-10

B O 0 0.0033186590299010277
. O 0 6.6859118241779925e-09

Methylation O 0 3.096129796986702e-09
analysis O 0 7.72603508947256e-11
at O 0 2.267416723128468e-12
exon O 0 6.418952869235994e-11
alpha O 0 6.555346977049625e-12
of O 0 2.418199917652436e-13
the O 0 3.6352472139282443e-13
small O 0 1.9688072006029955e-10
nuclear O 0 0.0010783950565382838
ribonucleoprotein O 0 1.675946441537235e-05
- O 0 2.2831849491922185e-05
associated O 0 5.264213509548199e-09
polypeptide O 0 5.383697931904408e-09
N O 0 6.3789267201741495e-09
( O 0 3.5464303883977685e-15
SNRPN O 0 8.927898420552083e-10
) O 0 1.5827134609548927e-15
gene O 0 1.0034200900732593e-11
showed O 0 3.0714262244657675e-09
a O 0 1.156360977024734e-13
pattern O 0 4.225551908376701e-09
characteristic O 0 4.892637406328504e-09
of O 0 1.2982507863884551e-13
only O 0 1.618643587220081e-11
the O 0 6.030461546790988e-11
maternal O 0 7.991641723492648e-06
chromosome O 0 2.551773263803625e-07
15 O 0 1.0830045887866291e-10
in O 0 1.940883564977014e-11
J O 0 0.0001537182688480243
. O 0 5.035951655685267e-10

B O 0 0.004746605176478624
. O 0 5.960234084056992e-09

Maternal B-Disease 0 0.0001844010257627815
disomy I-Disease 0 1.6761032384238206e-05
was O 0 3.6782163426174463e-10
confirmed O 0 1.6226550268380602e-12
by O 0 4.456438329456295e-16
polymerase O 0 3.1697149245613065e-13
chain O 0 5.077428928690342e-12
reaction O 0 7.054715427286251e-13
analysis O 0 5.3545394436719726e-14
of O 0 1.0763892464591492e-15
microsatellite O 0 4.3016791517747066e-11
repeats O 0 1.2167865326428995e-10
at O 0 3.772417220184593e-13
the O 0 6.717707766874239e-15
gamma O 0 2.533129261905742e-10
- O 0 2.767710149953473e-08
aminobutyric O 0 1.9657548477880482e-08
acid O 0 4.883151175083533e-11
receptor O 0 3.1510124370859316e-12
beta3 O 0 4.209589621329002e-10
subunit O 0 1.3651316188578733e-11
( O 0 6.272643537398592e-13
GABRB3 O 0 1.906220070679865e-08
) O 0 1.2514869782848104e-12
locus O 0 4.806569364745883e-09
. O 0 6.067893965067128e-10

A O 0 3.7316478795901276e-09
niece O 0 1.0825575600392767e-06
( O 0 1.4873579798346803e-11
B O 0 8.689525543559284e-07
. O 0 1.9984204178633003e-13
B O 0 3.1627084284835405e-10
. O 0 1.4125296128958084e-16
) O 0 1.6634325840116794e-17
with O 0 2.4424497848356394e-15
45 O 0 1.5430400894197484e-14
chromosomes O 0 2.647472085309799e-13
and O 0 8.968945242526435e-14
the O 0 9.383068459581714e-15
derivative O 0 3.5692268585130194e-10
3 O 0 1.0420965305957264e-12
but O 0 5.469954697523427e-11
without O 0 1.2607433153011272e-10
the O 0 1.9882702255447082e-12
der O 0 0.0015970621025189757
( O 0 3.942608229907246e-13
15 O 0 2.290283034837165e-13
) O 0 1.5106160281878563e-15
demonstrated O 0 8.618599757481693e-12
a O 0 1.8395764078693588e-11
phenotype O 0 3.4693624684223323e-07
consistent O 0 1.441164609872203e-08
with O 0 1.2004545307028186e-13
that O 0 1.0367971672170517e-12
reported O 0 1.945152719451393e-11
for O 0 4.0138367212198475e-15
haploinsufficiency O 0 2.1745178990784098e-09
of O 0 1.0950754327854542e-13
distal O 0 9.519227628373983e-10
3 O 0 1.536099958343584e-08
p O 0 0.0005829561268910766
. O 0 2.152256595167046e-09

Uniparental B-Disease 1 0.9999786615371704
disomy I-Disease 1 0.9999904632568359
associated O 0 9.736902484291932e-07
with O 0 2.5656031119036804e-12
unbalanced O 0 7.055096062913435e-08
segregation O 0 2.4940353782199054e-08
of O 0 6.258210529658248e-12
non O 0 6.170159139173848e-08
- O 0 1.2751360145557555e-06
Robertsonian O 0 1.0093605951055906e-08
translocations O 0 6.916902748344e-07
has O 0 2.3074846478010613e-09
been O 0 1.1936995662764627e-11
reported O 0 1.84466136810002e-10
previously O 0 4.170589429364213e-10
but O 0 7.690928449655132e-10
has O 0 1.80984081887825e-11
not O 0 5.966739147038325e-13
, O 0 5.528974211280147e-16
to O 0 2.3544441204071016e-14
our O 0 2.3581002601968937e-12
knowledge O 0 1.273123316838931e-13
, O 0 5.72034976488835e-15
been O 0 1.3306213769714859e-12
observed O 0 2.042041119532101e-10
in O 0 8.409744932770871e-14
a O 0 3.080836638320178e-13
case O 0 4.909002648822991e-10
of O 0 1.504693175613525e-10
PWS B-Disease 1 0.999997615814209
. O 0 2.567712042989001e-09

Furthermore O 0 9.438670645067759e-07
, O 0 1.6134529476352633e-11
our O 0 2.3117993630528133e-11
findings O 0 1.7947045759247882e-12
are O 0 8.628735645107872e-15
best O 0 8.898943729259909e-14
interpreted O 0 2.683450521252101e-13
as O 0 7.839219623103928e-15
true O 0 1.470780528617377e-12
gamete O 0 1.31805358294379e-10
complementation O 0 5.159202509652516e-10
resulting O 0 9.759528601938072e-11
in O 0 5.472315933729988e-10
maternal B-Disease 0 0.029814675450325012
UPD I-Disease 1 0.9999997615814209
15 I-Disease 0 1.9994116939869855e-07
and O 0 1.6006984537852986e-07
PWS B-Disease 1 0.9999903440475464

Schwartz B-Disease 1 0.9852425456047058
- I-Disease 1 0.9999573230743408
Jampel I-Disease 1 0.9994803071022034
syndrome I-Disease 1 0.9999881982803345
type I-Disease 0 0.00035260626464150846
2 I-Disease 0 3.51772189155497e-09
and O 0 1.4873772435919363e-08
Stuve B-Disease 1 0.9999849796295166
- I-Disease 1 0.9999998807907104
Wiedemann I-Disease 1 0.9999890327453613
syndrome I-Disease 1 0.9999960660934448
: O 0 7.460778956441816e-13
a O 0 5.000441385830459e-14
case O 0 4.579818729116836e-12
for O 0 3.629467061096181e-14
" O 0 3.0598323354225077e-12
lumping O 0 1.613337574646323e-09
" O 0 1.0677730921671014e-10
. O 0 7.335537559327587e-12

Recent O 0 8.761197323181591e-10
studies O 0 2.223033285231324e-10
demonstrated O 0 5.3532605431838576e-11
the O 0 2.3939217849797828e-14
existence O 0 4.785164235340811e-13
of O 0 6.044218529743426e-16
a O 0 3.3373779136309026e-14
genetically O 0 6.811617784575896e-13
distinct O 0 1.1028126111964354e-12
, O 0 8.844339242095392e-14
usually O 0 1.665900815732424e-12
lethal O 0 6.437042197014742e-13
form O 0 1.9094391324157856e-13
of O 0 2.6616626315630575e-14
the O 0 6.495137067075163e-11
Schwartz B-Disease 1 0.9699819087982178
- I-Disease 1 0.9999984502792358
Jampel I-Disease 1 0.9999116659164429
syndrome I-Disease 1 0.9999779462814331
( O 0 3.06527789262212e-11
SJS B-Disease 0 0.18467213213443756
) O 0 1.247064517623242e-12
of O 0 3.573194257838752e-12
myotonia B-Disease 1 0.9563521146774292
and O 0 8.465146805747281e-08
skeletal B-Disease 0 0.007186983712017536
dysplasia I-Disease 0 0.3034641444683075
, O 0 1.563216500688469e-10
which O 0 2.1175222686409256e-10
we O 0 5.63446123091893e-10
called O 0 4.5708434259772446e-10
SJS B-Disease 1 0.9990729093551636
type I-Disease 0 0.0014631893718615174
2 I-Disease 0 1.2753741396309692e-09
. O 0 1.2218961953358587e-10

This O 0 1.2008285033004995e-08
disorder O 0 0.004265724215656519
is O 0 1.1897672083649447e-11
reminiscent O 0 8.004157336927165e-09
of O 0 2.0061617569001183e-13
another O 0 4.462299453555918e-12
rare O 0 1.587829068228075e-08
condition O 0 3.4864278859458864e-06
, O 0 7.175463429811776e-14
the O 0 1.2418763066512906e-11
Stuve B-Disease 1 0.9998132586479187
- I-Disease 1 0.9999998807907104
Wiedemann I-Disease 1 0.9999934434890747
syndrome I-Disease 1 0.9999963045120239
( O 0 7.170368031966801e-12
SWS B-Disease 0 1.531253275288691e-07
) O 0 3.649245619227748e-13
, O 0 5.862172726411874e-15
which O 0 1.2383501410179361e-14
comprises O 0 9.590098897296895e-14
campomelia B-Disease 0 2.142702300034216e-07
at O 0 6.653206430229375e-09
birth O 0 2.917478809649765e-07
with O 0 2.222092232440076e-10
skeletal B-Disease 0 0.007299110759049654
dysplasia I-Disease 0 0.08194775134325027
, O 0 1.1435514341018305e-10
contractures B-Disease 0 0.04085693508386612
, O 0 2.925466813241684e-11
and O 0 9.655711646905374e-11
early B-Disease 0 5.617906140287232e-09
death I-Disease 0 7.528971224246561e-08
. O 0 2.514148784993342e-11

To O 0 1.080012988763368e-11
test O 0 2.5059271064470368e-12
for O 0 1.0041397712780807e-15
possible O 0 1.7300768023059687e-12
nosologic O 0 1.361822569379001e-06
identity O 0 1.954142135218717e-06
between O 0 8.821809949211001e-11
these O 0 2.865601679558072e-11
disorders O 0 1.5461445457276568e-07
, O 0 7.165134710052957e-15
we O 0 1.7449560405554537e-13
reviewed O 0 8.820030751761909e-14
the O 0 1.736004295672174e-15
literature O 0 1.949176768340638e-13
and O 0 2.0021955166542706e-15
obtained O 0 1.9613671309922504e-14
a O 0 5.60722639720017e-15
follow O 0 1.7873861570504024e-13
- O 0 1.680333983067328e-09
up O 0 1.0799167809993904e-10
of O 0 1.5557593055623084e-14
the O 0 5.440918440617615e-13
only O 0 2.6975435774012624e-12
two O 0 3.3488684237801755e-14
surviving O 0 1.4095096201316437e-09
patients O 0 3.6286819903030842e-12
, O 0 5.8133810875511845e-15
one O 0 4.587901442760188e-14
with O 0 4.576579566706318e-12
SJS B-Disease 0 0.0022796362172812223
type I-Disease 0 1.427710003554239e-06
2 I-Disease 0 4.1912411041789e-11
at O 0 2.865828685472138e-09
age O 0 4.907785751129268e-07
10 O 0 4.619076388739929e-12
years O 0 2.155909999135286e-12
and O 0 1.2367834349973766e-13
another O 0 6.332167591920762e-14
with O 0 2.9666640238151798e-12
SWS B-Disease 0 1.0405894812492988e-07
at O 0 4.075021209359875e-09
age O 0 3.115656710406256e-08
7 O 0 9.104413750682383e-11
years O 0 4.306456927172242e-11
. O 0 1.296069935402544e-11

Patients O 0 2.440154105443071e-07
reported O 0 4.173886125613535e-09
as O 0 7.636399325383625e-12
having O 0 7.515355804343926e-08
either O 0 0.0001784370979294181
neonatal O 1 0.9999892711639404
SJS B-Disease 1 0.9999659061431885
or O 0 1.3600657489121204e-08
SWS B-Disease 0 3.4473899290787813e-07
presented O 0 1.1643402171232498e-12
a O 0 8.379607161694384e-15
combination O 0 4.801941721858938e-13
of O 0 7.603105800925002e-15
a O 0 2.943275831390757e-11
severe O 0 2.3349764433078235e-06
, O 0 4.3165061802685756e-11
prenatal O 1 0.9996497631072998
- O 1 0.9999637603759766
onset O 0 0.08468597382307053
neuromuscular B-Disease 1 0.9995052814483643
disorder I-Disease 1 0.9998902082443237
( O 0 4.741821518772227e-11
with O 0 4.930820751702925e-10
congenital B-Disease 1 0.9999825954437256
joint I-Disease 0 0.18722715973854065
contractures I-Disease 1 0.9999990463256836
, O 0 4.083507519681007e-06
respiratory O 1 0.999971866607666
and O 0 4.89415885596145e-09
feeding O 0 2.384158506174572e-06
difficulties O 0 1.6315144648615387e-06
, O 0 4.019630765392246e-14
tendency O 0 1.0749963419431907e-11
to O 0 2.579891324443889e-13
hyperthermia B-Disease 0 3.758795355679467e-05
, O 0 8.882402625920438e-12
and O 0 1.939033308917537e-11
frequent O 0 3.717580057127634e-07
death O 0 5.197493464947911e-06
in O 0 1.4098799905326587e-10
infancy O 0 3.55190932221916e-10
) O 0 7.795111864683318e-16
with O 0 2.1284010964545564e-15
a O 0 3.726910002398859e-13
distinct O 0 6.553453335556014e-10
campomelic B-Disease 0 0.3946439027786255
- I-Disease 1 0.9985199570655823
metaphyseal I-Disease 0 0.08817784488201141
skeletal I-Disease 0 0.14164067804813385
dysplasia I-Disease 0 0.06727240234613419
. O 0 3.5514251095492e-08

The O 0 7.607682929802739e-13
similarity O 0 1.3333302344153974e-11
of O 0 2.096283894083631e-14
the O 0 1.8568512612920918e-13
clinical O 0 2.805271848149715e-10
and O 0 9.457360242159929e-12
radiographic O 0 0.00031934966682456434
findings O 0 4.618625482066818e-09
is O 0 3.684068241444072e-12
so O 0 5.174655056663577e-14
extensive O 0 1.1396766776833323e-12
that O 0 2.4679978061215024e-09
these O 0 3.774409396140044e-10
disorders O 0 2.1582084741567087e-07
appear O 0 8.693382125279925e-10
to O 0 1.2119524828158035e-10
be O 0 1.1277039746460105e-08
a O 0 1.518900283326019e-10
single O 0 1.1596265636626413e-07
entity O 0 5.813195912196534e-06
. O 0 3.0521836169583594e-09

The O 0 6.616711518969698e-12
follow O 0 1.672507965455594e-11
- O 0 3.648795399158189e-08
up O 0 4.306670645104482e-11
observation O 0 6.41882103025182e-10
of O 0 4.0140223908418857e-14
an O 0 1.657854388980532e-14
identical O 0 3.5688152877355606e-08
and O 0 3.127485249942996e-13
unique O 0 2.822061377985574e-12
pattern O 0 2.0418287505208355e-08
of O 0 3.261949087576821e-12
progressive O 0 1.0321997478968115e-06
bone B-Disease 0 0.459085613489151
dysplasia I-Disease 1 0.9931722283363342
in O 0 2.8556430109460962e-08
the O 0 2.9689074115824e-11
two O 0 9.383087362646592e-11
patients O 0 1.0496855988584297e-11
( O 0 4.318525314368944e-14
one O 0 5.119096986583305e-12
with O 0 2.622402572871607e-10
SJS B-Disease 1 0.9996869564056396
type I-Disease 1 0.7550266981124878
2 I-Disease 0 4.2453360826755215e-09
, O 0 1.309157751823442e-12
one O 0 4.187595582794135e-12
with O 0 1.996121670733153e-11
SWS B-Disease 0 1.202475004902226e-06
) O 0 1.625510300364355e-13
surviving O 0 8.732668477229311e-10
beyond O 0 5.795305901834524e-10
infancy O 0 6.313448375205866e-11
adds O 0 2.3629041431827424e-12
to O 0 8.686393813102183e-16
the O 0 1.1065401253704948e-15
evidence O 0 4.4861964837439317e-11
in O 0 7.26076967647038e-13
favor O 0 8.060431662404444e-12
of O 0 6.630237808433193e-13
identity O 0 1.219138539454434e-06
. O 0 1.0575315623206905e-10

The O 0 7.217252837032895e-12
hypothesis O 0 9.833428515904075e-11
that O 0 5.259666400331264e-13
SWS B-Disease 0 2.961794791644934e-07
and O 0 5.260153423947145e-11
SJS B-Disease 0 0.031150255352258682
type I-Disease 0 8.58890689414693e-06
2 I-Disease 0 6.939774449543634e-11
are O 0 1.3108968121081088e-12
the O 0 1.2413286544499247e-12
same O 0 4.5374495272199056e-08
disorder O 0 2.4451862827845616e-06
should O 0 1.2165375477823925e-11
be O 0 1.4079315580691094e-14
testable O 0 6.768694491617738e-14
by O 0 1.5220508406268914e-16
molecular O 0 6.550144541345171e-13
methods O 0 4.198807967981111e-12
. O 0 3.012673931938187e-13
. O 0 6.580426308022691e-12

A O 0 4.19575207910583e-11
mouse O 0 2.492997364100802e-09
model O 0 5.540704250961426e-08
of O 0 3.778958657107978e-08
severe O 1 0.9999963045120239
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999850988388062
defects O 1 0.9999991655349731
in O 0 3.9355406045160635e-08
hemostasis O 0 0.4126668870449066
and O 0 2.5989430696427007e-07
thrombosis B-Disease 0 0.0014522956917062402
. O 0 6.255642670538464e-09

von B-Disease 0 0.02854848839342594
Willebrand I-Disease 0 0.003429102012887597
factor I-Disease 0 2.971988351418986e-06
( I-Disease 0 2.221474559860326e-09
vWf I-Disease 0 0.0018096534768119454
) I-Disease 0 0.0005482628475874662
deficiency I-Disease 1 0.9999982118606567
causes O 1 0.9999164342880249
severe O 1 0.9999997615814209
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 7.637649105163291e-05
humans O 0 8.174817480721686e-07
. O 0 3.258582292886558e-10

We O 0 2.0213362927901102e-10
generated O 0 1.1333771378005397e-12
a O 0 1.0014281647040355e-14
mouse O 0 8.370323531514678e-12
model O 0 6.632294019537355e-11
for O 0 1.5927752552210434e-13
this O 0 2.7710866587482563e-11
disease O 0 6.029682864117092e-10
by O 0 1.3182866096019268e-15
using O 0 1.0310643398098174e-12
gene O 0 3.0253757832277017e-10
targeting O 0 5.444458661685303e-09
. O 0 2.0533116873444612e-11

vWf B-Disease 0 0.1686735600233078
- I-Disease 1 0.9999767541885376
deficient I-Disease 1 0.9737685322761536
mice O 0 0.0073840259574353695
appeared O 0 9.155045859188249e-07
normal O 0 1.2479426381162284e-08
at O 0 5.2119066007438875e-11
birth O 0 2.2314446124216403e-10
; O 0 2.3077736214529264e-14
they O 0 5.077668428950244e-13
were O 0 6.822331870444398e-13
viable O 0 3.9613659574833093e-11
and O 0 4.107228446237343e-11
fertile O 0 7.102267218783709e-09
. O 0 3.1187172844227007e-09

Neither O 0 2.2811586859461386e-06
vWf O 0 2.596943886601366e-05
nor O 0 3.067311581617105e-06
vWf O 0 2.160230178560596e-05
propolypeptide O 0 0.00012002746370853856
( O 0 5.071114084209682e-10
von B-Disease 0 0.00040959619218483567
Willebrand I-Disease 0 0.00010984596883645281
antigen O 0 1.291115131607512e-05
II O 0 0.001426086644642055
) O 0 4.141005593982783e-11
were O 0 6.696910248571442e-10
detectable O 0 2.5697187084006146e-05
in O 0 2.211840086085992e-12
plasma O 0 3.838210194118119e-09
, O 0 4.154497655183692e-13
platelets O 0 4.3496803381337656e-11
, O 0 7.493890897365338e-14
or O 0 1.0636152332141324e-12
endothelial O 0 2.107262064496296e-12
cells O 0 6.7928057926811e-13
of O 0 3.3880318391294253e-15
the O 0 5.435213368785996e-13
homozygous O 0 1.042868618128523e-07
mutant O 0 4.6495639338672845e-08
mice O 0 5.085348675493151e-07
. O 0 1.52749396464813e-10

The O 0 8.516683192016927e-11
mutant O 0 6.191320949255896e-07
mice O 0 0.00012247728591319174
exhibited O 0 0.00010058691987069324
defects O 1 0.9993834495544434
in O 0 1.2097762895624253e-11
hemostasis O 0 7.095410182955675e-06
with O 0 6.8962539671868495e-12
a O 0 1.7232680560308467e-10
highly O 0 5.157540385880566e-07
prolonged O 0 0.00012552912812680006
bleeding O 0 0.06424582004547119
time O 0 3.84079044124519e-07
and O 0 2.1579774078794856e-10
spontaneous O 0 1.799801196966655e-09
bleeding O 0 8.889928437838535e-08
events O 0 3.1578548803645745e-11
in O 0 1.0342590499312632e-12
approximately O 0 7.14780272188624e-14
10 O 0 3.060788113847662e-13
% O 0 9.169211613938022e-14
of O 0 4.861866551714167e-12
neonates O 0 5.1210987294325605e-05
. O 0 7.796904788470727e-10

As O 0 1.2920468514532324e-11
in O 0 1.2382545076100593e-12
the O 0 5.966864372389247e-13
human O 0 1.503508428868372e-10
disease O 0 7.253157185971304e-09
, O 0 5.9480607025931575e-16
the O 0 1.5041414142181629e-15
factor O 0 8.223407198248989e-12
VIII O 0 6.657219842054474e-08
level O 0 4.556342787509493e-07
in O 0 3.724566662033357e-12
these O 0 4.258118163624758e-12
mice O 0 9.852889171213519e-09
was O 0 1.3139879184720371e-09
reduced O 0 7.461469636593776e-11
strongly O 0 1.2322660253305528e-11
as O 0 1.300212853507475e-14
a O 0 5.2650334721356107e-14
result O 0 3.5717859225847803e-11
of O 0 1.1900286901462675e-14
the O 0 4.220629650896618e-13
lack O 0 4.882294221686401e-11
of O 0 6.950172147599919e-15
protection O 0 2.758125498825148e-11
provided O 0 2.3798918022920057e-13
by O 0 9.685176922610839e-13
vWf O 0 1.1012509126828718e-08
. O 0 7.304828408827291e-10

Defective O 0 0.007190607953816652
thrombosis B-Disease 0 0.019681517034769058
in O 0 2.3761046463732782e-09
mutant O 0 1.9820083707600133e-07
mice O 0 3.872807792504318e-05
was O 0 3.2931484206244477e-09
also O 0 5.526328960420157e-12
evident O 0 4.916029805457356e-10
in O 0 1.930119238535092e-14
an O 0 3.661950541689323e-16
in O 0 3.309444190045807e-13
vivo O 0 1.4312420137940762e-09
model O 0 9.735007244771055e-11
of O 0 5.8014712825404935e-12
vascular B-Disease 0 0.0017728640232235193
injury I-Disease 1 0.9996408224105835
. O 0 1.496020907154616e-08

In O 0 2.2313923278560743e-11
this O 0 2.7907823011634296e-14
model O 0 1.5012152979054783e-11
, O 0 1.89220892372801e-15
the O 0 1.87109256175955e-14
exteriorized O 0 1.248361680694643e-08
mesentery O 0 8.318069788515459e-09
was O 0 9.045385968020625e-12
superfused O 0 3.1475316797369146e-10
with O 0 3.115403781847083e-14
ferric O 0 7.049463096597819e-11
chloride O 0 1.3462563008825867e-10
and O 0 6.187522022527148e-11
the O 0 7.243603503473417e-13
accumulation O 0 8.106338378333078e-10
of O 0 1.679689644751986e-13
fluorescently O 0 6.796891227622837e-08
labeled O 0 7.308793215088372e-08
platelets O 0 8.29851565242734e-09
was O 0 1.196451410168109e-10
observed O 0 1.236605349369535e-11
by O 0 6.001216911648635e-14
intravital O 0 1.5417142007478901e-09
microscopy O 0 8.462620049165537e-10
. O 0 1.7371140983990507e-11

We O 0 7.236626853313055e-10
conclude O 0 5.405400085867207e-12
that O 0 3.2127205830032556e-15
these O 0 2.7533576750483034e-15
mice O 0 1.369518127375402e-11
very O 0 4.027690995393046e-13
closely O 0 7.2831292108332946e-09
mimic O 0 0.0028661717660725117
severe O 1 0.9416756629943848
human O 1 0.9818011522293091
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9541195631027222
will O 0 1.0063417903438676e-05
be O 0 1.5001941355841097e-10
very O 0 1.1734978257410631e-14
useful O 0 8.02380070192573e-16
for O 0 2.084200667335561e-17
investigating O 0 2.55439088934703e-13
the O 0 4.777708820745668e-15
role O 0 8.16143214208559e-13
of O 0 2.8889305922122745e-15
vWf O 0 2.271907141582208e-11
in O 0 1.2655208825318454e-10
normal O 0 2.798210196885975e-08
physiology O 0 5.118870216591631e-09
and O 0 4.459551217889102e-12
in O 0 1.9618565452739212e-11
disease O 0 2.2353050521672913e-09
models O 0 1.9897961750503512e-11
. O 0 5.245010155363605e-13
. O 0 1.477597037780054e-11

Oral O 0 1.3552293012253358e-06
contraceptives O 0 0.00011684199853334576
and O 0 7.102449878226835e-11
the O 0 1.602864542482596e-11
risk O 0 2.0371206119307317e-05
of O 0 3.049246899422542e-08
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.629503680713242e-06

Hereditary B-Disease 1 0.9999920129776001
Ovarian I-Disease 1 0.9999910593032837
Cancer I-Disease 1 0.9991638660430908
Clinical O 0 0.0004769678052980453
Study O 0 1.7585095690719754e-07
Group O 0 6.37044266227349e-08
. O 0 5.038882644470277e-10

BACKGROUND O 0 0.08457072824239731
Women O 0 2.9482680741210743e-09
with O 0 2.534967136376409e-13
mutations O 0 2.157690470738771e-09
in O 0 2.7312264862938695e-12
either O 0 6.352281894939082e-11
the O 0 1.37657268396707e-12
BRCA1 O 0 9.812206602788365e-10
or O 0 7.307235372344678e-11
the O 0 1.4896050159422108e-13
BRCA2 O 0 1.382499670299353e-10
gene O 0 1.750979916614881e-10
have O 0 3.7051100035268014e-12
a O 0 2.892870405030168e-13
high O 0 3.1845667769481167e-10
lifetime O 0 5.190130423216033e-07
risk O 0 0.00035767219378612936
of O 0 7.782151442370377e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.535085953553789e-07

Oral O 0 4.9105346988653764e-05
contraceptives O 1 0.9560683965682983
protect O 0 0.22607098519802094
against O 1 0.9999815225601196
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 3.8811524660786745e-08
general O 0 4.666757605353844e-11
, O 0 1.851113012873995e-12
but O 0 9.051173005536484e-11
it O 0 5.150021576728891e-13
is O 0 1.4391694216561723e-13
not O 0 1.3253819293153682e-14
known O 0 5.53632211621846e-15
whether O 0 4.754896996972402e-12
they O 0 3.694355585337483e-12
also O 0 2.3426911994507693e-13
protect O 0 1.9525769889838784e-10
against O 0 3.90442238540345e-08
hereditary B-Disease 0 0.01592443510890007
forms I-Disease 0 2.9900187655584887e-05
of I-Disease 0 0.09309110790491104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.8265491519287025e-07

METHODS O 0 4.2845837988636504e-10
We O 0 1.5794539287572462e-11
enrolled O 0 4.807937901973869e-12
207 O 0 2.854429713428086e-11
women O 0 4.6092596406310804e-10
with O 0 2.590104770661128e-07
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.0625005586462066e-07
161 O 0 6.465593251764323e-12
of O 0 3.405774739919515e-13
their O 0 1.6109874545477965e-10
sisters O 0 1.9879499435493386e-10
as O 0 6.200937116215832e-13
controls O 0 1.4943724480076526e-08
in O 0 2.745600621856248e-12
a O 0 1.1869017053911524e-12
case O 0 1.8971519466504105e-08
- O 0 0.001643648836761713
control O 0 1.2613587614396238e-06
study O 0 3.6438188577569974e-10
. O 0 9.840333409227853e-11

All O 0 1.1245619019328856e-11
the O 0 2.6039535111488377e-12
patients O 0 5.8013606939189e-12
carried O 0 6.412488161994245e-12
a O 0 6.458293101696544e-13
pathogenic O 0 1.8787625322147505e-07
mutation O 0 5.500845556838385e-09
in O 0 1.6298815324732735e-13
either O 0 1.7560418180337378e-12
BRCA1 O 0 9.927485916660928e-11
( O 0 2.494461885313437e-13
179 O 0 6.599581992006165e-12
women O 0 7.582006550377329e-11
) O 0 3.492184568864437e-13
or O 0 1.1966477808655895e-10
BRCA2 O 0 7.1747976448932604e-09
( O 0 2.743466218091406e-11
28 O 0 4.092577832182087e-09
women O 0 1.5222501037470693e-10
) O 0 3.5553354964940054e-12
. O 0 5.264680011385359e-11

The O 0 3.0562174319070934e-11
control O 0 3.5601196657353285e-08
women O 0 5.306277639505197e-10
were O 0 8.022684079567188e-12
enrolled O 0 4.796305280024837e-12
regardless O 0 1.5309999101820182e-10
of O 0 1.7491729051448998e-15
whether O 0 1.4652422070798865e-12
or O 0 9.294224417866204e-11
not O 0 5.551083898103215e-11
they O 0 4.134389445381581e-12
had O 0 4.01151637949293e-12
either O 0 3.359666364555203e-11
mutation O 0 7.256284462187068e-09
. O 0 1.1769516784776446e-11

Lifetime O 0 1.523759891597365e-07
histories O 0 6.128568230678866e-08
of O 0 1.7452565000825038e-12
oral O 0 1.5250726237425738e-09
- O 0 7.414546754347384e-09
contraceptive O 0 2.0603781181183223e-10
use O 0 1.1616383853094159e-12
were O 0 1.043544591017298e-12
obtained O 0 6.833688346100097e-13
by O 0 1.4063426089633551e-14
interview O 0 1.9081989321989568e-08
or O 0 1.0164590523442651e-11
by O 0 2.785292722983922e-15
written O 0 7.317559644164084e-14
questionnaire O 0 1.0185035188283939e-13
and O 0 2.2366897694863982e-14
were O 0 5.801114254765094e-13
compared O 0 3.1415262752299e-11
between O 0 2.8092688765524176e-12
patients O 0 6.7907884176987565e-12
and O 0 6.183557832439845e-11
control O 0 2.6247800633427687e-05
women O 0 4.6097805572742345e-09
, O 0 6.809377060557889e-15
after O 0 4.523402594332204e-14
adjustment O 0 1.8970840523491184e-11
for O 0 1.0722337028199196e-15
year O 0 2.7780322530215895e-13
of O 0 2.1618784643321828e-14
birth O 0 5.11274222958491e-09
and O 0 5.900099159239502e-11
parity O 0 1.2694191475759453e-08
. O 0 1.8162487139261607e-11

RESULTS O 0 5.171263417480532e-09
The O 0 2.5176696664963583e-12
adjusted O 0 2.290986776642967e-05
odds O 0 0.04747587814927101
ratio O 1 0.635247528553009
for O 0 0.00017408707935828716
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.476172747061355e-05
with O 0 4.615709940994361e-13
any O 0 1.0169050497499388e-11
past O 0 1.4260794801990162e-11
use O 0 7.674325855789449e-14
of O 0 4.627298978016059e-14
oral O 0 1.6495306509600738e-10
contraceptives O 0 2.1070991351734847e-06
was O 0 4.068613890240158e-09
0 O 0 6.729417717510344e-11
. O 0 4.8535090876877796e-12

5 O 0 6.499151911087964e-11
( O 0 1.7598967530681187e-13
95 O 0 8.651523941693995e-12
percent O 0 6.690302711831464e-08
confidence O 0 6.987172582739731e-06
interval O 0 5.442774009267737e-10
, O 0 4.640262478460607e-15
0 O 0 1.2272001381134594e-14
. O 0 2.7427580635650407e-16
3 O 0 8.23262322842324e-15
to O 0 5.275447572815513e-14
0 O 0 4.453694357753335e-12
. O 0 1.8524790805062724e-13
8 O 0 2.6968644331604175e-12
) O 0 8.706938300776304e-14
. O 0 9.34867634694303e-12

The O 0 1.226865692371959e-10
risk O 0 4.989966555513092e-07
decreased O 0 8.554196795351743e-10
with O 0 2.197255303594027e-14
increasing O 0 1.3238326233844244e-11
duration O 0 5.145041614973422e-10
of O 0 1.0901082155893534e-15
use O 0 2.857128596212011e-13
( O 0 3.001379594619498e-14
P O 0 7.1593366790523305e-09
for O 0 3.2883076009305665e-14
trend O 0 1.1926312160071006e-09
, O 0 1.1787516322997026e-14
< O 0 5.507724051140306e-12
0 O 0 1.2392604303856913e-13
. O 0 1.724505744003858e-16
001 O 0 3.064886016894831e-15
) O 0 2.7834617272651724e-18
; O 0 1.0551779557546672e-18
use O 0 1.4161613725362796e-15
for O 0 8.810312234538292e-14
six O 0 1.5192744794428198e-13
or O 0 1.3744797834613909e-11
more O 0 1.4201472300651857e-13
years O 0 1.4522669178340664e-10
was O 0 2.18600988005635e-11
associated O 0 2.3880515620522402e-11
with O 0 5.2228654615158604e-14
a O 0 5.78579068336027e-12
60 O 0 7.257671460342285e-12
percent O 0 2.045019931173897e-09
reduction O 0 3.79590886501191e-10
in O 0 6.796963547550661e-10
risk O 0 7.15514033799991e-05
. O 0 8.745069668414374e-10

Oral O 0 6.9474253905355e-07
- O 0 1.4537268100411893e-07
contraceptive O 0 4.478335924318344e-09
use O 0 8.550506136462133e-11
protected O 0 0.10464407503604889
against O 1 0.9997363686561584
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 1.960741638495911e-11
for O 0 2.501946268435376e-14
carriers O 0 5.609264138242698e-13
of O 0 1.4532995321086444e-15
the O 0 5.47587853966941e-13
BRCA1 O 0 2.5689773863746268e-08
mutation O 0 3.911488732910584e-08
( O 0 1.823773987733035e-12
odds O 0 4.383708437671885e-05
ratio O 0 7.96899939814466e-07
, O 0 1.936800549719739e-15
0 O 0 6.523381891631631e-15
. O 0 1.6533180510919525e-16
5 O 0 1.7940856625027566e-15
; O 0 4.1635184544279967e-16
95 O 0 1.2034645469841815e-13
percent O 0 6.685289832830676e-08
confidence O 0 2.3416987460223027e-05
interval O 0 1.4708213813552362e-10
, O 0 7.483260803283886e-15
0 O 0 1.3101905628129518e-14
. O 0 5.95982599023052e-16
3 O 0 1.1863074202990952e-14
to O 0 1.2112344818532988e-13
0 O 0 2.473111559292418e-12
. O 0 4.729908888059624e-14
9 O 0 4.170041861730617e-13
) O 0 3.3513824705071855e-16
and O 0 1.9640849209068105e-14
for O 0 9.942113592901342e-15
carriers O 0 1.5970654703226228e-12
of O 0 1.650628859127274e-14
the O 0 7.286842136633442e-12
BRCA2 O 0 8.969484355247914e-08
mutation O 0 2.512890091566078e-07
( O 0 4.525771684499302e-12
odds O 0 0.00022242993873078376
ratio O 0 2.131209384970134e-06
, O 0 4.709058917953075e-15
0 O 0 2.6238082209304944e-14
. O 0 2.2561138125658036e-16
4 O 0 3.8795108483124716e-15
; O 0 1.4225450363432616e-15
95 O 0 1.3172279022741207e-12
percent O 0 3.541256091921241e-06
confidence O 0 0.0010467285756021738
interval O 0 3.649076874001622e-10
, O 0 5.7577428813778385e-15
0 O 0 2.39501784561353e-14
. O 0 3.4084470801637077e-16
2 O 0 8.286248037280963e-15
to O 0 3.831414623501478e-13
1 O 0 9.277269057139659e-12
. O 0 8.236714804134293e-13
1 O 0 2.3908533573063773e-12
) O 0 3.9791428615640334e-13
. O 0 1.2129278484374062e-11

CONCLUSIONS O 0 2.0861111948988764e-08
Oral O 0 4.8917883077592705e-09
- O 0 4.3062313714870015e-09
contraceptive O 0 1.8319268324518134e-10
use O 0 3.645998433721154e-12
may O 0 4.537520706393572e-11
reduce O 0 7.022217876628822e-12
the O 0 4.543909519483247e-12
risk O 0 0.0001037026013364084
of O 0 5.847776378686831e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 3.7069844438519794e-07
women O 0 3.617456056925761e-10
with O 0 2.1328614872515028e-13
pathogenic O 0 5.8622799947727344e-09
mutations O 0 2.447828606477742e-10
in O 0 1.8972703182823514e-13
the O 0 2.5164679368083753e-13
BRCA1 O 0 3.6439598005699736e-09
or O 0 6.2045342197336595e-09
BRCA2 O 0 5.092335413792171e-06
gene O 0 9.18116929824464e-05

A O 0 6.806498697997654e-10
Japanese O 0 2.7496623644651663e-08
family O 0 8.220903124911416e-11
with O 0 9.345681346861756e-12
adrenoleukodystrophy B-Disease 1 0.9999998807907104
with O 0 1.1168581684484202e-11
a O 0 2.349314753152809e-12
codon O 0 1.1588903447989907e-11
291 O 0 5.111208561969262e-14
deletion O 0 2.825820957438885e-12
: O 0 8.623836237134364e-14
a O 0 1.0697631067655214e-13
clinical O 0 2.1352865309243185e-10
, O 0 6.440895451535755e-14
biochemical O 0 9.345803242410966e-09
, O 0 6.790133911952281e-14
pathological O 0 9.968727177067649e-09
, O 0 7.326444680967603e-13
and O 0 1.4108745421959057e-11
genetic O 0 7.174704563794876e-08
report O 0 5.7140020714996353e-08
. O 0 1.4559167760275216e-10

We O 0 1.2971255181071228e-08
report O 0 8.49208810910218e-12
a O 0 6.947524830826571e-14
Japanese O 0 1.0306097086854038e-09
family O 0 4.081395291177792e-11
with O 0 3.2568547858602415e-10
adrenoleukodystrophy B-Disease 1 1.0
( O 0 9.631258457432068e-09
ALD B-Disease 1 1.0
) O 0 1.2054362499500093e-12
with O 0 2.308918301777846e-14
a O 0 1.1140725928587836e-12
three O 0 8.470148952881285e-13
base O 0 1.3751333405309651e-10
pair O 0 6.419616505048964e-10
deletion O 0 1.7412482566925291e-10
( O 0 3.519115608727891e-14
delGAG O 0 1.0096190376784886e-11
291 O 0 1.79789668396102e-13
) O 0 1.9760338452871375e-14
in O 0 1.0636071016978388e-12
the O 0 6.807832075850229e-11
ALD B-Disease 1 0.9999995231628418
gene O 0 8.332363563567924e-07
. O 0 1.0029675978628916e-09

A O 0 9.721647098448472e-11
variety O 0 8.539293577802809e-11
of O 0 5.618304866478185e-12
phenotypes O 0 4.811782673641574e-06
were O 0 6.284748832463549e-10
observed O 0 4.910887696496502e-09
within O 0 1.2171009642833464e-12
this O 0 1.7060400943520737e-13
family O 0 7.296108162080372e-11
. O 0 2.531379619807872e-11

While O 0 1.8178090976928019e-10
the O 0 6.320779403351517e-13
proband O 0 1.7116938977324025e-07
( O 0 5.020870004479594e-12
patient O 0 3.1172719960892437e-09
1 O 0 7.26443037668556e-12
) O 0 1.5266761921491068e-13
was O 0 2.4669988274439447e-10
classified O 0 9.001834277988507e-10
as O 0 1.8520066123045575e-12
having O 0 4.82557951930751e-11
a O 0 4.109228216486911e-14
rare O 0 2.342656450771141e-12
intermediate O 0 1.5759690427663564e-11
type O 0 1.4565520700671186e-07
of O 0 1.1059938555268989e-11
adult O 0 0.000982165220193565
cerebral O 0 0.003847551764920354
and O 0 1.706574970228303e-08
cerebello O 1 0.9987875819206238
- O 1 0.99998939037323
brain O 0 0.0012806501472368836
stem O 0 5.173108608147459e-09
forms O 0 1.2014785832903385e-09
, O 0 5.476066648746336e-13
his O 0 5.103381692933562e-12
younger O 0 9.283367963242029e-10
brother O 0 7.295600568113514e-09
( O 0 5.564087385279137e-12
patient O 0 9.703909675806699e-09
2 O 0 1.8812010976754223e-11
) O 0 3.2588213811496347e-12
and O 0 7.446062100235906e-10
nephew O 0 8.432089998677839e-06
( O 0 2.123459602598743e-10
patient O 0 8.159480557878851e-07
3 O 0 1.1866215475497821e-11
) O 0 8.737636807663873e-13
had O 0 4.096482708604299e-09
a O 0 4.896670624532362e-09
childhood O 1 0.9947768449783325
ALD B-Disease 1 0.9999998807907104
type O 1 0.6437873244285583
. O 0 4.026209143859205e-09

Another O 0 2.5028881189825825e-09
nephew O 0 5.536435878639168e-07
( O 0 7.997875972609592e-11
patient O 0 1.275506633646728e-07
4 O 0 2.408287458344205e-11
) O 0 8.80279193721939e-13
of O 0 1.8826152442530386e-11
patient O 0 3.5350516554899514e-05
1 O 0 3.1941174705174546e-10
was O 0 6.947061814699396e-10
classified O 0 7.729827333768924e-10
as O 0 1.673564412052464e-11
having O 0 1.0447016585146685e-08
an O 0 7.786314995539279e-12
adolescent O 0 6.497514732473064e-06
form O 0 1.1293543877854972e-09
. O 0 5.855080864591855e-10

The O 0 1.271010748905843e-12
tau O 0 2.396712342478402e-11
level O 0 1.1008512990073882e-09
in O 0 2.1646701358485343e-12
the O 0 1.1483820144819745e-10
cerebrospinal O 0 0.35693225264549255
fluid O 0 6.023829882906284e-06
( O 0 1.380576070131312e-10
CSF O 0 3.059863593080081e-05
) O 0 2.2896374466535585e-12
in O 0 5.4974629015713816e-11
patient O 0 1.2129296678153878e-08
1 O 0 7.634943025025542e-12
was O 0 1.827554663158537e-09
as O 0 1.079240776608037e-11
high O 0 2.1040512387937582e-10
as O 0 6.938682484483594e-13
that O 0 3.6304748270155063e-12
of O 0 6.953497673489739e-12
patients O 0 1.3725085512561463e-09
with O 0 5.9536017005257236e-08
Alzheimers B-Disease 1 0.9999035596847534
disease I-Disease 0 0.10963709652423859
( O 0 1.765297001458943e-12
AD B-Disease 0 2.2908031027668585e-09
) O 0 1.2762099536878235e-11
. O 0 2.461118288332731e-11

His O 0 5.673816083628935e-09
brain O 0 6.97179757480626e-07
magnetic O 0 1.0082854373649752e-07
resonance O 0 2.0507983208517544e-05
image O 0 0.0022050226107239723
( O 0 5.908883798921849e-11
MRI O 0 2.629738264658954e-05
) O 0 3.4760128803101864e-11
showed O 0 6.154182483442128e-05
abnormalities B-Disease 0 0.11745627224445343
in I-Disease 0 4.900120240125538e-12
the I-Disease 0 5.1796789080071903e-11
bilateral I-Disease 0 0.16349588334560394
cerebellar I-Disease 1 0.9999028444290161
hemispheres I-Disease 1 0.9988993406295776
and O 0 1.4602852616008022e-07
brain O 0 1.5926175933600462e-07
stem O 0 5.752620046983736e-10
, O 0 1.4728600554892585e-13
but O 0 1.965934793429769e-12
not O 0 1.474381489292853e-12
in O 0 6.628113856377293e-13
the O 0 1.2172571110802277e-11
cerebral O 0 1.937140041263774e-06
white O 0 1.5183513113470326e-08
matter O 0 2.9227047448898702e-08
, O 0 3.1554401917034203e-15
where O 0 4.734455506810601e-15
marked O 0 1.697571526708061e-13
reductions O 0 2.0235621511766055e-10
of O 0 8.566094170526627e-15
the O 0 1.1101256199019804e-11
cerebral O 0 2.9340319542825455e-06
blood O 0 9.019884394945166e-09
flow O 0 4.8808210806328134e-08
and O 0 7.624883835433138e-09
oxygen O 0 1.7815356967432194e-09
metabolism O 0 3.673909093615535e-11
were O 0 1.2574849202282717e-13
clearly O 0 2.0495269977688357e-12
demonstrated O 0 7.127708389871937e-14
by O 0 1.0521172420698693e-14
positron O 0 4.572147531689552e-07
emission O 0 7.3702726695046294e-06
tomography O 0 9.69871962297475e-07
( O 0 2.763111614512148e-11
PET O 0 3.163038115872041e-07
) O 0 1.1030297335234973e-11
. O 0 1.647335219623347e-11

In O 0 2.0418666757393567e-09
patients O 0 4.532972608384256e-10
2 O 0 2.4240019713683836e-11
and O 0 3.540557777514941e-11
3 O 0 6.246214483140999e-12
, O 0 1.8910335808104e-14
the O 0 3.9438016654486097e-14
autopsy O 0 7.386213951576792e-07
findings O 0 1.1066491056865857e-09
showed O 0 2.5980899209798736e-08
massive O 0 1.2980318331301532e-07
demyelination B-Disease 1 1.0
of I-Disease 0 1.0275164052941932e-09
the I-Disease 0 1.3976847457186636e-09
cerebral I-Disease 0 6.319412023003679e-06
white I-Disease 0 1.1132761379428757e-08
matter I-Disease 0 1.558982387628305e-10
with O 0 1.9855004972638883e-15
sparing O 0 5.407274563003217e-13
of O 0 1.189439307680909e-13
the O 0 2.6402168212119603e-12
U O 0 1.868268952875951e-07
- O 0 9.477542334934697e-06
fibers O 0 8.282734498266109e-09
, O 0 1.1025926130231109e-14
compatible O 0 5.753881258171306e-14
with O 0 1.6623600960401566e-14
the O 0 4.610410835113703e-14
findings O 0 1.114732091356263e-11
of O 0 1.1605891594990148e-11
childhood O 0 0.0004941421211697161
ALD B-Disease 1 0.9999994039535522
. O 0 1.205755495448102e-09

Oleic O 0 0.00616603996604681
and O 0 3.940976878169522e-09
erucic O 0 0.00014733998978044838
acids O 0 6.067546465260421e-10
( O 0 6.481626216650604e-14
Lorenzos O 0 6.46890541133871e-10
Oil O 0 6.911572009160594e-11
) O 0 3.6978184694781615e-15
were O 0 5.5960322638791415e-14
administered O 0 4.18253187075765e-13
to O 0 1.2230700393439653e-12
patients O 0 7.664021327291604e-12
1 O 0 3.539129438730887e-13
and O 0 6.873719909233911e-12
4 O 0 3.5203122968757716e-13
, O 0 4.015659112605865e-15
but O 0 2.3400563171210864e-13
sufficient O 0 7.874278486197372e-13
effectiveness O 0 3.242385093055189e-12
was O 0 5.0279256452734344e-11
not O 0 7.835729135853564e-13
obtained O 0 5.2087067298201006e-11
. O 0 1.2049335487707147e-11

The O 0 5.29363662279958e-12
findings O 0 6.903439625505214e-12
in O 0 9.474430788525279e-14
this O 0 6.298532760618241e-15
family O 0 1.1901524687649156e-12
suggest O 0 1.7853642175769124e-11
that O 0 1.8277349780686757e-14
delGAG291 O 0 7.620989776746523e-12
is O 0 2.96772528155919e-14
part O 0 2.35387389782701e-14
of O 0 3.871765917855957e-14
the O 0 3.874422050548221e-12
cause O 0 2.3069037791145774e-09
of O 0 4.0000936590844915e-12
Japanese O 0 0.0001445098896510899
ALD B-Disease 1 0.9999985694885254
with O 0 2.1172495180687978e-12
phenotypic O 0 1.2241647695532265e-08
variations O 0 2.3357775091881194e-07
. O 0 4.3261705329200595e-09

Moreover O 0 1.0918975945628517e-08
, O 0 1.1702127439804089e-13
although O 0 2.296301712147175e-13
the O 0 1.0229692289922491e-14
scale O 0 1.0658435911636843e-07
of O 0 1.0913582320845605e-12
the O 0 5.6981767394825855e-12
study O 0 3.098996319977898e-12
is O 0 1.425681621369801e-12
limited O 0 4.930305295969273e-13
, O 0 8.273744645133363e-14
there O 0 2.0852716255126413e-12
is O 0 1.5890338090490674e-13
a O 0 2.6453050700988613e-14
possibility O 0 1.4488962113423653e-11
that O 0 7.664762921577584e-13
PET O 0 2.9118988109644306e-08
can O 0 6.091875337510544e-10
detect O 0 2.306142960151192e-06
an O 0 3.870677216244456e-12
insidious B-Disease 0 0.00534091517329216
lesion I-Disease 1 0.9999654293060303
which O 0 2.3333529952651588e-07
is O 0 3.372643830878985e-10
undetectable O 0 9.952839663540658e-10
by O 0 3.8510238597468886e-15
computed O 0 4.658258223599887e-10
tomogram O 0 1.0899520397344986e-08
( O 0 3.1717396043557874e-14
CT O 0 4.7653482937448643e-08
) O 0 1.2668616427170126e-13
or O 0 2.9112931683450416e-12
MRI O 0 1.2083477551882993e-09
analysis O 0 1.4387866766052415e-11
, O 0 1.2622349454712023e-14
and O 0 1.4599576430608663e-13
that O 0 4.51971122474807e-14
the O 0 1.5829746096828606e-13
higher O 0 8.825000286094564e-09
level O 0 2.845190749667381e-10
of O 0 5.962827663237352e-16
tau O 0 2.152563134791459e-14
reflects O 0 9.130822183414655e-13
the O 0 2.441656644359654e-16
process O 0 2.193443909441267e-15
of O 0 2.7056294860528917e-15
neuronal B-Disease 0 4.0503078668763237e-10
degeneration I-Disease 0 4.064117575808268e-08
in O 0 2.3018928985152343e-09
ALD B-Disease 1 0.9999995231628418
. O 0 3.6769696176719435e-09

Lorenzos O 0 2.912626769102644e-06
Oil O 0 1.2288064965559897e-07
should O 0 1.7341190983177768e-10
be O 0 1.7830481286330163e-13
given O 0 1.644523106830286e-14
in O 0 6.111598094873374e-15
the O 0 1.1415398655642214e-14
early O 0 8.749165454624563e-12
stage O 0 2.7635085886323907e-10
. O 0 2.5060644748622907e-13
. O 0 2.4683941956399336e-12

Nonsense O 0 2.156682967324741e-06
mutation O 0 2.257543663120032e-08
in O 0 6.990516021945781e-13
exon O 0 6.764965254646427e-10
4 O 0 7.017039727053032e-11
of O 0 5.583901938922831e-13
human O 0 1.6664300495072837e-10
complement O 0 6.517229533820057e-10
C9 O 0 1.4901365696928792e-09
gene O 0 3.15426851305034e-10
is O 0 1.179670510581543e-12
the O 0 6.95181623855054e-15
major O 0 3.961326492524231e-12
cause O 0 1.0785381476807743e-09
of O 0 5.902753112685399e-12
Japanese O 0 6.466930790338665e-05
complement B-Disease 0 9.509760161563463e-07
C9 I-Disease 0 0.0007071137661114335
deficiency I-Disease 0 0.08544501662254333
. O 0 8.89637807865995e-11

Deficiency B-Disease 1 0.9995545744895935
of I-Disease 0 4.690546128588435e-12
the I-Disease 0 1.18494732255503e-12
ninth I-Disease 0 2.2883988107236242e-11
component I-Disease 0 1.5760051250146567e-11
of I-Disease 0 1.6158588342688428e-14
human I-Disease 0 1.138757491081499e-12
complement I-Disease 0 1.0657277144110466e-11
( O 0 8.607760568235014e-15
C9 O 0 1.280982524914931e-11
) O 0 2.2317795618428124e-15
is O 0 5.842838775874321e-15
the O 0 8.710550133966691e-16
most O 0 2.6551116787489927e-14
common O 0 1.9960616493008843e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.1036601632596899e-09
Japan O 0 7.991108077476383e-07
but O 0 8.336450453561017e-12
is O 0 1.7101115784416178e-14
rare O 0 8.958093056406213e-13
in O 0 4.747871475314913e-13
other O 0 1.4875039676572055e-13
countries O 0 7.820443945205646e-12
. O 0 1.9109895957325485e-11

We O 0 6.351873471643898e-10
studied O 0 2.6976375994136603e-11
the O 0 7.955017497323063e-15
molecular O 0 3.950747281405986e-12
basis O 0 4.032597606534738e-12
of O 0 2.736534956970793e-12
C9 B-Disease 1 0.5368743538856506
deficiency I-Disease 1 0.9983805418014526
in O 0 5.007578379734312e-11
four O 0 8.561452762012589e-12
Japanese O 0 2.8113603889323713e-07
C9 B-Disease 0 2.920253336924361e-06
- I-Disease 0 0.004235077183693647
deficient I-Disease 0 4.314160378271481e-06
patients O 0 1.0695612173705626e-09
who O 0 9.569147252364019e-09
had O 0 1.9948153351379005e-08
suffered O 0 0.00011800108768511564
from O 0 6.176624083309434e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 0.9999998807907104
. O 0 4.689513222189134e-10

Direct O 0 7.395581543001573e-12
sequencing O 0 1.89057849236951e-11
of O 0 5.425870256564602e-13
amplified O 0 1.5810407427707673e-09
C9 O 0 1.438604235737273e-09
cDNA O 0 1.0213331048947172e-11
and O 0 7.52385675463485e-13
DNA O 0 9.342674550660846e-11
revealed O 0 1.2887745315381949e-09
a O 0 4.971391137295611e-13
nonsense O 0 5.984902157196714e-11
substitution O 0 1.5898129438352698e-13
( O 0 2.1801967376626832e-15
CGA O 0 1.5526378793762063e-10
- O 0 2.9528282041724196e-08
- O 0 1.1884869755007799e-09
> O 0 1.0018648237408723e-12
TGA O 0 6.269025576433052e-11
) O 0 1.5393654910879698e-14
at O 0 6.840701101277005e-14
codon O 0 3.3166733790813974e-13
95 O 0 3.830570131653065e-15
in O 0 2.202112868139941e-15
exon O 0 1.7043082223278105e-11
4 O 0 2.1436836680766014e-11
in O 0 2.665658709391505e-12
the O 0 1.9499967612857105e-11
four O 0 4.686669941023069e-10
C9 B-Disease 0 6.582512469321955e-06
- I-Disease 0 0.002237590029835701
deficient I-Disease 0 5.109820904181106e-07
individuals O 0 6.183950018723294e-10
. O 0 2.626968365060378e-10

An O 0 3.0761469760332005e-12
allele O 0 2.1316579612573605e-09
- O 0 2.5946009230004563e-10
specific O 0 9.362180085001337e-13
polymerase O 0 1.357231826926153e-10
chain O 0 4.956836607838966e-10
reaction O 0 4.3686398942810456e-10
system O 0 6.222218486978681e-12
designed O 0 1.7836393473302792e-10
to O 0 1.29751136050682e-12
detect O 0 4.332795455752603e-08
exclusively O 0 9.857992200323906e-11
only O 0 2.6348239996060174e-12
one O 0 2.512912634596888e-14
of O 0 3.765332501088486e-15
the O 0 1.5252042250696318e-12
normal O 0 5.57811907775374e-10
and O 0 4.53703128669089e-13
mutant O 0 2.087954158527805e-12
alleles O 0 1.18369582798733e-12
indicated O 0 3.5756048122337347e-10
that O 0 9.703403445332492e-14
all O 0 1.2308477160942206e-14
the O 0 4.425002438036493e-14
four O 0 1.2457616318725662e-12
patients O 0 1.9136503091789908e-13
were O 0 1.5825150434869983e-14
homozygous O 0 2.031143048891737e-12
for O 0 2.401155954569103e-14
the O 0 2.1732737679781844e-13
mutation O 0 2.901229534391092e-10
in O 0 4.3657985619683856e-14
exon O 0 2.1676457503949642e-11
4 O 0 3.1399927796771365e-11
and O 0 1.3552263478100457e-11
that O 0 5.30193250414257e-12
the O 0 4.704999410909405e-12
parents O 0 1.098448176861666e-08
of O 0 5.660750080488386e-12
patient O 0 6.048416878456919e-08
2 O 0 3.431259443242851e-11
were O 0 6.416764897210214e-10
heterozygous O 0 8.339726775830059e-08
. O 0 2.842077406750576e-10

The O 0 1.0395005169139271e-11
common O 0 1.1996934695668315e-11
mutation O 0 3.490658040394834e-10
at O 0 2.018795287189734e-12
codon O 0 4.015068225809992e-12
95 O 0 8.136574774402286e-14
in O 0 3.082769296455269e-14
exon O 0 1.8979463833890264e-10
4 O 0 3.5526273589603363e-10
might O 0 1.2023572359964874e-08
be O 0 2.6284757356775934e-11
responsible O 0 3.8574272248625974e-11
for O 0 3.8578943642106345e-13
most O 0 1.1888961169714829e-11
Japanese O 0 1.894989145512227e-05
C9 B-Disease 0 3.791744529735297e-05
deficiency I-Disease 0 4.230300692142919e-05
. O 0 6.543651254534155e-13
. O 0 4.9289817019571025e-12

BRCA1 O 0 2.913030243689718e-07
required O 0 1.0735994038224561e-10
for O 0 6.202412986423128e-14
transcription O 0 2.8885577263437767e-10
- O 0 7.584499144286383e-06
coupled O 0 3.159648898076739e-08
repair O 0 8.558934894153936e-09
of O 0 1.7139165520846378e-13
oxidative O 0 1.1960097481278353e-06
DNA O 0 2.322017053302261e-06
damage O 0 0.00919373705983162
. O 0 1.930915871639627e-09

The O 0 4.777433915137408e-08
breast B-Disease 1 0.9999936819076538
and I-Disease 1 0.9999971389770508
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999953508377075
gene O 0 0.02486378699541092
BRCA1 O 0 5.2300265451776795e-06
encodes O 0 3.6647165302383655e-09
a O 0 7.861519768503911e-10
zinc O 0 0.01609146222472191
finger O 0 7.421209829772124e-06
protein O 0 7.039743010750499e-09
of O 0 7.423224361591263e-12
unknown O 0 4.952399876856362e-07
function O 0 5.8474056707780164e-09
. O 0 1.8394405443267203e-10

Association O 0 5.028877869683868e-10
of O 0 1.2490491496999767e-13
the O 0 2.7956142853143365e-14
BRCA1 O 0 2.0577026194068537e-11
protein O 0 1.4989475860625184e-13
with O 0 1.7851221480966748e-15
the O 0 7.688651046400003e-15
DNA O 0 1.6898853150149051e-10
repair O 0 8.289269270989053e-11
protein O 0 7.409866448725155e-13
Rad51 O 0 1.959486461977633e-10
and O 0 1.7432927388975894e-13
changes O 0 3.99074138535474e-13
in O 0 1.043124992071052e-15
the O 0 3.0822705078693887e-17
phosphorylation O 0 4.1159249436711984e-15
and O 0 9.368725650685857e-15
cellular O 0 2.18215419692247e-13
localization O 0 1.3172373348330213e-13
of O 0 9.410840446460696e-17
the O 0 2.5783918495459357e-16
protein O 0 1.0436549594103253e-14
after O 0 1.345255829475478e-13
exposure O 0 4.1271346162830014e-07
to O 0 2.605467382642279e-13
DNA O 0 6.825082010664119e-08
- O 0 2.2033442292013206e-05
damaging O 0 3.658740155287887e-08
agents O 0 1.293908269417443e-08
are O 0 1.0954373259181027e-12
consistent O 0 1.7549042080622357e-11
with O 0 3.7199585342908496e-16
a O 0 2.365822949262279e-15
role O 0 4.874083450213951e-13
for O 0 9.728897612385542e-15
BRCA1 O 0 8.827882001793963e-12
in O 0 2.7009815282801053e-13
DNA O 0 1.1460368209981198e-09
repair O 0 9.792434241262526e-08
. O 0 1.1759244966658144e-10

Here O 0 6.170700572738497e-08
, O 0 9.791826908762263e-14
it O 0 1.9075962936544212e-14
is O 0 6.730147292737616e-15
shown O 0 6.970331972201704e-13
that O 0 2.23321557914994e-14
mouse O 0 5.247259293739148e-10
embryonic O 0 1.6480691256148816e-09
stem O 0 3.6761434785148595e-08
cells O 0 2.3691820061344515e-08
deficient B-Disease 0 3.4260136061448065e-08
in I-Disease 0 1.1809063926379593e-12
BRCA1 I-Disease 0 4.717484736183053e-10
are O 0 1.1173199952058122e-12
defective O 0 3.131190862148969e-10
in O 0 9.6040105664226e-14
the O 0 4.541808281462861e-14
ability O 0 1.8452026365189944e-11
to O 0 3.720418341891102e-13
carry O 0 3.142331117533814e-10
out O 0 5.987753695646525e-12
transcription O 0 5.509741534542867e-12
- O 0 2.9589056538270597e-08
coupled O 0 1.5433323508062813e-09
repair O 0 8.400464213131897e-10
of O 0 1.4531117872558855e-14
oxidative O 0 1.3819638411405322e-07
DNA O 0 4.603580237017013e-06
damage O 0 0.4571928083896637
, O 0 3.1944310478065896e-12
and O 0 6.345594622675366e-12
are O 0 4.19457394165712e-12
hypersensitive O 0 2.6583127237245208e-06
to O 0 8.201240575544944e-09
ionizing O 1 0.9999972581863403
radiation O 1 0.9999990463256836
and O 0 2.548993904838426e-09
hydrogen O 0 3.585086716384467e-08
peroxide O 0 9.122261701577372e-08
. O 0 7.174996013992185e-11

These O 0 6.306982280185336e-12
results O 0 6.698375881741825e-11
suggest O 0 6.246551192967686e-11
that O 0 7.825717748518105e-14
BRCA1 O 0 1.6245820660953925e-11
participates O 0 3.224327705872443e-12
, O 0 7.126210157994833e-15
directly O 0 2.6444994740033867e-13
or O 0 1.2768063516188644e-11
indirectly O 0 3.2881524170136345e-09
, O 0 2.5083505151429764e-13
in O 0 2.6042154001836015e-13
transcription O 0 3.066190357170484e-11
- O 0 5.572021422040052e-08
coupled O 0 1.877317634679798e-09
repair O 0 2.508516727672827e-10
of O 0 2.7397595775196723e-14
oxidative O 0 6.3916438364231e-08
DNA O 0 3.876492655763286e-07
damage O 0 0.0002817731292452663
. O 0 2.757941444664347e-11
. O 0 8.936310025298155e-11

Truncation O 0 1.643113911597993e-08
mutations O 0 3.1749864319863264e-06
in O 0 6.372471994531281e-12
the O 0 3.89605096231746e-13
transactivation O 0 4.115092337997339e-07
region O 0 4.11359879493034e-09
of O 0 7.33759082140184e-13
PAX6 O 0 4.0151380176212115e-07
result O 0 5.74385481399986e-08
in O 0 5.6079228066829856e-11
dominant O 0 4.4897649331687717e-07
- O 0 9.31826616579201e-06
negative O 0 4.664379673613439e-07
mutants O 0 1.3117467112522263e-09
. O 0 5.690389132118057e-12

PAX6 O 0 1.7083004422602244e-05
is O 0 4.479407816893044e-11
a O 0 8.775662488358371e-14
transcription O 0 8.36285034278017e-13
factor O 0 1.7013454447351029e-12
with O 0 6.470739640992724e-15
two O 0 2.0962239241509653e-14
DNA O 0 5.285633708496107e-09
- O 0 4.081008228240535e-05
binding O 0 1.8624486397555984e-09
domains O 0 1.2988007336289797e-09
( O 0 1.112810540872429e-13
paired O 0 2.8879201252607345e-09
box O 0 1.2296968776581707e-08
and O 0 1.5717175824714325e-12
homeobox O 0 6.952489799150197e-12
) O 0 3.1023480225739197e-13
and O 0 5.433865705485597e-13
a O 0 2.493154988014723e-12
proline O 0 4.152124404299684e-07
- O 0 1.2477523014808867e-08
serine O 0 3.3345851080390787e-10
- O 0 7.995378803471453e-10
threonine O 0 1.3120431824331646e-11
( O 0 9.878563251967693e-15
PST O 0 1.3207166471573828e-09
) O 0 8.707740474858672e-13
- O 0 1.0515748272155179e-08
rich O 0 1.1977512315297645e-09
transactivation O 0 2.0555920343667822e-07
domain O 0 3.9479890467930545e-09
. O 0 2.99031563399943e-11

PAX6 O 0 0.00016821094322949648
regulates O 0 6.648958219557244e-07
eye O 0 7.279726560227573e-06
development O 0 2.4374611704014448e-11
in O 0 2.151965888472218e-12
animals O 0 3.048781062678363e-12
ranging O 0 2.0214394394479918e-11
from O 0 1.429632101720632e-13
jellyfish O 0 4.561050322149374e-12
to O 0 1.1538906223747258e-14
Drosophila O 0 2.1746617161655553e-14
to O 0 2.8554930772348164e-14
humans O 0 8.345869134673833e-12
. O 0 2.7560521139585736e-12

Heterozygous O 0 1.6730741663195658e-06
mutations O 0 3.1791494166100165e-06
in O 0 8.028333206566707e-12
the O 0 1.7356916685168366e-13
human O 0 1.5144494816196619e-12
PAX6 O 0 9.584052662603426e-09
gene O 0 7.173565741425136e-09
result O 0 6.723210876913299e-10
in O 0 5.125872396352128e-14
various O 0 7.450507225059688e-14
phenotypes O 0 8.116491478915577e-09
, O 0 2.8361908904327854e-14
including O 0 9.370242429196374e-12
aniridia B-Disease 1 1.0
, O 0 1.2536354176972964e-07
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 2.3495152490227156e-09
autosomal B-Disease 1 0.7730511426925659
dominant I-Disease 0 0.0005090449121780694
keratitis I-Disease 1 0.535640299320221
, O 0 2.6301569255871016e-10
and O 0 8.416694563528893e-10
familial B-Disease 0 0.2040468007326126
foveal I-Disease 1 0.9502001404762268
dysplasia I-Disease 1 0.9981783628463745
. O 0 1.0945774420179077e-07

It O 0 4.3743991068323496e-11
is O 0 7.881145280656809e-13
believed O 0 1.2955806566461447e-11
that O 0 1.7038963894878446e-14
the O 0 6.260087205691789e-15
mutated O 0 4.1423958013764306e-11
allele O 0 8.58370579476242e-12
of O 0 3.550599696322391e-15
PAX6 O 0 1.4645459289752694e-09
produces O 0 1.5857073683636647e-12
an O 0 4.263898211424736e-15
inactive O 0 2.464693206472024e-11
protein O 0 6.409369562865308e-12
and O 0 6.52878806572943e-10
aniridia B-Disease 1 1.0
is O 0 3.3431194879085524e-07
caused O 0 4.553442956023446e-09
due O 0 2.362450339521427e-11
to O 0 1.5767680130313044e-12
genetic O 0 9.433706082973004e-08
haploinsufficiency O 0 0.00017019908409565687
. O 0 7.44217187875762e-10

However O 0 4.426919386624206e-10
, O 0 5.704616551409575e-15
several O 0 9.240694291367765e-16
truncation O 0 4.698795519342269e-11
mutations O 0 4.380233633582975e-07
have O 0 1.723234228923065e-11
been O 0 1.9171686807539778e-13
found O 0 2.0116831919887723e-13
to O 0 3.9239352869410715e-13
occur O 0 2.6883728576621024e-10
in O 0 3.338296436158905e-13
the O 0 1.8851942576447733e-12
C O 0 9.800768197010257e-08
- O 0 4.026011524160822e-08
terminal O 0 1.5347650234032173e-11
half O 0 3.882549663714041e-13
of O 0 1.1822093901969841e-15
PAX6 O 0 2.2246451902852016e-10
in O 0 1.1821932321964823e-12
patients O 0 2.65629830414546e-13
with O 0 3.2942726779956744e-13
Aniridia B-Disease 1 1.0
resulting O 0 2.081467886938526e-09
in O 0 8.110687143604578e-13
mutant O 0 2.5059797986726196e-12
proteins O 0 3.3743935922390944e-14
that O 0 1.0624502816967193e-14
retain O 0 2.7412575247937054e-12
the O 0 1.5491441476508418e-14
DNA O 0 3.0698316111354984e-10
- O 0 2.9019409097941207e-08
binding O 0 4.9713771294035425e-11
domains O 0 1.629175405692962e-10
but O 0 2.927935394136938e-10
have O 0 2.5507226539267513e-11
lost O 0 9.987468629901741e-10
most O 0 2.2577348112806997e-14
of O 0 8.577014966315577e-15
the O 0 4.4396981208581765e-13
transactivation O 0 8.16861245311884e-09
domain O 0 1.9779697879585e-09
. O 0 6.322136564262948e-11

It O 0 2.208747768017716e-10
is O 0 2.5478573244253067e-12
not O 0 6.527778670254239e-14
clear O 0 6.320101776993714e-14
whether O 0 3.076519548557248e-14
such O 0 1.3275677825390526e-14
mutants O 0 3.073333254555166e-11
really O 0 2.4491081385136226e-10
behave O 0 5.2609236411704785e-12
as O 0 2.4723451774342695e-14
loss O 0 4.6601576764171426e-11
- O 0 9.477816753644674e-09
of O 0 2.3915978572541796e-11
- O 0 5.4176598496269435e-06
function O 0 1.3081058458652706e-10
mutants O 0 5.979125614757885e-12
as O 0 3.7469224093865036e-14
predicted O 0 5.226318509909955e-12
by O 0 2.5148847305860034e-13
haploinsufficiency O 0 1.3189599030738464e-06
. O 0 1.0743286815717568e-10

Contrary O 0 9.104714759899935e-10
to O 0 1.8317282640765292e-13
this O 0 2.9611214738892166e-14
theory O 0 9.161459785245185e-12
, O 0 1.6326551587997166e-15
our O 0 1.1749312595977016e-14
data O 0 2.6133197507578233e-14
showed O 0 9.962857795697833e-12
that O 0 1.3393427898794846e-15
these O 0 2.570938753703486e-15
mutants O 0 1.3447657700935145e-13
are O 0 3.876302626321451e-14
dominant O 0 5.3054911575145525e-09
- O 0 6.795983722440724e-07
negative O 0 1.1524451792865875e-07
in O 0 2.237595552638874e-13
transient O 0 1.1995212765777974e-12
transfection O 0 1.3511748664374323e-10
assays O 0 4.694937216775941e-10
when O 0 3.5109415374989794e-11
they O 0 2.3872657323176227e-13
are O 0 3.888029458663008e-15
coexpressed O 0 4.349066592967965e-11
with O 0 3.609792857423716e-13
wild O 0 6.256480133970399e-08
- O 0 0.0014983644941821694
type O 0 6.700917310809018e-06
PAX6 O 0 2.9593711587949656e-06
. O 0 3.8179612249500394e-10

We O 0 8.638929849258403e-11
found O 0 7.19260534378513e-14
that O 0 1.9800320525564146e-15
the O 0 6.122892008675589e-15
dominant O 0 6.292692145137835e-09
- O 0 4.655775853734667e-07
negative O 0 2.276735102668681e-07
effects O 0 1.5939866671033087e-07
result O 0 3.155362082729596e-11
from O 0 7.287469984559002e-15
the O 0 9.617598541907511e-17
enhanced O 0 1.0512874208321032e-13
DNA O 0 5.8217975796096e-13
binding O 0 6.733214246573693e-12
ability O 0 1.3404566085589709e-12
of O 0 1.5378973712321413e-15
these O 0 5.816789378724346e-14
mutants O 0 1.7285541054068432e-11
. O 0 4.054345834753059e-12

Kinetic O 0 3.425928696287883e-08
studies O 0 7.499539877997563e-10
of O 0 4.567751884197724e-13
binding O 0 6.103720551209335e-08
and O 0 1.700973945029105e-10
dissociation O 0 4.4450050040723e-07
revealed O 0 2.8957178321853405e-10
that O 0 1.6833635273409242e-15
various O 0 3.675441923654512e-16
truncation O 0 1.277144297436028e-12
mutants O 0 1.6755669768331316e-11
have O 0 5.693404189939522e-13
3 O 0 7.279832796693378e-14
- O 0 6.764732662922768e-10
5 O 0 3.1385180912502086e-12
- O 0 1.0843135278548743e-09
fold O 0 3.6500011346696226e-11
higher O 0 2.600343985276199e-13
affinity O 0 2.3734974912808767e-15
to O 0 4.7618942921039565e-16
various O 0 7.384712755035584e-16
DNA O 0 4.998358064250974e-12
- O 0 3.114511079593818e-11
binding O 0 1.8164373542621515e-13
sites O 0 1.4894345251505875e-13
when O 0 1.1142000950342679e-12
compared O 0 3.1436629016091955e-13
with O 0 2.4965489321438243e-15
the O 0 4.937975484238522e-13
wild O 0 6.987026495153259e-07
- O 0 0.0009546043584123254
type O 0 4.956585144100245e-06
PAX6 O 0 2.6226412046526093e-06
. O 0 8.139121598915722e-10

These O 0 1.1421078492668268e-11
results O 0 5.66440037236271e-12
provide O 0 1.4770257296425372e-14
a O 0 4.628205811489389e-15
new O 0 3.112117844583152e-15
insight O 0 8.90678522147241e-15
into O 0 1.6162391838258955e-16
the O 0 6.44723098269551e-16
role O 0 7.61914023626048e-13
of O 0 2.8940113922914373e-14
mutant O 0 1.1226744534020838e-10
PAX6 O 0 1.8452439576321922e-08
in O 0 2.0886931073604842e-10
causing O 0 3.99084250091164e-08
aniridia B-Disease 1 0.9999998807907104
. O 0 1.226224677353116e-10
. O 0 1.747332487034292e-11

Reversal O 0 1.6640740341244964e-06
of O 0 3.634270218100255e-09
severe O 1 0.621579647064209
hypertrophic B-Disease 1 0.9999887943267822
cardiomyopathy I-Disease 1 1.0
and O 0 1.892201240139002e-08
excellent O 0 6.034054922388066e-10
neuropsychologic O 0 4.8481158643198796e-08
outcome O 0 5.2989985732665446e-09
in O 0 1.5714186896165216e-11
very B-Disease 0 9.043394366692326e-10
- I-Disease 0 1.4624171853938606e-05
long I-Disease 0 3.4471730714358273e-07
- I-Disease 0 8.56991573527921e-06
chain I-Disease 0 1.1120346421478189e-08
acyl I-Disease 0 2.978162250144578e-08
- I-Disease 0 6.251682727054231e-09
coenzyme I-Disease 0 4.4365219831199454e-10
A I-Disease 0 1.8578841590177753e-11
dehydrogenase I-Disease 0 1.2984889963263413e-06
deficiency I-Disease 0 0.01007948536425829
. O 0 5.7551848703374375e-11

Very B-Disease 0 6.358970239261907e-08
- I-Disease 0 0.0002705451915971935
long I-Disease 0 3.116855111784389e-07
- I-Disease 0 2.3576976673211902e-05
chain I-Disease 0 8.657053740535048e-08
acyl I-Disease 0 1.5863919600178633e-07
- I-Disease 0 4.26408997000749e-09
coenzyme I-Disease 0 1.971572037573477e-11
A I-Disease 0 6.522862491028375e-14
dehydrogenase I-Disease 0 3.925443997632172e-11
( I-Disease 0 5.405624407296694e-13
VLCAD I-Disease 0 4.141093540965812e-06
) I-Disease 0 4.029831676688467e-11
deficiency I-Disease 0 9.978287380363327e-06
is O 0 3.324051103814618e-13
a O 0 2.08478755092667e-11
disorder O 0 0.0017321535851806402
of O 0 7.37890868199309e-13
fatty O 0 5.116608292610181e-08
acid O 0 2.0401334788200387e-10
beta O 0 9.560786136311034e-14
oxidation O 0 8.906934217955964e-12
that O 0 8.354273761494724e-13
reportedly O 0 7.354012510063512e-09
has O 0 2.519256157851313e-11
high O 0 2.0214713236654802e-10
rates O 0 1.0012097391154384e-06
of O 0 1.7767041093560976e-12
morbidity O 0 0.00017390691209584475
and O 0 2.182241942705332e-09
mortality O 0 1.5303247380415996e-07
. O 0 9.60992049825471e-12

We O 0 1.048869602282565e-10
describe O 0 1.1459651587039654e-12
the O 0 3.5004098178240215e-15
outcome O 0 4.182675798596047e-13
of O 0 1.240311403455656e-15
a O 0 2.7155174268066185e-13
5 O 0 2.0151636435927767e-12
- O 0 2.4772410256446165e-07
year O 0 1.2008216643266678e-08
- O 0 0.00010427813685964793
old O 0 6.26644105068408e-05
girl O 0 0.0016733768861740828
with O 0 1.4174474038952667e-08
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 5.456778140455754e-09
was O 0 5.586120541828388e-12
first O 0 1.203794500198455e-14
seen O 0 4.841990697279641e-11
at O 0 7.393881378469844e-14
5 O 0 1.9710275417556856e-14
months O 0 6.886195173111398e-13
of O 0 2.649902053428882e-13
age O 0 3.707687938003801e-06
with O 0 2.6120329721379676e-07
severe O 1 0.9999908208847046
hypertrophic B-Disease 1 0.9999997615814209
cardiomyopathy I-Disease 1 1.0
, O 0 0.0015693361638113856
hepatomegaly B-Disease 1 1.0
, O 0 1.3620230276956136e-08
encephalopathy B-Disease 0 5.613049870589748e-05
, O 0 9.619640153890607e-12
and O 0 3.329467257451313e-11
hypotonia B-Disease 0 1.2243477613083087e-05
. O 0 2.411400523705254e-10

Biochemical O 0 2.350593604205642e-06
studies O 0 1.0778949217638e-06
indicated O 1 0.9850836396217346
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.0002939167898148298
by O 0 6.215291302458237e-12
a O 0 8.740266843609845e-10
stable O 0 5.1578226702986285e-05
yet O 0 2.454721315103825e-09
inactive O 0 9.530122524470386e-11
enzyme O 0 2.7725034074110866e-11
. O 0 1.7016310235873355e-12

Molecular O 0 4.631672823052213e-09
genetic O 0 5.656160428912926e-09
analysis O 0 1.9201367162935412e-09
of O 0 5.810939836953244e-12
her O 0 4.9448019012743316e-08
VLCAD O 0 0.002070085844025016
gene O 0 1.2456055742404715e-07
revealed O 0 1.859177167773396e-08
a O 0 5.011108715480272e-13
T1372C O 0 1.5515544404820503e-10
( O 0 7.01186477587365e-14
F458L O 0 1.0650820503332881e-10
) O 0 3.629683630480135e-13
missense O 0 6.478801992670924e-07
mutation O 0 4.1397629502171185e-06
and O 0 1.2883505894067948e-11
a O 0 8.74636613135138e-11
1668 O 0 2.1208809357631253e-06
ACAG O 0 1.777729812602047e-05
1669 O 0 1.7377761452053164e-08
splice O 0 1.2478665212256601e-08
site O 0 3.112022284312843e-08
mutation O 0 1.6505653547937982e-05
. O 0 6.418539588715078e-10

After O 0 1.44735490953396e-11
initial O 0 1.3531445929026997e-11
treatment O 0 1.7536461865974573e-11
with O 0 2.5278019152689957e-13
intravenous O 0 2.9390379019389457e-09
glucose O 0 4.292350865853223e-07
and O 0 5.2100383035602604e-11
carnitine O 0 3.168054973912149e-08
, O 0 8.422169889667555e-14
the O 0 7.000852669932986e-14
patient O 0 2.360627249231584e-10
has O 0 6.840387360273342e-14
thrived O 0 3.178483301211066e-12
on O 0 2.69034875757454e-13
a O 0 2.4208128990982347e-12
low O 0 1.4780257515667472e-06
- O 0 2.635237024151138e-07
fat O 0 9.798011291195508e-10
diet O 0 1.5541532904367328e-12
supplemented O 0 1.7311785414485942e-13
with O 0 4.3970364594367664e-14
medium O 0 1.1424859946984611e-09
- O 0 2.7725183926463615e-08
chain O 0 2.2282675704587973e-10
triglyceride O 0 2.841737511971587e-09
oil O 0 1.3263405651553484e-10
and O 0 3.562936621084867e-13
carnitine O 0 8.355019454064916e-10
and O 0 9.554428645822122e-13
avoidance O 0 8.69324889851697e-10
of O 0 7.858205188990275e-14
fasting O 0 9.781444404444173e-11
. O 0 1.5839850264764976e-11

Her O 0 1.2100433650630293e-06
ventricular O 0 2.275947917951271e-05
hypertrophy O 0 0.00020798300101887435
resolved O 0 2.358188879725276e-07
significantly O 0 9.145545987188086e-10
over O 0 1.0344943651707794e-11
1 O 0 3.140819201941092e-11
year O 0 7.904607524089613e-11
, O 0 7.166026127526648e-14
and O 0 1.408546751457962e-10
cognitively O 0 1.6144280579055703e-08
, O 0 3.6942389929463595e-14
she O 0 1.8136818713543335e-09
is O 0 1.4828815259049222e-12
in O 0 9.003807763382707e-14
the O 0 2.990801847174186e-14
superior O 0 1.3818292864120618e-11
range O 0 1.1626592050228979e-10
for O 0 9.605981808602504e-12
age O 0 1.4287611804775224e-07
. O 0 1.1970609226086282e-10

Clinical O 0 1.857628184609439e-08
recognition O 0 6.979794164863051e-08
of O 0 1.1954726915064384e-06
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.2190706222270364e-09
important O 0 3.924902937380015e-12
because O 0 1.889799775001144e-11
it O 0 1.4920354922810623e-14
is O 0 7.126046680636013e-15
one O 0 1.7461394684025453e-15
of O 0 3.808971837054375e-17
the O 0 9.281963218865652e-15
few O 0 4.039928461208042e-11
directly O 0 9.016023795993533e-06
treatable O 1 0.9999361038208008
causes O 0 3.469931471045129e-07
of O 0 2.5149246241085166e-08
cardiomyopathy B-Disease 1 1.0
in O 0 1.26412828649336e-07
children O 0 1.5863622915279763e-10
. O 0 1.0324300008662801e-12
. O 0 1.191952266055285e-11

Cloning O 0 1.305942465279486e-09
of O 0 1.1731410114179663e-12
a O 0 9.81060068253048e-13
novel O 0 2.653742243313717e-12
member O 0 2.8306274425099476e-12
of O 0 1.1953753145752671e-13
the O 0 7.03177793770493e-11
low O 0 0.024196382611989975
- O 0 0.0013990419683977962
density O 0 2.461388426411304e-09
lipoprotein O 0 4.837788310396718e-06
receptor O 0 1.8184517225350305e-09
family O 0 1.8318027983355023e-08
. O 0 5.341799225178079e-10

A O 0 1.1433741974042899e-11
gene O 0 4.264574110512953e-11
encoding O 0 8.001809284619021e-12
a O 0 1.6406992951745192e-12
novel O 0 2.6385567342135374e-11
transmembrane O 0 5.452897244850874e-09
protein O 0 2.995550335560537e-11
was O 0 5.543516166939266e-12
identified O 0 1.3956499801334732e-12
by O 0 3.936590651622485e-16
DNA O 0 1.55608639580522e-13
sequence O 0 1.4135551792125202e-14
analysis O 0 9.044527178256063e-15
within O 0 1.6908417694739956e-15
the O 0 2.3357676470076028e-12
insulin B-Disease 1 0.9367173314094543
- I-Disease 1 0.9999997615814209
dependent I-Disease 1 0.999996542930603
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 2.2772470131826594e-08
IDDM B-Disease 0 1.9590475858421996e-05
) O 0 7.165497036866475e-13
locus O 0 7.282930369889584e-10
IDDM4 O 0 5.320217724147369e-07
on O 0 3.300397177774528e-10
chromosome O 0 7.100536691950765e-08
11q13 O 0 5.078146259052119e-08
. O 0 1.195144538890247e-10

Based O 0 5.6628906425215675e-11
on O 0 1.6241792633042706e-11
its O 0 1.2928201261266925e-12
chromosomal O 0 6.804222357459366e-05
position O 0 7.248968177009374e-05
, O 0 2.0517944710873176e-13
this O 0 3.120879765147787e-15
gene O 0 8.065240641140503e-13
is O 0 9.049427263855929e-15
a O 0 1.5214653555718815e-15
candidate O 0 5.000169549240763e-12
for O 0 1.3211366848870244e-14
conferring O 0 5.206883813002605e-09
susceptibility O 0 0.0003204873646609485
to O 0 4.195694458530852e-08
diabetes B-Disease 0 0.0019555906765162945
. O 0 6.518053652371236e-09

The O 0 1.6678656069094022e-12
gene O 0 7.732433443541353e-11
, O 0 6.586196160934116e-14
termed O 0 7.736922214007791e-10
low O 0 0.00019419575983192772
- O 0 9.067571227205917e-05
density O 0 7.299010285066743e-09
lipoprotein O 0 2.8068138817616273e-06
receptor O 0 5.430620397817165e-10
related O 0 1.0749522383335375e-09
protein O 0 5.497098887197183e-10
5 O 0 3.2950914132662268e-12
( O 0 2.263197496164132e-14
LRP5 O 0 7.606265484128016e-08
) O 0 1.0349920993488713e-14
, O 0 2.905461313680669e-17
encodes O 0 2.673985605692892e-15
a O 0 1.3174049118313061e-14
protein O 0 4.950980489297485e-13
of O 0 9.654407671531515e-14
1615 O 0 5.312946882440883e-08
amino O 0 1.508318643594908e-11
acids O 0 2.2044822564626365e-12
that O 0 8.650949084149616e-15
contains O 0 1.2311013177586285e-14
conserved O 0 5.799656761784622e-12
modules O 0 3.645652529860044e-11
which O 0 4.398962097362791e-12
are O 0 8.269532519693257e-14
characteristic O 0 2.525425146782112e-10
of O 0 7.423474812293107e-13
the O 0 6.209778913301989e-09
low O 1 0.995646059513092
- O 1 0.9959059953689575
density O 0 3.1073093396116747e-06
lipoprotein O 1 0.6969457268714905
( O 0 2.4948141330582985e-09
LDL O 0 3.312537228339352e-05
) O 0 1.3807774368324033e-12
receptor O 0 5.834164401585795e-11
family O 0 1.2240800595364476e-09
. O 0 7.381605743317365e-11

These O 0 4.192790212242947e-12
modules O 0 4.125629959189636e-12
include O 0 8.873571365544675e-14
a O 0 1.5881733590999286e-13
putative O 0 1.297088825236159e-11
signal O 0 6.314300211168744e-12
peptide O 0 1.0484604720875645e-12
for O 0 7.45134883699608e-17
protein O 0 3.396585601347273e-15
export O 0 2.923221289596184e-13
, O 0 3.2797492647348037e-15
four O 0 1.3421104912104617e-14
epidermal O 0 8.530245954041504e-10
growth O 0 1.324465426222332e-09
factor O 0 2.0580873810738254e-11
( O 0 1.054532217705786e-14
EGF O 0 8.856389233091733e-11
) O 0 1.3369188568701507e-14
repeats O 0 1.7423637185820517e-11
with O 0 1.3284645363203108e-14
associated O 0 1.8260547587911624e-11
spacer O 0 2.862840409179057e-09
domains O 0 9.670912248793684e-08
, O 0 1.4982595242588048e-12
three O 0 2.1429138845341367e-12
LDL O 0 2.2184285626281053e-06
- O 0 1.543857131025561e-08
receptor O 0 1.8184254449438164e-11
( O 0 1.6959015843118902e-13
LDLR O 0 1.906554558672724e-08
) O 0 3.084686640234674e-14
repeats O 0 2.6092893470885947e-11
, O 0 2.06001525618327e-15
a O 0 4.5564460272309523e-14
single O 0 7.798759554811241e-11
transmembrane O 0 9.211686968768618e-10
spanning O 0 1.2682120111018325e-11
domain O 0 4.871553160867848e-10
, O 0 9.769185243743705e-13
and O 0 7.148979216768658e-13
a O 0 1.2054408035991337e-12
cytoplasmic O 0 4.2378506259765913e-10
domain O 0 1.1517744091804616e-08
. O 0 3.8573116922790973e-10

The O 0 4.7218734998411005e-12
encoded O 0 6.868556071126797e-12
protein O 0 7.76773298460931e-11
has O 0 1.2776560408614412e-12
a O 0 2.1635120520742575e-14
unique O 0 9.816104092758016e-13
organization O 0 8.616503642316573e-14
of O 0 2.9409578969314754e-15
EGF O 0 2.7427575766125756e-09
and O 0 2.5675516400480713e-12
LDLR O 0 3.850303187391546e-08
repeats O 0 6.490620263477354e-10
; O 0 4.317240534794549e-14
therefore O 0 1.9206309448665387e-13
, O 0 9.924790922097044e-16
LRP5 O 0 1.5043992718233312e-08
likely O 0 1.8969258108736398e-10
represents O 0 1.551409960784747e-13
a O 0 4.3507444148034244e-14
new O 0 6.507381981359084e-13
category O 0 8.242668214641924e-10
of O 0 5.645239118290575e-14
the O 0 6.529702993585129e-12
LDLR O 0 4.938307392876595e-05
family O 0 3.516132274228312e-09
. O 0 2.3268147131272343e-10

Both O 0 1.1550379402924804e-10
human O 0 1.7973842900143033e-11
and O 0 2.1233916589011997e-13
mouse O 0 4.3153478013202573e-10
LRP5 O 0 2.282722562085837e-07
cDNAs O 0 5.7034044154136154e-09
have O 0 1.4766089739826072e-10
been O 0 5.681561124348811e-12
isolated O 0 2.241699881277981e-10
and O 0 3.3705715302145833e-11
the O 0 7.012934747892621e-14
encoded O 0 1.643916231440501e-12
mature O 0 6.91986528841837e-12
proteins O 0 3.3035189150588907e-15
are O 0 8.27784017648828e-16
95 O 0 1.9551210253359024e-15
% O 0 1.2734075133333939e-13
identical O 0 2.9099120979481086e-07
, O 0 8.485348383137359e-13
indicating O 0 5.8027973537377875e-09
a O 0 1.0203834999167327e-10
high O 0 1.4000787196266629e-08
degree O 0 1.0159755259309122e-09
of O 0 1.6933980090296907e-15
evolutionary O 0 6.035979550379766e-13
conservation O 0 9.587672452834872e-13
. O 0 1.6584466005359344e-13
. O 0 4.2090801330441074e-12

The O 0 2.6888328369389924e-11
APC B-Disease 0 1.1263893984203577e-10
variants O 0 8.541211141133154e-12
I1307K O 0 2.131774756719551e-10
and O 0 1.4688819821931376e-13
E1317Q O 0 8.380136168328889e-11
are O 0 2.1481030929720868e-12
associated O 0 1.828742097131908e-05
with O 1 0.9999978542327881
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.0995645425282419e-05
but O 0 2.424634715225693e-08
not O 0 1.26906679609462e-10
always O 0 1.341232819251914e-10
with O 0 3.141531698951268e-15
a O 0 3.158188771265613e-13
family O 0 1.9859071331840283e-10
history O 0 1.617047651336634e-08
. O 0 3.311007024109358e-11

Classical O 1 0.9792901277542114
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.9999884366989136
polyposis I-Disease 1 0.9999996423721313
( O 0 7.138392543737382e-09
FAP B-Disease 0 9.297693992493805e-08
) O 0 1.3503954898741455e-12
is O 0 1.2129412058081712e-12
a O 0 3.06020729590184e-11
high O 0 0.049072857946157455
- O 1 1.0
penetrance O 1 0.9999908208847046
autosomal B-Disease 1 0.9999955892562866
dominant I-Disease 1 0.9953675270080566
disease I-Disease 0 0.002337232930585742
that O 0 1.3412505833624092e-14
predisposes O 0 2.0890306845489093e-11
to O 0 2.076929868865228e-14
hundreds O 0 1.0888750160862812e-13
or O 0 1.8636266141403013e-11
thousands O 0 5.873398989386658e-11
of O 0 2.243794187961612e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9900593757629395
carcinoma I-Disease 1 1.0
and O 0 2.8542707752876595e-08
that O 0 2.5262897242889215e-12
results O 0 1.0763853350304053e-11
from O 0 2.954407890749279e-14
truncating O 0 7.50177142627706e-10
mutations O 0 4.842420242567869e-09
in O 0 2.67712176212076e-13
the O 0 2.503368775566995e-14
APC B-Disease 0 1.627689823202605e-11
gene O 0 3.54439727567879e-10
. O 0 5.5260785530864e-11

A O 0 2.705920210122059e-10
variant O 0 9.625491514952955e-09
of O 0 1.0287958852883694e-11
FAP B-Disease 0 3.507549990899861e-05
is O 0 1.6734398400330974e-07
attenuated B-Disease 1 0.9988338351249695
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 0.9999444484710693
coli I-Disease 1 0.9999991655349731
, O 0 1.3066289369922934e-11
which O 0 1.9299656545210958e-13
results O 0 6.701439316664226e-12
from O 0 1.2143023132155095e-12
germ O 0 0.00011465183342806995
- O 0 4.539130259217927e-06
line O 0 3.834500272859032e-09
mutations O 0 2.1712882880553508e-10
in O 0 3.819869225617223e-14
the O 0 5.092406124606111e-15
5 O 0 8.44285307898679e-14
and O 0 5.491441719754353e-13
3 O 0 3.659840442857276e-13
regions O 0 1.0383115374434926e-11
of O 0 3.823493713479842e-13
the O 0 2.9685208284557785e-12
APC B-Disease 0 7.754809294713283e-11
gene O 0 3.7711928024819485e-10
. O 0 7.428057474667682e-11

Attenuated B-Disease 1 0.9994100332260132
adenomatous I-Disease 1 0.9999983310699463
polyposis I-Disease 1 0.999993085861206
coli I-Disease 1 0.9999998807907104
patients O 1 0.9984958171844482
have O 0 4.1688437590892136e-08
" O 0 1.0140821515847165e-09
multiple O 0 1.3973968862046604e-06
" O 1 0.5306389331817627
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
( O 0 8.668644690956739e-10
typically O 0 1.1232613450484763e-10
fewer O 0 1.2685065671480533e-12
than O 0 1.2400880832191125e-13
100 O 0 3.123984225602769e-14
) O 0 1.2230354253425758e-15
without O 0 9.308709402258697e-13
the O 0 1.7963405827929602e-13
florid O 0 7.700095494556081e-08
phenotype O 0 2.6063562419409436e-10
of O 0 1.0810836004616214e-13
classical O 0 9.627970420922338e-09
FAP B-Disease 0 1.1995207671589014e-07
. O 0 6.533979607370455e-11

Another O 0 1.1717170636527108e-11
group O 0 2.126693092463494e-11
of O 0 3.404761552989327e-13
patients O 0 2.5364012973261296e-11
with O 0 5.361829144741315e-13
multiple O 0 4.919806073644395e-08
adenomas B-Disease 0 0.06162884086370468
has O 0 5.144164560988429e-07
no O 0 2.0330492844777837e-09
mutations O 0 3.027592343496366e-10
in O 0 3.3165070218105566e-14
the O 0 1.1706983183229166e-15
APC B-Disease 0 1.1564867444767424e-13
gene O 0 5.378640241526789e-12
, O 0 3.0752286703456325e-14
and O 0 1.565087713291738e-13
their O 0 7.170555382102206e-13
phenotype O 0 7.064646784238349e-11
probably O 0 5.450050567096243e-12
results O 0 3.2254946868807977e-13
from O 0 5.350004090459194e-15
variation O 0 3.96080918063646e-10
at O 0 4.075394244296149e-09
a O 0 1.7597912710387575e-11
locus O 0 6.696415866258576e-09
, O 0 1.9836185645438764e-12
or O 0 1.6554987632491636e-12
loci O 0 4.246744557574733e-13
, O 0 6.684021012452052e-14
elsewhere O 0 1.0496820773697735e-10
in O 0 3.5768884056909533e-13
the O 0 4.1644782782825074e-13
genome O 0 1.2940987691167916e-11
. O 0 7.997994627695348e-12

Recently O 0 5.17282046530454e-07
, O 0 3.508797852963541e-12
however O 0 1.0756397942485174e-12
, O 0 3.0643365042703e-15
a O 0 8.840730204113731e-14
missense O 0 2.7996568618959827e-08
variant O 0 5.060623475827697e-09
of O 0 2.508336149464191e-13
APC B-Disease 0 6.765078081061304e-11
( O 0 7.320937611557735e-14
I1307K O 0 1.7751985992298103e-10
) O 0 3.1416668854096497e-13
was O 0 2.1720162127203402e-11
described O 0 2.221921605038979e-11
that O 0 1.0288002885044424e-14
confers O 0 5.396551261416249e-12
an O 0 1.2797082187335218e-14
increased O 0 5.658197324009961e-07
risk O 1 0.9997254014015198
of O 1 0.9999644756317139
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 6.266390073506045e-09
including O 0 4.686206392552628e-13
multiple O 0 4.222262539599342e-10
adenomas B-Disease 0 3.487501203380816e-07
, O 0 9.446255409828463e-12
in O 0 4.874459516579499e-11
Ashkenazim O 0 1.5616362816217588e-06
. O 0 7.1671485413205e-10

We O 0 1.1752710804557864e-08
have O 0 4.763691069213649e-13
studied O 0 7.981809657664485e-12
a O 0 2.8202142227443106e-13
set O 0 4.082127344484654e-11
of O 0 2.282501885251826e-14
164 O 0 1.28248600975156e-11
patients O 0 4.938580360630551e-12
with O 0 1.5652810991806376e-10
multiple O 1 0.9999114274978638
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.000955924391746521
/ I-Disease 0 0.4410039782524109
or I-Disease 0 0.001363281044177711
carcinoma I-Disease 1 1.0
and O 0 1.8466494111635257e-07
analyzed O 0 2.0347965801192913e-07
codons O 0 6.741860403280953e-09
1263 O 0 2.6225362148579734e-07
- O 0 4.42945378154036e-07
1377 O 0 1.413761729907037e-08
( O 0 8.000888905394798e-13
exon O 0 7.993823936125466e-10
15G O 0 1.7217247627598908e-09
) O 0 4.1942093380190407e-14
of O 0 1.7150856523694266e-15
the O 0 8.597947691541073e-15
APC B-Disease 0 4.110562801598605e-13
gene O 0 1.2413310396947042e-12
for O 0 2.325462142727802e-13
germ O 0 1.5399713220176636e-06
- O 0 8.030107210288406e-07
line O 0 1.0890432999843824e-09
variants O 0 1.417440470552478e-10
. O 0 2.1517782347602044e-11

Three O 0 6.899734672494162e-10
patients O 0 6.996178636420325e-11
with O 0 6.091409657498631e-14
the O 0 2.472605724768845e-13
I1307K O 0 1.272254523954075e-09
allele O 0 6.377220418407603e-10
were O 0 1.4890214061757945e-11
detected O 0 2.0049235160968237e-08
, O 0 1.4959927455073397e-15
each O 0 7.39382090031741e-15
of O 0 1.3029543264632404e-13
Ashkenazi O 0 8.712770505070466e-10
descent O 0 7.442462646167769e-08
. O 0 4.501807815415759e-10

Four O 0 1.682909589462156e-09
patients O 0 5.288111060153255e-10
had O 0 9.202931819385363e-12
a O 0 9.888870972085684e-12
germ O 0 0.030893821269273758
- O 0 0.007492503616958857
line O 0 5.1553616486899045e-08
E1317Q O 0 7.940696988839591e-10
missense O 0 2.112327646131007e-09
variant O 0 5.7992395607886493e-11
of O 0 7.85032168394359e-15
APC O 0 7.235263278261572e-13
that O 0 5.96314108660366e-14
was O 0 6.806894024130594e-12
not O 0 8.07521530112737e-13
present O 0 5.419313543926496e-13
in O 0 1.8437660252723642e-12
controls O 0 2.3240581015215867e-08
; O 0 4.3279445240303194e-13
one O 0 5.023779786270111e-13
of O 0 2.4630586470137522e-14
these O 0 3.673557118222259e-12
individuals O 0 5.739224373524365e-11
had O 0 1.514188996409871e-09
an O 0 3.146270678884566e-14
unusually O 0 9.025318825628403e-10
large O 0 3.0224744929086e-10
number O 0 4.152535382218048e-08
of O 0 4.111215708146876e-12
metaplastic B-Disease 0 2.1615651348838583e-06
polyps I-Disease 0 1.928226467384775e-08
of I-Disease 0 2.0837278842493479e-13
the I-Disease 0 2.1030061372884212e-12
colorectum I-Disease 0 1.0208135563516407e-06
. O 0 1.3328453618566272e-10

There O 0 7.893007081261061e-11
is O 0 1.1985555505977102e-13
increasing O 0 3.7988657900812905e-13
evidence O 0 2.8372987986857723e-11
that O 0 3.5030620765263976e-11
there O 0 3.3397579840555025e-11
exist O 0 4.5756237687655243e-10
germ O 0 1.3508069685030932e-07
- O 0 2.3368005308554984e-09
line O 0 2.9590520572025936e-12
variants O 0 4.837644702686793e-14
of O 0 7.953952247512772e-16
the O 0 1.1370151002632837e-15
APC B-Disease 0 6.62027737859984e-14
gene O 0 3.6675046002519404e-14
that O 0 8.124207458097663e-16
predispose O 0 1.957465358424018e-14
to O 0 3.8771141685882155e-15
the O 0 1.1520082610560426e-14
development O 0 4.3842428060388017e-13
of O 0 1.297331964078552e-10
multiple O 1 0.9999890327453613
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9984140396118164
carcinoma I-Disease 1 1.0
, O 0 3.774697221459178e-10
but O 0 6.109066377768535e-12
without O 0 2.2044276126731432e-12
the O 0 8.191339181387244e-14
florid O 0 5.81335726224097e-08
phenotype O 0 1.2840922769541407e-10
of O 0 8.292794754930291e-15
classical O 0 6.854490586238882e-11
FAP B-Disease 0 2.218280975574416e-10
, O 0 3.9009268905376704e-14
and O 0 7.941044333605388e-14
possibly O 0 5.894030923048188e-13
with O 0 1.3581277148364511e-14
importance O 0 1.2421103257054256e-08
for O 0 0.20524246990680695
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9995243549346924
in O 0 1.0162297435847845e-12
the O 0 2.1623721998371374e-15
general O 0 2.4388617956227175e-14
population O 0 2.004236823705506e-14
. O 0 8.498026094665503e-14
. O 0 5.549662292214652e-12

Genomic O 0 2.2758097628639007e-08
structure O 0 6.5973768670346544e-09
of O 0 9.815692095932471e-13
the O 0 1.0491216229091549e-10
human O 0 6.262817350943806e-06
congenital B-Disease 1 0.9999996423721313
chloride I-Disease 1 0.9999997615814209
diarrhea I-Disease 1 1.0
( O 0 2.3079221023181162e-07
CLD B-Disease 0 0.00021662746439687908
) O 0 1.3427833497892117e-11
gene O 0 7.504265653324182e-09
. O 0 1.4297024675258285e-10

Congenital B-Disease 1 0.9999991655349731
chloride I-Disease 1 0.9999967813491821
diarrhea I-Disease 1 1.0
( O 0 3.6893915478231065e-08
CLD B-Disease 0 0.0049482653848826885
) O 0 7.865535306406102e-11
is O 0 9.159367708733157e-11
caused O 0 6.128539342675765e-10
by O 0 4.580098453277337e-12
mutations O 0 1.9748094928218052e-05
in O 0 9.533281282447792e-12
a O 0 3.222813725958784e-13
gene O 0 5.480168055460588e-11
which O 0 3.8290093887444546e-14
encodes O 0 2.4690007525453306e-13
an O 0 3.5358502692602045e-13
intestinal O 0 0.014721855521202087
anion O 0 1.4215691408026032e-05
transporter O 0 9.49342665990116e-06
. O 0 1.5810528442017358e-09

We O 0 2.405270471683707e-08
report O 0 4.014541823971207e-11
here O 0 2.7789809299225143e-13
the O 0 3.8269319133863713e-16
complete O 0 1.1655165730922647e-14
genomic O 0 6.3652522922647e-13
organization O 0 2.927495485610665e-13
of O 0 9.020751810459582e-15
the O 0 1.6101094795547416e-13
human O 0 1.2736566142035333e-11
CLD B-Disease 0 2.7436167115979515e-08
gene O 0 3.675502124877994e-10
which O 0 2.1093853660308914e-12
spans O 0 1.0456091721622318e-11
approximately O 0 1.8645633268702527e-13
39kb O 0 3.622796995728095e-08
, O 0 2.4249998710479392e-12
and O 0 9.887985395751198e-12
comprises O 0 1.1059691357173662e-10
21 O 0 2.7420224077423505e-11
exons O 0 7.449201810949546e-10
. O 0 1.7555445985806273e-10

All O 0 4.822147889327333e-11
exon O 0 7.034937521410711e-09
/ O 0 9.922199240008922e-08
intron O 0 2.4129258591187863e-08
boundaries O 0 1.7388056272604757e-10
conform O 0 4.490599558870656e-10
to O 0 3.894444039172565e-14
the O 0 5.4061373026869156e-14
GT O 0 7.562335480049143e-11
/ O 0 3.5582305990544683e-09
AG O 0 9.759381782714627e-07
rule O 0 1.8384076483357603e-08
. O 0 2.426094325436168e-10

An O 0 3.038995311367525e-14
analysis O 0 8.286825544344401e-13
of O 0 7.35163442437941e-15
the O 0 4.512260722944021e-14
putative O 0 5.427513993794264e-10
promoter O 0 3.946880042349221e-06
region O 0 8.545162910600368e-10
sequence O 0 7.185226025274716e-11
shows O 0 7.82001546850708e-11
a O 0 5.047079290956824e-13
putative O 0 1.009400063534116e-10
TATA O 0 2.2130196286607173e-10
box O 0 8.756590119674001e-09
and O 0 5.185870066704013e-10
predicts O 0 1.3669391840664957e-08
multiple O 0 1.7357034212683864e-11
transcription O 0 1.18446946695272e-10
factor O 0 2.5102206424598705e-10
binding O 0 6.950150455153903e-10
sites O 0 3.2102984715010052e-09
. O 0 3.1613517359474486e-10

The O 0 2.2829221152376178e-12
genomic O 0 3.191529263091297e-10
structure O 0 4.571813594367313e-09
was O 0 3.2022513980767275e-12
determined O 0 6.561623531846361e-13
using O 0 1.519198483646792e-14
DNA O 0 5.7019517579748324e-11
from O 0 3.0265473151746755e-14
several O 0 7.367717568344519e-16
sources O 0 1.9911382384465298e-13
including O 0 6.563218698173948e-15
multiple O 0 6.7560865756044475e-12
large O 0 4.222079574844884e-09
- O 0 0.02081242762506008
insert O 0 1.4300748141238273e-08
libaries O 0 5.649704704069336e-08
and O 0 2.684693457398902e-14
genomic O 0 7.975475748572824e-13
DNA O 0 9.342193685313305e-11
from O 0 6.977864466795047e-12
Finnish O 0 5.428878012025962e-06
CLD B-Disease 0 0.0003313111374154687
patients O 0 1.0539442207857519e-08
and O 0 2.5562749833563103e-11
controls O 0 3.5769798500950856e-07
. O 0 1.2856687936491085e-09

Exon O 0 1.5585030155307322e-07
- O 0 3.4910410562360994e-08
specific O 0 5.188931749555703e-12
primers O 0 1.6314087858404491e-09
developed O 0 3.966476799788232e-11
in O 0 4.0326645018087803e-13
this O 0 1.1332354698460455e-14
study O 0 2.4846740807947347e-14
will O 0 8.539406703457486e-15
facilitate O 0 9.075702225879757e-15
mutation O 0 4.4315107139425436e-12
screening O 0 8.688660685027272e-13
studies O 0 2.74686306686589e-12
of O 0 3.9844717830044354e-14
patients O 0 5.155053359011397e-13
with O 0 2.2563153873490088e-13
the O 0 3.9257752604271445e-10
disease O 0 1.5265892216120847e-05
. O 0 7.047043504293526e-11

Genomic O 0 2.601756865505678e-10
sequencing O 0 8.611916041401102e-11
of O 0 1.3293478730996844e-12
a O 0 3.926836633638686e-11
BAC O 0 7.992716746230144e-06
clone O 0 3.7830409382877406e-07
H O 1 1.0
_ O 0 1.5522817406465883e-11
RG364P16 O 0 9.829861750965119e-12
revealed O 0 1.6137728306442334e-11
the O 0 4.528139033166661e-15
presence O 0 1.5243316591612155e-12
of O 0 4.653805688254256e-15
another O 0 4.3184119474792837e-13
, O 0 3.7490936089402006e-15
highly O 0 2.08088415747619e-13
homologous O 0 5.310117037922446e-13
gene O 0 2.0157461810832444e-10
3 O 0 1.3021673583163418e-12
of O 0 5.748700381149425e-15
the O 0 2.9504222958005866e-13
CLD B-Disease 0 5.2499274261208484e-08
gene O 0 4.5401196691052803e-10
, O 0 4.839361130251109e-14
with O 0 4.552977427311946e-15
a O 0 1.3194199693315062e-13
similar O 0 1.7865894310839514e-12
genomic O 0 1.2635552326667465e-10
structure O 0 4.446209231900866e-07
, O 0 5.600174932617573e-14
recently O 0 1.3078911564878837e-10
identified O 0 1.7481017522413822e-08
as O 0 3.576027529650361e-10
the O 0 3.5756743272941094e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 1.684452399786096e-06
( O 0 9.634753064813317e-12
PDS B-Disease 0 1.0695414331962638e-08
) O 0 5.924948574299871e-13
. O 0 3.1435851101033196e-13
. O 0 5.38357683085855e-12

The O 0 1.3625724160082342e-10
APCI1307K O 0 6.114491952757817e-06
allele O 0 1.5354574998127646e-06
and O 0 4.638665895839722e-09
cancer B-Disease 0 2.2532247385242954e-05
risk O 0 0.004670629743486643
in O 0 1.3667572282272111e-11
a O 0 2.2004659379348812e-12
community O 0 5.598138055548652e-13
- O 0 1.731744347921449e-08
based O 0 2.668874019354228e-12
study O 0 3.277039013413474e-13
of O 0 6.442947304147184e-14
Ashkenazi O 0 9.114126814369072e-11
Jews O 0 1.009627312309469e-10
. O 0 3.124757744221718e-11

Mutations O 0 4.374741365609225e-06
in O 0 1.6654570084151388e-11
APC O 0 2.0917201304371247e-09
are O 0 2.5724937804949555e-11
classically O 0 0.05839864909648895
associated O 0 1.4877985449857078e-05
with O 0 7.941845979075879e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 1.0
( O 0 2.6744733094830053e-09
FAP B-Disease 0 1.3840497636863347e-08
) O 0 4.56596620321964e-13
, O 0 8.070064053317984e-15
a O 0 4.4015216818515945e-12
highly O 0 0.03481706231832504
penetrant O 1 0.9999994039535522
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 5.786243491456844e-06
by O 0 2.0710861844963624e-11
multiple O 0 2.2002791411068756e-06
intestinal O 1 0.8659371137619019
polyps B-Disease 0 0.0022710261400789022
and O 0 1.1172086589184005e-09
, O 0 1.821415095842622e-14
without O 0 5.214288202604056e-13
surgical O 0 2.5395864231003706e-11
intervention O 0 2.7202648467117285e-10
, O 0 2.06402803241924e-14
the O 0 3.0512620425096615e-14
development O 0 7.413888947205294e-11
of O 0 0.0035564680583775043
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.957658035678378e-08
CRC B-Disease 0 9.244415366538306e-08
) O 0 5.042905763114058e-12
. O 0 1.1396314447686962e-11

APC B-Disease 0 2.2676471189697622e-07
is O 0 3.258992242738401e-10
a O 0 1.128493076762993e-09
tumour O 1 0.9999998807907104
- O 0 1.281141067011049e-05
suppressor O 0 2.0087208341124096e-08
gene O 0 5.346409537310137e-09
, O 0 5.4644612809294155e-14
and O 0 5.578299459721783e-14
somatic O 0 3.2507727065755887e-10
loss O 0 2.7181721762303823e-08
occurs O 0 1.3924561503841915e-09
in O 0 3.7773981165223347e-10
tumours B-Disease 1 0.9999997615814209
. O 0 8.012267294077446e-09

The O 0 3.445267335311364e-11
germline O 0 9.784853460814702e-08
T O 0 5.5394857554347254e-06
- O 0 7.610822194692446e-08
to O 0 8.87677951977306e-12
- O 0 7.270831492434127e-09
A O 0 1.2455811122108473e-12
transversion O 0 1.0190380761443407e-09
responsible O 0 2.4347789409628895e-12
for O 0 1.2570640210864516e-15
the O 0 1.042918104273685e-15
APC O 0 1.9005736112513716e-13
I1307K O 0 3.009865306210363e-13
allele O 0 2.7906293270131555e-13
converts O 0 7.939197124154015e-14
the O 0 4.956086336140898e-15
wild O 0 1.8221162426113047e-11
- O 0 8.394462014393866e-09
type O 0 1.3147324340323507e-09
sequence O 0 1.606046242177972e-12
to O 0 3.9814031520431226e-14
a O 0 5.654447830100162e-12
homopolymer O 0 6.0095371736679226e-05
tract O 0 2.5997810553235468e-06
( O 0 4.90574757466139e-13
A8 O 0 1.3881011617922212e-10
) O 0 4.559305949274062e-14
that O 0 1.5688692749440958e-12
is O 0 8.276167945409085e-12
genetically O 0 6.083355597041873e-09
unstable O 0 0.00034109922125935555
and O 0 6.397913665523447e-08
prone O 0 0.0052315182983875275
to O 0 6.8607259630371065e-12
somatic O 0 2.3327093146008337e-08
mutation O 0 7.307489227059705e-07
. O 0 7.58184764970693e-11

The O 0 1.1034484090344243e-11
I1307K O 0 8.136761819876881e-10
allele O 0 1.7613713820807675e-09
was O 0 8.222501846066876e-11
found O 0 7.421101060056667e-12
in O 0 9.609738352289732e-12
6 O 0 2.5767232791906736e-10
. O 0 9.878621531900222e-11

1 O 0 1.1282428463710303e-10
% O 0 3.2675286087968658e-12
of O 0 1.5169060397970252e-13
unselected O 0 1.2447949302440975e-06
Ashkenazi O 0 7.70967378826981e-09
Jews O 0 1.227858370533852e-10
and O 0 1.4232968970073756e-11
higher O 0 3.1468667671674666e-09
proportions O 0 4.562138755659362e-08
of O 0 1.861400844658384e-13
Ashkenazim O 0 2.4492040395784898e-08
with O 0 2.1552603451935326e-12
family O 0 1.0254131571629799e-10
or O 0 1.8724184425167323e-09
personal O 0 5.993295104644858e-08
histories O 0 2.3636573587282328e-08
of O 0 3.2354273340334805e-13
CRC B-Disease 0 4.179844914631303e-09
( O 0 5.112030590503913e-13
ref O 0 2.205904081620247e-08
. O 0 6.959236247168488e-14
2 O 0 1.0210320815825374e-13
) O 0 1.1250263822750947e-13
. O 0 1.166140968511531e-11

To O 0 1.90522493614953e-11
evaluate O 0 2.9433108728049717e-10
the O 0 9.218557720565984e-14
role O 0 2.32538380912084e-12
of O 0 2.7875264759207735e-14
I1307K O 0 2.2855135561883344e-09
in O 0 3.5345257970442745e-11
cancer B-Disease 0 2.7748339181954407e-09
, O 0 2.560029282745041e-13
we O 0 2.2978636354809012e-11
genotyped O 0 3.8073171282348994e-09
5 O 0 2.2669802233338254e-12
, O 0 3.9648595821437094e-14
081 O 0 9.884997265174889e-10
Ashkenazi O 0 9.286307833811236e-10
volunteers O 0 5.280388279405024e-11
in O 0 2.6715274957511692e-12
a O 0 2.2572894074757155e-12
community O 0 4.029844600378363e-12
survey O 0 2.365217888211646e-08
. O 0 3.273231685696487e-11

Risk O 0 6.380103150149807e-05
of O 0 4.443023379763211e-11
developing O 0 1.4775959016333218e-06
colorectal B-Disease 1 1.0
, I-Disease 0 2.210027005844495e-08
breast I-Disease 1 0.7012278437614441
and I-Disease 0 1.938508091825497e-07
other I-Disease 0 7.501542720333987e-10
cancers I-Disease 0 0.053813688457012177
were O 0 7.531474055522125e-11
compared O 0 3.8965896481668594e-11
between O 0 7.310416784726478e-14
genotyped O 0 1.57793766941694e-09
I1307K O 0 1.1088627932531736e-10
carriers O 0 2.670041271413126e-11
and O 0 1.4724338285102001e-12
non O 0 5.574183892242957e-10
- O 0 2.6343165870912344e-08
carriers O 0 6.950981457087835e-11
and O 0 1.857596325025024e-12
their O 0 1.8195341067173132e-13
first O 0 7.905806001171078e-13
- O 0 7.108610144967997e-09
degree O 0 5.130538771602744e-10
relatives O 0 1.5503830164131926e-10
. O 0 1.341303804136551e-11

Sperm O 0 6.4805916188959145e-09
DNA O 0 5.866482855054755e-10
analysis O 0 2.4778262774916016e-10
in O 0 4.27752451515051e-12
a O 0 4.544527254513042e-11
Friedreich B-Disease 0 0.0018447662005200982
ataxia I-Disease 1 0.918468177318573
premutation O 0 0.1897401064634323
carrier O 0 5.773483735538321e-06
suggests O 0 3.5103608908571005e-10
both O 0 2.3925614500664924e-14
meiotic O 0 8.836310155801996e-11
and O 0 4.1227312769188604e-14
mitotic O 0 3.5740737626410723e-12
expansion O 0 1.0744140820084791e-11
in O 0 3.178020455303632e-13
the O 0 1.7605548637868174e-13
FRDA B-Disease 0 1.316061997158613e-07
gene O 0 3.6466019093239765e-09
. O 0 7.901412163446864e-11

Friedreich B-Disease 1 0.9334729313850403
ataxia I-Disease 1 0.9997633099555969
is O 0 7.90693229646422e-05
usually O 0 7.488763912988361e-06
caused O 0 1.867531906896147e-09
by O 0 3.52636553313003e-14
an O 0 5.520105246926803e-15
expansion O 0 3.437746476375736e-10
of O 0 3.4091414587156255e-13
a O 0 3.131105444365012e-11
GAA O 0 5.42599849495673e-08
trinucleotide O 0 2.128490095287816e-08
repeat O 0 1.6366822341851162e-09
in O 0 3.438972400577299e-14
intron O 0 2.7409137459688537e-11
1 O 0 1.8048793796326956e-12
of O 0 1.5364965904956195e-14
the O 0 5.945654125288913e-13
FRDA B-Disease 0 7.60287122147929e-08
gene O 0 1.747114342087741e-09
. O 0 8.20583254124152e-11

Occasionally O 0 1.9956836183609994e-07
, O 0 2.1034070752518064e-12
a O 0 1.4569931632707478e-12
fully O 0 3.548618343618415e-10
expanded O 0 3.567297065382169e-12
allele O 0 7.81973166774641e-11
has O 0 4.4743654853234005e-13
been O 0 5.808031058049737e-14
found O 0 3.440383218654246e-14
to O 0 1.9576071517393885e-14
arise O 0 7.835732930561168e-12
from O 0 9.874188115036888e-16
a O 0 7.577480513171718e-15
premutation O 0 3.843563523009408e-10
of O 0 1.2333723994374657e-13
100 O 0 5.066053045815755e-12
or O 0 1.7410158037467482e-10
less O 0 2.6029889355072555e-09
triplet O 0 0.00010093166201841086
repeats O 0 2.661425355654501e-07
. O 0 2.5438831596780176e-10

We O 0 1.0462211541550914e-08
have O 0 5.346010635044751e-13
examined O 0 5.4817960067066185e-12
the O 0 3.1485381437327186e-15
sperm O 0 2.1780264224113832e-12
DNA O 0 5.454408192467897e-12
of O 0 2.0157842544688345e-14
a O 0 1.5739796618841062e-12
premutation O 0 1.5068450238686637e-06
carrier O 0 1.3657201236583205e-07
. O 0 1.7838332200259543e-10

This O 0 4.96545209463517e-12
mans O 0 1.1732680382792182e-09
leucocyte O 0 1.1000123478766e-08
DNA O 0 1.4826528449418674e-08
showed O 0 1.0178379170611151e-06
one O 0 4.786399141615272e-12
normal O 0 3.0007486079286494e-11
allele O 0 1.9873613171794702e-11
and O 0 3.3111046456729687e-13
one O 0 2.687306045821413e-14
allele O 0 1.1745963359940936e-12
of O 0 4.809452650993444e-15
approximately O 0 3.2550118199761724e-13
100 O 0 4.186229488056803e-12
repeats O 0 4.347271431726085e-09
. O 0 1.9071054457864278e-10

His O 0 4.801289366085371e-10
sperm O 0 5.407316372441073e-09
showed O 0 1.3414791499855028e-09
an O 0 1.9705903880516077e-15
expanded O 0 6.7168978712395244e-12
allele O 0 7.768714560540957e-10
in O 0 4.570307240298055e-12
a O 0 2.4666073003554168e-11
tight O 0 3.834627193555207e-07
range O 0 6.3380464071505216e-12
centering O 0 3.2938220293626808e-12
on O 0 5.229928469463463e-12
a O 0 1.2126167040979463e-13
size O 0 9.463392569575291e-11
of O 0 1.9393827635407618e-13
approximately O 0 1.6876740890209296e-12
320 O 0 4.045765805704704e-11
trinucleotide O 0 2.3102253976503562e-07
repeats O 0 1.1691743395658705e-07
. O 0 8.395782680192809e-11

His O 0 1.6539493330469668e-08
affected O 0 1.3285192501655274e-08
son O 0 1.6873221966307028e-06
has O 0 2.9565838666201216e-10
repeat O 0 3.949866211883091e-08
sizes O 0 5.920484102972523e-10
of O 0 2.6720203198486725e-13
1040 O 0 2.7985916362105456e-10
and O 0 1.0215824713943888e-11
540 O 0 6.492053422624267e-11
. O 0 1.2631087148440301e-11

These O 0 1.656695071926284e-13
data O 0 4.024358428965369e-13
suggest O 0 8.192655538349913e-13
that O 0 2.0479801885522073e-15
expansion O 0 7.836835022069499e-13
occurs O 0 2.585256878365194e-12
in O 0 1.2070870019677271e-14
two O 0 6.1822012556423354e-15
stages O 0 7.186058172126142e-12
, O 0 2.097498581681641e-15
the O 0 8.478120587470967e-16
first O 0 1.189003729458113e-13
during O 0 2.9632936729417914e-12
meiosis O 0 1.2845472949218895e-11
followed O 0 2.7322152244650677e-13
by O 0 2.3481106433022444e-15
a O 0 2.060550962170761e-14
second O 0 9.010439014920171e-14
mitotic O 0 5.342988898537904e-11
expansion O 0 4.4208103844312063e-10
. O 0 6.727671891804121e-11

We O 0 3.910308077337277e-09
also O 0 1.649018513969272e-13
show O 0 2.24611561988608e-11
that O 0 1.0688452618638766e-13
in O 0 3.7576577049600046e-14
all O 0 1.5187688261842974e-15
informative O 0 5.988024746189646e-13
carrier O 0 4.189498747919629e-11
father O 0 8.919281285768577e-11
to O 0 6.62877088289382e-13
affected O 0 5.794532076386361e-10
child O 0 1.1583775716417222e-07
transmissions O 0 3.211077626019687e-08
, O 0 9.169942264558324e-15
with O 0 2.536134805175517e-15
the O 0 5.891563499132177e-15
notable O 0 1.8768456840762004e-12
exception O 0 2.9086415567758372e-11
of O 0 2.0534963635662588e-14
the O 0 1.8480394081352158e-13
premutation O 0 1.0730539123926519e-08
carrier O 0 3.042510410278254e-10
, O 0 3.5202013779113287e-15
the O 0 1.6464586194664095e-15
expansion O 0 2.3094709738352703e-12
size O 0 1.0324197052824502e-09
decreases O 0 2.0753560647790437e-08
. O 0 2.4417269421650456e-12
. O 0 4.8486169940131774e-11

The O 0 7.91226632823605e-12
R496H O 0 6.415871167675391e-10
mutation O 0 3.62908703088749e-10
of O 0 8.655141050205577e-15
arylsulfatase O 0 1.6453970630436743e-08
A O 0 6.53826853769246e-11
does O 0 8.943804807870492e-09
not O 0 3.334413301026018e-10
cause O 0 1.97692642700531e-07
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 0.9999990463256836
. O 0 8.166279030774604e-08

Deficiency B-Disease 1 0.9997327923774719
of I-Disease 0 4.071418115841885e-12
arylsulfatase I-Disease 0 4.162323875789298e-06
A I-Disease 0 5.029520688815126e-10
( O 0 3.828253686277705e-12
ARSA O 0 7.607685574839707e-07
) O 0 4.565452291389882e-13
enzyme O 0 8.711503046709979e-11
activity O 0 1.4847752360935829e-08
causes O 0 1.6984150761345518e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 0.9999998807907104
( O 0 1.3532519460568437e-06
MLD B-Disease 1 0.9999984502792358
) O 0 1.1008885469898644e-10
. O 0 4.751264312541359e-11

A O 0 6.637358995753573e-10
number O 0 7.20628981834559e-12
of O 0 6.976822548507289e-13
ARSA O 0 0.0001320480223512277
gene O 0 1.8507537902223703e-07
mutations O 0 4.786025442626851e-07
responsible O 0 1.5930672336850193e-09
for O 0 5.952139475740026e-11
MLD B-Disease 1 1.0
have O 0 3.305560269950547e-08
been O 0 5.5652048941423615e-11
identified O 0 1.1749617279122049e-08
. O 0 3.406700616048752e-11

Recently O 0 1.8193512474340423e-08
, O 0 2.1447120880473125e-13
the O 0 6.22805436780241e-14
R496H O 0 5.333389840878056e-10
mutation O 0 3.9368727722255414e-10
of O 0 5.6672911128525724e-14
ARSA O 0 9.671318679238539e-08
was O 0 9.159467455333026e-12
proposed O 0 2.8503030014351283e-13
to O 0 3.839322523097044e-13
be O 0 1.3877828573816142e-11
a O 0 5.746999230671346e-12
cause O 0 8.530466288902971e-08
of O 0 3.1273483802607416e-09
MLD B-Disease 1 1.0
( O 0 1.849509156937046e-10
Draghia O 0 1.269048084395763e-07
et O 0 7.12621996967755e-08
al O 0 3.1732793104310986e-06
. O 0 4.8719197079383214e-12
, O 0 3.4842253051909494e-14
1997 O 0 9.951875478211858e-13
) O 0 5.0220139597443106e-14
. O 0 3.274241554968027e-12

We O 0 2.607142945976193e-09
have O 0 1.2662360580634885e-13
investigated O 0 7.761731361799473e-12
the O 0 1.0666818888946123e-14
R496H O 0 1.4288001337625644e-10
mutation O 0 2.6640145645018265e-10
and O 0 4.371581764119059e-14
found O 0 1.9392338212673166e-14
this O 0 1.758552948002794e-15
mutation O 0 1.3212236209605988e-12
at O 0 6.034963381893604e-14
a O 0 6.177065017256775e-14
relatively O 0 1.9861258471198795e-11
high O 0 7.775455973524359e-11
frequency O 0 1.2737605636914395e-08
in O 0 9.104249472369208e-13
an O 0 1.1236876297613003e-14
African O 0 3.600400142952931e-13
American O 0 5.526919200082858e-12
population O 0 8.000092016798022e-14
( O 0 6.446844333330912e-14
f O 0 2.761809980711405e-07
= O 0 1.590504727921882e-09
0 O 0 1.6200450269482358e-12
. O 0 3.12592122054655e-14
09 O 0 4.2743764257224814e-12
, O 0 9.108964362685486e-15
n O 0 5.669337888036807e-09
= O 0 2.3147418914959417e-07
61 O 0 5.936470065526223e-11
subjects O 0 1.9375248427877523e-07
) O 0 1.7692314627226757e-11
. O 0 4.420942778526893e-11

The O 0 4.4610846267056914e-11
ARSA O 0 2.3943636051626527e-07
enzyme O 0 4.840162645680657e-11
activity O 0 1.3363921080866703e-09
in O 0 3.324051103814618e-13
subjects O 0 4.606379278015993e-09
with O 0 1.82856659501629e-12
and O 0 3.415210475532504e-11
without O 0 1.1421426304725202e-11
the O 0 6.274527846893054e-15
R496H O 0 3.8054254192232406e-11
mutation O 0 8.291545922078924e-11
was O 0 1.2880359973044264e-11
determined O 0 9.488918539801716e-10
and O 0 1.0112432809530891e-12
found O 0 1.2407960943427998e-12
to O 0 3.818729187032854e-12
be O 0 1.6778784583948436e-08
normal O 0 5.124125568300997e-09
. O 0 4.206409526252841e-11

It O 0 1.509024433188344e-10
is O 0 2.726563115909575e-12
therefore O 0 6.776965598941087e-13
concluded O 0 1.2733936084405317e-12
that O 0 1.8299244735340333e-15
the O 0 2.4799284516528004e-15
R496H O 0 3.483652602498388e-11
mutation O 0 3.106093160454293e-11
of O 0 7.781923773452805e-15
ARSA O 0 4.140150622333749e-08
does O 0 4.695095354168011e-11
not O 0 2.6015429434723784e-14
negatively O 0 3.4288419542907733e-13
influence O 0 4.396552566454659e-13
the O 0 7.023375614813657e-14
activity O 0 1.091667381492023e-10
of O 0 7.876088426199065e-15
ARSA O 0 4.180724602065311e-07
and O 0 3.0479990753562447e-10
is O 0 5.216678217873083e-12
not O 0 8.72533002880399e-13
a O 0 1.0214611274872443e-12
cause O 0 1.3177079871695696e-08
of O 0 1.6608977304599648e-08
MLD B-Disease 1 0.9999991655349731

Down O 0 9.081152541057236e-08
- O 0 8.289027420005368e-08
regulation O 0 1.1958110057719296e-09
of O 0 2.2533405263230888e-12
transmembrane O 0 6.062716551014091e-08
carbonic O 0 8.364881409761438e-08
anhydrases O 0 9.933360161085147e-06
in O 0 2.0944668222000473e-09
renal B-Disease 0 0.00015896766853984445
cell I-Disease 1 0.9855456948280334
carcinoma I-Disease 1 1.0
cell O 1 0.992453396320343
lines O 0 1.3341026487978525e-06
by O 0 1.6450932630029946e-11
wild O 0 1.0283765732310712e-05
- O 1 0.9982163310050964
type O 1 0.9995614886283875
von B-Disease 1 0.9999916553497314
Hippel I-Disease 1 0.9999294281005859
- I-Disease 1 0.9999388456344604
Lindau I-Disease 0 0.41058018803596497
transgenes O 0 0.002539124572649598
. O 0 9.91366366775992e-09

To O 0 3.406570858732749e-11
discover O 0 1.5930581298562174e-09
genes O 0 3.214788157901438e-10
involved O 0 8.57574455892518e-10
in O 0 5.1822435231940744e-09
von B-Disease 1 0.9999920129776001
Hippel I-Disease 1 0.9999982118606567
- I-Disease 1 0.9999994039535522
Lindau I-Disease 1 0.9998512268066406
( O 0 3.377307677965291e-08
VHL B-Disease 0 1.9818920918623917e-05
) O 0 3.0690497886121104e-12
- O 0 9.958275093424618e-09
mediated O 0 1.8127965795144974e-09
carcinogenesis O 0 1.6555421780140023e-06
, O 0 2.111857130143724e-12
we O 0 1.9661756597844082e-11
used O 0 1.8866315454335592e-10
renal B-Disease 0 0.0004527767887338996
cell I-Disease 1 0.9995742440223694
carcinoma I-Disease 1 1.0
cell O 1 0.9999847412109375
lines O 0 0.12001288682222366
stably O 0 0.00016504150698892772
transfected O 0 5.415058694779873e-07
with O 0 2.910761909280524e-11
wild O 0 1.938994046213338e-06
- O 1 0.9762369394302368
type O 1 0.9876861572265625
VHL O 1 0.6365604996681213
- O 0 6.619869964197278e-05
expressing O 0 4.785268004070531e-08
transgenes O 0 1.6131234588101506e-06
. O 0 5.996640406458198e-10

Large O 0 7.514115996087867e-10
- O 0 2.9251762612148013e-07
scale O 0 8.824734720747074e-08
RNA O 0 1.336137089857914e-09
differential O 0 4.3974146546332804e-10
display O 0 1.0824980668788786e-11
technology O 0 4.038177778276086e-12
applied O 0 1.5819713594655838e-11
to O 0 9.028610649906843e-13
these O 0 6.4799389812297825e-12
cell O 0 1.1625362006384421e-08
lines O 0 3.404379000926383e-09
identified O 0 7.35850894106882e-11
several O 0 5.5084334717268174e-14
differentially O 0 7.799570767019759e-09
expressed O 0 5.513421316716283e-12
genes O 0 4.560667815622921e-12
, O 0 2.5337158908363957e-16
including O 0 6.498268423536725e-16
an O 0 1.4590384767878238e-14
alpha O 0 1.7145013186947722e-10
carbonic O 0 1.0070204226053647e-08
anhydrase O 0 6.389910822690581e-09
gene O 0 1.3960195222040284e-09
, O 0 1.6803956229966e-12
termed O 0 1.996176779428538e-09
CA12 O 0 9.594977200322319e-06
. O 0 4.3181225262145517e-10

The O 0 1.3078206052841157e-11
deduced O 0 1.698633178559561e-10
protein O 0 3.8494585123671765e-12
sequence O 0 1.4084117552770614e-11
was O 0 1.614239991676314e-12
classified O 0 1.4056797392747455e-11
as O 0 2.264774874799827e-13
a O 0 1.2719184212806045e-11
one O 0 1.3331136194949522e-08
- O 0 0.01644318550825119
pass O 0 2.7726142093342787e-07
transmembrane O 0 2.4686830784048652e-06
CA O 0 1.075118802873476e-06
possessing O 0 1.4324039350477324e-11
an O 0 1.0755155955015274e-14
apparently O 0 1.6032788430209166e-09
intact O 0 1.007593869450929e-10
catalytic O 0 7.962149169149502e-12
domain O 0 8.393701012021637e-11
in O 0 5.8625842895565494e-12
the O 0 4.3798320005505875e-12
extracellular O 0 3.186100983043616e-08
CA O 0 0.02752392739057541
module O 0 1.6664706947722152e-07
. O 0 4.869611380797778e-10

Reintroduced O 0 3.926857772285075e-08
wild O 0 1.4458568386999104e-07
- O 0 0.10261687636375427
type O 0 0.0004986466374248266
VHL B-Disease 0 7.299884600797668e-05
strongly O 0 4.2516465348363397e-10
inhibited O 0 1.5058265398493198e-11
the O 0 2.0447640044514827e-15
overexpression O 0 1.9159329613278875e-13
of O 0 6.410665099758133e-16
the O 0 3.3389678791761936e-15
CA12 O 0 3.826739203294238e-10
gene O 0 1.8786553909744264e-11
in O 0 1.374353213699775e-12
the O 0 2.1512201742179826e-11
parental O 1 0.9946512579917908
renal B-Disease 1 0.5396451950073242
cell I-Disease 1 0.9999102354049683
carcinoma I-Disease 1 1.0
cell O 1 0.9999266862869263
lines O 0 0.046699393540620804
. O 0 6.176904321364418e-09

Similar O 0 4.758358707057653e-10
results O 0 5.249601864321107e-10
were O 0 3.1022829704435706e-13
obtained O 0 1.8657454053938594e-12
with O 0 1.3412614931467698e-13
CA9 O 0 7.312885372812161e-07
, O 0 4.033129590659459e-15
encoding O 0 1.5147491551001369e-13
another O 0 1.7877050534353955e-11
transmembrane O 0 1.165686740023375e-06
CA O 0 0.00010353482502978295
with O 0 9.978765047342214e-14
an O 0 1.4763673139919775e-13
intact O 0 1.59847655112344e-08
catalytic O 0 3.283826544020485e-10
domain O 0 5.508993261571504e-09
. O 0 1.2455490805418634e-10

Although O 0 2.2160227819423284e-10
both O 0 2.362155067901772e-13
domains O 0 7.1768806175764865e-12
of O 0 2.960782660710315e-14
the O 0 1.2562791518871963e-13
VHL B-Disease 0 1.3065579729243382e-09
protein O 0 3.936324058590249e-14
contribute O 0 2.3603614925766202e-14
to O 0 5.723580348549178e-15
regulation O 0 3.982441806882342e-11
of O 0 4.679407089678428e-14
CA12 O 0 4.691029857895046e-07
expression O 0 2.0046768411940974e-10
, O 0 2.006882996984376e-15
the O 0 4.024659314126475e-16
elongin O 0 3.985511920490126e-11
binding O 0 1.4548437324637953e-12
domain O 0 6.134147009784208e-12
alone O 0 1.7297158150242353e-10
could O 0 1.2648107387824847e-11
effectively O 0 3.388273273063902e-10
regulate O 0 4.8840991695442426e-08
CA9 O 0 0.0006737687508575618
expression O 0 1.6994634961520205e-06
. O 0 8.703004428234351e-10

We O 0 2.2790360709734614e-09
mapped O 0 4.1224527791428045e-08
CA12 O 0 6.642761491093552e-06
and O 0 2.6847638695537412e-11
CA9 O 0 2.8450398303903057e-07
loci O 0 4.84939380318572e-11
to O 0 1.1444666828813732e-12
chromosome O 0 5.4586415387802845e-09
bands O 0 5.652396772859447e-09
15q22 O 0 1.2035158647449862e-08
and O 0 2.2652869163808376e-11
17q21 O 0 5.958017190721421e-09
. O 0 5.646626222155504e-11

2 O 0 1.0290501784027128e-09
respectively O 0 2.4616417793055234e-09
, O 0 2.6245316683826125e-12
regions O 0 2.4181412427992655e-08
prone O 0 0.003417548257857561
to O 0 9.613802809393945e-13
amplification O 0 6.037473854192399e-10
in O 0 3.0506016549664006e-12
some O 0 1.6018481300509452e-13
human O 0 1.6102510436155626e-09
cancers B-Disease 0 0.00011698481830535457
. O 0 1.1544675632135792e-10

Additional O 0 3.851443122759868e-11
experiments O 0 2.091313122676297e-09
are O 0 9.45135137687958e-13
needed O 0 3.2269918074506743e-12
to O 0 9.110220173733086e-14
define O 0 3.779183216368054e-11
the O 0 3.51111046974998e-14
role O 0 5.6473797860334685e-11
of O 0 8.253766593802059e-12
CA O 0 1.836571937019471e-05
IX O 0 2.061052484236825e-08
and O 0 4.387310792441923e-10
CA O 0 8.245632443504292e-08
XII O 0 2.4905660866991752e-11
enzymes O 0 7.273642679914843e-14
in O 0 2.052461628117893e-15
the O 0 2.2666307324575906e-15
regulation O 0 1.1756188904310516e-11
of O 0 1.8544090958985682e-13
pH O 0 1.0619596224614725e-07
in O 0 1.9021474662300059e-13
the O 0 4.6585863422085594e-14
extracellular O 0 6.442646763304971e-12
microenvironment O 0 3.0279043161662855e-10
and O 0 4.1826516750977094e-13
its O 0 8.334370520113321e-15
potential O 0 9.389671332127314e-12
impact O 0 2.882664551506764e-09
on O 0 6.305045729959602e-08
cancer B-Disease 0 2.0829233449148887e-07
cell O 0 8.851229971185148e-09
growth O 0 1.603790522608506e-08
. O 0 1.5483786128256405e-11

A O 0 2.0370061540320172e-11
gene O 0 2.741217149104802e-11
encoding O 0 1.3580494367948504e-11
a O 0 2.769473669492206e-12
transmembrane O 0 9.79619940721932e-10
protein O 0 7.742110771924438e-12
is O 0 2.5438985228228017e-13
mutated O 0 7.099419940814755e-10
in O 0 6.564584292823028e-11
patients O 0 2.1310411213448788e-08
with O 0 0.0002042927371803671
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9887686967849731
optic B-Disease 1 0.9999973773956299
atrophy I-Disease 1 0.9999936819076538
( O 0 0.09267434477806091
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 3.919873758917447e-09
. O 0 3.7815214848357925e-10

Wolfram B-Disease 1 0.999998927116394
syndrome I-Disease 1 1.0
( O 0 2.167449224543816e-07
WFS B-Disease 0 0.0005716645973734558
; O 0 7.536618551462482e-11
OMIM O 0 2.1122316411492648e-06
222300 O 0 5.885516518588929e-09
) O 0 1.7774318258542698e-13
is O 0 2.4195700781479146e-13
an O 0 9.737485340624574e-13
autosomal B-Disease 1 0.9999973773956299
recessive I-Disease 1 0.9999946355819702
neurodegenerative I-Disease 1 0.9998477697372437
disorder I-Disease 1 0.9999539852142334
defined O 0 2.430783929696645e-08
by O 0 9.49872298872112e-12
young O 0 1.2782220437657088e-07
- O 0 9.015581599669531e-05
onset O 0 1.1112268111901358e-05
non O 0 0.001432807999663055
- O 1 0.9949883222579956
immune O 0 0.4904855787754059
insulin B-Disease 1 0.9734575748443604
- I-Disease 1 0.999956488609314
dependent I-Disease 1 0.9680228233337402
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.9999998807907104
and O 0 2.125265439190116e-07
progressive O 0 3.308837040094659e-05
optic B-Disease 1 0.9950637221336365
atrophy I-Disease 1 0.5752826929092407
. O 0 2.5943016623841686e-08

Linkage O 0 3.214423998088023e-07
to O 0 2.06753000137061e-11
markers O 0 3.122504210750776e-08
on O 0 1.9939394579893133e-09
chromosome O 0 1.753241008373152e-06
4p O 0 8.510588713761535e-07
was O 0 7.218202568992638e-08
confirmed O 0 1.7709636779272842e-07
in O 0 2.7701776636468445e-11
five O 0 1.0592873800341351e-11
families O 0 3.152943878204084e-11
. O 0 1.796746779136882e-11

On O 0 2.941872787043387e-11
the O 0 3.3716078702821645e-14
basis O 0 1.729139157162149e-13
of O 0 6.703807532693323e-15
meiotic O 0 1.697964258084994e-08
recombinants O 0 0.0016729324124753475
and O 0 2.1884208933897753e-07
disease O 0 0.021814880892634392
- O 0 0.00011705511133186519
associated O 0 6.950899233970631e-08
haplotypes O 0 2.3018398565000098e-07
, O 0 2.856899558503073e-13
the O 0 5.033137535220833e-14
WFS B-Disease 0 4.653445129232381e-10
gene O 0 2.1834303462475724e-11
was O 0 1.8082355274576245e-12
localized O 0 5.109286604909613e-11
to O 0 3.3470452971695597e-12
a O 0 4.746076864847737e-10
BAC O 0 1.3961466720502358e-05
/ O 0 6.698078891531623e-08
P1 O 0 1.7537557184255093e-08
contig O 0 6.177387046335525e-09
of O 0 2.482903477003112e-13
less O 0 4.669880367819124e-12
than O 0 6.446478550622969e-13
250 O 0 8.373448961117302e-13
kb O 0 3.1630302821383793e-09
. O 0 9.547629353789944e-10

Mutations O 0 0.00038890642463229597
in O 0 7.221290926340274e-11
a O 0 1.2137187956062778e-12
novel O 0 2.8064571066382937e-12
gene O 0 1.886017120256156e-09
( O 0 9.87397772052312e-13
WFS1 O 0 1.4288834115916416e-08
) O 0 4.853279406233802e-15
encoding O 0 4.217778876809339e-14
a O 0 1.27662013989574e-13
putative O 0 3.685356186888811e-11
transmembrane O 0 1.9024106942544527e-11
protein O 0 1.5742197042450945e-12
were O 0 8.592382447908387e-13
found O 0 1.2552743566818236e-11
in O 0 2.4887283206487254e-11
all O 0 1.3107450021199174e-11
affected O 0 2.916741501102216e-11
individuals O 0 3.336606338444348e-11
in O 0 4.28405089181183e-11
six O 0 2.779692708648751e-12
WFS B-Disease 0 3.991713903861438e-10
families O 0 1.691018635882613e-12
, O 0 3.4316340459354666e-14
and O 0 3.2281304365722185e-12
these O 0 1.7735520083800305e-12
mutations O 0 1.0328451427454866e-09
were O 0 1.2953724464609406e-12
associated O 0 1.1415943884651725e-10
with O 0 2.281746623242209e-12
the O 0 7.087080922119071e-10
disease O 0 1.3094996802465175e-06
phenotype O 0 1.0810967232544044e-08
. O 0 2.35473515686202e-11

WFS1 O 0 7.39006418370991e-06
appears O 0 3.370317802620093e-09
to O 0 1.1826171552459241e-12
function O 0 3.81475649680052e-11
in O 0 1.1828794888035787e-11
survival O 0 1.094044819183182e-06
of O 0 9.356846894514881e-12
islet O 0 1.7547081370139495e-05
beta O 0 3.711044271881292e-08
- O 0 6.879455759190023e-05
cells O 0 1.1534930788315023e-09
and O 0 1.7682219620798745e-12
neurons O 0 2.9826772995900086e-11
. O 0 1.0252610121563172e-13
. O 0 1.2596820288257593e-12

Stable O 0 8.856771387399931e-07
interaction O 0 6.452623158015314e-11
between O 0 3.125177525618861e-13
the O 0 4.454826213999433e-15
products O 0 4.935320273118105e-13
of O 0 6.921042684543844e-15
the O 0 2.9427354650279902e-12
BRCA1 O 0 7.100211263377787e-08
and O 0 7.151799152893545e-10
BRCA2 O 0 5.1833239922416396e-08
tumor B-Disease 0 9.998318617476798e-09
suppressor O 0 2.7120963252968977e-09
genes O 0 5.278900649940965e-10
in O 0 3.118829792949501e-13
mitotic O 0 1.1244257747122788e-09
and O 0 1.6046386441814775e-11
meiotic O 0 3.3077870398301457e-07
cells O 0 1.0101410197194127e-07
. O 0 2.6066743208374987e-10

BRCA1 O 0 6.310090248007327e-05
and O 0 2.7985702644173216e-10
BRCA2 O 0 1.976145469484436e-08
account O 0 9.714602733357225e-11
for O 0 2.684084101896647e-14
most O 0 1.5441647797671126e-14
cases O 0 2.470263034924647e-13
of O 0 2.9660599300815934e-15
familial O 0 1.7724463674539948e-08
, O 0 2.520714756718001e-13
early O 0 3.1214576062810195e-11
onset O 0 1.2171457797194307e-07
breast B-Disease 0 0.4308990240097046
and I-Disease 0 0.0007898821495473385
/ I-Disease 1 0.999972939491272
or I-Disease 1 0.9999979734420776
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.0960759383449314e-10
encode O 0 1.8540696050933086e-13
products O 0 5.0783487658134785e-12
that O 0 2.15974766825007e-14
each O 0 9.79428686184768e-15
interact O 0 1.8399675229610613e-13
with O 0 1.0569254889694624e-12
hRAD51 O 0 1.0265221561667204e-07
. O 0 3.186170771662944e-10

Results O 0 1.2407694871541253e-09
presented O 0 6.393024998274655e-11
here O 0 1.3403549971313655e-11
show O 0 9.832641645335372e-11
that O 0 3.2549120733763037e-13
BRCA1 O 0 7.536449797562739e-10
and O 0 1.0948363743379375e-11
BRCA2 O 0 3.0946714080215543e-09
coexist O 0 1.996268261805767e-09
in O 0 7.073318710262844e-14
a O 0 9.497191580257539e-14
biochemical O 0 1.066234531221788e-10
complex O 0 4.199865281939719e-12
and O 0 3.235982716596336e-13
colocalize O 0 4.513410800655038e-08
in O 0 5.987388102673963e-12
subnuclear O 0 7.30993647835021e-08
foci O 0 2.8616897296274146e-08
in O 0 6.647154614930484e-13
somatic O 0 6.485726018745641e-12
cells O 0 2.529328482769877e-11
and O 0 4.3611736943137414e-13
on O 0 3.6389101909679866e-13
the O 0 6.855692822113754e-15
axial O 0 7.337258405015756e-12
elements O 0 1.639674784836842e-10
of O 0 1.0827804581767242e-12
developing O 0 5.053117368980509e-10
synaptonemal O 0 9.301347603241084e-08
complexes O 0 3.759224398436345e-08
. O 0 3.304510554080764e-10

Like O 0 1.5671917097392907e-08
BRCA1 O 0 1.312883341597626e-06
and O 0 9.071601803078977e-11
RAD51 O 0 5.944143140368396e-06
, O 0 4.595236517690449e-12
BRCA2 O 0 1.0931061389385377e-08
relocates O 0 1.6314213313606274e-09
to O 0 3.323837299146204e-12
PCNA O 0 2.7315028461316615e-08
+ O 0 5.5998179183947006e-12
replication O 0 1.0342945033423034e-12
sites O 0 2.239970795653301e-12
following O 0 2.5419208838500795e-12
exposure O 0 6.924103217897937e-06
of O 0 6.584918157623298e-13
S O 0 4.228013210649806e-07
phase O 0 3.7480716447158e-11
cells O 0 2.204191907120845e-12
to O 0 4.503026708566234e-14
hydroxyurea O 0 1.0076135481540405e-09
or O 0 2.2301001323388192e-10
UV O 0 5.0419766921550035e-05
irradiation O 0 6.042398581485031e-08
. O 0 1.547830058568067e-10

Thus O 0 1.1419157175396322e-08
, O 0 1.8742019654988118e-12
BRCA1 O 0 1.1359043705638783e-09
and O 0 3.8293344190032386e-12
BRCA2 O 0 1.621531353634964e-09
participate O 0 3.678985935340329e-11
, O 0 5.048020581730449e-14
together O 0 1.1240725147562691e-12
, O 0 5.6019486196091234e-14
in O 0 4.047820699503227e-14
a O 0 3.7364761892172416e-13
pathway O 0 4.966219276092421e-12
( O 0 1.3609678163085948e-13
s O 0 5.200415742478981e-08
) O 0 1.5209845373193726e-14
associated O 0 3.323585504033666e-11
with O 0 4.710606362444414e-14
the O 0 1.4575253371308487e-14
activation O 0 2.8383784038410464e-13
of O 0 4.0410474852438025e-14
double O 0 6.862597956569516e-08
- O 0 1.3349919925076392e-07
strand O 0 1.3281283850474779e-09
break O 0 5.581253859077151e-08
repair O 0 9.18043419062542e-09
and O 0 1.1908319816344992e-11
/ O 0 3.2477423528298743e-10
or O 0 3.7678527832485376e-12
homologous O 0 7.457685163858585e-11
recombination O 0 2.2506463359661666e-09
. O 0 1.0941814121423477e-10

Dysfunction O 0 5.060875992057845e-06
of O 0 1.961174495371254e-12
this O 0 1.623199052383159e-13
pathway O 0 5.7166502434591315e-12
may O 0 2.148523164935412e-10
be O 0 2.8540446508950115e-14
a O 0 4.674801517434322e-15
general O 0 4.390449592425738e-14
phenomenon O 0 8.337965040627893e-11
in O 0 5.065516555475755e-14
the O 0 4.821797309166728e-15
majority O 0 1.6016373882536683e-13
of O 0 3.549922493481061e-15
cases O 0 2.0978741747251783e-12
of O 0 4.951811530262695e-13
hereditary B-Disease 1 0.9864267706871033
breast I-Disease 1 0.9999057054519653
and I-Disease 1 0.7197256088256836
/ I-Disease 1 0.9999920129776001
or I-Disease 1 0.9999939203262329
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.824569325798336e-10
. O 0 1.8545597349484133e-11

A O 0 1.9083716551460128e-10
novel O 0 4.6654763385944875e-11
Arg362Ser O 0 2.7107324385156062e-08
mutation O 0 5.063616637102086e-09
in O 0 7.74542973161485e-13
the O 0 4.687145311634e-13
sterol O 0 4.704820821643807e-05
27 O 0 6.390739493156161e-09
- O 0 7.510168842372877e-08
hydroxylase O 0 2.3727506004433963e-07
gene O 0 1.4456127406248243e-09
( O 0 9.371965551709105e-14
CYP27 O 0 8.69288419025338e-10
) O 0 1.0577108782469473e-14
: O 0 3.621803191692719e-15
its O 0 1.2532909128229073e-15
effects O 0 1.3570869428214394e-10
on O 0 6.421867204675635e-11
pre O 0 2.632127689139452e-07
- O 0 1.915354957970905e-10
mRNA O 0 4.308422244187274e-14
splicing O 0 8.55568545697627e-13
and O 0 8.127407845033921e-14
enzyme O 0 3.316654134492836e-13
activity O 0 2.612386869327299e-11
. O 0 1.0046701968621785e-12

A O 0 1.2289758100081372e-10
novel O 0 3.483174165763714e-11
C O 0 3.739677900682636e-09
to O 0 8.0985023374891e-14
A O 0 3.914346711347827e-12
mutation O 0 1.2474707933307627e-09
in O 0 2.886961503190122e-13
the O 0 2.719430583497662e-13
sterol O 0 8.61071384861134e-06
27 O 0 1.395327409170477e-09
- O 0 5.221245213959946e-09
hydroxylase O 0 7.487395592420398e-09
gene O 0 7.941481500184366e-11
( O 0 2.202374431914053e-14
CYP27 O 0 2.8860478451520066e-09
) O 0 1.2401937929309298e-14
was O 0 2.2041152540272502e-13
identified O 0 3.2698962895011396e-13
by O 0 6.176139676113547e-16
sequencing O 0 9.83024493511793e-14
amplified O 0 1.2447250175018354e-10
CYP27 O 0 8.048559735351901e-11
gene O 0 2.113727162050827e-12
products O 0 1.0431883221834193e-12
from O 0 2.2370226534346692e-14
a O 0 1.2555473154207686e-11
patient O 0 5.6844125850830096e-08
with O 0 8.655096639387239e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.193459442383471e-09
CTX B-Disease 0 1.264657953470305e-06
) O 0 1.1955726339496486e-11
. O 0 3.776286575107868e-11

The O 0 7.161128461052879e-12
mutation O 0 2.2229327267808685e-09
changed O 0 2.898020365349474e-11
the O 0 3.196266756244604e-15
adrenodoxin O 0 1.1205714828266267e-10
cofactor O 0 1.7637623132837899e-12
binding O 0 4.5427312085621896e-12
residue O 0 9.407961909513318e-11
362Arg O 0 1.0192785504514745e-10
to O 0 2.4842489718991667e-13
362Ser O 0 6.759990345273081e-09
( O 0 1.0133143917056067e-13
CGT O 0 2.2200334626187868e-10
362Arg O 0 1.2581154174018394e-10
to O 0 2.905744221626261e-13
AGT O 0 2.5846840223664458e-09
362Ser O 0 1.563106172275397e-10
) O 0 1.6708443168530346e-14
, O 0 9.656129011886925e-16
and O 0 5.469602093292891e-14
was O 0 3.176133314686247e-11
responsible O 0 4.1622291724330296e-10
for O 0 1.9277602084089018e-11
deficiency O 0 0.00011587558401515707
in O 0 1.432828736300934e-13
the O 0 1.0068647304795064e-12
sterol O 0 2.6763000278151594e-05
27 O 0 1.896789170174884e-09
- O 0 2.142689403683562e-08
hydroxylase O 0 1.6716565198748867e-07
activity O 0 3.764584732834919e-08
, O 0 1.905420731881046e-15
as O 0 8.957144718318467e-15
confirmed O 0 1.8535826085824825e-12
by O 0 8.482945181259409e-15
expression O 0 1.264480360696485e-11
of O 0 1.6678823061639573e-15
mutant O 0 5.955459649736872e-13
cDNA O 0 4.1218680487016546e-13
into O 0 6.287595877979557e-12
COS O 0 7.468855187653389e-07
- O 0 6.878623821648944e-07
1 O 0 3.821470917486636e-11
cells O 0 2.0451319804326573e-10
. O 0 1.7016513198520045e-11

Quantitative O 0 1.7069931579349884e-10
analysis O 0 2.9370525456151597e-10
showed O 0 1.765232293671204e-09
that O 0 3.495847952479994e-14
the O 0 6.2667296380641575e-15
expression O 0 8.244955065905835e-12
of O 0 9.98254840470442e-15
CYP27 O 0 6.226379967166906e-10
gene O 0 1.2477497333962528e-12
mRNA O 0 4.928960343174305e-13
in O 0 4.324872640462489e-14
the O 0 3.6215151157873576e-14
patient O 0 6.848492606348344e-11
represented O 0 3.9455910760821666e-11
52 O 0 3.9017365727200826e-11
. O 0 4.360013738935464e-11

5 O 0 9.80511158377162e-11
% O 0 2.200608835781215e-12
of O 0 7.740478451343652e-14
the O 0 3.6281644355540266e-11
normal O 0 1.2893141843051126e-07
level O 0 1.4586983354547556e-07
. O 0 5.681196138529465e-11

As O 0 4.815040727246256e-12
the O 0 1.6806350690463934e-13
mutation O 0 2.118249325944177e-10
occurred O 0 2.5960449068218594e-11
at O 0 2.5831792691759052e-14
the O 0 7.80594276910074e-16
penultimate O 0 4.599363966940884e-13
nucleotide O 0 1.8710018343665036e-12
of O 0 1.5517576889854186e-15
exon O 0 8.058571171476459e-12
6 O 0 2.3627690515920508e-12
( O 0 1.1366905172378958e-14
- O 0 2.5392499214405007e-09
2 O 0 1.5355313591827735e-12
position O 0 4.402233688693968e-09
of O 0 4.76410665745889e-14
exon O 0 1.9158528097307226e-09
6 O 0 3.21752580134671e-09
- O 0 1.0994484966886375e-07
intron O 0 7.879207508665331e-09
6 O 0 2.146456406712516e-12
splice O 0 2.2833399667548937e-12
site O 0 5.425076620574343e-12
) O 0 6.101674256863343e-15
of O 0 1.3048977715629149e-15
the O 0 1.0559290597391031e-14
gene O 0 2.773931778721206e-11
, O 0 3.620575586842263e-14
we O 0 1.2103153494615743e-13
hypothesized O 0 5.2546302134774334e-14
that O 0 3.801204685217885e-14
the O 0 1.565938540946596e-13
mutation O 0 5.651073919921146e-08
may O 0 1.6750189013592376e-09
partially O 0 2.2002009103516684e-09
affect O 0 2.2942212019039232e-10
the O 0 5.713483207598138e-14
normal O 0 5.832512207579188e-13
splicing O 0 5.820510089529773e-13
efficiency O 0 1.7613660530102493e-11
in O 0 5.640180976342751e-14
exon O 0 3.1098945640906095e-10
6 O 0 4.040084655709819e-10
and O 0 2.2327194346832835e-12
cause O 0 3.75956861128901e-12
alternative O 0 4.710723252991135e-14
splicing O 0 4.153105376963895e-12
elsewhere O 0 9.360426878046724e-10
, O 0 2.124045441281538e-15
which O 0 4.216862048347231e-14
resulted O 0 6.451205021573703e-12
in O 0 1.239566695815375e-11
decreased O 0 1.1088866491704152e-09
transcript O 0 6.946422603792968e-11
in O 0 1.28255930181842e-11
the O 0 1.7996963294630852e-11
patient O 0 8.258944639294441e-09
. O 0 4.7430337435372394e-11

Transfection O 0 1.7158857872345834e-06
of O 0 1.1102209429569854e-11
constructed O 0 7.195172235796576e-10
minigenes O 0 2.1577116058324464e-06
, O 0 1.228896677344174e-13
with O 0 4.9168263590356615e-14
or O 0 3.7610928260711773e-10
without O 0 1.3055682923646117e-10
the O 0 3.2002395525254634e-14
mutation O 0 1.643641299453602e-11
, O 0 5.83381607504105e-16
into O 0 2.6346705714460836e-14
COS O 0 2.0197004957367426e-08
- O 0 5.915032375014562e-07
1 O 0 5.623858150005656e-12
cells O 0 1.962506763000804e-12
confirmed O 0 1.0983984555235082e-11
that O 0 2.3734974912808767e-15
the O 0 3.036409616241089e-15
mutant O 0 6.07667822311031e-12
minigene O 0 9.436042169852499e-09
was O 0 5.531037849948461e-10
responsible O 0 6.72163089077138e-11
for O 0 3.3097646395504124e-14
a O 0 2.4146323504038725e-13
mRNA O 0 3.697089021644645e-13
species O 0 2.2822841977843816e-14
alternatively O 0 1.805921812916486e-13
spliced O 0 2.4608518001123514e-10
at O 0 3.5256548791551268e-09
an O 0 1.1157206885811788e-12
activated O 0 1.090717614715686e-05
cryptic O 0 6.448237943601498e-09
5 O 0 2.459051300258974e-13
splice O 0 2.315532661445463e-11
site O 0 1.0094115820979965e-10
88 O 0 1.0325841744152076e-11
bp O 0 8.969540388203967e-11
upstream O 0 1.1757416871691073e-12
from O 0 7.714041536620309e-13
the O 0 5.027537088898859e-13
3 O 0 4.431172442864728e-12
end O 0 6.336378036847501e-12
of O 0 5.534424508306726e-14
exon O 0 6.550616715728097e-10
6 O 0 2.1783400083741356e-10
. O 0 1.5051373342123142e-11

Our O 0 3.272908610796321e-10
data O 0 1.4188617728644326e-12
suggest O 0 4.112682416845814e-12
that O 0 6.22071372617162e-15
the O 0 1.3613383932230185e-14
C O 0 1.6831430693642346e-10
to O 0 6.488636176618786e-15
A O 0 1.6672930397421126e-12
mutation O 0 1.0005443695781935e-10
at O 0 1.318700330139519e-13
the O 0 8.917659218691024e-16
penultimate O 0 5.740880318870489e-14
nucleotide O 0 4.622017829233882e-13
of O 0 3.106529597653201e-16
exon O 0 1.8932732985532663e-12
6 O 0 2.147151542935405e-13
of O 0 5.39782704126558e-16
the O 0 2.286318615712154e-14
CYP27 O 0 2.992601277895801e-09
gene O 0 3.281971222568458e-11
not O 0 1.088182582237307e-11
only O 0 6.98303584010726e-14
causes O 0 5.909627648348348e-11
the O 0 1.8660276449034008e-11
deficiency B-Disease 0 0.0003134126018267125
in I-Disease 0 1.0407040897456032e-12
the I-Disease 0 2.50558298067749e-12
sterol I-Disease 0 4.924810127704404e-05
27 I-Disease 0 2.8686943931433007e-09
- I-Disease 0 1.4553574345654852e-08
hydroxylase I-Disease 0 8.532483519729794e-08
activity I-Disease 0 2.0794421118353057e-07
, O 0 7.392555263687622e-14
but O 0 3.133583453482358e-12
also O 0 4.43187180747609e-13
partially O 0 4.097043260209432e-10
leads O 0 2.1246849765677034e-12
to O 0 5.0693437891446286e-14
alternative O 0 2.5342044001480657e-12
pre O 0 1.7442483013496712e-08
- O 0 3.439583062814222e-10
mRNA O 0 5.339201032249913e-14
splicing O 0 3.4766989092348266e-13
of O 0 5.9467709890518444e-15
the O 0 1.559294482270969e-14
gene O 0 4.3144977174280896e-11
. O 0 6.268101922918268e-12

To O 0 7.379324928891151e-11
our O 0 5.735905674042474e-12
knowledge O 0 7.160824667604149e-13
, O 0 2.883469770801326e-15
this O 0 1.6556098575494266e-15
is O 0 8.757432137047796e-15
the O 0 8.748312980337656e-16
first O 0 2.3524330947837305e-14
report O 0 2.945519262526064e-13
regarding O 0 1.2957868014262103e-13
effects O 0 1.257427495460206e-09
on O 0 1.2134653004647333e-10
pre O 0 9.425252756045666e-08
- O 0 6.91635984595429e-11
mRNA O 0 4.628664903346801e-15
splicing O 0 1.5961199172792075e-14
of O 0 2.1112084452076622e-16
a O 0 1.6042620850121605e-15
mutation O 0 2.885414617740528e-13
at O 0 3.989004086898604e-14
the O 0 2.8734569519801856e-14
- O 0 4.69174619865953e-06
2 O 0 1.163799612236005e-10
position O 0 2.031209078268148e-06
of O 0 3.6950444873978805e-13
a O 0 1.48096881980031e-11
5 O 0 1.5277837588784093e-12
splice O 0 2.0148351043136614e-10
site O 0 1.1139601241438868e-08
. O 0 1.21589860402338e-09

ATM O 0 1.9272026747785276e-06
germline O 0 6.0474158090073615e-05
mutations O 0 0.0013302851002663374
in O 0 2.8785672512299243e-08
classical O 1 0.9805397987365723
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9895793795585632
in O 0 2.2477204542070695e-09
the O 0 2.3695129192091713e-11
Dutch O 0 4.782001269632019e-06
population O 0 1.857278393579964e-11
. O 0 2.5016447247061535e-11

Germline O 0 7.2387697400699835e-06
mutations O 0 5.651856099575525e-06
in O 0 4.460137988104851e-12
the O 0 2.2586565525339018e-14
ATM O 0 1.981471930978529e-11
gene O 0 2.8707440938302575e-11
are O 0 4.12274686232509e-14
responsible O 0 3.003226356837474e-12
for O 0 1.8418433011396784e-12
the O 0 0.0018969562370330095
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.8272415399551392
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 9.98935489882058e-10
. O 0 4.190249883184727e-11

In O 0 6.997263324315384e-10
our O 0 2.6887559886890067e-11
study O 0 1.794210803150384e-13
, O 0 1.3755633798359125e-14
we O 0 1.0432878519428535e-12
have O 0 2.1942398663018017e-14
determined O 0 4.682963001753637e-13
the O 0 9.984561802020044e-16
ATM O 0 6.3957168554285015e-12
mutation O 0 4.096539513859243e-12
spectrum O 0 8.769882389736416e-12
in O 0 2.9005571815926556e-12
19 O 0 1.3248885495642515e-11
classical O 0 1.5027624158392427e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 8.758382108453588e-08
, O 0 2.141766429329282e-15
including O 0 5.16555737223865e-16
some O 0 6.204858539948441e-15
immigrant O 0 3.523759062318277e-09
populations O 0 2.5590957131171876e-10
, O 0 4.11828299869306e-14
as O 0 2.599821941930147e-14
well O 0 1.121162516125318e-12
as O 0 1.4974681650931077e-12
12 O 0 4.843205372341564e-13
of O 0 1.5595806438818693e-13
Dutch O 0 3.68581859220285e-05
ethnic O 0 1.4666984293754126e-09
origin O 0 1.427078046845054e-07
. O 0 1.617126016428827e-10

Both O 0 2.7896992441794888e-12
the O 0 2.9516760400877945e-14
protein O 0 2.7462588952052724e-13
truncation O 0 2.74951138246049e-11
test O 0 1.6283861759003315e-10
( O 0 9.118072507967312e-15
PTT O 0 1.7101771387917353e-10
) O 0 7.109212747842281e-15
and O 0 2.4991408529624224e-15
the O 0 3.9396254118538197e-16
restriction O 0 4.856319407481498e-14
endonuclease O 0 5.033574685536779e-12
fingerprinting O 0 2.0779870879561457e-11
( O 0 1.7429725604435273e-14
REF O 0 1.9703766396261813e-11
) O 0 1.0728872516044528e-17
method O 0 1.848488682880769e-15
were O 0 2.2751040688970964e-14
used O 0 2.4655416055140156e-13
and O 0 1.7125777792420527e-12
compared O 0 2.2852320730182285e-11
for O 0 5.1158875719698946e-15
their O 0 7.106531210937864e-14
detection O 0 1.2425254401760011e-11
efficiency O 0 1.1317677480957022e-12
, O 0 2.8497642651872685e-17
identifying O 0 2.321135905009042e-14
76 O 0 1.24326327092519e-14
% O 0 7.619568733287837e-15
and O 0 3.456505914822827e-13
60 O 0 3.125946767060239e-13
% O 0 6.259994963803833e-14
of O 0 1.8879820937959396e-13
the O 0 3.3367228424729944e-10
mutations O 0 6.259655265239417e-07
, O 0 2.1891006802415847e-12
respectively O 0 3.589039732077026e-09
. O 0 1.1826679913173876e-10

Most O 0 7.50285888972968e-10
patients O 0 2.74384431842023e-10
were O 0 1.063741542767227e-11
found O 0 7.320512251940414e-12
to O 0 3.729329779017521e-12
be O 0 2.633530338247425e-10
compound O 0 2.3199822063446618e-09
heterozygote O 0 7.974671234478592e-07
. O 0 2.3097378176739625e-10

Seventeen O 0 5.2553978946434654e-08
mutations O 0 1.2856135356287268e-07
were O 0 6.238736523916932e-12
distinct O 0 4.30315418714633e-12
, O 0 1.8167390335166456e-13
of O 0 1.8784240384938505e-13
which O 0 4.347296300721837e-09
10 O 0 3.988652463871034e-11
were O 0 6.587214662623353e-10
not O 0 2.3919163538721477e-08
reported O 0 5.358581134373708e-08
previously O 0 3.245720492373039e-08
. O 0 1.9917489879617278e-10

Mutations O 0 1.2118091035517864e-05
are O 0 5.347561044151405e-13
small O 0 2.2352578772297238e-13
deletions O 0 1.775979185936194e-08
or O 0 2.4183952973544365e-07
point O 0 7.307447162929748e-07
mutations O 0 5.768849950982258e-05
frequently O 0 2.717918157202348e-08
affecting O 0 9.146278734384339e-10
splice O 0 5.466852304181202e-09
sites O 0 1.6334240626747487e-08
. O 0 9.19097686846726e-10

Moreover O 0 7.808892377170196e-08
, O 0 9.684291129435918e-13
a O 0 5.952158470962088e-12
16 O 0 5.264559621576126e-11
. O 0 4.0134468665131706e-11

7 O 0 1.4987170615654577e-08
- O 0 2.001155685604772e-09
kb O 0 3.0417848795316615e-10
genomic O 0 8.476202378870923e-11
deletion O 0 8.541582552368254e-09
of O 0 3.924713744100916e-13
the O 0 1.7683693864702782e-13
3 O 0 5.415717787421448e-13
end O 0 3.038221800880092e-12
of O 0 2.0667529797622044e-15
the O 0 6.953646253233083e-15
gene O 0 5.478158725258364e-12
, O 0 4.414024636930193e-15
most O 0 2.4403076385120332e-15
likely O 0 7.493480662368324e-13
a O 0 1.3779582807909793e-14
result O 0 6.3040957003213105e-12
of O 0 4.486955338359091e-16
recombination O 0 9.431852000807428e-12
between O 0 6.127031659808324e-10
two O 0 1.6913163577991774e-11
LINE O 0 3.650180602221553e-08
elements O 0 9.140318724121244e-09
, O 0 3.5484386696343906e-12
was O 0 3.457014230434652e-09
identified O 0 3.046979770715552e-07
. O 0 2.2643031893920806e-10

The O 0 1.2049335487707147e-11
most O 0 3.3020355655506706e-13
frequently O 0 3.9436499205125486e-11
found O 0 4.0463890918496226e-12
mutation O 0 2.779822760867745e-10
, O 0 5.667007018002063e-15
identified O 0 5.362723806690006e-11
in O 0 5.850930091984285e-13
three O 0 1.2746857876947543e-13
unrelated O 0 2.3161357276535455e-09
Turkish O 0 0.004885134287178516
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 8.908871507173899e-08
, O 0 3.536033878898115e-12
was O 0 5.187195672995415e-10
previously O 0 5.978969402908874e-11
described O 0 5.627531080021342e-11
to O 0 4.3603939903213984e-12
be O 0 2.9170657556143453e-10
a O 0 1.1452824105750992e-10
Turkish O 0 0.12650416791439056
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 2.21523048793415e-08
mutation O 0 2.4452418756482075e-07
. O 0 4.294055389042484e-11

The O 0 7.296939094625365e-12
presence O 0 8.949751356679414e-11
of O 0 1.2826357340058221e-14
a O 0 3.862319264327091e-13
founder O 0 3.6327073293929146e-11
mutation O 0 3.107097690246974e-09
among O 0 2.1036015811215503e-14
relatively O 0 2.0908572928037515e-14
small O 0 1.1861446205666329e-14
ethnic O 0 2.0887199955743618e-11
population O 0 9.414490888259852e-12
groups O 0 1.9495644248274102e-12
in O 0 3.5325286532744693e-12
Western O 0 1.3622963868087368e-11
Europe O 0 6.462298696163771e-09
could O 0 3.78767905928612e-10
indicate O 0 5.7705517447770305e-11
a O 0 9.048211398882122e-13
high O 0 1.0677038420059404e-10
carrier O 0 7.833704518400708e-11
frequency O 0 7.316833805504075e-10
in O 0 4.0392618720283546e-13
such O 0 5.052415734049798e-13
communities O 0 7.115684430569758e-11
. O 0 7.912485666672353e-10

In O 0 1.947638272881136e-09
patients O 0 2.9117291910907284e-10
of O 0 1.68679219897383e-12
Dutch O 0 0.0026903024408966303
ethnic O 0 2.723439429530572e-08
origin O 0 4.28874187718975e-07
, O 0 9.96593107517596e-13
however O 0 6.816179565216629e-13
, O 0 2.573460370787462e-15
no O 0 1.498141617272547e-13
significant O 0 7.969814315878648e-14
founder O 0 2.4736601655916957e-11
effect O 0 1.7702232568694853e-08
could O 0 3.966178496739303e-09
be O 0 2.9218644864714705e-11
identified O 0 5.216984177991435e-09
. O 0 5.1064905776110336e-11

The O 0 2.886280190544932e-12
observed O 0 1.196612947618192e-11
genetic O 0 7.038026845346268e-12
heterogeneity O 0 2.0419620855305354e-11
including O 0 1.0531819963658859e-13
the O 0 6.217470115144064e-13
relative O 0 2.6722623260866385e-06
high O 0 4.843443548452342e-07
percentage O 0 3.464426526988973e-06
of O 0 3.766943557754164e-14
splice O 0 4.255997332336392e-09
- O 0 6.255621087802865e-07
site O 0 1.2248585257168543e-08
mutations O 0 7.832931260054465e-06
had O 0 1.1098960639444044e-09
no O 0 9.92926140613859e-12
reflection O 0 3.923692620810826e-11
on O 0 4.7124444103874286e-12
the O 0 2.1319473963998803e-12
phenotype O 0 4.551827803567221e-09
. O 0 7.764351661609936e-12

All O 0 8.524423389388858e-10
patients O 0 2.419402733710996e-10
manifested O 0 2.429670242776183e-09
classical O 0 2.5409574391233036e-06
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
and O 0 2.0434358372067862e-10
increased O 0 9.430197941973084e-12
cellular O 0 2.638827307707703e-12
radioresistant O 0 2.4559177608241e-11
DNA O 0 6.040474110485805e-12
synthesis O 0 1.2684879188706866e-11
. O 0 2.3304452985428714e-12

Determination O 0 2.824446987403917e-08
of O 0 8.93196784980746e-14
the O 0 3.276960408755969e-15
genomic O 0 1.0038465284717413e-12
structure O 0 3.786189070598134e-11
of O 0 2.329748451313429e-15
the O 0 3.4561070300673062e-15
COL4A4 O 0 1.3413614663448925e-09
gene O 0 9.263353972777111e-12
and O 0 1.4458799554774998e-13
of O 0 1.1094444319400404e-14
novel O 0 1.765831703082199e-09
mutations O 0 0.0012646977556869388
causing O 0 0.0002555713872425258
autosomal B-Disease 1 0.9999969005584717
recessive I-Disease 1 0.9999973773956299
Alport I-Disease 1 0.9999988079071045
syndrome I-Disease 1 0.9999995231628418
. O 0 2.506616567643505e-07

Autosomal B-Disease 1 0.999997615814209
recessive I-Disease 1 0.9999986886978149
Alport I-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999998807907104
is O 0 4.146636811697135e-09
a O 0 9.614618823317045e-11
progressive O 0 2.8386722988216206e-05
hematuric B-Disease 1 0.9999305009841919
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.0002496334782335907
by O 0 1.934543192305682e-09
glomerular B-Disease 1 0.9999372959136963
basement I-Disease 1 0.9999336004257202
membrane I-Disease 1 0.9988278746604919
abnormalities I-Disease 1 0.9999849796295166
and O 0 9.15276604507298e-11
associated O 0 4.479796977818751e-09
with O 0 4.4467003863790655e-12
mutations O 0 3.16016155466059e-08
in O 0 5.239890552705129e-13
either O 0 1.7872303029881076e-12
the O 0 2.2728658690372716e-14
COL4A3 O 0 3.993720909534204e-08
or O 0 4.954695508041507e-12
the O 0 2.930879687166807e-14
COL4A4 O 0 5.454978246888231e-09
gene O 0 1.1238350527964514e-11
, O 0 2.830892953457594e-15
which O 0 9.732638189289956e-17
encode O 0 3.7444322278127825e-16
the O 0 1.0493916594521945e-14
alpha3 O 0 3.837926598748709e-08
and O 0 3.0458302546776395e-11
alpha4 O 0 2.756531557679409e-06
type O 0 0.0012453584931790829
IV O 0 8.111222268780693e-05
collagen O 0 1.0332069905416574e-05
chains O 0 1.2948064522788627e-06
, O 0 2.057137619970728e-11
respectively O 0 1.4884784071966806e-08
. O 0 1.5581233525630012e-10

To O 0 5.1296527789346236e-12
date O 0 8.203547563478963e-11
, O 0 2.0247691564568345e-15
mutation O 0 8.825180034454858e-14
screening O 0 3.421990338661751e-12
in O 0 1.1145061653075605e-12
the O 0 7.315967899849604e-14
two O 0 3.28845945699735e-13
genes O 0 2.906090819376761e-11
has O 0 1.0328619036437114e-11
been O 0 3.758335222897591e-12
hampered O 0 1.1306038744107738e-10
by O 0 5.153755569010932e-13
the O 0 6.407353380505354e-12
lack O 0 3.7969717647801104e-11
of O 0 3.681856557103628e-15
genomic O 0 4.583707545469107e-12
structure O 0 1.9807018525330733e-10
information O 0 1.8569664902989835e-11
. O 0 1.458951535970865e-11

We O 0 1.3797114561953094e-08
report O 0 3.7507250777446544e-11
here O 0 7.03452053552045e-13
the O 0 3.22653590213121e-16
complete O 0 5.566052972667086e-15
characterization O 0 4.3368217003680876e-12
of O 0 2.2516195722147025e-14
the O 0 3.8171107442398766e-13
48 O 0 1.593875449375573e-13
exons O 0 3.4169664168449965e-13
of O 0 4.2147871564396366e-14
the O 0 6.551218985698104e-13
COL4A4 O 0 2.2788508147186803e-07
gene O 0 1.546643646488377e-10
, O 0 9.136700456543329e-15
a O 0 4.99878907866025e-15
comprehensive O 0 4.330851270054753e-13
gene O 0 2.15111348872421e-11
screen O 0 2.625504009756696e-07
, O 0 2.544742845264625e-13
and O 0 4.066904690618045e-14
the O 0 1.3968302807349235e-15
subsequent O 0 3.4740607742986263e-13
detection O 0 2.0452491089617553e-10
of O 0 1.2157285167989102e-14
10 O 0 3.57712516834037e-14
novel O 0 3.086748250665655e-13
mutations O 0 3.855900931881706e-09
in O 0 4.122477706425265e-11
eight O 0 4.712703116638295e-09
patients O 0 3.629969924645593e-08
diagnosed O 0 0.00639989273622632
with O 0 2.2193376025825273e-07
autosomal B-Disease 1 0.9999994039535522
recessive I-Disease 1 0.9999990463256836
Alport I-Disease 1 0.9999978542327881
syndrome I-Disease 1 0.9999986886978149
. O 0 9.229827213630415e-08

Furthermore O 0 1.4124847780294658e-07
, O 0 7.646339290900972e-12
we O 0 2.511070561553308e-12
identified O 0 2.149683968159788e-13
a O 0 1.0422301017622778e-15
glycine O 0 3.7302525976966316e-13
to O 0 6.360874385536158e-16
alanine O 0 1.0680546074295916e-13
substitution O 0 7.576935362766865e-14
in O 0 1.2706071038251585e-14
the O 0 8.295609445414017e-15
collagenous O 0 9.561316183237523e-10
domain O 0 3.73397909814166e-11
that O 0 3.4095335062211962e-12
is O 0 6.0336345295008975e-12
apparently O 0 1.8298602633137762e-09
silent O 0 3.194547559814964e-07
in O 0 2.0877392696572183e-12
the O 0 6.782781665970114e-14
heterozygous O 0 5.9802239549267e-11
carriers O 0 1.0504866941596358e-11
, O 0 2.7087083661128664e-14
in O 0 3.302176023942116e-12
11 O 0 1.3764316075803862e-11
. O 0 7.012420592117374e-12

5 O 0 7.342371849405893e-11
% O 0 7.172388225874793e-13
of O 0 2.767385048874603e-14
all O 0 1.956903606173399e-12
control O 0 3.468372256065777e-10
individuals O 0 1.5789355933826243e-11
, O 0 1.8090073167741083e-13
and O 0 5.180844989127742e-11
in O 0 5.163420472437119e-12
one O 0 2.0665591633772795e-12
control O 0 7.883907970906989e-10
individual O 0 6.302096431515247e-13
homozygous O 0 2.1059642744958307e-12
for O 0 9.896134738700247e-16
this O 0 1.6674687423274604e-15
glycine O 0 1.200791744683516e-12
substitution O 0 3.562829501910225e-12
. O 0 7.076939403417859e-13

There O 0 4.63185845234193e-09
has O 0 3.76068898244597e-11
been O 0 2.2399024909164345e-12
no O 0 8.925165294326742e-12
previous O 0 6.564239711688569e-13
finding O 0 5.908649085414538e-14
of O 0 1.6738791141420606e-16
a O 0 7.399460128042874e-16
glycine O 0 3.880933863663859e-14
substitution O 0 7.078434111637902e-14
that O 0 6.451096946945897e-15
is O 0 1.68013762353713e-14
not O 0 2.601890396387342e-14
associated O 0 1.4889494802036718e-12
with O 0 2.3205604308246773e-14
any O 0 1.351035811003598e-10
obvious O 0 7.49645501230134e-09
phenotype O 0 1.3517323926848235e-09
in O 0 1.7116429801289357e-13
homozygous O 0 8.876822610304202e-10
individuals O 0 1.584381653652045e-10
. O 0 8.041899784982931e-11

Founder O 0 5.3087635620840956e-08
BRCA1 O 0 1.1311182106510387e-06
and O 0 1.6488323206775846e-10
BRCA2 O 0 1.0271116934745805e-07
mutations O 0 7.204749863376492e-07
in O 0 1.8362296405616263e-10
French O 0 0.0003325180150568485
Canadian O 1 0.9918448328971863
breast B-Disease 1 0.9999995231628418
and I-Disease 1 0.9999985694885254
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.008891013043467e-05
. O 0 6.62306876009211e-10

We O 0 4.211987203461831e-08
have O 0 1.2606146595345313e-12
identified O 0 1.7759833534358727e-11
four O 0 1.1365256846263602e-14
mutations O 0 1.3944473830837523e-12
in O 0 4.088758055953911e-15
each O 0 1.8753871882087186e-14
of O 0 7.05235769413691e-14
the O 0 1.4038437967656137e-08
breast B-Disease 1 0.9999942779541016
cancer I-Disease 1 0.9999352693557739
- O 1 0.998009979724884
susceptibility O 1 0.8164806365966797
genes O 0 2.6969735245074844e-07
, O 0 4.146446911951901e-13
BRCA1 O 0 1.5146821297218338e-10
and O 0 1.2964352898506282e-12
BRCA2 O 0 3.515929214437108e-10
, O 0 8.238061518757792e-14
in O 0 2.460159680139906e-12
French O 0 4.824266579817049e-05
Canadian O 1 0.9532690048217773
breast B-Disease 1 0.9999964237213135
cancer I-Disease 1 0.9999092817306519
and O 1 0.8267076015472412
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.1402255495340796e-06
from O 0 3.3256924991675874e-10
Quebec O 0 1.5254610161719029e-06
. O 0 9.766405462130479e-10

To O 0 5.93603985410418e-11
identify O 0 1.083920730948762e-09
founder O 0 2.3275659177812713e-09
effects O 0 3.0705356039106846e-05
, O 0 8.792615246999702e-11
we O 0 8.107235438536975e-10
examined O 0 1.9109953619533826e-09
independently O 0 5.152289705989688e-10
ascertained O 0 2.9958638236848856e-08
French O 0 3.20565582967447e-08
Canadian O 0 1.8932190926079784e-08
cancer B-Disease 0 1.0032794595105088e-09
families O 0 8.233444172755719e-14
for O 0 1.6623679363888746e-16
the O 0 2.040774267511678e-15
distribution O 0 4.07574161595016e-14
of O 0 1.2771284104860694e-14
these O 0 1.748565268272495e-12
eight O 0 2.4442245102895832e-12
mutations O 0 8.655856587047595e-10
. O 0 1.719596340321594e-11

Mutations O 0 4.638342034013476e-06
were O 0 4.527751437666261e-11
found O 0 5.2043746916197176e-12
in O 0 9.075365242292022e-13
41 O 0 1.9032481753805675e-12
of O 0 8.589379614466416e-14
97 O 0 7.138085955649132e-11
families O 0 1.3809237087158976e-10
. O 0 3.722858965549136e-10

Six O 0 1.49137058258475e-09
of O 0 2.6990569067936176e-12
eight O 0 1.156706241206562e-11
mutations O 0 2.7665791879627477e-09
were O 0 1.3818187913350322e-11
observed O 0 4.274348375243875e-10
at O 0 1.3843415302972062e-10
least O 0 4.993174276823886e-12
twice O 0 7.946322710949971e-09
. O 0 5.318170556711799e-11

The O 0 3.439201007315873e-11
BRCA1 O 0 1.698865048638254e-08
C4446T O 0 3.80971387770046e-09
mutation O 0 7.604930374327523e-08
was O 0 6.672652881622998e-12
the O 0 4.205085325765081e-15
most O 0 3.68323340915939e-15
common O 0 1.8645028825991367e-13
mutation O 0 1.9314416732640893e-10
found O 0 3.811479940257073e-13
, O 0 7.425843086767477e-16
followed O 0 5.2684060185183984e-15
by O 0 7.231144834665432e-15
the O 0 1.8492919869050883e-12
BRCA2 O 0 1.768589719119973e-08
8765delAG O 0 3.51551676658346e-08
mutation O 0 2.0283505364204757e-07
. O 0 7.753316044745162e-11

Together O 0 4.543706522142088e-10
, O 0 2.7761359834219124e-13
these O 0 3.666133423316925e-14
mutations O 0 3.1378791925940064e-11
were O 0 2.3478946651472876e-12
found O 0 9.522231961267558e-12
in O 0 4.964157210296527e-11
28 O 0 7.818445543761321e-12
of O 0 3.86054205367848e-14
41 O 0 8.517231191162988e-12
families O 0 2.7076973475870236e-13
identified O 0 1.1811227551561387e-08
to O 0 7.334258200764054e-10
have O 0 1.049290787591417e-08
a O 0 2.9716168414850586e-10
mutation O 0 1.388819782732753e-06
. O 0 1.4590191554919585e-10

The O 0 1.154121329755009e-11
odds O 0 3.2578255648729737e-09
of O 0 1.7075130719418547e-15
detection O 0 1.2044670816280245e-11
of O 0 3.2223676529977716e-15
any O 0 2.5159235805816138e-11
of O 0 7.807171115105024e-14
the O 0 5.025487838372644e-12
four O 0 4.077199515506447e-12
BRCA1 O 0 2.71623612491112e-10
mutations O 0 3.1333309280512367e-09
was O 0 2.2265396193432707e-09
18 O 0 5.95005017478556e-11
. O 0 6.345110201144699e-12

7x O 0 3.5278139876027126e-06
greater O 0 5.323795848610757e-10
if O 0 1.9844115239919802e-10
one O 0 1.0191287816093981e-14
or O 0 7.534810042607656e-14
more O 0 8.854411480277782e-15
cases O 0 5.4765317281102455e-11
of O 0 3.390815663806279e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.0015567510854452848
also O 0 3.003445755989098e-11
present O 0 3.1975277460516427e-12
in O 0 8.543650812861681e-13
the O 0 5.247752102657821e-13
family O 0 2.899973872150241e-10
. O 0 9.210978507701029e-11

The O 0 1.1844824600315551e-11
odds O 0 4.178952295319505e-09
of O 0 2.8763616820662048e-15
detection O 0 4.348892426730977e-11
of O 0 7.415429557834814e-15
any O 0 6.016193099256384e-11
of O 0 1.0066804161101839e-12
the O 0 1.1513246085670392e-11
four O 0 1.3947140317660534e-11
BRCA2 O 0 7.275045010857184e-10
mutations O 0 4.2115031462230945e-09
was O 0 1.3751569327702384e-10
5 O 0 8.92768411281386e-12
. O 0 2.084644436239902e-11

3x O 0 3.427556691804057e-07
greater O 0 6.571966304491639e-10
if O 0 3.6695568805811263e-09
there O 0 2.308176653281757e-12
were O 0 1.024731731760764e-12
at O 0 2.5710406026391297e-12
least O 0 4.805603817984415e-14
five O 0 8.848231527894615e-15
cases O 0 4.706064639543872e-13
of O 0 1.7476416364417546e-12
breast B-Disease 1 0.8862938284873962
cancer I-Disease 0 0.41423046588897705
in O 0 1.3185067482268664e-09
the O 0 3.268937637940228e-12
family O 0 1.654945624984805e-09
. O 0 7.173969057694407e-11

Interestingly O 0 5.506199052263128e-09
, O 0 1.4899232292798353e-13
the O 0 6.0388519407478594e-15
presence O 0 6.433891180240847e-12
of O 0 1.8943259978763775e-14
a O 0 9.70090119345457e-11
breast B-Disease 0 0.0007373460102826357
cancer I-Disease 0 1.414808963318137e-07
case O 0 5.2352403662192515e-11
< O 0 1.5916633289148052e-10
36 O 0 1.7700634523647868e-13
years O 0 1.255531730014539e-13
of O 0 1.3411739268806826e-14
age O 0 8.264518513989572e-10
was O 0 5.191872105847484e-12
strongly O 0 2.450063589509721e-12
predictive O 0 1.9288847862702907e-12
of O 0 1.5505033390696534e-15
the O 0 5.103373930723633e-15
presence O 0 1.3419326413965926e-12
of O 0 9.161300834430435e-16
any O 0 1.4979574872175938e-11
of O 0 2.565434098337517e-14
the O 0 3.7108792601270313e-13
eight O 0 5.8897973304050666e-12
mutations O 0 1.7457843504153914e-10
screened O 0 2.8066288848549448e-08
. O 0 2.000284521352924e-10

Carriers O 0 4.2268575306536604e-09
of O 0 2.0987053241106057e-13
the O 0 5.522213681339108e-14
same O 0 1.3613086352615156e-12
mutation O 0 3.216675537043301e-11
, O 0 1.6014677233191685e-15
from O 0 3.563272791520973e-15
different O 0 2.0047501256715422e-13
families O 0 5.43657187410812e-13
, O 0 2.0325466129785235e-15
shared O 0 2.644287512478666e-13
similar O 0 7.281100635608828e-13
haplotypes O 0 5.020779347830739e-10
, O 0 1.168321624341051e-13
indicating O 0 5.253114609971021e-11
that O 0 1.0886693564866878e-13
the O 0 1.4228442507318792e-14
mutant O 0 3.3142783222722683e-12
alleles O 0 2.3078771966417166e-12
were O 0 3.058258507548928e-11
likely O 0 1.6420158288621423e-10
to O 0 1.6086951649257886e-12
be O 0 3.4634688450552176e-09
identical O 0 1.302699192962109e-08
by O 0 2.4639962379474634e-12
descent O 0 6.229426929849069e-08
for O 0 1.0253457154510426e-12
a O 0 1.4122691731344172e-11
mutation O 0 1.2554126627151163e-08
in O 0 1.4393540612861466e-12
the O 0 3.602988133538654e-14
founder O 0 2.3287226313950526e-11
population O 0 1.4122961480844687e-11
. O 0 2.9924212413545703e-11

The O 0 3.350837944789131e-13
identification O 0 8.7259002107265e-12
of O 0 5.941570206755703e-14
common O 0 8.290945013866846e-11
BRCA1 O 0 2.3970687834662385e-07
and O 0 1.1175027569976237e-09
BRCA2 O 0 7.752143460493244e-08
mutations O 0 4.2945533351712584e-08
will O 0 2.7906453189951996e-13
facilitate O 0 1.0490440032493234e-13
carrier O 0 5.567827102148648e-11
detection O 0 9.681312418408083e-10
in O 0 8.732464751304292e-11
French O 0 0.0003562054189387709
Canadian O 1 0.5461892485618591
breast B-Disease 1 0.9999892711639404
cancer I-Disease 1 0.9994373917579651
and O 0 0.1504865139722824
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.632141892419895e-06
. O 0 8.604170709247683e-10

Are O 0 3.4600600162804085e-10
Dp71 O 0 8.931651223065273e-07
and O 0 2.6824928389679314e-10
Dp140 O 0 8.862228924044757e-07
brain O 0 6.143678774606087e-07
dystrophin O 0 8.48028580691107e-09
isoforms O 0 3.8171729666025556e-11
related O 0 1.8664128575984762e-10
to O 0 3.916691623806479e-12
cognitive B-Disease 0 5.614046472146583e-07
impairment I-Disease 0 0.0003166109963785857
in O 0 2.5617209686856768e-08
Duchenne B-Disease 1 0.9983264803886414
muscular I-Disease 1 0.9632734656333923
dystrophy I-Disease 1 0.9982196688652039
? O 0 0.0005333091830834746

Molecular O 0 5.865962293682969e-07
study O 0 1.623028933472881e-09
and O 0 1.9749443400107758e-11
neuropsychological O 0 1.963303297713992e-09
analysis O 0 2.8450535330404314e-11
were O 0 1.3656125926256313e-12
performed O 0 3.743440019771116e-12
concurrently O 0 9.764304165563176e-13
on O 0 7.127637369208628e-11
49 O 0 5.051816187595648e-10
patients O 0 1.9171560172726032e-11
with O 0 9.304635534279626e-11
Duchenne B-Disease 1 0.8804157376289368
muscular I-Disease 0 0.09523291885852814
dystrophy I-Disease 0 0.04302583634853363
( O 0 4.495366301426884e-09
DMD B-Disease 1 0.9999998807907104
) O 0 3.6080363696733286e-10
in O 0 3.951606836888333e-12
order O 0 4.033056711944677e-13
to O 0 3.178516206747001e-14
find O 0 2.605617761483603e-12
a O 0 4.91067859390449e-14
molecular O 0 3.480336895414493e-12
explanation O 0 3.955533275055989e-13
for O 0 1.835357427561017e-14
the O 0 2.3622464661449127e-12
cognitive B-Disease 0 1.843783969945889e-08
impairment I-Disease 0 6.475970426578215e-09
observed O 0 1.4109889923119567e-09
in O 0 3.566802408982994e-11
most O 0 1.1397544019686734e-09
DMD B-Disease 1 0.9999997615814209
patients O 0 1.0061722122145511e-07
. O 0 3.560360617438363e-10

Complete O 0 2.8876472393801755e-11
analysis O 0 3.5506658377371103e-12
of O 0 1.31069547915281e-14
the O 0 4.0254617402011444e-14
dystrophin O 0 2.292633305422953e-10
gene O 0 2.695324796686549e-10
was O 0 8.390980271721915e-11
performed O 0 6.4763559098901524e-12
to O 0 1.9825044993778025e-14
define O 0 6.298882249122784e-11
the O 0 4.5918408235912783e-14
localization O 0 3.952941272922228e-12
of O 0 1.4462143926724378e-16
deletions O 0 3.6377061085612894e-11
and O 0 1.245376848521551e-12
duplications O 0 7.258579293178968e-10
in O 0 7.343247104135697e-13
relation O 0 9.656706684291194e-11
to O 0 3.3693981307293674e-13
the O 0 7.890289983880638e-13
different O 0 3.2171312835949095e-10
DMD B-Disease 1 0.9999966621398926
promoters O 0 2.952862985239335e-07
. O 0 3.335704490403657e-10

Qualitative O 0 4.551093876759005e-11
analysis O 0 9.345290166717923e-12
of O 0 2.7773473421804397e-14
the O 0 2.3915943078473174e-14
Dp71 O 0 9.538346779081053e-10
transcript O 0 3.1396052424526033e-10
and O 0 1.0457144048250933e-12
testing O 0 1.0954744191849289e-13
for O 0 1.5992508792775264e-16
the O 0 2.401739952022499e-16
specific O 0 8.747349903876628e-15
first O 0 4.699440435320529e-15
exon O 0 5.44467628534745e-13
of O 0 2.845445572414486e-14
Dp140 O 0 4.0286959879232143e-10
were O 0 9.863789784958499e-10
also O 0 1.687887329904214e-11
carried O 0 2.6535440511565866e-09
out O 0 1.9826296160374568e-10
. O 0 2.4151783004078275e-11

Neuropsychological O 0 5.580081960943062e-07
analysis O 0 4.4373002494602076e-10
assessed O 0 1.1474919681120355e-08
verbal O 0 2.2842165492420463e-07
and O 0 9.433040286388472e-12
visuospatial O 0 1.579056174705329e-07
intelligence O 0 9.3102192622041e-09
, O 0 2.4117602988489584e-13
verbal O 0 8.07999267493642e-09
memory O 0 4.131189612621711e-08
, O 0 2.5576487542450232e-12
and O 0 2.3185510802936626e-11
reading O 0 2.4154755973171405e-09
skills O 0 3.2172311481559746e-09
. O 0 9.345147052031155e-12

Comparison O 0 5.498577149154471e-10
of O 0 4.2670755167131813e-13
molecular O 0 4.160056743529594e-09
and O 0 9.337147374721688e-12
psychometric O 0 1.4544813211614382e-06
findings O 0 8.388648109480812e-10
demonstrated O 0 4.9775732147150364e-11
that O 0 1.166467812267855e-15
deletions O 0 2.5931451430594166e-11
and O 0 4.4316433118682386e-13
duplications O 0 1.0132547023644634e-09
that O 0 5.165094914272306e-12
were O 0 1.3929267895368413e-12
localized O 0 4.1852996068847403e-10
in O 0 1.6880137565511433e-10
the O 0 2.5291281655764886e-13
distal O 0 5.7331825918660595e-12
part O 0 1.2072574884225418e-10
of O 0 7.645459786098652e-13
the O 0 1.8928245472740746e-13
gene O 0 8.1262725715181e-11
seemed O 0 2.8310837008049816e-10
to O 0 4.649141247220316e-14
be O 0 7.210300607442266e-13
preferentially O 0 3.3043465186288756e-10
associated O 0 6.782526984494552e-09
with O 0 1.3572448720466923e-10
cognitive B-Disease 0 7.56215797537152e-07
impairment I-Disease 0 5.469347001962888e-07
. O 0 1.8064584550447904e-10

Two O 0 6.760356857649086e-11
altered O 0 6.798259732931911e-10
Dp71 O 0 7.90350007662255e-09
transcripts O 0 9.235118780814844e-10
and O 0 2.1783213254022993e-12
two O 0 4.6050652948868755e-15
deleted O 0 1.1791215790216136e-12
Dp140 O 0 8.940426524106648e-13
DNA O 0 1.626567804058343e-13
sequences O 0 1.5689201240259854e-12
were O 0 3.948430531098765e-14
found O 0 9.639651002337629e-14
in O 0 1.764721181685136e-12
four O 0 1.201474943840486e-11
patients O 0 3.495066389080925e-11
with O 0 1.9653341176706363e-09
severe O 1 0.9998319149017334
cerebral B-Disease 1 0.9999427795410156
dysfunction I-Disease 1 0.9307306408882141
. O 0 3.8473228158864003e-08

These O 0 3.3858534465719403e-12
findings O 0 3.7684495281242736e-12
suggest O 0 3.768817896654397e-11
that O 0 3.400340583105746e-14
some O 0 4.3794718866106447e-16
sequences O 0 1.0192619318005747e-12
located O 0 7.966322913832702e-13
in O 0 1.1353525541588083e-12
the O 0 9.4652865596399e-15
distal O 0 2.928478314880023e-13
part O 0 5.1443888211821776e-12
of O 0 8.327002011098567e-14
the O 0 1.6339770384172017e-14
gene O 0 1.4756931787651695e-11
and O 0 2.9041014384945107e-11
, O 0 5.408032200093218e-15
in O 0 1.669996775686012e-14
particular O 0 5.624844773982618e-12
, O 0 4.052502081196112e-14
some O 0 9.131479345456453e-14
DMD B-Disease 1 0.9999979734420776
isoforms O 0 4.3217290857100465e-11
expressed O 0 1.5629184058063572e-10
in O 0 3.5535744485892806e-11
the O 0 3.209211715815563e-11
brain O 0 3.8499583752127364e-06
may O 0 5.4097476498427e-10
be O 0 1.6795294538810013e-13
related O 0 8.389451243082102e-13
to O 0 1.4747434501881374e-13
the O 0 4.2145845841057294e-11
cognitive B-Disease 0 1.8266899814989301e-06
impairment I-Disease 0 6.956674383218342e-07
associated O 0 8.583690203067817e-08
with O 0 4.277220799764336e-09
DMD B-Disease 1 1.0
. O 0 1.870769095191349e-09
. O 0 7.884520814016582e-11

I1307K O 0 6.651203676710793e-08
APC O 0 3.868483311464388e-09
and O 0 8.885673447034392e-12
hMLH1 O 0 1.2499556056866368e-08
mutations O 0 7.424668524436129e-08
in O 0 1.797657617381987e-12
a O 0 3.839149050749446e-12
non O 0 7.584906924762436e-09
- O 0 1.674672347462547e-07
Jewish O 0 5.1588355115539386e-11
family O 0 2.1182412768272485e-10
with O 0 1.4801562753241626e-10
hereditary B-Disease 1 0.9999233484268188
non I-Disease 1 0.9999865293502808
- I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999986886978149
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.02688681838481e-07

We O 0 3.8694997206434323e-10
describe O 0 4.572934392266248e-11
a O 0 2.9625421039958244e-12
French O 0 6.861956194370578e-07
Canadian O 0 0.0001246114115929231
hereditary B-Disease 1 0.9999936819076538
non I-Disease 1 0.9999954700469971
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 5.070210704616329e-07
HNPCC B-Disease 0 0.36383581161499023
) O 0 5.699972785433438e-11
kindred O 0 1.4095995481966384e-07
which O 0 1.809660385952705e-12
carries O 0 9.008312758934656e-13
a O 0 3.1548639975410506e-14
novel O 0 6.073039640619449e-12
truncating O 0 3.859926156479787e-09
mutation O 0 6.393644014224265e-08
in O 0 1.6653045262216004e-11
hMLH1 O 0 3.519582847388847e-08
. O 0 1.1093832796849057e-10

Interestingly O 0 1.1028315149985701e-08
, O 0 1.1409528378504563e-13
the O 0 7.399407929637499e-15
I1307K O 0 1.4362121734945443e-11
APC O 0 1.5972237638398057e-12
polymorphism O 0 1.1143521522205546e-10
, O 0 1.6157777096883195e-15
associated O 0 7.360786107154724e-14
with O 0 1.4753412352203326e-15
an O 0 4.301089988182662e-14
increased O 0 0.00013234907237347215
risk O 1 0.99993896484375
of O 1 0.9937198162078857
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.9617460988996527e-09
is O 0 3.216612523213036e-12
also O 0 1.0971388728076015e-13
present O 0 4.816710723852535e-13
in O 0 2.7525427683666726e-12
this O 0 2.4035597730870384e-12
family O 0 5.30018862132664e-10
. O 0 3.1982871906421906e-10

The O 0 1.3800487662363192e-11
I1307K O 0 1.4340675313917473e-09
polymorphism O 0 2.3699909590391144e-08
has O 0 9.087307989430471e-11
previously O 0 4.3181860864827115e-11
only O 0 8.870440731771623e-14
been O 0 4.1864748430084364e-13
identified O 0 5.6909785911551936e-11
in O 0 3.026571506435649e-13
individuals O 0 3.741262941808765e-12
of O 0 1.1227980351025124e-11
self O 1 0.9998108744621277
- O 1 0.9162775278091431
reported O 0 1.1695918828991125e-06
Ashkenazi O 0 2.238445206970141e-09
Jewish O 0 2.580318458900166e-10
origins O 0 3.798989123282581e-09
. O 0 3.69316001391784e-11

In O 0 1.0362064505053947e-11
addition O 0 3.001451084200246e-12
, O 0 2.8923407722689087e-13
in O 0 2.472101028657553e-13
this O 0 9.935598215471061e-14
family O 0 2.612556351810902e-11
, O 0 2.9123787935328785e-14
there O 0 4.0998668761164925e-13
appears O 0 4.298630340571208e-10
to O 0 5.056852506180043e-12
be O 0 5.3997100124547615e-09
no O 0 8.379884008924421e-10
relationship O 0 4.2854503279343703e-10
between O 0 1.1475694695992512e-14
the O 0 8.50575291979277e-16
I1307K O 0 1.0870079792876797e-12
polymorphism O 0 5.228215430030936e-11
and O 0 4.4203990511373914e-13
the O 0 1.489144060612315e-14
presence O 0 1.8901144538396863e-10
or O 0 2.662713938228478e-10
absence O 0 8.244047111638508e-11
of O 0 5.528729600870474e-13
cancer B-Disease 0 2.1869168698174235e-09
. O 0 6.3943842625383e-13
. O 0 1.067336757171189e-11

Identification O 0 1.0920427895300122e-09
of O 0 1.0297194547774849e-13
a O 0 1.1096609335613586e-13
novel O 0 1.012109558488905e-12
mutation O 0 9.284802371389844e-10
of O 0 1.1267824340406834e-14
the O 0 4.219468538132522e-14
CPO O 0 1.386699421956905e-09
gene O 0 9.894776838159647e-12
in O 0 4.3978774615094363e-13
a O 0 2.296999179404735e-12
Japanese O 0 6.571997346327407e-07
hereditary B-Disease 0 0.000136536531499587
coproporphyria I-Disease 0 4.946970148012042e-05
family O 0 2.1297692498478682e-08
. O 0 6.152948150983661e-10

Hereditary B-Disease 1 0.969399094581604
coproporphyria I-Disease 0 0.0013712540967389941
( O 0 1.5573121958656344e-10
HCP B-Disease 0 6.726539254486852e-07
) O 0 1.689068373014746e-12
is O 0 1.0962133978331678e-11
an O 0 2.1178968301338585e-11
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999817609786987
characterized O 0 6.181090128620781e-08
by O 0 2.486297842954621e-12
a O 0 7.656766887187416e-10
deficiency B-Disease 0 2.8117192414356396e-05
of I-Disease 0 1.4763243863622107e-14
coproporphyrinogen I-Disease 0 2.115703701122129e-08
oxidase I-Disease 0 8.357601277708682e-10
( O 0 2.0810111446556423e-13
CPO O 0 7.00994418068035e-09
) O 0 1.5046248752134672e-13
caused O 0 3.856557434511743e-12
by O 0 1.0086397185136639e-14
a O 0 3.406147109155655e-12
mutation O 0 9.400186407049205e-09
in O 0 2.94615975495946e-13
the O 0 8.238187557260343e-14
CPO O 0 2.5203352738145668e-09
gene O 0 1.7999375601096546e-10
. O 0 1.8549417210578234e-11

Only O 0 3.887453692286158e-10
11 O 0 9.11892176352902e-12
mutations O 0 1.6711505790301118e-10
of O 0 3.249390163949199e-14
the O 0 8.716608706528517e-14
gene O 0 2.7072882824441535e-10
have O 0 1.3172392343552275e-10
been O 0 2.8735106308297453e-11
reported O 0 1.5417730425681953e-09
in O 0 9.803124458029888e-12
HCP B-Disease 0 1.3507195035344921e-05
patients O 0 7.98096588816577e-10
. O 0 1.1251868881068106e-10

We O 0 1.1166702229559178e-08
report O 0 1.3814498156516919e-11
another O 0 1.1641596432514223e-13
mutation O 0 6.346932424072804e-10
in O 0 9.804596370899255e-13
a O 0 1.1711294260752236e-11
Japanese O 0 1.0018229659181088e-06
family O 0 7.875596841344645e-10
. O 0 1.941865557242295e-10

Polymerase O 0 3.052259334168639e-09
chain O 0 2.48140774594674e-09
reaction O 0 1.0368125247239846e-09
- O 0 9.244923049323006e-09
single O 0 2.0178867257691913e-12
strand O 0 2.335002677322784e-11
conformational O 0 1.87739342301374e-12
polymorphism O 0 7.404703239455301e-11
and O 0 6.582349784320634e-15
direct O 0 1.0558605347736703e-14
sequence O 0 1.5628183426194542e-12
analyses O 0 5.716562639923595e-12
demonstrated O 0 2.2745065379747853e-13
a O 0 1.6930177759396682e-14
C O 0 7.421808827234866e-12
to O 0 6.853548134691306e-15
T O 0 1.735451712892022e-11
substitution O 0 1.5676741792181557e-14
in O 0 1.8962842109954874e-15
exon O 0 4.672898895087541e-13
1 O 0 7.464646576641615e-14
of O 0 7.544970329864914e-16
the O 0 1.8767470149022407e-14
CPO O 0 6.029173688082423e-11
gene O 0 1.272950928693506e-13
at O 0 2.493038531148871e-14
nucleotide O 0 1.000803346445922e-11
position O 0 4.2929357291221493e-10
85 O 0 1.9948330639250889e-13
, O 0 1.153067814569763e-14
which O 0 4.3232110599755735e-12
lies O 0 1.754350553717643e-09
in O 0 4.255325258828435e-12
the O 0 4.852522666998725e-14
putative O 0 5.7306347167607186e-12
presequence O 0 5.250760937158816e-11
for O 0 2.2577766970599414e-15
targeting O 0 4.430124669885238e-12
to O 0 3.502645872996424e-12
mitochondria O 0 3.757352207145459e-09
. O 0 8.217092978268781e-11

This O 0 6.399292554193359e-12
mutation O 0 3.690359129393528e-10
changes O 0 1.1873296399886324e-12
the O 0 3.032150099307584e-15
codon O 0 3.084121838665445e-14
for O 0 1.3593436200443228e-17
glutamine O 0 4.163911985935291e-14
to O 0 1.3214988761752703e-15
a O 0 8.840612297127473e-14
termination O 0 1.652556043396647e-11
codon O 0 3.893415537886691e-12
at O 0 3.0026691853410337e-13
amino O 0 3.3278574665916716e-13
acid O 0 4.943594145156993e-12
position O 0 2.034888035851168e-09
29 O 0 7.050001554764762e-11
. O 0 8.860945831246081e-12

MaeI O 0 8.67285336880741e-08
restriction O 0 2.9258867551007484e-10
analysis O 0 7.11084038873544e-11
showed O 0 1.76100856119632e-09
two O 0 6.395451117476025e-15
other O 0 8.094915152957478e-15
carriers O 0 4.923550716434688e-12
in O 0 3.3860840021639194e-13
the O 0 6.850052751590507e-13
family O 0 7.142665348069954e-10
. O 0 8.50642334349061e-11

The O 0 2.661933340419864e-09
C O 0 0.12071382999420166
- O 1 0.9997304081916809
T O 1 0.9679220914840698
mutation O 0 1.7706979633658193e-06
is O 0 5.869969007393783e-12
located O 0 2.638002013014007e-12
within O 0 9.20896713919872e-13
a O 0 1.0603459299832196e-12
recently O 0 6.755471876340735e-11
proposed O 0 5.251136439739235e-13
putative O 0 6.771800568211583e-12
alternative O 0 1.3665917085025486e-13
translation O 0 2.2033754215698004e-13
initiation O 0 2.6587616114813473e-13
codon O 0 3.9703353452158474e-12
( O 0 6.636101648120445e-15
TIC O 0 2.6127930929931154e-09
- O 0 7.474995733502965e-09
1 O 0 4.982897232851113e-13
) O 0 1.9388334287931495e-15
, O 0 9.263065622644833e-17
supporting O 0 4.670100569280355e-13
that O 0 1.510312925070978e-12
TIC O 0 1.3212968497100519e-08
- O 0 6.579407685336491e-09
1 O 0 3.4648228296879635e-13
is O 0 5.497024276740481e-14
the O 0 5.1495452731619915e-15
real O 0 2.1790143023281416e-09
TIC O 0 6.567844046401206e-10
rather O 0 7.122710082331507e-13
than O 0 1.322725837280686e-13
TIC O 0 4.139862341823175e-10
- O 0 3.934831072083256e-10
2 O 0 3.6400692030903736e-13
. O 0 7.947166010121784e-14
. O 0 2.4809828670646628e-12

Human B-Disease 0 1.704579921657512e-09
complement I-Disease 0 9.296696745764166e-09
factor I-Disease 0 0.00014275682042352855
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999905824661255
associated O 0 6.336289516184479e-05
with O 0 9.740322639117949e-06
hemolytic B-Disease 1 0.9999982118606567
uremic I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999998807907104
. O 0 3.0131187145343574e-07

This O 0 3.1841852288563843e-13
study O 0 6.009738063098014e-14
reports O 0 1.0417586931987799e-12
on O 0 6.211021822723206e-13
six O 0 1.4292749926300696e-13
cases O 0 2.1062885051555125e-13
of O 0 2.4953422574774953e-13
deficiency B-Disease 0 1.721327680570539e-05
in I-Disease 0 6.225713846362557e-14
the I-Disease 0 1.1211400087658436e-14
human I-Disease 0 3.7074672758902194e-14
complement I-Disease 0 1.3711732080702935e-14
regulatory I-Disease 0 1.968860594307384e-13
protein I-Disease 0 1.2762482043404688e-12
Factor I-Disease 0 7.758611808572624e-11
H I-Disease 1 1.0
( O 0 1.238020103100368e-13
FH O 0 3.4037557217203585e-09
) O 0 6.733177976622892e-15
in O 0 1.9628029788927885e-15
the O 0 5.197261286058786e-16
context O 0 1.192788597927097e-12
of O 0 2.1545029757659429e-13
an O 0 2.004723720361312e-09
acute B-Disease 1 0.9999761581420898
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.62608121172525e-05

Five O 0 4.7885379689249774e-11
of O 0 4.877930606097744e-14
the O 0 1.161761794621699e-13
cases O 0 3.9800554345326145e-12
were O 0 6.854500474162695e-12
observed O 0 7.634371357312375e-09
in O 0 1.0672432555758338e-11
children O 0 1.4913065574106987e-11
presenting O 0 3.5357967664850776e-09
with O 0 1.1546115956662106e-06
idiopathic O 1 0.9999979734420776
hemolytic B-Disease 1 0.9999997615814209
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.276310184854083e-05
HUS B-Disease 1 0.9998468160629272
) O 0 2.453468823659932e-07
. O 0 8.111941340871454e-09

Two O 0 2.2902445998701504e-12
of O 0 3.913834995027468e-14
the O 0 1.070086185460395e-12
children O 0 8.896734737806611e-11
exhibited O 0 4.3116248349406305e-08
a O 0 1.606845434487525e-09
homozygous O 1 0.9899918437004089
deficiency O 1 0.6771594285964966
characterized O 0 3.1814689771536564e-11
by O 0 5.1489482843407666e-14
the O 0 3.7819340758041275e-13
absence O 0 3.09475708948348e-11
of O 0 1.05842071303257e-15
the O 0 3.0327864328092086e-15
150 O 0 1.988646377629991e-15
- O 0 2.2432500735442007e-12
kD O 0 1.441013974812222e-11
form O 0 2.7440284202859266e-13
of O 0 1.0983903978684876e-14
Factor O 0 1.0753660462103909e-10
H O 1 1.0
and O 0 1.736160173959611e-11
the O 0 2.2379955554778855e-14
presence O 0 2.1108836900651795e-11
, O 0 7.428959638617781e-16
upon O 0 2.9774417235520862e-15
immunoblotting O 0 2.8884073952073486e-11
, O 0 1.0490989036897997e-15
of O 0 2.250329106931649e-16
the O 0 3.8866303296407334e-14
42 O 0 4.948100848327364e-13
- O 0 8.977995430425878e-11
kD O 0 4.085831228906045e-09
Factor O 0 1.1911291508681643e-08
H O 1 1.0
- O 0 6.820084195169329e-07
like O 0 2.8137910404457678e-11
protein O 0 2.7868488766680244e-12
1 O 0 3.9765478236641894e-13
( O 0 3.212867543219604e-15
FHL O 0 6.130828483774664e-11
- O 0 3.595984274240571e-11
1 O 0 3.775128606530072e-14
) O 0 5.407843735262454e-16
and O 0 1.2736886943905644e-14
other O 0 8.091060644827702e-14
FH O 0 3.128872094748658e-07
- O 0 1.9940678275265356e-10
related O 0 1.3672839770106915e-11
protein O 0 2.850576328802812e-12
( O 0 2.368361379950258e-14
FHR O 0 1.259294779565323e-09
) O 0 7.247303343387024e-14
bands O 0 8.155375819107746e-10
. O 0 1.3031475898372946e-10

Southern O 0 3.2461027199559567e-09
blot O 0 5.850640860671774e-09
and O 0 2.4809993130563666e-14
PCR O 0 3.7057298419088114e-13
analysis O 0 1.0685553563673494e-14
of O 0 1.4478861908648565e-17
DNA O 0 1.5683836878960938e-13
of O 0 2.5669600281919957e-15
one O 0 9.003675084141849e-13
patient O 0 2.826896494667608e-10
with O 0 4.22857712387148e-12
homozygous O 0 0.08436761051416397
deficiency O 1 0.972713828086853
ruled O 0 4.716615098487864e-09
out O 0 3.773059555761682e-12
the O 0 1.438831150578357e-14
presence O 0 3.5307637889780974e-12
of O 0 6.302567284425132e-16
a O 0 2.22769665127881e-15
large O 0 4.8930077925588705e-14
deletion O 0 3.5069724901859445e-11
of O 0 1.291008315876252e-13
the O 0 1.051899778219123e-12
FH O 0 1.23315359701337e-07
gene O 0 8.579990017076877e-12
as O 0 5.318469189358188e-13
the O 0 2.070377154222633e-13
underlying O 0 1.2156881723512925e-08
defect O 0 5.271686420726951e-10
for O 0 6.634636958748052e-14
the O 0 6.099165061890233e-10
deficiency O 0 0.004444556776434183
. O 0 7.174789928843239e-11

The O 0 2.527827122969506e-12
other O 0 2.0684036352181662e-13
four O 0 8.432119477479183e-14
children O 0 1.7541393684816775e-13
presented O 0 1.581322746357916e-11
with O 0 1.0264155081429749e-09
heterozygous O 0 0.27803468704223633
deficiency O 1 0.9129492044448853
and O 0 2.6697801955299916e-12
exhibited O 0 9.471202488953168e-09
a O 0 1.1411257355709026e-11
normal O 0 5.251524770599758e-10
immunoblotting O 0 9.150435964500048e-09
pattern O 0 1.7987579203904147e-09
of O 0 1.8170222135715716e-14
proteins O 0 3.4013522792579465e-14
of O 0 1.9021029461782982e-14
the O 0 8.079933423721375e-12
FH O 0 2.47735770244617e-05
family O 0 1.0438327979755968e-09
. O 0 1.0021907609347736e-10

Factor B-Disease 0 0.35096821188926697
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999309778213501
is O 0 4.643466167131294e-12
the O 0 7.22864259769529e-13
only O 0 2.2944850464057254e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 2.100184701703256e-07
with O 0 2.136871513069849e-10
HUS B-Disease 0 0.10371728241443634
. O 0 3.2995932652823967e-09

These O 0 8.588979354129389e-12
observations O 0 9.440568465857169e-11
suggest O 0 1.1910159490591266e-11
a O 0 1.762428737835369e-14
role O 0 6.00057818104377e-13
for O 0 1.2860929498020174e-13
FH O 0 2.731842187131406e-06
and O 0 6.815497471945875e-11
/ O 0 1.321367459894418e-08
or O 0 1.79187414905968e-10
FH O 0 1.244178520209971e-07
receptors O 0 9.78086188430094e-12
in O 0 1.457567790422165e-13
the O 0 6.341135299139933e-14
pathogenesis O 0 2.5576646703329153e-11
of O 0 3.04553067877536e-13
idiopathic O 0 6.633759767282754e-06
HUS B-Disease 1 0.8659321665763855
. O 0 3.735528775195007e-09
. O 0 1.3107388507904716e-09

Further O 0 2.3974747968141807e-12
evidence O 0 1.6137721584388864e-12
for O 0 2.7435128228606035e-15
a O 0 1.5151212058518888e-14
major O 0 2.660406617227551e-12
ancient O 0 2.9050073457881354e-09
mutation O 0 0.20695087313652039
underlying O 0 0.004496211186051369
myotonic B-Disease 1 0.9999994039535522
dystrophy I-Disease 1 0.9999996423721313
from O 0 5.975161337934409e-11
linkage O 0 6.2255041122227794e-09
disequilibrium O 0 9.24541687652436e-09
studies O 0 4.7705697031608096e-11
in O 0 1.3654062689522073e-13
the O 0 7.612192939789736e-14
Japanese O 0 2.2493257034739145e-08
population O 0 6.54849546984082e-13
. O 0 5.496139134086864e-12

The O 0 3.6241100787037794e-08
myotonic B-Disease 1 0.999991774559021
dystrophy I-Disease 1 0.9999995231628418
( O 0 6.4183764152403455e-06
DM B-Disease 1 1.0
) O 0 1.1884438988474244e-09
mutation O 0 1.3357628176891012e-06
is O 0 1.3814235345910308e-11
an O 0 6.674851101527712e-13
unstable O 0 1.9973862436017953e-05
( O 0 3.0954340653199797e-12
CTG O 0 1.0608518508092857e-08
) O 0 3.1912138404900647e-13
n O 0 2.782408969892458e-08
repeat O 0 8.280539987026714e-07
, O 0 6.609817538140786e-14
present O 0 8.437432610225448e-13
at O 0 8.504905764025739e-13
a O 0 1.3329214542821734e-14
copy O 0 2.54807841493232e-10
number O 0 2.6868834848009504e-12
of O 0 6.29416495052243e-14
5 O 0 8.214816847595952e-12
- O 0 6.091195814406092e-07
37 O 0 3.9814067841204e-12
repeats O 0 2.979505808742289e-10
on O 0 3.217646982189848e-10
normal O 0 3.472933052250937e-10
chromosomes O 0 1.0358464303319992e-12
but O 0 2.4225193113449825e-14
amplified O 0 1.9550643656079947e-12
to O 0 8.501154695559482e-14
50 O 0 2.2272824860489204e-13
- O 0 9.316569044015566e-11
3000 O 0 8.046744694178987e-12
copies O 0 4.180678025988982e-11
on O 0 5.34159596554673e-07
DM B-Disease 1 1.0
chromosomes O 0 4.3951300199296384e-07
. O 0 1.4592502206589586e-10

Previous O 0 2.632220885701031e-09
findings O 0 2.559320255723918e-10
in O 0 7.847039858177585e-12
Caucasian O 0 1.4351654975541805e-08
populations O 0 1.0553760088072295e-09
of O 0 8.16224149900735e-13
a O 0 9.420683788619044e-09
DM B-Disease 1 1.0
founder O 0 6.81778011824008e-09
chromosome O 0 8.032790788092825e-08
raise O 0 7.56998422279942e-11
a O 0 2.0865796070135278e-13
question O 0 7.489154262019238e-12
about O 0 4.932454116912503e-15
the O 0 3.7086800259003626e-16
molecular O 0 2.701666744053116e-13
events O 0 2.1296701381567917e-13
involved O 0 1.1608061734058595e-11
in O 0 7.946625128762985e-13
the O 0 2.0654704617657782e-13
expansion O 0 4.072983339487024e-10
mutation O 0 5.308203654408317e-09
. O 0 8.251059557817797e-12

To O 0 6.4966213832173825e-12
investigate O 0 3.6227384980769273e-10
whether O 0 1.0663585292558508e-10
a O 0 5.777285659418208e-13
founder O 0 1.5440367083854878e-12
chromosome O 0 1.2690570816431546e-10
for O 0 5.10914214039114e-14
the O 0 1.9822921082379708e-11
DM B-Disease 1 1.0
mutation O 0 8.851772008711123e-07
exists O 0 4.4338633459206633e-11
in O 0 2.3992196372516796e-14
the O 0 3.6806347120772135e-15
Japanese O 0 1.4051129149095232e-09
population O 0 3.911580870948235e-14
, O 0 1.738278303849844e-14
we O 0 3.0410626274124386e-12
genotyped O 0 9.690544894302988e-11
families O 0 1.684128842784592e-14
using O 0 8.102580970536719e-14
polymorphic O 0 1.0107583520158059e-10
markers O 0 3.237705437086902e-09
near O 0 2.332699144957928e-09
the O 0 4.092805955258072e-12
( O 0 1.514818544039176e-13
CTG O 0 9.96115745444115e-10
) O 0 5.966841604143625e-13
n O 0 2.007085981858836e-07
repeat O 0 5.552232687477954e-05
region O 0 2.060707089412972e-07
and O 0 3.3500632823368903e-10
constructed O 0 3.511241430942391e-08
haplotypes O 0 4.972822011950484e-07
. O 0 8.379468785513211e-10

Six O 0 5.7410201592666965e-11
different O 0 1.2682833028156842e-13
haplotypes O 0 9.105855652835615e-11
were O 0 7.414224616197895e-12
found O 0 1.0445332793151962e-10
and O 0 5.1405546486194e-08
DM B-Disease 1 1.0
alleles O 0 1.3736070059167105e-07
were O 0 1.058082843563568e-09
always O 0 1.9501513737196774e-09
haplotype O 0 6.076754099915149e-10
A O 0 3.6339892900416615e-11
. O 0 1.0796772330345927e-11

To O 0 4.180540462417337e-12
find O 0 1.4578307311330363e-11
an O 0 1.1955525308084917e-14
origin O 0 2.3867992651749326e-11
of O 0 5.381220303884125e-14
the O 0 3.427043804987706e-13
( O 0 4.7416243701596875e-14
CTG O 0 5.8158106802652654e-11
) O 0 6.0206809664468865e-15
n O 0 1.0078379103495294e-10
repeat O 0 3.3367242302517752e-09
mutation O 0 6.357497306375137e-10
and O 0 6.869986926615144e-15
to O 0 6.464297108395908e-16
investigate O 0 7.149105092640884e-12
the O 0 4.197762810639362e-14
mechanism O 0 1.698100102372202e-12
of O 0 1.2963144690710318e-15
the O 0 2.567665183120585e-15
expansion O 0 1.6026037918601133e-12
mutation O 0 1.0810249397030791e-11
in O 0 5.000508132026703e-14
the O 0 9.74074421518584e-15
Japanese O 0 3.2285787376906683e-09
population O 0 5.370157375966626e-14
we O 0 8.869739144545807e-12
have O 0 1.0480680180061791e-13
studied O 0 8.979600917002895e-12
90 O 0 2.0494712968822243e-13
Japanese O 0 2.427360641377163e-07
DM B-Disease 1 0.9999998807907104
families O 0 3.105613335940838e-11
comprising O 0 1.3319925674590283e-12
190 O 0 2.5642723621571717e-12
affected O 0 5.5861443942761824e-11
and O 0 2.838500615109929e-11
130 O 0 8.893032144019486e-12
unaffected O 0 1.3823455269346141e-08
members O 0 1.0170485981175759e-11
. O 0 1.6754750364889048e-10

The O 0 5.114571266506829e-11
results O 0 1.5852492929457895e-10
suggest O 0 1.2107534419492083e-10
that O 0 3.232058175782482e-14
a O 0 1.8311056609789794e-14
few O 0 8.832875159374073e-14
common O 0 1.6359228425036343e-14
ancestral O 0 3.252954502985794e-11
mutations O 0 4.697032762734921e-10
in O 0 2.683901278305312e-13
both O 0 2.117374851839937e-12
Caucasian O 0 2.5123691571593554e-08
and O 0 1.6634402300041984e-08
Japanese O 0 2.5180984266626183e-06
populations O 0 8.694206465875709e-11
have O 0 3.476911412860634e-13
originated O 0 1.7205319471653296e-14
by O 0 2.224578775939526e-16
expansion O 0 4.31098705995156e-14
of O 0 4.796679817665322e-16
an O 0 6.289261985010543e-16
ancestral O 0 1.7569883048462742e-10
n O 0 3.204134486622934e-07
= O 0 2.164496848422459e-08
5 O 0 2.9838005438827253e-13
repeat O 0 2.4913179852426026e-10
to O 0 1.938622005981383e-12
n O 0 5.885732434762758e-07
= O 0 1.3517532124751597e-06
19 O 0 2.380639851917721e-10
- O 0 3.0922361560214995e-08
37 O 0 3.692031055879674e-12
copies O 0 2.5031386685636647e-11
. O 0 1.66577463628359e-11

These O 0 1.3971088825767697e-13
data O 0 4.2924278904508603e-14
support O 0 7.60641346458403e-15
multistep O 0 1.1491176066247277e-11
models O 0 1.8612156260644497e-10
of O 0 1.11304466077905e-12
triplet O 0 2.62082048720913e-05
repeat O 0 1.581449424747916e-07
expansion O 0 1.3597789561003992e-10
that O 0 9.547578656496358e-13
have O 0 7.82365844201674e-14
been O 0 3.943716792747295e-15
proposed O 0 1.0733801407382046e-14
for O 0 4.45114221360194e-14
both O 0 2.8652766825842946e-09
DM B-Disease 1 1.0
and O 0 2.62689585639464e-08
Friedreichs B-Disease 0 4.1245220927521586e-07
ataxia I-Disease 0 1.8177369156546774e-06
. O 0 2.4884483362797027e-11
. O 0 3.7612704617551174e-11

The O 0 1.8804395974375554e-12
molecular O 0 2.920879649259689e-10
basis O 0 4.766615990803302e-10
of O 0 9.674141665527713e-08
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.2665368460426123e-10
the O 0 3.930204414952926e-13
western O 0 2.185309572189098e-11
Cape O 0 3.6619760002132296e-10
, O 0 1.2011490977195671e-12
South O 0 8.156860603625304e-12
Africa O 0 1.2642608314406001e-11
. O 0 2.5868107569188004e-12

Deficiency B-Disease 1 0.9995519518852234
of I-Disease 0 3.0346946743725622e-12
the I-Disease 0 8.996002185367169e-13
sixth I-Disease 0 3.244427990156673e-11
component I-Disease 0 1.2261866001728183e-11
of I-Disease 0 1.378594487237662e-14
human I-Disease 0 1.4197821520886555e-12
complement I-Disease 0 5.0947258564693065e-12
( O 0 4.3268364016474034e-14
C6 O 0 3.757765487666376e-10
) O 0 3.245549716566348e-14
has O 0 7.776045432561496e-12
been O 0 2.1270093325531647e-11
reported O 0 5.958264437389005e-10
in O 0 9.553549086809693e-14
a O 0 1.6535886971768415e-13
number O 0 1.5774056323289432e-12
of O 0 1.7083675376032212e-14
families O 0 3.487139234054776e-13
from O 0 1.889156420274013e-13
the O 0 2.5381420055980985e-12
western O 0 2.3172845864394276e-09
Cape O 0 4.454805413445229e-09
, O 0 7.304236208927062e-12
South O 0 4.581848095375207e-11
Africa O 0 1.8554689035221728e-11
. O 0 3.695652724816645e-12

Meningococcal B-Disease 1 0.9981020092964172
disease I-Disease 1 0.8701897263526917
is O 0 3.738589993140806e-11
endemic O 0 1.8021095726794556e-09
in O 0 6.606052510571558e-13
the O 0 6.932355487180783e-14
Cape O 0 2.471350624144719e-10
and O 0 9.155991936848906e-12
almost O 0 3.042105413061935e-13
all O 0 1.1639038223606925e-14
pedigrees O 0 9.1486991593559e-11
of O 0 1.8384705650215105e-12
total O 0 7.447741154464893e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 5.284365393182222e-12
C6Q0 O 0 7.7172394696845e-08
) O 0 1.9362411522207135e-13
have O 0 1.02511293724461e-12
been O 0 1.3332889479966692e-12
ascertained O 0 1.6679573278111093e-09
because O 0 3.393782130323153e-11
of O 0 1.852564759582953e-12
recurrent O 0 0.2432814985513687
disease O 0 0.13262680172920227
. O 0 1.1702107061140055e-09

We O 0 8.051546984688684e-09
have O 0 3.1338148222259665e-13
sequenced O 0 1.1787887289546606e-12
the O 0 9.804492761829146e-15
expressed O 0 1.0175520636594021e-13
exons O 0 2.6656179433898197e-12
of O 0 2.6625613335200943e-14
the O 0 4.7583580142524645e-14
C6 O 0 3.326832559435999e-11
gene O 0 2.6179308287160863e-13
from O 0 7.0672198189327285e-15
selected O 0 7.536693166255992e-14
cases O 0 2.332578845787997e-13
and O 0 6.745704797701813e-13
have O 0 1.22519069542526e-11
found O 0 5.999116568095042e-12
three O 0 8.557284655180686e-13
molecular O 0 2.0855350157944486e-07
defects O 0 0.0006390716880559921
leading O 0 2.487713923748913e-10
to O 0 1.4889263155737353e-09
total O 0 1.0516546353755984e-05
deficiency O 1 0.9082373976707458
879delG O 0 5.411455390458286e-07
, O 0 1.0730236144063099e-11
which O 0 4.49021765949742e-12
is O 0 9.084838458774114e-13
the O 0 1.4147212047677105e-13
common O 0 2.6828406163303953e-10
defect O 0 3.1236365316544834e-07
in O 0 4.8228443808029375e-12
the O 0 5.535124225283794e-13
Cape O 0 2.7959454196313516e-10
and O 0 9.780935610048669e-12
hitherto O 0 1.0403340688913687e-10
unreported O 0 1.659474363480129e-10
, O 0 1.8896419056780613e-14
and O 0 1.22658298990809e-13
1195delC O 0 5.750809828342085e-10
and O 0 4.535130083971328e-12
1936delG O 0 1.882222377957987e-09
, O 0 1.8999320346158033e-13
which O 0 1.7421668491515718e-12
have O 0 6.095774492814732e-12
been O 0 3.2872461697142086e-11
previously O 0 1.8185523087410616e-09
reported O 0 1.165711349671028e-08
in O 0 7.685818127767252e-12
African O 0 4.266947472436611e-12
- O 0 2.8140825634181965e-06
Americans O 0 1.2886787192911697e-09
. O 0 7.488469046246227e-12

We O 0 2.5882753718065032e-09
also O 0 8.640959855196056e-14
show O 0 4.7912125655802384e-12
that O 0 7.462649950578347e-15
the O 0 2.831022549498524e-15
879delG O 0 5.026598248747405e-09
and O 0 1.5862776370223486e-10
1195delC O 0 3.4636665077414364e-05
defects O 1 0.6003138422966003
are O 0 4.602532005688886e-13
associated O 0 1.9030575726386445e-10
with O 0 3.018192640258377e-11
characteristic O 0 0.004099481739103794
C6 O 0 0.004914925433695316
/ O 0 0.0009999250760301948
C7 O 0 8.225806595874019e-07
region O 0 8.115717875512019e-09
DNA O 0 3.064334119784462e-09
marker O 0 2.7178492789659003e-09
haplotypes O 0 8.963631614733458e-09
, O 0 2.4419306637532556e-13
although O 0 4.5263996001874973e-13
small O 0 4.857470762426042e-13
variations O 0 6.540123109743945e-08
were O 0 8.433527654005957e-08
observed O 0 4.001079219051462e-07
. O 0 2.7828997439804937e-10

The O 0 9.383964438836045e-11
1936delG O 0 3.5403746778683853e-07
defect O 0 1.7714932255330496e-05
was O 0 1.9244915383520578e-10
observed O 0 2.5235277756330277e-10
only O 0 7.114997610177531e-13
once O 0 1.3190946945851323e-10
in O 0 1.4418539062352465e-13
the O 0 6.010896804169857e-14
Cape O 0 1.0108412024090185e-10
, O 0 3.6469004899286617e-13
but O 0 6.278795842626361e-13
its O 0 1.853891059018357e-15
associated O 0 1.1223265155776985e-12
haplotype O 0 8.617141028510744e-11
could O 0 1.0206033934645475e-10
be O 0 1.7440684313418942e-12
deduced O 0 8.586313604563856e-11
. O 0 6.975895121968945e-12

The O 0 8.028068227555751e-13
data O 0 7.484552799578992e-13
from O 0 1.09197759612812e-14
the O 0 4.15520652011659e-15
haplotypes O 0 1.1347820599860725e-10
indicate O 0 2.518441899468371e-09
that O 0 8.425736914815032e-14
these O 0 2.5718424108032642e-14
three O 0 7.260558392572017e-14
molecular O 0 2.981464319873339e-08
defects O 0 3.793296855292283e-06
account O 0 1.665793718241826e-11
for O 0 4.727151829697629e-13
the O 0 4.795578378846699e-10
defects O 1 0.9718272686004639
in O 0 3.1106228703947636e-11
all O 0 7.703190841278074e-13
the O 0 1.5429935703702852e-13
38 O 0 1.4217490032497615e-13
unrelated O 0 1.4463387085217327e-12
C6Q0 O 0 3.1485374307749225e-08
individuals O 0 3.4933070325315896e-11
we O 0 1.3743421956036173e-09
have O 0 1.3316318533962423e-12
studied O 0 1.7971853172316088e-11
from O 0 1.8589987947452424e-13
the O 0 1.1362796554365007e-12
Cape O 0 1.468089538825268e-09
. O 0 1.271043548189965e-10

We O 0 2.437506729791039e-08
have O 0 5.090080375420858e-13
also O 0 8.806847192157664e-15
observed O 0 1.827172094182039e-12
the O 0 1.6691146755747413e-14
879delG O 0 2.1832078367367558e-09
defect O 0 3.478558596725634e-08
in O 0 5.101630055903694e-12
two O 0 4.074010462318256e-09
Dutch O 1 0.9999961853027344
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999998807907104
kindreds O 0 5.06010383105604e-06
, O 0 7.856650443074931e-13
but O 0 8.126182696579012e-14
the O 0 1.079506730045695e-14
879delG O 0 3.801584380624945e-09
defect O 0 4.34133262672276e-08
in O 0 4.730200606206658e-13
the O 0 9.864164877710496e-14
Cape O 0 1.3097534168338143e-10
probably O 0 2.0509183240591256e-09
did O 0 1.6506974606644853e-11
not O 0 5.246278129804327e-14
come O 0 4.6724864916861814e-14
from O 0 4.0376552876966385e-15
The O 0 6.884156601976582e-14
Netherlands O 0 1.1969523256993853e-06
. O 0 8.478683250282004e-13
. O 0 4.8084882429966225e-12

Complement B-Disease 1 0.5361093878746033
C7 I-Disease 1 0.9999988079071045
deficiency I-Disease 1 1.0
: O 0 3.326529884883911e-10
seven O 0 4.945723192963103e-13
further O 0 1.6782270018111944e-12
molecular O 0 0.09455344080924988
defects O 1 0.9999967813491821
and O 0 1.2606099275558336e-08
their O 0 4.988607790745725e-11
associated O 0 4.1718226095888156e-10
marker O 0 1.2348631450720404e-08
haplotypes O 0 3.841449824903975e-07
. O 0 3.7554298559783206e-10

Seven O 0 1.294185245082069e-11
further O 0 1.7434756980141963e-13
molecular O 0 1.5784433760046568e-09
bases O 0 9.329560270998627e-07
of O 0 1.0394900300525478e-06
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 6.610124003714191e-09
described O 0 1.2268481341948245e-08
. O 0 1.1244402631227501e-10

All O 0 1.324668022842368e-12
these O 0 1.5040791149448923e-14
new O 0 4.1937636631635133e-13
molecular O 0 2.1210331269116978e-08
defects O 0 4.190654362901114e-05
involve O 0 1.5812511022783582e-10
single O 0 4.705003608940217e-10
- O 0 1.0830428998076513e-08
nucleotide O 0 3.0602773787302695e-11
events O 0 1.6645310076026515e-13
, O 0 2.1589248551511512e-17
deletions O 0 4.216799706722313e-13
and O 0 3.909985060875608e-14
substitutions O 0 4.435110319365304e-13
, O 0 7.640200655937939e-16
some O 0 1.3830605955070024e-15
of O 0 3.959639961834821e-13
which O 0 3.306628859611749e-10
alter O 0 4.512444196080878e-09
splice O 0 8.34382007930401e-11
sites O 0 4.494989269687721e-09
, O 0 5.760200910004398e-12
and O 0 2.660575579294111e-11
others O 0 1.421744926649593e-11
codons O 0 1.0891529345080642e-10
. O 0 1.2617049766072697e-11

They O 0 3.8033082239152805e-10
are O 0 1.290739298212204e-14
distributed O 0 3.793720810315714e-15
along O 0 1.3697284409128208e-13
the O 0 1.5589442172066204e-13
C7 O 0 1.1346219103147703e-10
gene O 0 3.75648852302124e-11
, O 0 3.091802394617968e-14
but O 0 3.709306353825298e-14
predominantly O 0 1.2696768075391891e-14
towards O 0 2.139947561600325e-13
the O 0 5.295795269324999e-13
3 O 0 4.015006643126595e-12
end O 0 9.515409987725931e-11
. O 0 1.0755746120139076e-11

All O 0 4.712089052283375e-10
were O 0 8.135046455914896e-12
found O 0 5.31024139591163e-12
in O 0 3.5067237742075763e-12
compound O 0 6.52309928295125e-10
heterozygous O 0 4.67859795350023e-09
individuals O 0 1.8362050768772065e-10
. O 0 7.859251444086723e-11

The O 0 8.084016123177662e-09
C6 O 0 0.00024213582219090313
/ O 0 9.269110159948468e-05
C7 O 0 5.166135679246509e-07
marker O 0 3.7211517422974794e-08
haplotypes O 0 9.372964768772363e-07
associated O 0 1.2882129851732316e-07
with O 0 5.908331462967098e-11
most O 0 9.53449097451653e-10
C7 B-Disease 0 0.2421194463968277
defects I-Disease 1 0.9998921155929565
are O 0 1.2415198868964694e-09
tabulated O 0 1.9405444618314505e-05
. O 0 2.2849565121940696e-12
. O 0 1.1828637028199473e-11

A O 0 2.6147312093272035e-10
genome O 0 7.330506340830212e-11
- O 0 3.2850682174512258e-09
wide O 0 2.0089282667945518e-11
search O 0 6.69570301981004e-12
for O 0 2.042626186466237e-13
chromosomal O 0 2.284740048708045e-06
loci O 0 2.830912171347677e-09
linked O 0 0.00019912823336198926
to O 0 5.767916366750114e-09
mental O 0 0.38047146797180176
health O 0 1.3221439054689199e-08
wellness O 0 4.818885845914167e-10
in O 0 1.768363558883601e-12
relatives O 0 4.3004485389408487e-11
at O 0 5.99654562116747e-11
high O 0 4.224681493525395e-09
risk O 0 1.8161878188038827e-06
for O 0 4.968588040998867e-12
bipolar B-Disease 0 2.3508657250204124e-05
affective I-Disease 0 0.0006628078990615904
disorder I-Disease 1 0.9765217304229736
among O 0 2.428963453982025e-11
the O 0 1.006166417544252e-11
Old O 0 1.4179211405007663e-07
Order O 0 1.4314316225394474e-11
Amish O 0 2.505620377846185e-09
. O 0 8.322870864718723e-11

Bipolar B-Disease 1 0.8333107829093933
affective I-Disease 0 0.22098471224308014
disorder I-Disease 1 0.9997766613960266
( O 0 7.512675637144639e-08
BPAD B-Disease 1 1.0
; O 0 0.00021709517750423402
manic B-Disease 1 0.9999994039535522
- I-Disease 1 1.0
depressive I-Disease 1 0.9999998807907104
illness I-Disease 1 0.9999934434890747
) O 0 2.3292957840315154e-11
is O 0 9.153368167591491e-13
characterized O 0 8.945172727536921e-12
by O 0 3.2593590641120246e-14
episodes O 0 9.26008575374837e-12
of O 0 1.5988507176198374e-13
mania B-Disease 0 4.8819014608625366e-08
and O 0 4.365622099933297e-11
/ O 0 1.9639246318092773e-07
or O 0 1.1192498039491738e-09
hypomania B-Disease 0 1.5702741507084284e-07
interspersed O 0 1.0605700762056358e-09
with O 0 2.7406302054167053e-12
periods O 0 1.4970257922186647e-08
of O 0 1.4723727445598023e-11
depression B-Disease 0 1.3342231852675468e-07
. O 0 1.0883326184707443e-10

Compelling O 0 9.42414701832206e-10
evidence O 0 6.948181613397608e-12
supports O 0 6.3402950424562565e-12
a O 0 1.0414874868015962e-14
significant O 0 1.569262874214026e-14
genetic O 0 3.205418569462992e-11
component O 0 4.840236197956038e-11
in O 0 2.559033443049613e-13
the O 0 6.468373877971043e-14
susceptibility O 0 3.2263152149880625e-08
to O 0 2.314384794921409e-11
develop O 0 6.103261398493487e-07
BPAD B-Disease 1 1.0
. O 0 1.4318434438109762e-08

To O 0 1.4064736354735263e-11
date O 0 1.566016538667725e-09
, O 0 3.542091885641932e-14
however O 0 1.6640707637804314e-13
, O 0 7.505297953593483e-16
linkage O 0 2.361045040033538e-11
studies O 0 7.827517280178942e-12
have O 0 1.125633738779594e-13
attempted O 0 2.2629925277434237e-12
only O 0 3.639144243111972e-14
to O 0 1.3271526516916033e-14
identify O 0 6.484541376083897e-11
chromosomal O 0 1.0144636917175376e-06
loci O 0 7.911938465499091e-11
that O 0 7.209754494807985e-12
cause O 0 3.9469330581631823e-10
or O 0 1.8268593235393205e-11
increase O 0 4.3963388485224186e-11
the O 0 2.640555482602558e-11
risk O 0 3.8469820538011845e-06
of O 0 2.3417628513405786e-12
developing O 0 3.006118447501649e-07
BPAD B-Disease 1 1.0
. O 0 8.796583017556259e-09

To O 0 3.423400452007286e-12
determine O 0 4.7951548981517433e-11
whether O 0 4.829612404444461e-11
there O 0 1.3561107965742725e-11
could O 0 1.190262610695214e-10
be O 0 8.022420076338188e-13
protective O 0 1.1923803611146866e-10
alleles O 0 1.2062482089569837e-12
that O 0 1.2814863949996928e-14
prevent O 0 3.5639442785839748e-12
or O 0 2.1721570722665895e-11
reduce O 0 2.56699606016042e-10
the O 0 4.221920122532419e-12
risk O 0 8.144750296423808e-08
of O 0 6.738178943846776e-14
developing O 0 1.188498299775631e-09
BPAD B-Disease 1 1.0
, O 0 1.7534996553185932e-14
similar O 0 8.207099584623626e-15
to O 0 4.855520655412237e-15
what O 0 2.658214089384242e-13
is O 0 1.4227790291949406e-14
observed O 0 3.4409311337746384e-12
in O 0 1.917095497107335e-13
other O 0 7.947512092876252e-11
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 6.690762527350458e-12
we O 0 1.3611074767272413e-10
used O 0 4.974635814392059e-09
mental O 0 0.000512596860062331
health O 0 7.511680166771839e-10
wellness O 0 3.492254402326367e-11
( O 0 3.0092971842719807e-13
absence O 0 1.166820751130615e-09
of O 0 8.72303314650158e-13
any O 0 1.8938351331598824e-06
psychiatric B-Disease 0 0.002216777764260769
disorder I-Disease 0 8.86632187757641e-06
) O 0 2.3894875675009065e-14
as O 0 7.255602233391042e-14
the O 0 1.5765626380347814e-13
phenotype O 0 3.3105431729296697e-09
in O 0 8.829056734847851e-13
our O 0 1.879263454920843e-12
genome O 0 5.302789457539703e-13
- O 0 6.25692830880098e-10
wide O 0 3.7301141342371835e-11
linkage O 0 1.3236756579715347e-08
scan O 0 1.615391198583893e-07
of O 0 7.652634358449803e-14
several O 0 1.0381198532099026e-14
large O 0 1.61945890725379e-11
multigeneration O 0 0.0011429938022047281
Old O 0 2.466306341375457e-06
Order O 0 1.3553427477552837e-11
Amish O 0 1.1900634921957476e-09
pedigrees O 0 3.323983577274703e-08
exhibiting O 0 2.0642920706137602e-10
an O 0 8.688026426756368e-14
extremely O 0 1.2211401667627797e-08
high O 0 1.8908777121851017e-07
incidence O 0 0.3236667811870575
of O 0 1.0038370135134755e-08
BPAD B-Disease 1 1.0
. O 0 1.3736274340203636e-08

We O 0 1.3528310205401795e-07
have O 0 1.8978397412633408e-12
found O 0 1.1913056261955712e-13
strong O 0 6.495564719780078e-13
evidence O 0 3.1270574237657334e-12
for O 0 1.4851616505075042e-14
a O 0 4.425342199892296e-13
locus O 0 5.571749728261466e-10
on O 0 1.8646133526090125e-09
chromosome O 0 5.489047083528931e-08
4p O 0 4.909454620616316e-09
at O 0 4.979270468163932e-12
D4S2949 O 0 6.700522775515694e-11
( O 0 1.659259616640027e-13
maximum O 0 9.634115033518853e-11
GENEHUNTER O 0 6.492021839221707e-06
- O 0 2.4827659217407927e-07
PLUS O 0 8.040489801741657e-11
nonparametric O 0 6.136399721690111e-10
linkage O 0 2.1439474640061462e-09
score O 0 2.93376045679139e-10
= O 0 5.964344296227608e-11
4 O 0 8.553261621375725e-15
. O 0 1.1761459048440642e-15
05 O 0 4.646947757147579e-12
, O 0 2.649009780451915e-15
P O 0 1.4333495812479669e-07
= O 0 5.990489770901775e-10
5 O 0 1.238530355747794e-13
. O 0 2.6705312359273994e-14
22 O 0 2.2339110270809537e-13
x O 0 4.3952197437135965e-09
10 O 0 5.572924066665763e-12
( O 0 1.357279089467256e-13
- O 0 2.6093613314515096e-07
4 O 0 2.642635025737472e-12
) O 0 8.672888931549397e-15
; O 0 1.8261450125233846e-15
SIBPAL O 0 7.870457063852143e-11
Pempirical O 0 3.5185437896601e-11
value O 0 5.90315019088905e-11
< O 0 9.734110219261627e-12
3 O 0 2.6401754046889714e-13
x O 0 6.060471235969089e-09
10 O 0 6.972103883812197e-12
( O 0 1.4487178546639806e-13
- O 0 1.90733715044189e-07
5 O 0 2.034442492943045e-12
) O 0 1.8588913909675306e-14
) O 0 1.4385511214859946e-14
and O 0 7.907102706969371e-13
suggestive O 0 3.6052572038869357e-10
evidence O 0 1.1117827145024073e-11
for O 0 3.840763495546913e-14
a O 0 9.405511309026893e-13
locus O 0 1.6249710466098577e-09
on O 0 2.944347166078387e-08
chromosome O 0 1.3806737115373835e-05
4q O 0 9.327174666395877e-06
at O 0 7.687782702103796e-12
D4S397 O 0 9.413094609334038e-11
( O 0 1.140974521893906e-13
maximum O 0 6.937710128607222e-11
GENEHUNTER O 0 5.103906460135477e-06
- O 0 5.272445946502557e-07
PLUS O 0 7.371025317892688e-11
nonparametric O 0 2.124873610398481e-10
linkage O 0 2.706897150872578e-09
score O 0 2.532718756942387e-10
= O 0 2.5965403438465984e-11
3 O 0 9.808084181525505e-15
. O 0 2.641945525671814e-15
29 O 0 2.150910200816869e-13
, O 0 5.730415586796165e-16
P O 0 2.6764034544157767e-08
= O 0 3.489539490697524e-10
2 O 0 1.9110205768096272e-13
. O 0 4.3624690448593184e-14
57 O 0 1.3340648030712998e-12
x O 0 1.1122514820272045e-07
10 O 0 4.8328379492756923e-11
( O 0 7.089557890402332e-13
- O 0 8.449771371488168e-07
3 O 0 3.989114594205034e-12
) O 0 8.81538443723304e-15
; O 0 1.2334603892200265e-15
SIBPAL O 0 4.5011615962264884e-11
Pempirical O 0 1.8664830098158447e-11
value O 0 4.599684869099896e-11
< O 0 6.75423128884689e-12
1 O 0 2.278909754047792e-13
x O 0 1.1045241166129927e-08
10 O 0 1.1989340076290489e-11
( O 0 2.1019461399294365e-13
- O 0 3.7798457697135746e-07
3 O 0 2.6532565207404435e-12
) O 0 8.044430295235227e-15
) O 0 2.208480861837399e-15
that O 0 1.4077980317953043e-13
are O 0 4.202563590096492e-13
linked O 0 3.9333041712552586e-08
to O 0 5.219788490329336e-10
mental O 0 0.026500355452299118
health O 0 2.6329209390496544e-07
wellness O 0 1.5837580136235374e-08
. O 0 3.565164830021672e-10

These O 0 1.514398328961164e-11
findings O 0 2.403249127480578e-11
are O 0 7.361403424766683e-14
consistent O 0 3.800215784416361e-12
with O 0 1.584453266628553e-15
the O 0 2.115458009504037e-15
hypothesis O 0 5.948682844057751e-13
that O 0 3.616665248653352e-16
certain O 0 2.7305661360200583e-15
alleles O 0 1.6177777704701884e-13
could O 0 2.1077564606869492e-12
prevent O 0 4.223065994124475e-11
or O 0 5.967052546518303e-11
modify O 0 6.84569692599446e-11
the O 0 1.5122145614714089e-13
clinical O 0 8.486680108665823e-12
manifestations O 0 1.6677115244334573e-10
of O 0 8.757174130812062e-13
BPAD B-Disease 1 1.0
and O 0 2.9990393501933e-10
perhaps O 0 7.376252386670501e-12
other O 0 1.3979991480856518e-13
related O 0 4.2428185409448815e-09
affective B-Disease 0 2.0708994270535186e-05
disorders I-Disease 0 0.004800916649401188
. O 0 6.248317974133499e-10

Segregation O 0 1.5096215975063387e-05
distortion O 0 0.00022999959765002131
in O 0 2.8363083970361913e-07
myotonic B-Disease 1 0.9999967813491821
dystrophy I-Disease 1 0.9999990463256836
. O 0 2.8241356631042436e-07

Myotonic B-Disease 1 0.9999830722808838
dystrophy I-Disease 1 0.999998927116394
( O 0 3.7618538044625893e-06
DM B-Disease 1 1.0
) O 0 3.640255319403707e-10
is O 0 2.5550171353638795e-11
an O 0 1.8596630312062157e-12
autosomal B-Disease 1 0.9999903440475464
dominant I-Disease 1 0.9999986886978149
disease I-Disease 1 0.9999904632568359
which O 0 5.130303404321523e-10
, O 0 6.176935590622434e-14
in O 0 1.7843478159872833e-13
the O 0 1.6708578693801907e-13
typical O 0 3.8417331538198596e-09
pedigree O 0 7.81412197170539e-08
, O 0 5.4937620987507204e-15
shows O 0 6.103510925836719e-12
a O 0 3.467612752928312e-13
three O 0 1.9945363991056425e-13
generation O 0 8.850743922483861e-12
anticipation O 0 1.9084799712798528e-11
cascade O 0 2.706260771034863e-10
. O 0 7.659991391184562e-11

This O 0 2.2996426811416892e-12
results O 0 1.181022363239137e-10
in O 0 1.6307048766872612e-10
infertility B-Disease 1 0.9793780446052551
and O 0 0.0037488616071641445
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.4317335095270778e-09
CDM B-Disease 0 5.341007192072311e-09
) O 0 2.9921767510541694e-14
with O 0 1.140164707574354e-14
the O 0 3.8840512837229335e-14
disappearance O 0 9.51178580343992e-10
of O 0 4.541191381268739e-11
DM B-Disease 1 1.0
in O 0 4.247901475018523e-10
that O 0 1.5903604821954076e-11
pedigree O 0 1.841211911823848e-07
. O 0 5.1354875213460716e-12

The O 0 1.7814853325165414e-12
concept O 0 2.337514730388346e-12
of O 0 9.219120828069319e-14
segregation O 0 2.475379623501084e-10
distortion O 0 4.8205826885805436e-08
, O 0 1.2647492103091962e-13
where O 0 2.8175904534868956e-13
there O 0 2.1481909201243217e-14
is O 0 4.7020226152602335e-15
preferential O 0 9.033645359535214e-12
transmission O 0 9.447449766941673e-11
of O 0 2.5576744295077204e-15
the O 0 4.386061538242487e-15
larger O 0 2.0190946625146117e-13
allele O 0 3.0615020067681353e-12
at O 0 1.3588209333767476e-12
the O 0 3.916153859528926e-12
DM B-Disease 1 0.9999998807907104
locus O 0 1.8150245750803151e-09
, O 0 1.8845615172569108e-12
has O 0 2.4242413632080684e-12
been O 0 3.1429273246452727e-12
put O 0 1.7135270979906636e-10
forward O 0 2.8860849821121803e-10
to O 0 2.6776235308861862e-12
explain O 0 2.775215168782097e-09
partially O 0 2.5448159135521564e-09
the O 0 2.1029888713688244e-13
maintenance O 0 1.6489415735621016e-11
of O 0 7.579656303643989e-13
DM B-Disease 1 1.0
in O 0 5.800016578128009e-10
the O 0 2.6910494665965956e-11
population O 0 4.3888569861705307e-11
. O 0 1.0204223577225946e-10

In O 0 3.367461171022157e-11
a O 0 1.83358558371316e-12
survey O 0 1.3723383540664713e-09
of O 0 4.1069834165463615e-12
DM B-Disease 1 1.0
in O 0 7.848672112231725e-08
Northern O 0 8.824024178011314e-09
Ireland O 0 2.511440698071965e-06
, O 0 7.930786561326231e-13
59 O 0 8.561692479112926e-13
pedigrees O 0 6.131848917512173e-10
were O 0 1.0669277093755536e-11
ascertained O 0 3.747075094651109e-09
. O 0 9.917809629111929e-12

Sibships O 0 1.4784105815124349e-06
where O 0 1.476718886062045e-10
the O 0 2.363380758457767e-13
status O 0 1.5373703698973173e-10
of O 0 7.046092360832659e-14
all O 0 2.619988915490007e-13
the O 0 1.5311108162037977e-14
members O 0 1.4045687356245562e-13
had O 0 4.233697836752981e-10
been O 0 4.4411653174480925e-12
identified O 0 2.780510717503848e-11
were O 0 2.088630104372241e-13
examined O 0 4.7606146455492215e-12
to O 0 2.355603030885535e-14
determine O 0 1.1520143346210876e-11
the O 0 5.2016496578793925e-14
transmission O 0 9.487247792927533e-11
of O 0 6.212935422616984e-15
the O 0 5.788362410913406e-12
DM B-Disease 1 0.9999998807907104
expansion O 0 1.8513056365687675e-10
from O 0 7.395049156366795e-11
affected O 0 1.059777487988356e-09
parents O 0 2.8826629971945295e-10
to O 0 4.742832428877852e-12
their O 0 2.5133431794110983e-11
offspring O 0 4.816864129786325e-10
. O 0 4.365120244431697e-12

Where O 0 1.914687519644076e-09
the O 0 5.343098359589238e-12
transmitting O 0 5.803950671179336e-07
parent O 0 2.3872765098076343e-08
was O 0 2.809803500980479e-09
male O 0 5.674598213545323e-08
, O 0 3.6219313138963205e-13
58 O 0 1.9415599770283842e-12
. O 0 9.105087343808105e-12

3 O 0 4.008183715487057e-11
% O 0 9.419802177862424e-13
of O 0 1.836057754401807e-14
the O 0 1.0861872382431081e-12
offspring O 0 3.516413826787357e-09
were O 0 2.0012003165703618e-10
affected O 0 3.263506825890161e-11
, O 0 4.9988675986144607e-14
and O 0 5.015777723715864e-12
in O 0 4.739954088950338e-13
the O 0 2.225812002971169e-14
case O 0 5.185056203838023e-11
of O 0 3.447904871225864e-14
a O 0 6.017156911619637e-11
female O 0 1.5729405049569323e-06
transmitting O 0 5.641764346364653e-06
parent O 0 1.6034225058803031e-09
, O 0 5.580665053336875e-13
68 O 0 1.5558832000550638e-11
. O 0 1.3668615718442911e-11

7 O 0 7.537215296338218e-09
% O 0 5.2388364479849514e-11
were O 0 1.0581126252962036e-10
affected O 0 8.477228696790462e-09
. O 0 7.447141792127354e-10

Studies O 0 2.033172380455639e-10
on O 0 1.5123163138452966e-12
meiotic O 0 4.746638082586685e-10
drive O 0 1.8218146435877713e-10
in O 0 7.841268606645357e-11
DM B-Disease 1 1.0
have O 0 5.284058191001861e-10
shown O 0 2.841134549846913e-10
increased O 0 4.743169398913061e-11
transmission O 0 4.1180534676721336e-11
of O 0 1.2257258137412922e-15
the O 0 1.4892171172040157e-15
larger O 0 4.618843217510209e-14
allele O 0 1.4153346463569028e-12
at O 0 9.409997737616638e-13
the O 0 3.540110262226226e-12
DM B-Disease 1 0.9999994039535522
locus O 0 1.46874832296362e-08
in O 0 4.717109813867637e-09
non O 0 1.324074219155591e-05
- O 1 0.9537559747695923
DM O 1 0.9999997615814209
heterozygotes O 0 2.519957433833042e-07
for O 0 6.832623009045413e-12
CTGn O 0 1.3095991846512334e-07
. O 0 1.2026953044586008e-10

This O 0 7.0809261232263054e-12
study O 0 1.128417563382722e-13
provides O 0 5.356579607228729e-15
further O 0 2.2444492689096054e-15
evidence O 0 1.3589116810985846e-12
that O 0 1.4275048157430525e-12
the O 0 3.345736881987804e-12
DM B-Disease 1 0.9999997615814209
expansion O 0 1.0248030896109483e-10
tends O 0 5.324993779254328e-10
to O 0 4.669361685499807e-13
be O 0 2.3434532092636573e-11
transmitted O 0 6.117891082624283e-09
preferentially O 0 2.44835285378997e-09
. O 0 3.569443005058126e-11

Diagnosis O 0 0.002094980562105775
of O 0 1.1604492478056727e-08
hemochromatosis B-Disease 1 0.9999992847442627
. O 0 9.766671382749337e-07

If O 0 4.646621164283715e-06
untreated O 0 6.203398515935987e-05
, O 0 1.2487318123977076e-10
hemochromatosis B-Disease 1 1.0
can O 1 0.9922480583190918
cause O 1 0.5816590189933777
serious O 1 0.9998606443405151
illness O 1 0.99998939037323
and O 0 7.913920074820169e-10
early B-Disease 0 1.2919223468799146e-09
death I-Disease 0 2.1461199484207327e-09
, O 0 1.7380858579642278e-14
but O 0 1.651039981814817e-12
the O 0 5.708878465446321e-13
disease O 0 3.854930596958184e-09
is O 0 1.5121893537708986e-12
still O 0 2.0199066030901491e-10
substantially O 0 1.6185689233338962e-08
under O 0 1.0972174635526244e-07
- O 1 0.9999589920043945
diagnosed O 0 0.03844593092799187
. O 0 7.25127291545391e-10

The O 0 7.770096415241068e-13
cornerstone O 0 1.0531870514585151e-11
of O 0 7.256037333040223e-16
screening O 0 2.401479405958473e-12
and O 0 7.199440560856293e-14
case O 0 1.4982386533669845e-13
detection O 0 1.2529636182756487e-11
is O 0 8.095841807001774e-15
the O 0 5.125339189111832e-16
measurement O 0 8.845511996480315e-12
of O 0 8.276707905196037e-15
serum O 0 1.182478559513811e-10
transferrin O 0 2.0901946840012897e-11
saturation O 0 5.126606361649522e-10
and O 0 9.46418117486747e-12
the O 0 3.8076456050639695e-12
serum O 0 5.273086856050213e-09
ferritin O 0 6.758742188139877e-08
level O 0 2.7706468230803694e-08
. O 0 5.904883526586246e-11

Once O 0 9.898722197476673e-08
the O 0 7.329132092892543e-12
diagnosis O 0 1.4313410900967938e-08
is O 0 1.8090004049852587e-13
suspected O 0 2.583667446653948e-10
, O 0 3.4527156795530894e-14
physicians O 0 3.649732697053737e-13
must O 0 1.0927042257136144e-11
use O 0 5.135411540457824e-11
serum O 0 3.3756768971215934e-06
ferritin O 0 0.0011086040176451206
levels O 0 2.473106542311143e-05
and O 0 2.3751143413131004e-11
hepatic O 0 8.210039226241861e-08
iron O 0 1.2755738225678215e-06
stores O 0 2.076506327997052e-10
on O 0 3.016502325703385e-10
liver O 0 2.620222927518512e-10
biopsy O 0 3.422023198140778e-08
specimens O 0 3.3381120090325567e-09
to O 0 5.839123672427005e-13
assess O 0 1.6339132713483195e-08
patients O 0 1.8727083685859958e-12
for O 0 4.097392286301748e-15
the O 0 1.8079380223814945e-13
presence O 0 2.02455918696387e-09
of O 0 1.4442113303869686e-11
iron B-Disease 0 0.000337040051817894
overload I-Disease 0 1.4566714526154101e-05
. O 0 2.3448135100245793e-10

Liver O 0 0.0011440617963671684
biopsy O 0 0.018771003931760788
is O 0 1.4146241955614869e-09
also O 0 1.6423077090974014e-13
used O 0 1.2242737748059673e-13
to O 0 2.621922217370138e-14
establish O 0 2.278467562191744e-12
the O 0 5.332873357320744e-13
presence O 0 1.0803293815087045e-09
or O 0 1.0532021921250134e-09
absence O 0 2.289317846404515e-09
of O 0 3.2066766776639444e-12
cirrhosis B-Disease 0 2.519327146899286e-08
, O 0 2.1172686271320879e-13
which O 0 1.4191873370927865e-11
can O 0 2.2528979570779484e-08
affect O 0 1.7023916143443785e-07
prognosis O 0 4.665679114168597e-07
and O 0 1.071953810438675e-11
management O 0 1.3654759267733851e-10
. O 0 1.058118089675153e-11

A O 0 2.0286777466238526e-11
DNA O 0 1.1112596953744003e-10
- O 0 4.64915572706559e-08
based O 0 4.3822215821387456e-12
test O 0 3.2226552156011667e-12
for O 0 5.89920648917349e-16
the O 0 6.096811440713156e-15
HFE O 0 5.134689340380305e-10
gene O 0 2.8394196716075015e-12
is O 0 4.475384974178716e-15
commercially O 0 5.799404620405015e-15
available O 0 1.739585106280868e-14
, O 0 2.0458719235464913e-15
but O 0 1.0691470766436423e-13
its O 0 7.105440168974329e-16
place O 0 7.653397230203418e-13
in O 0 2.2231400205983964e-13
the O 0 1.1462931298611423e-12
diagnosis O 0 5.677921421920473e-07
of O 0 6.769372822706954e-12
hemochromatosis B-Disease 1 1.0
is O 0 7.132026075851172e-05
still O 0 4.969479405758648e-08
being O 0 2.85555301626772e-10
evaluated O 0 4.2851558412770885e-10
. O 0 5.692625190678591e-12

Currently O 0 2.5648548174217467e-08
, O 0 2.4452491355526906e-13
the O 0 7.597626344789214e-15
most O 0 3.8503314632520674e-16
useful O 0 1.8849252874145704e-15
role O 0 1.454609951370353e-13
for O 0 5.749840911012903e-15
this O 0 2.5389143437919322e-14
test O 0 7.963948782125502e-14
is O 0 3.6760306115528535e-16
in O 0 1.878793721788515e-16
the O 0 4.93725181740487e-16
detection O 0 7.235353288725932e-11
of O 0 6.810630618497848e-13
hemochromatosis B-Disease 1 1.0
in O 0 2.929082087987922e-09
the O 0 2.0030685281020172e-13
family O 0 4.12278241060382e-12
members O 0 1.7054700072972537e-14
of O 0 1.812789556052824e-13
patients O 0 2.815271236619732e-12
with O 0 2.046848848996207e-14
a O 0 9.61048948755483e-12
proven O 0 1.2412199268396762e-08
case O 0 3.3091997024559117e-12
of O 0 1.990647365912937e-14
the O 0 7.569348620117822e-11
disease O 0 3.527803187353129e-07
. O 0 2.304429737309821e-11

It O 0 7.056078811518152e-12
is O 0 4.515842317058191e-14
crucial O 0 1.7458025042965675e-12
to O 0 1.4901159473001968e-10
diagnose O 1 0.9997552037239075
hemochromatosis B-Disease 1 1.0
before O 0 0.20916984975337982
hepatic B-Disease 1 0.9993540644645691
cirrhosis I-Disease 1 0.9967963099479675
develops O 0 2.272835217809188e-06
because O 0 7.960881953650301e-10
phlebotomy O 0 9.579498146194965e-05
therapy O 0 1.636749402678106e-05
can O 0 3.3522309195177513e-07
avert O 0 0.019673528149724007
serious O 1 0.9999774694442749
chronic O 1 0.9999997615814209
disease O 1 0.999997615814209
and O 0 1.587272002723239e-08
can O 0 1.5511950834934396e-08
even O 0 1.792328785388264e-10
lead O 0 1.9778394200198335e-11
to O 0 2.4975863391341058e-12
normal O 0 7.695070358693101e-09
life O 0 3.6959189042562457e-09
expectancy O 0 6.923196044228419e-11
. O 0 1.0117380803314254e-14
. O 0 9.73297289118269e-13

Prevalence O 0 0.00045155611587688327
of O 0 3.625953975006785e-13
the O 0 8.997353372324629e-14
I1307K O 0 1.1521864018426697e-10
APC B-Disease 0 2.6148783659196706e-12
gene O 0 2.9582902967562053e-12
variant O 0 9.590864213926409e-11
in O 0 5.00503338860675e-13
Israeli O 0 1.49734974419502e-10
Jews O 0 3.275415745920829e-12
of O 0 2.375354399259495e-15
differing O 0 2.0313601061666686e-12
ethnic O 0 2.0193805395224418e-12
origin O 0 9.31146182381326e-09
and O 0 1.0717626786060919e-09
risk O 0 4.3727666820814193e-07
for O 0 1.5803722774876405e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.504951706645443e-08

BACKGROUND O 0 7.748821371933445e-05
& O 0 3.0048525889725397e-09
AIMS O 0 2.6416613341240236e-09
Israeli O 0 1.5949590093100596e-08
Jews O 0 7.105620952740921e-11
of O 0 1.5568412444627588e-12
European O 0 2.493283979276839e-08
birth O 0 7.714310612527697e-08
, O 0 1.0477407786854687e-12
i O 0 4.296886402244127e-09
. O 0 1.3786200252810217e-15
e O 0 1.74251821197062e-13
. O 0 9.81927179269284e-16
, O 0 1.2412385074862055e-16
Ashkenazim O 0 8.705082553232824e-13
, O 0 1.1289250885840579e-14
have O 0 1.0492972810083323e-11
the O 0 4.12991907339233e-09
highest O 1 0.9999970197677612
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9999948740005493
of O 0 7.69370938485947e-12
any O 0 7.516696154397096e-10
Israeli O 0 1.9585581867431756e-06
ethnic O 0 9.74824576616129e-09
group O 0 3.494658429303854e-08
. O 0 6.693969684112844e-11

The O 0 2.4853556712667313e-11
I1307K O 0 1.1510227215794089e-09
APC B-Disease 0 5.098364092015473e-11
gene O 0 3.81475649680052e-11
variant O 0 7.60988960735176e-09
was O 0 1.4960258587493058e-09
found O 0 6.050278333891157e-11
in O 0 1.0795563054610824e-10
6 O 0 1.3498437922976336e-09
. O 0 1.3911440055469626e-10

1 O 0 1.609642141797707e-10
% O 0 8.022588127674923e-13
of O 0 6.975671227444063e-15
American O 0 1.873072660515951e-12
Jews O 0 6.417329775215697e-13
, O 0 1.2207242324185213e-14
28 O 0 8.116811801676949e-14
% O 0 1.9719525017340873e-14
of O 0 8.707407624791719e-13
their O 0 0.0017497193766757846
familial O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.0007705144817009568
, O 0 2.386174374410799e-12
but O 0 4.959999858750175e-12
not O 0 2.998475599758077e-12
in O 0 3.2477080920412238e-12
non O 0 8.380112603845191e-09
- O 0 1.5623319313817774e-06
Jews O 0 1.151984840852549e-09
. O 0 1.4615286758612456e-10

We O 0 3.813863669321904e-10
assessed O 0 9.233564607358247e-11
the O 0 4.227306303400055e-14
I1307K O 0 4.934875841300368e-10
prevalence O 0 1.6080543119301183e-08
in O 0 1.445940670799159e-13
Israeli O 0 5.253826193540867e-11
Jews O 0 6.977727857321314e-13
of O 0 1.8952285961849717e-15
differing O 0 1.382722387109625e-12
ethnic O 0 1.5055040547551357e-12
origin O 0 3.5712170998181136e-09
and O 0 2.2630899931819215e-10
risk O 0 1.506886775359817e-07
for O 0 3.884559518496644e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.020299991860156e-08

METHODS O 0 6.80199160885131e-11
DNA O 0 1.130866927878671e-10
samples O 0 1.1341545758103422e-10
from O 0 1.521582881393313e-13
500 O 0 8.214839263475868e-14
unrelated O 0 2.901890750264813e-12
Jews O 0 5.333160996157105e-12
of O 0 2.0363204666310614e-13
European O 0 9.743631457226343e-10
or O 0 3.5600569159299766e-09
non O 0 2.478353522405996e-08
- O 0 4.3513597347555333e-07
European O 0 7.893763975808099e-10
origin O 0 1.4132750525419624e-10
, O 0 9.445195785163975e-15
with O 0 1.0625881786605323e-14
or O 0 1.5124814595202096e-11
without O 0 1.832232499401898e-12
a O 0 2.008461654639821e-14
personal O 0 5.08463493531508e-10
and O 0 6.675647534759577e-11
/ O 0 6.400461938227409e-09
or O 0 1.2122467474284804e-09
family O 0 3.7092451332654264e-09
history O 0 1.9192002653767304e-08
of O 0 5.888547570560843e-13
neoplasia B-Disease 0 1.7609826485909252e-08
, O 0 2.3714274359314114e-13
were O 0 1.7399750260396751e-12
examined O 0 1.1596427290649913e-10
for O 0 5.2425769346380047e-14
the O 0 8.915695330451168e-14
I1307K O 0 5.5355095507358953e-11
variant O 0 5.333428143572405e-11
by O 0 4.756963594733377e-13
the O 0 3.8837219031029324e-12
allele O 0 1.9167765985539376e-10
- O 0 5.068851449685496e-10
specific O 0 3.6186667811549666e-12
oligonucleotide O 0 1.2896794743255668e-09
( O 0 7.797695865743859e-13
ASO O 0 1.4991860197710594e-08
) O 0 2.5291509338221108e-14
method O 0 5.379368825386699e-12
. O 0 2.4218392916108833e-11

RESULTS O 0 1.019847406524832e-08
In O 0 2.7270400564452513e-13
persons O 0 1.3243067666784958e-12
at O 0 4.515625373624488e-11
average O 0 9.83743461802078e-07
risk O 0 0.000560231099370867
for O 0 0.005258389748632908
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.606372812545942e-10
I1307K O 0 1.1046541459336368e-09
was O 0 1.631961926706893e-10
found O 0 3.650110595720957e-12
in O 0 1.191192543908981e-12
5 O 0 4.2137946777709434e-12
. O 0 1.759858404837278e-11

0 O 0 1.586507591966324e-10
% O 0 9.19415368491605e-13
of O 0 3.199000851543399e-14
120 O 0 1.561784447427772e-12
European O 0 5.715413142759473e-10
and O 0 5.792410440186302e-10
1 O 0 4.10031092412666e-10
. O 0 1.3315570868144277e-10

6 O 0 4.162705458110594e-10
% O 0 1.6983301700732034e-12
of O 0 9.685985059805155e-14
188 O 0 4.117587781155008e-12
non O 0 1.6459612561803283e-09
- O 0 3.490006577067106e-07
European O 0 8.579327248625646e-10
Jews O 0 1.5335769112945208e-11
( O 0 3.1749066266642534e-13
P O 0 8.388479955101502e-08
= O 0 3.258346092938069e-10
0 O 0 5.314453846612388e-13
. O 0 6.0443144562247024e-15
08 O 0 3.261400210227e-13
) O 0 1.3130575152295234e-14
. O 0 1.2964352898506282e-12

It O 0 1.184162351508533e-10
occurred O 0 9.695357849892616e-10
in O 0 1.5164844206772e-12
15 O 0 5.978236568976447e-12
. O 0 1.1348031021818361e-11

4 O 0 2.904330109743114e-10
% O 0 2.897250798647444e-12
of O 0 1.377134083851983e-13
52 O 0 5.5848447394479805e-11
Ashkenazi O 0 6.059408086400708e-09
Israelis O 0 1.0622422941253262e-09
with O 0 1.6624862944625285e-11
familial O 0 0.027839403599500656
cancer B-Disease 0 0.000632838811725378
( O 0 3.492893821399612e-11
P O 0 0.005181162618100643
= O 0 1.2032477059165103e-07
0 O 0 5.30412736302055e-12
. O 0 9.801202038829063e-15
02 O 0 1.3161649233591616e-13
) O 0 3.8155618195584624e-16
and O 0 1.5575838145306942e-12
was O 0 3.6226587951659894e-08
not O 0 2.648078423206357e-09
detected O 0 1.4879923355692881e-06
in O 0 1.575151641064476e-11
51 O 0 8.145139077098129e-12
non O 0 2.49958553855123e-10
- O 0 4.519602470054451e-09
European O 0 7.180087774338872e-11
Jews O 0 7.719815238449446e-12
at O 0 4.452337803995121e-11
increased O 0 1.2914123104224018e-09
cancer B-Disease 0 1.1079279005343778e-07
risk O 0 7.487690254492918e-07
. O 0 9.26836038472878e-11

Colorectal B-Disease 1 0.8656303286552429
neoplasia I-Disease 1 0.5404748916625977
occurred O 0 1.3068201042187866e-05
personally O 0 6.729760571033694e-08
or O 0 6.076371628083166e-10
in O 0 1.6125690192880793e-12
the O 0 2.5505934712378997e-13
families O 0 2.368291543777823e-12
of O 0 1.957876948673748e-13
13 O 0 4.057177337146722e-12
of O 0 1.4968591416277682e-13
20 O 0 1.8952424265389345e-12
Ashkenazi O 0 6.90232029518234e-12
I1307K O 0 2.7394453025464394e-11
carriers O 0 7.077239835839855e-12
, O 0 1.0534465755772902e-14
8 O 0 1.4991791987516156e-13
of O 0 7.61829360988904e-14
whom O 0 1.1291318742223666e-06
also O 0 6.280272657477326e-08
had O 0 3.7839928523908384e-08
a O 0 3.91705765045991e-12
personal O 0 6.874334985695896e-07
or O 0 1.749562805741789e-08
family O 0 1.2132460591729455e-09
history O 0 4.7347228360195e-09
of O 0 7.0424712068917206e-12
noncolonic O 0 5.306900493451394e-05
neoplasia B-Disease 0 0.00012648096890188754
. O 0 7.223057707506086e-10

CONCLUSIONS O 0 1.087018475232071e-08
The O 0 3.699621446869028e-13
I1307K O 0 3.6466904496101904e-10
APC O 0 4.4121317710477115e-11
variant O 0 1.1599662341765793e-09
may O 0 1.413164446573134e-10
represent O 0 1.4511071652015956e-13
a O 0 1.395814345182822e-13
susceptibility O 0 1.742196786835848e-08
gene O 0 1.5879191295198325e-09
for O 0 3.545233898116784e-11
colorectal B-Disease 1 1.0
, I-Disease 0 2.785596059373674e-11
or I-Disease 0 9.360564406923899e-11
other I-Disease 0 3.553220218055486e-12
, I-Disease 0 2.5329639427584816e-11
cancers I-Disease 0 7.443326467182487e-05
in O 0 5.307709566998442e-12
Ashkenazi O 0 6.820156661646593e-10
Jews O 0 8.284231078903304e-10
, O 0 1.5715827077211753e-12
and O 0 6.526079589924683e-12
partially O 0 1.540409932943021e-08
explains O 0 3.5022371669413133e-09
the O 0 2.5467642317950068e-12
higher O 0 1.951257786458882e-07
incidence O 0 0.34933415055274963
of O 0 0.0006409901543520391
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.914343788518181e-08
European O 0 5.003516267976238e-09
Israelis O 0 1.1334890803738062e-09
. O 0 5.1177815457714715e-11

Systematic O 0 2.354781092339664e-10
analysis O 0 9.631432457135602e-11
of O 0 1.1001233561278023e-12
coproporphyrinogen O 0 3.1260969990398735e-06
oxidase O 0 1.6828643083499628e-06
gene O 0 0.0006624991074204445
defects O 1 0.9995805621147156
in O 0 1.9528824390935284e-10
hereditary B-Disease 0 0.026343755424022675
coproporphyria I-Disease 0 0.035777054727077484
and O 0 1.9772228299075323e-09
mutation O 0 2.4838959689077456e-07
update O 0 1.600606225338197e-08
. O 0 3.0553084368056815e-11

Hereditary B-Disease 0 0.2244398444890976
coproporphyria I-Disease 0 0.000290734606096521
( O 0 7.052775585769666e-10
HC B-Disease 0 0.06837338209152222
) O 0 2.5637160797065128e-11
is O 0 1.659619941474233e-10
an O 0 8.858010852597076e-11
acute O 1 0.9922211766242981
hepatic B-Disease 1 0.9992722868919373
porphyria I-Disease 1 0.9999874830245972
with O 0 6.457268000303884e-07
autosomal O 1 0.9999686479568481
dominant O 1 0.701972246170044
inheritance O 1 0.5086657404899597
caused O 0 1.819328986130131e-06
by O 0 1.6720550291560166e-11
deficient B-Disease 0 2.0960308688700025e-07
activity I-Disease 0 1.5291767851977056e-09
of I-Disease 0 3.5527573179379435e-13
coproporphyrinogen I-Disease 0 7.641658044121868e-07
III I-Disease 0 9.653201971104863e-08
oxidase I-Disease 0 1.7723381873224753e-08
( O 0 3.087786103195267e-12
CPO O 0 5.524914303833839e-09
) O 0 5.029359090649721e-13
. O 0 2.8829352100023797e-12

Clinical O 0 3.7179844980528287e-07
manifestations O 0 9.844796267088896e-08
of O 0 8.870077415623623e-12
the O 0 7.705627247389657e-10
disease O 0 1.1341392564645503e-05
are O 0 2.920184168260509e-13
characterized O 0 2.348224115156228e-10
by O 0 1.803680121925666e-10
acute O 0 0.00019027540110982955
attacks O 0 6.514187407447025e-05
of O 0 1.466654442339177e-08
neurological B-Disease 1 0.9999065399169922
dysfunction I-Disease 0 2.327062247786671e-06
often O 0 7.371625879160071e-12
precipitated O 0 7.904031595895589e-12
by O 0 3.076365430912495e-15
drugs O 0 1.5664433725831595e-13
, O 0 4.3515616216030235e-16
fasting O 0 2.2668752454584745e-13
, O 0 8.277813283192204e-15
cyclical O 0 3.788988234276758e-09
hormonal O 0 2.3727727338496152e-08
changes O 0 1.3750914296117855e-10
, O 0 1.218585237057479e-12
or O 0 8.410187746221709e-08
infectious B-Disease 0 0.000490414968226105
diseases I-Disease 0 2.6490424716030248e-06
. O 0 3.983482987912623e-11

Skin O 1 0.9998493194580078
photosensitivity O 1 0.9997066855430603
may O 0 0.001046311459504068
also O 0 4.4731239545736656e-11
be O 0 7.324771865435675e-12
present O 0 2.4785718616415764e-11
. O 0 7.66240265681617e-11

The O 0 1.6447301853794727e-10
seven O 0 1.5455393041763354e-12
exons O 0 9.422862663754916e-12
, O 0 1.5108589360613052e-14
the O 0 5.516126733173549e-15
exon O 0 1.5008323750453911e-10
/ O 0 2.1520267790009484e-09
intron O 0 2.2438526592338803e-09
boundaries O 0 5.366428135200607e-11
and O 0 1.0610378678096999e-12
part O 0 3.9226556573269955e-13
of O 0 2.296792313630225e-13
3 O 0 2.0612436995963435e-13
noncoding O 0 1.2501451263080554e-10
sequence O 0 6.410620645436182e-11
of O 0 3.991271763504993e-14
the O 0 5.5355856210708224e-14
CPO O 0 3.2035743502412117e-10
gene O 0 3.0683125311348203e-12
were O 0 7.678941575488263e-13
systematically O 0 1.3969610190844861e-11
analyzed O 0 1.1437073076797644e-12
by O 0 1.2000113757703094e-15
an O 0 3.5350422421801713e-16
exon O 0 1.3491295754175514e-11
- O 0 2.9213320651422237e-09
by O 0 1.5462646354297283e-12
- O 0 3.082484667515928e-08
exon O 0 3.7071514746855883e-09
denaturing O 0 5.860818319547434e-08
gradient O 0 1.7429645282618367e-08
gel O 0 2.2972097113438394e-08
electrophoresis O 0 5.43433020805395e-10
( O 0 1.4091868947782582e-13
DGGE O 0 1.1413054945563772e-09
) O 0 1.1747917109196414e-15
strategy O 0 5.94187649386943e-14
followed O 0 1.5752926053039977e-15
by O 0 8.498965638168977e-18
direct O 0 5.491538001989467e-16
sequencing O 0 4.201102830956975e-14
in O 0 3.2062471167632056e-13
seven O 0 1.2509088274763325e-13
unrelated O 0 3.326339759190944e-10
heterozygous O 0 9.903367725883072e-08
HC B-Disease 0 0.4911005198955536
patients O 0 6.367551463881682e-08
from O 0 3.9499021831090886e-09
France O 0 0.14257074892520905
, O 0 2.223527351824517e-12
Holland O 0 7.529602896738652e-08
, O 0 9.663960603978339e-12
and O 0 7.981974192716734e-09
Czech O 1 0.9997100234031677
Republic O 0 0.0018331723986193538
. O 0 1.7898059923027176e-08

Seven O 0 1.7097726012771375e-10
novel O 0 2.1405622066539287e-11
mutations O 0 2.100196283549849e-08
and O 0 1.1365246851274824e-12
two O 0 9.865344455792843e-15
new O 0 1.2070417365270258e-13
polymorphisms O 0 7.593042639086889e-09
were O 0 2.546262978242453e-09
detected O 0 4.115721822017804e-05
. O 0 4.1420953472703914e-11

Among O 0 6.700705545981123e-10
these O 0 3.317959405488291e-12
mutations O 0 3.0673983353324275e-09
two O 0 4.1342534322190427e-13
are O 0 3.2753893998080374e-13
missense O 0 2.9770887977065286e-08
( O 0 1.2560730179491525e-13
G197W O 0 4.058371000370542e-11
, O 0 7.798327413509332e-15
W427R O 0 8.830846644214407e-12
) O 0 7.776957111063285e-14
, O 0 2.633248572534233e-14
two O 0 1.7705800746999761e-13
are O 0 1.4215740563872092e-11
nonsense O 0 2.968255152779875e-08
( O 0 4.662904516173662e-15
Q306X O 0 3.6048271572636237e-12
, O 0 4.7798776486071125e-15
Q385X O 0 6.607592945018226e-12
) O 0 9.543732313764194e-14
, O 0 4.6259491463113145e-14
two O 0 2.0651386620196797e-14
are O 0 9.774505254397502e-15
small O 0 1.331706724332516e-14
deletions O 0 3.3849094638327415e-09
( O 0 7.050155815049863e-13
662de14bp O 0 4.213356885607311e-10
; O 0 1.04543259357541e-13
1168del3bp O 0 6.174874500608496e-10
removing O 0 1.48611886685579e-11
a O 0 1.7341693131413954e-13
glycine O 0 1.2838639006085284e-11
at O 0 1.9108839510728615e-11
position O 0 1.5483550205863672e-11
390 O 0 7.0601331177795254e-15
) O 0 2.297666231403225e-15
, O 0 2.613947910391507e-14
and O 0 7.893651010615343e-12
one O 0 1.811058898334994e-12
is O 0 1.6867591850176777e-13
a O 0 2.6001043427147617e-14
splicing O 0 1.0635757552446279e-10
mutation O 0 1.475846667098324e-09
( O 0 4.016595676935644e-14
IVS1 O 0 2.863513515194427e-08
- O 0 4.02164452850684e-08
15c O 0 1.2417645578466363e-08
- O 0 8.32111712867345e-09
- O 0 5.372783551393923e-09
> O 0 4.627950800362157e-11
g O 0 3.5510219764667283e-10
) O 0 4.233073411924731e-15
which O 0 5.782703671784002e-15
creates O 0 2.6409457303325223e-13
a O 0 1.6458410900962138e-14
new O 0 4.1230690736582254e-14
acceptor O 0 1.1399652651965936e-13
splice O 0 3.9993709732843996e-11
site O 0 1.8373164101248562e-09
. O 0 3.2636579549993883e-10

The O 0 4.6341311864261936e-12
pathological O 0 3.205542775663872e-10
significance O 0 1.908222607704957e-10
of O 0 1.789576245438823e-13
the O 0 2.42639594397534e-13
point O 0 2.9684997515655454e-11
mutations O 0 6.610924307981492e-11
G197W O 0 2.411770436139271e-12
, O 0 1.4117323431342053e-16
W427R O 0 2.4997151158896724e-13
, O 0 1.1775374740972846e-15
and O 0 2.986338322355335e-14
the O 0 4.735803559746156e-14
in O 0 2.364645805552623e-11
- O 0 1.8405161839041284e-08
frame O 0 3.235448176042155e-08
deletion O 0 6.97646052039147e-10
390delGly O 0 1.920653192044597e-09
were O 0 1.4367538192158746e-12
assessed O 0 1.828319960706093e-11
by O 0 1.2163066506667292e-13
their O 0 8.838125543919606e-12
respective O 0 6.074004493816787e-11
expression O 0 7.92671137062051e-11
in O 0 5.282737477172762e-14
a O 0 1.1186408380549698e-14
prokaryotic O 0 6.674746340492796e-14
system O 0 1.7404146903494087e-14
using O 0 8.62617269281607e-14
site O 0 3.2852314202358457e-09
- O 0 2.9705554993597616e-07
directed O 0 3.959119254659527e-09
mutagenesis O 0 4.0735005768510746e-07
. O 0 3.8933081758507626e-10

These O 0 9.398684087946751e-12
mutations O 0 1.2728832432529202e-09
resulted O 0 1.3465073674112649e-11
in O 0 4.733828346675795e-13
the O 0 1.566072982015984e-13
absence O 0 2.0940182920980988e-10
or O 0 1.7699933315892813e-12
a O 0 1.5479487808743586e-13
dramatic O 0 1.6859167395466557e-09
decrease O 0 1.2677447536191266e-08
of O 0 2.8882846635214232e-12
CPO O 0 1.3784456314169802e-06
activity O 0 2.3934131121450264e-08
. O 0 2.4789170716132958e-11

The O 0 1.9431836348338116e-11
two O 0 2.9151925014583857e-13
polymorphisms O 0 1.4071966925044421e-09
were O 0 1.941941616193099e-12
localized O 0 1.4000433035121773e-09
in O 0 1.9555503050217027e-11
noncoding O 0 2.2747290273628096e-08
part O 0 9.158074298909469e-11
of O 0 9.349702137723473e-14
the O 0 4.703852206426303e-15
gene O 0 5.257209056107326e-13
1 O 0 2.6397407412617584e-14
) O 0 1.606404601912681e-16
a O 0 3.48175400186404e-14
C O 0 4.8488507653488e-10
/ O 0 3.959751415649748e-10
G O 0 2.104662222279785e-09
polymorphism O 0 3.224873923457494e-09
in O 0 1.5734582040072276e-11
the O 0 2.2828264886060046e-12
promotor O 0 5.751527965003334e-07
region O 0 1.551383466136258e-09
, O 0 1.356383538472783e-13
142 O 0 3.279702627100728e-13
bp O 0 3.7412437731143555e-11
upstream O 0 1.0667846814249593e-12
from O 0 3.7162747244757696e-14
the O 0 1.5172112384734151e-15
transcriptional O 0 1.2007384561467382e-13
initiation O 0 1.1602509927756584e-14
site O 0 1.1198673282100668e-12
( O 0 1.0752940963858204e-14
- O 0 2.3027866072333758e-11
142C O 0 2.8764771814460133e-11
/ O 0 8.750108415611635e-10
G O 0 5.194898400340264e-10
) O 0 2.833172530876892e-15
, O 0 1.4279329070416278e-15
and O 0 7.76441831293849e-14
2 O 0 2.063390386016547e-14
) O 0 1.135771020622004e-15
a O 0 1.6507997226133941e-13
6 O 0 2.1230766710650384e-12
bp O 0 4.937619757505729e-12
deletion O 0 1.2315533792425781e-12
polymorphism O 0 2.5036044348780706e-09
in O 0 6.148624578233841e-12
the O 0 1.2324693945530568e-13
3 O 0 1.2231766977326836e-13
noncoding O 0 4.6202684039764463e-11
part O 0 5.894472410172824e-12
of O 0 2.528235867188533e-13
the O 0 2.1157588756069018e-13
CPO O 0 4.5123557668169667e-10
gene O 0 1.3531749505635293e-12
, O 0 2.649616256042149e-15
574 O 0 7.129203911243609e-14
bp O 0 1.412306144428499e-12
downstream O 0 6.382294324112914e-14
of O 0 5.5070859270110305e-15
the O 0 3.200955397009847e-13
last O 0 4.1808136813648034e-11
base O 0 1.6268517782913605e-11
of O 0 5.951264075320555e-15
the O 0 9.94424703172625e-13
normal O 0 3.6887690124665085e-10
termination O 0 1.1037937057423175e-11
codon O 0 1.4311798274269094e-12
( O 0 7.593048131709305e-15
+ O 0 1.2617500360495582e-12
574 O 0 3.612928966417739e-12
delATTCTT O 0 1.0871376021626133e-10
) O 0 2.102797536790435e-12
. O 0 2.7215556197557333e-11

Five O 0 3.05540315270747e-10
intragenic O 0 8.061385159408019e-08
dimorphisms O 0 1.321977151746978e-06
are O 0 1.886403880324572e-11
now O 0 1.1687195482223967e-11
well O 0 1.707918745666448e-13
characterized O 0 2.1678814993153495e-11
and O 0 4.097546954517917e-12
the O 0 1.6849136018695643e-13
high O 0 3.462144460009142e-11
degree O 0 1.39287435751978e-11
of O 0 4.38076080605857e-15
allelic O 0 1.0637705299965106e-10
heterogeneity O 0 4.671747433349083e-10
in O 0 6.867000718058236e-11
HC B-Disease 0 9.000601130537689e-05
is O 0 1.7093323978478736e-10
demonstrated O 0 1.336725313771936e-10
with O 0 6.43986342659282e-14
seven O 0 2.535884337533014e-14
new O 0 2.5936936585567623e-15
different O 0 1.970635492556049e-15
mutations O 0 1.613438928901173e-13
making O 0 9.961170987181616e-15
a O 0 1.56700526035905e-13
total O 0 1.1264355333912013e-12
of O 0 6.148973474492947e-13
nineteen O 0 1.4260926661791018e-08
CPO O 0 6.203144494065782e-06
gene B-Disease 0 6.935663259355351e-05
defects I-Disease 1 0.994857668876648
reported O 0 2.9081856922630323e-08
so O 0 1.5957568599844763e-11
far O 0 1.0812538364657343e-11
. O 0 4.599556954927586e-13
. O 0 1.0149634604994517e-11

Coincidence O 0 1.507104485654054e-08
of O 0 7.497840781404974e-13
two O 0 2.1501995740554405e-14
novel O 0 1.3378615706591268e-12
arylsulfatase O 0 5.293271154727108e-09
A O 0 8.372016621627232e-12
alleles O 0 7.673927465701169e-11
and O 0 9.370957135268476e-12
mutation O 0 2.835283785529441e-09
459 O 0 3.1950053713813986e-11
+ O 0 2.2069443494920904e-11
1G O 0 5.1652011556768684e-09
> O 0 5.924765122955478e-10
A O 0 3.507909240862972e-11
within O 0 4.031426613978345e-13
a O 0 1.4174823424403793e-12
family O 0 1.1636270835779783e-09
with O 0 1.952996164789056e-08
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 0.9999997615814209
: O 0 3.7616649378735545e-11
molecular O 0 2.2848922406892846e-11
basis O 0 2.089256719017829e-12
of O 0 1.850197919135363e-13
phenotypic O 0 4.8739373426087695e-08
heterogeneity O 0 6.363681677612476e-06
. O 0 4.91125504709089e-08

In O 0 5.158717550357572e-11
a O 0 1.0620158181692818e-12
family O 0 1.8986849592561583e-10
with O 0 3.1880172113307736e-11
three O 0 1.4723791630366634e-10
siblings O 0 1.1386407550162403e-07
, O 0 2.734998066509977e-14
one O 0 3.677640535311964e-14
developed O 0 3.734540020977617e-12
classical O 0 6.489945292287302e-08
late O 0 3.226114495191723e-05
infantile O 1 0.9998419284820557
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 0.9999982118606567
( O 0 1.2243655866939207e-08
MLD B-Disease 1 0.9999957084655762
) O 0 7.625944146993913e-13
, O 0 1.6474961924751487e-14
fatal O 0 3.337157217231379e-09
at O 0 1.099116242464504e-09
age O 0 4.278912228983245e-07
5 O 0 7.510014138345511e-11
years O 0 5.615932163749449e-10
, O 0 2.4597958761009286e-14
with O 0 9.47630168779412e-12
deficient O 0 6.783246817576583e-07
arylsulfatase O 0 3.120700853287417e-07
A O 0 2.719128811001781e-10
( O 0 4.4764135432272256e-13
ARSA O 0 1.0444147768851053e-08
) O 0 8.04084446595632e-14
activity O 0 9.382103427491018e-11
and O 0 1.2297830126201809e-13
increased O 0 1.1148936808480503e-11
galactosylsulfatide O 0 1.1746305261794987e-07
( O 0 4.733761299613448e-11
GS O 1 0.9999995231628418
) O 0 1.716468357422854e-13
excretion O 0 2.2080391334777794e-11
. O 0 5.495446979419949e-12

The O 0 2.331144478839864e-11
two O 0 1.0260885294644667e-13
other O 0 2.37373543130609e-13
siblings O 0 4.935407815764847e-08
, O 0 1.1320872624759337e-12
apparently O 0 2.081314143254076e-08
healthy O 0 2.5528570368749115e-09
at O 0 1.0048162822628992e-11
12 O 0 2.2618696195533805e-13
( O 0 1.1464706349326018e-15
1 O 0 5.12108394969471e-14
/ O 0 2.902290734130286e-11
2 O 0 4.9605908573543966e-14
) O 0 3.4738983218496724e-15
and O 0 1.230792594578145e-12
15 O 0 4.5176709595473596e-13
years O 0 9.50955893891381e-13
, O 0 3.0194534989447155e-15
respectively O 0 3.554862654242541e-11
, O 0 9.093056169140468e-13
and O 0 3.38842331970568e-09
their O 0 1.1694927692929014e-08
father O 0 0.00013982714153826237
, O 0 6.230959324893259e-12
apparently O 0 1.204505561958058e-08
healthy O 0 3.206729048965684e-10
as O 0 7.614444014550359e-14
well O 0 1.1439429048118455e-12
, O 0 3.0389587618958507e-15
presented O 0 2.4007280538529407e-12
ARSA O 0 6.333435749183991e-07
and O 0 2.9179034299886553e-08
GS O 1 0.9999998807907104
values O 0 1.472253541301427e-09
within O 0 1.4223339980844532e-14
the O 0 1.3768496840696129e-14
range O 0 1.3202822515823165e-11
of O 0 2.5822372018424744e-11
MLD B-Disease 1 0.9999994039535522
patients O 0 2.8925231099208304e-09
. O 0 6.397489482612428e-11

Mutation O 0 2.8298879684029998e-08
screening O 0 2.8890315140195355e-10
and O 0 9.309822471314025e-14
sequence O 0 7.390327905849522e-14
analysis O 0 2.890662562831173e-14
disclosed O 0 2.527269192531545e-11
the O 0 2.086843965996366e-15
involvement O 0 1.9224141376006365e-11
of O 0 1.1837631027321327e-13
three O 0 1.2831452751455724e-13
different O 0 1.278215949968367e-13
ARSA O 0 3.213785859657037e-08
mutations O 0 5.650399592660449e-10
being O 0 1.226607140511482e-12
the O 0 1.3244411509966765e-15
molecular O 0 4.816710723852535e-13
basis O 0 6.03795713514238e-14
of O 0 3.6484849836411135e-14
intrafamilial O 0 1.1178214265328279e-07
phenotypic O 0 5.778628064945224e-07
heterogeneity O 0 3.1010076781967655e-05
. O 0 3.772462875417659e-08

The O 0 1.7546038233451355e-10
late O 0 8.978470589227072e-08
infantile O 1 0.9688001275062561
patient O 0 8.788399281911552e-05
inherited O 0 0.0007382266339845955
from O 0 1.1171122360487118e-10
his O 0 2.600615556236363e-10
mother O 0 2.7734598617712436e-08
the O 0 2.565386325679292e-13
frequent O 0 2.2520676434822917e-09
0 O 0 1.5226195859696645e-09
- O 0 1.0729074801929528e-06
type O 0 1.7283035049331374e-05
mutation O 0 1.3158294009940619e-08
459 O 0 7.419515522799625e-12
+ O 0 4.837278039064585e-13
1G O 0 5.6943116888419354e-11
> O 0 4.34622043216093e-12
A O 0 2.0821636515649944e-12
, O 0 3.0283952022524055e-14
and O 0 1.5441021725126625e-11
from O 0 6.338641417302782e-11
his O 0 2.4292358347111076e-08
father O 0 4.835408162762178e-07
a O 0 7.687954548148135e-13
novel O 0 3.5200976248456195e-13
, O 0 1.9485463555993145e-15
single O 0 1.0318940255223119e-13
basepair O 0 1.5733268854400961e-10
microdeletion O 0 1.7017884323955457e-10
of O 0 5.8332181756594065e-15
guanine O 0 7.752517378056822e-11
at O 0 9.395251503868662e-14
nucleotide O 0 1.4654862393048695e-11
7 O 0 3.149082015117821e-13
in O 0 2.9572590460013844e-15
exon O 0 3.925863453768663e-11
1 O 0 5.227228372373105e-11
( O 0 3.244090651492726e-13
7delG O 0 4.5924832825505746e-09
) O 0 6.519236973173692e-12
. O 0 3.4701966994399314e-11

The O 0 2.2971285984496603e-10
two O 0 3.6172124323607946e-11
clinically O 0 2.0275035694794497e-07
unaffected O 0 5.735654440286453e-07
siblings O 0 8.813699281517984e-08
carried O 0 4.247601714801874e-10
the O 0 1.4942099207243542e-12
maternal O 0 6.265890561962806e-08
mutation O 0 9.622329599778823e-10
459 O 0 7.953391417681033e-12
+ O 0 4.3506743346855e-12
1G O 0 2.808473453796978e-10
> O 0 5.0670703743982415e-11
A O 0 5.015445350697867e-11
and O 0 1.0640709147136107e-10
, O 0 2.173729810516986e-13
on O 0 4.5198497722331865e-10
their O 0 6.418315878775616e-11
paternal O 0 3.310442142634429e-09
allele O 0 1.2001785849868885e-11
, O 0 3.5713135164705805e-16
a O 0 1.0068094073695895e-15
novel O 0 2.5815734641145005e-14
cytosine O 0 9.017756159857004e-12
to O 0 2.6969323635087214e-15
thymidine O 0 5.3471990724140994e-11
transition O 0 7.146640917943259e-11
at O 0 7.996785200171941e-13
nucleotide O 0 3.3184042319556184e-11
2435 O 0 2.676737720364031e-10
in O 0 3.2795821451343105e-14
exon O 0 1.5015990187383643e-11
8 O 0 1.803406490981374e-12
, O 0 7.556750969974445e-16
resulting O 0 5.736589588772878e-14
in O 0 4.688105863936845e-15
substitution O 0 1.4994051193793073e-13
of O 0 9.218306998813597e-15
alanine O 0 9.732291361697065e-12
464 O 0 2.783776627181961e-13
by O 0 5.282337609859022e-13
valine O 0 1.120128558795841e-07
( O 0 6.544500184835211e-13
A464V O 0 4.471173153941521e-10
) O 0 2.616329895788194e-12
. O 0 1.0125175003983244e-11

The O 0 2.1926212234735232e-10
fathers O 0 6.74533273681277e-09
genotype O 0 7.365902998657248e-09
thus O 0 1.0642368063196184e-11
was O 0 4.909822114845808e-12
7delG O 0 7.260770207295764e-09
/ O 0 4.5288633288009805e-08
A464V O 0 1.5479646009453063e-08
. O 0 1.1317127096566182e-10

Mutation O 0 3.0902734238225094e-07
A464V O 0 7.069008045590408e-09
was O 0 9.538996675884093e-11
not O 0 3.8407506884087506e-13
found O 0 4.2002959812527385e-13
in O 0 3.898506083926945e-12
18 O 0 5.750050088848546e-11
unrelated O 0 2.4975514634206775e-07
MLD B-Disease 1 1.0
patients O 0 6.970747534751354e-08
and O 0 3.728406819392127e-11
50 O 0 9.69198245964753e-12
controls O 0 6.437696242755919e-08
. O 0 1.3171495005792622e-09

A464V O 0 1.0797370464388223e-07
, O 0 1.9841294406075516e-12
although O 0 1.2632043848437302e-12
clearly O 0 2.1556808421641094e-11
modifying O 0 1.4744729048832284e-10
ARSA O 0 1.0062313776870724e-05
and O 0 1.9174824501533294e-06
GS O 1 1.0
levels O 0 0.0017926095752045512
, O 0 1.05297368047097e-12
apparently O 0 2.4714932322922323e-09
bears O 0 7.672892321508584e-10
little O 0 5.2406572191663475e-14
significance O 0 1.0173196920287841e-12
for O 0 9.194740848155088e-15
clinical O 0 2.700642660891095e-12
manifestation O 0 1.1889511597473756e-10
of O 0 9.318950472403387e-11
MLD B-Disease 1 1.0
, O 0 2.20867833571059e-12
mimicking O 0 4.4363210882636395e-09
the O 0 2.0307052480544874e-12
frequent O 0 6.329698720719534e-08
ARSA O 0 0.0001915826869662851
pseudodeficiency O 0 3.965405085182283e-06
allele O 0 2.971524395434244e-07
. O 0 2.849383506919878e-10

Our O 0 1.539081639911899e-09
results O 0 6.037801768971063e-12
demonstrate O 0 4.957698748059292e-13
that O 0 1.274295529969801e-15
in O 0 1.2296972335936124e-15
certain O 0 1.234761126895148e-13
genetic O 0 4.748306636770394e-09
conditions O 0 3.7531498264797847e-07
MLD B-Disease 1 0.9999995231628418
- O 0 1.2517708682935336e-06
like O 0 7.210944064084401e-10
ARSA O 0 6.680963451799471e-06
and O 0 3.1756172802488436e-08
GS O 1 0.9999996423721313
values O 0 2.7507836009021958e-09
need O 0 5.192196499137491e-13
not O 0 1.7818030918445062e-14
be O 0 1.4196825943771341e-15
paralleled O 0 3.122881727518623e-14
by O 0 1.0225230628576124e-13
clinical O 0 5.79792107657795e-08
disease O 0 2.478902842995012e-06
, O 0 9.666638149663509e-15
a O 0 1.9527750998258459e-13
finding O 0 7.899675705247411e-12
with O 0 9.329047950812352e-12
serious O 0 5.8992757345777136e-08
diagnostic O 0 6.31782404170167e-10
and O 0 3.320024810626876e-11
prognostic O 0 3.272759556693927e-07
implications O 0 5.979913453302288e-07
. O 0 1.166713947675646e-09

Moreover O 0 1.596956735738786e-07
, O 0 1.980953161923038e-12
further O 0 1.3743172398716919e-11
ARSA O 0 4.61467971035745e-05
alleles O 0 9.231602149384344e-09
functionally O 0 3.5689412536399345e-10
similar O 0 2.949433449209171e-12
to O 0 3.413702697255272e-13
A464V O 0 9.057312233551329e-09
might O 0 8.854610911157579e-08
exist O 0 4.293549960010523e-10
which O 0 1.2105231097028768e-13
, O 0 2.651384119682187e-16
together O 0 7.772448862904818e-14
with O 0 4.536324007403669e-12
0 O 0 6.217411030462472e-09
- O 0 0.005501504521816969
type O 0 0.28146597743034363
mutations O 0 0.00011820784857263789
, O 0 2.233541476770462e-12
may O 0 2.474190019530198e-10
cause O 0 1.832842350113495e-10
pathological O 0 1.6322786677847034e-07
ARSA O 0 0.04686751216650009
and O 0 3.871582157444209e-05
GS O 1 1.0
levels O 0 3.8410944398492575e-06
, O 0 2.4229536698403345e-14
but O 0 2.7588185642218876e-12
not O 0 4.267468323160273e-12
clinical O 0 1.1085387816023307e-11
outbreak O 0 2.747835015082245e-10
of O 0 1.1228762060791486e-13
the O 0 1.5703138789291415e-10
disease O 0 2.4246585894616146e-07
. O 0 3.304801365292681e-13
. O 0 1.177530989382447e-11

Human O 0 2.7813754059025086e-05
MLH1 O 1 0.9972618818283081
deficiency O 1 0.9969494938850403
predisposes O 0 1.8389622709946707e-05
to O 0 2.9790527822370905e-09
hematological B-Disease 1 0.9983850717544556
malignancy I-Disease 1 0.9998478889465332
and O 0 5.0991108224707204e-08
neurofibromatosis B-Disease 1 0.9969944953918457
type I-Disease 1 0.9733979105949402
1 I-Disease 0 3.396290821910952e-07
. O 0 1.0669003458474435e-09

Heterozygous O 0 9.316684554505628e-06
germ O 0 0.0003547459782566875
- O 0 0.000710110820364207
line O 0 1.6246277212417226e-08
mutations O 0 2.3538573312720246e-09
in O 0 2.2873479301496573e-14
the O 0 4.457698926240046e-15
DNA O 0 2.895237383171434e-10
mismatch O 0 3.516906019740418e-07
repair O 0 2.7373117106321843e-09
genes O 0 7.607853791391506e-10
lead O 0 1.2680536620734983e-09
to O 0 4.2572070313440236e-09
hereditary B-Disease 1 0.999998927116394
nonpolyposis I-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.850533388089389e-06

The O 0 1.1569120661469867e-10
disease O 0 4.2323456739268295e-08
susceptibility O 0 3.0109069371064834e-07
of O 0 1.8203403194527734e-12
individuals O 0 5.065374786283883e-09
who O 0 2.9873791618229006e-07
constitutionally O 0 5.680661843143753e-07
lack O 0 2.722107261821094e-10
both O 0 1.4243308138831012e-12
wild O 0 1.7171080557432106e-08
- O 0 2.2789670765632764e-05
type O 0 1.4872898645990063e-07
alleles O 0 5.5869545101394635e-11
is O 0 1.788595313523267e-11
unknown O 0 2.115775332711678e-09
. O 0 6.621319378202761e-12

We O 0 3.132962334007061e-08
have O 0 1.1600928551125378e-12
identified O 0 1.6804732952402368e-11
three O 0 2.182044963553592e-14
offspring O 0 8.962883386864906e-12
in O 0 1.6013472286472569e-13
a O 0 8.153011599176807e-10
hereditary B-Disease 1 0.9999996423721313
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.011747638694941998
who O 0 2.269775301044774e-08
developed O 0 1.5987746682100124e-09
hematological B-Disease 0 0.16422617435455322
malignancy I-Disease 1 0.7432133555412292
at O 0 6.719800826893163e-10
a O 0 1.0619428513630735e-12
very O 0 5.849995834972255e-12
early O 0 2.7640992272814913e-10
age O 0 7.901317644609662e-08
, O 0 2.528466022980961e-14
and O 0 3.2336522782366872e-12
at O 0 1.8125457731943406e-11
least O 0 2.1453584080673854e-13
two O 0 4.272448416104205e-14
of O 0 4.8008309567332264e-14
them O 0 2.1885505560592655e-11
displayed O 0 6.276863587117987e-06
signs O 0 2.3970873371581547e-05
of O 0 5.416259801771517e-11
neurofibromatosis B-Disease 0 0.042860448360443115
type I-Disease 1 0.6514217257499695
1 I-Disease 0 6.181478795497242e-08
( O 0 8.608221080397271e-11
NF1 B-Disease 0 3.881612542500079e-07
) O 0 3.143366122948521e-11
. O 0 9.429087372003764e-11

DNA O 0 4.0719735916461275e-10
sequence O 0 1.6821665588251378e-11
analysis O 0 4.415648836159081e-12
and O 0 6.113000188510964e-14
allele O 0 7.444890190444475e-12
- O 0 9.240994254533508e-12
specific O 0 2.5792172217431464e-13
amplification O 0 1.0559512986230146e-10
in O 0 2.235075622844529e-12
two O 0 6.698854795525455e-13
siblings O 0 3.463481945686908e-09
revealed O 0 7.305023252968113e-10
a O 0 8.927854983076244e-12
homozygous O 0 3.5253714258942637e-07
MLH1 O 0 0.00017548419418744743
mutation O 0 1.0115793713794119e-07
( O 0 2.488858728486032e-13
C676T O 0 1.0059794108840947e-09
- O 0 1.6055393643910065e-05
- O 0 4.773098680743715e-06
> O 0 3.2784694403709125e-10
Arg226Stop O 0 4.452257229559109e-09
) O 0 7.869758989441367e-13
. O 0 2.2068421309112685e-12

Thus O 0 6.273251362820531e-10
, O 0 5.859046158396969e-14
a O 0 3.7065925957875667e-13
homozygous O 0 1.7221763926045242e-07
germ O 0 0.3543687164783478
- O 0 0.22947415709495544
line O 0 6.799465609219624e-06
MLH1 O 0 0.0002841070236172527
mutation O 0 1.9144663099268655e-07
and O 0 7.39325441145855e-12
consequent O 0 6.896951276758045e-08
mismatch O 0 0.007616033311933279
repair O 0 0.00618624035269022
deficiency O 1 0.9995166063308716
results O 0 3.099321688182499e-08
in O 0 2.70803952179266e-12
a O 0 1.9093100364631077e-11
mutator O 0 1.7302050764556043e-05
phenotype O 0 2.9136165835552674e-07
characterized O 0 8.131207374084681e-10
by O 0 2.7465554136574255e-11
leukemia B-Disease 0 0.005514590535312891
and O 0 1.7054750500733462e-08
/ O 1 0.9999070167541504
or O 1 0.9999886751174927
lymphoma B-Disease 1 1.0
associated O 0 0.0004428219108376652
with O 0 1.4272075743448909e-09
neurofibromatosis B-Disease 0 0.014058629050850868
type I-Disease 0 0.01834370382130146
1 I-Disease 0 2.6617406057027893e-09
. O 0 5.736639028391943e-12
. O 0 3.131266773648278e-11

Missense O 0 0.00013353049871511757
mutations O 0 9.975817374652252e-05
in O 0 3.063781867096438e-11
the O 0 4.1714878486155335e-14
most O 0 3.894204328848492e-15
ancient O 0 1.036675966966695e-13
residues O 0 6.742550962002269e-10
of O 0 1.8453263277238424e-14
the O 0 1.0542431592422061e-13
PAX6 O 0 1.4068594289540215e-08
paired O 0 2.6618812709600093e-10
domain O 0 2.1756150700436017e-11
underlie O 0 8.645523880135286e-11
a O 0 1.8984938404340013e-13
spectrum O 0 3.2375557790231824e-10
of O 0 1.1544118959372351e-11
human O 0 1.016698206512956e-05
congenital B-Disease 1 0.9999861717224121
eye I-Disease 1 0.9999678134918213
malformations I-Disease 1 0.9999374151229858
. O 0 2.505450140688481e-07

Mutations O 0 8.86388590970455e-07
of O 0 7.323986252541492e-13
the O 0 3.963637144194232e-13
human O 0 2.7072455388577055e-11
PAX6 O 0 9.433842933503911e-06
gene O 0 3.5774093703366816e-05
underlie O 1 0.8883159160614014
aniridia B-Disease 1 1.0
( O 0 3.2248823345071287e-07
congenital B-Disease 1 0.9999394416809082
absence I-Disease 0 5.982594188935764e-07
of I-Disease 0 2.989679630163028e-13
the I-Disease 0 2.9243588887256644e-13
iris I-Disease 0 7.632029905835225e-07
) O 0 1.1138097388840862e-11
, O 0 8.939466463082912e-14
a O 0 3.008868328102654e-12
rare O 0 3.066195404244354e-07
dominant O 0 0.2685835361480713
malformation B-Disease 1 0.967279851436615
of I-Disease 0 2.6995436441801246e-10
the I-Disease 0 2.2348447537012817e-09
eye I-Disease 1 0.9933571219444275
. O 0 1.4043901153115712e-08

The O 0 7.180481469831745e-12
spectrum O 0 2.453353353804033e-10
of O 0 1.0043099164802616e-12
PAX6 O 0 1.0621338333294261e-05
mutations O 0 3.098107481491752e-05
in O 0 4.163422051561838e-09
aniridia B-Disease 1 1.0
patients O 0 3.027353443485481e-07
is O 0 2.8407413140557614e-12
highly O 0 1.419116235114315e-12
biased O 0 7.692975596829132e-12
, O 0 1.9617850570484256e-15
with O 0 4.3294900605799446e-16
92 O 0 1.2914978162164702e-14
% O 0 4.0789278150845515e-15
of O 0 1.929515473450289e-14
all O 0 1.1763327811831203e-10
reported O 0 9.078759966030248e-09
mutations O 0 4.123386521115435e-09
leading O 0 2.0508693701626335e-11
to O 0 3.4300193978500926e-13
premature O 0 8.735825431094302e-12
truncation O 0 2.9123706484640577e-12
of O 0 3.036794990821101e-13
the O 0 2.2774510142348214e-12
protein O 0 3.924861824433634e-10
( O 0 2.856633983180923e-12
nonsense O 0 1.833533644912677e-07
, O 0 1.140986308357367e-15
splicing O 0 2.6380812681928156e-13
, O 0 6.243890135795274e-16
insertions O 0 4.376875598066654e-12
and O 0 3.602349470696424e-14
deletions O 0 4.708625850335935e-12
) O 0 6.93554304156789e-14
and O 0 1.5971233667186335e-12
just O 0 1.250546758160831e-12
2 O 0 9.769771187255298e-15
% O 0 1.2847308700008556e-15
leading O 0 5.3018360372542733e-14
to O 0 1.6691489380574577e-15
substitution O 0 8.319889644847062e-14
of O 0 2.89632349577591e-15
one O 0 1.0236606619870928e-13
amino O 0 1.9136676564137506e-14
acid O 0 2.5037413006571974e-14
by O 0 2.325069441312796e-15
another O 0 7.573904611118953e-13
( O 0 5.245080086403731e-13
missense O 0 2.5519723223510482e-08
) O 0 6.7001361056528985e-12
. O 0 8.479629498570063e-11

The O 0 8.286952395998581e-13
extraordinary O 0 1.0975852388420138e-12
conservation O 0 2.838947067880515e-13
of O 0 3.2343749802998117e-15
the O 0 8.201654009805728e-15
PAX6 O 0 5.4180580161267144e-11
protein O 0 2.833823670514435e-13
at O 0 3.275395633970529e-13
the O 0 9.800940305648362e-15
amino O 0 3.4872322043910664e-13
acid O 0 1.0445881356083153e-12
level O 0 4.509288342030571e-12
amongst O 0 1.414850631402051e-13
vertebrates O 0 5.398520172561483e-11
predicts O 0 1.228995238911068e-09
that O 0 3.426259655766456e-13
pathological O 0 1.8632064779922075e-08
missense O 0 6.966201908653602e-06
mutations O 0 0.00020956774824298918
should O 0 3.685439153855441e-08
in O 0 1.9926742547693443e-12
fact O 0 3.030942163917416e-11
be O 0 7.092861454421895e-12
common O 0 1.2487877485561905e-12
even O 0 1.1167096414244071e-10
though O 0 2.716939520586159e-11
they O 0 5.733947604918965e-12
are O 0 2.975434839919827e-13
hardly O 0 1.6417222026277045e-09
ever O 0 4.628325722677573e-09
seen O 0 4.847690249221159e-08
in O 0 1.4735845876856501e-10
aniridia B-Disease 1 1.0
patients O 0 5.009723746951522e-09
. O 0 6.525510687360736e-11

This O 0 1.6224391621855183e-11
indicates O 0 1.3767263717934242e-10
that O 0 3.083704420829038e-14
there O 0 2.363924960185719e-14
is O 0 1.070415694829404e-14
a O 0 1.512901268022407e-13
heavy O 0 7.991575046162325e-08
ascertainment O 0 3.323094688312267e-06
bias O 0 4.334820857820887e-07
in O 0 6.947978976011571e-13
the O 0 1.5707561085967405e-15
selection O 0 7.289834053514788e-15
of O 0 4.284376926990503e-15
patients O 0 1.8035354161722097e-14
for O 0 1.004798868790163e-15
PAX6 O 0 6.220136627987927e-10
mutation O 0 2.449687397376721e-10
analysis O 0 4.7026575342168364e-12
and O 0 1.9680722438027154e-13
that O 0 3.847824362195225e-14
the O 0 5.196763700789087e-13
missing O 0 2.8167807641921172e-08
PAX6 O 0 2.422167017357424e-05
missense O 0 0.0005941507988609374
mutations O 0 0.0002241862384835258
frequently O 0 1.3368776308197994e-07
may O 0 1.2423733153354988e-08
underlie O 0 1.5545246867532114e-07
phenotypes O 0 8.995783673526603e-08
distinct O 0 4.944316067678756e-10
from O 0 2.4428101208506803e-10
textbook O 0 0.0003464330511633307
aniridia B-Disease 1 0.9999997615814209
. O 0 3.174985829801358e-09

Here O 0 3.609526899595039e-08
we O 0 6.20865997502662e-11
present O 0 6.147331992403804e-13
four O 0 6.538283234052908e-14
novel O 0 1.1007011274655198e-11
PAX6 O 0 1.4851157459361275e-07
missense O 0 1.5617555391145288e-06
mutations O 0 3.287419303887873e-06
, O 0 6.457036511378633e-13
two O 0 1.4486847864977198e-13
in O 0 1.993822208029572e-12
association O 0 8.0592433768234e-13
with O 0 9.330253583628156e-13
atypical O 0 3.9097578508062725e-08
phenotypes O 0 8.095527732621122e-07
ectopia B-Disease 0 1.7177752624775167e-06
pupillae I-Disease 0 6.612877768930048e-06
( O 0 4.687239138490007e-11
displaced B-Disease 0 3.5742837578567332e-09
pupils I-Disease 0 1.3274300769694491e-08
) O 0 1.2003011917727235e-09
and O 0 1.8846216676138283e-07
congenital B-Disease 1 0.9989476799964905
nystagmus I-Disease 0 4.059062121086754e-06
( O 0 5.825755242799824e-12
searching B-Disease 0 5.600656605153631e-10
gaze I-Disease 0 6.585702067241073e-06
) O 0 1.931130168969508e-12
, O 0 2.9897536269613e-13
and O 0 1.9830068143100732e-11
two O 0 2.2172973093009807e-12
in O 0 6.245046580560798e-12
association O 0 1.8862569926142436e-14
with O 0 4.512407090237307e-14
more O 0 1.6601564957821613e-12
recognizable O 0 1.504652937001083e-05
aniridia B-Disease 1 0.9999997615814209
phenotypes O 0 0.00011355541209923103
. O 0 5.009119230514614e-10

Strikingly O 0 5.334616730579e-07
, O 0 1.6987846893079528e-11
all O 0 5.615197976732711e-12
four O 0 5.686458790822579e-13
mutations O 0 3.077899046743937e-10
are O 0 3.932797013397882e-14
located O 0 1.4995310223565872e-13
within O 0 1.1292400662558238e-13
the O 0 1.0285887674368541e-13
PAX6 O 0 2.360052153704828e-09
paired O 0 2.67282973531735e-10
domain O 0 1.3195376735719577e-10
and O 0 1.8970443271815185e-11
affect O 0 6.909529198795283e-11
amino O 0 6.163980458863405e-13
acids O 0 2.8078583837361226e-13
which O 0 2.4049052612068293e-14
are O 0 3.1186541860788765e-15
highly O 0 4.021496135230007e-13
conserved O 0 6.412344266681913e-11
in O 0 9.026016045687868e-12
all O 0 1.440432788237661e-13
known O 0 1.8851970494653675e-13
paired O 0 1.2190840004144832e-10
domain O 0 1.682692873927749e-11
proteins O 0 9.701026440489535e-12
. O 0 8.744126950288589e-12

Our O 0 2.220745809466962e-09
results O 0 6.067401355641655e-12
support O 0 4.9080561798997904e-14
the O 0 5.7286481466726005e-15
hypothesis O 0 4.239816776743094e-13
that O 0 4.3308940176900186e-16
the O 0 3.791331648008865e-16
under O 0 1.3976427437265015e-12
- O 0 1.5672805275812607e-09
representation O 0 1.6314763429114976e-10
of O 0 1.5514640353680997e-12
missense O 0 1.192069066746626e-05
mutations O 0 9.340448059447226e-07
is O 0 2.2740650508501492e-12
caused O 0 4.755731832645216e-12
by O 0 1.7319944035833895e-13
ascertainment O 0 2.3197017071652226e-06
bias O 0 2.3449044874723768e-06
and O 0 1.3536583312601103e-11
suggest O 0 2.2415862568903044e-12
that O 0 9.57050033366662e-16
a O 0 1.92705797676042e-15
substantial O 0 1.3791857413070208e-11
burden O 0 1.2046607480442617e-05
of O 0 6.5470246411736266e-12
PAX6 B-Disease 0 0.03218432143330574
- I-Disease 1 0.9998049139976501
related I-Disease 0 0.02045498788356781
disease I-Disease 0 0.027836009860038757
remains O 0 1.909927549448298e-09
to O 0 1.8991058725603693e-13
be O 0 1.8207987201313003e-12
uncovered O 0 1.7515018324587572e-09
. O 0 3.221303432332512e-12
. O 0 7.492355694194153e-12

The O 0 3.994947168212137e-12
chromosomal O 0 1.9047395483084983e-07
order O 0 2.6420922741299258e-11
of O 0 1.5517947170307078e-13
genes O 0 7.21670945225128e-10
controlling O 0 1.0071033784697647e-07
the O 0 8.691615135947295e-12
major O 0 8.721112026988109e-11
histocompatibility O 0 1.0147985562980466e-08
complex O 0 9.605582995675377e-11
, O 0 1.5295783641956252e-14
properdin O 0 7.579726291062627e-10
factor O 0 2.3371529156435145e-09
B O 0 3.854179340123665e-06
, O 0 1.0019904421150819e-13
and O 0 2.2968395241296236e-10
deficiency B-Disease 0 6.7635910454555415e-06
of I-Disease 0 2.1232608770141437e-14
the I-Disease 0 5.821453887520922e-13
second I-Disease 0 5.288085941357323e-12
component I-Disease 0 1.4668816508689453e-11
of I-Disease 0 9.431267344785915e-14
complement I-Disease 0 9.331223987940618e-11
. O 0 5.5503743962015406e-11

The O 0 3.9662179790456165e-12
relationship O 0 2.489308759123787e-10
of O 0 1.399673918569622e-14
the O 0 5.132698634874051e-15
genes O 0 6.952005296304367e-14
coding O 0 1.0988309735856724e-13
for O 0 4.416246086713486e-16
HLA O 0 2.3846502029967187e-12
to O 0 8.380406760796592e-15
those O 0 4.843698616567409e-15
coding O 0 1.068900352886766e-13
for O 0 1.1901641942420045e-15
properdin O 0 3.3318639514057224e-10
Factor O 0 1.7726702050691046e-11
B O 0 3.9808412122255277e-10
allotypes O 0 1.2474654642602445e-10
and O 0 4.380013604414479e-13
for O 0 1.4950300925627852e-13
deficiency B-Disease 0 1.3493365713657113e-07
of I-Disease 0 1.9476919111137718e-15
the I-Disease 0 5.958865941912278e-14
second I-Disease 0 7.113070982917025e-13
component I-Disease 0 3.684489779248734e-12
of I-Disease 0 1.0942167277241868e-14
complement I-Disease 0 8.435746892687668e-12
( O 0 1.157510773428655e-13
C2 O 0 2.1146485951195615e-10
) O 0 1.9253971569090913e-15
was O 0 2.280625167883077e-11
studied O 0 5.511926026713354e-09
in O 0 7.879987894837681e-13
families O 0 9.592038263932928e-14
of O 0 1.955578033492264e-13
patients O 0 5.858317303486515e-11
with O 0 1.5361899530219603e-09
connective O 1 0.9982728958129883
tissue O 1 0.999988317489624
disorders O 1 0.9998887777328491
. O 0 7.112434641243226e-09

Patients O 0 2.2028227419923496e-07
were O 0 1.1527835977465095e-11
selected O 0 8.153065896021605e-12
because O 0 3.418456143156057e-11
they O 0 1.968850429912017e-12
were O 0 2.1559829117313856e-13
heterozygous O 0 1.878139484212671e-11
or O 0 2.280472859161886e-11
homozygous O 0 2.517658401757217e-07
for O 0 1.735270984681847e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.2267773463747744e-09

12 O 0 4.697106259499151e-09
families O 0 1.7428822274290212e-11
with O 0 2.947238807171626e-13
15 O 0 3.101692947621304e-12
matings O 0 6.833157328856032e-08
informative O 0 3.1105262223718455e-06
for O 0 0.010371306911110878
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 2.7199080765427652e-09
found O 0 1.8619399078101395e-10
. O 0 1.0325216376338986e-10

Of O 0 6.274768205027925e-11
57 O 0 2.7086607262694073e-11
informative O 0 1.5250718743420322e-10
meioses O 0 2.7642897748592077e-07
, O 0 6.2402062412769e-14
two O 0 5.766268373871071e-16
crossovers O 0 3.2206891233815815e-12
were O 0 2.039096539188656e-12
noted O 0 1.1698976509766368e-10
between O 0 9.234198822261064e-11
the O 0 3.6589958654076327e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.999998927116394
gene O 0 6.546603537049833e-11
and O 0 3.9894931976036663e-13
the O 0 2.5147971134979394e-14
HLA O 0 1.1125692367386364e-08
- O 0 5.150539436726831e-06
B O 0 6.0183800165702905e-09
gene O 0 6.808348156084332e-12
, O 0 3.7523538387541824e-16
with O 0 1.758041366572432e-17
a O 0 1.6535703080915566e-16
recombinant O 0 5.014908962679447e-15
fraction O 0 9.243175886144983e-13
of O 0 9.24841366684026e-13
0 O 0 5.442317152493104e-10
. O 0 2.728468492807501e-11

035 O 0 0.004687416832894087
. O 0 5.538063518883973e-08

A O 0 9.907044073997895e-10
lod O 0 6.99986849213019e-05
score O 0 2.2824118151021366e-09
of O 0 2.997397862141045e-14
13 O 0 8.306585806564307e-14
was O 0 9.121643598872936e-14
calculated O 0 8.159070641333699e-12
for O 0 1.386579551534723e-14
linkage O 0 4.503775926423259e-06
between O 0 0.0023675851989537477
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.035471621640971e-11
HLA O 0 1.1725074244850475e-09
- O 0 2.0904454345327395e-07
B O 0 2.594988002257992e-09
at O 0 4.1587765945826777e-14
a O 0 1.5796675304765662e-15
maximum O 0 4.394118939153244e-14
likelihood O 0 4.8858642554949067e-14
value O 0 7.346903575962405e-13
of O 0 3.513744789861544e-17
the O 0 2.842468532184551e-17
recombinant O 0 5.684259702709094e-16
fraction O 0 9.737814667034467e-14
of O 0 2.1799493362794492e-13
0 O 0 9.343280316098657e-11
. O 0 2.556713694923385e-11

04 O 0 0.00011108301987405866
. O 0 6.834262933352875e-09

18 O 0 1.500533954867933e-07
families O 0 3.428623357448757e-11
with O 0 4.2761519152001437e-13
21 O 0 1.2312973991096543e-12
informative O 0 1.2016531433095556e-12
matings O 0 6.191668844302001e-10
for O 0 8.225470543403446e-14
both O 0 7.631269748065161e-13
properdin O 0 2.452383398576785e-07
Factor O 0 1.0335546862805245e-09
B O 0 6.527459017746651e-09
allotype O 0 1.937257243511681e-09
and O 0 1.0534502957459946e-11
HLA O 0 6.658614104537719e-09
- O 0 1.0999065125361085e-05
B O 0 3.1944591682986356e-07
were O 0 2.8767940720569873e-12
found O 0 1.1003673666687419e-11
. O 0 2.8858301165390898e-11

Of O 0 8.589703948125305e-11
72 O 0 6.197112267791738e-11
informative O 0 8.347751656589963e-11
meioses O 0 2.710893340918119e-07
, O 0 8.77951791128373e-13
three O 0 9.225171353818146e-14
recombinants O 0 1.6806417590942146e-07
were O 0 2.2788262943329585e-10
found O 0 7.894931236540614e-12
, O 0 2.1945486521627233e-15
giving O 0 1.6728013441260183e-15
a O 0 2.2608696378668405e-16
recombinant O 0 1.884673718629236e-15
fraction O 0 4.662375628801396e-13
of O 0 5.032391062025077e-13
0 O 0 3.969551909399627e-10
. O 0 3.457854835797747e-11

042 O 0 4.252522558090277e-05
. O 0 1.3148859778766564e-08

A O 0 5.727941454480856e-10
lod O 0 1.090953537641326e-05
score O 0 1.0243150772026866e-09
of O 0 3.027176491247896e-14
16 O 0 2.769931636489864e-13
between O 0 9.884223295527836e-14
HLA O 0 7.522953815453093e-09
- O 0 2.7421177946962416e-05
B O 0 4.1732195654731186e-07
and O 0 1.1738678605544006e-13
Factor O 0 1.7473715616805885e-12
B O 0 1.609929897727902e-11
allotypes O 0 8.68346367033368e-12
was O 0 1.0620785934750687e-12
calculated O 0 5.031991316684081e-12
at O 0 4.0844575849774065e-14
a O 0 5.151411710261266e-15
maximum O 0 1.5782775748211103e-13
likelihood O 0 1.3605058106578444e-13
value O 0 3.4929056175192486e-12
of O 0 5.932535382763374e-17
the O 0 4.651742488048312e-17
recombinant O 0 4.987947798089224e-16
fraction O 0 1.6625195415221478e-13
of O 0 2.881789858827366e-13
0 O 0 9.070978690406406e-11
. O 0 1.778183156275759e-11

04 O 0 7.888073741924018e-05
. O 0 6.029065247048493e-09

A O 0 2.0603260417195735e-11
crossover O 0 6.187286100134415e-11
was O 0 4.0049970284616876e-11
shown O 0 4.970580544383374e-11
to O 0 1.1480545247105622e-12
have O 0 2.304429737309821e-11
occurred O 0 7.22377088702153e-11
between O 0 9.048392189594384e-15
genes O 0 7.312591965335027e-14
for O 0 1.6861912409562143e-15
Factor O 0 1.6513682782326455e-11
B O 0 3.2837903507498822e-09
and O 0 7.679410492927863e-13
HLA O 0 1.1219472018098031e-09
- O 0 3.86625089277004e-07
D O 0 1.946059455804061e-06
, O 0 1.0050471468524974e-13
in O 0 1.8445812097808018e-13
which O 0 5.822153197922175e-13
HLA O 0 5.3088822227209675e-09
- O 0 5.0014676844512e-07
D O 0 7.738582041838526e-08
segregared O 0 6.395226570532486e-09
with O 0 2.0773113047420355e-13
HLA O 0 8.778426319189236e-10
- O 0 2.6903862249127997e-08
A O 0 1.588097015003953e-10
and O 0 3.5490244076896715e-10
B O 0 7.504580956663176e-09
. O 0 1.7447905099887695e-12

These O 0 4.363205977075957e-12
studies O 0 2.53647710474203e-12
suggest O 0 1.3808116976210538e-12
that O 0 2.1230968173201724e-16
the O 0 5.0236925222889065e-17
genes O 0 2.5452160571612674e-15
for O 0 6.329263115944627e-16
Factor O 0 7.3683619206121875e-09
B O 1 0.9981611371040344
and O 1 0.9958672523498535
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.665653075536011e-12
located O 0 1.753323235296339e-13
outside O 0 1.8018603969993663e-11
those O 0 3.003614609635441e-13
for O 0 2.2212644948355975e-15
HLA O 0 1.0139765763139685e-11
, O 0 9.605728010426452e-15
that O 0 1.2869290052022753e-14
the O 0 2.2927894392094084e-15
order O 0 2.6080715346166357e-14
of O 0 1.1313473910549684e-15
genese O 0 1.0118216264842772e-09
is O 0 1.8006224766428658e-12
HLA O 0 4.835495892585584e-10
- O 0 7.195329487785784e-08
A O 0 9.539474765674072e-10
, O 0 2.7604817303544804e-12
- O 0 7.848954055589275e-07
B O 0 1.5682740439615372e-08
, O 0 3.495361416755091e-14
- O 0 1.6469724473111569e-09
D O 0 6.648585570978582e-10
, O 0 3.714727788204199e-15
Factor O 0 1.9941350654084644e-11
B O 0 8.731877443324265e-08
allotype O 0 2.037491685769055e-05
, O 0 1.144548491538444e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 1.647200916789736e-14
that O 0 5.328960615675845e-16
the O 0 6.026812532072942e-16
genes O 0 5.686328686561881e-13
coding O 0 1.7204961066941138e-10
for O 0 1.5375162831787748e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.0570169179112696e-10
Factor O 0 1.3079367588986202e-09
B O 0 6.591141499256992e-08
allotypes O 0 1.614510414249537e-09
are O 0 3.8776357884177937e-13
approximately O 0 5.071645685882087e-14
3 O 0 2.1321750788561022e-12
- O 0 1.2676147775891877e-07
- O 0 2.3841867147211815e-08
5 O 0 9.084712962372649e-14
centimorgans O 0 3.784376631510433e-11
from O 0 2.2544688216426766e-14
the O 0 8.814543333516417e-15
HLA O 0 1.020258270229002e-11
- O 0 2.8913949359776758e-11
A O 0 1.1745022272455219e-12
and O 0 1.5987387195354197e-12
HLA O 0 3.6553463034216804e-10
- O 0 2.6804086061815724e-08
B O 0 2.0469261702293906e-11
loci O 0 1.2859229841708213e-14
, O 0 1.0061451217807053e-15
and O 0 1.397315312976345e-15
that O 0 1.5690673366581523e-15
the O 0 1.8664864389440284e-15
apparent O 0 4.958725097203853e-11
lack O 0 8.221996000701282e-12
of O 0 1.2222612372287853e-15
recombinants O 0 3.915291424405609e-10
between O 0 4.203740152741546e-14
the O 0 4.210938238727313e-14
Factor O 0 3.5130198750010777e-10
B O 0 9.866094075050569e-08
gene O 0 7.088992788339965e-07
and O 0 0.1598384827375412
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
gene O 0 1.535551130693591e-09
suggests O 0 1.052504819409883e-10
that O 0 4.877837771286725e-14
these O 0 1.5827203642734128e-14
two O 0 1.7983280270190798e-14
genes O 0 5.3239350428224697e-11
lie O 0 5.395326070356532e-07
in O 0 3.1248276535777997e-12
close O 0 1.7078170821971383e-10
proximity O 0 1.9216744862049495e-10
to O 0 2.1317227982819986e-09
one O 0 4.05856681595651e-10
another O 0 3.8989711459436194e-10
. O 0 3.665015513298897e-10

Distribution O 0 2.6843643627372238e-11
of O 0 5.351029949002273e-13
emerin O 0 7.835992619220633e-07
and O 0 1.1375863445683976e-10
lamins O 0 8.006935968296602e-05
in O 0 4.707487871735694e-11
the O 0 5.871010275160238e-12
heart O 0 2.708363977532713e-09
and O 0 4.856710736703129e-13
implications O 0 4.790107113045172e-12
for O 0 2.5926428972450344e-13
Emery B-Disease 0 1.2606408290594118e-06
- I-Disease 1 0.99997878074646
Dreifuss I-Disease 1 0.9982494115829468
muscular I-Disease 0 0.16384918987751007
dystrophy I-Disease 0 0.013464100658893585
. O 0 5.301525884959801e-09

Emerin O 0 3.413312697375659e-06
is O 0 5.366775773785193e-11
a O 0 2.530378901202668e-12
nuclear O 0 5.291103732929514e-08
membrane O 0 1.0024583940726473e-10
protein O 0 6.857756116446234e-12
which O 0 2.831934122968227e-12
is O 0 2.1529401525444136e-11
missing O 0 3.3291087664366614e-09
or O 0 7.322767947570696e-10
defective O 0 3.173122919974958e-08
in O 0 7.703580134910126e-11
Emery B-Disease 0 0.0001242304570041597
- I-Disease 1 0.9999992847442627
Dreifuss I-Disease 1 0.9999743700027466
muscular I-Disease 1 0.9959977865219116
dystrophy I-Disease 1 0.8254696130752563
( O 0 1.2101289748045474e-08
EDMD B-Disease 1 0.9999998807907104
) O 0 4.518126150987456e-10
. O 0 1.4278875304363225e-10

It O 0 1.3265631648717857e-10
is O 0 2.0975859937877317e-12
one O 0 6.758451491593181e-14
member O 0 1.5811882510784192e-13
of O 0 1.0987801177275193e-14
a O 0 2.1745185947025236e-12
family O 0 1.0302677599938193e-09
of O 0 3.098501663578723e-11
lamina O 0 0.2881336510181427
- O 0 0.2872985601425171
associated O 0 1.6944936476193107e-07
proteins O 0 8.81828984833355e-12
which O 0 2.8299765485119595e-14
includes O 0 1.819994790996666e-14
LAP1 O 0 3.183535879358601e-09
, O 0 4.7786949365028614e-14
LAP2 O 0 1.738184778332652e-07
and O 0 1.2681110328482958e-10
lamin O 0 1.9920296836062334e-05
B O 0 3.566179657354951e-06
receptor O 0 5.115002865707652e-10
( O 0 3.397784484326927e-11
LBR O 0 0.07270526885986328
) O 0 8.687604455270836e-12
. O 0 2.8967659868039952e-11

A O 0 2.902890150480175e-10
panel O 0 7.035457216808538e-10
of O 0 1.426647428665051e-12
16 O 0 3.958101207901521e-12
monoclonal O 0 4.9675097368862e-11
antibodies O 0 9.91763116076072e-10
( O 0 4.349441678130547e-14
mAbs O 0 3.023026620696534e-11
) O 0 2.5140391884167362e-14
has O 0 7.906585678058367e-14
been O 0 6.838274521289711e-14
mapped O 0 1.296174417797502e-10
to O 0 1.825951770426798e-13
six O 0 2.1796645892135707e-15
specific O 0 1.2826888853232623e-15
sites O 0 7.061927811188168e-14
throughout O 0 3.64893018415819e-14
the O 0 1.2420782718319812e-14
emerin O 0 1.222674739231877e-10
molecule O 0 1.2249511301132276e-13
using O 0 4.4003613686866005e-13
phage O 0 1.14663600836451e-09
- O 0 1.8853528516160623e-08
displayed O 0 1.4650201884958136e-10
peptide O 0 2.4450172789181046e-12
libraries O 0 2.7801352664230325e-14
and O 0 1.560038854825016e-13
has O 0 5.1598909335797555e-14
been O 0 8.373823620730532e-15
used O 0 4.1987396090341356e-14
to O 0 4.3111019176192075e-14
localize O 0 6.427384735552266e-10
emerin O 0 1.5320962120313197e-05
in O 0 1.6678038117223792e-10
human O 0 1.8053081252134007e-10
and O 0 1.0656368149009054e-10
rabbit O 0 0.00019716228416655213
heart O 0 1.4227313840819988e-05
. O 0 1.2328573717468316e-09

Several O 0 4.590742282845062e-12
mAbs O 0 3.2909008851333965e-09
against O 0 2.0599607089555327e-11
different O 0 2.286075788306835e-13
emerin O 0 1.0152554352771404e-08
epitopes O 0 1.1872962346615168e-07
did O 0 2.1053088161693267e-09
not O 0 4.151458257023455e-12
recognize O 0 8.462439082812523e-11
intercalated O 0 1.1659280485520895e-10
discs O 0 4.111041729260023e-09
in O 0 6.157218485070004e-11
the O 0 3.672921342068314e-11
heart O 0 8.135683060572774e-08
, O 0 1.1595481248360268e-13
though O 0 6.287368195523335e-12
they O 0 5.467448976198552e-12
recognized O 0 6.916464623252239e-11
cardiomyocyte O 0 4.528928627678397e-07
nuclei O 0 2.2983625669326102e-08
strongly O 0 1.7544508068567666e-09
, O 0 3.4933817313507684e-14
both O 0 8.868325859908918e-14
at O 0 1.0184113101441294e-11
the O 0 5.085790729525419e-13
rim O 0 7.540705837527639e-10
and O 0 1.4314358587341758e-09
in O 0 2.0390432398098568e-11
intranuclear O 0 1.5533777286691475e-07
spots O 0 2.4873559212323926e-08
or O 0 5.103542588535959e-10
channels O 0 3.6139473635898867e-09
. O 0 1.3171344015461273e-09

A O 0 1.4807076675893427e-09
polyclonal O 0 6.10625363606232e-07
rabbit O 0 1.4308488971437328e-07
antiserum O 0 1.4710759899116965e-07
against O 0 3.2545943717821046e-10
emerin O 0 1.348949325574722e-07
did O 0 8.156371134049323e-10
recognize O 0 5.295155980356014e-10
both O 0 2.859659557763461e-12
nuclear O 0 4.803960251820172e-08
membrane O 0 2.0662853372765966e-10
and O 0 2.5532327987964898e-12
intercalated O 0 5.395494120929989e-11
discs O 0 2.484100980471027e-10
but O 0 2.4140440080949732e-12
, O 0 5.917865830908114e-17
after O 0 1.338193075002485e-16
affinity O 0 1.7285635347470186e-15
purification O 0 5.974830225979064e-15
against O 0 6.778788684894121e-13
a O 0 2.391330948363357e-13
pure O 0 2.086236600140623e-10
- O 0 1.1070212622144027e-06
emerin O 0 5.4537014904099124e-08
band O 0 3.8699848881051935e-11
on O 0 1.8703166185934927e-12
a O 0 1.1462487588872333e-13
western O 0 4.862812409689443e-12
blot O 0 1.1404176092355556e-07
, O 0 1.5605575642493874e-12
it O 0 7.143118019824202e-13
stained O 0 4.484090609935265e-08
only O 0 2.4746970965494608e-12
the O 0 3.7964030248464897e-13
nuclear O 0 2.834034660281759e-07
membrane O 0 1.478342032124047e-10
. O 0 2.91713111999492e-11

These O 0 1.1638877361885847e-11
results O 0 2.2674742292116967e-11
would O 0 4.484147699424651e-13
not O 0 4.9689619145655214e-14
be O 0 5.069575876172176e-14
expected O 0 1.4075462800508531e-12
if O 0 1.506285439260846e-12
immunostaining O 0 1.753343581434308e-09
at O 0 1.860549908583309e-12
intercalated O 0 2.0161410735353158e-11
discs O 0 3.402756076908986e-09
were O 0 7.566783311041547e-10
due O 0 1.4859240227149684e-10
to O 0 2.088355259121516e-13
a O 0 2.817896740600623e-13
product O 0 7.442789440315067e-12
of O 0 2.184475736353975e-15
the O 0 4.055038097840191e-14
emerin O 0 2.2552786305141126e-09
gene O 0 2.0867538252922202e-10
and O 0 1.408766991950472e-10
, O 0 2.7947027084565014e-14
therefore O 0 2.551606712378196e-12
, O 0 7.948735053953278e-16
cast O 0 4.7294264858555035e-12
some O 0 1.3148702504399423e-13
doubt O 0 3.8268978264088815e-11
upon O 0 6.066376784588656e-14
the O 0 6.159085302995292e-15
hypothesis O 0 6.261745028740551e-12
that O 0 1.3212294106001998e-11
cardiac B-Disease 0 8.353050020559749e-07
defects I-Disease 1 0.9903590083122253
in O 0 3.7363573568427455e-08
EDMD B-Disease 1 1.0
are O 0 1.7960680054329714e-07
caused O 0 4.87227103107557e-09
by O 0 3.0284093375382293e-12
absence O 0 1.117750692003483e-08
of O 0 1.0484124419313234e-12
emerin O 0 1.719125634735974e-06
from O 0 3.9862110140509444e-11
intercalated O 0 6.073607750067822e-08
discs O 0 1.228539332487344e-07
. O 0 4.2947456702080444e-10

Although O 0 6.60562993193281e-11
emerin O 0 4.434222766747098e-09
was O 0 1.973256627540998e-12
abundant O 0 6.855777881162317e-13
in O 0 4.754513839924646e-13
the O 0 5.170306999376095e-13
membranes O 0 7.381134370376685e-09
of O 0 1.8532883019027613e-13
cardiomyocyte O 0 4.271524574051e-07
nuclei O 0 1.4936201608861666e-08
, O 0 9.491378223733943e-14
it O 0 4.1475620138863023e-13
was O 0 2.6665497934730276e-11
absent O 0 2.635510143456088e-10
from O 0 4.728017565132359e-13
many O 0 2.9610209141377186e-13
non O 0 5.264396918391867e-08
- O 0 3.1552741575069376e-07
myocyte O 0 2.0275821910331615e-08
cells O 0 4.3348244438412564e-10
in O 0 4.787403112826993e-12
the O 0 2.082826966454121e-12
heart O 0 6.9380079459335775e-09
. O 0 4.20608825546509e-11

This O 0 1.3436582575743206e-13
distribution O 0 3.6703177660763614e-14
of O 0 1.0275490514347584e-14
emerin O 0 9.657622257464027e-08
was O 0 1.8266024803814673e-10
similar O 0 2.335442386355857e-12
to O 0 6.014535115610176e-13
that O 0 1.915250727110851e-12
of O 0 1.4569305505952868e-14
lamin O 0 2.818049082975449e-08
A O 0 2.049057146180644e-09
, O 0 2.3907459196473475e-14
a O 0 1.1564861854349972e-14
candidate O 0 4.052422980516113e-11
gene O 0 5.4911513704125614e-12
for O 0 1.45474232567935e-14
an O 0 2.9656205740918526e-14
autosomal O 0 2.6596806492307223e-05
form O 0 1.8785308384394739e-06
of O 0 1.1866634253010488e-07
EDMD B-Disease 1 1.0
. O 0 1.4675042336875777e-07

In O 0 2.8246974204115816e-10
contrast O 0 7.587598993552547e-09
, O 0 6.421643165138713e-12
lamin O 0 8.695645192347001e-06
B1 O 0 0.022886203601956367
was O 0 3.1283744483801e-09
absent O 0 4.991639546148008e-09
from O 0 9.3150140378917e-13
cardiomyocyte O 0 5.253233439361793e-07
nuclei O 0 5.6001816517436964e-08
, O 0 8.654435810573693e-14
showing O 0 2.567664481034626e-08
that O 0 5.7214743359734754e-11
lamin O 0 1.4293106687546242e-05
B1 O 0 0.002129007363691926
is O 0 8.398550084554035e-12
not O 0 1.0513656189137938e-13
essential O 0 7.976866712197488e-15
for O 0 2.0250387246922982e-16
localization O 0 3.0158761230546227e-13
of O 0 6.368643795244848e-16
emerin O 0 1.8192738426847654e-09
to O 0 7.669153506695281e-12
the O 0 1.321797116204948e-10
nuclear O 0 0.00021999070304445922
lamina O 0 1.6142591903189896e-06
. O 0 2.4876664617146105e-10

Lamin O 0 0.03967064991593361
B1 O 1 0.9917463064193726
is O 0 4.67480720800495e-09
also O 0 5.930833602008079e-11
almost O 0 3.969534770331684e-11
completely O 0 9.582297622046099e-09
absent O 0 1.042158714881225e-07
from O 0 1.0207416162311134e-10
skeletal O 0 0.016956306993961334
muscle O 0 8.668717055115849e-05
nuclei O 0 0.0001287486811634153
. O 0 9.349774288125445e-10

In O 0 2.7451754203156042e-09
EDMD B-Disease 1 0.9999994039535522
, O 0 1.6603740409480705e-13
the O 0 8.743408659573054e-16
additional O 0 8.921275583507679e-14
absence O 0 1.347560691505878e-11
of O 0 3.990817279506814e-13
lamin O 0 0.00010271292558172718
B1 O 0 0.00572953512892127
from O 0 4.742674031277261e-10
heart O 0 5.400201916927472e-05
and O 0 2.343081284550408e-08
skeletal O 1 0.8522723317146301
muscle O 0 0.060324300080537796
nuclei O 0 0.0013036055024713278
which O 0 3.096159106874552e-09
already O 0 1.5994456870060958e-09
lack O 0 2.3298644263869406e-11
emerin O 0 5.6252751789998e-08
may O 0 1.1736660254779707e-10
offer O 0 1.2541858454833289e-14
an O 0 5.270772694747476e-17
alternative O 0 2.4533203092191695e-14
explanation O 0 1.266234187814741e-12
of O 0 7.802734695340485e-14
why O 0 1.917261194250841e-08
these O 0 6.0116477768046295e-12
tissues O 0 5.550567783174642e-10
are O 0 4.581118470681211e-13
particularly O 0 4.131380307303978e-11
affected O 0 3.9292416542657804e-11
. O 0 1.3335025358246488e-12
. O 0 2.0556941565663678e-11

Genetic O 0 2.1807659678074742e-08
mapping O 0 2.4549413613073057e-09
of O 0 2.8534158542925514e-12
the O 0 2.0876207013076353e-11
copper B-Disease 0 9.226966358255595e-05
toxicosis I-Disease 0 0.004300272092223167
locus O 0 9.177671955740152e-08
in O 0 4.7140829434466625e-11
Bedlington O 0 3.73634989614402e-08
terriers O 0 1.4783471158352768e-07
to O 0 8.78801632159254e-12
dog O 0 8.53186350013857e-07
chromosome O 0 1.2197828027638025e-06
10 O 0 6.639150167131458e-12
, O 0 3.626240797303384e-15
in O 0 4.7337534012006216e-14
a O 0 5.751264482017904e-12
region O 0 1.6043932404841144e-08
syntenic O 0 0.00011240257299505174
to O 0 1.7919425665535726e-10
human O 0 1.3967252909807826e-09
chromosome O 0 3.388044547136815e-07
region O 0 2.1457895016396833e-08
2p13 O 0 2.7803832836070796e-07
- O 0 2.2290532797342166e-06
p16 O 0 1.633346258245183e-08
. O 0 4.708655340635026e-11

Abnormal O 1 0.6265415549278259
hepatic B-Disease 0 0.21842554211616516
copper I-Disease 0 0.0017979283584281802
accumulation I-Disease 0 1.8606284356792457e-05
is O 0 2.8870083407239733e-11
recognized O 0 5.197542049528714e-11
as O 0 1.2010076093360578e-11
an O 0 2.9613673291351006e-08
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 2.741138132478227e-06
man O 0 4.385539341456024e-06
, O 0 3.32366919359936e-14
mouse O 0 8.739696466530944e-11
, O 0 2.475899802019399e-13
rat O 0 8.275394236534339e-08
and O 0 1.4947529325404219e-10
dog O 0 5.886209237360163e-06
. O 0 7.781498223558003e-10

The O 0 6.05122115610035e-12
major O 0 1.6379736109128906e-11
cause O 0 9.397851385983813e-10
of O 0 2.4682623566557593e-12
hepatic B-Disease 0 0.00013696515816263855
copper I-Disease 1 0.7934340834617615
accumulation I-Disease 0 0.11497078090906143
in O 0 9.432587155799865e-09
man O 0 1.8969489246956073e-05
is O 0 5.501425270199034e-12
a O 0 1.5285474708887081e-12
dysfunctional O 0 1.3485937699897477e-08
ATP7B O 0 1.5446737222646334e-07
gene O 0 3.695293671057698e-08
, O 0 1.7852483380487172e-11
causing O 0 5.042338813154856e-08
Wilson B-Disease 0 0.004619187209755182
disease I-Disease 0 5.2278130169725046e-05
( O 0 7.663407235181108e-12
WD B-Disease 0 0.003985690884292126
) O 0 2.5939675407649077e-10
. O 0 2.797246601016212e-10

Mutations O 0 3.541705382303917e-06
in O 0 2.8850486236131623e-11
the O 0 6.123529417909057e-13
ATP7B O 0 1.480987407376233e-06
genes O 0 8.818870633753306e-10
have O 0 8.58370579476242e-12
also O 0 9.914626628373946e-13
been O 0 7.26156287877977e-12
demonstrated O 0 2.107279281626795e-11
in O 0 1.2909467874029634e-13
mouse O 0 9.108361842535828e-10
and O 0 1.5631210215083513e-10
rat O 0 3.082542889387696e-06
. O 0 2.0882907902919357e-10

The O 0 9.10411503129982e-12
ATP7B O 0 1.7563735354997334e-08
gene O 0 1.4513039658936577e-09
has O 0 1.5468909139726428e-11
been O 0 4.005046619869057e-13
excluded O 0 1.7146803074630235e-11
in O 0 2.4955742089797714e-14
the O 0 1.444715382583814e-15
much O 0 3.3092799334166756e-13
rarer O 0 5.203518504970361e-09
human O 0 1.729677068240676e-09
copper B-Disease 0 0.0001522324891993776
overload I-Disease 0 0.00044747450738213956
disease O 0 0.0006388945039361715
non B-Disease 0 8.519443326804321e-06
- I-Disease 1 0.5983378291130066
Indian I-Disease 0 1.6759178933511976e-08
childhood I-Disease 0 0.007402772083878517
cirrhosis I-Disease 0 8.339359283127123e-07
, O 0 1.6600914029942307e-14
indicating O 0 7.403512698733739e-12
genetic O 0 6.742962854744405e-10
heterogeneity O 0 1.5985406776053424e-08
. O 0 6.341728808756386e-10

By O 0 9.15832730832844e-13
investigating O 0 1.964028939482887e-10
the O 0 2.1291109066762237e-12
common O 0 8.083548830306597e-10
autosomal O 0 0.00792803056538105
recessive O 0 0.05076509714126587
copper B-Disease 0 0.018000945448875427
toxicosis I-Disease 0 0.23423916101455688
( O 0 1.6727345203415567e-11
CT B-Disease 0 2.2469504983746447e-05
) O 0 2.6061758653939116e-11
in O 0 3.638801066019326e-12
Bedlington O 0 5.512654155381824e-08
terriers O 0 2.665766487552901e-06
, O 0 1.8340655383308757e-11
we O 0 4.941258860413633e-11
have O 0 2.1844852654746318e-14
identified O 0 2.146017467462985e-13
a O 0 4.859207789831635e-15
new O 0 8.93915543258468e-15
locus O 0 5.749126001652893e-12
involved O 0 6.306001831823949e-10
in O 0 3.001262527391191e-08
progressive O 1 0.9999381303787231
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.171198675820051e-07

We O 0 6.924110729222832e-10
examined O 0 7.749028502201938e-11
whether O 0 1.7846583585945375e-12
the O 0 7.106205950286118e-14
WD B-Disease 0 1.8431830540066585e-05
gene O 0 1.3410340615749305e-09
ATP7B O 0 9.836074923441629e-07
was O 0 8.142093770036052e-12
also O 0 2.619146998621754e-15
causative O 0 1.1550903462886897e-11
for O 0 5.598097923127611e-16
CT B-Disease 0 1.562842477653703e-08
by O 0 1.0422078781588406e-12
investigating O 0 1.6812325753789992e-08
the O 0 1.2152644342233732e-11
chromosomal O 0 2.3146472813095897e-05
co O 0 3.915373326890403e-06
- O 0 3.924446545511273e-08
localization O 0 4.0286959879232143e-10
of O 0 9.561127490588777e-15
ATP7B O 0 3.413403559804351e-09
and O 0 3.081764037753468e-14
C04107 O 0 6.909680076369606e-13
, O 0 7.6656825833649e-17
using O 0 3.562906026254812e-15
fluorescence O 0 1.0537341138538991e-10
in O 0 1.1776151343130536e-13
situ O 0 2.3667123816295543e-11
hybridization O 0 3.021958551452375e-12
( O 0 1.5830651405642632e-13
FISH O 0 1.1653367160135986e-10
) O 0 1.6159157345541075e-12
. O 0 5.625467539710494e-12

C04107 O 0 1.4496068843072862e-06
is O 0 7.969005316743605e-11
an O 0 6.576200748640041e-15
anonymous O 0 1.797079152154879e-11
microsatellite O 0 1.4120078617452236e-07
marker O 0 1.8843790883238398e-07
closely O 0 9.36143162988401e-09
linked O 0 4.144251164461821e-08
to O 0 7.146038101535357e-12
CT B-Disease 0 0.0033836800139397383
. O 0 2.9232161136150125e-09

However O 0 1.3393347764178998e-08
, O 0 5.609181955718023e-12
BAC O 0 3.744918686265919e-08
clones O 0 6.234363025825473e-11
containing O 0 7.74060503194729e-12
ATP7B O 0 4.0340363938184964e-08
and O 0 8.352261888838405e-14
C04107 O 0 9.48784020099458e-12
mapped O 0 5.300774819083642e-10
to O 0 1.426429720868816e-12
the O 0 1.0783349040088819e-12
canine O 0 1.1840216274094928e-07
chromosome O 0 3.23655939382661e-07
regions O 0 3.4615799116011203e-09
CFA22q11 O 0 1.1752910040740971e-06
and O 0 4.300686543001753e-11
CFA10q26 O 0 1.0847215570208846e-08
, O 0 1.3403332805618506e-13
respectively O 0 8.701169125491237e-12
, O 0 2.9974418655026548e-15
demonstrating O 0 8.952132112861888e-13
that O 0 2.151075541648173e-12
WD B-Disease 0 0.026746951043605804
cannot O 0 2.6576024936275644e-08
be O 0 1.2132875541921717e-13
homologous O 0 4.902595256844888e-13
to O 0 1.0515707228597737e-12
CT B-Disease 0 8.365997928194702e-05
. O 0 3.0858302579872543e-09

The O 0 5.247687007159385e-11
copper O 0 3.3760713336050685e-08
transport O 0 6.157207382839758e-11
genes O 0 6.716914524584894e-11
CTR1 O 0 5.5642367158270645e-08
and O 0 5.907821541001335e-12
CTR2 O 0 1.8400621684122598e-06
were O 0 4.0116941019130437e-11
also O 0 5.87180261010789e-13
excluded O 0 1.3651628438804408e-11
as O 0 1.0838600558781084e-14
candidate O 0 8.191972274140813e-12
genes O 0 1.0869866747149903e-13
for O 0 6.924340289686623e-16
CT B-Disease 0 1.2910481927974615e-06
since O 0 1.6825131865516596e-07
they O 0 2.3312989993334865e-12
both O 0 2.799738996954286e-14
mapped O 0 7.55856444101255e-09
to O 0 1.8442736920976088e-11
canine O 0 1.3726776160183363e-06
chromosome O 0 1.0210549589828588e-05
region O 0 3.2707751529414963e-07
CFA11q22 O 0 7.975981861818582e-05
. O 0 9.994424177151018e-10

2 O 0 5.7034725386984064e-08
- O 0 0.002122970065101981
22 O 0 1.340742517008664e-09
. O 0 2.973163035213666e-11

5 O 0 2.650302910467417e-08
. O 0 1.0134634242930929e-09

A O 0 1.5208685699708013e-10
transcribed O 0 1.858072862237492e-10
sequence O 0 3.1962609642333106e-11
identified O 0 2.8177706695720062e-11
from O 0 7.648038018864822e-14
the O 0 5.1902529989806753e-14
C04107 O 0 7.412468416845286e-09
- O 0 1.4708206208524643e-07
containing O 0 1.9858238664571815e-10
BAC O 0 2.487498989012238e-07
was O 0 9.25804224949367e-11
found O 0 3.908674599262252e-13
to O 0 1.9224991607350028e-14
be O 0 4.0487009361420134e-14
homologous O 0 8.781087564978945e-14
to O 0 1.864843322081297e-14
a O 0 3.144561027583828e-14
gene O 0 2.981653118849792e-11
expressed O 0 1.0368589667408834e-11
from O 0 4.711345788326049e-13
human O 0 1.0549683522598219e-11
chromosome O 0 1.6734956753694519e-09
2p13 O 0 1.538421279256852e-09
- O 0 1.1741820848953921e-08
p16 O 0 3.964344130746866e-11
, O 0 3.356388382285899e-14
a O 0 4.595856572912893e-13
region O 0 6.416287501309625e-10
devoid O 0 7.839306448431671e-08
of O 0 7.90744558590642e-14
any O 0 8.53056254107587e-12
positional O 0 4.678963883009146e-09
candidate O 0 4.3012263972741493e-08
genes O 0 6.0755285247182655e-09
. O 0 7.321898642942415e-11

Molecular O 0 1.7104845317916784e-09
analysis O 0 4.0735793210844307e-11
of O 0 8.785007633458838e-14
the O 0 6.16970599501103e-14
APC B-Disease 0 2.8037821630383375e-12
gene O 0 1.1613597236670437e-11
in O 0 1.4217163416593154e-13
205 O 0 5.390198514311842e-14
families O 0 1.679029772204757e-13
: O 0 7.186873302424471e-14
extended O 0 3.984432575543373e-11
genotype O 0 2.5054814614122733e-05
- O 0 9.376135494676419e-06
phenotype O 0 2.4692139888315978e-08
correlations O 0 1.452890918685057e-09
in O 0 2.0015028046396766e-13
FAP B-Disease 0 5.032077185496142e-12
and O 0 8.079825049243906e-16
evidence O 0 1.0092555961696125e-14
for O 0 1.2343588794188265e-16
the O 0 1.031766465536829e-16
role O 0 8.63094521525408e-14
of O 0 1.7561462097622892e-15
APC B-Disease 0 1.6865928141943098e-12
amino O 0 1.4786782909226304e-13
acid O 0 8.371660027532701e-13
changes O 0 7.320404005195513e-11
in O 0 4.739089490612969e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9944287538528442
. O 0 9.540043421907285e-09

BACKGROUND O 0 4.960453225066885e-06
/ O 0 8.89825813032985e-08
AIMS O 0 1.4811926685176502e-10
The O 0 5.671984353006719e-14
development O 0 3.392162202173199e-12
of O 0 3.1713986459180887e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 9.55520884637906e-10
a O 0 1.1210171246139877e-12
variable O 0 3.525948699678594e-10
range O 0 8.773562605590701e-12
of O 0 3.638799060245307e-13
extracolonic O 0 0.012273315340280533
manifestations O 0 0.04314742237329483
in O 0 3.1105498692340916e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999948740005493
polyposis I-Disease 1 0.9999998807907104
( O 0 1.1432510493847303e-09
FAP B-Disease 0 6.158822341006953e-09
) O 0 4.783695141397093e-13
is O 0 1.2077970188654336e-13
the O 0 5.424623457947562e-15
result O 0 2.9030866252610643e-12
of O 0 3.369021878694197e-15
the O 0 4.129580249805087e-13
dominant O 0 9.037468657879799e-07
inheritance O 0 0.0005682308110408485
of O 0 2.5959407139453106e-06
adenomatous B-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999836683273315
coli I-Disease 1 0.9999991655349731
( O 0 1.8645057719979263e-10
APC B-Disease 0 2.5664279035275683e-10
) O 0 2.6957678710831656e-13
gene O 0 1.183765419021654e-09
mutations O 0 2.463600026203494e-07
. O 0 1.5591697377637104e-10

In O 0 5.654439763635999e-11
this O 0 3.706675469491126e-14
study O 0 1.8370667400485763e-14
, O 0 4.0791574801272656e-17
direct O 0 8.526711373644039e-15
mutation O 0 9.409535650650724e-12
analysis O 0 1.0810031662129502e-13
of O 0 2.058089950294161e-16
the O 0 7.077360497377257e-16
APC B-Disease 0 1.3296109276517837e-13
gene O 0 3.2502594908036253e-13
was O 0 8.60117153281964e-13
performed O 0 3.357286508260532e-13
to O 0 4.34912624306099e-14
determine O 0 3.0468342515632685e-08
genotype O 0 3.101563561358489e-05
- O 0 2.0844106529693818e-06
phenotype O 0 1.0330913902123484e-09
correlations O 0 3.0512842252861105e-11
for O 0 3.1017845084947704e-14
nine O 0 4.4032326070898853e-13
extracolonic O 0 7.951397318350928e-10
manifestations O 0 3.6194300334635443e-10
and O 0 4.352645156737063e-14
to O 0 1.6759886232274178e-15
investigate O 0 2.7554647799576948e-11
the O 0 6.371365674634477e-12
incidence O 0 8.805515108178952e-07
of O 0 2.874038016582002e-14
APC B-Disease 0 1.1015376111256359e-10
mutations O 0 2.345942107240262e-09
in O 0 8.789412253573659e-11
non O 0 0.00033341447124257684
- O 1 0.999984622001648
FAP O 1 0.9997963309288025
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1390730492166767e-07

METHODS O 0 5.077608333792227e-10
The O 0 8.653400261973698e-13
APC B-Disease 0 2.3380332392353154e-11
gene O 0 7.097127746602538e-11
was O 0 6.024997774994878e-12
analysed O 0 2.8609867946949308e-11
in O 0 3.341868543504066e-14
190 O 0 4.062919231194624e-14
unrelated O 0 5.244032205004023e-12
FAP B-Disease 0 1.4345380439095834e-09
and O 0 3.348594179719555e-10
15 O 0 7.367318421991342e-10
non O 0 0.0002580226573627442
- O 1 0.9999933242797852
FAP O 1 0.9999247789382935
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 4.687673360592726e-09
using O 0 3.1023553951486926e-12
denaturing O 0 8.582756549913029e-08
gradient O 0 6.17332602814713e-08
gel O 0 7.114119426887555e-08
electrophoresis O 0 1.9927037797629055e-09
, O 0 1.0034591972456208e-13
the O 0 3.566264511890675e-15
protein O 0 1.8586362646438176e-14
truncation O 0 3.955980508452139e-12
test O 0 5.81144160571867e-11
, O 0 7.316686480250407e-16
and O 0 1.003435251624202e-15
direct O 0 2.8338453545578846e-13
sequencing O 0 1.6118963802602693e-11
. O 0 2.1334860961230717e-11

RESULTS O 0 4.61556339814706e-07
Chain O 0 1.9397492501127545e-09
terminating O 0 1.231333923712441e-10
signals O 0 9.9170260892123e-10
were O 0 6.3524120859359545e-12
only O 0 5.410369418104577e-13
identified O 0 9.359181873946909e-09
in O 0 8.325585360013932e-11
patients O 0 7.411086501429853e-12
belonging O 0 7.663630147147771e-11
to O 0 5.9603381258321875e-12
the O 0 2.736869108080353e-12
FAP B-Disease 0 6.7691896532551254e-09
group O 0 2.080624561529021e-11
( O 0 5.830373754319232e-14
105 O 0 1.280715550971978e-12
patients O 0 3.690981981857577e-12
) O 0 1.351348828844412e-12
. O 0 5.985495432625498e-11

Amino O 0 1.7304688793018386e-09
acid O 0 2.8419908093546553e-10
changes O 0 1.618804049141609e-11
were O 0 1.9026310475039887e-12
identified O 0 5.130619484816634e-09
in O 0 8.418039876278982e-11
four O 0 1.6870248253919584e-11
patients O 0 3.841448860397723e-12
, O 0 1.4085384571758171e-14
three O 0 2.2469392069613542e-14
of O 0 5.087379492283925e-14
whom O 0 3.4062819231905905e-09
belonged O 0 8.089599212723897e-09
to O 0 1.6261630930713977e-11
the O 0 5.820171775083871e-11
non O 0 7.949006999297126e-07
- O 0 9.844154646998504e-07
FAP O 0 1.0367813274569926e-08
group O 0 1.7186078116182557e-09
of O 0 4.899952443793154e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 4.703008926298935e-06
. O 0 3.5110639395874443e-10

Genotype O 1 0.9658817052841187
- O 0 0.13546018302440643
phenotype O 0 1.60846900598699e-06
correlations O 0 4.032172817858282e-09
identified O 0 5.356756704877341e-10
significant O 0 1.4525015738786617e-11
differences O 0 9.660676596467965e-07
in O 0 4.431546796190844e-11
the O 0 7.506937915258485e-14
nature O 0 3.404265064288481e-11
of O 0 4.466822741631396e-15
certain O 0 1.4779853773141949e-12
extracolonic O 0 6.299419652577853e-08
manifestations O 0 2.5013147109120837e-08
in O 0 1.8048449020036106e-12
FAP B-Disease 0 3.977617790695831e-09
patients O 0 5.92651101805064e-12
belonging O 0 1.4451260500758512e-11
to O 0 2.6609445983455382e-12
three O 0 6.123275064079392e-12
mutation O 0 1.4027785155690253e-08
subgroups O 0 4.385531049422298e-09
. O 0 6.735632884780074e-11

CONCLUSIONS O 0 3.5623884286906105e-08
Extended O 0 8.23295764895704e-10
genotype O 0 1.6234341728704749e-06
- O 0 7.270404012160725e-07
phenotype O 0 1.5198050595799373e-09
correlations O 0 1.2010105410187322e-10
made O 0 4.754985467869677e-13
in O 0 1.0969630965303873e-13
this O 0 7.870652168743587e-15
study O 0 1.290478954165536e-13
may O 0 8.459303570129695e-12
have O 0 2.804098548478862e-15
the O 0 7.08554243860104e-17
potential O 0 5.0376037705451154e-14
to O 0 3.2350661591847713e-15
determine O 0 1.7148863926119695e-11
the O 0 5.723100080868085e-15
most O 0 9.268725787965962e-16
appropriate O 0 9.105003636624125e-15
surveillance O 0 2.7150334064307557e-11
and O 0 3.577234604997155e-14
prophylactic O 0 3.441064447273767e-11
treatment O 0 1.2692906621591948e-12
regimens O 0 2.5933909967440494e-12
for O 0 1.9059878204392327e-15
those O 0 1.542258833663046e-12
patients O 0 1.0921905740923776e-13
with O 0 2.1249219086237094e-14
mutations O 0 7.52364304190678e-09
associated O 0 1.2996904663609143e-09
with O 0 5.5223908779211683e-11
life O 0 7.377342967629374e-07
threatening O 0 7.268897024914622e-05
conditions O 0 1.9446925136890059e-07
. O 0 7.170782023724342e-11

This O 0 5.299708154965499e-12
study O 0 3.4435228648578564e-13
also O 0 1.4065458545190488e-15
provided O 0 2.2577496449451885e-16
evidence O 0 1.377863667210771e-14
for O 0 9.588224498087916e-16
the O 0 1.0325037706597224e-14
pathological O 0 4.6885984678057824e-11
nature O 0 7.0317740345771096e-12
of O 0 3.182227185143864e-15
amino O 0 4.824771495954422e-14
acid O 0 3.464992913903772e-14
changes O 0 4.511098932553567e-14
in O 0 7.142457096956118e-15
APC O 0 2.9723150481685e-13
associated O 0 3.146081702445902e-12
with O 0 2.995180329885133e-14
both O 0 1.6030990554125046e-12
FAP B-Disease 0 2.3526902648285386e-09
and O 0 3.3537987942366954e-09
non O 0 0.004110343288630247
- O 1 0.9999942779541016
FAP O 1 0.9999514818191528
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.353283091200865e-07
. O 0 1.2739329990213433e-12
. O 0 5.100501184601702e-12

Inherited B-Disease 1 0.9999247789382935
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.999974250793457
and O 0 2.264562135678716e-05
cancer B-Disease 0 0.09261197596788406
risk O 0 0.00029642871231772006
of O 0 1.4218797580317633e-12
the O 0 1.3060477178916674e-12
APC O 0 4.266528796925684e-10
I1307K O 0 6.036057209612977e-10
polymorphism O 0 1.5583863088863836e-08
. O 0 1.0694178875780835e-10

Germ O 0 0.00043769055628217757
- O 0 0.0010661520063877106
line O 0 4.759425564770936e-08
and O 0 1.6393916389342844e-12
somatic O 0 4.678405926550333e-11
truncating O 0 1.6367197597233485e-09
mutations O 0 1.6975361116777776e-09
of O 0 2.950674169517782e-14
the O 0 1.3444061199041103e-14
APC B-Disease 0 7.139930465437094e-13
gene O 0 2.14181081724385e-12
are O 0 5.777580562409124e-14
thought O 0 1.5244188290158833e-12
to O 0 6.733672864092655e-13
initiate O 0 9.476837476540823e-06
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999483823776245
formation O 0 0.23883625864982605
in O 0 0.0018966076895594597
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.437642933728057e-06
sporadic O 0 0.1427941471338272
colorectal O 1 1.0
carcinogenesis O 1 0.9997808337211609
, O 0 3.822334893044399e-09
respectively O 0 3.356693056844051e-08
. O 0 1.908080637935683e-10

Recently O 0 4.07572251504007e-08
, O 0 4.1807933525740693e-13
an O 0 3.349750015671678e-14
isoleucine O 0 1.8138405266654445e-06
- O 0 0.0002224182680947706
- O 0 1.518289764135261e-06
> O 0 4.998493979835317e-11
lysine O 0 1.1598411467361736e-11
polymorphism O 0 1.1807160804622185e-10
at O 0 1.5160564860797199e-12
codon O 0 1.9707666488316677e-12
1307 O 0 1.310802508203146e-11
( O 0 1.1123849703439047e-15
I1307K O 0 4.4622972309414644e-13
) O 0 1.5706722523349623e-15
of O 0 1.5916744342621327e-15
the O 0 3.11378188315968e-14
APC B-Disease 0 1.1075343116576097e-12
gene O 0 2.0101356343338317e-11
has O 0 1.0931837032823744e-11
been O 0 1.9291340714547994e-13
identified O 0 6.963611545035553e-12
in O 0 1.8753810895714984e-13
6 O 0 4.4140125582403655e-13
% O 0 5.0621555287410497e-14
- O 0 6.4710929947864315e-09
7 O 0 1.0594611125902542e-11
% O 0 8.67686456539063e-14
of O 0 2.122961196757405e-14
the O 0 5.18920887163099e-12
Ashkenazi O 0 5.523952961716816e-10
Jewish O 0 5.383202772435425e-10
population O 0 4.849587745270334e-11
. O 0 3.75637368432713e-11

To O 0 1.8372445925729508e-11
assess O 0 1.2857944930999565e-08
the O 0 3.751045047489798e-12
risk O 0 1.6338571384721945e-08
of O 0 4.6602012105225e-15
this O 0 2.0222962437673256e-14
common O 0 4.273510256606883e-13
APC B-Disease 0 1.6939637192958656e-11
allelic O 0 9.215482821289811e-10
variant O 0 1.3216451577591215e-07
in O 0 2.1082675161210318e-08
colorectal O 1 0.9999997615814209
carcinogenesis O 0 0.08279890567064285
, O 0 4.288949750907989e-10
we O 0 2.5933938330169326e-10
have O 0 7.163771664634236e-14
analyzed O 0 5.630230439854222e-13
a O 0 6.465287289911248e-15
large O 0 7.893495969704678e-13
cohort O 0 7.474991181588564e-10
of O 0 4.576132224889951e-13
unselected O 0 9.575352123647463e-06
Ashkenazi O 0 3.797390490944963e-08
Jewish O 0 9.939071787812281e-09
subjects O 0 3.1477122774958843e-07
with O 0 1.8341450320341623e-12
adenomatous B-Disease 0 1.2597787701906782e-07
polyps I-Disease 0 3.7995530419721035e-06
and O 0 4.615417492637164e-10
. O 0 5.977852240990345e-11
or O 1 0.6924940347671509
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 2.412295189990754e-12
for O 0 1.881089710471166e-15
the O 0 1.3073347912312839e-14
APC O 0 1.0709686609766678e-11
I1307K O 0 7.100147553229519e-11
polymorphism O 0 8.523404204652252e-09
. O 0 9.834891928628409e-11

The O 0 1.4104870917075463e-11
APC O 0 4.200029768419711e-10
I1307K O 0 6.454756174001375e-10
allele O 0 1.5925598617627656e-09
was O 0 3.787539379351834e-11
identified O 0 8.436717297000129e-11
in O 0 6.767768311911893e-13
48 O 0 2.526105409919599e-13
( O 0 5.731576763087732e-15
10 O 0 2.5892465661770878e-14
. O 0 1.1500143031465586e-15
1 O 0 1.5403465246474797e-14
% O 0 3.46620747444684e-15
) O 0 7.91726248600686e-16
of O 0 2.294010860719349e-14
476 O 0 5.715911771675408e-11
patients O 0 2.5577098772266993e-10
. O 0 2.0883585138964378e-10

Compared O 0 2.7592422791045124e-10
with O 0 3.168540869133776e-14
the O 0 5.376870281480206e-14
frequency O 0 2.3780373226145457e-08
in O 0 1.076078896128374e-12
two O 0 8.72458843451801e-15
separate O 0 1.1124376159826754e-12
population O 0 7.072486585095461e-13
control O 0 6.830740972851856e-10
groups O 0 5.816048597589996e-13
, O 0 2.9886505105431024e-15
the O 0 8.684377239413007e-15
APC O 0 5.880704777305734e-12
I1307K O 0 1.2475932613387197e-11
allele O 0 2.6178238396457054e-11
is O 0 2.018824967224206e-13
associated O 0 3.2402336022641087e-12
with O 0 9.969723478850043e-15
an O 0 1.8423791612871658e-14
estimated O 0 2.4784407859357316e-10
relative O 0 1.0953749551845249e-05
risk O 0 0.00037042732583358884
of O 0 1.8999302131561535e-11
1 O 0 2.135124743674055e-09
. O 0 3.494668443515536e-10

5 O 0 6.014710152157932e-08
- O 0 1.78035279532196e-05
1 O 0 6.990206191659354e-10
. O 0 1.306504904263761e-10

7 O 0 2.9861254802199255e-08
for O 0 6.526360007974574e-10
colorectal B-Disease 1 0.9999998807907104
neoplasia I-Disease 1 0.9977814555168152
( O 0 4.532687281066927e-10
both O 0 3.4724101372063387e-10
P O 1 0.6018476486206055
= O 0 1.260038743566838e-06
. O 0 1.3357223313525957e-12
01 O 0 2.5924724172954328e-11
) O 0 6.490619673671372e-14
. O 0 3.873645761792721e-12

Furthermore O 0 6.255630680129798e-09
, O 0 2.7262079312778686e-13
compared O 0 2.42814709311423e-12
with O 0 2.1076859739932105e-14
noncarriers O 0 5.9205127911354793e-08
, O 0 9.735915280353544e-15
APC O 0 3.469756491673859e-13
I1307K O 0 1.1262147464607963e-11
carriers O 0 9.868108066801717e-12
had O 0 2.9721919370118144e-12
increased O 0 1.9170233976628648e-12
numbers O 0 1.6695016679876828e-12
of O 0 5.0648690834908736e-14
adenomas B-Disease 0 3.819771791313542e-06
and O 0 2.1620726329274476e-05
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999958276748657
per O 0 2.692295808515155e-08
patient O 0 1.2755285183629894e-07
( O 0 1.4677875885202307e-12
P O 0 0.00034270124160684645
= O 0 2.196659067976725e-07
. O 0 2.8061881702894087e-13
03 O 0 1.113091910309727e-11
) O 0 7.41497724224098e-15
, O 0 4.996882407495981e-15
as O 0 7.032585234642563e-14
well O 0 2.46717988920675e-12
as O 0 2.0353265242894353e-13
a O 0 6.056544588767254e-12
younger O 0 1.6365089550163248e-07
age O 0 9.10730690861783e-09
at O 0 1.7428223794691e-11
diagnosis O 0 9.671572875902257e-09
. O 0 3.2537611494021235e-11

We O 0 8.416534136301834e-10
conclude O 0 1.7156453341327094e-11
that O 0 4.389325579704732e-15
the O 0 1.6385825894854838e-15
APC O 0 1.5740696506644225e-12
I1307K O 0 9.84263712200395e-12
variant O 0 2.555553338390304e-11
leads O 0 4.534386321281003e-12
to O 0 1.1947307292786702e-12
increased O 0 3.344205978805803e-08
adenoma B-Disease 1 1.0
formation O 0 9.013583053274488e-07
and O 0 1.2810239848060068e-11
directly O 0 8.304769090299036e-13
contributes O 0 8.401813316252782e-13
to O 0 2.321507921879476e-14
3 O 0 5.0178391037538836e-14
% O 0 1.467413769163685e-14
- O 0 2.2689626219540848e-11
4 O 0 1.9503108438130579e-13
% O 0 7.781478234122549e-15
of O 0 6.19811658120477e-15
all O 0 1.4797978120650868e-10
Ashkenazi O 0 1.233941134159977e-06
Jewish O 0 0.237976536154747
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.5469993286387762e-08

The O 0 1.1080335433899524e-11
estimated O 0 1.9032090139980973e-11
relative O 0 3.868438902543403e-09
risk O 0 1.6905737254546693e-08
for O 0 4.0318879420027376e-13
carriers O 0 2.209271432462856e-09
may O 0 1.434246558323915e-11
justify O 0 1.5889348213907195e-12
specific O 0 1.640710103314926e-14
clinical O 0 4.490159346361199e-15
screening O 0 1.3463819936601704e-14
for O 0 4.241848885016522e-16
the O 0 1.3977311002743285e-15
360 O 0 2.634216985302829e-15
, O 0 7.390123177986171e-16
000 O 0 5.6810462502896245e-14
Americans O 0 2.625491783616457e-13
expected O 0 3.5440945425797843e-13
to O 0 1.079074489132711e-14
harbor O 0 2.571963995945392e-11
this O 0 7.534853410694556e-14
allele O 0 7.147397365799002e-13
, O 0 3.8188528072563414e-16
and O 0 2.2715820635507656e-15
genetic O 0 1.0028112238172349e-12
testing O 0 1.8412534951578463e-12
in O 0 2.123876500560208e-14
the O 0 7.851609174023416e-15
setting O 0 1.127924351140841e-10
of O 0 4.148084328282897e-13
long O 0 4.986044466193107e-09
- O 0 4.161939796176739e-05
term O 0 4.152029191573092e-07
- O 0 1.999775278704874e-08
outcome O 0 2.2004880556592e-11
studies O 0 7.474082117098213e-13
may O 0 5.174558698195497e-13
impact O 0 6.291770490024495e-12
significantly O 0 5.337076558475928e-09
on O 0 0.3099362850189209
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 1.6005920770112425e-05
in O 0 6.412191741120288e-13
this O 0 7.32761494168753e-14
population O 0 8.127690686275668e-13
. O 0 1.3848002605731935e-11

Localization O 0 3.331397024908256e-08
of O 0 7.029825940113588e-13
human O 0 1.3288257213334154e-12
BRCA1 O 0 9.108709897454048e-10
and O 0 6.10545511717242e-12
its O 0 8.201864751603005e-13
loss O 0 6.020492548941547e-09
in O 0 1.1198637503428976e-11
high O 0 1.6526342960787588e-08
- O 0 0.003091806313022971
grade O 0 1.643843347665097e-06
, O 0 1.4255193379886233e-11
non B-Disease 0 1.4046430806047283e-05
- I-Disease 1 0.9989110231399536
inherited I-Disease 1 0.9991611242294312
breast I-Disease 1 0.9999392032623291
carcinomas I-Disease 1 1.0
. O 0 5.394852564677421e-07

Although O 0 8.959007841147226e-11
the O 0 3.129548215626693e-14
link O 0 2.1957840060093936e-11
between O 0 5.668550698278985e-12
the O 0 2.330713226583736e-11
BRCA1 O 0 1.9645312931970693e-05
tumour B-Disease 1 0.9999998807907104
- O 0 5.721558977711538e-07
suppressor O 0 5.520500501177139e-09
gene O 0 1.8476745822226803e-07
and O 0 1.1506791963711294e-07
hereditary B-Disease 1 0.9999996423721313
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 2.1399290517365444e-07
established O 0 3.7777329008059635e-12
, O 0 3.56834493068825e-16
the O 0 3.5828421642783036e-17
role O 0 5.521510982806066e-13
, O 0 3.157631465937967e-15
if O 0 1.0697795053233802e-13
any O 0 2.6394488537081345e-14
, O 0 6.577025017576838e-16
of O 0 2.6349003291330263e-15
BRCA1 O 0 3.1983253823142377e-09
in O 0 4.7326487617738167e-08
non B-Disease 1 0.9268156290054321
- I-Disease 1 0.9999927282333374
familial I-Disease 1 0.9999580383300781
cancers I-Disease 1 0.9999842643737793
is O 0 2.509446650478253e-09
unclear O 0 3.766285061601593e-09
. O 0 2.4887283206487254e-11

BRCA1 O 0 0.00033610532409511507
mutations O 0 3.166884198435582e-05
are O 0 3.941640416837977e-12
rare O 0 2.5768265299319637e-10
in O 0 7.140006641481733e-11
sporadic B-Disease 0 0.0003979422908741981
cancers I-Disease 1 0.9999970197677612
, O 0 1.0565315289312593e-10
but O 0 5.167218875001822e-10
loss O 0 1.1402452593234358e-10
of O 0 1.0733515110245874e-14
BRCA1 O 0 5.623134180510192e-10
resulting O 0 8.863081102372661e-11
from O 0 3.315557203786845e-11
reduced O 0 3.236052847910287e-08
expression O 0 1.654763934766379e-07
or O 0 8.246635374575817e-09
incorrect O 0 2.4735223647098792e-08
subcellular O 0 3.711941420903031e-09
localization O 0 6.199890600910862e-11
is O 0 8.631829856464192e-15
postulated O 0 3.156045032520066e-13
to O 0 1.0245000716378218e-14
be O 0 8.83609388457364e-14
important O 0 1.8383643945237699e-13
in O 0 1.6402627867062591e-10
non B-Disease 0 0.00029152483330108225
- I-Disease 1 0.9996440410614014
familial I-Disease 1 0.9999921321868896
breast I-Disease 1 0.9999998807907104
and I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 2.124067890463266e-07

Epigenetic O 0 1.4360836757987272e-05
loss O 0 0.001088940305635333
, O 0 3.3840974727333828e-12
however O 0 7.97803489938076e-12
, O 0 1.2297877560046855e-13
has O 0 3.625886700261982e-12
not O 0 5.808419337952758e-14
received O 0 2.5940796938224734e-15
general O 0 9.94510954843578e-15
acceptance O 0 2.6860111357329686e-13
due O 0 1.3776785701830052e-12
to O 0 3.8794905195217375e-14
controversy O 0 7.083671843544082e-11
regarding O 0 1.0183497795024365e-10
the O 0 2.591985328627422e-13
subcellular O 0 5.869303376648816e-10
localization O 0 2.0340321441048026e-11
of O 0 7.46740604057718e-15
BRCA1 O 0 2.038996575748353e-11
proteins O 0 3.5383531499753873e-13
, O 0 9.130115622411374e-15
reports O 0 6.080655076678987e-12
of O 0 2.231005839597143e-14
which O 0 2.4755765146156072e-11
have O 0 1.3116077668406945e-11
ranged O 0 3.5766825612348896e-10
from O 0 1.173566127089798e-12
exclusively O 0 9.887561880361773e-10
nuclear O 0 7.072986772982404e-05
, O 0 9.808982036449594e-15
to O 0 1.463090513000899e-14
conditionally O 0 5.582799847414499e-11
nuclear O 0 1.8841557647419904e-08
, O 0 2.3174620266552684e-16
to O 0 1.0742520764541082e-15
the O 0 9.017556802182539e-14
ER O 0 8.712243371178374e-09
/ O 0 1.3086896843983453e-10
golgi O 0 3.501151452089957e-11
, O 0 1.5126061956249014e-14
to O 0 1.4345892095785073e-14
cytoplasmic O 0 1.581162804853431e-11
invaginations O 0 1.681431349709328e-08
into O 0 2.8817367329209143e-12
the O 0 4.108589770485116e-12
nucleus O 0 1.6566091554093276e-10
. O 0 1.3325548130216358e-11

In O 0 5.834473529309214e-12
an O 0 2.4145838831786306e-15
attempt O 0 1.5409130568744267e-11
to O 0 9.564060481082048e-12
resolve O 0 2.4738243453725772e-08
this O 0 5.292815881755009e-13
issue O 0 4.059116653909456e-10
, O 0 1.7445624412855236e-14
we O 0 3.6083629573885334e-12
have O 0 2.3916047094119097e-13
comprehensively O 0 5.707787575914836e-10
characterized O 0 7.688343711675927e-11
19 O 0 3.537816914422898e-11
anti O 0 1.1061499805009589e-07
- O 0 0.0005262054037302732
BRCA1 O 0 1.3974405987937644e-07
antibodies O 0 1.78501267100728e-08
. O 0 2.3137181406895913e-11

These O 0 3.449934348614958e-12
reagents O 0 1.5256654273265724e-10
detect O 0 2.4042328128359713e-09
a O 0 1.6126982561870395e-12
220 O 0 3.5897324609374115e-12
- O 0 2.2754049755491224e-09
kD O 0 4.9867385776281026e-09
protein O 0 9.305003816073576e-12
localized O 0 1.7441667554685125e-10
in O 0 1.4300500887631795e-12
discrete O 0 3.174693563590125e-10
nuclear O 0 4.89663591451972e-07
foci O 0 3.1879125117484364e-08
in O 0 2.070079177518558e-11
all O 0 4.64677081535303e-12
epithelial O 0 3.289434147291104e-08
cell O 0 7.357943445640558e-07
lines O 0 1.4557967631390056e-07
, O 0 2.5241774951690124e-14
including O 0 5.097070311530167e-15
those O 0 7.442937461016666e-14
derived O 0 2.2688359437722516e-12
from O 0 7.446512850783904e-11
breast B-Disease 0 0.0016750945942476392
malignancies I-Disease 0 0.2947509288787842
. O 0 7.265452683924423e-09

Immunohistochemical O 0 3.1967833820090163e-06
staining O 0 7.718504093645606e-07
of O 0 1.5772621056453495e-11
human O 0 9.45055367296277e-10
breast O 0 0.07918987423181534
specimens O 0 0.001104680704884231
also O 0 1.1144106082383587e-08
revealed O 0 1.4991327589086723e-05
BRCA1 O 0 2.11176234188315e-06
nuclear O 0 1.2323358760113479e-06
foci O 0 3.6024363225806155e-07
in O 0 3.5195370923224445e-11
benign O 0 0.00041962284012697637
breast O 0 0.40753015875816345
, O 0 2.9827142977723042e-09
invasive B-Disease 1 0.6715348958969116
lobular I-Disease 1 0.9999746084213257
cancers I-Disease 1 0.9999998807907104
and O 0 0.0066399239003658295
low B-Disease 1 0.9999579191207886
- I-Disease 1 0.9999784231185913
grade I-Disease 1 0.8664465546607971
ductal I-Disease 1 0.997307538986206
carcinomas I-Disease 1 1.0
. O 0 1.3073845366307069e-06

Conversely O 0 1.0934527239214731e-07
, O 0 1.024841236180185e-12
BRCA1 O 0 1.3960461675566194e-09
expression O 0 2.6204054037748392e-08
was O 0 2.8504285598529577e-09
reduced O 0 5.157559379576071e-10
or O 0 4.0283426594456273e-10
undetectable O 0 6.730633117513207e-08
in O 0 9.784396058122591e-14
the O 0 4.616509133520755e-14
majority O 0 1.8004757407208416e-11
of O 0 9.96631683430893e-12
high O 0 8.654074008518364e-06
- O 1 0.886680543422699
grade O 0 6.081245373934507e-06
, O 0 3.5425280330708686e-12
ductal B-Disease 0 1.340241624347982e-06
carcinomas I-Disease 1 1.0
, O 0 1.5686936125081097e-11
suggesting O 0 5.509098510714239e-09
that O 0 1.252451701377888e-12
absence O 0 8.330791785582381e-12
of O 0 1.6966286773938133e-14
BRCA1 O 0 2.3021771988762652e-10
may O 0 2.7531428525850998e-11
contribute O 0 1.2563940773174798e-13
to O 0 3.322021206297182e-14
the O 0 3.5202164127461424e-14
pathogenesis O 0 1.1549889517015188e-11
of O 0 6.236749118654328e-16
a O 0 1.6523551122737783e-14
significant O 0 6.9296920632289094e-12
percentage O 0 1.155618519987911e-06
of O 0 3.192433296883568e-12
sporadic B-Disease 0 0.028191812336444855
breast I-Disease 1 0.9999980926513672
cancers I-Disease 1 0.999997615814209
. O 0 2.2148491929385727e-09
. O 0 1.48080853135113e-10

